id|nct_id|pi_employee|agreement
78|NCT03489551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
79|NCT03405818|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
80|NCT03363633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
81|NCT03350724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
82|NCT03349099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
83|NCT03292692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
84|NCT03271424|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
85|NCT03256552|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
86|NCT03255733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
87|NCT03255655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
88|NCT03254602|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
89|NCT03247985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
90|NCT03238924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
91|NCT03238001|Principal Investigators are NOT employed by the organization sponsoring the study.|
92|NCT03235817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
93|NCT03231371|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
94|NCT03225001|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
95|NCT03218163|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
96|NCT03191552|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
97|NCT03182582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
98|NCT03163134|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
99|NCT03159143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
100|NCT03157232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
101|NCT03151226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4766|NCT01911403|Principal Investigators are NOT employed by the organization sponsoring the study.|
102|NCT03134326|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
103|NCT03134313|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
104|NCT03128307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
105|NCT03125031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
106|NCT03125018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
107|NCT03125005|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
108|NCT03124979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
109|NCT03124966|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
110|NCT03124927|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
111|NCT03124901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
112|NCT03124836|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
113|NCT03124823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
114|NCT03124797|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
115|NCT03124784|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
116|NCT03124771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
117|NCT03124758|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
118|NCT03124693|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
119|NCT03124199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
120|NCT03119831|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
121|NCT03115853|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
122|NCT03109769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
123|NCT03106870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
124|NCT03106337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
125|NCT03105518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
126|NCT03098966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
127|NCT03091751|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the study, after providing Sponsor 30 days’ notice prior to submitting a manuscript or other materials related to the study to any outside party. At Sponsor’s request, site will remove any confidential information (other than study results) and site will, upon Sponsor’s request, delay publication or presentation for a period of up to 120 days to allow Sponsor to protect its interests in any Sponsor interventions.
128|NCT03073798|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
129|NCT03072719|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
130|NCT03070730|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
131|NCT03069313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
132|NCT03065933|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
133|NCT03061513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
134|NCT03057704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
135|NCT03055221|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the Study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
136|NCT03054103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
137|NCT03054077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
138|NCT03052530|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
139|NCT03050775|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
140|NCT03048383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
141|NCT03048006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
142|NCT03047447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
143|NCT03046225|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
144|NCT03046212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
145|NCT03044431|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
146|NCT03043534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
147|NCT03041298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
148|NCT03039543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
149|NCT03039179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
150|NCT03037905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
151|NCT03037541|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
152|NCT03035955|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
153|NCT03035916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
154|NCT03032965|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
155|NCT03028987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
156|NCT03028025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
157|NCT03026803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
158|NCT03024112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
159|NCT03023709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
160|NCT03023683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
161|NCT03023553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
162|NCT03023488|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
163|NCT03023176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
164|NCT03023137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
165|NCT03022435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
166|NCT03022422|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
167|NCT03022396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
168|NCT03021343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
169|NCT03021304|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
170|NCT03020576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3090|NCT02117544|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
171|NCT03020537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
172|NCT03020498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
173|NCT03020472|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
174|NCT03020004|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Ascletis, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The study has been completed at all study sites for at least 3 years."
175|NCT03019783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
176|NCT03018106|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
177|NCT03017612|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agreed to hold this information in confidence and not to disclose it to any third parties for a period of three years from the date of this agreement, or until this information becomes a matter of public knowledge or until a formal agreement for that purpose has been entered into by the parties.
178|NCT03016078|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
179|NCT03011099|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
180|NCT03010800|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
181|NCT03005041|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
182|NCT03002454|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
183|NCT03001674|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
184|NCT03001258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
185|NCT03000088|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
186|NCT02997904|Principal Investigators are NOT employed by the organization sponsoring the study.|Not without sponsor permission
187|NCT02990910|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
188|NCT02988882|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
189|NCT02988622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
190|NCT02988219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
191|NCT02987868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
192|NCT02987374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
193|NCT02987205|Principal Investigators are NOT employed by the organization sponsoring the study.|There are restrictions within the site contracts that the sites cannot publish any results and also have confidentiality agreements in place separately that restrict any publications by sites regarding results, findings, etc.
194|NCT02986282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14699|NCT01104155|Principal Investigators are NOT employed by the organization sponsoring the study.|
195|NCT02984878|Principal Investigators are NOT employed by the organization sponsoring the study.|There are restrictions within the site contracts, sites cannot publish any results and also have confidentiality agreements in place separately that restrict any publications by sites regarding results, findings, etc.
196|NCT02983981|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
197|NCT02977572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
198|NCT02974543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
199|NCT02971670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
200|NCT02968173|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
201|NCT02967393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
202|NCT02967354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
203|NCT02966509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
204|NCT02966015|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
205|NCT02966002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
206|NCT02965833|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
207|NCT02965820|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
208|NCT02964767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
209|NCT02962882|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
210|NCT02961244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
211|NCT02959840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
212|NCT02958995|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
213|NCT02958956|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
214|NCT02958787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
215|NCT02958345|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
216|NCT02956460|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the PI is that the sponsor should be notified of any use of study data for results communication.
15061|NCT01079949|Principal Investigators are NOT employed by the organization sponsoring the study.|
217|NCT02951767|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
218|NCT02951702|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
219|NCT02951312|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
220|NCT02951273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
221|NCT02949141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
222|NCT02948582|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
223|NCT02947984|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
224|NCT02947022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
225|NCT02945254|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
226|NCT02943226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
227|NCT02943213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
228|NCT02941640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
229|NCT02939170|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
230|NCT02937870|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
231|NCT02937623|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
232|NCT02937506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
233|NCT02934347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
234|NCT02933476|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
235|NCT02928380|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
236|NCT02923245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
237|NCT02922868|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
238|NCT02921412|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the PI is that the sponsor should be notified of any results communications and has ability to review.
239|NCT02921386|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
240|NCT02921295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
241|NCT02920957|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the PI is that the sponsor should be notified of any results communications and has ability to review.
242|NCT02920749|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
243|NCT02919657|Principal Investigators are NOT employed by the organization sponsoring the study.|
244|NCT02918396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
245|NCT02915978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
246|NCT02915302|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
247|NCT02914236|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication of study results shall be made in conjunction with the results from all clinical study centers participating in the multicenter study. If results of the multi-center study have not been published in full within 18 months after completion of the study, investigator shall be free to publish results. Investigator agrees to submit all proposed publications to the sponsor at least 60 days prior submission; the company has the right to comment.
248|NCT02912650|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
249|NCT02910362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
250|NCT02908269|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
251|NCT02907268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
252|NCT02903238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
253|NCT02901054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
254|NCT02895347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
255|NCT02891863|Principal Investigators are NOT employed by the organization sponsoring the study.|This an early-stage feasibility study with significant intellectual property value to the sponsor. The sponsor controls access to the data and no publications can be submitted without the sponsors approval. Since the study was stopped early due to futility it may not be publishable, but preliminary data was submitted via abstract for presentation at Heart Rhythm 2017.
256|NCT02890303|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
257|NCT02889289|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
258|NCT02886338|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
259|NCT02884427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
260|NCT02882152|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
261|NCT02881658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
262|NCT02877732|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
263|NCT02877082|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
264|NCT02876757|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
265|NCT02874846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
266|NCT02873429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
267|NCT02873104|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
268|NCT02871375|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
269|NCT02870205|Principal Investigators are NOT employed by the organization sponsoring the study.|Per the agreement, Sponsor reserves the right for publishing trial results and the Investigator cannot publish without written consent from the CRO/Sponsor.
270|NCT02869451|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
271|NCT02867150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
272|NCT02865083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
273|NCT02864732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
274|NCT02863198|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
275|NCT02862730|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
276|NCT02862600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
277|NCT02862106|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators can't publish articles relevant to the study unless the sponsor permits.
278|NCT02856880|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
279|NCT02855411|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
280|NCT02855086|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
281|NCT02852434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
282|NCT02851823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
283|NCT02850159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
284|NCT02849678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4522|NCT01938989|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
285|NCT02848222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
286|NCT02847260|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the Study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed, except as provided below. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
287|NCT02847169|Principal Investigators are NOT employed by the organization sponsoring the study.|
288|NCT02844998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
289|NCT02844543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
290|NCT02840916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
291|NCT02839772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
292|NCT02838901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
293|NCT02837952|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
294|NCT02836249|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
295|NCT02836236|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
296|NCT02834624|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
297|NCT02832674|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
298|NCT02832375|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
299|NCT02831660|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
300|NCT02829996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
301|NCT02829983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
302|NCT02829775|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
303|NCT02829463|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
304|NCT02829138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
305|NCT02828137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
306|NCT02826551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
307|NCT02826421|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
308|NCT02824913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
309|NCT02823964|Principal Investigators are NOT employed by the organization sponsoring the study.|
310|NCT02823080|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
311|NCT02822885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
312|NCT02822287|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
313|NCT02821403|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
314|NCT02818244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
315|NCT02817763|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
316|NCT02815735|Principal Investigators are NOT employed by the organization sponsoring the study.|
317|NCT02815397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
318|NCT02814643|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 30 days prior to submission for publication/presentation, Institution and PI shall jointly provide AZ with material for review. No publication/presentation may include any of AZ's Confidential Information without AZ's written approval. AZ can request Institution and PI to withhold material from submission for publication/presentation for an additional 90 days to allow AZ to establish and preserve its proprietary rights in the material being submitted for publication/presentation.
319|NCT02814279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
320|NCT02814227|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
321|NCT02813070|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI and/or institution is that the Sponsor can review results communications prior to public release and can restrict communications regarding trial results for a period that is more than 30 days (publications/abstracts) but not to exceed 90 days (patent related issues) from the time submitted to the Sponsor to review. The PI may be asked to remove any Sponsor confidential information and/or delay publication to protect any proprietary information.
322|NCT02811965|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
323|NCT02810873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
324|NCT02809911|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication Rights. Independent analysis and/or publication of data is not permitted without the prior written consent of the sponsor. Such consent may be contingent on sponsor review and approval of any proposed analysis and manuscript. Institution will retain the right to review and analyze the database created from this study for its own scientific purposes so long as such scientific purposes are non-commercial in nature.
325|NCT02809833|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
326|NCT02808130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15939|NCT01022112|Principal Investigators are NOT employed by the organization sponsoring the study.|
327|NCT02806869|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
328|NCT02806544|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
329|NCT02806505|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
330|NCT02805907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
331|NCT02802878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
332|NCT02802592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
333|NCT02802449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
334|NCT02801396|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
335|NCT02801006|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the PI is that the sponsor should be notified of any results communications and has ability to review.
336|NCT02800213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
337|NCT02799082|Principal Investigators are NOT employed by the organization sponsoring the study.|A publication or presentation of the study results may be planned and initiated by everybody of the scientific personnel involved in this clinical trial but not before the integrated report has been issued. Each party generating the manuscript for publication should allow the other parties a sufficient time in which to review and comment upon the prepublication manuscript.
338|NCT02799069|Principal Investigators are NOT employed by the organization sponsoring the study.|The publication of study results requires Biofrontera's acceptance. Investigators can claim an authorship if they have completely treated and documented at least 35 patients. Planned publications and presentations of investigations which are within the scope of the clinical study should be previously presented to Biofrontera for a statement.
339|NCT02798289|Principal Investigators are NOT employed by the organization sponsoring the study.|The data provided by this clinical trial, and all related information and any materials containing such data and information, are the exclusive property of Oculeve and are confidential to Oculeve. The investigator or other study-related personnel may not disclose to anyone or use any data, information, or materials related to this clinical trial without the express written consent of Oculeve.
340|NCT02797080|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights.
341|NCT02796963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
342|NCT02796651|Principal Investigators are NOT employed by the organization sponsoring the study.|All clinical study findings and documents will be regarded as confidential. The investigator and members of his/her research team must not disclose such information without prior written approval from the sponsor.
343|NCT02796352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
344|NCT02796092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
345|NCT02794844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
346|NCT02794480|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
347|NCT02793947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20636|NCT00752128|Principal Investigators are NOT employed by the organization sponsoring the study.|
348|NCT02793154|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
349|NCT02792062|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
350|NCT02792049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
351|NCT02791659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
352|NCT02791269|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
353|NCT02790281|Principal Investigators are NOT employed by the organization sponsoring the study.|Manuscripts or abstracts will be prepared in collaboration between Ferring and the Investigators.
354|NCT02788357|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
355|NCT02788097|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
356|NCT02787564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
357|NCT02786927|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
358|NCT02786810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
359|NCT02786771|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
360|NCT02786004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
361|NCT02784925|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
362|NCT02784106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
363|NCT02782676|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results.
364|NCT02782169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
365|NCT02781818|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
366|NCT02781649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
367|NCT02780622|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
368|NCT02780349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
392|NCT02761733|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
369|NCT02780167|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
370|NCT02777931|Principal Investigators are NOT employed by the organization sponsoring the study.|The information generated by this study is the property of Medgenics. Publication or other public presentation of NFC-1 data resulting from this study requires prior review and written approval of Medgenics. Abstracts, manuscripts, and presentation materials should be provided to Medgenics for review at least 30 days prior to the relevant submission deadline.
371|NCT02777268|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must obtain written consent from the Sponsor prior to any publication of results.
372|NCT02777242|Principal Investigators are NOT employed by the organization sponsoring the study.|
373|NCT02777125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
374|NCT02774343|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
375|NCT02774278|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
376|NCT02774148|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
377|NCT02773758|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
378|NCT02772666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
379|NCT02770625|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
380|NCT02770248|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
381|NCT02769858|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
382|NCT02768194|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
383|NCT02767843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
384|NCT02767765|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
385|NCT02766400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
386|NCT02766283|Principal Investigators are NOT employed by the organization sponsoring the study.|
387|NCT02766244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
388|NCT02765269|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
389|NCT02764970|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
390|NCT02763189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
391|NCT02762370|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
393|NCT02761629|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
394|NCT02760810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
395|NCT02760654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
396|NCT02759692|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
397|NCT02759471|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigator and the Sponsor that restricts the PI's rights to discuss or publish trial results after the trial is completed.
398|NCT02758613|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
399|NCT02758210|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
400|NCT02758171|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
401|NCT02757053|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
402|NCT02756637|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
403|NCT02756624|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
404|NCT02756351|Principal Investigators are NOT employed by the organization sponsoring the study.|"As stated in the Clinical Investigation Plan (CIP):~The Principal Investigator may publish results from this investigation; however as some of the information regarding the investigational medical device and development activities may be of a strictly confidential nature, the Sponsor must first be given the opportunity to review any publication manuscript prior to submission to journals, meetings or conferences."
405|NCT02755935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
406|NCT02755805|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
407|NCT02755090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
408|NCT02754492|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor retains the right to review and comment on any public disclosure of study results. If no response is received within 30 days, the Principal Investigator may presume that the submission for publication may proceed without delay. If the Sponsor asks to defer publication, Study Site shall not publish, or otherwise disclose to any third party, any of the information contained in the publication or presentation until such time as permission is granted from the Sponsor.
409|NCT02754440|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor retains the right to review and comment on any public disclosure of study results. If no response is received within 30 days, the Principal Investigator may presume that the submission for publication may proceed without delay. If the Sponsor asks to defer publication, Study Site shall not publish, or otherwise disclose to any third party, any of the information contained in the publication or presentation until such time as permission is granted from the Sponsor.
410|NCT02753699|Principal Investigators are NOT employed by the organization sponsoring the study.|
411|NCT02753413|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
412|NCT02753075|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
413|NCT02752802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
414|NCT02752633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
415|NCT02752490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
416|NCT02751450|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
417|NCT02751320|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
418|NCT02750943|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
419|NCT02750930|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
420|NCT02750813|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
421|NCT02750709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
422|NCT02750345|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
423|NCT02750332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
424|NCT02750267|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
425|NCT02748213|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
426|NCT02746809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
427|NCT02746679|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
428|NCT02746406|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release regarding trial results for a period that is less than 60 days. The sponsor can request changes to the communication.
429|NCT02746107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
430|NCT02745626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
431|NCT02745392|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
432|NCT02743962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
433|NCT02743936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
434|NCT02743780|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
435|NCT02743702|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
436|NCT02743117|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises on-going studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
437|NCT02742987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
438|NCT02742818|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
439|NCT02741245|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
440|NCT02739698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
441|NCT02739594|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
442|NCT02739321|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
443|NCT02738853|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
444|NCT02738333|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
445|NCT02738138|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
446|NCT02737852|Principal Investigators are NOT employed by the organization sponsoring the study.|Master service agreement and confidentiality agreement in place
447|NCT02737631|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidentiality agreement in place with PIs.
448|NCT02737618|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidentiality agreement in place with PI
449|NCT02737592|Principal Investigators are NOT employed by the organization sponsoring the study.|Master service agreement and confidentiality agreement in place
450|NCT02736721|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
451|NCT02736175|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
452|NCT02735200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
453|NCT02734940|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
454|NCT02734810|Principal Investigators are NOT employed by the organization sponsoring the study.|
455|NCT02734355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
456|NCT02734212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
457|NCT02734056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5341|NCT01849692|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
458|NCT02732899|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
459|NCT02732639|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
460|NCT02732561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
461|NCT02732327|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
462|NCT02732210|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
463|NCT02731833|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
464|NCT02731313|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
465|NCT02731300|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
466|NCT02731131|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
467|NCT02730819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
468|NCT02730351|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
469|NCT02730260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
470|NCT02727816|Principal Investigators are NOT employed by the organization sponsoring the study.|
471|NCT02726971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
472|NCT02726178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
473|NCT02726022|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
474|NCT02725788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
475|NCT02724644|Principal Investigators are NOT employed by the organization sponsoring the study.|
476|NCT02724449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
477|NCT02724111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5890|NCT01790685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is a restriction on the PI regarding disclosure of study results, which will be updated once the manuscript is published.
478|NCT02723201|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
479|NCT02723188|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
480|NCT02722967|Principal Investigators are NOT employed by the organization sponsoring the study.|Until the information herein is released by Otsuka to the public domain, the contents of this document are Otsuka confidential information and should not be duplicated or re-distributed without prior written consent of Otsuka.
481|NCT02722564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
482|NCT02722278|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
483|NCT02722239|Principal Investigators are NOT employed by the organization sponsoring the study.|PI signed the Protocol and agreed to conform fully to the Protocol requirements. According to the Protocol the PI should inform the Sponsor in writing beforehand and provide the sponsor with all manuscripts or abstracts before submitting them to the editorial office or scientific expert board, and obtain a written permission from the Sponsor. The period is not mentioned.
484|NCT02722044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
485|NCT02721641|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
486|NCT02721277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
487|NCT02720952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
488|NCT02718898|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosures are prohibited until after the sponsor discloses the primary and secondary publications of clinical trial data.
489|NCT02717754|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
490|NCT02716779|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
491|NCT02716714|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
492|NCT02716298|Principal Investigators are NOT employed by the organization sponsoring the study.|
493|NCT02714062|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may publish the result of the study 12 months or longer after termination of the study. The PI will provide the sponsor a copy of any proposed publication at least 30 days prior to submission for publication
494|NCT02713594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
495|NCT02713256|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
496|NCT02712333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
497|NCT02712099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
498|NCT02711995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
499|NCT02710630|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
500|NCT02710292|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
501|NCT02709577|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
502|NCT02709096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
503|NCT02708524|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
504|NCT02708355|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
505|NCT02708277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
506|NCT02708238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
507|NCT02708212|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
508|NCT02707640|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
509|NCT02707172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
510|NCT02706327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
511|NCT02705807|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
512|NCT02705716|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
513|NCT02705365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
514|NCT02704689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
515|NCT02703948|Principal Investigators are NOT employed by the organization sponsoring the study.|Any and all data resulting from the Study will not be presented or published in any form or media by the PI without the prior written consent of the Sponsor.
516|NCT02702011|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
517|NCT02701556|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
518|NCT02701387|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
519|NCT02701361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
520|NCT02701296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
521|NCT02701270|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot release information without the sponsor's approval.
522|NCT02699892|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
523|NCT02699684|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
524|NCT02699632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
525|NCT02699593|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
526|NCT02698566|Principal Investigators are NOT employed by the organization sponsoring the study.|Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
527|NCT02698436|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
528|NCT02698423|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
529|NCT02697890|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
530|NCT02696317|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
531|NCT02696291|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
532|NCT02696226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
533|NCT02696083|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication Rights. Independent analysis and/or publication of data generated or arising from the performance of this Agreement is not permitted without the prior written consent of Regenesis. Such consent may be contingent on Regenesis' review and approval of any proposed analysis and manuscript. Institution will retain the right to review and analyze the database created from this study for its own scientific purposes so long as such scientific purposes are non-commercial in nature.
534|NCT02696070|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication Rights. Independent analysis and/or publication of data generated or arising from the performance of this Agreement is not permitted without the prior written consent of Regenesis. Such consent may be contingent on Regenesis' review and approval of any proposed analysis and manuscript. Institution will retain the right to review and analyze the database created from this study for its own scientific purposes so long as such scientific purposes are non-commercial in nature.
535|NCT02695446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
536|NCT02695290|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
537|NCT02694744|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements generally provide that PI cannot publish single site data before publication of the multi-site publication, unless 1 year has elapsed since completion of the study at all sites. Thereafter, PI may publish provided that PI shall: provide a copy of the publication to sponsor at least 60 days in advance of submission for publication; delete sponsor’s confidential information as requested; and delay publication up to an additional 90 days to permit protection of intellectual property.
560|NCT02684630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
538|NCT02694718|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
539|NCT02694536|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
540|NCT02694315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
541|NCT02694198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
542|NCT02693704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
543|NCT02692859|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
544|NCT02692703|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
545|NCT02692560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
546|NCT02692495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
547|NCT02691507|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigators agreed not to publish the study results without prior sponsor approval.
548|NCT02691416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
549|NCT02691143|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
550|NCT02690935|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
551|NCT02690727|Principal Investigators are NOT employed by the organization sponsoring the study.|
552|NCT02689804|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
553|NCT02689206|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
554|NCT02687217|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
555|NCT02687126|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
556|NCT02686437|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
557|NCT02685488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
558|NCT02685202|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
559|NCT02684942|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
561|NCT02684604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
562|NCT02684396|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
563|NCT02684188|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
564|NCT02683954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
565|NCT02683746|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
566|NCT02683707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
567|NCT02683577|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI will provide the sponsor with any results communications for public release at least 90 days prior to the planned submission for their review.
568|NCT02682498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
569|NCT02681510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
570|NCT02681458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
571|NCT02679976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
572|NCT02679469|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
573|NCT02678923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
574|NCT02678676|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
575|NCT02678286|Principal Investigators are NOT employed by the organization sponsoring the study.|Discussion and/or publication of data generated is not permitted without the prior written consent of the sponsor.
576|NCT02678039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
577|NCT02677779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
578|NCT02677493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
579|NCT02675907|Principal Investigators are NOT employed by the organization sponsoring the study.|Discussion and/or publication of data generated is not permitted without the prior written consent of the sponsor.
580|NCT02675634|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
581|NCT02675543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
582|NCT02674334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
606|NCT02664987|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator may not publish the results of the study without prior approval from Mundipharma.
583|NCT02673944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
584|NCT02673619|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
585|NCT02673489|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
586|NCT02672514|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
587|NCT02671760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
588|NCT02670811|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
589|NCT02670473|Principal Investigators are NOT employed by the organization sponsoring the study.|
590|NCT02670343|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
591|NCT02669095|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
592|NCT02669043|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
593|NCT02668952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
594|NCT02668822|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
595|NCT02668783|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
596|NCT02667821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
597|NCT02667704|All Principal Investigators ARE employed by the organization sponsoring the study.|
598|NCT02667288|Principal Investigators are NOT employed by the organization sponsoring the study.|The institution and Investigator agree not to publish the results of this study without the prior written consent of the Sponsor
599|NCT02667275|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution and Investigator agree not to publish the results of this study without the prior written consent of the Sponsor.
600|NCT02667236|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution and Investigator agree not to publish the results of this study without the prior written consent of Sponsor.
601|NCT02666560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
602|NCT02666222|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
603|NCT02665455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
604|NCT02665260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
605|NCT02665221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
607|NCT02664610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
608|NCT02664532|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
609|NCT02664311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
610|NCT02663453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
611|NCT02663232|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
612|NCT02662608|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
613|NCT02662556|Principal Investigators are NOT employed by the organization sponsoring the study.|
614|NCT02662387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
615|NCT02661594|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
616|NCT02658461|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
617|NCT02658149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
618|NCT02657629|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
619|NCT02657538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
620|NCT02657252|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
621|NCT02657031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
622|NCT02656485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
623|NCT02656160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
624|NCT02654145|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
625|NCT02653872|Principal Investigators are NOT employed by the organization sponsoring the study.|All of the study information and data collected during the study were considered confidential and the property of AstraZeneca. After completion of the study, the investigator should prepare a joint publication with AstraZeneca. The investigator must undertake not to submit any part of the individual data from this clinical study protocol for publication without prior consent of AstraZeneca at a mutually agreed time.
626|NCT02653560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
627|NCT02653495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
628|NCT02652221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
629|NCT02652208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
630|NCT02651922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
631|NCT02651467|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
632|NCT02651194|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
633|NCT02650440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
634|NCT02650219|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
635|NCT02649634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
636|NCT02648438|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
637|NCT02648204|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
638|NCT02648022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
639|NCT02647944|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
640|NCT02647320|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
641|NCT02646449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
642|NCT02645760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
643|NCT02645253|Principal Investigators are NOT employed by the organization sponsoring the study.|All clinical study findings and documents will be regarded as confidential. The investigator and members of his/her research team must not disclose such information without prior written approval from the sponsor.
644|NCT02645123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
645|NCT02644356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
646|NCT02644109|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior authorization of the text by the Sponsor
647|NCT02644096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
648|NCT02643862|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
649|NCT02643615|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
650|NCT02643394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
688|NCT02633215|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
651|NCT02643251|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
652|NCT02643225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
653|NCT02643199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
654|NCT02643004|Principal Investigators are NOT employed by the organization sponsoring the study.|
655|NCT02642835|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
656|NCT02642679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
657|NCT02642575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
658|NCT02642536|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
659|NCT02642432|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
660|NCT02642159|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
661|NCT02641912|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
662|NCT02641561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
663|NCT02641379|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
664|NCT02641249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
665|NCT02640482|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
666|NCT02640404|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
667|NCT02640157|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
668|NCT02639338|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
689|NCT02632812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
669|NCT02639247|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
670|NCT02639052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
671|NCT02638493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
672|NCT02638259|Principal Investigators are NOT employed by the organization sponsoring the study.|Terms related to publication are part of the contract templates between Sponsor and sites/investigators. In general, these terms outlined that authorship of any publications relating to the clinical study shall be determined by agreement with the Sponsor. Sponsor reserves the right to request amendments or deletions to proposed publications, or request that any publication or presentation be delayed up to four months. A very limited number of exceptions can be granted to modify these terms.
673|NCT02638129|Principal Investigators are NOT employed by the organization sponsoring the study.|If not already published by Sponsor as part of a multi-center publication, 24 months after conclusion, abandonment or termination of the study or notification that there will be no such multi-center publication, PI may publish the results for PI's study center individually. Prior to such publication, PI must provide Sponsor with at least 60 days to review and comment on the proposed publication. Sponsor may delay publication for up to an additional 6 month period to file for patent protection.
674|NCT02638051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
675|NCT02637999|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
676|NCT02637804|Principal Investigators are NOT employed by the organization sponsoring the study.|
677|NCT02637323|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
678|NCT02637063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
679|NCT02637037|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
680|NCT02636907|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
681|NCT02636595|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
682|NCT02635828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
683|NCT02635425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
684|NCT02635204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
685|NCT02634788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
686|NCT02634073|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
687|NCT02633787|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
13845|NCT01157169|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
690|NCT02632110|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication of results will be made by the Sponsor. If publication is not submitted within 12 months after the date of study final report, the PI may publish the results from the site individually, subject to compliance with the other terms of the clinical trial agreement, including a requirement that the PI provide a draft of the publication for the sponsor's review 30 days before submission for publication so that sponsor can review the publication for confidential information
691|NCT02631057|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
692|NCT02630992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
693|NCT02630563|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
694|NCT02629354|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
695|NCT02628938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
696|NCT02628418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
697|NCT02628236|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication of results will be made by the Sponsor. If publication is not submitted within 12 months after the date of study final report, the PI may publish the results from the site individually, subject to compliance with the other terms of the clinical trial agreement, including a requirement that the PI provide a draft of the publication for the sponsor's review 30 days before submission for publication so that sponsor can review the publication for confidential information
698|NCT02628106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
699|NCT02627794|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
700|NCT02627144|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
701|NCT02627001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
702|NCT02626910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
703|NCT02626611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
704|NCT02625844|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
705|NCT02625402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
706|NCT02625298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
707|NCT02625259|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
747|NCT02609178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
708|NCT02625233|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
709|NCT02625220|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
710|NCT02625207|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
711|NCT02624791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
712|NCT02622568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
713|NCT02622321|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
714|NCT02621034|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
715|NCT02620683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
716|NCT02619812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
717|NCT02619799|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
718|NCT02619591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
719|NCT02618772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
720|NCT02618512|Principal Investigators are NOT employed by the organization sponsoring the study.|
721|NCT02617901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
722|NCT02617888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
723|NCT02617784|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
724|NCT02616523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
725|NCT02616250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
726|NCT02615990|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
727|NCT02615743|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
728|NCT02615717|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
729|NCT02614924|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14373|NCT01124175|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
730|NCT02614586|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
731|NCT02614469|Principal Investigators are NOT employed by the organization sponsoring the study.|All data and results and all intellectual-property rights in the data and results derived from the study will be the property of the sponsor. No publication or disclosure of study results will be permitted except as specified in a separate, written agreement between the Sponsor and the Investigator. If results of this study are reported in medical journals or at meetings, all subjects’ identities will remain confidential.
732|NCT02614222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
733|NCT02614079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
734|NCT02613910|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
735|NCT02613871|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
736|NCT02613403|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
737|NCT02612610|Principal Investigators are NOT employed by the organization sponsoring the study.|In order to ensure that the Sponsor will be able to make comments and suggestions where pertinent, material for public dissemination will be submitted to the Sponsor for review at least sixty (60) days prior to submission for publication, public dissemination, or review by a publication committee. All reasonable comments made by the Sponsor in relation to a proposed publication by the Trust, University and/or the Investigator will be incorporated into the publication.
738|NCT02612077|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
739|NCT02612064|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
740|NCT02611765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
741|NCT02611154|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
742|NCT02610634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
743|NCT02609841|Principal Investigators are NOT employed by the organization sponsoring the study.|ZS Pharma has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication
744|NCT02609672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
745|NCT02609659|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
746|NCT02609633|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
748|NCT02609113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
749|NCT02608489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
750|NCT02607800|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
751|NCT02607735|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
752|NCT02606838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
753|NCT02606734|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
754|NCT02606279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
755|NCT02605928|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
756|NCT02605863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
757|NCT02605304|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
758|NCT02604589|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
759|NCT02604550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
760|NCT02604407|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
761|NCT02604342|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
762|NCT02604264|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
763|NCT02604173|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
764|NCT02604017|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
765|NCT02603666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
766|NCT02602223|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
767|NCT02601573|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
768|NCT02601560|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
769|NCT02600871|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
770|NCT02600845|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
771|NCT02600767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
772|NCT02600403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
773|NCT02600351|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
774|NCT02599129|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
775|NCT02598934|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but only after the first publication or presentation that involves the Overall Study. The sponsor may request that the confidential information be deleted and/or the publication to be postponed inorder to present the Sponsor's intellectual property rights.
776|NCT02598622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
777|NCT02598583|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
778|NCT02598128|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
779|NCT02597907|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
780|NCT02597855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
781|NCT02597582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
782|NCT02597543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
783|NCT02597049|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
784|NCT02596958|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
785|NCT02596945|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
786|NCT02596867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14374|NCT01124162|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
787|NCT02596854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
788|NCT02596620|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
789|NCT02596451|Principal Investigators are NOT employed by the organization sponsoring the study.|Per the agreement, Sponsor reserves the right for publishing trial results and the Investigator cannot publish without written consent from the Sponsor.
790|NCT02596321|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
791|NCT02596022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
792|NCT02595567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
793|NCT02595502|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
794|NCT02595450|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
795|NCT02594826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
796|NCT02593773|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights .
797|NCT02592655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
798|NCT02591537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
799|NCT02591290|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
800|NCT02591238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
801|NCT02591056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
802|NCT02590939|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of 60 days from the time submitted to the sponsor for review. Sponsor may request:~deletion of any trade secret, proprietary, or confidential information of Sponsor~an additional 90 days to take measures to preserve its IP rights~Sponsor cannot require editorial changes. Sponsor's consent is required for results communication before trial completion"
803|NCT02590588|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
804|NCT02590562|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
805|NCT02590003|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
806|NCT02588976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
807|NCT02588872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
808|NCT02588599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
809|NCT02587819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
810|NCT02587234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
811|NCT02587117|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
812|NCT02586805|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
813|NCT02586506|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
814|NCT02586493|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
815|NCT02585999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
816|NCT02585895|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
817|NCT02585778|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
818|NCT02585245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
819|NCT02584790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
820|NCT02584686|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
821|NCT02584673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
822|NCT02584660|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
823|NCT02584504|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
824|NCT02583425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
825|NCT02582983|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
826|NCT02582970|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
827|NCT02582684|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
828|NCT02582632|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
829|NCT02582242|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
830|NCT02581475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
831|NCT02581410|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
832|NCT02580799|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
833|NCT02580357|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
834|NCT02580318|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
835|NCT02580240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
836|NCT02579603|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights
837|NCT02579057|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
838|NCT02578992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
839|NCT02578706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
840|NCT02578316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
841|NCT02578199|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
842|NCT02578186|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
843|NCT02577718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
844|NCT02577510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
845|NCT02577445|Principal Investigators are NOT employed by the organization sponsoring the study.|The legal manufacturer of the medical device, Respicardia, shall be the owner of the Clinical study data including any results, and Respicardia shall have the right to control the publication timing, content and method for any public disclosure of the clinical study data. Respicardia's prior written approval must be obtained prior to any publication or disclosure of Clinical study data or results by Sponsor or Institution.
864|NCT02572752|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19250|NCT00829452|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
846|NCT02577315|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
847|NCT02577107|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
848|NCT02577016|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
849|NCT02577003|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
850|NCT02576938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
851|NCT02576639|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
852|NCT02576535|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
853|NCT02576249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
854|NCT02576145|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
855|NCT02576041|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI can disclose the results after sending to the Sponsor, for appropriate knowledge and / or possible review, copy of the document, at least 90 days prior to publication and / or presentation. If requested in writing by the Sponsor, the PI will agree to make changes to the manuscript and / or deferred publication of the manuscript further 90 days to allow the patent application.
856|NCT02575911|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
857|NCT02574858|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
858|NCT02574845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
859|NCT02574832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
860|NCT02574260|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
861|NCT02574247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
862|NCT02573870|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
863|NCT02573467|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
24323|NCT00551525|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
865|NCT02572609|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
866|NCT02572427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
867|NCT02571634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
868|NCT02571153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
869|NCT02570425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
870|NCT02570295|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
871|NCT02570165|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
872|NCT02570126|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
873|NCT02570022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
874|NCT02569996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
875|NCT02569957|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
876|NCT02569658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
877|NCT02569437|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
878|NCT02569086|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
879|NCT02568852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
880|NCT02568384|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
881|NCT02568345|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
882|NCT02568254|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
883|NCT02567552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
884|NCT02567188|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but only after the first publication or presentation that involves the Overall Study. The sponsor may request that the confidential information be deleted and/or the publication to be postponed inorder to present the Sponsor's intellectual property rights.
923|NCT02553538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
885|NCT02566759|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
886|NCT02566005|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
887|NCT02565628|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
888|NCT02565381|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
889|NCT02564211|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
890|NCT02564055|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
891|NCT02564042|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
892|NCT02564029|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
893|NCT02563899|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
894|NCT02563834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
895|NCT02563106|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators do not see trial results ahead of public disclosure unless it is under CDA. Investigators will not be allowed to publish or disclose any study results prior to sponsor communicating it to the public.
896|NCT02563093|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
897|NCT02562521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
898|NCT02561806|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
899|NCT02561702|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
900|NCT02561572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
901|NCT02561195|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
902|NCT02559622|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
903|NCT02559414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
904|NCT02558829|Principal Investigators are NOT employed by the organization sponsoring the study.|INSTITUTIONS / INVESTIGATORS are allowed to publish data pursuant to the Sponsor’s publication policies per individual agreements. Any material prepared for publication shall be submitted to the Sponsor for review and comment within an individually agreed period (30 up to 180 days). INSTITUTION / INVESTIGATOR shall modify the publication / presentation according to the comments by the Sponsor, provided that the scientific neutrality of the publication is not impaired hereby.
905|NCT02558790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
906|NCT02558374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
907|NCT02557698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
908|NCT02557646|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
909|NCT02557555|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
910|NCT02557399|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
911|NCT02556632|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
912|NCT02556333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
913|NCT02556307|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
914|NCT02556138|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
915|NCT02555722|Principal Investigators are NOT employed by the organization sponsoring the study.|
916|NCT02555618|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
917|NCT02555228|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
918|NCT02554981|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
919|NCT02554877|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
920|NCT02554279|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
921|NCT02553772|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
922|NCT02553629|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
924|NCT02553512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
925|NCT02553421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
926|NCT02552810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
927|NCT02552303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
928|NCT02551887|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
929|NCT02551822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
930|NCT02551224|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until publication of the pooled data (i.e.,data from all sites)in the clinical trial.
931|NCT02550288|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
932|NCT02550197|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
933|NCT02550132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
934|NCT02549755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
935|NCT02549573|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the first right, within 9 months following the later to occur 1) close out meeting or 2) Sponsor possessing all data, to publish the lead paper. Following the foregoing, Institution has the right to publish the results provided the Institution provides a Publications Committee, which includes the Sponsor, with a draft at least 30 days before submission. At Sponsor's request, Institution shall withhold publication for 45 days to allow filing of a patent application.
936|NCT02549027|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
937|NCT02549014|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
938|NCT02548455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
939|NCT02548156|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
940|NCT02548078|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
941|NCT02547714|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
942|NCT02547454|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
943|NCT02547064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
944|NCT02546986|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year from study completion. Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 additional days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
945|NCT02546609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
946|NCT02545543|Principal Investigators are NOT employed by the organization sponsoring the study.|Seqirus agreements and restrictions on publishing may vary with individual investigators; however, Seqirus will not prohibit any investigator from publishing. Seqirus supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
947|NCT02545322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
948|NCT02545101|Principal Investigators are NOT employed by the organization sponsoring the study.|"As a multicentre study, the first publication shall be based on consolidated analysed data from all centres, i.e. the publication of results from individual institution/Investigator is not allowed before the publication of the full study results.~The PI agrees to give the sponsor 60 days to review the communications. If case of propietary information inadvertenly divulged, intellectual property rights at risk or inaccurate information presented, changes can be required by the sponsor."
949|NCT02544074|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
950|NCT02543918|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
951|NCT02543528|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
952|NCT02543437|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
953|NCT02543398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
954|NCT02542943|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
955|NCT02542761|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
956|NCT02542280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
957|NCT02542072|Principal Investigators are NOT employed by the organization sponsoring the study.|
958|NCT02541864|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
959|NCT02541422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
960|NCT02540850|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement between the sponsor and the clinical hospitals was signed and will be valid if no parties propose to change the agreement, the detailed trial data will not be made public until the trial data is published by the sponsor and/or the hospitals.
961|NCT02540772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
962|NCT02540447|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
963|NCT02540434|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30850|NCT00068250|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
964|NCT02540356|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until completion of the multi-center publication or twelve months following the conclusion of the study at all sites, whichever is first. Baxalta requires a review of results communication at least 90 days prior to submission. Baxalta may request an additional delay up to 60 days (e.g. for intellectual property protection).
965|NCT02540265|Principal Investigators are NOT employed by the organization sponsoring the study.|Discussion and/or publication of data generated is not permitted without the prior written consent of the sponsor.
966|NCT02540213|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
967|NCT02539992|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
968|NCT02539797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
969|NCT02539134|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
970|NCT02539108|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
971|NCT02538679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
972|NCT02538107|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
973|NCT02537730|Principal Investigators are NOT employed by the organization sponsoring the study.|
974|NCT02537522|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
975|NCT02536781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
976|NCT02536664|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
977|NCT02536313|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
978|NCT02535741|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
979|NCT02535416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
980|NCT02535026|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1001|NCT02530125|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
981|NCT02534935|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
982|NCT02534493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
983|NCT02534324|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
984|NCT02534129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
985|NCT02533999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
986|NCT02533726|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
987|NCT02533531|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
988|NCT02533466|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
989|NCT02533401|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
990|NCT02533258|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
991|NCT02532998|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
992|NCT02532374|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specify that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belong to the Sponsor."
993|NCT02532179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
994|NCT02531867|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigators are subject to certain disclosure and publication limitations. In cases of publication of the study results at conferences or on academic journals, the post-approval clinical study coordinating investigator and the study sponsor should discuss about details of publication, publication methods and presenters before decision-making
995|NCT02531698|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
996|NCT02531646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
997|NCT02531373|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
998|NCT02531308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
999|NCT02530671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1000|NCT02530450|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1002|NCT02529995|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1003|NCT02529488|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1004|NCT02528786|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1005|NCT02528721|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1006|NCT02528331|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1007|NCT02528305|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1008|NCT02528097|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1009|NCT02527161|Principal Investigators are NOT employed by the organization sponsoring the study.|Discloser must give at least 40 days notice to Sponsor including a copy of the proposed publication. The Sponsor can then provide comments (which Discloser is not bound to follow), request delay of publication by no more than 120 days to allow for Sponsor to protect its intellectual property, or request that the Discloser remove certain proprietary or confidential information from the study (other than the results of the study).
1010|NCT02527148|Principal Investigators are NOT employed by the organization sponsoring the study.|Discloser must give at least 40 days notice to Sponsor including a copy of the proposed publication. The Sponsor can then provide comments (which Discloser is not bound to follow), request delay of publication by no more than 120 days to allow for Sponsor to protect its intellectual property, or request that the Discloser remove certain proprietary or confidential information from the study (other than the results of the study).
1011|NCT02526550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1012|NCT02526524|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study may be published by INSTITUTE, however the publication shall not disclose any SPONSOR Confidential Information, the INSTITUTE shall send the SPONSOR a copy of any such proposed publication 90 days prior to submission for publication, the INSTITUTE, on request of the SPONSOR, shall delete any SPONSOR Confidential Information in the proposed publication, and the INSTITUTE shall, on the SPONSOR’s request, delay submission while the SPONSOR files applications for patents.
1013|NCT02526290|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
1014|NCT02525536|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
1015|NCT02525094|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises on-going studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
1016|NCT02524665|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1017|NCT02524561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1018|NCT02524418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1019|NCT02524288|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
1020|NCT02524158|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1021|NCT02524054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1022|NCT02522624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1023|NCT02520726|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1024|NCT02520414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1025|NCT02519855|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
1026|NCT02519842|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
1027|NCT02519712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1028|NCT02519595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1029|NCT02519387|Principal Investigators are NOT employed by the organization sponsoring the study.|Data emerging from the study cannot be released by the PI without permission from the sponsor.
1030|NCT02518048|Principal Investigators are NOT employed by the organization sponsoring the study.|Before submitting or presenting a manuscript about the clinical trial to a third party, the investigator shall give LEO a copy of any such manuscript, and LEO has the right to review and comment. Upon the request of LEO, the investigator shall remove any confidential information before submitting or presenting a manuscript. To allow LEO to protect its inventions and other intellectual property rights, the publication or presentation can be delayed.
1031|NCT02517580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1032|NCT02517567|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1033|NCT02517515|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1034|NCT02517047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1035|NCT02516306|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1036|NCT02516163|Principal Investigators are NOT employed by the organization sponsoring the study.|Discloser must give at least 40 days notice to Sponsor including a copy of the proposed publication. The Sponsor can then provide comments (which Discloser is not bound to follow), request delay of publication by no more than 120 days to allow for Sponsor to protect its intellectual property, or request that the Discloser remove certain proprietary or confidential information from the study (other than the results of the study).
1037|NCT02516150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1038|NCT02516098|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI`s intellectual property right.
1039|NCT02515994|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1040|NCT02515851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1041|NCT02515279|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
1042|NCT02515058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1043|NCT02515045|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1044|NCT02514889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1045|NCT02514772|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to the first publication or presentation of the results of the study which is intended to be a joint, multi-center publication of the study results. Following the first publication, institutions and/or Principal Investigators may publish or present data or results from the study per the terms of the clinical trial agreement.
1046|NCT02514473|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: PI is free to publish results of the study after (1)first multi-center publication, (2)if sponsor elects not to publish the results, or (3)18 months after close of the study, whichever occurs first.Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
1047|NCT02513771|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
1048|NCT02513550|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1049|NCT02513160|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
1050|NCT02513095|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI has no right to discuss/publish/disclose the trial data.
1051|NCT02512900|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
1052|NCT02512783|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1053|NCT02512679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1054|NCT02512393|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1055|NCT02512224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1056|NCT02512094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1057|NCT02511782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1058|NCT02511587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1059|NCT02511431|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1060|NCT02510820|Principal Investigators are NOT employed by the organization sponsoring the study.|
1061|NCT02510014|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications shall be submitted to Sponsor 30 days prior to submission for publication, and may be withheld for an additional period, up to 90 days, to allow Sponsor to file patent applications. If a multi-center publication isn't submitted for publication within 12 months of the conclusion of the Study at all sites, or is published in a shorter period, the results from the institution's site may be published individually.
1062|NCT02508194|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises on-going studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
1063|NCT02508103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1064|NCT02507752|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1065|NCT02507388|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1066|NCT02507375|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study.~The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."
1067|NCT02507219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1068|NCT02506881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1069|NCT02506309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1070|NCT02506257|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1071|NCT02506101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1072|NCT02504931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1073|NCT02504775|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1074|NCT02504723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1075|NCT02504541|Principal Investigators are NOT employed by the organization sponsoring the study.|
1076|NCT02504502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1077|NCT02504320|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1078|NCT02504099|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1079|NCT02504073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1080|NCT02503982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31091|NCT00004259|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
1081|NCT02503865|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1082|NCT02503787|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restrictions on the PI allow for the sponsor to review results communications prior to public release and to embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to sponsor for review. The sponsor is also allowed to require changes for technical correctness and to protect confidential information, copyrightable or patentable material; and when reasonably requested, extend the embargo up to an additional 90 days.
1083|NCT02503254|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
1084|NCT02503215|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1085|NCT02503085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1086|NCT02502734|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1087|NCT02502526|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1088|NCT02502487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1089|NCT02502149|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
1090|NCT02501590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1091|NCT02500836|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor right of review of publication, right to remove confidential or proprietary information, and all multi-center data publication done before any additional publications.
1092|NCT02500758|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1093|NCT02500628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1094|NCT02500537|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1095|NCT02500368|Principal Investigators are NOT employed by the organization sponsoring the study.|
1096|NCT02500056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1097|NCT02499952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1098|NCT02499692|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1099|NCT02499575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1100|NCT02498821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1101|NCT02498678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1122|NCT02493127|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1102|NCT02498652|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
1103|NCT02498522|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1104|NCT02497976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1105|NCT02497781|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1106|NCT02497755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1107|NCT02497235|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1108|NCT02497040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1109|NCT02496533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1110|NCT02496221|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1111|NCT02496039|Principal Investigators are NOT employed by the organization sponsoring the study.|
1112|NCT02496000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1113|NCT02495948|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1114|NCT02495831|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1115|NCT02495623|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators do not see trial results ahead of public disclosure unless it is under CDA. Investigators will not be allowed to publish or disclose any study results prior to sponsor communicating it to the public.
1116|NCT02495038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1117|NCT02494596|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1118|NCT02494440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1119|NCT02494323|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1120|NCT02494076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1121|NCT02493855|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1123|NCT02493088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1124|NCT02493036|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators do not see trial results ahead of public disclosure unless it is under CDA. Investigators will not be allowed to publish or disclose any study results prior to sponsor communicating it to the public.
1125|NCT02492984|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from completion/termination at all participating sties. Investigator may not disclose previously undisclosed confidential information other than study results.
1126|NCT02492841|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1127|NCT02492763|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
1128|NCT02492451|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1129|NCT02492165|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
1130|NCT02491944|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent application.
1131|NCT02491892|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1132|NCT02491073|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the study is part of a multi-center study, the first publication of the results of the study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the study at all sites, institution and investigator shall be free to publish
1133|NCT02490670|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1134|NCT02490475|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1135|NCT02490293|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1136|NCT02489799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1137|NCT02488980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1138|NCT02488681|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and Participating Institutions will provide any publication of Study Data generated by PI and/or Participating Institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
1139|NCT02488317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1140|NCT02488070|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1141|NCT02488018|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1142|NCT02487771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1143|NCT02487498|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
1144|NCT02487446|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1145|NCT02487199|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1146|NCT02487030|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1147|NCT02486952|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1148|NCT02485483|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1149|NCT02485353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1150|NCT02485301|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1151|NCT02485158|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1152|NCT02484911|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1153|NCT02484898|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1154|NCT02484729|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
1155|NCT02483975|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1156|NCT02483611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1157|NCT02482870|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1158|NCT02482805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1159|NCT02482571|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1179|NCT02478372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1160|NCT02482428|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1161|NCT02482298|Principal Investigators are NOT employed by the organization sponsoring the study.|Public disclosure of trial results by Principle Investigators within two years of trial completion requires Sponsor’s prior written consent.
1162|NCT02482129|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1163|NCT02481934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1164|NCT02481219|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior written consent is required for PI to independently publish any study results before a multi-center publication is released. If a multi-center manuscript is not submitted for publication within 1 year after completion of the Trial, PI shall have the right to Publish results. Sponsor shall respond within 45 days and shall have the right to delay the Publication for an additional 90.
1165|NCT02481141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1166|NCT02480712|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1167|NCT02480621|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1168|NCT02480582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1169|NCT02480439|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1170|NCT02480166|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1171|NCT02480153|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1172|NCT02480010|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1173|NCT02479763|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1174|NCT02479412|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed.
1175|NCT02479139|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
1176|NCT02478671|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall be permitted to publish the results of the Study in a manner that fairly and accurately sets forth the conclusions reached. The party seeking publication shall submit to SPONSOR for review a draft of the proposed publication at least thirty (30) days prior to submission of the draft for publication.
1177|NCT02478632|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1178|NCT02478580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31092|NCT00004228|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
1180|NCT02478164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1181|NCT02477709|Principal Investigators are NOT employed by the organization sponsoring the study.|60 days prior to the submission of any results, the PI shall submit to SPONSOR any proposed PUBLICATION, which period may be extended for an additional 30 days if requested by SPONSOR. If any Confidential Information should be redacted or patent applications relating to an Invention should be filed prior to PUBLICATION, then PUBLICATION will be delayed until patent application has been filed. Delay of a PUBLICATION shall not exceed 24 months from the date of such notice to the PI.
1182|NCT02477605|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1183|NCT02477527|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1184|NCT02477020|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1185|NCT02476994|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1186|NCT02476890|Principal Investigators are NOT employed by the organization sponsoring the study.|The contents of this protocol and any amendments and results obtained during the course of this study will be kept confidential by the Investigator(s), the Investigator’s staff, and IRB. No data collected as part of this study will be utilized in any written work, including publications, without the written consent of Sponsor. These obligations shall in no way diminish such obligations as set forth in the Confidentiality Agreement between the Sponsor and the Investigator(s).
1187|NCT02476617|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1188|NCT02476565|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1189|NCT02476422|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1190|NCT02476175|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1191|NCT02476032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1192|NCT02475980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1193|NCT02475564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1194|NCT02475395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1195|NCT02475278|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1196|NCT02475031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1197|NCT02474901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1198|NCT02474589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1199|NCT02474498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1200|NCT02474082|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
1201|NCT02473991|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1202|NCT02473783|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1203|NCT02473718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1204|NCT02473640|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators do not see trial results ahead of public disclosure unless it is under CDA. Investigators will not be allowed to publish or disclose any study results prior to sponsor communicating it to the public.
1205|NCT02473523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1206|NCT02473510|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
1207|NCT02473471|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1208|NCT02473445|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights .
1209|NCT02473367|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
1210|NCT02472977|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
1211|NCT02472886|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1212|NCT02472847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1213|NCT02472756|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
1214|NCT02472639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1215|NCT02472522|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1216|NCT02472366|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1217|NCT02471755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1218|NCT02471612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1219|NCT02471326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1220|NCT02471183|Principal Investigators are NOT employed by the organization sponsoring the study.|"Any study-related publication written independently by investigators must be submitted to Actelion for review at least 30 days prior to submission for publication or presentation.~Upon review, Actelion may provide comments, and may also request changes for the sole purpose of protecting its confidential information and/or patent rights.~Neither the institution nor the investigator should permit publication during such a review period."
1221|NCT02470949|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1222|NCT02470494|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1223|NCT02470429|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1224|NCT02470403|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1225|NCT02470390|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees that sponsor shall have the right to the first publication of the study results which is intended to be a joint, multi-center publication. Following the first publication, the PI may publish study data or results, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may remove any information that is considered confidential and / or proprietary other than study data.
1226|NCT02469961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1227|NCT02469701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1228|NCT02469597|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1229|NCT02469415|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1230|NCT02469298|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1231|NCT02469168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1232|NCT02469116|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1233|NCT02468700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1234|NCT02468583|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1235|NCT02468414|Principal Investigators are NOT employed by the organization sponsoring the study.|Should the Primary Investigator (PI) wish to publish the results of this study, the PI agrees to provide the Sponsor with a manuscript for review 60 days prior to submission for publication. The Sponsor retains the right to delete from the manuscript information that is confidential and proprietary and to object to suggested publication and/or its timing (at the Sponsor’s sole discretion).
1236|NCT02468154|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1237|NCT02467777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1238|NCT02467491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1239|NCT02467075|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1240|NCT02466659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1241|NCT02466425|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
1242|NCT02466412|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specify that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belong to the Sponsor."
1243|NCT02465866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1244|NCT02465632|Principal Investigators are NOT employed by the organization sponsoring the study.|Per the agreement, Sponsor reserves the right for publishing trial results and the Investigator cannot publish without written consent from the Sponsor.
1245|NCT02465489|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor retained title to and the right to publish all documentation, records, raw data, specimens or other work product generated in connection with the trial. Such publications shall not be made without the prior written consent of Sponsor. Neither Party will use the other Party's name in connection with any publication or promotion without the other Party's prior written consent. However, Sponsor has the right to publish appropriate information in order to satisfy regulatory requirements.
1246|NCT02465463|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1247|NCT02465450|Principal Investigators are NOT employed by the organization sponsoring the study.|
1248|NCT02465203|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Publications from a single site are postponed until publication of the pooled clinical trial data (i.e., data from all sites) or disclosure of trial results in their entirety.
1249|NCT02465099|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed that the first publication of results should be made in conjunction with the presentation of a joint, multicenter publication of the results with all sites contributing data, analyses, and comments. If this publication was not submitted within 12 months after conclusion of the Study at all sites, or after Sponsor confirmed there would be no multicenter Study publication, whichever is first, the PIs could have published the results from their individual sites.
1250|NCT02465073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1251|NCT02464176|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1252|NCT02464163|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1253|NCT02463981|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1254|NCT02463409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1255|NCT02463331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1256|NCT02463227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1257|NCT02463097|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1258|NCT02462720|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1259|NCT02462473|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
1260|NCT02462291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1261|NCT02461992|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1262|NCT02461966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1263|NCT02461693|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1264|NCT02461589|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property
1265|NCT02461550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1266|NCT02461433|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1267|NCT02461290|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1268|NCT02461134|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related publication written independently by investigators must be submitted to Actelion for review at least 30 days prior to submission for publication or presentation. Upon review, Actelion may provide comments, and may also request alterations and/or deletions for the sole purpose of protecting its confidential information and/or patent rights.
1269|NCT02460991|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1270|NCT02460822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1271|NCT02460458|Principal Investigators are NOT employed by the organization sponsoring the study.|
1272|NCT02460159|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
1273|NCT02459418|Principal Investigators are NOT employed by the organization sponsoring the study.|Contract agreement. Results may not be published or referred to, in whole or in part, without the prior express written consent of the Sponsor.
1274|NCT02458768|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1275|NCT02458365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1276|NCT02458287|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1277|NCT02457728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1278|NCT02457611|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1279|NCT02457247|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1280|NCT02455518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1281|NCT02455050|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
1282|NCT02454959|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent it's opinions, or the opinions of the publication committee, if these differ with the proposed publication.
1283|NCT02454608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1284|NCT02454296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1285|NCT02454283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1286|NCT02454127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1287|NCT02454101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1288|NCT02453581|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication and reporting of results and outcomes of this trial will be accurate and honest, undertaken with integrity and transparency and in accordance with QIMR’s Policy on Criteria for Authorship. Publication of results will be subjected to fair peer-review. Data will not be released publicly until the manuscript is accepted for publication.
1289|NCT02453347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1290|NCT02453321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1291|NCT02452944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1292|NCT02452892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1293|NCT02452528|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1294|NCT02452320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1295|NCT02451917|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1296|NCT02451358|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
1297|NCT02451150|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1298|NCT02450799|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1299|NCT02450747|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1300|NCT02450591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1301|NCT02450383|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1302|NCT02449915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1303|NCT02449902|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may publish their own data provided that the information is reviewed by the Sponsor. Otherwise, publication of the outcome and results of the study will be the sole domain of Sponsor, and publication of the study results by the Institution or Principal Investigator is not permitted, except with the Sponsor’s prior written consent.
1304|NCT02449798|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1305|NCT02449356|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1306|NCT02449044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1307|NCT02449018|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
1308|NCT02448914|Principal Investigators are NOT employed by the organization sponsoring the study.|
1309|NCT02448862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1310|NCT02448810|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
1311|NCT02448563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1312|NCT02448537|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1313|NCT02447848|Principal Investigators are NOT employed by the organization sponsoring the study.|
1314|NCT02447458|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1315|NCT02447432|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1316|NCT02447328|Principal Investigators are NOT employed by the organization sponsoring the study.|14.1 The Institution and the Principal Investigator shall be entitled to publish the results of, or make presentations related to, the Study, provided that any publications or presentations to be made within 2 years of completion of the Study shall require the Company’s prior written consent.
1317|NCT02447133|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1318|NCT02447029|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1319|NCT02446990|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review publication and/or communication related to the study results and can require changes. In case of a patent application, the sponsor can delay its authorization for publication or communication of the study results until the date of international registration of the patent.
1320|NCT02446743|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1321|NCT02446717|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1322|NCT02446613|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1323|NCT02446496|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1324|NCT02446483|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1325|NCT02446171|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
1326|NCT02446015|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1327|NCT02445807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1328|NCT02445755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1329|NCT02445573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1330|NCT02445326|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1331|NCT02445287|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1332|NCT02445196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1333|NCT02444936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1334|NCT02444715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1335|NCT02444533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1336|NCT02444182|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1337|NCT02443883|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1338|NCT02443792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1339|NCT02443740|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1340|NCT02443402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1341|NCT02443103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1342|NCT02442804|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1343|NCT02442700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1344|NCT02442349|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1345|NCT02442310|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor retained title to and the right to publish all documentation, records, raw data, specimens or other work product generated in connection with the trial. Such publications shall not be made without the prior written consent of Sponsor. Neither Party will use the other Party's name in connection with any publication or promotion without the other Party's prior written consent. However, Sponsor has the right to publish appropriate information in order to satisfy regulatory requirements.
1346|NCT02442284|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1347|NCT02442271|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1348|NCT02441946|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1349|NCT02441517|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript prior to publication for review and comment as specified in the Investigator Agreement
1350|NCT02441218|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review publication and/or communication related to the study results and can require changes. In case of a patent application, the sponsor can delay its authorization for publication or communication of the study results until the date of international registration of the patent.
1351|NCT02441179|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1352|NCT02441114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1353|NCT02440659|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1354|NCT02440633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1355|NCT02440308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1356|NCT02439879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1357|NCT02439164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1358|NCT02439138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1359|NCT02438540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1360|NCT02438137|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1361|NCT02437903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1362|NCT02437513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1363|NCT02437409|Principal Investigators are NOT employed by the organization sponsoring the study.|"Data must only be published after completion of the study. Publication of e.g. single center experience within the study is not allowed until the aggregate data have been submitted.~All information and data generated in association with this study will be held in strict confidence and remain in the sole property of phenox GmbH. The investigator agrees to use this information for the sole purpose of completing this study and for no other purpose without written consent from phenox GmbH."
1364|NCT02437344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1365|NCT02437305|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1366|NCT02437253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1367|NCT02437162|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
1368|NCT02436811|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1369|NCT02436577|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
1370|NCT02436330|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1371|NCT02436304|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1372|NCT02436031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1373|NCT02435966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1374|NCT02435836|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1375|NCT02435277|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1376|NCT02434939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1377|NCT02434523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1378|NCT02434497|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon completion of the Clinical Trial (CT), the Principal Investigator (PI) may prepare the data derived from the CT for publication or presentation. Material should be submitted to the Sponsor for review prior to review or submission for publication. Publications from individual sites must not precede the primary manuscript, but if published within twelve months after completion of the CT, the PI has the right to publish or present the methods and results of the CT.
1379|NCT02434471|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1380|NCT02434146|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1381|NCT02433834|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent it's opinions, or the opinions of the publication committee, if these differ with the proposed publication.
1382|NCT02433483|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1383|NCT02433366|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
1384|NCT02433340|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1385|NCT02432300|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1386|NCT02432287|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1387|NCT02432105|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1388|NCT02432040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1389|NCT02431754|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1390|NCT02431741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1391|NCT02431598|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1392|NCT02431455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1393|NCT02431299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1394|NCT02430870|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1395|NCT02430532|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
1396|NCT02430389|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1397|NCT02430090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1398|NCT02429791|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1399|NCT02429258|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution & PI agree they will not use or disclose and confidential information to third parties for a period of 10 years from receipt
1400|NCT02428478|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1401|NCT02428413|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1402|NCT02428231|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
1403|NCT02427984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1404|NCT02427750|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1405|NCT02427477|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1406|NCT02427399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1407|NCT02426541|Principal Investigators are NOT employed by the organization sponsoring the study.|"All drafts of proposed publications, written reports, training materials, advertisements and similar documents related to the Services and intended to be communicated or published to any third party (Communications) must be submitted to Antaros for AstraZeneca's review and approval prior to dissemination."
1408|NCT02425956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1409|NCT02425826|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
1410|NCT02425449|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1411|NCT02424591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1412|NCT02424578|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1413|NCT02424565|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1414|NCT02424357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1415|NCT02424149|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1416|NCT02423993|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1417|NCT02423980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1418|NCT02423798|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1419|NCT02423577|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1420|NCT02423447|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1421|NCT02423408|Principal Investigators are NOT employed by the organization sponsoring the study.|An industry standard NDA in place with all study investigators.
1422|NCT02423317|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1423|NCT02423291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1424|NCT02423200|Principal Investigators are NOT employed by the organization sponsoring the study.|"Clinical study was conducted at at clinical pharmacology unit owned by a contract research organization (CRO; Parexel) that was contracted by the sponsor to conduct the study. Site principal investigator is an employee of a contract research organization. As per the contract, the sponsor has all rights, title and interest in the results."
1425|NCT02423109|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the PI is that the sponsor should be notified of any results communications and has ability to review.
1426|NCT02422797|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1427|NCT02422303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1428|NCT02421419|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1429|NCT02421211|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
1430|NCT02421146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1431|NCT02421120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1432|NCT02420951|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1433|NCT02420262|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
1434|NCT02420210|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1435|NCT02420093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1436|NCT02420041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1437|NCT02419937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1438|NCT02419755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1439|NCT02419521|Principal Investigators are NOT employed by the organization sponsoring the study.|
1440|NCT02419313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1441|NCT02419001|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators do not see trial results ahead of public disclosure unless it is under CDA. Investigators will not be allowed to publish or disclose any study results prior to sponsor communicating it to the public.
1442|NCT02418676|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1443|NCT02418468|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1444|NCT02418234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1445|NCT02418026|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1446|NCT02417961|Principal Investigators are NOT employed by the organization sponsoring the study.|≥ 60 days prior to submission of material for publication/presentation, Institution and PI shall jointly provide AZ with material for review. No publication/presentation may include any of AZ’s Confidential Information without AZ’s written approval. AZ can request Inst. and PI to withhold material from submission for publication/presentation for an additional 90 days to allow AZ to establish and preserve its proprietary rights in the material being submitted for publication or presentation.
1447|NCT02417753|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1448|NCT02417532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1449|NCT02417376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1450|NCT02417129|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
1451|NCT02416973|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication Rights. Independent analysis and/or publication of data generated is not permitted without the prior written consent of sponsor. Such consent may be contingent on sponsor review and approval of any proposed analysis and manuscript. Institution will retain the right to review and analyze the database created from this study for its own scientific purposes so long as such scientific purposes are non-commercial in nature.
1452|NCT02416934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1453|NCT02416180|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1454|NCT02415959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1455|NCT02415439|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1456|NCT02415166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1457|NCT02415127|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights .
1458|NCT02414828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1459|NCT02414152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1460|NCT02413918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1461|NCT02413879|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1462|NCT02413593|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1463|NCT02413346|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
1464|NCT02413333|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1465|NCT02413294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1466|NCT02413203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1467|NCT02413034|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1468|NCT02412657|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1469|NCT02412501|Principal Investigators are NOT employed by the organization sponsoring the study.|
1470|NCT02411929|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator will provide manuscripts, abstracts, or the full text of any other intended disclosure (poster presentation, invited speaker or guest lecturer presentation) to the sponsor at least 30 days before they are submitted for publication or otherwise disclosed. An additional 60 days will be requested if any patent action is required to protect intellectual property rights. The investigator will, on request, remove any previously undisclosed confidential information before disclosure.
1471|NCT02411747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1472|NCT02411578|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1473|NCT02411539|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1474|NCT02411292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1475|NCT02411201|Principal Investigators are NOT employed by the organization sponsoring the study.|"All written or oral papers and publications must have the joint agreement of the investigator and Guerbet.~The Investigator shall not use the sponsor’s name in any publication without the prior permission of Guerbet.~Each investigator agrees not to publish/present the evaluation of the main criterion involving only the patients he/she has included.~Any abstract project will be first submitted to Guerbet at least 10 working days before submission to the congress scientific committee."
1476|NCT02411110|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
1477|NCT02410824|Principal Investigators are NOT employed by the organization sponsoring the study.|
1478|NCT02410291|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1479|NCT02410213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1480|NCT02410200|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
1481|NCT02409784|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1482|NCT02409459|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1483|NCT02408692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1484|NCT02408263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1485|NCT02408068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1486|NCT02407704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1487|NCT02406937|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1488|NCT02406586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1489|NCT02406495|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
1490|NCT02406443|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1491|NCT02405429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1492|NCT02405390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1493|NCT02404649|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1494|NCT02404545|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1495|NCT02404493|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigators agreed not to publish the study results without prior sponsor approval.
1496|NCT02404389|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1497|NCT02404103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1498|NCT02403830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1499|NCT02403674|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
1500|NCT02403206|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1501|NCT02403180|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1502|NCT02403154|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1503|NCT02402933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1504|NCT02402764|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1505|NCT02402322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1506|NCT02402296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1507|NCT02402127|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1508|NCT02401867|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1509|NCT02401555|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a five year period from the time of the non-disclosure agreement execution.
1510|NCT02401529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1511|NCT02401464|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
1512|NCT02401256|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1513|NCT02401230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1514|NCT02401022|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1515|NCT02400996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1516|NCT02400710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1517|NCT02400580|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1518|NCT02400346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1519|NCT02400333|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
1520|NCT02399345|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1521|NCT02399163|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1522|NCT02399111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1523|NCT02397915|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1524|NCT02397785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1525|NCT02397694|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1526|NCT02397655|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1527|NCT02397564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1528|NCT02397122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1529|NCT02396537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1530|NCT02396316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1531|NCT02396160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1532|NCT02396147|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1533|NCT02395822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1534|NCT02395653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1535|NCT02395536|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1536|NCT02395302|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1537|NCT02395185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1538|NCT02395055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1539|NCT02394925|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1540|NCT02394808|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1541|NCT02394756|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1542|NCT02394665|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1543|NCT02394600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1544|NCT02394457|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1545|NCT02393950|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1546|NCT02393677|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1547|NCT02393547|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1548|NCT02393209|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
1549|NCT02392806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1550|NCT02392767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1551|NCT02392624|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1552|NCT02392377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1553|NCT02392247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1554|NCT02392208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1555|NCT02392000|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1556|NCT02391714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1557|NCT02391311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1615|NCT02376166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1558|NCT02391116|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1559|NCT02391038|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
1560|NCT02390219|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: PI is free to publish results of the study after (1)first multi-center publication, (2)if sponsor elects not to publish the results, or (3)18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days(which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
1561|NCT02390167|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1562|NCT02389881|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1563|NCT02389452|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
1564|NCT02389374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1565|NCT02389361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1566|NCT02389088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1567|NCT02388815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1568|NCT02388776|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1569|NCT02388763|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1570|NCT02388347|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
1571|NCT02388321|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1572|NCT02388295|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1573|NCT02388269|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1574|NCT02388191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1575|NCT02388074|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1617|NCT02375373|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1576|NCT02387996|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
1577|NCT02387983|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
1578|NCT02387801|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1579|NCT02387749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1580|NCT02387710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1581|NCT02387580|Principal Investigators are NOT employed by the organization sponsoring the study.|Quotient shall have the right to publish the results of the research, subject to the sponsor’s prior written consent, which shall not be unreasonably withheld or delayed. Following the receipt of such consent, Quotient shall submit a copy of the proposed publication to the sponsor who shall have 30 days in which to request amendments thereto which, to the extent that such proposed amendments are reasonable, Quotient shall be obliged to incorporate prior to such publication.
1582|NCT02387554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1583|NCT02387502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1584|NCT02387476|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1585|NCT02387268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1586|NCT02384538|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1587|NCT02384070|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1588|NCT02383862|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1589|NCT02383758|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1590|NCT02383719|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1591|NCT02383576|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1592|NCT02383420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1593|NCT02382913|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
1594|NCT02382744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1616|NCT02375724|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication and/or presentation whether complete or partial, of any part of the data or results of this trial will not be allowed until global publication and study results disclosure by the sponsor as per EMA / FDA regulatory compliance obligations, and only after mutual agreement between the investigator and the sponsor
1595|NCT02382640|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1596|NCT02382133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1597|NCT02381795|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1598|NCT02381678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1599|NCT02381418|Principal Investigators are NOT employed by the organization sponsoring the study.|
1600|NCT02381392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1601|NCT02381288|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1602|NCT02380742|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1603|NCT02380287|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1604|NCT02380261|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1605|NCT02380248|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1606|NCT02379637|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall review results communications prior to public release to evaluate the manuscript for accuracy, ascertain whether information (other than the results of the Clinical Trial) is being improperly disclosed, provided information which may have not have yet been made available by the Sponsor, provide input for consideration regarding the content and/or conclusion(s) of the manuscript and determine whether the manuscript discloses any potentially patentable invention(s).
1607|NCT02379585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1608|NCT02378961|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1609|NCT02378935|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1610|NCT02378753|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1611|NCT02378506|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1612|NCT02377427|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1613|NCT02376998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1614|NCT02376530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1618|NCT02375347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1619|NCT02374593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1620|NCT02374398|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1621|NCT02374346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1622|NCT02374164|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1623|NCT02373202|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
1624|NCT02372344|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1625|NCT02372097|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
1626|NCT02372071|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1627|NCT02372058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1628|NCT02371876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1629|NCT02371850|Principal Investigators are NOT employed by the organization sponsoring the study.|Restricted until the manuscript is published in a peer-reviewed journal.
1630|NCT02371759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1631|NCT02371616|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1632|NCT02370914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1633|NCT02370667|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1634|NCT02370615|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
1635|NCT02370602|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1636|NCT02370537|Principal Investigators are NOT employed by the organization sponsoring the study.|Each Principal Investigator has signed a Confidential Disclosure Agreement which does not allow them to disclose any study related information for 10 years unless it is publically available.
1637|NCT02370420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1638|NCT02370407|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1639|NCT02370394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1640|NCT02370121|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1641|NCT02369848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1642|NCT02369796|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1643|NCT02369510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1644|NCT02369341|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1645|NCT02368457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1646|NCT02368314|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1647|NCT02368093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1648|NCT02367885|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1649|NCT02367872|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1650|NCT02367391|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1651|NCT02367170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1652|NCT02367066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1653|NCT02366936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1654|NCT02366923|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
1655|NCT02366910|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
1656|NCT02366767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1657|NCT02366689|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1658|NCT02366663|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1659|NCT02366637|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1660|NCT02366338|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1661|NCT02365714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1662|NCT02365688|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1663|NCT02365519|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1664|NCT02365298|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1665|NCT02364778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1666|NCT02364700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1667|NCT02364180|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1668|NCT02363933|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1669|NCT02363907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1670|NCT02363478|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1671|NCT02363439|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1672|NCT02363270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1673|NCT02362412|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi­center data. Sponsor must receive a site's manuscript prior to publication for review and comment.
1674|NCT02362373|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1675|NCT02362360|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1676|NCT02362321|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1677|NCT02361736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1678|NCT02361580|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1679|NCT02360995|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1680|NCT02360475|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1681|NCT02360228|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1682|NCT02360124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1683|NCT02360059|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1684|NCT02359955|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1685|NCT02359916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1686|NCT02359903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1687|NCT02359890|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
1688|NCT02359877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1689|NCT02359851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1690|NCT02359435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1691|NCT02359305|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1692|NCT02359110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1693|NCT02359058|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
1694|NCT02359045|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
1695|NCT02358876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1696|NCT02358668|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1697|NCT02358044|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
1698|NCT02357940|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigators agreed not to publish the study results without prior sponsor approval.
1699|NCT02357901|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications shall be submitted to Sponsor 30 days prior to submission for publication, and may be withheld for an additional period, up to 90 days, to allow Sponsor to file patent applications. If a multi-center publication isn't submitted for publication within 12 months of the conclusion of the Study at all sites, or is published in a shorter period, the results from the institution's site may be published individually.
1700|NCT02357485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1701|NCT02357459|Principal Investigators are NOT employed by the organization sponsoring the study.|
1702|NCT02357342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1703|NCT02357264|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1704|NCT02357173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1705|NCT02356900|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1706|NCT02356783|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1707|NCT02356588|Principal Investigators are NOT employed by the organization sponsoring the study.|
1708|NCT02356562|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1709|NCT02356107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1710|NCT02355977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1711|NCT02355743|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1712|NCT02355691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1713|NCT02355275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1714|NCT02355158|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1715|NCT02355028|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1716|NCT02354924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1717|NCT02354833|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1718|NCT02354599|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1719|NCT02353871|Principal Investigators are NOT employed by the organization sponsoring the study.|A plan for scientific publication and presentation of the results could be agreed and implemented by the study investigators or a steering committee. The sponsor required that reasonable opportunity be given to review the content and conclusions of any abstract, presentation, or paper before the material was submitted for publication or communicated. This condition also applied to any amendments that were subsequently requested by referees or journal editors.
1720|NCT02353754|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1721|NCT02353572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1722|NCT02353468|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1723|NCT02353442|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1724|NCT02353299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1725|NCT02352779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1726|NCT02352298|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1727|NCT02351960|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1728|NCT02351934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1729|NCT02351817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1730|NCT02351505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1731|NCT02350881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1732|NCT02350569|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1733|NCT02349711|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall provide the sponsor copies of any proposed publication or presentation at least 30 days in advance of submission to a journal, editor, or other third party to allow sponsor to determine whether patentable subject matter or sponsor's confidential information would be disclosed.
1734|NCT02349685|Principal Investigators are NOT employed by the organization sponsoring the study.|
1735|NCT02349542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1736|NCT02349451|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
1737|NCT02349438|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1738|NCT02349360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1739|NCT02349295|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1740|NCT02349152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1741|NCT02349048|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
1742|NCT02348723|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
1743|NCT02348658|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1744|NCT02347774|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study , the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
1745|NCT02347761|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
1746|NCT02347605|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1747|NCT02347488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1748|NCT02347189|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1749|NCT02347176|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises on-going studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
1750|NCT02347124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1751|NCT02347085|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
1752|NCT02347072|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
1753|NCT02346877|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
1754|NCT02346721|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1755|NCT02346643|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1756|NCT02345772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1757|NCT02345720|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1758|NCT02345642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1759|NCT02345330|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1779|NCT02341859|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
1760|NCT02345252|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1761|NCT02345226|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1762|NCT02345031|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1763|NCT02344745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1764|NCT02344407|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1765|NCT02344342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1766|NCT02344251|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1767|NCT02343380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1768|NCT02343159|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
1769|NCT02343081|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1770|NCT02343003|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1771|NCT02342704|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
1772|NCT02342561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1773|NCT02342548|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1774|NCT02342535|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1775|NCT02342418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1776|NCT02342288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1777|NCT02342223|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1778|NCT02342197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1780|NCT02341482|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1781|NCT02341417|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
1782|NCT02341144|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1783|NCT02340715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1784|NCT02340338|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1785|NCT02340104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1786|NCT02340000|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1787|NCT02339831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1788|NCT02339584|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1789|NCT02339506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1790|NCT02339389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1791|NCT02339246|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1792|NCT02339155|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1793|NCT02339038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1794|NCT02338843|Principal Investigators are NOT employed by the organization sponsoring the study.|All investigators were restricted from publishing individual papers until the study-wide publication was published. After this time, investigator restrictions varied by institution.
1795|NCT02338713|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
1796|NCT02338492|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall submit copies of any material to sponsor for review at least 30 days in advance of submission to a publisher or other third party. The sponsor shall review the data provided for consistency and reserves the right to delete any confidential information or other proprietary information from the proposed material. Sponsor may extend such review period for another 60 days to allow for filing of patent applications or take other steps to protect the sponsor’s IP interests.
1797|NCT02338336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1798|NCT02338076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1799|NCT02337959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1800|NCT02337491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1801|NCT02337062|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1802|NCT02336958|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1803|NCT02336763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1804|NCT02336607|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1805|NCT02336594|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
1806|NCT02336438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1807|NCT02336425|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1808|NCT02336178|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1809|NCT02335710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1810|NCT02335502|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1811|NCT02335489|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1812|NCT02335346|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1813|NCT02335216|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1814|NCT02334982|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1815|NCT02334813|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1816|NCT02334800|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1817|NCT02334787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1818|NCT02334527|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1819|NCT02334267|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1820|NCT02333045|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1821|NCT02332902|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1822|NCT02332889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1823|NCT02332798|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1824|NCT02332707|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
1825|NCT02332590|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
1826|NCT02332239|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1827|NCT02331940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1828|NCT02331589|Principal Investigators are NOT employed by the organization sponsoring the study.|
1829|NCT02331446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1830|NCT02331108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1831|NCT02330588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1832|NCT02330523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1833|NCT02330276|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1834|NCT02330172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1835|NCT02330055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1836|NCT02329964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1837|NCT02329730|Principal Investigators are NOT employed by the organization sponsoring the study.|
1838|NCT02329600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1839|NCT02329587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1840|NCT02329431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1841|NCT02329223|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1842|NCT02329015|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1843|NCT02328937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1844|NCT02328404|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1845|NCT02327429|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1846|NCT02327117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1847|NCT02327013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1848|NCT02326844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1849|NCT02326649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1850|NCT02325856|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1851|NCT02325713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1852|NCT02325518|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1853|NCT02324673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1854|NCT02324660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1855|NCT02324504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1856|NCT02323854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1857|NCT02322892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1858|NCT02322879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1859|NCT02322866|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
1860|NCT02322788|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1861|NCT02322775|Principal Investigators are NOT employed by the organization sponsoring the study.|≥ 60 days prior to submission of material for publication/presentation, Institution and PI shall jointly provide AZ with material for review. No publication/presentation may include any of AZ’s Confidential Information without AZ’s written approval. AZ can request Inst. and PI to withhold material from submission for publication/presentation for an additional 90 days to allow AZ to establish and preserve its proprietary rights in the material being submitted for publication or presentation.
1862|NCT02322749|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither Party (PI or Sponsor) will use the other Party's name in connection with any publication or promotion without the other Party's prior, written consent.
1863|NCT02322528|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1864|NCT02322216|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
1865|NCT02321527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1866|NCT02321436|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the first communication or publication regarding the study must be a joint publication between the PI and Sponsor.
1867|NCT02320903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1868|NCT02320838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1869|NCT02320721|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
1870|NCT02320695|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
1871|NCT02320487|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1872|NCT02320396|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
1873|NCT02320227|Principal Investigators are NOT employed by the organization sponsoring the study.|Master service agreement and confidentiality agreement in place
1874|NCT02320214|Principal Investigators are NOT employed by the organization sponsoring the study.|Master service agreement and confidentiality agreement in place
1875|NCT02320149|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
1876|NCT02319824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1877|NCT02319668|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1878|NCT02319525|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1879|NCT02319486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1880|NCT02319317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1881|NCT02319148|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1882|NCT02319031|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
1883|NCT02318940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1884|NCT02318797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1885|NCT02318693|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential may be deleted prior to submission; this confidentiality does not include efficacy and safety results.
1886|NCT02318303|Principal Investigators are NOT employed by the organization sponsoring the study.|Per the agreement, Sponsor reserves the right for publishing trial results and the Investigator cannot publish without written consent from the CRO/ Sponsor.
1887|NCT02317809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1888|NCT02317744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1889|NCT02317692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1890|NCT02317549|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1891|NCT02317510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1892|NCT02317016|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent application.
1893|NCT02316769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1894|NCT02316678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1895|NCT02316613|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
1896|NCT02316548|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
1897|NCT02316470|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 60 days prior to the earlier of Publication or submission for Publication of any Manuscript Sponsor has to be provided with a copy of the Manuscript (unless the Manuscript is an abstract, presentation, or poster: not less than 30 days prior to the earlier of Publication or submission for Publication). Site shall delay Publication/ submission for Publication of the Manuscript, as the case may be, for an additional 120 days to allow patent applications to be filed.
1898|NCT02316366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1899|NCT02315989|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1900|NCT02315352|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1901|NCT02314689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1902|NCT02314637|Principal Investigators are NOT employed by the organization sponsoring the study.|
1903|NCT02314546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1904|NCT02314520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1905|NCT02314260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1906|NCT02314117|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1907|NCT02314104|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1908|NCT02313766|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1909|NCT02313675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1910|NCT02313558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1911|NCT02313233|Principal Investigators are NOT employed by the organization sponsoring the study.|
1912|NCT02313155|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
1913|NCT02312882|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1914|NCT02312739|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1915|NCT02312726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1916|NCT02312713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1917|NCT02312154|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1918|NCT02311972|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1919|NCT02311907|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1920|NCT02311881|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1921|NCT02311309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1922|NCT02310789|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1923|NCT02310776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1924|NCT02310750|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1925|NCT02310646|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators' right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
1926|NCT02310581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1927|NCT02310568|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1928|NCT02310126|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1929|NCT02309723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1930|NCT02309294|Principal Investigators are NOT employed by the organization sponsoring the study.|Master service agreement and confidentiality agreement in place
1931|NCT02309112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1932|NCT02308787|Principal Investigators are NOT employed by the organization sponsoring the study.|Study Site reserves the right to publish the results of its work on the Study. Study Site and the PI agree to submit copies of any manuscript/abstract proposed for publication to Sponsor at least 30 days in advance of the presentation. Sponsor may require the delay of publication for no longer than 90 days for the purpose of filing patent applications.
1933|NCT02308748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1934|NCT02308371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1935|NCT02308124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1936|NCT02307838|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
1937|NCT02307552|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1938|NCT02307526|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1939|NCT02307318|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1940|NCT02307266|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreement covered by contract.
1941|NCT02307188|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1942|NCT02307123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1943|NCT02306928|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1944|NCT02306759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1945|NCT02305446|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1946|NCT02305381|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
1947|NCT02305329|Principal Investigators are NOT employed by the organization sponsoring the study.|
1948|NCT02305316|Principal Investigators are NOT employed by the organization sponsoring the study.|
1949|NCT02305277|Principal Investigators are NOT employed by the organization sponsoring the study.|
1950|NCT02305238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1951|NCT02305017|Principal Investigators are NOT employed by the organization sponsoring the study.|
1952|NCT02304926|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1953|NCT02304432|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1954|NCT02303743|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1955|NCT02303704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1956|NCT02302807|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
1957|NCT02302716|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1958|NCT02302365|Principal Investigators are NOT employed by the organization sponsoring the study.|Study Site reserves the right to publish the results of its work on the Study. The timing of publication however shall not exceed the 6 months after completion of the Study. Study Site and the PI agree to submit copies of any manuscript/abstract proposed for publication to Sponsor at least 30 days in advance of the presentation. Sponsor may require the delay of publication for no longer than 90 days for the purpose of filing patent applications.
1959|NCT02302092|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
1960|NCT02301975|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
1961|NCT02301936|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1962|NCT02301429|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1963|NCT02301377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1964|NCT02301364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1965|NCT02301169|Principal Investigators are NOT employed by the organization sponsoring the study.|Specific agreement as part of Eureka project
1966|NCT02300558|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1967|NCT02300311|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
1968|NCT02300129|Principal Investigators are NOT employed by the organization sponsoring the study.|
1969|NCT02300103|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
1970|NCT02300025|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
1971|NCT02299869|Principal Investigators are NOT employed by the organization sponsoring the study.|
1972|NCT02299791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1973|NCT02299635|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
1974|NCT02299427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1975|NCT02299349|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1976|NCT02299258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1977|NCT02299206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1978|NCT02299089|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
1979|NCT02299076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1980|NCT02298868|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1981|NCT02298842|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor retains the right to review and comment on any public disclosure of study results. If no response is received within 30 days,the Principal Investigator may presume that the submission for publication may proceed without delay. If the Sponsor asks to defer publication, Study Site shall not publish, or otherwise disclose to any third party, any of the information contained in the publication or presentation until such time as permission is granted from the Sponsor.
1982|NCT02298803|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1983|NCT02298361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1984|NCT02298192|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator (s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for upto 60 days to protect intellectual property.
1985|NCT02297841|Principal Investigators are NOT employed by the organization sponsoring the study.|Master service agreement and confidentiality agreement in place
1986|NCT02297815|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1987|NCT02297308|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall be permitted to publish the results of the study in a manner that fairly and accurately sets forth the conclusions reached. The party seeking publication shall submit to the sponsor for review a draft of the proposed publication at least thirty (30) days prior to submission of the draft for publication.
1988|NCT02297230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1989|NCT02297100|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1990|NCT02296931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1991|NCT02296840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1992|NCT02296606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1993|NCT02296476|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor has the opportunity to review proposed publications regarding this trial 45 days prior to submission for publication. Publication can be withheld an additional 90 days to allow for filing a patent or taking other measures to establish and preserve proprietary rights. Publication of the results of the study shall be made only as part of a publication of the results obtained by all sites performing the study.
1994|NCT02296099|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1995|NCT02295774|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must send a manuscript to Sponsor prior to its submission for publication. Sponsor will have 60 days after receipt of the manuscript in which to suggest changes. PI will accept to incorporate the publication comments that do not conflict with the reliability of data, with the rights, the safety and welfare of patients. PI retains the right to publish the result of trial in accordance with current legislation with the consent of the Sponsor subject to the rights of intellectual property.
1996|NCT02295644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1997|NCT02295280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1998|NCT02295020|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
1999|NCT02294773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2000|NCT02294734|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2001|NCT02294682|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2002|NCT02294604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2003|NCT02294474|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
2004|NCT02294461|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or 18 months after study completion date at all sites, whichever is first. Sponsor must receive a site’s manuscript at least 45 days prior to publication for review and comment. If requested Sponsor may delay the publication for up to 60 days to seek patent protection.
2005|NCT02294019|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2006|NCT02293902|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
2007|NCT02293538|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2008|NCT02293395|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
2009|NCT02292849|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2010|NCT02292537|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
2011|NCT02292433|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2012|NCT02292212|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2013|NCT02291861|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data
2014|NCT02291718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2015|NCT02291679|Principal Investigators are NOT employed by the organization sponsoring the study.|PI may publish or disclose the results of the study 24 months after final data lock provided that sponsor can review the publication prior to public release, sponsor can request removal of confidential information of sponsor (not including results of trial), and sponsor can request a publication delay in order to protect potentially patentable information. Furthermore, if a publication committee is developing an initial publication, PI is to delay disclosure until that publication is published.
2016|NCT02291510|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study may be published by INSTITUTE, however the publication shall not disclose any SPONSOR Confidential Information, the INSTITUTE shall send the SPONSOR a copy of any such proposed publication 90 days prior to submission for publication, the INSTITUTE, on request of the SPONSOR, shall delete any SPONSOR Confidential Information in the proposed publication, and the INSTITUTE shall, on the SPONSOR’s request, delay submission while the SPONSOR files applications for patents.
2017|NCT02291419|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2018|NCT02291237|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2019|NCT02290821|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
2020|NCT02290691|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor may invite Study's Investigators to participate in the preparation of a multicenter article for a professional journal; terms will be at the discretion of the sponsor. Investigators may also wish to publish, present, or use for instruction and research the results of the Study collected at their individual research sites only after publication of pooled, multicenter results and under the following conditions. Materials will be provided to Sponsor for approval prior to submission.
2021|NCT02290509|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2022|NCT02289989|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2023|NCT02289963|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
2024|NCT02289833|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
2025|NCT02289820|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
2026|NCT02289755|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2027|NCT02289742|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2028|NCT02289469|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2029|NCT02289456|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than one year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene sixty days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to ninety day and must delete confidential information before submission or defer publication to permit patent applications.
2030|NCT02289105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2031|NCT02289079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2032|NCT02288364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2033|NCT02288312|Principal Investigators are NOT employed by the organization sponsoring the study.|
2034|NCT02288273|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution & PI agree they will not use or disclose and confidential information to third parties for a period of 10 years from receipt.
2035|NCT02288091|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2036|NCT02287883|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2037|NCT02287779|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
2038|NCT02287623|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2039|NCT02287610|Principal Investigators are NOT employed by the organization sponsoring the study.|Physician agrees to obtain written consent of Horizon prior to publishing or presenting any results of the SUNRAY Observational Study.
2040|NCT02287415|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2041|NCT02287402|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
2042|NCT02287376|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees that sponsor shall have the right to the first publication of the study results which is intended to be a joint, multi-center publication. Following the first publication, the PI may publish study data or results, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may remove any information that is considered confidential and / or proprietary other than study data.
2043|NCT02287350|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees that sponsor shall have the right to the first publication of the study results which is intended to be a joint, multi-center publication. Following the first publication, the PI may publish study data or results, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may remove any information that is considered confidential and / or proprietary other than study data.
2044|NCT02287025|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2045|NCT02286518|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
2046|NCT02286193|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2047|NCT02286102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2048|NCT02285998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2049|NCT02285907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2050|NCT02285777|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2051|NCT02285270|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2052|NCT02284880|Principal Investigators are NOT employed by the organization sponsoring the study.|
2053|NCT02284867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2054|NCT02284854|Principal Investigators are NOT employed by the organization sponsoring the study.|
2055|NCT02284828|Principal Investigators are NOT employed by the organization sponsoring the study.|
2056|NCT02284555|Principal Investigators are NOT employed by the organization sponsoring the study.|
2057|NCT02284516|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
2058|NCT02284386|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2059|NCT02284347|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2060|NCT02284243|Principal Investigators are NOT employed by the organization sponsoring the study.|Discussion and/or publication of data generated is not permitted without the prior written consent of the sponsor.
2061|NCT02284165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2062|NCT02283840|Principal Investigators are NOT employed by the organization sponsoring the study.|
2063|NCT02283827|Principal Investigators are NOT employed by the organization sponsoring the study.|
2064|NCT02283814|Principal Investigators are NOT employed by the organization sponsoring the study.|
2065|NCT02283788|Principal Investigators are NOT employed by the organization sponsoring the study.|
2066|NCT02283411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2067|NCT02283268|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until completion of the multicenter publication or one year after the conclusion of the study at all sites. Baxalta requires a review of results communication (e.g. for confidential information) >= 30 days prior to submission. Baxalta may request an additional delay of <= 6 months (e.g. for intellectual property protection).
2068|NCT02282982|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2069|NCT02282813|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2070|NCT02282722|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2071|NCT02282631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2072|NCT02282605|Principal Investigators are NOT employed by the organization sponsoring the study.|
2073|NCT02282527|Principal Investigators are NOT employed by the organization sponsoring the study.|The site may publish results from the study, after providing Sponsor at least 30 days notice prior to submitting a manuscript or other materials related to the study to any outside party. At Sponsor’s request, Site will remove any any confidential information (other than study results), and incorporate all reasonable comments by Sponsor, or delay publication or presentation for a period of up to 120 days to allow Sponsor to protect its interests in any Sponsor’s Inventions.
2074|NCT02281773|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2075|NCT02281591|Principal Investigators are NOT employed by the organization sponsoring the study.|
2076|NCT02281526|Principal Investigators are NOT employed by the organization sponsoring the study.|
2077|NCT02281448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2078|NCT02281422|Principal Investigators are NOT employed by the organization sponsoring the study.|
2079|NCT02281357|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2080|NCT02281318|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2101|NCT02278003|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2081|NCT02281136|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication of results will be made by the Sponsor. If publication is not submitted within 12 months after the date of study final report, the PI may publish the results from the site individually, subject to compliance with the other terms of the clinical trial agreement, including a requirement that the PI provide a draft of the publication for the sponsor's review 30 days before submission for publication so that sponsor can review the publication for confidential information
2082|NCT02280811|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2083|NCT02280655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2084|NCT02280499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2085|NCT02280473|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2086|NCT02280226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2087|NCT02280187|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2088|NCT02280122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2089|NCT02279667|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2090|NCT02279641|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
2091|NCT02279420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2092|NCT02279407|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2093|NCT02279108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2094|NCT02279082|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2095|NCT02278783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2096|NCT02278640|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed that the first publication of results should be made in conjunction with the presentation of a joint, multicenter publication of the results with all PIs contributing data, analyses, and comments. If this publication was not submitted within 12 months after conclusion of the Study at all sites, or after Sponsor confirmed there would be no multicenter Study publication, whichever is first, the PIs could have published the results from their individual sites.
2097|NCT02278614|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever form without prior written agreement of THEA."
2098|NCT02278562|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2099|NCT02278484|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2100|NCT02278146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2102|NCT02277769|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor’s request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
2103|NCT02277743|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor’s request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
2104|NCT02277691|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2105|NCT02277639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2106|NCT02277626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2107|NCT02277249|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2108|NCT02277119|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2109|NCT02277093|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2110|NCT02276612|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2111|NCT02276560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2112|NCT02276274|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2113|NCT02276222|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study , the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
2114|NCT02276040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2115|NCT02275767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2116|NCT02275611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2117|NCT02275546|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
2118|NCT02275481|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming with twenty-four (24) months following completion of the study at all sites, institution and investigator shall be free to publish.
2119|NCT02275364|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2120|NCT02275156|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
2121|NCT02275052|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2122|NCT02274948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2123|NCT02274792|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
2124|NCT02274766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2125|NCT02274688|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2126|NCT02274675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2127|NCT02274558|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the PI has the right to publish results provided such publication does not violate confidentiality or IP provisions within the contract with the Sponsor. Prior to submission for publication or presentation of results, the PI must provide the Sponsor time for review. The Sponsor can request the PI to withhold or remove information from all publications. For a multi-center study, any publication of results by the PI shall not be made before the first multi-center publication.
2128|NCT02273973|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
2129|NCT02273908|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2130|NCT02273752|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2131|NCT02273323|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2132|NCT02273310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2133|NCT02273180|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
2134|NCT02273167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2135|NCT02273141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2136|NCT02273115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2137|NCT02273050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2159|NCT02268526|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­ site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
2138|NCT02272803|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
2139|NCT02272725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2140|NCT02271984|Principal Investigators are NOT employed by the organization sponsoring the study.|
2141|NCT02271945|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises on-going studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
2142|NCT02271880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2143|NCT02271854|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
2144|NCT02271698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2145|NCT02271529|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2146|NCT02271477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2147|NCT02271217|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding the study results for a period up to 30 days from the date the communication is submitted to the sponsor. The sponsor shall have the right to defer proposed publication an additional 60 days from the end of the review period. The sponsor cannot require changes to the communication and cannot unilaterally extend the embargo.
2148|NCT02270944|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2149|NCT02270684|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2150|NCT02270515|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2151|NCT02269709|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2152|NCT02269657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2153|NCT02269488|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2154|NCT02269475|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2155|NCT02269098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2156|NCT02268994|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2157|NCT02268877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2158|NCT02268864|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
2160|NCT02268396|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
2161|NCT02268214|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
2162|NCT02268058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2163|NCT02267850|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2164|NCT02267837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2165|NCT02267824|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2166|NCT02267629|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2167|NCT02267538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2168|NCT02267447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2169|NCT02267187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2170|NCT02267135|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until publication of the pooled data (i.e., data from all sites) in the clinical trial.
2171|NCT02267083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2172|NCT02266875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2173|NCT02266810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2174|NCT02266797|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2175|NCT02266472|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2176|NCT02266381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2177|NCT02266277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2178|NCT02265848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2179|NCT02265796|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2180|NCT02265783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2220|NCT02256891|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2181|NCT02265237|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2182|NCT02264977|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2183|NCT02264821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2184|NCT02264249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2185|NCT02263911|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2186|NCT02263833|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
2187|NCT02263365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2188|NCT02263131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2189|NCT02263118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2190|NCT02262754|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2191|NCT02262728|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
2192|NCT02262078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2193|NCT02262039|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2194|NCT02261974|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2195|NCT02261948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2196|NCT02261818|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2197|NCT02261805|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2198|NCT02261493|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2199|NCT02261467|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2200|NCT02261428|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2201|NCT02260986|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor’s request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
2202|NCT02260882|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
2203|NCT02260791|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator and Sponsor will discuss the preparation of a manuscript for publication in a peer reviewed journal or an abstract for presentation. Either party may undertake the task but both must agree to the strategy before work is started. Each party will allow the other 30 days to comment before any results are submitted for publication or presentation. Authorship should reflect work done by the Investigators and Sponsor, in accordance with recognised principles of scientific collaboration.
2204|NCT02260492|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2205|NCT02260440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2206|NCT02260401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2207|NCT02259608|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2208|NCT02259400|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2209|NCT02259348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2210|NCT02258529|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2211|NCT02258477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2212|NCT02258412|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2213|NCT02258334|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
2214|NCT02257918|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2215|NCT02257684|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2216|NCT02257385|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2217|NCT02257372|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2218|NCT02256982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2219|NCT02256969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2221|NCT02256553|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 45 days prior to submission for publication/presentation.
2222|NCT02256488|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site was postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
2223|NCT02256436|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
2224|NCT02256358|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2225|NCT02256345|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2226|NCT02256072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2227|NCT02255565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2228|NCT02255279|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
2229|NCT02255149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2230|NCT02255097|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
2231|NCT02254772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2232|NCT02254551|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
2233|NCT02254486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2234|NCT02254460|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2235|NCT02254421|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2236|NCT02254304|Principal Investigators are NOT employed by the organization sponsoring the study.|
2237|NCT02254252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2238|NCT02253654|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
2239|NCT02253173|Principal Investigators are NOT employed by the organization sponsoring the study.|
2240|NCT02253160|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2281|NCT02247011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2241|NCT02253147|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2242|NCT02252965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2243|NCT02252939|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2244|NCT02252744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2245|NCT02252718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2246|NCT02252445|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2247|NCT02252354|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
2248|NCT02252146|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2249|NCT02252133|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2250|NCT02252016|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
2251|NCT02251990|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
2252|NCT02251912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2253|NCT02251886|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2254|NCT02251717|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2255|NCT02251652|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2256|NCT02251613|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2257|NCT02251561|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2258|NCT02250807|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
2259|NCT02250703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2260|NCT02250443|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
2261|NCT02250274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2262|NCT02249819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2263|NCT02249728|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2264|NCT02249104|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish, present, or use any results that do not disclose any confidential information furnished by Galderma. The investigator shall provide their draft of such publication to sponsor for review and approval at least 45 days prior to the date of the intended publication. Upon written request from Galderma, within the forty-five (45) day review period, the investigator will delay the publication or presentation for a maximum of an additional one-hundred eighty (180) days.
2265|NCT02249065|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2266|NCT02249052|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2267|NCT02248818|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2268|NCT02248766|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There is an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
2269|NCT02248727|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There is an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
2270|NCT02248675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2271|NCT02248558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2272|NCT02248480|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2273|NCT02248285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2274|NCT02248246|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed that the first publication of results should be made in conjunction with the presentation of a joint, multicenter publication of the results with all PIs contributing data, analyses, and comments. If this publication was not submitted within 12 months after conclusion of the Study at all sites, or after Sponsor confirmed there would be no multicenter Study publication, whichever is first, the PIs could have published the results from their individual sites.
2275|NCT02248103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2276|NCT02247960|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2277|NCT02247765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2278|NCT02247739|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2279|NCT02247401|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2280|NCT02247063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2282|NCT02246998|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2283|NCT02246764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2284|NCT02246673|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
2285|NCT02246660|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2286|NCT02246621|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2287|NCT02246582|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2288|NCT02246309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2289|NCT02246166|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2290|NCT02246114|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2291|NCT02246062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2292|NCT02245412|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication rights are tied to the completion of the multi-center publication
2293|NCT02245360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2294|NCT02245217|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2295|NCT02244944|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2296|NCT02244840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2297|NCT02244619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2298|NCT02244580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2299|NCT02243943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2300|NCT02243293|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2301|NCT02243280|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2302|NCT02243202|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
2303|NCT02243176|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2304|NCT02243046|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2305|NCT02243007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2306|NCT02242994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2307|NCT02242643|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2308|NCT02242630|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2309|NCT02242305|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
2310|NCT02242201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2311|NCT02242019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2312|NCT02241889|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2313|NCT02241785|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
2314|NCT02241720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2315|NCT02241486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2316|NCT02241187|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2317|NCT02240654|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2318|NCT02240628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2319|NCT02240589|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2320|NCT02240368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2321|NCT02240329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2322|NCT02240030|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding the study results for a period up to 30 days from the date the communication is submitted to the sponsor. The sponsor shall have the right to defer proposed publication an additional 60 days from the end of the review period. The sponsor cannot require changes to the communication and cannot unilaterally extend the embargo.
2323|NCT02239978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2324|NCT02239939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2325|NCT02239926|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2326|NCT02239744|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2327|NCT02239692|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
2328|NCT02239679|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication of results will be made by the Sponsor. If publication is not submitted within 12 months after the date of study final report, the PI may publish the results from the site individually, subject to compliance with the other terms of the clinical trial agreement, including a requirement that the PI provide a draft of the publication for the sponsor's review 30 days before submission for publication so that sponsor can review the publication for confidential information
2329|NCT02239289|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2330|NCT02239094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2331|NCT02238925|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2332|NCT02238782|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2333|NCT02238483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2334|NCT02238379|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2335|NCT02238080|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
2336|NCT02238067|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
2337|NCT02238028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2338|NCT02237118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2339|NCT02237092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2340|NCT02236767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2341|NCT02236611|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2342|NCT02236598|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2343|NCT02236546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2344|NCT02236338|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2345|NCT02236130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2346|NCT02235987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2347|NCT02235870|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2348|NCT02235831|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2349|NCT02235493|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this single-center study involves a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis. Therefore, the PI is subject to certain disclosure and publication limitations.
2350|NCT02235454|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2351|NCT02235311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2352|NCT02235285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2353|NCT02235077|Principal Investigators are NOT employed by the organization sponsoring the study.|To minimize the probability of inaccurate data in published materials, it is the policy of the Heart Failure Network that all data and text considered for all papers, and all abstracts for presentation at scientific meetings be submitted to the Publication and Presentation Subcommittee, the NHLBI Project Officer, and the Coordinating Center for review and approval prior to presentation or publication.
2354|NCT02235064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2355|NCT02234752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2356|NCT02234479|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2357|NCT02234427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2358|NCT02234362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2359|NCT02234115|Principal Investigators are NOT employed by the organization sponsoring the study.|All information from the trial is property of the Sponsor and the PI has no right on it except the prior writing authorization of the sponsor.
2360|NCT02234011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2361|NCT02233998|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
2362|NCT02233985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2363|NCT02233842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2364|NCT02233803|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2365|NCT02233647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2366|NCT02233309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2367|NCT02233296|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2368|NCT02233101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2369|NCT02232880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2370|NCT02232698|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2371|NCT02232126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2372|NCT02231918|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
2373|NCT02231580|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not proceed to publication or communication in connection with the subject matter of this Agreement or Results, without the prior written consent of Ipsen.
2374|NCT02231177|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2375|NCT02231164|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
2376|NCT02230995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2377|NCT02230956|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2378|NCT02230904|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2379|NCT02230761|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2380|NCT02230683|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2381|NCT02230670|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2382|NCT02230566|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2383|NCT02230540|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators who want to publish/present results based on own data from a Coloplast-sponsored investigation, must send the publication/presentation to sponsor for review 60 days prior to submission. Sponsor reserves the right to delay publications to avoid compromising intellectual property. Publications of sub-analyses may be delayed by sponsor until main results of investigation have been published.
2384|NCT02230384|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2385|NCT02230332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2386|NCT02230306|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2387|NCT02230085|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for an undescribed period .
2388|NCT02229864|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators shall not present or publish, nor submit for publication, any work resulting from the Services without Sponsor’s prior written approval.~Except as specifically set forth herein, neither party shall use the other party’s name or trademark, or the name nor trademark of such other party’s affiliate, in any publicity, advertising or announcement, or disclose the existence or terms of this Agreement, without the consenting party’s prior written approval."
2389|NCT02229539|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2390|NCT02229513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2391|NCT02229487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2392|NCT02229474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2393|NCT02229461|Principal Investigators are NOT employed by the organization sponsoring the study.|
2394|NCT02229396|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 30 days prior to submission for publication or presentation, Authors shall provide Sponsor with such material for its review. Sponsor shall have 30 days to comment. If requested by Sponsor, Authors shall withhold material for an additional 90 days to allow for the taking of measures to establish its proprietary rights. No publication or presentation shall be made unless and until any information determined at Sponsor’s sole discretion to be Confidential has been removed.
2395|NCT02229383|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 30 days prior to submission for publication or presentation, Authors shall provide Sponsor with such material for its review. Sponsor shall have 30 days to comment. If requested by Sponsor, Authors shall withhold material for an additional 90 days to allow for the taking of measures to establish its proprietary rights. No publication or presentation shall be made unless and until any information determined at Sponsor’s sole discretion to be Confidential has been removed.
2396|NCT02229318|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2397|NCT02229214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2398|NCT02228980|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
2399|NCT02228720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2400|NCT02228395|All Principal Investigators ARE employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2401|NCT02227810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2402|NCT02227784|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2403|NCT02227485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2404|NCT02227368|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor can require Confidential Information to be removed and the sponsor can extend the embargo for an additional 90 days.
2405|NCT02227329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2406|NCT02227121|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and Participating Institutions will provide any publication of Study Data generated by PI and/or Participating Institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
2407|NCT02227108|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
2408|NCT02226562|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2409|NCT02226549|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2410|NCT02226198|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon completion of the Clinical Trial (CT), the Principal Investigator (PI) may prepare the data derived from the CT for publication or presentation. Material should be submitted to the Sponsor for review prior to review or submission for publication, or public dissemination. Publications from individual sites must not precede the primary manuscript, but if not published within twelve months after completion of the CT, the PI has the right to publish or present the methods and results of the CT.
2411|NCT02226172|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. Investigators will, on request, remove any previously undisclosed Confidential Information (other than the Study results themselves) before disclosure.
2412|NCT02226003|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
2413|NCT02225860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2414|NCT02224846|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2415|NCT02224820|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2416|NCT02224664|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2417|NCT02224625|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidential information based on contract
2418|NCT02224508|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2419|NCT02224404|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2420|NCT02224053|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent application.
2421|NCT02223871|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the data is under the responsibility of Actelion Pharmaceuticals Ltd. The PI has the opportunity to review the analysis of the data and to discuss with the sponsor the interpretation of the study results prior to publication.
2422|NCT02223754|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2423|NCT02223715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2424|NCT02223650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2425|NCT02223429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2426|NCT02223364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2427|NCT02223338|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2428|NCT02223260|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
2429|NCT02223065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2430|NCT02222870|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
2431|NCT02222818|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and Participating Institutions will provide any publication of Study Data generated by PI and/or Participating Institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
2432|NCT02222558|Principal Investigators are NOT employed by the organization sponsoring the study.|At 60 days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy and allow Sponsor 60 days to review and comment and provide written permission prior to publication.
2433|NCT02222493|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2434|NCT02222246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2435|NCT02222207|Principal Investigators are NOT employed by the organization sponsoring the study.|In mulit centre studies result of study are to be published only through coordination by Bayer in order to combine the results of all centres. Center free to publish its results provided the overall results have not been published within 18 months from study completion (data base lock), subject to the compliance to remaining terms set forth in the PI contract.
2436|NCT02222181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2437|NCT02222129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2438|NCT02221947|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot disclose trial results without permission from sponsor.
2439|NCT02221674|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
2440|NCT02221648|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2441|NCT02221557|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 30 days from the time submitted to the sponsor for review. Sponsor reserves the right to require the PI to remove sponsor's confidential information. Upon sponsor's written request, publication will be delayed up to 60 days to enable sponsor to secure adequate intellectual property protection.
2442|NCT02220998|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2443|NCT02220920|Principal Investigators are NOT employed by the organization sponsoring the study.|
2444|NCT02220764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2445|NCT02220205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2446|NCT02219997|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2447|NCT02219932|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
2448|NCT02219685|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2449|NCT02219516|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
2450|NCT02219503|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2451|NCT02219477|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2452|NCT02219464|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2453|NCT02219282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2454|NCT02219256|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
2455|NCT02219087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2456|NCT02218697|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2457|NCT02218307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2458|NCT02218268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2459|NCT02218216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2460|NCT02218203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2461|NCT02217982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2462|NCT02217878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2463|NCT02217800|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2464|NCT02217280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2465|NCT02216695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2466|NCT02216591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2467|NCT02216526|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2468|NCT02216422|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2469|NCT02216357|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2470|NCT02216123|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2471|NCT02216097|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2472|NCT02215954|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
2473|NCT02215252|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2474|NCT02214615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2475|NCT02214420|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2476|NCT02214277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2477|NCT02214238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2478|NCT02214225|Principal Investigators are NOT employed by the organization sponsoring the study.|"bioCSL agreements and restrictions on publishing may vary with individual investigators; however, bioCSL will not prohibit any investigator from publishing. bioCSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.~(Note: bioCSL was previously known as CSL Biotherapies; bioCSL QIV & TIV were called CSL QIV & TIV in the original protocol)"
2479|NCT02214186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2480|NCT02214121|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication can be made in advance of the first multicenter publication by the sponsor. Any publication will be submitted to the sponsor for review prior to the being published. The sponsor has the right to defer this publication for a period between 60 days to 6 months. The sponsor has the right to restrict the use of confidential information in any of the publications submitted.
2481|NCT02213900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2482|NCT02213666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2483|NCT02213510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2484|NCT02213250|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2485|NCT02213198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2486|NCT02213055|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2487|NCT02212977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2488|NCT02212834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2489|NCT02212457|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2490|NCT02212301|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2491|NCT02212197|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2492|NCT02212106|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
2493|NCT02212028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2494|NCT02211534|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication Rights. Independent analysis and/or publication of data generated is not permitted without the prior written consent of the sponsor. Such consent may be contingent on Regenesis' review and approval of any proposed analysis and manuscript. Institution will retain the right to review and analyze the database created from this study for its own scientific purposes so long as such scientific purposes are non-commercial in nature.
2495|NCT02210208|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2496|NCT02210195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2497|NCT02210091|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, results may not be published without prior written approval of Sponsor.
2498|NCT02210052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2499|NCT02210000|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2500|NCT02209766|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2501|NCT02209506|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
2502|NCT02209454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2503|NCT02209259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2504|NCT02209181|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2505|NCT02209064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2506|NCT02208310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2507|NCT02207972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2508|NCT02207907|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2509|NCT02207829|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2510|NCT02207803|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2511|NCT02207634|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
2512|NCT02207621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2513|NCT02207608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2514|NCT02207569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2515|NCT02207491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2516|NCT02207478|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2517|NCT02207413|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2518|NCT02207400|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2519|NCT02207244|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
2520|NCT02207231|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
2541|NCT02203565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2521|NCT02207088|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2522|NCT02206776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2523|NCT02206607|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2524|NCT02205814|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting the results of this study for publication or presentation, the Investigator will allow the sponsor at least 30 days time to review and comment upon the publication manuscript. It is agreed, that the results of the study will not be submitted for presentation, abstract, poster exhibition, or publication by the investigator until the sponsor has reviewed/commented and agreed to any publication.
2525|NCT02205801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2526|NCT02205476|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2527|NCT02205333|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
2528|NCT02204748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2529|NCT02204657|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2530|NCT02204579|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
2531|NCT02204449|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2532|NCT02204410|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2533|NCT02204371|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2534|NCT02204319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2535|NCT02204007|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2536|NCT02203916|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2537|NCT02203786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2538|NCT02203747|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Trial Agreement
2539|NCT02203721|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results.
2540|NCT02203578|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2542|NCT02203331|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of five (5) years from the date of last disclosure under this Agreement. Recipient shall (a) maintain all Confidential Information in confidence and not disclose the same to any third party unless required to do so by court order or by law, in which case Recipient shall notify Bayer in writing prior to making such a disclosure, and (b) not use any Confidential Information for its own benefit or for the benefit of any third party.
2543|NCT02203162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2544|NCT02203149|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator or sub-investigators may publicly present the academic accomplishment acquired from the Study at a specialized academic meeting or research conference. The Sponsor may freely use the information acquired from the Study for the purpose of marketing authorization application of the test drug.
2545|NCT02203032|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
2546|NCT02202980|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2547|NCT02202785|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
2548|NCT02202759|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
2549|NCT02202538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2550|NCT02202317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2551|NCT02202252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2552|NCT02202161|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2553|NCT02202135|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to use such Confidential study information and not to disclose them to any other third parties, except that the undersigned shall not be prevented from using or disclosing information: (a) which by written records was previously known; (b) which is now public knowledge, (c) which is lawfully obtained by the undersigned from sources who have a lawful right to disclose such information.
2554|NCT02201953|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2555|NCT02201940|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2556|NCT02201901|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2557|NCT02201784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2581|NCT02197234|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent application.
2558|NCT02201524|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2559|NCT02201446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2560|NCT02201420|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall not submit a publication to journals or professional societies without the prior written approval of the Sponsor.
2561|NCT02201394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2562|NCT02201056|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
2563|NCT02200536|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2564|NCT02200458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2565|NCT02200328|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2566|NCT02199795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2567|NCT02199717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2568|NCT02199574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2569|NCT02199509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2570|NCT02199041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2571|NCT02198963|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure Agreement
2572|NCT02198833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2573|NCT02198430|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2574|NCT02198235|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2575|NCT02198040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2576|NCT02197806|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2577|NCT02197481|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2578|NCT02197455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2579|NCT02197273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2580|NCT02197247|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent application.
2582|NCT02197130|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2583|NCT02197065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2584|NCT02196922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2585|NCT02196766|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
2586|NCT02196714|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
2587|NCT02196701|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2588|NCT02196675|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication or presentation, the Institution will provide Sponsor with at least sixty (60) days for review of a manuscript. Notwithstanding the foregoing, no paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor’s prior written consent.
2589|NCT02196259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2590|NCT02196168|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2591|NCT02196077|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
2592|NCT02195986|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2593|NCT02195713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2594|NCT02195700|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
2595|NCT02195687|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2596|NCT02195583|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2597|NCT02195427|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2598|NCT02195414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2659|NCT02183519|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2599|NCT02194699|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2600|NCT02194621|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2601|NCT02194088|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2602|NCT02194062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2603|NCT02193828|Principal Investigators are NOT employed by the organization sponsoring the study.|
2604|NCT02193815|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2605|NCT02193178|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There is an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
2606|NCT02193165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2607|NCT02193087|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2608|NCT02193074|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
2609|NCT02192905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2610|NCT02192879|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2611|NCT02192814|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2612|NCT02192684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2613|NCT02192606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2614|NCT02192541|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2615|NCT02192164|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2616|NCT02191865|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
2617|NCT02191267|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2618|NCT02191137|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2619|NCT02191046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2620|NCT02191033|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2621|NCT02190604|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
2622|NCT02190591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2623|NCT02190435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2624|NCT02189954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2625|NCT02189941|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2626|NCT02189915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2627|NCT02189863|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2628|NCT02189837|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
2629|NCT02189759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2630|NCT02189668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2631|NCT02189317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2632|NCT02189252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2633|NCT02189161|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2634|NCT02189122|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2635|NCT02188849|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2636|NCT02188784|Principal Investigators are NOT employed by the organization sponsoring the study.|To minimize the probability of inaccurate data in published materials, it is the policy of The Heart Failure Network (HFN) that all data and text considered for all papers, and all abstracts for presentation at scientific meetings, be submitted to the Publication & Presentation Subcommittee, the NHLBI Project Officer and the Coordinating Center for review and approval prior to presentation or publication.
2637|NCT02188589|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2638|NCT02187887|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2660|NCT02182895|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2639|NCT02187861|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
2640|NCT02187809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2641|NCT02187744|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2642|NCT02187029|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2643|NCT02187016|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2644|NCT02186873|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
2645|NCT02186808|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2646|NCT02186665|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2647|NCT02186587|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2648|NCT02186223|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2649|NCT02185729|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2650|NCT02185534|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
2651|NCT02185339|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2652|NCT02185183|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2653|NCT02185131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2654|NCT02185105|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There is an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
2655|NCT02184624|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2656|NCT02184494|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2657|NCT02184208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2658|NCT02183675|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2661|NCT02182115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2662|NCT02181790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2663|NCT02181673|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
2664|NCT02181634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2665|NCT02181530|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2666|NCT02181517|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2667|NCT02181504|Principal Investigators are NOT employed by the organization sponsoring the study.|If the site intends to publish the Clinical Trial results and other information with an academic intention, or Allergan intends to utilize the related information for distribution activities of its own, the said party must obtain the consent from the other party in advance. However, except for the case based on the due reason including that the consent of trial subjects cannot be obtained though it is mandatory, the other party cannot refuse the consent.
2668|NCT02181387|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2669|NCT02181140|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2670|NCT02181127|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2671|NCT02180893|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2672|NCT02180828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2673|NCT02180646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2674|NCT02180438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2675|NCT02180230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2676|NCT02180061|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
2677|NCT02179892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2678|NCT02179424|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2679|NCT02179398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2680|NCT02178995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2681|NCT02178787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2682|NCT02178696|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2730|NCT02169466|Principal Investigators are NOT employed by the organization sponsoring the study.|
2683|NCT02178540|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
2684|NCT02178059|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
2685|NCT02177266|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2686|NCT02177201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2687|NCT02177136|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators must wait 18 months after the study ends to publish their results and a multi-center publication must come first. The sponsor has a 45 day review period with the option to extend to an additional 90 days.
2688|NCT02177032|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
2689|NCT02176837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2690|NCT02176655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2691|NCT02176642|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2692|NCT02176525|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2693|NCT02176421|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2694|NCT02176356|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2695|NCT02176343|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2696|NCT02176018|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2697|NCT02175771|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
2698|NCT02175745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2699|NCT02175368|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2700|NCT02175212|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2701|NCT02175199|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2702|NCT02175121|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2731|NCT02169453|Principal Investigators are NOT employed by the organization sponsoring the study.|
2703|NCT02173769|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2704|NCT02173535|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2705|NCT02173392|Principal Investigators are NOT employed by the organization sponsoring the study.|
2706|NCT02173054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2707|NCT02172755|Principal Investigators are NOT employed by the organization sponsoring the study.|
2708|NCT02172742|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2709|NCT02172625|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2710|NCT02172040|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2711|NCT02171611|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
2712|NCT02171247|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2713|NCT02171234|Principal Investigators are NOT employed by the organization sponsoring the study.|
2714|NCT02171195|Principal Investigators are NOT employed by the organization sponsoring the study.|
2715|NCT02170779|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2716|NCT02170688|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2717|NCT02170662|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2718|NCT02170649|Principal Investigators are NOT employed by the organization sponsoring the study.|
2719|NCT02170532|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2720|NCT02170519|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2721|NCT02170376|Principal Investigators are NOT employed by the organization sponsoring the study.|
2722|NCT02170363|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2723|NCT02170220|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
2724|NCT02170207|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2725|NCT02170077|Principal Investigators are NOT employed by the organization sponsoring the study.|
2726|NCT02170064|Principal Investigators are NOT employed by the organization sponsoring the study.|
2727|NCT02170025|Principal Investigators are NOT employed by the organization sponsoring the study.|PI(s) shall provide to Bayer any proposed publication or oral presentation relating to the Study or the Study Drug or the Results at least sixty (60) days prior to the intended submission or presentation of the Publication in order to allow Bayer to review it.
2728|NCT02169895|Principal Investigators are NOT employed by the organization sponsoring the study.|
2729|NCT02169479|Principal Investigators are NOT employed by the organization sponsoring the study.|
2732|NCT02169440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2733|NCT02169427|Principal Investigators are NOT employed by the organization sponsoring the study.|
2734|NCT02169414|Principal Investigators are NOT employed by the organization sponsoring the study.|
2735|NCT02169336|Principal Investigators are NOT employed by the organization sponsoring the study.|Discussion and/or publication of data generated is not permitted without the prior written consent of the sponsor.
2736|NCT02169115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2737|NCT02168777|Principal Investigators are NOT employed by the organization sponsoring the study.|Written consent must be obtained from Bayer prior to any information being submitted for publication. Material proposed for publication or presentation must be provided to Bayer at least 60 days prior to submission.
2738|NCT02168491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2739|NCT02168478|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2740|NCT02168439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2741|NCT02168387|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2742|NCT02168361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2743|NCT02168309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2744|NCT02168270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2745|NCT02167893|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
2746|NCT02167867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2747|NCT02167815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2748|NCT02167217|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2749|NCT02167139|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty (60) days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy of all such manuscripts and materials, and allow Sponsor sixty (60) days to review and comment on them.
2750|NCT02166697|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
2751|NCT02166476|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2752|NCT02166346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2753|NCT02165826|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2873|NCT02147522|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2754|NCT02165761|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2755|NCT02165462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2756|NCT02165111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2757|NCT02165072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2758|NCT02164929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2759|NCT02164916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2760|NCT02164539|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2761|NCT02164396|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2762|NCT02164318|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2763|NCT02163915|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
2764|NCT02163733|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent application.
2765|NCT02163538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2766|NCT02163421|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2767|NCT02163395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2768|NCT02163187|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2769|NCT02162979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2770|NCT02162862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2771|NCT02162758|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2772|NCT02162680|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2773|NCT02162576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2774|NCT02161757|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2775|NCT02161549|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2776|NCT02161484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2777|NCT02161146|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2778|NCT02161016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2779|NCT02160990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2780|NCT02160977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2781|NCT02160873|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2782|NCT02160314|Principal Investigators are NOT employed by the organization sponsoring the study.|"The STUDY SITE and PRINCIPAL INVESTIGATOR agree that all data, calculations, interpretations, opinions and recommendations regarding the STUDY (hereinafter referred to as~“RESULTS”) shall be the property of P&G. The STUDY SITE and PRINCIPAL INVESTIGATOR agree to consider the RESULTS as INFORMATION subject to confidentiality restrictions"
2783|NCT02160002|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators must adhere to the Neonatal Research Network Publication policies.
2784|NCT02159950|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2785|NCT02159859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2786|NCT02159768|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2787|NCT02159547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2788|NCT02159482|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2789|NCT02159469|Principal Investigators are NOT employed by the organization sponsoring the study.|
2790|NCT02159365|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
2791|NCT02159352|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
2792|NCT02159118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2793|NCT02159040|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
2794|NCT02158975|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2874|NCT02147288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2795|NCT02158936|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novaratis does not prohibit any investigation from publishing. Any publications from a single-site are postposed until the publication of the pooled data (ie. data from all sites) in the clinical trial.
2796|NCT02158728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2797|NCT02158572|Principal Investigators are NOT employed by the organization sponsoring the study.|Approval by Agile Therapeutics, Inc. of any publication, including oral presentations and abstracts, utilizing data or any information from the ATI-CL23 study is required prior to publication submission.
2798|NCT02158442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2799|NCT02158364|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2800|NCT02158273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2801|NCT02158247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2802|NCT02158039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2803|NCT02157948|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
2804|NCT02157935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2805|NCT02157909|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2806|NCT02157883|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent application.
2807|NCT02157623|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2808|NCT02157376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2809|NCT02157298|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
2810|NCT02157168|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2811|NCT02157116|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2812|NCT02157103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2813|NCT02156466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2814|NCT02156271|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2815|NCT02156167|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2816|NCT02155985|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2817|NCT02155881|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2818|NCT02155543|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2819|NCT02155335|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
2820|NCT02155322|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
2821|NCT02155309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2822|NCT02155283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2823|NCT02155010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2824|NCT02154906|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2825|NCT02154425|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2826|NCT02154386|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2827|NCT02154243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2828|NCT02154139|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
2829|NCT02154087|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2830|NCT02154048|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2831|NCT02153827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2832|NCT02153788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2833|NCT02153736|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2834|NCT02153489|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the Investigator will be subject to mutual agreement between the investigator and sponsor.
2835|NCT02153398|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AstraZeneca approval before this study was completed.
2836|NCT02153346|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2837|NCT02153099|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
2838|NCT02153086|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2839|NCT02152605|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2840|NCT02152566|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2841|NCT02152371|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2842|NCT02152007|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2843|NCT02151994|Principal Investigators are NOT employed by the organization sponsoring the study.|
2844|NCT02151981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review, should the submission for publication be delayed in order to file patent application. The sponsor cannot require changes to the communication and cannot extend the embargo.
2845|NCT02151851|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2846|NCT02151786|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2847|NCT02151773|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2848|NCT02151643|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2849|NCT02151461|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2850|NCT02151253|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2851|NCT02151058|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
2852|NCT02150954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2853|NCT02150499|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish
2854|NCT02150460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2855|NCT02150213|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
2856|NCT02150109|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2857|NCT02150044|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2858|NCT02149875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2859|NCT02149342|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2860|NCT02149303|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
2861|NCT02149264|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
2862|NCT02149108|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
2863|NCT02148809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2864|NCT02148718|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2865|NCT02148588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2866|NCT02148523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2867|NCT02148445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2868|NCT02148107|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2869|NCT02147899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2870|NCT02147691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2871|NCT02147587|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2872|NCT02147561|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2875|NCT02147184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2876|NCT02147093|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2877|NCT02146599|Principal Investigators are NOT employed by the organization sponsoring the study.|
2878|NCT02146482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2879|NCT02146352|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must wait 9 months after close of study for Sponsor to present collaborative publication. If Sponsor does not publish within 9 months after close of study, PI may publish institution's results at that time. Sponsor can review results prior to public release and embargo communications on trial results for a period that is more than 60 days but less than or equal to 6 months from the date the PI gets the objection. The Sponsor cannot require changes to the communication nor extend the embargo.
2880|NCT02146326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2881|NCT02146248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2882|NCT02146105|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2883|NCT02146001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2884|NCT02145754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2885|NCT02145676|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2886|NCT02145468|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2887|NCT02145299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2888|NCT02145156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2889|NCT02144519|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2890|NCT02144337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2891|NCT02144259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2892|NCT02144220|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2893|NCT02144012|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
2894|NCT02143947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2895|NCT02143583|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI coordinator of the study owns shares in Anergis SA
2896|NCT02143141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2915|NCT02140593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2897|NCT02142738|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
2898|NCT02142712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2899|NCT02142504|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2900|NCT02142361|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
2901|NCT02142153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2902|NCT02141997|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2903|NCT02141984|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
2904|NCT02141867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2905|NCT02141854|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
2906|NCT02141633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2907|NCT02141620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2908|NCT02141581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2909|NCT02141516|Principal Investigators are NOT employed by the organization sponsoring the study.|"The terms and conditions of Novartis’ agreement with its investigators may vary.~However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial."
2910|NCT02141360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2911|NCT02141217|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2912|NCT02140957|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2913|NCT02140788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2914|NCT02140645|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
2916|NCT02140372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2917|NCT02140164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2918|NCT02140060|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
2919|NCT02139982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2920|NCT02139943|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
2921|NCT02139878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2922|NCT02139644|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
2923|NCT02139228|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement: The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
2924|NCT02139176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2925|NCT02139137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2926|NCT02139046|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2927|NCT02139007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2928|NCT02138838|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
2929|NCT02138825|Principal Investigators are NOT employed by the organization sponsoring the study.|Written consent must be obtained from Bayer prior to any information being submitted for publication. Material proposed for publication or presentation must be provided to Bayer prior to submission. All reasonable comments made by the Sponsor in relation to a proposed publication by the Investigator will be incorporated by the Investigator into the publication.
2930|NCT02138747|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after primary publication of the multi-site data. Sponsor must receive a site’s manuscript at least 45 days prior to planned submission to ensure that no confidential information of Sponsor is included in the document. In addition if requested by sponsor any publication or presentation shall be delayed for a period not to exceed 60 days.
2931|NCT02138578|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2932|NCT02138461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2933|NCT02138227|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2934|NCT02138097|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2935|NCT02138006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2936|NCT02137785|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of results from multi-center trial will be made by the Sponsor. If publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from the site individually, subject to compliance with the other terms of the clinical trial agreement, including a requirement that the PI provide a draft of the publication for the sponsor's review 30-75 days before submission so that sponsor can review the publication for confidential information.
2937|NCT02137772|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
2938|NCT02137603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2939|NCT02137512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2940|NCT02137447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2941|NCT02137382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2942|NCT02137226|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
2943|NCT02136914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2944|NCT02136498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2945|NCT02136420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2946|NCT02136238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2947|NCT02136134|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
2948|NCT02136004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2949|NCT02135900|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2950|NCT02135848|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2951|NCT02135692|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2952|NCT02135614|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
2953|NCT02135445|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2954|NCT02135432|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2955|NCT02135029|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
2956|NCT02135016|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2957|NCT02134977|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
2958|NCT02134951|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2959|NCT02134925|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2960|NCT02134717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2961|NCT02134587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2962|NCT02134184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2963|NCT02134119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2964|NCT02134015|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2965|NCT02133781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2966|NCT02133664|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2967|NCT02133534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2968|NCT02133508|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
2969|NCT02133352|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2970|NCT02133235|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2971|NCT02133131|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
2972|NCT02133066|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2973|NCT02132949|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
2974|NCT02132936|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
2975|NCT02132884|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2976|NCT02132832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2977|NCT02132767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2978|NCT02132637|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2979|NCT02132611|Principal Investigators are NOT employed by the organization sponsoring the study.|Any previously unpublished information provided to the Investigators by the Sponsor is confidential and will remain the sole property of the Sponsor. The Investigator agrees to use this information only in accomplishing this study not use it for other purposes without the Sponsor's written consent. An Investigator can generate additional publication ideas based on the trial data. The Sponsor reserves the right to review the manuscript prior to submission in order to verify accuracy of the data.
2980|NCT02132572|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2981|NCT02132468|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2982|NCT02132247|Principal Investigators are NOT employed by the organization sponsoring the study.|
2983|NCT02132169|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2984|NCT02132117|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2985|NCT02131662|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2986|NCT02131636|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
2987|NCT02131532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2988|NCT02131402|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
2989|NCT02131324|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2990|NCT02131311|Principal Investigators are NOT employed by the organization sponsoring the study.|"The STUDY SITE and PRINCIPAL INVESTIGATOR agree that all data, calculations, interpretations, opinions and recommendations regarding the STUDY (hereinafter referred to as~“RESULTS”) shall be the property of P&G. The STUDY SITE and PRINCIPAL INVESTIGATOR agree to consider the RESULTS as INFORMATION subject to confidentiality restrictions"
2991|NCT02131272|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
2992|NCT02131233|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
2993|NCT02131064|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
2994|NCT02130999|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2995|NCT02130635|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
2996|NCT02130622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2997|NCT02130284|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
2998|NCT02130258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
2999|NCT02130193|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3000|NCT02130063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3001|NCT02129777|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3002|NCT02129725|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3003|NCT02129608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3004|NCT02129192|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3005|NCT02129062|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3006|NCT02128997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3007|NCT02128932|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator (s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for upto 60 days to protect intellectual property.
3008|NCT02128919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3009|NCT02128867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3010|NCT02128542|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3011|NCT02128490|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3012|NCT02128269|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication rights are tied to the completion of the multi-center publication
3013|NCT02128217|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
3014|NCT02127892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3015|NCT02127710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3016|NCT02127632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3017|NCT02127567|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3018|NCT02127372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3019|NCT02127307|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI and/or institution is that the Sponsor can review results communications prior to public release and can restrict communications regarding trial results for a period that is more than 30 days (publications/abstracts) but not to exceed 90 days (patent related issues) from the time submitted to the Sponsor to review. The PI may be asked to remove any Sponsor confidential information and/or delay publication to protect any proprietary information.
3020|NCT02127281|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3021|NCT02126839|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
3022|NCT02126748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3023|NCT02126670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3024|NCT02126319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3025|NCT02126306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3026|NCT02125877|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3027|NCT02125838|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3028|NCT02125734|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
3029|NCT02125604|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
3030|NCT02125292|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
3031|NCT02124863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3053|NCT02121808|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3032|NCT02124798|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3033|NCT02124603|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3034|NCT02124460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3035|NCT02124304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3036|NCT02124161|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3037|NCT02124122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3038|NCT02124083|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3039|NCT02124044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3040|NCT02123745|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3041|NCT02123472|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3042|NCT02123459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3043|NCT02123446|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3044|NCT02123329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3045|NCT02123017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3046|NCT02122796|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3047|NCT02122549|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3048|NCT02122445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3049|NCT02122406|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3050|NCT02122146|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3051|NCT02121860|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3052|NCT02121847|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3054|NCT02121795|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3055|NCT02121535|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
3056|NCT02121522|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
3057|NCT02121509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3058|NCT02121483|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
3059|NCT02121418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3060|NCT02121210|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
3061|NCT02121067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3062|NCT02121041|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3063|NCT02120833|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
3064|NCT02120664|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3065|NCT02120625|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor has final say on publication of data, after their review.~Abstract of data from first 6 cases published:~Bainbridge JS, et al; Pain Medicine 2015, Volume 16, Number 8, p.1650"
3066|NCT02120443|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3067|NCT02120417|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
3068|NCT02120300|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3069|NCT02120027|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting the results of this study for publication or presentation, the Investigator will allow the sponsor at least 30 days time to review and comment upon the publication manuscript. It is agreed, that the results of the study will not be submitted for presentation, abstract, poster exhibition, or publication by the investigator until Menarini Ricerche S.p.A. has reviewed/commented and agreed to any publication.
3070|NCT02120001|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3071|NCT02119936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3072|NCT02119871|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3073|NCT02119676|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
3074|NCT02119663|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
3075|NCT02119650|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
3076|NCT02119325|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3077|NCT02119299|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3078|NCT02119286|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3079|NCT02119104|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3080|NCT02118961|Principal Investigators are NOT employed by the organization sponsoring the study.|
3081|NCT02118896|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained during the conduct of the study is regarded as confidential. Agreement from the sponsor is required prior to disclosing any information relevant to the study.
3082|NCT02118831|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3083|NCT02118792|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3084|NCT02118766|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results
3085|NCT02118597|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
3086|NCT02118441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3087|NCT02117934|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator may communicate study results with prior written consent from Dynavax.
3088|NCT02117687|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3089|NCT02117570|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3091|NCT02117479|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
3092|NCT02117414|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and Participating Institutions will provide any publication of Study Data generated by PI and/or Participating Institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
3093|NCT02117310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3094|NCT02117193|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3095|NCT02117050|Principal Investigators are NOT employed by the organization sponsoring the study.|The study as a whole will be published prior to any individual investigator publications. It is required that copies of all papers, abstracts, articles, etc. that contain study data are to be forward to the Sponsor for review 30 days prior to submission for publication.
3096|NCT02116972|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3097|NCT02116803|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3098|NCT02116621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3099|NCT02116582|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall provide sponsor with a copy of proposed publication/presentation for review and comment at least 45 days prior to submission for publication/presentation. The sponsor can embargo communications regarding trial results for a period that is 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication and can extend the embargo.
3100|NCT02116530|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3101|NCT02116361|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3102|NCT02116322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3103|NCT02116309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3104|NCT02115984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3105|NCT02115815|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
3106|NCT02115646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3107|NCT02115581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3108|NCT02115321|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
3109|NCT02115269|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3110|NCT02115256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3111|NCT02114931|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3112|NCT02114892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3113|NCT02114268|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
3114|NCT02114216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3115|NCT02114203|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3116|NCT02114177|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
3117|NCT02114151|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
3118|NCT02113579|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators agreed not to publish the study results without prior sponsor approval.
3119|NCT02113449|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3120|NCT02113436|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3121|NCT02113124|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3122|NCT02113007|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
3123|NCT02112448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3124|NCT02112370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3125|NCT02111863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3126|NCT02111772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3127|NCT02111603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3128|NCT02111369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3129|NCT02111252|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3130|NCT02111200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3131|NCT02111096|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3132|NCT02111083|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3133|NCT02110693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3134|NCT02110381|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3135|NCT02110277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3136|NCT02110238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3137|NCT02110147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3138|NCT02109731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3139|NCT02109640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3140|NCT02109497|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3141|NCT02109484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3142|NCT02109458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3143|NCT02109445|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3144|NCT02109172|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may communicate the trial results generated by the PI, but only after the first publication or presentation of the combined study results generated by all participating sites. The Sponsor can then review trial results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The Sponsor cannot require changes to the communication and cannot extend the embargo.
3145|NCT02109159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3146|NCT02109133|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3147|NCT02109107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3148|NCT02108977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3149|NCT02108951|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3150|NCT02108691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3151|NCT02108652|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3152|NCT02108288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3153|NCT02108223|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3154|NCT02108171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3155|NCT02107898|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
3156|NCT02107703|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3157|NCT02107599|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3158|NCT02107482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3159|NCT02107339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3160|NCT02107313|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3161|NCT02107274|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3162|NCT02107196|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting the results of this study for publication or presentation, the Investigator will allow the sponsor at least 30 days time to review and comment upon the publication manuscript. It is agreed, that the results of the study will not be submitted for presentation, abstract, poster exhibition, or publication by the investigator until Menarini Ricerche S.p.A. has reviewed/commented and agreed to any publication.
3163|NCT02107014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3164|NCT02106962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3165|NCT02106923|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3166|NCT02106832|Principal Investigators are NOT employed by the organization sponsoring the study.|Bayer acknowledges and accepts the interest in the non-commercial scientific publication of Results. In a multi-center study the Principal Investigators will not make any publication of the results before the first multi-center publication. Proposed publication/presentation shall be provided to Bayer at least 60 days prior to the intended submission or presentation of the publication in order to allow Bayer to review it. Any difference of opinion shall be discussed.
3167|NCT02106728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3168|NCT02106494|Principal Investigators are NOT employed by the organization sponsoring the study.|A period of 60 working days for presentational material and abstracts and 90 days for manuscripts is permitted for the sponsor's review. The sponsor can request modifications of any manuscript or other materials to be published or presented. The sponsor can also request additional time to obtain additional patent protection or take such other measures to establish and preserve its intellectual property and proprietary rights before publishing information from this trial.
3169|NCT02106403|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3188|NCT02104830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3170|NCT02106156|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3171|NCT02105987|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3172|NCT02105974|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3173|NCT02105961|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3174|NCT02105948|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3175|NCT02105740|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3176|NCT02105701|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
3177|NCT02105688|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
3178|NCT02105662|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
3179|NCT02105636|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
3180|NCT02105467|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3181|NCT02105454|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3182|NCT02105324|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3183|NCT02105285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3184|NCT02105272|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3185|NCT02105012|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
3186|NCT02104947|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3187|NCT02104895|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3189|NCT02104804|Principal Investigators are NOT employed by the organization sponsoring the study.|Without limitation to any other right of AstraZeneca hereunder, Institution and Principal Investigator acknowledge and agree that only AZ as Sponsor will register the Study and post the Study results in accordance with AZ internal policy on one or more publicly-accessible trial registries and websites (including the publicly-funded website http://www.clinicaltrials.gov/ and on its own website http://www.astrazenecaclinicaltrials.com) to avoid duplication.
3190|NCT02104505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3191|NCT02104427|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3192|NCT02104219|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in a multicenter study involves a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis. Therefore, PIs are subject to certain disclosure and publication limitations.
3193|NCT02103855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3194|NCT02103439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3195|NCT02103309|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3196|NCT02103114|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3197|NCT02103062|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally sixty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
3198|NCT02102932|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
3199|NCT02102490|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3200|NCT02102464|Principal Investigators are NOT employed by the organization sponsoring the study.|Within 18 months of Sponsor’s receipt of data from all sites, Investigators may publish or present the Investigator's individual results. Investigator must submit materials to Sponsor for review and comment at least 30 days prior to presentation or submission for publication. Investigator will consider all reasonable comments from Sponsor. Upon Sponsor’s written request, Investigator agrees to delete any Proprietary Information other than Investigator’s individual Study results.
3201|NCT02102399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3202|NCT02102204|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3203|NCT02101359|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever form without prior written agreement of THEA.
3204|NCT02101294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3205|NCT02101190|Principal Investigators are NOT employed by the organization sponsoring the study.|
3206|NCT02101112|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
3225|NCT02099344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3207|NCT02101021|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3208|NCT02101008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3209|NCT02100839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3210|NCT02100826|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3211|NCT02100670|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3212|NCT02100644|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3213|NCT02100579|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3214|NCT02100514|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results
3215|NCT02100475|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of trial, one or more scientific publications may be prepared collaboratively by the investigators and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
3216|NCT02100410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3217|NCT02100280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3218|NCT02100228|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3219|NCT02100189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3220|NCT02100007|Principal Investigators are NOT employed by the organization sponsoring the study.|Each PI has a CDA in place that restricts them from discussing the results of the clinical study at a scientific meeting or any other public or private forum or to publish in a scientific or academic journal the results of the clinical study without the approval of the Sponsor Company (MEI Pharma Inc.).
3221|NCT02099838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3222|NCT02099708|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3223|NCT02099682|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3224|NCT02099461|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3226|NCT02099318|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3227|NCT02099266|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3228|NCT02099110|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
3229|NCT02099084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3230|NCT02099006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3231|NCT02098746|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3232|NCT02098733|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3233|NCT02098395|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to Novo Nordisk before submission for comments. Comments will be given within four weeks from receipt of the planned communication.
3234|NCT02098304|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor will not suppress or veto publications however the Sponsor reserves the right to postpone publication and/or communication for a short time to protect intellectual property.
3235|NCT02098109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3236|NCT02097992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3237|NCT02097849|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
3238|NCT02097823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3239|NCT02097745|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3240|NCT02097732|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3241|NCT02097719|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3242|NCT02097537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3243|NCT02097303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3244|NCT02097290|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3245|NCT02097238|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3246|NCT02097108|Principal Investigators are NOT employed by the organization sponsoring the study.|
3247|NCT02097056|Principal Investigators are NOT employed by the organization sponsoring the study.|
3248|NCT02097030|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor.
3249|NCT02096952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3250|NCT02096900|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3251|NCT02096861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3252|NCT02096835|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3253|NCT02096744|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3254|NCT02096731|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3255|NCT02096718|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3256|NCT02096705|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
3257|NCT02096692|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators agree to submit copies of any manuscript proposed for publication to Sponsor for review at least 30 days in advance of submission for publication or presentation. Sponsor may extend such review period for another 90 days to file patent applications or take other steps to protect its intellectual property interests, or to remove from the paper or presentation any language that is detrimental to Sponsor's intellectual property interests.
3258|NCT02096679|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent applications
3259|NCT02096575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3260|NCT02096458|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
3261|NCT02096081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3262|NCT02096042|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3263|NCT02095873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3285|NCT02093949|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3264|NCT02095691|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
3265|NCT02095561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3266|NCT02095535|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3267|NCT02095223|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3268|NCT02095197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3269|NCT02095158|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3270|NCT02095106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3271|NCT02094937|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3272|NCT02094898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3273|NCT02094885|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3274|NCT02094677|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
3275|NCT02094664|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3276|NCT02094612|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3277|NCT02094573|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3278|NCT02094534|Principal Investigators are NOT employed by the organization sponsoring the study.|"Agreement is work for hire"
3279|NCT02094443|Principal Investigators are NOT employed by the organization sponsoring the study.|
3280|NCT02094352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3281|NCT02094326|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3282|NCT02094300|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3283|NCT02094261|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review, should the submission for publication be delayed in order to file patent application. The sponsor cannot require changes to the communication and cannot extend the embargo.
3284|NCT02093962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3286|NCT02093923|Principal Investigators are NOT employed by the organization sponsoring the study.|Dyax agreements vary, but Dyax will not prohibit any investigator from publishing. Dyax reviews publications prior to public release and can request deferral by up to 60 days beyond the proposed publication date if necessary to preserve its intellectual property. Dyax can request changes to publications to remove non-study-related confidential information. Dyax can also request deferral of single-center publications until after disclosure of the clinical trial's primary publication.
3287|NCT02093897|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
3288|NCT02093819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3289|NCT02093702|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3290|NCT02093689|Principal Investigators are NOT employed by the organization sponsoring the study.|The data resulting from the Study was to be made public by the sponsor at the end of the study after all results were available and analyzed, with a report on the study to have been prepared in consultation with the PI, rather than being published by the PI.
3291|NCT02093520|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3292|NCT02093390|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
3293|NCT02093351|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3294|NCT02093234|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor will conduct a peer review of the research report before it may be published.
3295|NCT02093221|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3296|NCT02093026|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3297|NCT02092961|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review and comment on results communications prior to publication. Sponsor will be allowed a review period of at least 60 days from submission but can request that publication be delayed for a period up to 6 months. Any reasonable comments made by the sponsor will be incorporated by the PI into the publication.
3298|NCT02092857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3299|NCT02092662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3300|NCT02092649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3301|NCT02092610|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3302|NCT02092441|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3303|NCT02092415|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3304|NCT02092389|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3305|NCT02092350|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
3306|NCT02092311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3307|NCT02092285|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to provide to the Sponsor 45 days prior to submission, review copies of abstracts or manuscripts for publication that report any results of the trial. The Sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation with regards to proprietary information, data accuracy, fairness, and compliance with federal regulations.
3308|NCT02092220|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3309|NCT02092168|Principal Investigators are NOT employed by the organization sponsoring the study.|
3310|NCT02092116|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor (or designee) will prepare a final report on the study. The Investigator may not publish or present any information on this study without the express written approval of the Sponsor. Additionally, the Sponsor, may, for any reason, withhold approval for publication or presentation.
3311|NCT02091986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3312|NCT02091960|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript prior to publication for review and comment as specified in the Investigator Agreement.
3313|NCT02091869|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3314|NCT02091856|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3315|NCT02091778|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3316|NCT02091752|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3317|NCT02091739|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study information usually requires agreement with the sponsor. In case of justified doubts by the sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
3318|NCT02091726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3319|NCT02091466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3320|NCT02091414|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3321|NCT02090855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3322|NCT02090777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3323|NCT02090764|Principal Investigators are NOT employed by the organization sponsoring the study.|Any and all data resulting from the Study will not be presented or published in any form or media by the Institution, Investigator or Research Staff without the prior written consent of Sponsor which consent maybe as directed within the Protocol.
3324|NCT02090413|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
3325|NCT02090088|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3326|NCT02089737|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3327|NCT02089347|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
3328|NCT02089191|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3329|NCT02089113|Principal Investigators are NOT employed by the organization sponsoring the study.|
3330|NCT02088957|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3331|NCT02088177|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3332|NCT02087995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3333|NCT02087943|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is > 12 months since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
3334|NCT02087774|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3335|NCT02087748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3336|NCT02087670|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3337|NCT02087514|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3338|NCT02087423|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3339|NCT02087241|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3340|NCT02087176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3341|NCT02087059|Principal Investigators are NOT employed by the organization sponsoring the study.|"The terms and conditions of Novartis' agreements with its investigators may vary.~However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."
3342|NCT02086786|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor intends to publish clinical data from all centers participating in the investigation. A draft manuscripts will submit to all participating investigators for their comments. Individual investigators subsequently may publish additional findings of this study in scientific journals/scientific meetings, provided that the sponsor is given ample opportunity to review any proposed abstract, manuscript, or slide presentation prior to its submission.
3343|NCT02086708|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3344|NCT02086591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3345|NCT02085785|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3346|NCT02085720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3389|NCT02080312|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3347|NCT02085161|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3348|NCT02084797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3349|NCT02084706|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3350|NCT02084628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3351|NCT02084238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3352|NCT02084134|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3353|NCT02084082|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3354|NCT02084069|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3355|NCT02084056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3356|NCT02083965|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
3357|NCT02083861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3358|NCT02083679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3359|NCT02083406|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3360|NCT02083380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3361|NCT02083263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3362|NCT02083185|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
3363|NCT02083107|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3364|NCT02082912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3365|NCT02082769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3366|NCT02082392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3367|NCT02082288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3390|NCT02080091|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3368|NCT02082262|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3369|NCT02082184|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3370|NCT02082158|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3371|NCT02081859|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3372|NCT02081690|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related publication written independently by investigators must be submitted to Actelion for review at least 30 days prior to submission for publication or presentation. Upon review, Actelion may provide comments, and may also request alterations and/or deletions for the sole purpose of protecting its confidential information and/or patent rights.
3373|NCT02081677|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3374|NCT02081599|Principal Investigators are NOT employed by the organization sponsoring the study.|
3375|NCT02081586|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3376|NCT02081573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3377|NCT02081443|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3378|NCT02081365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3379|NCT02081183|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3380|NCT02081079|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3381|NCT02081014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3382|NCT02081001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3383|NCT02080832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3384|NCT02080819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3385|NCT02080780|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3386|NCT02080546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3387|NCT02080507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3388|NCT02080481|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3391|NCT02079844|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
3392|NCT02079805|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3393|NCT02079649|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3394|NCT02079610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3395|NCT02079532|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3396|NCT02079519|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3397|NCT02079311|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator shall provide the Sponsor with a draft of the manuscript intended for publication or presentation at least [14] days before the date of intended submission for publication. However the Sponsor should be notified about the intention to publish the results at least [14] days before the manuscript is sent for review. All comments and suggested changes made by the Sponsor shall be considered in good faith in determining the final form of such publication.
3398|NCT02078492|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3399|NCT02078193|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3400|NCT02078180|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3401|NCT02077374|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3402|NCT02077140|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3403|NCT02076919|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3404|NCT02076334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3405|NCT02076321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3406|NCT02076243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3407|NCT02076178|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3408|NCT02076009|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
3409|NCT02075840|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3410|NCT02075658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3411|NCT02075632|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3412|NCT02075515|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3413|NCT02075463|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3414|NCT02075411|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3415|NCT02075320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3416|NCT02075255|Principal Investigators are NOT employed by the organization sponsoring the study.|≥ 60 days prior to submission of material for publication/presentation, Institution and PI shall jointly provide AZ with material for review. No publication/presentation may include any of AZ’s Confidential Information without AZ’s written approval. AZ can request Inst. and PI to withhold material from submission for publication/presentation for an additional 90 days to allow AZ to establish and preserve its proprietary rights in the material being submitted for publication or presentation.
3417|NCT02075125|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3418|NCT02075073|Principal Investigators are NOT employed by the organization sponsoring the study.|Project results may not be published or referred to, in whole or in part, by the Service Provider or any of its Affiliates without the prior expressed written consent of Sponsor, which will not be unreasonably withheld or delayed. Neither Party shall use the other Party’s name in connection with any publication or promotion without the other Party’s prior written consent.
3419|NCT02075021|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3420|NCT02075008|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3421|NCT02074995|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
3422|NCT02074982|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3423|NCT02074904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3424|NCT02074709|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3425|NCT02074553|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3426|NCT02074514|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3427|NCT02074384|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3469|NCT02066896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3428|NCT02074358|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
3429|NCT02074345|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3430|NCT02074059|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3431|NCT02073747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3432|NCT02073656|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3433|NCT02073461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3434|NCT02073448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3435|NCT02072980|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3436|NCT02072928|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3437|NCT02072421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3438|NCT02072200|Principal Investigators are NOT employed by the organization sponsoring the study.|PI/ Institution shall provide to Mundipharma any proposed presentation at least 15 working days prior to being disclosed and any other proposed publication at least 45 working days prior to being disclosed. Mundipharma may in its sole discretion permit such publications and presentations and shall have the right to require amendments to any such proposed presentation or publication on reasonable grounds.
3439|NCT02072096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3440|NCT02071849|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication by the investigator was not allowed until completion of the trial. All proposed publications must be cleared by unanimous vote of a publication committee consisting of the sponsor and representatives of the study investigators. Publication materials must be submitted for review at least 60 day in advance of publication. The Sponsor may embargo publication for 60 additional days to allow for patent filing or may prevent publication if filling of such application would be premature.
3441|NCT02071823|Principal Investigators are NOT employed by the organization sponsoring the study.|
3442|NCT02071810|Principal Investigators are NOT employed by the organization sponsoring the study.|
3443|NCT02071771|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3444|NCT02071420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3445|NCT02071108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3446|NCT02071095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3447|NCT02071082|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3448|NCT02070965|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3449|NCT02070744|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
3450|NCT02070692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3451|NCT02070640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3452|NCT02070588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3453|NCT02070380|Principal Investigators are NOT employed by the organization sponsoring the study.|Study results may be presented at scientific symposia or published in a peer-review journal after review by sponsor in accordance with the guidelines set forth in the applicable publication or financial agreement
3454|NCT02070302|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3455|NCT02070237|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3456|NCT02069093|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3457|NCT02068547|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3458|NCT02068443|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3459|NCT02068222|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3460|NCT02068157|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3461|NCT02068027|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3462|NCT02067728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3463|NCT02067676|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3464|NCT02067611|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3465|NCT02067585|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3466|NCT02067533|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3467|NCT02067273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3468|NCT02066922|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3470|NCT02066857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3471|NCT02066740|Principal Investigators are NOT employed by the organization sponsoring the study.|"There is an agreement between the Principal Investigator and Sponsor [or its agents] that restricts PI's rights to discuss or publish trial results without permission of the Sponsor.~Trial is still ongoing."
3472|NCT02066727|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3473|NCT02066402|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3474|NCT02066233|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3475|NCT02066051|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3476|NCT02065895|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3477|NCT02065453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3478|NCT02064985|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator may use the Study results (data generated at the site) and shall not publish or present any such results until the earlier of (i) the date of the first Study results publication and (ii) the end of the eighteen (18) month period following the completion, or early termination, of the Study at all participating sites.
3479|NCT02064920|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3480|NCT02064907|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property
3481|NCT02064894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3482|NCT02064439|Principal Investigators are NOT employed by the organization sponsoring the study.|The steering committee will be responsible for the publication and presentation strategy. All publications will be based on data released or agreed by Bayer, verified by the steering committee.
3483|NCT02064270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3484|NCT02064231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3485|NCT02064205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3486|NCT02063880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3487|NCT02063854|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3488|NCT02063737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3489|NCT02063672|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3611|NCT02046382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3490|NCT02063659|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution must provide any proposed publication or presentation to Sponsor for Sponsor's review, comment and approval at least thirty (30) days prior to the proposed submission for publication date or the proposed presentation date. Sponsor shall have the right to have deleted from the final version of the publication any Confidential Information, proprietary information or patentable subject matter.
3491|NCT02063516|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3492|NCT02063230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3493|NCT02063217|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3494|NCT02063035|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3495|NCT02062905|Principal Investigators are NOT employed by the organization sponsoring the study.|
3496|NCT02062879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3497|NCT02062801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3498|NCT02062710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3499|NCT02062658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3500|NCT02062645|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
3501|NCT02062580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3502|NCT02062502|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3503|NCT02062450|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3504|NCT02062437|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3505|NCT02062385|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3506|NCT02062359|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3507|NCT02062294|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
3508|NCT02062177|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3509|NCT02061748|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3510|NCT02061696|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3511|NCT02061683|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of at least 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3512|NCT02061592|Principal Investigators are NOT employed by the organization sponsoring the study.|"Prior to submission for publication or presentation the Institution will provide sponsor with at least sixty (60) days for review of a manuscript.~If needed, the Institution and Principal Investigator will withhold publication for up to an additional sixty days to allow for filing of a patent application."
3513|NCT02061540|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
3514|NCT02061358|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor will make the results of the study publicly available, including for purposes of national and international registration, publication, and information for medical and pharmaceutical professionals.
3515|NCT02061280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3516|NCT02060890|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3517|NCT02060838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3518|NCT02060539|Principal Investigators are NOT employed by the organization sponsoring the study.|All information gathered during this study is proprietary and should be made available only to those directly involved in the study. Information and reports arising from this project are the property of the sponsor.
3519|NCT02060526|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
3520|NCT02060461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3521|NCT02060058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3522|NCT02059993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3523|NCT02059928|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3524|NCT02059902|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3525|NCT02059642|Principal Investigators are NOT employed by the organization sponsoring the study.|"Publication of the Study results in scientific literature is encouraged, but any publication should require gaining prior approval from the Company and the Company reserves the right to review any paper written utilizing data generated from the Study before such paper is presented or submitted for publication."
3526|NCT02059395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3527|NCT02059291|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3528|NCT02059187|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
3529|NCT02059174|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3530|NCT02059161|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/ presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
3631|NCT02044367|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3531|NCT02059135|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site may publish the results of the study after the multi-center publication or 18 months after the sponsor's final evaluation of all study data from all sites, whichever occurs first.~Up to 90 days prior to submitting a manuscript or prior to any public presentation, a copy of the abstract, manuscript, or presentation will be provided to Sponsor by the Site for review and comment. Sponsor shall have said 90 day period to respond to the Site with comments."
3532|NCT02059070|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3533|NCT02058992|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3534|NCT02058836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3535|NCT02058628|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3536|NCT02058563|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3537|NCT02058537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3538|NCT02058498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3539|NCT02058290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3540|NCT02058160|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
3541|NCT02058147|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
3542|NCT02058069|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3543|NCT02057952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3544|NCT02057835|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3545|NCT02057692|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
3546|NCT02057549|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3547|NCT02057406|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3548|NCT02057393|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3549|NCT02057276|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3550|NCT02057250|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
3551|NCT02057237|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3552|NCT02057068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3553|NCT02056834|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3554|NCT02056652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3555|NCT02056639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3556|NCT02056431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3557|NCT02056392|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3558|NCT02056171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3559|NCT02055430|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3560|NCT02055404|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3561|NCT02055365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3562|NCT02055352|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3563|NCT02054910|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3564|NCT02054897|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property
3565|NCT02054754|Principal Investigators are NOT employed by the organization sponsoring the study.|
3566|NCT02054715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3567|NCT02054702|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3568|NCT02054572|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3569|NCT02054481|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
3570|NCT02054325|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3571|NCT02053753|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3572|NCT02053610|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3573|NCT02053493|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3574|NCT02053168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3575|NCT02052895|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 50 days from the time submitted to the sponsor for review. Only if the disclosure becomes an obstacle to the sponsor's business or registration or maintenance of the sponsor's invention, the sponsor may require changes to the communication and may extend the embargo.
3576|NCT02052752|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3577|NCT02052661|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3578|NCT02052635|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall provide the Sponsor with copies of any materials at least thirty days in advance of publication, submission or presentation. At the request of the Sponsor, the PI shall withhold publication, submission for publication or presentation for a period of ninety days from the date on which the Sponsor receives the material to allow the Sponsor to take such measures as the Sponsor considers necessary to preserve its proprietary rights and/or protect its Confidential Information.
3579|NCT02052596|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3580|NCT02052544|Principal Investigators are NOT employed by the organization sponsoring the study.|Any proposed publication, lecture, manuscript, poster presentation or other disclosure or dissemination of the data or Results of this study by PI shall be submitted to DSM at least forty-five (45) days prior to its submission for publication or use for DSM’s review, comment and approval. DSM reserves the right to have deleted from the proposed text all of DSM’s Confidential Information which may be contained therein. DSM’s comments shall be provided without undue delay.
3581|NCT02052466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3582|NCT02052440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3583|NCT02052414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3584|NCT02052011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3585|NCT02051816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3586|NCT02051790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3587|NCT02051686|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3588|NCT02051595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3589|NCT02051426|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3590|NCT02051335|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
3591|NCT02050334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3592|NCT02050321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3593|NCT02050048|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3594|NCT02049931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3595|NCT02049450|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety
3596|NCT02049385|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3597|NCT02049151|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication will be publication of results of the analysis of primary endpoint(s) that will include data from all trial centers. Any publications and presentations of results, either in whole or in part, by investigators or their representatives will require pre-submission review by the sponsor/CRO. Sponsor will not suppress or veto publications, but maintains right to delay publication in order to protect intellectual property rights.
3598|NCT02048904|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3599|NCT02048891|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3600|NCT02048241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3601|NCT02048072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3602|NCT02047747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3603|NCT02047500|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3604|NCT02047227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3605|NCT02046993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3606|NCT02046980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3607|NCT02046863|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3608|NCT02046772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3609|NCT02046616|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/ or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
3610|NCT02046564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3612|NCT02046369|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
3613|NCT02046265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3614|NCT02046226|Principal Investigators are NOT employed by the organization sponsoring the study.|An agreement between Sponsor and Investigator(s) in the final form of abstracts and articles shall be obtained within an appropriate time frame of 60 days. Any and all information supplied or obtained during this study by or on behalf of any party involved in the study (in whatever form) shall be treated as confidential, shall not be disclosed to any third party unless with the prior written consent of the Sponsor in each case.
3615|NCT02046200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3616|NCT02046148|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3617|NCT02045836|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3618|NCT02045797|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3619|NCT02045732|Principal Investigators are NOT employed by the organization sponsoring the study.|"Pfizer has the right to review disclosures, requesting a delay of less than 60 days.~Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results."
3620|NCT02045511|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3621|NCT02045264|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
3622|NCT02045238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3623|NCT02045108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3624|NCT02044991|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3625|NCT02044848|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3626|NCT02044822|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3627|NCT02044458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3628|NCT02044419|Principal Investigators are NOT employed by the organization sponsoring the study.|Described in contract.
3629|NCT02044393|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3630|NCT02044380|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
3632|NCT02044302|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3633|NCT02044094|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications shall be submitted to Sponsor 30 days prior to submission for publication, and may be withheld for an additional period, up to 90 days, to allow Sponsor to file patent applications. If a multi-center publication isn't submitted for publication within 12 months of the conclusion of the Study at all sites, or is published in a shorter period, the results from the institution's site may be published individually.
3634|NCT02043938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3635|NCT02043808|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3636|NCT02043782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3637|NCT02043704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3638|NCT02043652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3639|NCT02043379|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3640|NCT02043366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3641|NCT02043145|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3642|NCT02043132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3643|NCT02043015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3644|NCT02042924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3645|NCT02042911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3646|NCT02042872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3647|NCT02042534|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3648|NCT02042443|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3649|NCT02042404|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3650|NCT02042274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3651|NCT02042131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3652|NCT02041533|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
3653|NCT02041520|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3654|NCT02041377|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3655|NCT02041325|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3656|NCT02041286|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3657|NCT02041221|Principal Investigators are NOT employed by the organization sponsoring the study.|
3658|NCT02040844|Principal Investigators are NOT employed by the organization sponsoring the study.|To avoid disclosures that may affect the proprietary rights of the Sponsor, the Investigator agrees to allow Circassia the opportunity to review all manuscripts and abstracts 60 days prior to submission for publication. Circassia reserves the right to include the report of this study in any regulatory documentation or submission or in any informational materials.
3659|NCT02040792|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may communicate the trial results generated by the PI, but only after the first publication or presentation of the combined study results generated by all participating sites. The Sponsor can then review trial results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The Sponsor cannot require changes to the communication and cannot extend the embargo.
3660|NCT02040779|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
3661|NCT02040766|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
3662|NCT02040623|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3663|NCT02040532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3664|NCT02040428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3665|NCT02040116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3666|NCT02040077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3667|NCT02039817|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3668|NCT02039778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3669|NCT02039687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3670|NCT02039674|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3671|NCT02039427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3672|NCT02039414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3673|NCT02039115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3674|NCT02038959|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3675|NCT02038933|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
3676|NCT02038907|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3677|NCT02038829|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
3678|NCT02038790|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications shall be submitted to Sponsor 30 days prior to submission for publication, and may be withheld for an additional period, up to 90 days, to allow Sponsor to file patent applications. If a multi-center publication isn't submitted for publication within 12 months of the conclusion of the Study at all sites, or is published in a shorter period, the results from the institution's site may be published individually.
3679|NCT02038543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3680|NCT02038075|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3681|NCT02037776|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results.
3682|NCT02037607|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3683|NCT02037568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3684|NCT02037477|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3685|NCT02037425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3686|NCT02037347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3687|NCT02036840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3688|NCT02036775|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3689|NCT02036580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3690|NCT02036541|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the results of the multi-center trial must be published first, prior to any of the individual data being published
3810|NCT02020304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3691|NCT02036515|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
3692|NCT02036424|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3693|NCT02036320|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3694|NCT02035748|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3695|NCT02035696|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3696|NCT02035553|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish the study results, relative to his/her own patients, only after review, comment and approval by the sponsor. No publication of confidential information shall be made without the sponsor's prior written consent. At least 60 days prior to submitting a manuscript or prior to any public presentation, a copy of the manuscript or presentation will be provided to the sponsor for review and comment. The sponsor has 60 days to review and comment.
3697|NCT02035475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3698|NCT02035345|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3699|NCT02035332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3700|NCT02034916|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3701|NCT02034877|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3702|NCT02034799|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3703|NCT02034708|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator agrees not to publish/present the results of the study main criterion involving only the patients included in his/her center. Publications on specific topics can be performed only after main publication.The sponsor can review the publication at least 30 days before the submission to the scientific review and any abstract project at least 10 working days before submission to the congress scientific committee. The sponsor can require changes to the publication or the abstract.
3704|NCT02034591|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3705|NCT02034578|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trials primary publication.
3706|NCT02034565|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3707|NCT02034552|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3708|NCT02034513|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
3709|NCT02034162|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
3710|NCT02033499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3711|NCT02033369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3712|NCT02033317|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements generally provide that PI cannot publish single site data before publication of the multi-site publication, unless 1 year has elapsed since completion of the study at all sites. Thereafter, PI may publish provided that PI shall: provide a copy of the publication to sponsor at least 60 days in advance of submission for publication; delete sponsor’s confidential information as requested; and delay publication up to an additional 90 days to permit protection of intellectual property.
3713|NCT02033213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3714|NCT02033200|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3715|NCT02033174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3716|NCT02032901|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
3717|NCT02032888|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
3718|NCT02032875|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
3719|NCT02032758|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3720|NCT02032706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3721|NCT02032641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3722|NCT02032433|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3723|NCT02032420|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3724|NCT02032407|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3725|NCT02032238|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3726|NCT02032212|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3727|NCT02031679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3728|NCT02031640|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
3729|NCT02031471|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
3730|NCT02031458|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3731|NCT02030600|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
3732|NCT02030574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3733|NCT02030535|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3734|NCT02030405|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3735|NCT02030119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3736|NCT02030080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3737|NCT02030041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3738|NCT02029989|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3739|NCT02029911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3740|NCT02029872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3741|NCT02029846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3742|NCT02029755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3743|NCT02029703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3744|NCT02029521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3745|NCT02029495|Principal Investigators are NOT employed by the organization sponsoring the study.|
3746|NCT02029417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3747|NCT02029196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3748|NCT02028780|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
3749|NCT02028767|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
3750|NCT02028754|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3751|NCT02028676|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3752|NCT02028325|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3753|NCT02028169|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3754|NCT02028065|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
3755|NCT02027883|Principal Investigators are NOT employed by the organization sponsoring the study.|
3756|NCT02027844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3757|NCT02027402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3758|NCT02027311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3759|NCT02027272|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3760|NCT02026453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3761|NCT02026258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3762|NCT02026206|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3763|NCT02026193|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3764|NCT02026141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3765|NCT02025907|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
3766|NCT02025829|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3767|NCT02025647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3768|NCT02025621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3769|NCT02025075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3808|NCT02020512|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3770|NCT02024971|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3771|NCT02024932|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3772|NCT02024867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3773|NCT02024724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3774|NCT02024698|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor.
3775|NCT02024386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3776|NCT02024165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3777|NCT02023983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3778|NCT02023918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3779|NCT02023879|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
3780|NCT02023866|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights .
3781|NCT02023801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3782|NCT02023515|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3783|NCT02023268|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever from without prior written agreement of THEA
3784|NCT02023151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3785|NCT02023125|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
3786|NCT02023112|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3787|NCT02023099|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3788|NCT02022826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3789|NCT02022748|Principal Investigators are NOT employed by the organization sponsoring the study.|"The PIs shall be entitled to publish or make presentations related to the Study within 2 years of completion of the Study with Sponsor's prior written consent. PIs shall provide the Sponsor with copies of any materials at least thirty (30) days in advance of publication, submission or presentation.~All such publications or presentations shall be consistent with applicable standards, guidelines and laws, not be false or misleading, and not be made for any commercial purpose."
3790|NCT02022670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3791|NCT02022085|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3792|NCT02022020|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
3793|NCT02022007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3794|NCT02021942|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3795|NCT02021812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3796|NCT02021643|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3797|NCT02021565|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3798|NCT02021461|Principal Investigators are NOT employed by the organization sponsoring the study.|
3799|NCT02021331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3800|NCT02021292|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related publication written independently by investigators must be submitted to Actelion for review at least 30 days prior to submission for publication or presentation. Upon review, Actelion may provide comments, and may also request alterations and/or deletions for the sole purpose of protecting its confidential information and/or patent rights.
3801|NCT02021071|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3802|NCT02020941|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3803|NCT02020889|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3804|NCT02020863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3805|NCT02020837|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3806|NCT02020616|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3807|NCT02020577|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3809|NCT02020369|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3811|NCT02020135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3812|NCT02020031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3813|NCT02019979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3814|NCT02019719|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3815|NCT02019563|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3816|NCT02019550|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish or present any results from the Study to any third parties until i- EMD Serono publishes results from all sites participating in such Study;ii- Institution receives notification from EMD Serono that publication of the multi-site results is no longer planned;or iii- twenty-four months following completion of the multi-site study at all sites, whichever comes first. Prior to publishing or presenting results from the study, PI must provide proposed publication to EMD Serono.
3817|NCT02019472|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
3818|NCT02018809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3819|NCT02018562|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3820|NCT02017574|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3821|NCT02017093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3822|NCT02017015|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally sixty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner
3823|NCT02016963|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3824|NCT02016898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3825|NCT02016690|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3826|NCT02016625|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3827|NCT02016612|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3828|NCT02016482|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3829|NCT02016170|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3865|NCT02013050|Principal Investigators are NOT employed by the organization sponsoring the study.|There were limitations put on the sites from publishing data until the sponsor had published data. That data is now published.
3830|NCT02016105|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to the first publication or presentation of the results of the study which is intended to be a joint, multi-center publication of the study results. Following the first publication, institutions and/or Principal Investigators may publish or present data or results from the study per the terms of the clinical trial agreement.
3831|NCT02015910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3832|NCT02015793|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
3833|NCT02015754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3834|NCT02015676|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3835|NCT02015663|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
3836|NCT02015637|Principal Investigators are NOT employed by the organization sponsoring the study.|Melinta has the right to first publication of results, which would be made in conjunction with the PIs from all appropriate sites. Thereafter, PIs may publish results provided the PI submits the proposed publication to Melinta for review at least 60 days prior to the date of the proposed publication. Melinta may remove any information that is considered confidential and/or proprietary. If a publication is not submitted within 12 months of study conclusion, the PI may publish results.
3837|NCT02015546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3838|NCT02015481|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3839|NCT02015234|Principal Investigators are NOT employed by the organization sponsoring the study.|An industry standard NDA in place with all study investigators.
3840|NCT02015221|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3841|NCT02015195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3842|NCT02015039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3843|NCT02014740|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3844|NCT02014584|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3845|NCT02014480|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3846|NCT02014467|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3847|NCT02014441|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3866|NCT02012686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3848|NCT02014402|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the study, after providing Sponsor 30 days' notice prior to submitting a manuscript or other materials related to the study to any outside party. At Sponsor's request, site will remove any confidential information (other than study results) and site will, upon Sponsor's request, delay publication or presentation for a period of up to 120 days to allow Sponsor to protect its interests in any Sponsor interventions.
3849|NCT02014363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3850|NCT02014272|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3851|NCT02014051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3852|NCT02013830|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3853|NCT02013817|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3854|NCT02013791|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3855|NCT02013765|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3856|NCT02013687|Principal Investigators are NOT employed by the organization sponsoring the study.|In no event shall the PI publish or present, at any time, the data generated in the course of the performance of the study.
3857|NCT02013622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3858|NCT02013609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3859|NCT02013544|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators shall provide to the SPONSOR 30 days prior to submission all documents for publication, presentation, etc that report any trial results. The SPONSOR shall have editorial rights on documents and the right to review/comment with regard to (1) proprietary information, (2) accuracy of the information, (3) correctness of the scientific evaluation/conclusions and (4) to ensure that the information is fairly balanced and in compliance with regulations.
3860|NCT02013531|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3861|NCT02013388|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3862|NCT02013245|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3863|NCT02013206|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3864|NCT02013167|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3867|NCT02012582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3868|NCT02012452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3869|NCT02012218|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3870|NCT02011893|Principal Investigators are NOT employed by the organization sponsoring the study.|
3871|NCT02011542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3872|NCT02011516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3873|NCT02011490|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
3874|NCT02011464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3875|NCT02011113|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements varied; the Investigators shall not disclose any material/information disclosed by the Sponsor (Celgene KK) with the clinical trial or information obtained by conducting the clinical trial to third parties without Sponsor’s prior written approval.
3876|NCT02010996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3877|NCT02010684|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3878|NCT02010632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3879|NCT02010567|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3880|NCT02010255|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
3881|NCT02010216|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3882|NCT02009982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3883|NCT02009878|Principal Investigators are NOT employed by the organization sponsoring the study.|Center may publish study results but ≥ 60 days prior to any public presentation, a copy is sent to Sponsor for review and Center can delay publication for 60 days to permit Sponsor to protect its intellectual property rights or confidential information contained within the publication. The first publication is a joint publication, if Center is part of a multi-center study. Center is free to publish, if there is no multi-center publication within 18 months of completion/ termination of study.
3884|NCT02009865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3885|NCT02009722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3886|NCT02009696|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators agree to submit copies of any manuscript proposed for publication to Sponsor for review at least 30 days in advance of submission for publication or presentation. Sponsor may extend such review period for another 90 days to file patent applications or take other steps to protect its intellectual property interests, or to remove from the paper or presentation any language that is detrimental to Sponsor's intellectual property interests.
3907|NCT02006719|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3887|NCT02009163|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
3888|NCT02008942|Principal Investigators are NOT employed by the organization sponsoring the study.|Standard confidentiality agreement
3889|NCT02008682|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
3890|NCT02008617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3891|NCT02008526|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3892|NCT02008227|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
3893|NCT02007954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3894|NCT02007863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3895|NCT02007577|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3896|NCT02007512|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3897|NCT02007434|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
3898|NCT02007369|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3899|NCT02007278|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3900|NCT02007252|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3901|NCT02007200|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3902|NCT02007096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3903|NCT02007070|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
3904|NCT02006888|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3905|NCT02006836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3906|NCT02006732|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
3908|NCT02006706|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3909|NCT02006667|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3910|NCT02006654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3911|NCT02006641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3912|NCT02006407|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3913|NCT02006342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3914|NCT02006108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3915|NCT02005692|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3916|NCT02005601|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3917|NCT02005562|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3918|NCT02005549|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3919|NCT02005536|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
3920|NCT02005484|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3921|NCT02005393|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3922|NCT02005211|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3923|NCT02005029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3924|NCT02004990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3925|NCT02004977|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3926|NCT02004886|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
3927|NCT02004873|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and Participating Institutions will provide any publication of Study Data generated by PI and/or Participating Institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
3928|NCT02004847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3929|NCT02004262|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3930|NCT02004236|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3931|NCT02004158|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3932|NCT02004132|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3933|NCT02004093|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3934|NCT02003963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3935|NCT02003638|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3936|NCT02003534|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3937|NCT02003404|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3938|NCT02003391|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3939|NCT02003365|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3940|NCT02003352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3941|NCT02003053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3942|NCT02003014|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
3943|NCT02002936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3944|NCT02002871|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3945|NCT02002702|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-­site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
3946|NCT02002689|Principal Investigators are NOT employed by the organization sponsoring the study.|"The terms and conditions of Novartis' agreements with its investigators may vary.~However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."
3947|NCT02002650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3948|NCT02002533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3949|NCT02002221|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
3950|NCT02002208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3951|NCT02001714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3952|NCT02001181|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
3953|NCT02001051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3954|NCT02000973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3955|NCT02000921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3956|NCT02000752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3957|NCT02000622|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3958|NCT02000531|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3959|NCT02000440|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
3960|NCT02000427|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3961|NCT02000180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3962|NCT02000154|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3963|NCT01999920|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3964|NCT01999894|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study are the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
3965|NCT01999400|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3966|NCT01999348|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3967|NCT01999322|Principal Investigators are NOT employed by the organization sponsoring the study.|“At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property”
3968|NCT01999231|Principal Investigators are NOT employed by the organization sponsoring the study.|
3969|NCT01999218|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
3970|NCT01999192|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3971|NCT01998919|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3972|NCT01998906|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3973|NCT01998893|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3974|NCT01998880|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3975|NCT01998737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3976|NCT01998581|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
3977|NCT01998477|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
3978|NCT01998438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3979|NCT01998399|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3980|NCT01998360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3981|NCT01998269|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
3982|NCT01997905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3983|NCT01997892|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
3984|NCT01997723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3985|NCT01997567|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3986|NCT01997437|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3987|NCT01997411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3988|NCT01997398|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3989|NCT01997229|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication rights are tied to the completion of the multi-center publication.
3990|NCT01997216|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3991|NCT01996904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3992|NCT01996813|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3993|NCT01996748|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor does not object to publication by Institution of the results of the Trial based on information collected or generated by Institution, whether or not the results are favorable to the Sponsor Drug. However, to ensure against inadvertent disclosure of Confidential Information or unprotected Inventions, Institution will provide Sponsor an opportunity to review any proposed publication or other type of disclosure before it is submitted or otherwise disclosed.
3994|NCT01996709|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
3995|NCT01996657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3996|NCT01996644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3997|NCT01996410|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
3998|NCT01996332|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
3999|NCT01996319|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
4000|NCT01995513|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4001|NCT01995461|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4002|NCT01995357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4003|NCT01995201|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4004|NCT01995136|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4005|NCT01995071|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4006|NCT01995045|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4007|NCT01994993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4008|NCT01994902|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4009|NCT01994876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4010|NCT01994863|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4011|NCT01994837|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4012|NCT01994785|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4013|NCT01994746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4014|NCT01994720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4015|NCT01994629|Principal Investigators are NOT employed by the organization sponsoring the study.|
4016|NCT01994486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4017|NCT01994395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4018|NCT01994291|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4019|NCT01994226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4020|NCT01993940|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
4021|NCT01993888|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4022|NCT01993823|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor does not object to publication by Institution of the results of the Trial based on information collected or generated by Institution, whether or not the results are favorable to the Sponsor Drug. However, to ensure against inadvertent disclosure of Confidential Information or unprotected Inventions, Institution will provide Sponsor an opportunity to review any proposed publication or other type of disclosure before it is submitted or otherwise disclosed.
4023|NCT01993238|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall notify Sponsor of the intent to publish or present independent Study Data, and agrees not to publish or publicly present and/or discuss such data, Investigator’s current findings and/or the results of the Study independently without the express written consent of Sponsor, which consent may be withheld. Prior to submission for publication or presentation, all draft manuscripts must be submitted, reviewed and approved by Sponsor for confidential material.
4024|NCT01993030|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4025|NCT01992874|Principal Investigators are NOT employed by the organization sponsoring the study.|
4026|NCT01992536|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4027|NCT01992523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4028|NCT01992185|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4029|NCT01992172|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4030|NCT01992107|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
4031|NCT01992094|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial
4032|NCT01991990|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4033|NCT01991548|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4034|NCT01991314|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4035|NCT01990898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4036|NCT01990859|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
4037|NCT01990794|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4038|NCT01990703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4039|NCT01990677|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4040|NCT01990664|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4041|NCT01990560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4042|NCT01990534|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
4043|NCT01990339|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4044|NCT01990313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4065|NCT01987765|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4045|NCT01990261|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
4046|NCT01989689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4047|NCT01989676|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4048|NCT01989572|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4049|NCT01989455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4050|NCT01989195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4051|NCT01989169|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
4052|NCT01989156|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belong to the Sponsor."
4053|NCT01989130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4054|NCT01988922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4055|NCT01988857|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4056|NCT01988662|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigators from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
4057|NCT01988415|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor shall have the first right of publication of study data for the first 12 months. The institution or principal investigator may not disclose any of the Sponsor's proprietary information.
4058|NCT01988402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4059|NCT01988129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4060|NCT01988012|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4061|NCT01987986|Principal Investigators are NOT employed by the organization sponsoring the study.|
4062|NCT01987960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4063|NCT01987908|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, results may not be published without prior written approval of Sponsor.
4064|NCT01987895|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related publication written independently by investigators must be submitted to Actelion for review at least 30 days prior to submission for publication or presentation. Upon review, Actelion may provide comments, and may also request alterations and/or deletions for the sole purpose of protecting its confidential information and/or patent rights.
4066|NCT01987752|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4067|NCT01987583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4068|NCT01987557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4069|NCT01987479|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4070|NCT01987453|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4071|NCT01987349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4072|NCT01987232|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4073|NCT01987219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4074|NCT01986985|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4075|NCT01986946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4076|NCT01986855|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
4077|NCT01986790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4078|NCT01986751|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4079|NCT01986686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4080|NCT01986361|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4081|NCT01986231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4082|NCT01986062|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4083|NCT01985685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4084|NCT01985581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4085|NCT01985425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4086|NCT01985321|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 40 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and but can extend the embargo for up to 120 day to file patents or take other measures to preserve or secure its Intellectual Property.
4087|NCT01985126|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
4088|NCT01984892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4089|NCT01984697|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
4090|NCT01984684|Principal Investigators are NOT employed by the organization sponsoring the study.|Melinta has the right to first publication of results, which would be made in conjunction with the PIs from all appropriate sites. Thereafter, PIs may publish results provided the PI submits the proposed publication to Melinta for review at least 60 days prior to the date of the proposed publication. Melinta may remove any information that is considered confidential and/or proprietary. If a publication is not submitted within 12 months of study conclusion, the PI may publish results.
4091|NCT01984515|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4092|NCT01984424|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4093|NCT01984294|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4094|NCT01984242|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4095|NCT01984229|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4096|NCT01983878|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4097|NCT01983839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4098|NCT01983787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4099|NCT01983683|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related publication written independently by investigators must be submitted to Actelion for review at least 30 days prior to submission for publication or presentation. Upon review, Actelion may provide comments, and may also request alterations and/or deletions for the sole purpose of protecting its confidential information and/or patent rights.
4100|NCT01983566|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4101|NCT01983254|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4102|NCT01983111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4103|NCT01983020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4104|NCT01982812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4105|NCT01982773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4106|NCT01982695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4107|NCT01982539|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees that sponsor shall have the right to the first publication of the study results which is intended to be a joint, multi-center publication. Following the first publication, the PI may publish study data or results, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may remove any information that is considered confidential and / or proprietary other than study data.
4108|NCT01982435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4109|NCT01982383|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4110|NCT01982292|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4111|NCT01982253|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4112|NCT01981967|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4113|NCT01981863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4114|NCT01981616|Principal Investigators are NOT employed by the organization sponsoring the study.|
4115|NCT01981564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4116|NCT01981473|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4117|NCT01981356|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4118|NCT01981057|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4119|NCT01980992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4120|NCT01980940|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
4121|NCT01980888|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4122|NCT01980875|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4123|NCT01980628|Principal Investigators are NOT employed by the organization sponsoring the study.|"Agreement restrictions can vary and typically include (but are not limited to):~Required submission of all material for sponsor review at least thirty days prior to the proposed date of any presentation or submission. Materials must remove Proprietary Information, excluding Data /Study results. All Sponsor's comments are required to be included. Sponsor may delay the presentation/submission upon Sponsor review of materials that are being proposed for presentation/submission."
4124|NCT01980589|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4125|NCT01980524|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4126|NCT01980342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4127|NCT01980095|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agree that the Sponsor shall have the right to the first publication of the results of the Study. Following the first publication, the PI may publish data or results from the Study; subject to Sponsor for review and approval in writing at least sixty (60) days prior to the date of the publication. Sponsor may require changes and may extend the embargo to protect its intellectual property or other proprietary interests and to allow for the taking actions for this purpose.
4128|NCT01979952|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4129|NCT01979445|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4130|NCT01979276|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4131|NCT01979185|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
4132|NCT01979133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4133|NCT01979029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4134|NCT01978743|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4135|NCT01978600|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4136|NCT01978535|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4137|NCT01978314|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4138|NCT01978145|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4139|NCT01978119|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4140|NCT01977820|Principal Investigators are NOT employed by the organization sponsoring the study.|All written or oral publications and/or information related to Study and/or results of Study should be submitted at first in writing to Sponsor at least 30 working days for publication and 15 working days for brief review, abstract before planned date of submission. If Sponsor is filing a patent application on Study results, Sponsor can delay its authorization for publication/communication of Study results to Investigator and/or Research Centre until date of international registration of patent.
4141|NCT01977794|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4142|NCT01977781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4143|NCT01977729|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4144|NCT01977690|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4145|NCT01977625|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4146|NCT01977612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4147|NCT01977573|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4148|NCT01977482|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4149|NCT01977456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4150|NCT01977352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4151|NCT01977222|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4152|NCT01976988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4153|NCT01976871|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4154|NCT01976845|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4155|NCT01976819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4156|NCT01976806|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4157|NCT01976663|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4158|NCT01976650|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4159|NCT01976624|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4160|NCT01976572|Principal Investigators are NOT employed by the organization sponsoring the study.|
4161|NCT01976507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4162|NCT01976442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4184|NCT01974245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4163|NCT01976338|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
4164|NCT01976312|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
4165|NCT01976299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4166|NCT01976273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4167|NCT01976104|Principal Investigators are NOT employed by the organization sponsoring the study.|
4168|NCT01975974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4169|NCT01975948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4170|NCT01975935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4171|NCT01975922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4172|NCT01975909|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4173|NCT01975675|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4174|NCT01975467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4175|NCT01975285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4176|NCT01975246|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4177|NCT01975220|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4178|NCT01975090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4179|NCT01974895|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4180|NCT01974817|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4181|NCT01974752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4182|NCT01974700|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4183|NCT01974323|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4185|NCT01974141|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4186|NCT01974050|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4187|NCT01973777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4188|NCT01973608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4189|NCT01973595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4190|NCT01973491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4191|NCT01973439|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4192|NCT01973413|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4193|NCT01973387|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
4194|NCT01973348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4195|NCT01973231|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager before submission for comments. Comments will be given within four weeks from receipt of the planned communication.
4196|NCT01973218|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
4197|NCT01973205|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall review results communications prior to public release to evaluate the manuscript for accuracy, ascertain whether information (other than the results of the Clinical Trial) is being improperly disclosed, provided information which may have not have yet been made available by the Sponsor, provide input for consideration regarding the content and/or conclusion(s) of the manuscript and determine whether the manuscript discloses any potentially patentable invention(s).
4198|NCT01972776|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4199|NCT01972659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4200|NCT01972568|Principal Investigators are NOT employed by the organization sponsoring the study.|
4201|NCT01972529|Principal Investigators are NOT employed by the organization sponsoring the study.|
4202|NCT01972516|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4203|NCT01972464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4204|NCT01972438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4205|NCT01972152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4206|NCT01971723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4207|NCT01971645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4208|NCT01971593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4209|NCT01971580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4210|NCT01971567|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4211|NCT01971554|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
4212|NCT01971385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4213|NCT01971255|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4214|NCT01971203|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4215|NCT01971086|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4216|NCT01970995|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
4217|NCT01970982|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
4218|NCT01970878|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
4219|NCT01970865|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4220|NCT01970787|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4221|NCT01970488|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4222|NCT01970475|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4223|NCT01970462|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4243|NCT01968135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4224|NCT01970397|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4225|NCT01969799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4226|NCT01969747|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4227|NCT01969721|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4228|NCT01969565|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4229|NCT01969539|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4230|NCT01969448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4231|NCT01969435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4232|NCT01969162|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is no more than 120 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4233|NCT01969084|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4234|NCT01969058|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
4235|NCT01968980|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4236|NCT01968967|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4237|NCT01968954|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4238|NCT01968811|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4239|NCT01968694|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4240|NCT01968551|Principal Investigators are NOT employed by the organization sponsoring the study.|
4241|NCT01968434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4242|NCT01968226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4244|NCT01968057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4245|NCT01967940|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4246|NCT01967836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4247|NCT01967784|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4248|NCT01967732|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
4249|NCT01967719|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
4250|NCT01967706|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
4251|NCT01967628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4252|NCT01967550|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
4253|NCT01967342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4254|NCT01967277|Principal Investigators are NOT employed by the organization sponsoring the study.|PI may not disclose the results of the trial.
4255|NCT01967147|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4256|NCT01967121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4257|NCT01967069|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4258|NCT01966926|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4259|NCT01966770|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior consent from the sponsor.
4260|NCT01966718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4261|NCT01966458|Principal Investigators are NOT employed by the organization sponsoring the study.|In most cases, the contract allows the principal investigator to publish their data after the release of the multi-center publication (or one year after the conclusion of the study if no multi-center publication is submitted) following the sponsor review for (a) disclosure of confidential information, and (b) information that would impair the sponsor’s ability to obtain patent protection.
4262|NCT01966432|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4263|NCT01966380|Principal Investigators are NOT employed by the organization sponsoring the study.|
4264|NCT01966354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4265|NCT01966159|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4266|NCT01966120|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor will review results communications prior to public release and has to approve in order to ensure the adequate reporting of study results. The sponsor can't refuse publication for unfair reasons.
4267|NCT01966068|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4268|NCT01966042|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4269|NCT01966003|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4270|NCT01965938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4271|NCT01965899|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4272|NCT01965834|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4273|NCT01965756|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4274|NCT01965665|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4275|NCT01965652|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
4276|NCT01965600|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4277|NCT01965561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4278|NCT01965535|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4279|NCT01965431|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4280|NCT01965327|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4281|NCT01965288|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor.
4282|NCT01965262|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS an agreement between the Principal Investigator and the Sponsor that restricts the PI's right to discuss or publish trial results after the trial is completed without prior approval of Sponsor.~The investigator will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor."
4302|NCT01963091|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4283|NCT01965158|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
4284|NCT01965067|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4285|NCT01965002|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4286|NCT01964976|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4287|NCT01964950|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4288|NCT01964898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4289|NCT01964716|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4290|NCT01964547|Principal Investigators are NOT employed by the organization sponsoring the study.|GW Pharma Ltd (GW) will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
4291|NCT01964352|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4292|NCT01964326|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4293|NCT01964222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4294|NCT01964105|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4295|NCT01963845|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4296|NCT01963767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4297|NCT01963676|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4298|NCT01963611|Principal Investigators are NOT employed by the organization sponsoring the study.|
4299|NCT01963403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4300|NCT01963260|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
4301|NCT01963143|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4303|NCT01962974|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
4304|NCT01962961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4305|NCT01962922|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has no objection to publication of the results of the Study by Site based on information collected or generated by Site; provided, however, that such publication must not precede the primary manuscript (unless no such multi-site publication is completed within twelve (12) months following the completion of the Study or unless Sponsor notifies Site in writing that no such multi­ center publication shall be made).
4306|NCT01962675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4307|NCT01962558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4308|NCT01962493|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4309|NCT01962441|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4310|NCT01962428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4311|NCT01961544|Principal Investigators are NOT employed by the organization sponsoring the study.|
4312|NCT01961349|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4313|NCT01961323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4314|NCT01961297|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4315|NCT01961271|Principal Investigators are NOT employed by the organization sponsoring the study.|Data emerging from the study cannot be released without the permission of the sponsor.
4316|NCT01961115|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4317|NCT01961089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4318|NCT01960907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4319|NCT01960842|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4320|NCT01960816|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4321|NCT01960725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4322|NCT01960530|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must obtain written consent from the Sponsor prior to any publication of results.
4323|NCT01960400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4324|NCT01960387|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4325|NCT01960296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4326|NCT01960140|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4327|NCT01960114|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4328|NCT01959945|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4329|NCT01959932|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO's prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
4330|NCT01959880|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator and his/her collaborators are free to publish the background, methods, and results of their own research without restraint. Prior review of any proposed manuscript or abstract will be provided to the sponsor to prevent premature disclosure of trade secrets or proprietary information. The review will occur 30 days prior to submission of manuscript or abstract for consideration of publication or to a conference. Sponsor reserves right to publish or present the overall study results.
4331|NCT01959685|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
4332|NCT01959607|Principal Investigators are NOT employed by the organization sponsoring the study.|"We confirm we have the contractual provisions in place which specifies that in no event will the study site be allowed to disclose to any third party (or publicly release) any information obtained through the study without the CRO’s prior written consent which in turn cannot provide such consent without Sponsor's approval unless such publication is made to satisfy regulatory requirements.~The Intellectual Property rights and research results from the present study belongs to the Sponsor."
4333|NCT01959581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4334|NCT01959529|Principal Investigators are NOT employed by the organization sponsoring the study.|“At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property”
4335|NCT01959516|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
4336|NCT01959503|Principal Investigators are NOT employed by the organization sponsoring the study.|INSTITUTION and INVESTIGATOR agree if the Study is part of a multi-center study, the first publication of the results of the Study shall be made in coajunction with the results from the investigators at the other Study centers. In the event no publication of the multi-center study has been made within two years after the completion of the Study at all Study centers, then INSTITUTION and INVESTIGATOR shall be free to publish the Study results generated.
4337|NCT01959412|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
4338|NCT01959035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4339|NCT01958827|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4340|NCT01958788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4341|NCT01958671|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator will provide manuscripts, abstracts, or the full text of any other intended disclosure (poster presentation, invited speaker or guest lecturer presentation, etc.) to Sponsor at least 30 days before they are submitted for publication or otherwise disclosed. If any patent action is required to protect intellectual property rights, investigator agrees to delay the disclosure for a period not to exceed an additional 60 days.
4342|NCT01958645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4343|NCT01958619|Principal Investigators are NOT employed by the organization sponsoring the study.|After completion of the study, the Investigator may prepare a joint publication with MMV. The Investigator must undertake not to submit any part of the individual data from this protocol for publication without prior consent of MMV at a mutually agreed time. The confidentiality obligation applies to all personnel involved at the investigational site.
4344|NCT01958606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4345|NCT01958346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4346|NCT01958164|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4347|NCT01958060|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4348|NCT01958021|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
4349|NCT01958008|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4350|NCT01957930|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4351|NCT01957865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4352|NCT01957761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4353|NCT01957657|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4354|NCT01957579|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4355|NCT01957553|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4356|NCT01957488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4357|NCT01957475|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4358|NCT01957462|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4359|NCT01957410|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
4360|NCT01957397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4361|NCT01957384|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4362|NCT01957215|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4363|NCT01957202|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4364|NCT01957163|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4365|NCT01957137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4366|NCT01957111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4367|NCT01956435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4368|NCT01956240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4369|NCT01956097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4370|NCT01956032|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4371|NCT01955954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4372|NCT01955733|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4373|NCT01955720|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4374|NCT01955707|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
4375|NCT01955629|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
4376|NCT01955564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4377|NCT01955473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4378|NCT01955434|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4379|NCT01955382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4380|NCT01955369|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4381|NCT01955161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4382|NCT01955122|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4383|NCT01955083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4384|NCT01955044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4385|NCT01955005|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4386|NCT01954771|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4387|NCT01954745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4388|NCT01954628|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators shall not publish any articles or make any presentations or communications (including any written, oral or electronic manuscript, abstract, presentation or other publication) relating to the Services, Sponsor Information, Study Drug or other Material, Deliverables or other Developments, in whole or part, without the prior written consent of the Sponsor.
4389|NCT01954251|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4390|NCT01954160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4391|NCT01954121|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4392|NCT01953874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4393|NCT01953354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4394|NCT01953328|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4395|NCT01953237|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4396|NCT01953081|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may communicate the trial results generated by the PI, but only after the first publication or presentation of the combined study results generated by all participating sites. The Sponsor can then review trial results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The Sponsor cannot require changes to the communication and cannot extend the embargo.
4397|NCT01952834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4398|NCT01952691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4399|NCT01952665|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor.
4400|NCT01952600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4401|NCT01952418|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4402|NCT01952366|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4403|NCT01952301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4404|NCT01952145|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
4405|NCT01952080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4406|NCT01951963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4407|NCT01951950|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4408|NCT01951820|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4409|NCT01951703|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4410|NCT01951651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4411|NCT01951586|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4412|NCT01951573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4413|NCT01951417|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4414|NCT01951170|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4415|NCT01951092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4416|NCT01951066|Principal Investigators are NOT employed by the organization sponsoring the study.|
4417|NCT01950741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4418|NCT01950663|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4419|NCT01950364|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
4420|NCT01950078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4421|NCT01949870|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4422|NCT01949545|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4423|NCT01949532|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4424|NCT01949389|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4425|NCT01949155|Principal Investigators are NOT employed by the organization sponsoring the study.|"From the Protocol; 14.11. Use of Information and Publication. All information concerning OTO-201...remains the sole property of Otonomy.~Any publication or other public presentation of results from this study requires prior review and written approval of Otonomy. Draft abstracts, manuscripts, and materials for presentation at scientific meetings should be provided to the sponsor at least 30 working days prior to abstract or other relevant submission deadlines."
4426|NCT01949142|Principal Investigators are NOT employed by the organization sponsoring the study.|"From the Protocol:~14.11. Use of Information and Publication. All information concerning OTO-201...remains the sole property of Otonomy. Any publication or other public presentation of results from this study requires prior review and written approval of Otonomy. Draft abstracts, manuscripts, and materials for presentation at scientific meetings should be provided to the sponsor at least 30 working days prior to abstract or other relevant submission deadlines."
4427|NCT01949116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4428|NCT01949090|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4429|NCT01949051|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4430|NCT01948947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4431|NCT01948908|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4432|NCT01948830|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
4433|NCT01948791|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data in the clinical trial.
4434|NCT01948518|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4435|NCT01948375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4436|NCT01948310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4437|NCT01948193|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4438|NCT01948141|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4439|NCT01948076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4440|NCT01948063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4441|NCT01948050|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4442|NCT01947946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4443|NCT01947907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4444|NCT01947855|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4445|NCT01947582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4446|NCT01947517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4447|NCT01947491|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4448|NCT01947335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4449|NCT01947153|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4450|NCT01947127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4451|NCT01946542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4452|NCT01946529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4453|NCT01946438|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4454|NCT01946425|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4455|NCT01946412|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
4456|NCT01946243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4457|NCT01946178|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4458|NCT01946126|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4459|NCT01945970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4460|NCT01945944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4461|NCT01945489|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4462|NCT01945294|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
4463|NCT01945242|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4464|NCT01945138|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4465|NCT01945112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4466|NCT01945086|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
4467|NCT01945034|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4468|NCT01945021|Principal Investigators are NOT employed by the organization sponsoring the study.|PI will provide publication/disclosures at least 30 days before submission for publication; PI agrees to delay this for a period not to exceed an added 60 days if action is required to protect IP rights, & will remove, on request, any previously undisclosed Confidential Info (other than the Study results) before disclosure. Multi-centre study: PI agrees 1st publication will be joint & cover all sites; but may publish separately if this isn't submitted by12 mos of completion of study at all sites
4469|NCT01944969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4470|NCT01944878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4471|NCT01944774|Principal Investigators are NOT employed by the organization sponsoring the study.|PI needs to inform sponsor and asks for permission before he/she discusses or publishes trial results after the trial is completed.
4472|NCT01944722|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4473|NCT01944670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4474|NCT01944631|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4475|NCT01944462|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4476|NCT01944345|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4477|NCT01944319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4478|NCT01944098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4479|NCT01944059|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4480|NCT01943864|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4481|NCT01943565|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4482|NCT01943552|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4483|NCT01943539|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4484|NCT01943474|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4485|NCT01943435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4486|NCT01943344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4487|NCT01943292|Principal Investigators are NOT employed by the organization sponsoring the study.|The site is not able to publish any clinical trial results without first seeking permission from Verastem.
4488|NCT01943110|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor, funder, and PI of this study have jointly published the results.
4489|NCT01942785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4490|NCT01942733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4491|NCT01942720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4492|NCT01942707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4493|NCT01942590|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4494|NCT01942161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4495|NCT01942148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4496|NCT01942135|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4497|NCT01941940|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4498|NCT01941615|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4499|NCT01941498|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4500|NCT01941485|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4501|NCT01941472|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4502|NCT01941186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4503|NCT01940523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4504|NCT01940510|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4505|NCT01940497|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4506|NCT01940484|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4507|NCT01940471|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4508|NCT01940354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4509|NCT01940341|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4510|NCT01940146|Principal Investigators are NOT employed by the organization sponsoring the study.|
4511|NCT01940120|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4512|NCT01939938|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4513|NCT01939548|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4514|NCT01939496|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
4515|NCT01939405|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4516|NCT01939314|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4517|NCT01939301|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4518|NCT01939223|Principal Investigators are NOT employed by the organization sponsoring the study.|
4519|NCT01939197|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4520|NCT01939145|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4521|NCT01939002|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
4523|NCT01938833|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4524|NCT01938573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4525|NCT01938430|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4526|NCT01938391|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4527|NCT01938170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4528|NCT01938079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4529|NCT01938066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4530|NCT01938040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4531|NCT01937975|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor will provide separate guidance on the criteria for publication of clinical trial data when contacted for permission to publish.
4532|NCT01937871|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4533|NCT01937715|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4534|NCT01937598|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4535|NCT01937520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4536|NCT01937507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4537|NCT01937364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4538|NCT01937351|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the earliest of (a)publication of results, (b)receipt of notice stating that Study has been terminated or (c)18 months after completion or termination, Institution/Investigator (IN) shall have right to publish information & data collected or produced, provided that drafts are provided to Sponsor (SP) at least 60 days prior to the first submission. SP shall comment within 45 days. IN shall delay publication/presentation to enable SP to secure patent or other proprietary protection.
4539|NCT01937312|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4540|NCT01937299|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4541|NCT01937260|Principal Investigators are NOT employed by the organization sponsoring the study.|
4542|NCT01937195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4543|NCT01937130|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4544|NCT01937026|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4545|NCT01936974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4546|NCT01936909|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4547|NCT01936896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4548|NCT01936870|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4549|NCT01936844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4550|NCT01936662|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4551|NCT01936649|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI and/or institution is that the Sponsor can review results communications prior to public release and can restrict communications regarding trial results for a period that is more than 30 days (publications/abstracts) but not to exceed 90 days (patent related issues) from the time submitted to the Sponsor to review. The PI may be asked to remove any Sponsor confidential information and/or delay publication to protect any proprietary information.
4552|NCT01936623|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4553|NCT01936467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4554|NCT01936389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4555|NCT01936363|Principal Investigators are NOT employed by the organization sponsoring the study.|
4556|NCT01936181|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty (60) days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy of all such manuscripts and materials, and allow Sponsor sixty (60) days to review and comment on them. If the Sponsor requests, the Site shall remove any Confidential Information (other than Study results) prior to submitting or presenting the materials.
4557|NCT01935622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4558|NCT01935180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4559|NCT01934894|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4560|NCT01934790|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreed point of publication is 12-18 months after database lock at the earliest. Bayer will have 30-45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable). No publication of single center data should be done prior of publication if multi-center data.
4561|NCT01934582|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the Study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed, except as provided below. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
4562|NCT01934517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4563|NCT01934504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4564|NCT01934231|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4565|NCT01934218|Principal Investigators are NOT employed by the organization sponsoring the study.|
4566|NCT01934192|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4567|NCT01934010|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to submit a copy of any intended communication, presentation or publication (abstract, poster, article, etc.) (all together “Communication”) at least 2 month in advance of the submission of proposed Communication. The Sponsor shall have 60 days, after receipt of said copies, to object to such proposed Communication. In case of such objection, the Investigator shall refrain from making such Communication for 6 months from date of receipt of such objection.
4568|NCT01933932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4569|NCT01933919|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4570|NCT01933880|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days .In the event that issues arise regarding scientific integrity, the sponsor will review these issues with the investigator.
4571|NCT01933776|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4572|NCT01933672|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4573|NCT01933425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4574|NCT01933399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4575|NCT01933334|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4576|NCT01933243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4577|NCT01933230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4578|NCT01933048|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4579|NCT01932970|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4580|NCT01932762|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
4581|NCT01932606|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4582|NCT01932164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4583|NCT01932112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4584|NCT01932060|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4585|NCT01931956|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4586|NCT01931878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4587|NCT01931865|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4588|NCT01931839|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
4589|NCT01931709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4590|NCT01931527|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4591|NCT01931475|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4592|NCT01931462|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4593|NCT01931397|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4594|NCT01931150|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4595|NCT01931059|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4596|NCT01930890|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
4597|NCT01930799|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4598|NCT01930487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4599|NCT01930435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4600|NCT01930162|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4601|NCT01930058|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
4602|NCT01930045|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
4603|NCT01929993|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4604|NCT01929980|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4605|NCT01929889|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4606|NCT01929876|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4607|NCT01929863|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4608|NCT01929759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4609|NCT01929681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4610|NCT01929473|Principal Investigators are NOT employed by the organization sponsoring the study.|
4611|NCT01929460|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4612|NCT01929317|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4613|NCT01929135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4614|NCT01929083|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4615|NCT01929044|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4616|NCT01929031|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4617|NCT01928940|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4618|NCT01928927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4619|NCT01928862|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
4620|NCT01928797|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4621|NCT01928771|Principal Investigators are NOT employed by the organization sponsoring the study.|≥ 60 days prior to submission of material for publication/presentation, Institution and PI shall jointly provide AZ with material for review. No publication/presentation may include any of AZ’s Confidential Information without AZ’s written approval. AZ can request Inst. and PI to withhold material from submission for publication/presentation for an additional 90 days to allow AZ to establish and preserve its proprietary rights in the material being submitted for publication or presentation.
4622|NCT01928693|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4623|NCT01928680|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4624|NCT01928615|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4625|NCT01928472|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4626|NCT01928433|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4627|NCT01928381|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4628|NCT01928186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4629|NCT01928082|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4630|NCT01928030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4631|NCT01927887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4632|NCT01927757|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4633|NCT01927575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4634|NCT01927419|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
4635|NCT01927120|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4636|NCT01927055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4637|NCT01926977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4638|NCT01926782|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor's request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
4639|NCT01926626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4640|NCT01926119|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4641|NCT01926015|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
4642|NCT01925781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4663|NCT01923805|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4643|NCT01925768|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications
4644|NCT01925703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4645|NCT01925469|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4646|NCT01925417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4647|NCT01925274|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4648|NCT01925209|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4649|NCT01925183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4650|NCT01925170|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4651|NCT01925144|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4652|NCT01924975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4653|NCT01924949|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4654|NCT01924871|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4655|NCT01924767|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
4656|NCT01924559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4657|NCT01924390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4658|NCT01924364|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4659|NCT01924299|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4660|NCT01924182|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restrictions on the PI allow for the sponsor to review results communications prior to public release and to embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to sponsor for review. The sponsor is also allowed to require changes for technical correctness and to protect confidential information, copyrightable or patentable material; and when reasonably requested, extend the embargo up to an additional 90 days.
4661|NCT01924169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4662|NCT01923896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4664|NCT01923740|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4665|NCT01923480|Principal Investigators are NOT employed by the organization sponsoring the study.|
4666|NCT01923467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4667|NCT01923389|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4668|NCT01922986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4669|NCT01922934|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4670|NCT01922739|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
4671|NCT01922349|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
4672|NCT01922271|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4673|NCT01922219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4674|NCT01922115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4675|NCT01922089|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4676|NCT01922037|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
4677|NCT01922011|Principal Investigators are NOT employed by the organization sponsoring the study.|The data generated in this clinical study are the exclusive property of the Sponsor and are confidential. The Sponsor will make all reasonable efforts to publish the results of the study in an appropriate peer-reviewed journal. Authorship on the primary publication of the results from this study will be based on contributions to study design, enrollment, data analysis, and interpretation of results.
4678|NCT01921894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4679|NCT01921829|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4680|NCT01921751|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
4681|NCT01921452|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review the results communications prior to public release, and the sponsor can embargo communications regarding trial results if the PI does not get approval from the sponsor.
4682|NCT01921348|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4683|NCT01921322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4684|NCT01921296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4685|NCT01921270|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4686|NCT01921257|Principal Investigators are NOT employed by the organization sponsoring the study.|To avoid disclosures that may affect the proprietary rights of the Sponsor, the Investigator agrees to allow Circassia the opportunity to review all manuscripts and abstracts 60 days prior to submission for publication. Circassia reserves the right to include the report of this study in any regulatory documentation or submission or in any informational materials.
4687|NCT01921205|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4688|NCT01921166|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4689|NCT01921101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4690|NCT01920958|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4691|NCT01920893|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
4692|NCT01920854|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4693|NCT01920802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4694|NCT01920594|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4695|NCT01920568|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4696|NCT01920555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4697|NCT01920282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4698|NCT01920178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4699|NCT01919996|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4700|NCT01919801|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
4701|NCT01919723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4702|NCT01919606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4703|NCT01919450|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4704|NCT01919307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4705|NCT01919229|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
4706|NCT01919216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4707|NCT01918800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4708|NCT01918371|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4709|NCT01918332|Principal Investigators are NOT employed by the organization sponsoring the study.|
4710|NCT01918306|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4711|NCT01918085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4712|NCT01918033|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
4713|NCT01917812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4714|NCT01917773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4715|NCT01917656|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
4716|NCT01917526|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4717|NCT01917513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4718|NCT01917344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4719|NCT01917214|Principal Investigators are NOT employed by the organization sponsoring the study.|"Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days.~Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results."
4720|NCT01916980|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
4721|NCT01916967|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
4722|NCT01916941|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4723|NCT01916928|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4724|NCT01916824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4725|NCT01916681|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4726|NCT01916629|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4727|NCT01916590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4728|NCT01916304|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4729|NCT01916226|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4730|NCT01916109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4731|NCT01915940|Principal Investigators are NOT employed by the organization sponsoring the study.|No presentation or publication of Institution’s data relating to the Trial may occur until after the Trial has been completed at all sites. If Investigator desires to present or publish, investigator must submit any and all manuscripts, posters, abstracts, or other intended publications (hereinafter collectively referred to as “manuscripts”) to Sponsor at least sixty (60) days prior to the actual submission of such manuscript(s) for publication.
4732|NCT01915914|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4733|NCT01915849|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4734|NCT01915823|Principal Investigators are NOT employed by the organization sponsoring the study.|Meda Pharmaceuticals requests that it receive copies of any intended communication at least 15 working days for an abstract or oral presentation and 45 working days for a manuscript). This is to allow Meda Pharmaceuticals to review the communications for accuracy , to verify that confidential information is not being inadvertently divulged, to provide any relevant supplementary information, and to allow establishment of co-authorship.
4735|NCT01915732|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4736|NCT01915173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4737|NCT01915108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4738|NCT01914926|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4739|NCT01914757|Principal Investigators are NOT employed by the organization sponsoring the study.|≥ 60 days prior to submission of material for publication/presentation, Institution and PI shall jointly provide AZ with material for review. No publication/presentation may include any of AZ’s Confidential Information without AZ’s written approval. AZ can request Inst. and PI to withhold material from submission for publication/presentation for an additional 90 days to allow AZ to establish and preserve its proprietary rights in the material being submitted for publication or presentation.
4740|NCT01914679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4741|NCT01914666|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4742|NCT01914003|Principal Investigators are NOT employed by the organization sponsoring the study.|As outlined in each Clinical Trial Agreement between Sponsor and PI.
4743|NCT01913795|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4744|NCT01913600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4745|NCT01913535|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4746|NCT01913483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4747|NCT01913470|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4748|NCT01913405|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication. The sponsor requires a review of results communication (e .g. for confidential information) >= 30 days prior to submission and may request an additional delay of <=180 days (e .g. for intellectual property protection).
4749|NCT01913041|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4750|NCT01912781|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4751|NCT01912768|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4752|NCT01912599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4753|NCT01912495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4754|NCT01912404|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4755|NCT01912352|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4756|NCT01912339|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4757|NCT01912222|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
4758|NCT01911845|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
4759|NCT01911819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4760|NCT01911793|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4761|NCT01911780|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4762|NCT01911689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4763|NCT01911546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4764|NCT01911442|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS agreement between Principal Investigator and Sponsor that restricts PI's rights to discuss or publish trial results after trial is completed.~In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication provided, if a multicenter publication is not forthcoming within 24 months post completion of study at all sites, PI shall be free to publish."
4765|NCT01911429|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
4767|NCT01911390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4768|NCT01911351|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4769|NCT01911273|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator will provide manuscripts, abstracts, or the full text of any other intended disclosure (poster presentation, invited speaker or guest lecturer presentation, etc.) to Pfizer at least 30 days before they are submitted for publication or otherwise disclosed. If any patent action is required to protect intellectual property rights, Investigator agrees to delay the disclosure for a period not to exceed an additional 60 days.
4770|NCT01911260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4771|NCT01911221|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4772|NCT01911169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4773|NCT01911065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4774|NCT01910831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4775|NCT01910792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4776|NCT01910688|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4777|NCT01910636|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4778|NCT01910441|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
4779|NCT01910402|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4780|NCT01910389|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4781|NCT01910311|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4782|NCT01910181|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4783|NCT01910116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4784|NCT01910064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4785|NCT01909804|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4786|NCT01909778|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4787|NCT01909713|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4788|NCT01909674|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4789|NCT01909570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4790|NCT01909466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4791|NCT01909336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4792|NCT01909180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4793|NCT01909141|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4794|NCT01909011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4795|NCT01908907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4796|NCT01908842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4797|NCT01908829|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall provide sponsor with a copy of proposed publication/presentation for review and comment at least 30 days prior to submission for publication/presentation. The sponsor can delay communications regarding trial results for an additional 90 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication and can extend the delay.
4798|NCT01908803|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4799|NCT01908140|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of AstraZeneca. This information will not be given to a third party without the written consent of AstraZeneca. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and AstraZeneca.
4800|NCT01908127|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4801|NCT01907906|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4802|NCT01907854|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more public disclosures may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property. The results of this trial will be subject to public disclosure on external web sites according to international regulations, as reflected in the Novo Nordisk Code of Conduct for Clinical Trial Disclosure.
4803|NCT01907815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4804|NCT01907516|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4805|NCT01907490|Principal Investigators are NOT employed by the organization sponsoring the study.|For any publication or presentation the materials will be provided to the sponsor for approval. Sponsor will be permitted of 90-120 days for a review and shall have right to request modification if the material to be published will jeopardize the intellectual property of the sponsor .
4806|NCT01907334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4807|NCT01907321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4808|NCT01907113|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
4809|NCT01906658|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution/Investigator shall not, without Sponsor’s prior written consent, independently publish or otherwise disclose any results of the study until a Multi-Center Publication is published. If a Multi-Center Publication is not submitted for publication within the specified timeframe, Institution and Principal Investigator shall have the right to publish and present the results of Institution’s and Principal Investigator’s activities solely in accordance with the Sponsor’s written provisions.
4810|NCT01906515|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4811|NCT01906372|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4812|NCT01905956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4813|NCT01905683|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study information usually requires agreement with the sponsor. In case of justified doubts by the sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
4814|NCT01905657|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
4815|NCT01905553|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
4816|NCT01905540|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
4817|NCT01905423|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4818|NCT01905254|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4819|NCT01904864|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4820|NCT01904773|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4821|NCT01904760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4822|NCT01904721|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4823|NCT01904604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4824|NCT01904526|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4825|NCT01904279|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4826|NCT01904149|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting the results of this study for publication or presentation, the PI will allow the Sponsor at least 60 days to review and comment upon the publication manuscript. The Sponsor will provide any manuscript of the results of this study at least 60 days before publishing to the authors for a complete review.
4827|NCT01904071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4828|NCT01904058|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
4829|NCT01903993|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
4830|NCT01903876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4831|NCT01903863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4832|NCT01903720|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4833|NCT01903564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4834|NCT01903460|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually
4835|NCT01903265|Principal Investigators are NOT employed by the organization sponsoring the study.|An industry standard NDA in place with all study investigators.
4836|NCT01903187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4837|NCT01903148|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4838|NCT01903031|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
4839|NCT01903005|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4840|NCT01902888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4841|NCT01902758|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4842|NCT01902459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4843|NCT01902303|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4844|NCT01902134|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting the results of this study for publication or presentation, the PI will allow the Sponsor at least 60 days to review and comment upon the publication manuscript. The Sponsor will provide any manuscript of the results of this study at least 60 days before publishing to the authors for a complete review.
4845|NCT01901809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4846|NCT01901588|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4847|NCT01901575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4848|NCT01901393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4849|NCT01901341|Principal Investigators are NOT employed by the organization sponsoring the study.|
4850|NCT01901328|Principal Investigators are NOT employed by the organization sponsoring the study.|
4851|NCT01901302|Principal Investigators are NOT employed by the organization sponsoring the study.|
4852|NCT01901250|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4853|NCT01901211|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4854|NCT01901185|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4855|NCT01900665|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4856|NCT01900444|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4857|NCT01900431|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
4858|NCT01900314|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4859|NCT01900249|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4860|NCT01900067|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreement state that sponsor is the owner of all results. The Investigator may perform a secondary publication from an individual investigation site without disclosing confidential information received from sponsor after the multi-center publication or within 12 months after termination of the investigation if no such multi-centre publication takes place.
4861|NCT01900054|Principal Investigators are NOT employed by the organization sponsoring the study.|
4862|NCT01899911|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4863|NCT01899768|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4864|NCT01899742|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4865|NCT01899677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4866|NCT01899144|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
4867|NCT01898884|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution may publish results generated from the site individually.
4868|NCT01898598|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
4869|NCT01898442|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4870|NCT01898403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4871|NCT01898286|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall submit any paper or presentation to the Sponsor for review and comments at least 60 days prior to submitting the same to a third party. Upon receiving any request from the Sponsor to delete any Confidential Information or request to delay in publication up to 90 days to allow the filing of any Sponsor application, the Investigator shall take the request action. Investigator shall not be restricted after 18 months from completion of their site's performance in the study.
4872|NCT01898208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4873|NCT01898195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4874|NCT01898091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4875|NCT01897792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4876|NCT01897727|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4877|NCT01897402|Principal Investigators are NOT employed by the organization sponsoring the study.|All abstracts, presentations or manuscripts, and any data analyses conducted independently by the Investigator must be submitted in advance to the sponsor for review and approval. The sponsor will not unreasonably withhold publication of study findings. The objective of this policy is to ensure consistency between data filed with a regulatory authority and those appearing in the publication.
4878|NCT01897285|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidentiality Agreement
4879|NCT01897233|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
4880|NCT01897025|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4881|NCT01896986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4882|NCT01896934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4883|NCT01896895|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study information usually requires agreement with the sponsor. In case of justified doubts by the sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
4884|NCT01896726|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4885|NCT01896700|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4886|NCT01896687|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4887|NCT01896557|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4888|NCT01896544|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4889|NCT01896297|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
4890|NCT01896232|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4891|NCT01896206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4892|NCT01896193|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
4893|NCT01896115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4894|NCT01896050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4895|NCT01895946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4896|NCT01895634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4897|NCT01895608|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4898|NCT01895543|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
4899|NCT01895452|Principal Investigators are NOT employed by the organization sponsoring the study.|Should an Investigator desire to disclose study results, Sponsor will review the results disclosure prior to public release and can embargo the disclosure for a period of at least 60 days. Revisions to the disclosure will be negotiated in good faith. For a multicenter study the Investigators agree to publish/publicly present the results together with the other sites for the 12 month period after study results are available unless Sponsor grants written permission in advance.
4900|NCT01895335|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
4901|NCT01895322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4902|NCT01895309|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty (60) days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy of all such manuscripts and materials, and allow Sponsor sixty (60) days to review and comment on them. If the Sponsor requests, the Site shall remove any Confidential Information (other than Study results) prior to submitting or presenting the materials.
4903|NCT01895270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4904|NCT01895127|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4905|NCT01895101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4906|NCT01895088|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4907|NCT01895062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4908|NCT01895036|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4909|NCT01894984|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4910|NCT01894906|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4911|NCT01894672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4912|NCT01894620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4913|NCT01894607|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4914|NCT01894581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4915|NCT01894555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4916|NCT01894477|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4917|NCT01894256|Principal Investigators are NOT employed by the organization sponsoring the study.|
4918|NCT01894230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4919|NCT01894100|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4920|NCT01894087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4921|NCT01894022|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4922|NCT01893905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4923|NCT01893879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4924|NCT01893567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4925|NCT01893411|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study information usually requires agreement with the sponsor. In case of justified doubts by the sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
4926|NCT01893359|Principal Investigators are NOT employed by the organization sponsoring the study.|Site has the right to publish or communicate study results upon the earlier of: (a) publication of a multi-center publication of the Study results coordinated by Sponsor; or (b) submission of the Study data by Sponsor to the FDA; provided that the Sponsor reviews the proposed communication of results within ninety (90) days in advance of its release. Sponsor can request delay of publication or data release to allow for filing of patent application prior to the publication or release.
4927|NCT01893346|Principal Investigators are NOT employed by the organization sponsoring the study.|
4928|NCT01893281|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4929|NCT01893203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4930|NCT01892865|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4931|NCT01892709|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4932|NCT01892657|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4933|NCT01892306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4934|NCT01892267|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4935|NCT01892189|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property
4936|NCT01892163|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4937|NCT01892020|Principal Investigators are NOT employed by the organization sponsoring the study.|Authorship of publications should be in accordance with the Uniform Requirements of the International Committee of Medical Journal Editors. The Investigators offered authorship will be asked to comment and approve the publication. No permission to publish will be granted to any clinical research organization involved in the trial described in trial protocol.
4938|NCT01891968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4939|NCT01891890|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4940|NCT01891864|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty days prior to submitting/presenting manuscript or other materials relating to the study a copy should be provided to Sandoz and Sandoz has sixty days to review and comment. Sandoz has the right to require amendments to any such proposed presentation or publication on reasonable grounds. Sandoz may require any proposed publication or presentation to be delayed for up to four months to enable a patent application to be prepared and filed.
4941|NCT01891734|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4942|NCT01891669|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
4943|NCT01890967|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4944|NCT01890954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4945|NCT01890915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4946|NCT01890785|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
4947|NCT01890759|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
4948|NCT01890746|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
4949|NCT01890694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4950|NCT01890642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4951|NCT01890577|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
4952|NCT01890512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4953|NCT01890473|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
4954|NCT01890434|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4955|NCT01890421|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is interested in the publication of the results of every study it performs. All relevant aspects regarding the publication will be part of the contract between the sponsor and the investigator/institution. The sponsor has made the information regarding the study protocol publicly available on the internet at www.clinicaltrials.gov.
4956|NCT01890343|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4957|NCT01890148|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4958|NCT01890122|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
4959|NCT01890031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4960|NCT01889797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4961|NCT01889667|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4962|NCT01889563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4963|NCT01889420|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4964|NCT01889251|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
4965|NCT01888965|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4966|NCT01888952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4967|NCT01888900|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4968|NCT01888367|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4969|NCT01888003|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4970|NCT01887990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4971|NCT01887678|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agreements in place restricting the PI from independently publishing the study results.
4972|NCT01887470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4973|NCT01887418|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4974|NCT01887353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4975|NCT01887288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4976|NCT01887171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4977|NCT01887132|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4978|NCT01886963|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4979|NCT01886937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4980|NCT01886807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4981|NCT01886781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4982|NCT01886716|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4983|NCT01886690|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
4984|NCT01886313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4985|NCT01886300|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but only after the first publication or presentation that involves the overall study. The sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the sponsor's intellectual property rights.
4986|NCT01886287|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4987|NCT01886235|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4988|NCT01885936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4989|NCT01885910|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4990|NCT01885871|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4991|NCT01885559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4992|NCT01885208|Principal Investigators are NOT employed by the organization sponsoring the study.|"At the end of the trial, one or more scientific publications may be prepared collaboratively by the Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property."
4993|NCT01885117|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
4994|NCT01885104|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators have agreed to provide the Sponsor with the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication or presentation.
4995|NCT01885000|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreement covered by contract.
4996|NCT01884688|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4997|NCT01884675|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
4998|NCT01884597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
4999|NCT01884571|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5000|NCT01884545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5001|NCT01884519|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5002|NCT01884064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5003|NCT01883999|Principal Investigators are NOT employed by the organization sponsoring the study.|
5004|NCT01883986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5005|NCT01883908|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5006|NCT01883895|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5007|NCT01883804|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5008|NCT01883635|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5009|NCT01883453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5010|NCT01883440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5011|NCT01883427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5012|NCT01882907|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5013|NCT01882868|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
5014|NCT01882725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5034|NCT01880515|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5015|NCT01882647|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor has first right to publish pooled study data. In the event that such manuscript has not been submitted for publication within 12 months from study completion/termination at all participating sites, the PI shall have the right to single center publications provided they submit any data for presentation, oral or written, to the Sponsor for review thirty days prior to public disclosure. The PI may not disclose previously undisclosed confidential information other than study results.
5016|NCT01882543|Principal Investigators are NOT employed by the organization sponsoring the study.|1st publication to be a joint publication within 18 months of completion or termination of the trial at all sites. If not done the PI can publish separately, pending sponsor review 60 days prior to publication. PI agrees to remove sponsor confidential info. If sponsor identifies info it wishes to obtain IP protection for, PI agrees to remove sponsor identified info, or delay publication until the sponsor obtains IP protection and 120 calendar days from 1st submission for review to sponsor.
5017|NCT01882465|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5018|NCT01882439|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5019|NCT01882413|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5020|NCT01882257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5021|NCT01882062|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5022|NCT01881984|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5023|NCT01881932|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5024|NCT01881776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5025|NCT01881737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5026|NCT01881230|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 12 months since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for 90 more days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
5027|NCT01881126|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5028|NCT01881113|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5029|NCT01881087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5030|NCT01880840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5031|NCT01880736|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
5032|NCT01880723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5033|NCT01880697|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5035|NCT01880437|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5036|NCT01880424|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this trial will be the property of AstraZeneca and Ironwood Pharmaceuticals, Inc. An integrated clinical and statistical report will be prepared at the completion of the trial. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator, AstraZeneca, and Ironwood Pharmaceuticals, Inc.
5037|NCT01880320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5038|NCT01880099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5039|NCT01880086|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5040|NCT01879852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5041|NCT01879800|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5042|NCT01879735|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5043|NCT01879722|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
5044|NCT01879683|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5045|NCT01879618|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5046|NCT01879579|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5047|NCT01879553|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5048|NCT01879540|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5049|NCT01879410|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5050|NCT01879371|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5051|NCT01879345|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5052|NCT01879332|Principal Investigators are NOT employed by the organization sponsoring the study.|
5053|NCT01879319|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5054|NCT01879176|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5055|NCT01879072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5056|NCT01879059|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5057|NCT01878825|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5058|NCT01878812|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5059|NCT01878799|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5060|NCT01878656|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5061|NCT01878604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5062|NCT01878526|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5063|NCT01878214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5064|NCT01878175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5065|NCT01878149|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5066|NCT01878097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5067|NCT01877941|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5068|NCT01877720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5069|NCT01877668|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5070|NCT01877642|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5071|NCT01877564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5072|NCT01877538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5073|NCT01877421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5074|NCT01877408|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5075|NCT01877343|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5076|NCT01877278|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5077|NCT01877161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5078|NCT01877148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5079|NCT01876992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5080|NCT01876979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5081|NCT01876823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5082|NCT01876810|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5083|NCT01876784|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
5084|NCT01876732|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5085|NCT01876706|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5086|NCT01876368|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5087|NCT01876329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5088|NCT01875991|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5089|NCT01875978|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5090|NCT01875848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5091|NCT01875783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5092|NCT01875731|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5093|NCT01875510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5094|NCT01875471|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5095|NCT01875445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5096|NCT01875185|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5097|NCT01875159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5098|NCT01874951|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5137|NCT01870583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5099|NCT01874665|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for up to 1 year (to first generate a multicenter publication) and a period that is 60 to 120 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication to delete confidential information, excluding the results of the Study.
5100|NCT01874353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5101|NCT01874340|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis doesn not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data (i.e. data from all sites) in the clinical trial or disclosure of the trial results in their entirety.
5102|NCT01874275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5103|NCT01874262|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AstraZeneca (AZ) for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites.
5104|NCT01874145|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
5105|NCT01874132|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5106|NCT01874119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5107|NCT01874054|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 18 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to the Sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
5108|NCT01873989|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5109|NCT01873950|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5110|NCT01873859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5111|NCT01873729|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5112|NCT01873417|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
5113|NCT01872910|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5114|NCT01872819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5115|NCT01872715|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5116|NCT01872611|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5136|NCT01870596|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5117|NCT01872078|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca will manage the publication of the results of the Clinical Trial in partnership with the authors. AstraZeneca recognises that Institutions/Investigators may wish to make publications regarding Clinical Trial results. The Institution/Investigator agrees to collaborate in good faith with AstraZeneca. Prior to any such publication, the Institution/Investigator shall provide AstraZeneca with preliminary data and drafts of proposed publications.
5118|NCT01871870|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5119|NCT01871805|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5120|NCT01871558|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
5121|NCT01871532|Principal Investigators are NOT employed by the organization sponsoring the study.|
5122|NCT01871519|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5123|NCT01871441|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5124|NCT01871402|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor has first right to publish pooled study data. In the event that such manuscript has not been submitted for publication within 12 months from study completion/termination at all participating sites, the PI shall have the right to single center publications provided they submit any data for presentation, oral or written, to the Sponsor for review 30 days prior to public disclosure. The PI may not disclose previously undisclosed confidential information other than study results.
5125|NCT01871285|Principal Investigators are NOT employed by the organization sponsoring the study.|PI and Institution reserve the right to publish and present the results of the work performed provided that Institution and/or PI submits a copy of any proposed publication to Sponsor's agent for review and comment at least 90 days in advance of its presentation or submission for publication. In addition, if Sponsor's agent requests, Institution and/or PI will withhold publication or presentation for an additional 60 days to allow for establishing and preserving its proprietary rights.
5126|NCT01871142|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5127|NCT01871090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5128|NCT01870999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5129|NCT01870973|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5130|NCT01870921|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty (60) days prior to submission of any material for publication or presentation, Institution shall provide AstraZeneca with such material for review. If requested in writing by AstraZeneca, Institution shall withhold material from submission for publication or presentation for an additional ninety (90) days to allow for the filing of a patent application or the taking of such measures as AstraZeneca deems appropriate to establish and preserve its proprietary rights.
5131|NCT01870856|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5132|NCT01870843|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
5133|NCT01870778|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5134|NCT01870739|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5135|NCT01870726|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
5138|NCT01870388|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5139|NCT01870076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5140|NCT01869959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5141|NCT01869699|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5142|NCT01869686|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5143|NCT01869647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5144|NCT01869478|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5145|NCT01869439|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5146|NCT01869348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5147|NCT01869075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5148|NCT01868997|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights.
5149|NCT01868893|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5150|NCT01868789|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5151|NCT01868776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5152|NCT01868633|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5153|NCT01868542|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
5154|NCT01868503|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5155|NCT01868334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5156|NCT01868243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5157|NCT01868074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5158|NCT01868035|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5159|NCT01868009|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5160|NCT01867710|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
5161|NCT01867658|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5162|NCT01867632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5163|NCT01867580|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5164|NCT01867515|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5165|NCT01867424|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5166|NCT01867307|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5167|NCT01867164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5168|NCT01867086|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5169|NCT01867047|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5170|NCT01867021|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial
5171|NCT01866943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5172|NCT01866709|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI cannot publish any results related to the study without prior written approval of the Sponsor.
5173|NCT01866592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5174|NCT01866423|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5175|NCT01866319|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
5176|NCT01866306|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
5177|NCT01866293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5178|NCT01866163|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators’ right to publish the results of the trial, irrespective of outcome. Pubs/presentations by investigator(s) shall not be made before the results of a joint publication is public. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
5179|NCT01866150|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5180|NCT01865812|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators must wait 18 months after the study ends to publish their results and a multi-center publication must come first. The sponsor has a 45 day review period with the option to extend to an additional 90 days.
5181|NCT01865747|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements with investigators vary; constant is our right to review results communications prior to public release, and embargo communications for a period of ≤60 days from submittal for review. We do not prohibit investigators from publishing, but we may require previously undisclosed confidential information, other than study results, to be removed from publications, and single-center publications are postponed until after publication of the trial’s primary multicenter publication.
5182|NCT01865708|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5183|NCT01865084|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5184|NCT01864538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5185|NCT01864434|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5186|NCT01864200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5187|NCT01864174|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5188|NCT01864148|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
5189|NCT01864005|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5190|NCT01863953|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5191|NCT01863771|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
5192|NCT01863758|Principal Investigators are NOT employed by the organization sponsoring the study.|Octapharma agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Octapharma supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. Octapharma also reserves the right to review data prior to publishing and provide comments/changes within a certain time period.
5193|NCT01863680|Principal Investigators are NOT employed by the organization sponsoring the study.|The study as a whole will be published prior to any individual investigator publications. It is required that copies of all papers, abstracts, articles, etc. that contain study data are to be forward to the Sponsor for review 30 days prior to submission for publication.
5194|NCT01863667|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.~Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results."
5195|NCT01863563|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5217|NCT01860586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5196|NCT01863433|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
5197|NCT01863368|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5198|NCT01863134|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5199|NCT01862991|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5200|NCT01862484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5201|NCT01862419|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5202|NCT01862250|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5203|NCT01862159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5204|NCT01862133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5205|NCT01861925|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor can require an extension of the embargo for 90 days. If the communication contains confidential information of the sponsor, the sponsor can require to replace this information by scientifically meaningful equivalent information.
5206|NCT01861756|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5207|NCT01861704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5208|NCT01861665|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5209|NCT01861522|Principal Investigators are NOT employed by the organization sponsoring the study.|
5210|NCT01861457|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5211|NCT01861301|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5212|NCT01860989|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5213|NCT01860976|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5214|NCT01860846|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5215|NCT01860703|Principal Investigators are NOT employed by the organization sponsoring the study.|"All unpublished information given to the CRO by ApoPharma shall not be published or disclosed to a third party without the prior written consent of ApoPharma.~The data generated by this study are considered confidential information and the property of ApoPharma. This confidential information may be published only in collaboration with participating personnel from ApoPharma or upon ApoPharma written consent to publish the article."
5216|NCT01860677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5218|NCT01860573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5219|NCT01860534|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5220|NCT01860521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5221|NCT01860170|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5222|NCT01860079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5223|NCT01860040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5224|NCT01859988|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor’s request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
5225|NCT01859949|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5226|NCT01859793|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5227|NCT01859715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5228|NCT01859702|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5229|NCT01859637|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5230|NCT01859611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5231|NCT01859598|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5232|NCT01859507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5233|NCT01859494|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5234|NCT01859390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5235|NCT01859325|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5236|NCT01859312|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5237|NCT01859247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5238|NCT01859195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5239|NCT01859143|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
5240|NCT01859078|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5241|NCT01859013|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5242|NCT01858766|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5243|NCT01858701|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5244|NCT01858636|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5245|NCT01858545|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5246|NCT01858428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5247|NCT01858389|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5248|NCT01858376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5249|NCT01857986|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5250|NCT01857882|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5251|NCT01857713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5252|NCT01857622|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
5253|NCT01857583|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
5254|NCT01857531|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5255|NCT01857362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5256|NCT01857323|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
5257|NCT01857297|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
5258|NCT01857258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5259|NCT01857206|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5260|NCT01857102|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5261|NCT01857063|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
5262|NCT01856933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5263|NCT01856907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5264|NCT01856764|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
5265|NCT01856686|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5266|NCT01856673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5267|NCT01856569|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5268|NCT01856530|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5269|NCT01856491|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5270|NCT01856361|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5271|NCT01856322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5272|NCT01856270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5273|NCT01856257|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5274|NCT01856218|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5275|NCT01855997|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5276|NCT01855958|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5277|NCT01855945|Principal Investigators are NOT employed by the organization sponsoring the study.|
5278|NCT01855919|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5279|NCT01855789|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5298|NCT01853696|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5280|NCT01855074|Principal Investigators are NOT employed by the organization sponsoring the study.|"All the information generated through services from the Principal Investigator (PI), the Sponsor has the rights to publish the data without previous consent from the PI.~The PI must not publish completely or partially any results from the study, without previous authorization from the Sponsor."
5281|NCT01854944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5282|NCT01854905|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5283|NCT01854827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5284|NCT01854710|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5285|NCT01854697|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5286|NCT01854658|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
5287|NCT01854645|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
5288|NCT01854632|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5289|NCT01854593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5290|NCT01854528|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5291|NCT01854281|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5292|NCT01854268|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5293|NCT01854242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5294|NCT01854047|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
5295|NCT01854034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5296|NCT01853982|Principal Investigators are NOT employed by the organization sponsoring the study.|
5297|NCT01853839|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5299|NCT01853605|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5300|NCT01853475|Principal Investigators are NOT employed by the organization sponsoring the study.|After completion of the study, the Investigator may prepare a joint publication with the Sponsor. The Investigator must undertake not to submit any part of the individual data from this protocol for publication without prior consent of the Sponsor at a mutually agreed time.
5301|NCT01853397|Principal Investigators are NOT employed by the organization sponsoring the study.|Authorship and manuscript composition will reflect joint cooperation between the PI and Solta Medical personnel. Authorship will be established prior to the writing of the manuscript. No individual publications will be allowed prior to completion of the final report of the study except as agreed with Solta Medical. All publications must be reviewed and approved by Solta Medical prior to submission for publication.
5302|NCT01853384|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5303|NCT01853371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5304|NCT01853332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5305|NCT01853280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5306|NCT01853254|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5307|NCT01853215|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5308|NCT01853176|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5309|NCT01853085|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5310|NCT01853072|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5311|NCT01853046|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5312|NCT01852955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5313|NCT01852825|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
5314|NCT01852812|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
5315|NCT01852669|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5316|NCT01852591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5317|NCT01852383|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5318|NCT01852344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5319|NCT01852214|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5320|NCT01852175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5321|NCT01852162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5322|NCT01852110|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
5323|NCT01852032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5324|NCT01852019|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication or presentation, the Institution will provide the Sponsor thirty (30) days for review and comment, If necessary, Sponsor will be given an additional sixty (60) days to allow Sponsor to file a patent application or taking such other measures as Sponsor deems appropriate to establish and preserve its proprietary rights upon the manuscript or other material for such publication. Sponsor may remove confidential or proprietary information.
5325|NCT01851876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5326|NCT01851863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5327|NCT01851772|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5328|NCT01851720|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5329|NCT01851655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5330|NCT01851590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5331|NCT01851330|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5332|NCT01851174|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5333|NCT01850615|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
5334|NCT01850589|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5335|NCT01850550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5336|NCT01850485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5337|NCT01850394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5338|NCT01850030|Principal Investigators are NOT employed by the organization sponsoring the study.|"At least sixty (60) days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy of all such manuscripts and materials, and allow sponsor sixty (60) days to review and comment on them.~If the Sponsor requests, the Site shall remove any Confidential Information (other than Study results) prior to submitting or presenting the materials."
5339|NCT01849848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5340|NCT01849770|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5342|NCT01849588|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5343|NCT01849562|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting/presenting a manuscript or materials relating to a Study to a publisher, reviewer, or outside person, the Institution shall provide to Achillion a copy of all such manuscripts or materials, and Achillion shall have thirty (30) days to review and comment. The Institution shall, upon Achillion's request, further delay publication or presentation for a period of up to sixty (60) days to allow Achillion to protect its interests in any Achillion Inventions.
5344|NCT01849497|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5345|NCT01849458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5346|NCT01849419|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5347|NCT01849289|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to Novo Nordisk before submission for comments. Comments will be given within four weeks from receipt of the planned communication.
5348|NCT01849263|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5349|NCT01849068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5350|NCT01848990|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained as a result of this study or during the conduct of this study will be regarded as confidential. The Investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless written permission from the sponsor (Halozyme) is obtained.
5351|NCT01848977|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5352|NCT01848938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5353|NCT01848899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5354|NCT01848847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5355|NCT01848834|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
5356|NCT01848756|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5357|NCT01848366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5358|NCT01848288|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5359|NCT01848210|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 30 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results.
5360|NCT01848145|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
5361|NCT01848067|All Principal Investigators ARE employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5362|NCT01848054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5363|NCT01847885|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5364|NCT01847547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5365|NCT01847443|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5366|NCT01847430|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5367|NCT01847196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5368|NCT01847131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5369|NCT01846741|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted for sponsor's review if such publication contains Confidential Information or will adversely affect any intellectual property or proprietary right of the sponsor. The sponsor can require changes to the communication, but cannot extend the embargo set forth in the study agreement.
5370|NCT01846455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5371|NCT01846442|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators shall provide to the SPONSOR 30 days prior to submission all documents for publication, presentation, etc that report any trial results. The SPONSOR shall have editorial rights on documents and the right to review/comment with regard to (1) proprietary information, (2) accuracy of the information, (3) correctness of the scientific evaluation/conclusions and (4) to ensure that the information is fairly balanced and in compliance with regulations.
5372|NCT01846416|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5373|NCT01846299|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5374|NCT01846221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5375|NCT01846104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5376|NCT01846039|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5377|NCT01845974|Principal Investigators are NOT employed by the organization sponsoring the study.|
5378|NCT01845831|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5379|NCT01845636|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5380|NCT01845220|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5381|NCT01845155|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5382|NCT01845103|Principal Investigators are NOT employed by the organization sponsoring the study.|Site and Investigator agree not to publish or present results prior to Sponsor's final report, but in no event shall Site or Investigator be restricted after the expiration of 12m from Project completion. Publication or disclosure made by Site or Investigator shall not contain Sponsor Confidential Information (CI) and text shall be submitted for Sponsor CI review and comment 30d prior to submission or disclosure and can be deferred, not exceeding 90d for the Sponsor to protect its rights in CI.
5383|NCT01845077|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
5384|NCT01845025|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5385|NCT01844895|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5386|NCT01844856|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 60 days prior to submitting or presenting a manuscript, poster, presentation, abstract or other materials relating to the Trial, the PI shall provide to Sponsor all such manuscripts and materials, and Sponsor shall have 60 days to review and comment. If requested, the PI shall remove confidential information prior to submitting or presenting the materials, and shall delay publication or presentation for up to 90 days to allow Sponsor to protect its interests in any such materials.
5387|NCT01844830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5388|NCT01844817|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
5389|NCT01844778|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5390|NCT01844765|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
5391|NCT01844700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5392|NCT01844687|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5393|NCT01844531|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5394|NCT01844518|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5395|NCT01844505|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5396|NCT01844479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5397|NCT01844388|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5398|NCT01844206|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5399|NCT01843972|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
5400|NCT01843933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5401|NCT01843920|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5402|NCT01843777|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5403|NCT01843673|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5404|NCT01843660|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the PI is that the PI should submit manuscript to the Sponsor for review no less than 60 days prior to public release. Only with written approval of the Sponsor, the results communications could be public released.
5405|NCT01843465|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5406|NCT01843374|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the communication of results, it being understood that results shall be published regardless of outcome
5407|NCT01843348|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trail results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigation from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., from all sites) in the clinical trial.
5408|NCT01843205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5409|NCT01843192|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5410|NCT01842958|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5411|NCT01842906|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5412|NCT01842841|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
5413|NCT01842789|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5414|NCT01842646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5415|NCT01842633|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5416|NCT01842620|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5417|NCT01842607|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5418|NCT01842594|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5419|NCT01842464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5420|NCT01842438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5421|NCT01841970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5422|NCT01841931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5423|NCT01841697|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
5424|NCT01841619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5425|NCT01841606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5426|NCT01841593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5427|NCT01841567|Principal Investigators are NOT employed by the organization sponsoring the study.|
5428|NCT01841216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5429|NCT01841021|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5430|NCT01840943|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
5431|NCT01840605|Principal Investigators are NOT employed by the organization sponsoring the study.|
5432|NCT01840410|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5433|NCT01840345|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5434|NCT01840319|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5435|NCT01840072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5436|NCT01839708|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5437|NCT01839695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5438|NCT01839604|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5439|NCT01839318|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5440|NCT01839279|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
5441|NCT01839058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5442|NCT01838980|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5443|NCT01838941|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5444|NCT01838785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5445|NCT01838694|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5446|NCT01838681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5447|NCT01838655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5448|NCT01838642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5449|NCT01838616|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
5450|NCT01838590|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5451|NCT01838499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5452|NCT01838304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5453|NCT01838213|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5454|NCT01838044|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5455|NCT01837966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5456|NCT01837823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5457|NCT01837797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5458|NCT01837719|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5459|NCT01837680|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5460|NCT01837550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5461|NCT01837537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5462|NCT01837524|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5463|NCT01836809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5464|NCT01836523|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk commits to communicating, and otherwise making available for public disclosure, results of trials regardless of outcome.At the end of the trial, one or more public disclosures may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
5465|NCT01836471|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
5466|NCT01836458|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5467|NCT01836133|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5468|NCT01836042|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5469|NCT01835912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5470|NCT01835899|Principal Investigators are NOT employed by the organization sponsoring the study.|
5471|NCT01835756|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5472|NCT01835743|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5473|NCT01835548|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5474|NCT01835496|Principal Investigators are NOT employed by the organization sponsoring the study.|"All unpublished information given to the PI by ApoPharma shall not be published or disclosed to a third party without the prior written consent of ApoPharma.~The data generated by this study are considered confidential information and the property of ApoPharma. This confidential information may be published only in collaboration with participating personnel from ApoPharma or upon ApoPharma written consent to publish the article."
5475|NCT01835470|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5476|NCT01835431|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to Novo Nordisk before submission for comments. Comments will be given within four weeks from receipt of the planned communication
5477|NCT01835379|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release.
5478|NCT01835262|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5479|NCT01835132|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5480|NCT01835015|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5481|NCT01834651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5482|NCT01834586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5483|NCT01834404|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5484|NCT01834274|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
5485|NCT01834261|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5486|NCT01834222|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5487|NCT01834027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5488|NCT01833988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5489|NCT01833936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5490|NCT01833897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5491|NCT01833845|Principal Investigators are NOT employed by the organization sponsoring the study.|The publication of the results of the Research in their entirety or in part, will be at the sole initiative of BIOLINERX Ltd. Reference to the results of the search cannot be made without the prior written agreement of BioLineRx Ltd..
5492|NCT01833741|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5493|NCT01833533|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5494|NCT01833481|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5495|NCT01833403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5496|NCT01833247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5497|NCT01833169|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
5498|NCT01833130|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5499|NCT01833117|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5500|NCT01833078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5501|NCT01833065|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
5502|NCT01832766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5503|NCT01832506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5504|NCT01832493|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5505|NCT01832155|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5506|NCT01832090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5507|NCT01831934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5508|NCT01831817|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5509|NCT01831791|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5510|NCT01831765|Principal Investigators are NOT employed by the organization sponsoring the study.|"At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk.~Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property."
5511|NCT01831726|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5512|NCT01831466|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The PI must remove any previously undisclosed Confidential Information (other than the Study results themselves) before public release.
5513|NCT01831258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5514|NCT01831232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5515|NCT01831219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5516|NCT01831154|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5517|NCT01830972|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5518|NCT01830933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5519|NCT01830920|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5520|NCT01830881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5521|NCT01830855|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5522|NCT01830842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5523|NCT01830790|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5524|NCT01830699|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5525|NCT01830543|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
5526|NCT01830205|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5527|NCT01830140|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5528|NCT01830127|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5529|NCT01829919|Principal Investigators are NOT employed by the organization sponsoring the study.|
5530|NCT01829516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5531|NCT01829503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5532|NCT01829477|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
5533|NCT01829464|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
5534|NCT01829399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5535|NCT01829243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5536|NCT01829230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5537|NCT01829191|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5538|NCT01829165|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5539|NCT01828983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5540|NCT01828593|Principal Investigators are NOT employed by the organization sponsoring the study.|If no multi-site publication is made within 18 months, Site may publish Site’s results, subject to the following. At least 30 days prior to submitting a manuscript the Site shall provide to Entera a copy, and Entera shall have 30 days to review. Site shall remove any Confidential Information, upon Entera's request, prior to submitting the materials, and the Site shall delay publication for an additional period of up to 60 days to allow Entera to protect its interests in any Inventions.
5541|NCT01828476|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5542|NCT01828281|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5543|NCT01828216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5544|NCT01828164|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5545|NCT01828112|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
5546|NCT01828099|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
5547|NCT01827839|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5548|NCT01827670|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5549|NCT01827592|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
5550|NCT01827475|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5551|NCT01827462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5552|NCT01827371|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5553|NCT01827358|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5554|NCT01827332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5555|NCT01827319|Principal Investigators are NOT employed by the organization sponsoring the study.|Additionally, Sponsor has the right to request removal of any confidential information prior to publication.
5556|NCT01827306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5557|NCT01827267|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5558|NCT01827254|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5559|NCT01826981|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5560|NCT01826812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5561|NCT01826604|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5562|NCT01826513|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Sponsor has the right to~review~provide comments (site is not bound to follow them)~request delay of publication for no more than 120 days to allow for securing of IP~request the removal of specified confidential information~within 40 days of the proposed publication being released to those not bound by confidentiality obligations."
5563|NCT01826422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5564|NCT01826370|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5565|NCT01826227|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5566|NCT01826214|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
5567|NCT01826201|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor approves content of communication.
5568|NCT01825837|Principal Investigators are NOT employed by the organization sponsoring the study.|
5569|NCT01825798|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5570|NCT01825577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5571|NCT01825408|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5572|NCT01825200|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5573|NCT01825122|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5574|NCT01824979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5575|NCT01824901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5576|NCT01824823|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5577|NCT01824602|Principal Investigators are NOT employed by the organization sponsoring the study.|
5578|NCT01824589|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5579|NCT01824576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5580|NCT01824498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5581|NCT01824446|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
5582|NCT01824355|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5583|NCT01824342|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5606|NCT01822223|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5584|NCT01824303|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5585|NCT01824160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5586|NCT01823679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5587|NCT01823653|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall notify Sponsor of the intent to publish or present independent Study Data, and agrees not to publish or publicly present and/or discuss such data, Investigator’s current findings and/or the results of the Study independently without the express written consent of Sponsor, which consent may be withheld. Sponsor reserves the right to require Investigator to remove any/all confidential information from any/all publications.
5588|NCT01823614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5589|NCT01823536|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
5590|NCT01823510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5591|NCT01823341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5592|NCT01823289|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5593|NCT01823224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5594|NCT01823146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5595|NCT01822899|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5596|NCT01822821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5597|NCT01822756|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
5598|NCT01822691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5599|NCT01822678|Principal Investigators are NOT employed by the organization sponsoring the study.|
5600|NCT01822665|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5601|NCT01822574|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5602|NCT01822561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5603|NCT01822548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5604|NCT01822535|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5605|NCT01822301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5607|NCT01822197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5608|NCT01822119|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5609|NCT01821963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5610|NCT01821937|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5611|NCT01821859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5612|NCT01821807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5613|NCT01821534|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5614|NCT01821417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5615|NCT01821378|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS agreement between Principal Investigator and Sponsor that restricts PI's rights to discuss or publish trial results after trial is completed.~In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication provided, if a multicenter publication is not forthcoming within 24 months post completion of study at all sites, PI shall be free to publish."
5616|NCT01821352|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5617|NCT01821326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5618|NCT01821118|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5619|NCT01821105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5620|NCT01820754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5621|NCT01820585|Principal Investigators are NOT employed by the organization sponsoring the study.|
5622|NCT01820559|Principal Investigators are NOT employed by the organization sponsoring the study.|
5623|NCT01820416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5624|NCT01820364|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of the sponsor's agreements with its investigators may vary. However, the sponsor does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in the clinical trial.
5625|NCT01819935|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5626|NCT01819922|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5627|NCT01819844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5628|NCT01819415|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5629|NCT01819311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5630|NCT01819272|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study may be published by INSTITUTE, however the publication shall not disclose any SPONSOR Confidential Information, the INSTITUTE shall send the SPONSOR a copy of any such proposed publication 90 days prior to submission for publication, the INSTITUTE, on request of the SPONSOR, shall delete any SPONSOR Confidential Information in the proposed publication, and the INSTITUTE shall, on the SPONSOR’s request, delay submission while the SPONSOR files applications for patents.
5631|NCT01819194|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5632|NCT01819129|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more public disclosures may be prepared collaboratively by the Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
5633|NCT01818752|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5634|NCT01818700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5635|NCT01818596|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5636|NCT01818414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5637|NCT01818336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5638|NCT01818297|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restrictions on the PI allow for the sponsor to review results communications prior to public release and to embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to sponsor for review. The sponsor is also allowed to require changes for technical correctness and to protect confidential information, copyrightable or patentable material; and when reasonably requested, extend the embargo up to an additional 90 days.
5639|NCT01818141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5640|NCT01818063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5641|NCT01817907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5642|NCT01817855|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5643|NCT01817790|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5644|NCT01817777|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5645|NCT01817764|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5646|NCT01817725|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5647|NCT01817374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5648|NCT01816893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5649|NCT01816776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5650|NCT01816685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5651|NCT01816477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5652|NCT01816451|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5653|NCT01816295|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5654|NCT01816243|Principal Investigators are NOT employed by the organization sponsoring the study.|"Timing and publication of the results will be subject to mutual agreement in the project between all Investigators participating in the project and Janssen-Cilag., Thailand.~All manuscripts and abstracts utilizing the data from this study are subjected to the approval of Janssen. All manuscripts and abstract must be sent to Janssen at least one month prior to the submission for publication or presentation."
5655|NCT01816074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5656|NCT01816048|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5657|NCT01815918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5658|NCT01815840|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5659|NCT01815736|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5660|NCT01815671|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5661|NCT01815645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5662|NCT01815138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5663|NCT01815099|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5664|NCT01815008|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5665|NCT01814878|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) cannot provide any trial related information to external parties’ without mutual agreement with the Sponsor. This is valid even after the contract is cancelled.
5666|NCT01814800|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication (sponsor coordinated), the Institution/PI may publish data or results from the study, if the material is reviewed by the sponsor at least 60 days prior to the proposed deadline; sponsor may remove any information considered confidential other than study data and results. If a multi-center publication is not submitted within 24 months after conclusion of the study at all sites, the Institution/PI may publish the study results following review by the Sponsor.
5667|NCT01814787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5668|NCT01814774|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5669|NCT01814761|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5670|NCT01814748|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
5671|NCT01814722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5672|NCT01814696|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5673|NCT01814670|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5674|NCT01814553|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
5675|NCT01814397|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5676|NCT01814332|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5677|NCT01814241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5678|NCT01814137|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
5679|NCT01814046|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5680|NCT01813890|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5681|NCT01813721|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5682|NCT01813474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5683|NCT01813422|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5684|NCT01813110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5685|NCT01813019|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5686|NCT01812837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5687|NCT01812707|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
5688|NCT01812681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5689|NCT01812655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5690|NCT01812473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5691|NCT01812057|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5692|NCT01812044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5693|NCT01811953|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5694|NCT01811732|Principal Investigators are NOT employed by the organization sponsoring the study.|Melinta has the right to first publication of results, which would be made in conjunction with the PIs from all appropriate sites. Thereafter, PIs may publish results provided the PI submits the proposed publication to Melinta for review at least 60 days prior to the date of the proposed publication. Melinta may remove any information that is considered confidential and/or proprietary. If a publication is not submitted within 12 months of study conclusion, the PI may publish results.
5695|NCT01811706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5696|NCT01811680|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5697|NCT01811563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5698|NCT01811485|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5699|NCT01811472|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5700|NCT01811355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5701|NCT01811316|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. PI shall delay publications for up to 90 days upon receipt of a written request from the sponsor in order to allow the sponsor to register intellectual property rights that are included in the proposed publication.
5702|NCT01811303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5703|NCT01811238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5704|NCT01811212|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5705|NCT01811186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5706|NCT01810952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5707|NCT01810939|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements generally provide that PI cannot publish single site data before publication of the multi-site publication, unless 1 year has elapsed since completion of the study at all sites. Thereafter, PI may publish provided that PI shall: provide a copy of the publication to sponsor at least 60 days in advance of submission for publication; delete sponsor’s confidential information as requested; and delay publication up to an additional 90 days to permit protection of intellectual property.
5708|NCT01810783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5709|NCT01810692|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5710|NCT01810666|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5711|NCT01810380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5712|NCT01810302|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5713|NCT01810289|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5714|NCT01810263|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5715|NCT01810042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5716|NCT01809938|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5717|NCT01809899|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5718|NCT01809834|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5719|NCT01809639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5720|NCT01809327|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
5721|NCT01809314|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5722|NCT01809262|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5723|NCT01809210|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5724|NCT01809197|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5725|NCT01809106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5726|NCT01809054|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5727|NCT01808963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5728|NCT01808950|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator is granted a right to publish and present Trial Results together with other investigators of Trial and to be referred to in publications containing such results. However, investigator shall not publish or present Trial Results unless Investigator has submitted to Spirig a draft of the intended publication or presentation for review and approval.
5729|NCT01808755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5730|NCT01808651|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5731|NCT01808612|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5732|NCT01808560|Principal Investigators are NOT employed by the organization sponsoring the study.|Within 18 months of Sponsor's receipt of data from all sites, Investigators may publish or present the Investigator's individual results. Investigator must submit materials to Sponsor for review and comment at least 30 days prior to presentation or submission for publication. Investigator will consider all reasonable comments from Sponsor. Upon Sponsor's written request, Investigator agrees to delete any Proprietary Information other than Investigator's individual Study results.
5733|NCT01808547|Principal Investigators are NOT employed by the organization sponsoring the study.|
5734|NCT01808534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5735|NCT01808508|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5736|NCT01808339|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5737|NCT01808326|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5738|NCT01808313|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5739|NCT01808261|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5740|NCT01808248|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5741|NCT01808209|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor. Assuming that the product is marketed, and only with the sponsor's permission, will they allow publication of the results of the study.
5742|NCT01808144|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
5743|NCT01808118|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5744|NCT01808092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5745|NCT01808066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5765|NCT01806389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5746|NCT01807949|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
5747|NCT01807923|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
5748|NCT01807871|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5749|NCT01807624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5750|NCT01807520|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5751|NCT01807455|Principal Investigators are NOT employed by the organization sponsoring the study.|
5752|NCT01807234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5753|NCT01807156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5754|NCT01807000|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
5755|NCT01806961|Principal Investigators are NOT employed by the organization sponsoring the study.|"There is an agreement between the PI and the Sponsor that restricts the PI's rights to discuss or publish trial results after the trial is completed.~Investigator is granted a right to publish and present Trial Results together with other investigators of Trial and to be referred to in publications containing such results. However, PI shall not publish or present Results unless Investigator has submitted to Spirig a draft of the intented publication or presentation for review and approval."
5756|NCT01806896|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5757|NCT01806857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5758|NCT01806779|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5759|NCT01806714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5760|NCT01806662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5761|NCT01806623|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5762|NCT01806597|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
5763|NCT01806584|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually
5764|NCT01806545|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually
5766|NCT01806298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5767|NCT01806051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5768|NCT01805895|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5769|NCT01805882|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5770|NCT01805687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5771|NCT01805440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5772|NCT01805323|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5773|NCT01805297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5774|NCT01805180|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5775|NCT01805089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5776|NCT01804946|Principal Investigators are NOT employed by the organization sponsoring the study.|
5777|NCT01804881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5778|NCT01804842|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study may be published by INSTITUTE, however the publication shall not disclose any SPONSOR Confidential Information, the INSTITUTE shall send the SPONSOR a copy of any such proposed publication 90 days prior to submission for publication, the INSTITUTE, on request of the SPONSOR, shall delete any SPONSOR Confidential Information in the proposed publication, and the INSTITUTE shall, on the SPONSOR’s request, delay submission while the SPONSOR files applications for patents.
5779|NCT01804673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5780|NCT01804257|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5781|NCT01804140|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5782|NCT01804101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5783|NCT01804075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5784|NCT01804062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5785|NCT01804036|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5786|NCT01803737|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5787|NCT01803711|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5788|NCT01803646|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to submit a copy of any intended communication, presentation or publication (abstract, poster, article, etc.) (all together “Communication”) at least 2 month in advance of the submission of proposed Communication. The Sponsor shall have 60 days, after receipt of said copies, to object to such proposed Communication. In case of such objection, the Investigator shall refrain from making such Communication for 6 months from date of receipt of such objection.
5789|NCT01803607|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
5790|NCT01803464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5791|NCT01802775|Principal Investigators are NOT employed by the organization sponsoring the study.|A study site may not publish results of a study until after a coordinated multicenter publication has been submitted for publication or until one year after the study has ended, whichever occurs first. The site may publish the results with proper regard to the protection of subjects’ identities, provided that sponsor (including legal and intellectual property) has had the opportunity to review and comment on the proposed publication prior to its being submitted for publication.
5792|NCT01802632|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review, should the submission for publication be delayed in order to file patent application. The sponsor cannot require changes to the communication and cannot extend the embargo.
5793|NCT01802554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5794|NCT01802515|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5795|NCT01802320|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5796|NCT01802151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5797|NCT01801982|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5798|NCT01801917|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
5799|NCT01801735|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator is required to submit any materials describing the results of the study at the site to sponsor for review not less than 30 days prior to publication and agrees to remove any of the Sponsor's confidential information. Sponsor also retains right to delay publication for an additional 60 day period to allow time for filing of patent applications.
5800|NCT01801475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5801|NCT01801449|All Principal Investigators ARE employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5802|NCT01801436|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5803|NCT01801358|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of the sponsor's agreements with its investigators may vary. However, the sponsor does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e. data from all sites) in the clinical trial.
5804|NCT01801280|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5805|NCT01801124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5828|NCT01798264|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5806|NCT01801111|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5807|NCT01800968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5808|NCT01800916|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5809|NCT01800903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5810|NCT01800890|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5811|NCT01800786|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5812|NCT01800318|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5813|NCT01800162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5814|NCT01799941|Principal Investigators are NOT employed by the organization sponsoring the study.|
5815|NCT01799720|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5816|NCT01799590|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the Sponsor requires.
5817|NCT01799278|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5818|NCT01799239|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5819|NCT01799226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5820|NCT01798992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5821|NCT01798966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5822|NCT01798927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5823|NCT01798706|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
5824|NCT01798550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5825|NCT01798485|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right, 60 days before submission for publication, to review disclosures and require deletion of its confidential information, excluding the study results. Public disclosure shall be delayed for up to 60 additional days in order for the Sponsor to file a patent application, if needed. Single center publications will be postponed until after disclosure of pooled data (all sites), or, for a period of 18 months from study completion/termination at all participating sites.
5826|NCT01798394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5827|NCT01798316|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5829|NCT01798186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5830|NCT01798134|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5831|NCT01798004|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
5832|NCT01797783|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5833|NCT01797731|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5834|NCT01797705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5835|NCT01797575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5836|NCT01797536|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
5837|NCT01797484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5838|NCT01797471|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5839|NCT01797458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5840|NCT01797445|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5841|NCT01797380|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5842|NCT01797328|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5843|NCT01797120|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5844|NCT01797094|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5845|NCT01797081|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5846|NCT01797029|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5847|NCT01796977|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5848|NCT01796964|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5849|NCT01796860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5871|NCT01792830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5850|NCT01796548|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall have first to present the data of Clinical Trial (CT) without approval from the Institution or PI. If the Institution and PI wish to publish data from CT, a copy of the same must be provided to Sponsor for review at least 60 days prior to submission. No paper with Confidential Information will be submitted with Sponsor’s prior written consent. If requested in writing, Institution and PI will withhold publication for up to an additional 60 days to allow filing of patent application.
5851|NCT01796236|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5852|NCT01795937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5853|NCT01795898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5854|NCT01795859|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5855|NCT01795716|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5856|NCT01795547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5857|NCT01795534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5858|NCT01795495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5859|NCT01794949|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5860|NCT01794936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5861|NCT01794845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5862|NCT01794806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5863|NCT01794741|Principal Investigators are NOT employed by the organization sponsoring the study.|Meda Pharmaceuticals requests that it receive copies of any intended communication at least 15 working days for an abstract or oral presentation and 45 working days for a manuscript). This is to allow Meda Pharmaceuticals to review the communications for accuracy , to verify that confidential information is not being inadvertently divulged, to provide any relevant supplementary information, and to allow establishment of co-authorship.
5864|NCT01794455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5865|NCT01794000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5866|NCT01793935|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5867|NCT01793883|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5868|NCT01793688|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5869|NCT01793285|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5870|NCT01792986|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5872|NCT01792817|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5873|NCT01792635|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5874|NCT01792518|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5875|NCT01792284|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5876|NCT01792024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5877|NCT01791972|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
5878|NCT01791894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5879|NCT01791803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5880|NCT01791725|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5881|NCT01791517|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5882|NCT01791491|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5883|NCT01791465|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5884|NCT01791413|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5885|NCT01791244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5886|NCT01791205|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
5887|NCT01791153|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
5888|NCT01790828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5889|NCT01790750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5891|NCT01790659|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5892|NCT01790633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5893|NCT01790594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5894|NCT01790581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5895|NCT01790568|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5896|NCT01790516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5897|NCT01790490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5898|NCT01790438|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5899|NCT01790178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5900|NCT01789970|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
5901|NCT01789814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5902|NCT01789775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5903|NCT01789606|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5904|NCT01789476|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5905|NCT01789255|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5906|NCT01789138|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5907|NCT01788943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5908|NCT01788631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5909|NCT01788566|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5910|NCT01788358|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5911|NCT01788228|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5912|NCT01788215|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5913|NCT01788163|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5914|NCT01788046|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5915|NCT01787916|Principal Investigators are NOT employed by the organization sponsoring the study.|
5916|NCT01787838|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5917|NCT01787825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5918|NCT01787799|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5919|NCT01787760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5920|NCT01787591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5921|NCT01787461|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5922|NCT01787383|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5923|NCT01787279|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights
5924|NCT01787240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5925|NCT01787188|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5926|NCT01787175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5927|NCT01787032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5928|NCT01786993|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5929|NCT01786954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5930|NCT01786902|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5931|NCT01786876|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
5932|NCT01786707|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5933|NCT01786668|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5934|NCT01786629|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extend the embargo.
5935|NCT01786551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5936|NCT01786330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5937|NCT01786252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5938|NCT01786239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5939|NCT01786174|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5940|NCT01786161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5941|NCT01786109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5942|NCT01785875|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5943|NCT01785849|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
5944|NCT01785628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5945|NCT01785615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5946|NCT01785602|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5947|NCT01785524|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5948|NCT01785472|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5949|NCT01785186|Principal Investigators are NOT employed by the organization sponsoring the study.|
5950|NCT01785160|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
5951|NCT01785134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5952|NCT01785095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5953|NCT01784965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5954|NCT01784770|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5955|NCT01784666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5956|NCT01784614|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5957|NCT01784055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5958|NCT01783938|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
5959|NCT01783912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5960|NCT01783886|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5961|NCT01783860|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5962|NCT01783821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5963|NCT01783743|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5964|NCT01783730|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5965|NCT01783678|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
5966|NCT01783639|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5967|NCT01783574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5968|NCT01783561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5969|NCT01783548|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
5970|NCT01783496|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall notify Sponsor of the intent to publish or present independent Study Data, and agrees not to publish or publicly present and/or discuss such data, Investigator's current findings and/or the results of the Study independently without the express written consent of Sponsor, which consent may be withheld. Prior to submission for publication or presentation, all draft manuscripts must be submitted, reviewed and approved by Sponsor for confidential material.
5971|NCT01783483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5972|NCT01783470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5973|NCT01783418|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5974|NCT01783236|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5975|NCT01783080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5976|NCT01783054|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5977|NCT01783015|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
5978|NCT01782963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5979|NCT01782898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5980|NCT01782885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5981|NCT01782872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5982|NCT01782859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5983|NCT01782742|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5984|NCT01782664|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
5985|NCT01782495|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5986|NCT01782482|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
5987|NCT01782469|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
5988|NCT01782326|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
5989|NCT01782222|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
5990|NCT01781962|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
5991|NCT01781832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5992|NCT01781806|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5993|NCT01781637|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5994|NCT01781481|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5995|NCT01781403|Principal Investigators are NOT employed by the organization sponsoring the study.|
5996|NCT01781299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5997|NCT01781208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5998|NCT01781169|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
5999|NCT01781078|Principal Investigators are NOT employed by the organization sponsoring the study.|The restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor can request changes to the communication.
6000|NCT01781026|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6001|NCT01780987|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6002|NCT01780974|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6003|NCT01780935|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6004|NCT01780922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6005|NCT01780870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6006|NCT01780584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6007|NCT01780545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6008|NCT01780506|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6009|NCT01780389|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6010|NCT01780350|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6011|NCT01780337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6012|NCT01780324|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6013|NCT01779648|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6014|NCT01779219|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6015|NCT01779167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6016|NCT01778985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6017|NCT01778855|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6018|NCT01778751|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6019|NCT01778634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6020|NCT01778530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6021|NCT01778296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6022|NCT01778127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6023|NCT01778062|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
6024|NCT01778049|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
6025|NCT01778023|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones, e.g. when the clinical trial report is available. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
6026|NCT01778010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6027|NCT01777997|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
6028|NCT01777945|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6029|NCT01777932|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6030|NCT01777776|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of the sponsor's agreements with its investigators may vary. However, the sponsor does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in the clinical trial.
6031|NCT01777763|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
6032|NCT01777620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6033|NCT01777581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6034|NCT01777542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6035|NCT01777438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6036|NCT01777425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6037|NCT01777412|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6038|NCT01777334|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6039|NCT01777321|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6040|NCT01777282|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6041|NCT01777269|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6042|NCT01777217|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6043|NCT01777191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6044|NCT01777126|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6045|NCT01776645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6046|NCT01776554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6047|NCT01776541|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6048|NCT01776268|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6049|NCT01776008|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6050|NCT01775995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6051|NCT01775865|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6052|NCT01775852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6053|NCT01775787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6054|NCT01775774|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6055|NCT01775722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6056|NCT01775670|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6057|NCT01775553|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6058|NCT01775189|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6059|NCT01775137|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data (i.e, data from all sites) in the clinical trial.
6060|NCT01775124|Principal Investigators are NOT employed by the organization sponsoring the study.|"The terms and conditions of Novartis' agreements with its investigators may vary.~However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety"
6061|NCT01774981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6062|NCT01774968|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6063|NCT01774929|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator wishes to publish information from the study, a copy of the manuscript must be provided to the Sponsor for review at least 60 days before submission for publication. If requested by the Sponsor, the Investigator will withhold it up to an additional 60 days to allow for filing of a patent application. The Sponsor will not change or suppress the scientific content. For multicenter study, results may not be published before the primary endpoints of a study have been published.
6064|NCT01774903|Principal Investigators are NOT employed by the organization sponsoring the study.|Company has the right to publish the data which generated here under by Principal Investigator (PI), without PIs approval. The PI has the right to publish the results, but prior to submission, PI will provide at least 60 days to company for review. No paper that incorporates Company Confidential Information will be submitted for publication without Company prior written consent. If requested, the PI will withhold such publication for up to an additional 60 days to allow for filing of a patent.
6065|NCT01774851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6066|NCT01774786|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but only after the first publication or presentation that involves the overall study. The Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6067|NCT01774604|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6068|NCT01774591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6069|NCT01774344|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6070|NCT01774305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6071|NCT01774253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6072|NCT01774149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6073|NCT01774110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6074|NCT01774097|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6075|NCT01774084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6076|NCT01774045|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6077|NCT01773954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6078|NCT01773889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6079|NCT01773473|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6080|NCT01773291|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6081|NCT01773226|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6082|NCT01773135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6083|NCT01773122|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6084|NCT01773070|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6085|NCT01772823|Principal Investigators are NOT employed by the organization sponsoring the study.|The Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications, and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by the protocol team and AMLG.
6086|NCT01772758|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6087|NCT01772654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6088|NCT01772576|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6089|NCT01772550|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6090|NCT01772537|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6091|NCT01772368|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
6092|NCT01772316|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6093|NCT01772147|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6094|NCT01772134|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6095|NCT01771991|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6096|NCT01771965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6097|NCT01771913|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6098|NCT01771666|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6099|NCT01771172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6100|NCT01770860|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6101|NCT01770743|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor is responsible for public disclosure of study data. Any proposed publication is subject to review agreed between the Division of Microbiology and Infectious Diseases (DMID) and Emergent; between Emergent and the contract research organizations (CROs)/vendors; and between the CROs and the site Principal Investigator. Data are the property of the sponsor and cannot be published without prior authorization from the sponsor, but data and publication thereof will not be unduly withheld.
6102|NCT01770691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6103|NCT01770652|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6104|NCT01770509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6105|NCT01770483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6106|NCT01770431|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6107|NCT01770392|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
6108|NCT01770379|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
6109|NCT01770366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6110|NCT01770314|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6111|NCT01770145|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the first right, within nine months following the Sponsor having in its possession all data related to the Study, to publish the Study lead paper. Following the foregoing, the Institution shall have the right, consistent with academic standards, to publish the results of Study provided the Institution provides a publications committee, comprised of at least the Sponsor, with a draft at least thirty (30) days prior to planned submission.
6112|NCT01769612|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6113|NCT01769586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6114|NCT01769508|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
6154|NCT01766310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6115|NCT01769456|Principal Investigators are NOT employed by the organization sponsoring the study.|The Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications, and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by the protocol team and AMLG.
6116|NCT01769443|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6117|NCT01769391|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6118|NCT01769378|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6119|NCT01769365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6120|NCT01769352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6121|NCT01769339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6122|NCT01769326|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6123|NCT01769248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6124|NCT01769222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6125|NCT01769196|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6126|NCT01769105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6127|NCT01768676|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
6128|NCT01768572|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
6129|NCT01768559|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
6130|NCT01768325|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6131|NCT01768286|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6132|NCT01768117|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6273|NCT01753557|Principal Investigators are NOT employed by the organization sponsoring the study.|
6133|NCT01768013|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
6134|NCT01768000|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6135|NCT01767987|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6136|NCT01767935|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6137|NCT01767701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6138|NCT01767688|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor will provide separate guidance on the criteria for publication of clinical trial data when contacted for permission to publish.
6139|NCT01767597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6140|NCT01767519|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6141|NCT01767506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6142|NCT01767467|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6143|NCT01767376|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6144|NCT01767285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6145|NCT01767116|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6146|NCT01767103|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor retained title to and the right to publish all documentation, records, raw data, specimens or other work product generated in connection with the trial. Such publications shall not be made without the prior written consent of Sponsor. Neither Party will use the other Party's name in connection with any publication or promotion without the other Party's prior written consent. However, Sponsor has the right to publish appropriate information in order to satisfy regulatory requirements.
6147|NCT01767064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6148|NCT01766921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6149|NCT01766778|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6150|NCT01766713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6151|NCT01766466|Principal Investigators are NOT employed by the organization sponsoring the study.|
6152|NCT01766440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6153|NCT01766336|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6155|NCT01766102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6156|NCT01766076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6157|NCT01766050|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6158|NCT01766037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6159|NCT01766024|Principal Investigators are NOT employed by the organization sponsoring the study.|
6160|NCT01765972|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6161|NCT01765803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6162|NCT01765764|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6163|NCT01765751|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6164|NCT01765673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6165|NCT01765582|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6166|NCT01765569|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6167|NCT01765543|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6168|NCT01765530|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6169|NCT01765465|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6170|NCT01765426|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor is permitted to protect any proprietary information and to provide comments based on information from other studies that may not be available to the Investigator.
6171|NCT01765270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6172|NCT01765192|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
6173|NCT01765179|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6174|NCT01765153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6175|NCT01764997|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
6176|NCT01764945|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6177|NCT01764919|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6178|NCT01764841|Principal Investigators are NOT employed by the organization sponsoring the study.|Bayer acknowledges and accepts the interest in the noncommercial scientific publication of Results. In a multicenter study the PIs will not make any publication of the results before the first multi-center publication. Proposed publication/presentation shall be provided to Bayer at least 60 days prior to the intended submission or presentation of the publication in order to allow Bayer to review it. Any difference of opinion shall be discussed.
6179|NCT01764685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6180|NCT01764633|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6181|NCT01764607|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6182|NCT01764386|Principal Investigators are NOT employed by the organization sponsoring the study.|If not already published by Sponsor as part of a multi-center publication, 24 months after conclusion, abandonment or termination of the study or notification that there will be no such multi-center publication, PI may publish the results for PI's study center individually. Prior to such publication, PI must provide Sponsor with at least 90 days to review and comment on the proposed publication. Sponsor may delay publication for up to an additional 6 month period to file for patent protection.
6183|NCT01764022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6184|NCT01763996|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
6185|NCT01763918|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6186|NCT01763905|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6187|NCT01763866|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6188|NCT01763827|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6189|NCT01763645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6190|NCT01763567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6191|NCT01763047|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6192|NCT01762982|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6193|NCT01762943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6194|NCT01762904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6195|NCT01762800|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6196|NCT01762761|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
6197|NCT01762722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6198|NCT01762501|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PIs is that PIs must get approval about publish by study director(Kazuo Kario).
6199|NCT01762345|Principal Investigators are NOT employed by the organization sponsoring the study.|"The STUDY SITE and PRINCIPAL INVESTIGATOR agree that all data, calculations, interpretations, opinions and recommendations regarding the STUDY (hereinafter referred to as~“RESULTS”) shall be the property of P&G. The STUDY SITE and PRINCIPAL INVESTIGATOR agree to consider the RESULTS as INFORMATION subject to confidentiality restrictions"
6200|NCT01762059|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6201|NCT01761747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6202|NCT01761565|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must be able to review any publications prior to publication
6203|NCT01761279|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6204|NCT01761175|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6205|NCT01761162|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators agree to submit copies of any manuscript proposed for publication to Sponsor for review at least 30 days in advance of submission for publication or presentation. Sponsor may extend such review period for another 90 days to file patent applications or take other steps to protect its intellectual property interests, or to remove from the paper or presentation any language that is detrimental to Sponsor's intellectual property interests.
6206|NCT01761019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6207|NCT01760993|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6208|NCT01760941|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6209|NCT01760889|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6210|NCT01760876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6211|NCT01760785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6212|NCT01760473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6213|NCT01760304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6214|NCT01759602|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6215|NCT01759511|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6216|NCT01759420|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6217|NCT01759407|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6218|NCT01759381|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6219|NCT01759368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6220|NCT01759290|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6221|NCT01759264|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6222|NCT01759251|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall not publish /present the results without Abbott’s prior written consent. In the event that applicable law permits Investigator to publish or present results without Abbott’s prior written consent, Investigator shall provide Abbott with a complete copy of such publication or presentation at least 60 days prior to submission for publication or presentation and Investigator shall reasonably consider all comments which Abbott may provide regarding such publication or presentation.
6223|NCT01759160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6224|NCT01758900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6225|NCT01758289|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6226|NCT01757964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6227|NCT01757847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6228|NCT01757821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6229|NCT01757717|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6230|NCT01757704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6231|NCT01757691|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis doesn not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data (i.e. data from all sites) in the clinical trial or disclosure of the trial results in their entirety.
6232|NCT01757678|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6233|NCT01757561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6234|NCT01757405|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, results may not be published without prior written approval of Sponsor.
6235|NCT01757275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6236|NCT01757197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6237|NCT01757184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6238|NCT01757171|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6239|NCT01756976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6240|NCT01756586|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6241|NCT01756391|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6242|NCT01756300|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
6243|NCT01756274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6244|NCT01756235|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6245|NCT01756157|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicentre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicentre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6246|NCT01756079|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
6247|NCT01756053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6248|NCT01755702|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6249|NCT01755637|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6250|NCT01755455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6251|NCT01755234|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6252|NCT01755169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6253|NCT01755156|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
6254|NCT01755143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6255|NCT01755091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6256|NCT01755026|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6257|NCT01754922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6258|NCT01754766|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6259|NCT01754727|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6260|NCT01754714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6261|NCT01754623|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6262|NCT01754519|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6263|NCT01754493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6264|NCT01754480|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the Study, after providing Sponsor thirty days’ notice prior to submitting a manuscript or other materials related to the Study to any outside party. At Sponsors’ request, Site will remove any Confidential Information (other than Study results), and Site will upon Sponsors’ request, delay publication or presentation for a period of up to one hundred twenty days to allow Sponsor to protect its interests in any Sponsor Inventions.
6265|NCT01754467|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6266|NCT01754402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6267|NCT01754389|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6268|NCT01754376|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6269|NCT01754259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6270|NCT01754194|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6271|NCT01753856|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6272|NCT01753713|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6274|NCT01753518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6275|NCT01753336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6276|NCT01753323|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6277|NCT01753310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6278|NCT01753115|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor is responsible for public disclosure of study data. Any proposed publication is subject to review agreed between the Biomedical Advanced Research & Development Authority (BARDA) and Emergent; between Emergent and the contract research organizations (CROs)/vendors; and between the CROs and the site Principal Investigator. Data are the property of the sponsor and cannot be published without prior authorization from the sponsor, but data and publication thereof will not be unduly withheld.
6279|NCT01753076|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6280|NCT01752907|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6281|NCT01752855|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6282|NCT01752712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6283|NCT01752400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6284|NCT01752023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6285|NCT01751971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6286|NCT01751906|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6287|NCT01751867|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6288|NCT01751802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6289|NCT01751724|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6290|NCT01751412|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6291|NCT01751386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6292|NCT01751308|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
6293|NCT01751178|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6294|NCT01751165|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6295|NCT01751113|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6296|NCT01751087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6297|NCT01751022|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6298|NCT01750931|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6299|NCT01750840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6300|NCT01750684|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
6301|NCT01750502|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6302|NCT01750398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6303|NCT01750346|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6304|NCT01750294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6305|NCT01750281|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6306|NCT01750255|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6307|NCT01750242|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6308|NCT01750229|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Trust and/or the PI may prepare the data derived from the study for publication. Data will be submitted to the Sponsor for review and comment prior to publication and at least sixty (60) days prior to submission for publication, public dissemination, or review by a publication committee.~All reasonable comments made by the Sponsor in relation to a proposed publication will be incorporated by the Trust and/or the Investigator into the publication."
6309|NCT01750086|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6310|NCT01749982|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6311|NCT01749956|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
6312|NCT01749800|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6313|NCT01749735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6314|NCT01749631|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6315|NCT01749605|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6316|NCT01749501|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6317|NCT01749410|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6318|NCT01748955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6319|NCT01748942|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6320|NCT01748916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6321|NCT01748890|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6322|NCT01748799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6323|NCT01748760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6324|NCT01748695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6325|NCT01748643|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6326|NCT01748292|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6327|NCT01748227|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6328|NCT01748162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6329|NCT01748071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6330|NCT01748045|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6331|NCT01747928|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6332|NCT01747850|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6333|NCT01747811|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6334|NCT01747772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6356|NCT01744977|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6335|NCT01747655|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6336|NCT01747629|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
6337|NCT01747551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6338|NCT01747343|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6339|NCT01747330|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6340|NCT01746979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6341|NCT01746940|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor right of review of publication, right to remove confidential or proprietary information, and all multi-center data publication done before any additional publications.
6342|NCT01746862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6343|NCT01746784|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6344|NCT01746511|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6345|NCT01746368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6346|NCT01746264|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6347|NCT01746173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6348|NCT01746108|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6349|NCT01745952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6350|NCT01745913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6351|NCT01745848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6352|NCT01745380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6353|NCT01745133|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6354|NCT01745094|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi center data. Sponsor must receive a site's manuscript prior to publication for review and comment.
6355|NCT01745055|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6357|NCT01744860|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6358|NCT01744821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6359|NCT01744782|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights .
6360|NCT01744730|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6361|NCT01744691|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6362|NCT01744496|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6363|NCT01744483|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6364|NCT01744392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6365|NCT01744353|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6366|NCT01744340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6367|NCT01744197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6368|NCT01743963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6369|NCT01743729|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicentre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicentre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6370|NCT01743521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6371|NCT01743469|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor required reasonable opportunity to review any abstract, presentation, or paper before the material was submitted for publication or communicated. This also applied to any amendments that were requested by referees or journal editors. The Sponsor committed to comment on the draft documents within a time period agreed in the contractual arrangements between the Sponsor and authors or their institution. Delays were also possible if publication would adversely affect patentability.
6372|NCT01743092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6373|NCT01743027|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6374|NCT01743001|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related publication written independently by investigators must be submitted to Actelion for review at least 60 days prior to submission for publication or presentation. Upon review, Actelion may provide comments, and may also request alterations and/or deletions for the sole purpose of protecting its confidential information and/or patent rights.
6375|NCT01742936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6376|NCT01742897|Principal Investigators are NOT employed by the organization sponsoring the study.|Company shall have right to publish data or information generated in trial without approval of Principal Investigator (PI). PI shall have right to publish results and information provided by Company if necessary. Prior to submission, PI will provide company 60 days for review. No paper with confidential Information will be submitted without company consent. If requested, PI will withhold it for 60 days to allow patent application filing. PI warrants compliance of all personnel involved in Study.
6377|NCT01742832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6378|NCT01742364|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6379|NCT01741792|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6380|NCT01741701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6381|NCT01741688|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6382|NCT01741350|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6383|NCT01741272|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6384|NCT01741259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6385|NCT01740817|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6386|NCT01740726|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6387|NCT01740713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6388|NCT01740440|Principal Investigators are NOT employed by the organization sponsoring the study.|
6389|NCT01740427|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6390|NCT01740414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6391|NCT01740401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6392|NCT01740388|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6393|NCT01740362|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6394|NCT01740297|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6395|NCT01740206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6396|NCT01740128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6397|NCT01740089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6398|NCT01739803|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6399|NCT01739790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6400|NCT01739595|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
6401|NCT01739361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6402|NCT01739348|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor, 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
6403|NCT01739335|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6404|NCT01738984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6405|NCT01738971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6406|NCT01738919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6407|NCT01738750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6408|NCT01738737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6409|NCT01738698|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6410|NCT01738672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6411|NCT01738646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6412|NCT01738581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6413|NCT01738503|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications shall be submitted to Sponsor 30 days prior to submission for publication, and may be withheld for an additional period, up to 90 days, to allow Sponsor to file patent applications. If a multi-center publication isn't submitted for publication within 12 months of the conclusion of the Study at all sites, or is published in a shorter period, the results from the institution's site may be published individually.
6414|NCT01738477|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6415|NCT01738438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6416|NCT01738321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6417|NCT01737996|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6438|NCT01736215|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6418|NCT01737944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6419|NCT01737931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6420|NCT01737879|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6421|NCT01737840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6422|NCT01737762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6423|NCT01737710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6424|NCT01737684|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication or presentation.
6425|NCT01737593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6426|NCT01737268|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript prior to publication for review and comment.
6427|NCT01737021|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6428|NCT01736930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6429|NCT01736917|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6430|NCT01736696|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6431|NCT01736657|Principal Investigators are NOT employed by the organization sponsoring the study.|If Study Site is performing services in a multi-center Study, it agrees not to independently publish, publicly disclose, present or discuss any results of or information pertaining to the Study until a multi-center manuscript is published; provided however, that if a multi-center manuscript is not published within one year after completion of the Study at all Study sites, Study Site may publish the Study data generated by Study Site
6432|NCT01736579|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 12 months after study completion. Baxalta requires a review of results communications (eg, for confidential information) ≥30 days prior to submission or communication. Baxalta may request an additional delay of ≤60 days eg, for intellectual property protection.
6433|NCT01736553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6434|NCT01736540|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6435|NCT01736527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6436|NCT01736475|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per individual PI, but contain common elements. For this study, PIs may be restricted from independently publishing results without prior approval.
6437|NCT01736397|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6439|NCT01736176|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6440|NCT01735916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6441|NCT01735877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6442|NCT01735630|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6443|NCT01735617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6444|NCT01735396|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6445|NCT01735214|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6446|NCT01735201|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6447|NCT01735175|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6448|NCT01734993|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6449|NCT01734889|Principal Investigators are NOT employed by the organization sponsoring the study.|The results are intended to be published as a whole. If no comprehensive publication appears within 12 months of the trial termination, Investigators have the right to publish their results. Such data to be submitted to the Sponsor for review at least 60 days prior to submission for publication, public dissemination, or review by a publication committee. The Sponsor shall be entitled to make a reasoned request that publication be delayed for a period of up to 6 months.
6450|NCT01734785|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6451|NCT01734772|All Principal Investigators ARE employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
6452|NCT01734655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6453|NCT01734551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6454|NCT01734395|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6455|NCT01734317|Principal Investigators are NOT employed by the organization sponsoring the study.|
6456|NCT01734239|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
6457|NCT01734161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6458|NCT01733953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6459|NCT01733758|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6460|NCT01733745|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6461|NCT01733732|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6462|NCT01733368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6463|NCT01733329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6464|NCT01733316|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. The Investigator is able to present at professional conferences or publish in reputable journals the results of the Study, but only after the first publication or presentation that involves the Overall Study. In order to protect the Sponsor's intellectual property rights, the Sponsor may request that Confidential Information be deleted and/or the publication be postponed.
6465|NCT01733277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6466|NCT01733212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6467|NCT01733121|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the PI has the right to publish results provided such publication does not violate confidentiality or IP provisions within the contract with the Sponsor. Prior to submission for publication or presentation of results, the PI must provide the Sponsor time for review. The Sponsor can request the PI to withhold or remove information from all publications. For a multi-center study, any publication of results by the PI shall not be made before the first multi-center publication.
6468|NCT01733069|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6469|NCT01733056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6470|NCT01732926|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6471|NCT01732913|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6472|NCT01732835|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication by the investigator was not allowed until completion of the trial. All proposed publications must be cleared by unanimous vote of a publication committee consisting of the sponsor and representatives of the study investigators. Publication materials must be submitted for review at least 60 day in advance of publication. The Sponsor may embargo publication for 60 additional days to allow for patent filing or may prevent publication if filling of such application would be premature.
6473|NCT01732822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6474|NCT01732796|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6475|NCT01732770|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6476|NCT01732757|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6477|NCT01732692|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
6478|NCT01732588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6479|NCT01732549|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6480|NCT01732510|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
6481|NCT01732484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6482|NCT01732471|Principal Investigators are NOT employed by the organization sponsoring the study.|All written or oral publications and/or information related to Study and/or results of Study should be submitted at first in writing to Sponsor at least 30 working days for publication and 15 working days for brief review, abstract before planned date of submission. If Sponsor is filing a patent application on Study results, Sponsor can delay its authorization for publication/communication of Study results to Investigator and/or Research Centre until date of international registration of patent.
6483|NCT01732458|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
6484|NCT01732445|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6485|NCT01732263|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6486|NCT01731990|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6487|NCT01731938|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the study, after providing Sponsor at least thirty days’ notice prior to submitting a manuscript or other materials related to the study to any outside party. At Sponsor’s request, the site will remove any confidential information (other than study results), and incorporate all reasonable comments by Sponsor, or delay publication or presentation for a period of up to 120 days to allow Sponsor to protect its interests in any Sponsor’s Inventions.
6488|NCT01731470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6489|NCT01731119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6490|NCT01731041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6491|NCT01731002|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6492|NCT01730846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6493|NCT01730378|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6513|NCT01727895|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6494|NCT01730339|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6495|NCT01730053|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor’s request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
6496|NCT01730040|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor's request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
6497|NCT01729923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6498|NCT01729871|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
6499|NCT01729845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6500|NCT01729728|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
6501|NCT01729559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6502|NCT01729338|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6503|NCT01729247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6504|NCT01729026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6505|NCT01728792|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
6506|NCT01728584|Principal Investigators are NOT employed by the organization sponsoring the study.|Initial public presentation of the Investigator's results will occur only together with the other sites unless permission is obtained from Sponsor. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. In case of disagreement concerning appropriateness of materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues, prior to submission for publication/presentation.
6507|NCT01728376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6508|NCT01728337|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6509|NCT01728324|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
6510|NCT01728246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6511|NCT01728116|Principal Investigators are NOT employed by the organization sponsoring the study.|PI to provide to Sponsor for review at least sixty (60) days in advance of submission for publication. Sponsor reserves the right to delete any Confidential Information or other proprietary information of Sponsor (including trade secrets but not including Results) from the proposed publication or presentation.
6512|NCT01728077|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6514|NCT01727791|All Principal Investigators ARE employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6515|NCT01727713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6516|NCT01727700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6517|NCT01727505|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6518|NCT01727414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6519|NCT01727297|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and participating institutions will provide any publication of study data generated by the Investigator and/or participating institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
6520|NCT01727258|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
6521|NCT01727180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6522|NCT01727167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6523|NCT01727141|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6524|NCT01727024|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6525|NCT01726621|Principal Investigators are NOT employed by the organization sponsoring the study.|
6526|NCT01726517|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6527|NCT01726504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6528|NCT01726335|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the Principal Investigator is that the Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the Sponsor for review. The Sponsor can require changes to the communication and can extend the embargo.
6529|NCT01726049|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6530|NCT01726023|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to use such Confidential study information and not to disclose them to any other third parties, except that the undersigned shall not be prevented from using or disclosing information: (a) which by written records was previously known; (b) which is now public knowledge, (c) which is lawfully obtained by the undersigned from sources who have a lawful right to disclose such information.
6531|NCT01725984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6532|NCT01725529|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
6533|NCT01725451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6534|NCT01725386|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6535|NCT01725308|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript prior to publication for review and comment.
6536|NCT01725282|Principal Investigators are NOT employed by the organization sponsoring the study.|PI needs to get prior approval from Sponsor in writing for publication of trial data.
6537|NCT01725217|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6538|NCT01725126|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6539|NCT01724528|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6540|NCT01724359|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6541|NCT01724216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6542|NCT01724177|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements varied; the Investigators shall not disclose any material/information disclosed by the Sponsor (Celgene KK) with the clinical trial or information obtained by conducting the clinical trial to third parties without Sponsor's prior written approval.
6543|NCT01724021|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6544|NCT01723904|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6545|NCT01723722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6546|NCT01723397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6547|NCT01723254|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6548|NCT01723228|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
6549|NCT01722994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6550|NCT01722929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6551|NCT01722877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6552|NCT01722734|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6553|NCT01722552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6554|NCT01722487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6555|NCT01722435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6556|NCT01722266|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6557|NCT01722162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6558|NCT01722097|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6559|NCT01722071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6560|NCT01722045|Principal Investigators are NOT employed by the organization sponsoring the study.|After completion of the trial, the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review; provided that the sponsor can remove confidential or proprietary information from such communications. The sponsor cannot require other changes to the communication and cannot extend the embargo.
6561|NCT01721967|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6562|NCT01721837|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6563|NCT01721772|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6564|NCT01721759|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6565|NCT01721746|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6566|NCT01721681|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6567|NCT01721603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6568|NCT01721564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6569|NCT01721486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6570|NCT01721460|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6571|NCT01721408|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6572|NCT01721330|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6573|NCT01721317|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6574|NCT01721226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6575|NCT01721200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6576|NCT01721161|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
6577|NCT01721109|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6578|NCT01721096|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6579|NCT01721070|Principal Investigators are NOT employed by the organization sponsoring the study.|Requires prior approval from AcelRx Pharmaceuticals, Inc.
6580|NCT01721057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6581|NCT01721044|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6582|NCT01720797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6583|NCT01720602|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6584|NCT01720446|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
6585|NCT01720316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6586|NCT01720277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6587|NCT01720251|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI of the trial owns options in the sponsor company and is member of the Board of Anergis SA
6588|NCT01720173|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6589|NCT01720043|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6590|NCT01719861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6591|NCT01719757|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6592|NCT01719744|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6593|NCT01719653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6594|NCT01719224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6595|NCT01719172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6596|NCT01719003|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
6597|NCT01718691|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6598|NCT01718535|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6599|NCT01718509|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6600|NCT01718483|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6601|NCT01718353|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
6602|NCT01718028|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6603|NCT01717989|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6604|NCT01717976|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6605|NCT01717898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6606|NCT01717872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6607|NCT01717768|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: At 60 days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy and allow Sponsor 60 days to review and comment and provide written permission prior to publication.
6608|NCT01717638|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
6609|NCT01717456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6610|NCT01717391|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6611|NCT01717326|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
6612|NCT01717313|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/ presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
6613|NCT01717287|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
6614|NCT01717209|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6615|NCT01717040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6616|NCT01717014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6617|NCT01716754|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6618|NCT01716663|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present, or publish trial results after the trial is completed. Please contact Biosense Webster for additional information.
6619|NCT01716585|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6620|NCT01716559|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights
6621|NCT01716520|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6622|NCT01716468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6623|NCT01716455|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6624|NCT01716234|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation with regard to proprietary information, accuracy, fair balance, and compliance.
6625|NCT01716221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6626|NCT01716169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6627|NCT01716156|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
6628|NCT01716052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6629|NCT01716013|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall have been furnished copies of any proposed publication or presentation at least thirty (30) days in advance of the submission of such proposed publication or presentation to a journal, editor, or other third party. Sponsor reserves the right to object to the proposed presentation or publication.
6630|NCT01715948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6631|NCT01715896|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
6632|NCT01715857|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6633|NCT01715831|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
6634|NCT01715415|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6635|NCT01715298|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
6636|NCT01715207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6637|NCT01715129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6638|NCT01715064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6639|NCT01714817|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6640|NCT01714804|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator may not submit the results of the study for publication, without the sponsor’s prior permission.
6641|NCT01714635|Principal Investigators are NOT employed by the organization sponsoring the study.|After the trial is completed, investigators must obtain approval from AMO in writing prior to disclosing trial results.
6642|NCT01714609|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6643|NCT01714544|Principal Investigators are NOT employed by the organization sponsoring the study.|No report, abstract, oral presentation, or publication proposed by the Investigator/Institution in regard to Study shall be presented or published without the prior written consent of the Sponsor. Sponsor reserves the right to comment on and delay the proposed report, abstract, oral presentation, or publication and to revise as necessary to protect confidential information or intellectual property.
6644|NCT01714505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6645|NCT01714492|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6646|NCT01714336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6647|NCT01714310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6648|NCT01714232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6649|NCT01714024|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6650|NCT01713998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6651|NCT01713933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6652|NCT01713686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6689|NCT01710527|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6653|NCT01713660|Principal Investigators are NOT employed by the organization sponsoring the study.|"Clinical Trial Agreement including Neither Institution nor Principal Investigator shall have any right to publish or present any information or results concerning the Study without express written consent of Sponsor. Under no circumstances shall Institution or Principal Investigator publish or disclose any of Sponsor’s proprietary information, as defined by the CDAs, without Sponsor’s prior written approval."
6654|NCT01713621|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6655|NCT01713608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6656|NCT01713530|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
6657|NCT01713400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6658|NCT01713348|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6659|NCT01713283|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6660|NCT01713036|All Principal Investigators ARE employed by the organization sponsoring the study.|
6661|NCT01712984|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
6662|NCT01712854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6663|NCT01712776|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6664|NCT01712711|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6665|NCT01712685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6666|NCT01712516|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6667|NCT01712399|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
6668|NCT01712360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6669|NCT01712334|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6670|NCT01712256|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor (or designee) will prepare a final report on the study. The Investigator may not publish or present any information on this study without the express written approval of the Sponsor. Additionally, the Sponsor, may, for any reason, withhold approval for publication or presentation.
6671|NCT01712204|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6672|NCT01712178|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6673|NCT01712074|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6674|NCT01712061|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6675|NCT01712009|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
6676|NCT01711918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6677|NCT01711866|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6678|NCT01711853|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
6679|NCT01711736|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6680|NCT01711645|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6681|NCT01711424|All Principal Investigators ARE employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6682|NCT01711359|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6683|NCT01711216|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall not publish/present the results without Abbott's prior written consent. In the event that applicable law permits Investigator to publish or present results without Abbott's prior written consent, Investigator shall provide Abbott with a complete copy of such publication or presentation at least 60 days prior to submission for publication or presentation and Investigator shall reasonably consider all comments which Abbott may provide regarding such publication or presentation
6684|NCT01711177|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6685|NCT01710839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6686|NCT01710800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6687|NCT01710787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6688|NCT01710657|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6690|NCT01710514|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
6691|NCT01710501|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
6692|NCT01710358|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6693|NCT01710345|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must be able to review and approve all published
6694|NCT01710332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6695|NCT01710254|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6696|NCT01710046|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6697|NCT01710033|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6698|NCT01710020|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6699|NCT01709903|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
6700|NCT01709864|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6701|NCT01709799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6702|NCT01709786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6703|NCT01709708|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6704|NCT01709695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6705|NCT01709578|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
6706|NCT01709513|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor's request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
6707|NCT01709500|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor's request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
6708|NCT01709474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6709|NCT01709422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6710|NCT01709409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6711|NCT01709383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6712|NCT01709331|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, e.g., any computer access system such as the Internet, World Wide Web, etc) that report any results of the trial.
6713|NCT01709305|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
6714|NCT01709227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6715|NCT01709162|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6716|NCT01709136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6717|NCT01709110|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6718|NCT01709084|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
6719|NCT01708967|Principal Investigators are NOT employed by the organization sponsoring the study.|
6720|NCT01708954|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6721|NCT01708915|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
6722|NCT01708902|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
6723|NCT01708525|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6724|NCT01708317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6725|NCT01708291|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6726|NCT01708278|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6727|NCT01708213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6728|NCT01708187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6765|NCT01704651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6729|NCT01708174|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6730|NCT01708122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6731|NCT01708057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6732|NCT01707667|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
6733|NCT01707654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6734|NCT01707290|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
6735|NCT01707238|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor.
6736|NCT01707225|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6737|NCT01707095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6738|NCT01707043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6739|NCT01706965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6740|NCT01706952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6741|NCT01706926|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
6742|NCT01706822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6743|NCT01706770|Principal Investigators are NOT employed by the organization sponsoring the study.|Release of this data (through presentation, publication or other written or oral communication) to other than listed personnel (see protocol) requires the prior written permission from the study Sponsor. Study investigators and all office personnelare prohibited from acknowledging participation in the study to individuals and organizations except those listed.
6744|NCT01706666|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6745|NCT01706588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6746|NCT01706575|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6747|NCT01706549|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6748|NCT01706536|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following the completion of the study at all sites, Institution and Investigator shall be free to publish.
6749|NCT01706328|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6750|NCT01706263|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6751|NCT01706250|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6752|NCT01706159|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Novo Nordisk reserves the right to prior review of such publications and to ask for delay of publication of individual site results until after the primary manuscript is accepted for publication.
6753|NCT01706146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6754|NCT01705717|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6755|NCT01705652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6756|NCT01705587|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6757|NCT01705574|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6758|NCT01705496|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6759|NCT01705145|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
6760|NCT01705106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6761|NCT01704976|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6762|NCT01704846|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6763|NCT01704781|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor (or designee) will prepare a final report on the study. The Investigator may not publish or present any information on this study without the express written approval of the Sponsor. Additionally, the Sponsor, may, for any reason, withhold approval for publication or presentation.
6764|NCT01704755|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
6766|NCT01704599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6767|NCT01704521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6768|NCT01704495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6769|NCT01704404|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may communicate the trial results generated by the PI, but only after the first publication or presentation of the combined study results generated by all participating sites. The Sponsor can then review trial results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The Sponsor cannot require changes to the communication and cannot extend the embargo.
6770|NCT01704287|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
6771|NCT01704261|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
6772|NCT01704196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6773|NCT01704079|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6774|NCT01703988|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
6775|NCT01703858|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6776|NCT01703845|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6777|NCT01703832|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agreements in place restricting the PI from independently publishing the study results. Currently working with both PIs on several publications of the NEUPRO studies.
6778|NCT01703819|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agreements are in place restricting the PI from independently publishing the study results. Currently working with both PIs on several publications of the NEUPRO studies.
6779|NCT01703741|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
6780|NCT01703702|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6781|NCT01703663|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6782|NCT01703286|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
6783|NCT01703260|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
6784|NCT01703221|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
6785|NCT01703208|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
6786|NCT01703169|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6787|NCT01703091|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6788|NCT01703000|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Investigator shall have the right to publish the results, provided that before publishing, Institution and Investigator shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
6789|NCT01702987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6790|NCT01702961|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6791|NCT01702909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6792|NCT01702896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6793|NCT01702532|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6794|NCT01702519|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6795|NCT01702454|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6796|NCT01702363|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6797|NCT01702311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6798|NCT01702298|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
6799|NCT01702259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6800|NCT01702246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6801|NCT01702233|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6802|NCT01702025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6803|NCT01701999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6804|NCT01701973|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6805|NCT01701674|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6806|NCT01701622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6807|NCT01701505|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6808|NCT01701414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6809|NCT01701401|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6810|NCT01701375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6811|NCT01701362|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6812|NCT01701271|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6813|NCT01701258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6814|NCT01701245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6815|NCT01701115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6816|NCT01701102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6817|NCT01701063|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
6818|NCT01701037|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6819|NCT01701024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6820|NCT01701011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6821|NCT01700907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6822|NCT01700816|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6823|NCT01700530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6824|NCT01700517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6847|NCT01698710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6825|NCT01700439|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can't publish/present on overall study results not yet published but may publish his own data subject to EW review prior to submission/presentation, but data analyses of site-specific results can occur only in intervals as specified in the CTA. Publication/presentation of the PI’s site-specific results of devices which haven't been market released and which still may be undergoing development, shall not include claims of device safety/effectiveness and will require the review/approval of EW.
6826|NCT01700387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6827|NCT01700348|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6828|NCT01700335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6829|NCT01700192|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation.
6830|NCT01700179|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting/presenting a manuscript or materials relating to a Study to a publisher, reviewer, or outside person, the Institution shall provide to Achillion a copy of all such manuscripts or materials, and Achillion shall have thirty (30) days to review and comment. The Institution shall, upon Achillion's request, further delay publication or presentation for a period of up to sixty (60) days to allow Achillion to protect its interests in any Achillion Inventions.
6831|NCT01700140|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results without prior approval from the sponsor.
6832|NCT01700036|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6833|NCT01699867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6834|NCT01699815|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6835|NCT01699789|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6836|NCT01699763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6837|NCT01699750|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6838|NCT01699698|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can ask PI to consider that PI delete Sponsor's confidential information from any publication or extend the publication for a certain time to seek patent protection, provided, however that, PI can publish or registry any other information in accordance with FDAAA.
6839|NCT01699685|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6840|NCT01699607|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6841|NCT01699373|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6842|NCT01699087|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study
6843|NCT01699022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6844|NCT01698814|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6845|NCT01698801|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements varied; the Investigators shall not disclose any material/information disclosed by the Sponsor (Celgene KK) with the clinical trial or information obtained by conducting the clinical trial to third parties without Sponsor’s prior written approval.
6846|NCT01698775|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.
6848|NCT01698684|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6849|NCT01698554|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
6850|NCT01698528|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6851|NCT01698502|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6852|NCT01698320|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
6853|NCT01698268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6854|NCT01697969|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6855|NCT01697956|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
6856|NCT01697696|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
6857|NCT01697592|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
6858|NCT01697579|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
6859|NCT01697501|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6860|NCT01697462|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6861|NCT01697449|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6862|NCT01697358|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6863|NCT01697345|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6864|NCT01697332|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6865|NCT01697319|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6866|NCT01696994|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6867|NCT01696981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6868|NCT01696968|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6869|NCT01696942|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6870|NCT01696929|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6871|NCT01696773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6872|NCT01696760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6873|NCT01696695|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
6874|NCT01696643|Principal Investigators are NOT employed by the organization sponsoring the study.|
6875|NCT01696357|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6876|NCT01696214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6877|NCT01696188|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6878|NCT01696084|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6879|NCT01696071|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific and statistical accuracy, within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
6880|NCT01696058|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6881|NCT01696045|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6882|NCT01695993|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6883|NCT01695772|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6884|NCT01695746|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6885|NCT01695668|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6886|NCT01695369|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6887|NCT01695330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6888|NCT01695304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6889|NCT01695239|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6890|NCT01695044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6891|NCT01694966|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications to be reviewed by sponsor prior to submission.
6892|NCT01694771|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
6893|NCT01694706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6894|NCT01694667|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6895|NCT01694641|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6896|NCT01694420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6897|NCT01694199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6898|NCT01694108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6899|NCT01693900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6900|NCT01693653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6901|NCT01693484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6902|NCT01693367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6903|NCT01693185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6904|NCT01693120|Principal Investigators are NOT employed by the organization sponsoring the study.|
6905|NCT01693068|Principal Investigators are NOT employed by the organization sponsoring the study.|
6906|NCT01693029|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to the first publication or presentation of the results of the study which is intended to be a joint, multi-center publication of the study results. Following the first publication, institutions and/or Principal Investigators may publish or present data or results from the study per the terms of the clinical trial agreement.
6907|NCT01692951|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6908|NCT01692938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6909|NCT01692782|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS agreement between Principal Investigator and Sponsor that restricts PI's rights to discuss or publish trial results after trial is completed.~In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication provided, if a multicenter publication is not forthcoming within 24 months post completion of study at all sites, PI shall be free to publish."
6910|NCT01692730|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6911|NCT01692691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6912|NCT01692626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6913|NCT01692340|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6914|NCT01692301|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6915|NCT01691898|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6916|NCT01691885|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6917|NCT01691859|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6918|NCT01691794|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
6919|NCT01691781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6920|NCT01691690|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6921|NCT01691612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6922|NCT01691560|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6923|NCT01691534|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator or any Sub-Investigator shall submit any oral or written publication or abstract concerning this study to the Sponsor not less than thirty (30) days prior to submission to any journal, other publication or meeting, for review and removal of confidential information.
6924|NCT01691521|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6925|NCT01691508|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6926|NCT01691482|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6927|NCT01691430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6928|NCT01691339|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
6929|NCT01691326|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
6930|NCT01691313|Principal Investigators are NOT employed by the organization sponsoring the study.|
6931|NCT01691248|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication or other public presentation of results from this study requires prior review and written approval of the Sponsor. Draft abstracts, manuscripts, and materials for presentation at scientific meetings should be provided to the Sponsor at least 90 working days prior to abstract or other relevant submission deadlines.
6932|NCT01691092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6933|NCT01691027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6934|NCT01691014|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
6935|NCT01690988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6936|NCT01690923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6937|NCT01690663|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6938|NCT01690546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6939|NCT01690299|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 12 months since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
6940|NCT01690273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6941|NCT01690117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6942|NCT01690052|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6943|NCT01690000|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6944|NCT01689974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6945|NCT01689857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6946|NCT01689779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6947|NCT01689649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6948|NCT01689532|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
6968|NCT01688050|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6949|NCT01689519|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
6950|NCT01689441|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6951|NCT01689363|Principal Investigators are NOT employed by the organization sponsoring the study.|
6952|NCT01689350|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6953|NCT01689337|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor can with reasonable grounds require changes to the communication which do not change the scientific statement or neutrality of the communication.
6954|NCT01689324|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
6955|NCT01689207|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidentiality clauses are in place through a Master Services agreement, which limits the discloser of confidential information to what’s expressed in 33.2 and 33.3: disclosure to third party only after written consent, or disclosure of confidential information only to the extent necessary to comply with reporting obligations from AZ, CRO or applicable laws.
6956|NCT01689155|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
6957|NCT01688921|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6958|NCT01688882|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6959|NCT01688843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6960|NCT01688830|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
6961|NCT01688726|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
6962|NCT01688635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6963|NCT01688609|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6964|NCT01688466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6965|NCT01688336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6966|NCT01688310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6967|NCT01688102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6988|NCT01686633|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6969|NCT01688037|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the PI has the right to publish results provided such publication does not violate confidentiality or IP provisions within the contract with the Sponsor. Prior to submission for publication or presentation of results, the PI must provide the Sponsor time for review. The Sponsor can request the PI to withhold or remove information from all publications. For a multi-center study, any publication of results by the PI shall not be made before the first multi-center publication.
6970|NCT01687998|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6971|NCT01687972|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6972|NCT01687790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6973|NCT01687712|Principal Investigators are NOT employed by the organization sponsoring the study.|Contract agreement. Results may not be published or referred to, in whole or in part, without the prior express written consent of the Sponsor.
6974|NCT01687478|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6975|NCT01687296|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6976|NCT01687283|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6977|NCT01687270|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6978|NCT01687257|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
6979|NCT01687244|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor will complete its review within the review period and will have authority to require that the Institution and/or Investigator delete from the disclosure of any reference to Confidential Information, other than results.
6980|NCT01687218|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6981|NCT01687114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6982|NCT01687101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6983|NCT01687088|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6984|NCT01687036|Principal Investigators are NOT employed by the organization sponsoring the study.|Following approval of the Sponsor and before publishing or presenting data related to the Trial or the Device, Research lnstitution, Principal lnvestigator, and Co-lnvestigator agree to submit copies of any and all proposed manuscripts or abstracts to Sponsor at least 30 days in advance of the date that the applicable party proposes to submit such proposed manuscripts or abstracts to a publisher or other third party.
6985|NCT01686932|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
6986|NCT01686828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6987|NCT01686646|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
6989|NCT01686568|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6990|NCT01686503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6991|NCT01686451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
6992|NCT01685996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6993|NCT01685983|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
6994|NCT01685840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6995|NCT01685801|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
6996|NCT01685684|Principal Investigators are NOT employed by the organization sponsoring the study.|If a joint manuscript has not been submitted for publication within twelve (12) months of completion or termination of the study, the PI is free to publish separately, upon provision of any proposed publication or manuscript to the Sponsor at least sixty (60) days before it is submitted or otherwise disclosed.
6997|NCT01685606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6998|NCT01685567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
6999|NCT01685437|Principal Investigators are NOT employed by the organization sponsoring the study.|
7000|NCT01685372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7001|NCT01685320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7002|NCT01685242|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7003|NCT01685216|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
7004|NCT01685203|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7005|NCT01685060|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety
7006|NCT01685021|Principal Investigators are NOT employed by the organization sponsoring the study.|As specified in the respective clinical trial agreements with the PI.
7007|NCT01684930|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7008|NCT01684878|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7009|NCT01684839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7051|NCT01681472|Principal Investigators are NOT employed by the organization sponsoring the study.|
7010|NCT01684826|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7011|NCT01684748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7012|NCT01684592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7013|NCT01684566|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7014|NCT01684436|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7015|NCT01684423|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7016|NCT01684410|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the Study, after providing Sponsor thirty days’ notice prior to submitting a manuscript or other materials related to the Study to any outside party. At Sponsors’ request, Site will remove any Confidential Information (other than Study results), and Site will upon Sponsors’ request, delay publication or presentation for a period of up to one hundred twenty days to allow Sponsor to protect its interests in any Sponsor Inventions.
7017|NCT01684215|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7018|NCT01684046|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7019|NCT01684033|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7020|NCT01684007|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7021|NCT01683864|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7022|NCT01683838|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
7023|NCT01683812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7024|NCT01683630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7025|NCT01683604|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7026|NCT01683526|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7027|NCT01683409|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7028|NCT01683383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7029|NCT01683266|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7073|NCT01680159|Principal Investigators are NOT employed by the organization sponsoring the study.|
7030|NCT01683058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7031|NCT01683019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7032|NCT01682954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7033|NCT01682876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7034|NCT01682863|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7035|NCT01682837|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7036|NCT01682759|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
7037|NCT01682720|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
7038|NCT01682681|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot provide any trial related information to external parties’ without mutual agreement with the Sponsor. This is valid even after the contract is canceled.
7039|NCT01682642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7040|NCT01682603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7041|NCT01682538|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7042|NCT01682512|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7043|NCT01682460|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7044|NCT01682135|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7045|NCT01682044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7046|NCT01682031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7047|NCT01681849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7048|NCT01681628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7049|NCT01681576|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7050|NCT01681511|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7052|NCT01681368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7053|NCT01681277|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
7054|NCT01681212|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7055|NCT01681121|Principal Investigators are NOT employed by the organization sponsoring the study.|
7056|NCT01681095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7057|NCT01681069|Principal Investigators are NOT employed by the organization sponsoring the study.|
7058|NCT01681030|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7059|NCT01681004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7060|NCT01680991|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7061|NCT01680900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7062|NCT01680861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7063|NCT01680848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7064|NCT01680783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7065|NCT01680666|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7066|NCT01680653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7067|NCT01680549|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7068|NCT01680497|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7069|NCT01680458|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7070|NCT01680341|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
7071|NCT01680328|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to defer the release of data until specified milestones are reached, for example when the clinical trial report is available. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
7072|NCT01680172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7074|NCT01680016|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial
7075|NCT01679613|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
7076|NCT01679600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7077|NCT01679314|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7078|NCT01679236|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7079|NCT01679197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7080|NCT01679028|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can be co-authored with sponsor for the publication but cannot publish the result solely.
7081|NCT01679002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7082|NCT01678976|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7083|NCT01678911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7084|NCT01678885|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7085|NCT01678846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7086|NCT01678820|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
7087|NCT01678807|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor has the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results.
7088|NCT01678443|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7089|NCT01678313|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7090|NCT01678196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7091|NCT01678131|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
7092|NCT01677988|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7093|NCT01677936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7094|NCT01677910|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution must provide any proposed publication or presentation to Sponsor for Sponsor's review, comment and approval at least thirty (30) days prior to the proposed submission for publication date or the proposed presentation date. Sponsor shall have the right to have deleted from the final version of the publication any confidential information, proprietary information, or patentable subject matter.
7115|NCT01675622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7095|NCT01677858|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
7096|NCT01677767|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7097|NCT01677624|Principal Investigators are NOT employed by the organization sponsoring the study.|
7098|NCT01677507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7099|NCT01677299|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study may be published by INSTITUTE, however the publication shall not disclose any SPONSOR Confidential Information, the INSTITUTE shall send the SPONSOR a copy of any such proposed publication 90 days prior to submission for publication, the INSTITUTE, on request of the SPONSOR, shall delete any SPONSOR Confidential Information in the proposed publication, and the INSTITUTE shall, on the SPONSOR’s request, delay submission while the SPONSOR files applications for patents.
7100|NCT01677286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7101|NCT01677195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7102|NCT01677182|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7103|NCT01676961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7104|NCT01676896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7105|NCT01676714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7106|NCT01676701|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7107|NCT01676532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7108|NCT01676415|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7109|NCT01676298|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7110|NCT01676220|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7111|NCT01676012|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7112|NCT01675830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7113|NCT01675661|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications/dissemination products must be reviewed and approved by the Center for Clinical Trials Network (CCTN) Publications Committee before publishing/disseminating.
7114|NCT01675635|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7116|NCT01675544|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7117|NCT01675531|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7118|NCT01675492|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must review results communications prior to public release and can embargo communications regarding trial results at any time.
7119|NCT01675479|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must review results communications prior to public release and can embargo communications regarding trial results at any time.
7120|NCT01675453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7121|NCT01675427|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7122|NCT01675167|Principal Investigators are NOT employed by the organization sponsoring the study.|PI and Institution reserve the right to publish and present the results of the work performed provided that Institution and/or PI submits a copy of any proposed publication to Sponsor’s agent for review and comment at least 90 days in advance of its presentation or submission for publication. In addition, if Sponsor’s agent requests, Institution and/or PI will withhold publication or presentation for an additional 60 days to allow for establishing and preserving its proprietary rights.
7123|NCT01675141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7124|NCT01675128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7125|NCT01675063|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is not involved with the ultimate analysis of the data which is to be used for proprietary algorithm development. The PI was engaged with his opinion on algorithm development and review of waveform data.
7126|NCT01675050|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7127|NCT01675011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7128|NCT01674725|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7129|NCT01674712|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty (60) days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the PI shall provide to Sponsor a copy of all such manuscripts and materials, and allow Sponsor sixty (60) days to review and comment on them. If the Sponsor requests, the PI shall remove any Confidential Information (other than Study results) prior to submitting or presenting the materials.
7130|NCT01674647|All Principal Investigators ARE employed by the organization sponsoring the study.|The Consultant agrees not to publish or cause to be published any works of authorship relating to the Project rendered pursuant to this Agreement without first notifying Bayer in writing and obtaining Bayer’s written consent. Bayer will respond to such notification within sixty (60) days of receipt.Bayer reserves the right to insist on the removal of all or any of its Confidential Information from any such work prior to publication
7131|NCT01674634|Principal Investigators are NOT employed by the organization sponsoring the study.|
7132|NCT01674621|Principal Investigators are NOT employed by the organization sponsoring the study.|Results may not be published prior to the Study Report completion. Investigators may publish results, providing a manuscript to the Sponsor =/> 30 days prior to its submission to a publisher. Sponsor will provide manuscript to Investigators =/> 30 days prior to its submission. Investigator shall comply with Sponsor's policy, withholding publication for an additional 60 days to permit the Sponsor to obtain patent or other proprietary rights protection, if deemed necessary.
7133|NCT01674062|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7134|NCT01674010|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7135|NCT01673984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7136|NCT01673919|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7137|NCT01673867|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7138|NCT01673854|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7139|NCT01673828|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7140|NCT01673802|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7141|NCT01673698|Principal Investigators are NOT employed by the organization sponsoring the study.|After 12 months after the clinical study report is available, the PI may publish clinical study results, subject to confidentiality agreements and sponsor approval. The PI shall provide sponsor a copy of proposed publication at least 60 days prior to submission so that sponsor may have the opportunity to protect its proprietary rights to information, inventions, or products developed under the clinical study. PI agrees to remove confidential information upon sponsor request.
7142|NCT01673620|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
7143|NCT01673594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7144|NCT01673568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7145|NCT01673490|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7146|NCT01673425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7147|NCT01673347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7148|NCT01673282|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7149|NCT01673256|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7150|NCT01673191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7151|NCT01673178|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7152|NCT01673126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7153|NCT01673113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7154|NCT01673009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7155|NCT01672996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7156|NCT01672983|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7157|NCT01672970|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7158|NCT01672957|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7159|NCT01672892|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
7160|NCT01672827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7161|NCT01672788|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7162|NCT01672723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7163|NCT01672658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7164|NCT01672294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7165|NCT01672242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7166|NCT01671839|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees that the first publication of the results shall be made in conjunction with the results from all study centers. If Investigator desires independently to publish information about data obtained at Investigator’s facility, then Investigator may do so, provided a copy of any proposed oral presentation or written publication is received by Company at least 45 days in advance of submission for publication.
7167|NCT01671748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7168|NCT01671605|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7169|NCT01671488|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7170|NCT01671319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7171|NCT01671293|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7172|NCT01671280|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7173|NCT01671176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7174|NCT01671111|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
7175|NCT01671059|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7176|NCT01670825|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7177|NCT01670721|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7178|NCT01670656|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including slides and texts of oral or other public presentations and texts of any transmission through any electronic media that report results of the trial. The Sponsor has the right to review and comment with respect to publications, abstracts, slides, and manuscripts, as wells as comment on the data analysis and presentation.
7179|NCT01670526|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7180|NCT01670487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7181|NCT01670292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7182|NCT01670279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7183|NCT01670201|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7184|NCT01670188|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7185|NCT01670045|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7186|NCT01670019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7187|NCT01669902|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7188|NCT01669863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7189|NCT01669811|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study withiout AZ approval before this study was completed.
7190|NCT01669785|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7191|NCT01669720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7192|NCT01669642|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7193|NCT01669629|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7194|NCT01669603|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7195|NCT01669577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7196|NCT01669434|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7197|NCT01669174|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
7198|NCT01669148|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7199|NCT01669122|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7200|NCT01668836|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7201|NCT01668797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7202|NCT01668784|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7203|NCT01668667|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7204|NCT01668654|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7205|NCT01668628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7206|NCT01668589|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
7207|NCT01668173|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7208|NCT01668030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7209|NCT01668017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7210|NCT01668004|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation with regard to proprietary information, accuracy of information, and regulatory compliance.
7211|NCT01667978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7212|NCT01667926|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7213|NCT01667900|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7214|NCT01667848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7215|NCT01667796|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7216|NCT01667731|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
7217|NCT01667679|Principal Investigators are NOT employed by the organization sponsoring the study.|
7218|NCT01667536|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7219|NCT01667471|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7220|NCT01667432|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7221|NCT01667224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7222|NCT01667107|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
7223|NCT01666951|Principal Investigators are NOT employed by the organization sponsoring the study.|
7224|NCT01666912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7225|NCT01666782|Principal Investigators are NOT employed by the organization sponsoring the study.|All research data and results generated during the course of or as a result of the Research Project shall be the property of Investigator and/or institution. Sanofi Pasteur will have access to the full set of data collected during the Research Project. The text of any manuscript, abstract or oral presentation based on this Research Project will be provided to Sanofi Pasteur at least 30 days prior to submission to a journal, a congress, or prior to an oral presentation.
7226|NCT01666314|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7227|NCT01666210|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agree that the first publication of the data and results of the Study shall be made in conjunction with the presentation of a joint, multi-center publication of the Study results, with the investigators from all appropriate sites contributing data, analyses, and comments.
7228|NCT01666197|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
7229|NCT01666119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7230|NCT01666002|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7231|NCT01665950|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7232|NCT01665911|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7233|NCT01665807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7234|NCT01665599|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
7235|NCT01665508|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7236|NCT01665430|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7237|NCT01665170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7238|NCT01665157|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7239|NCT01665053|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications to public release and can embargo communications regarding trial results for a period less or equal to 45 days from the time submitted to the sponsor. If the sponsor determines the communication would be detrimental to the intellectual property, the PI will redact or modify or will refrain the publication to a publisher or other party for an additional 120 days to permit the sponsor to file patent applications or take other steps to protect interests
7240|NCT01664975|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7241|NCT01664949|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7242|NCT01664923|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees not to independently publish the results before the publication of the multi-center PI paper. Sponsor shall review and comment 30 days prior to submission or disclosure. If publication or disclosure contains Sponsor Confidential Information, other than study data, PI agrees to remove Confidential Information from publication or disclosure. Sponsor may request that PI delay such publication for an additional 60 days to protect the patentability of any invention described.
7243|NCT01664806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7244|NCT01664793|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7245|NCT01664624|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights therefrom or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
7246|NCT01664559|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7247|NCT01664533|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7248|NCT01664494|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7249|NCT01664247|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
7287|NCT01661972|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7250|NCT01664117|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7251|NCT01664104|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7252|NCT01664052|Principal Investigators are NOT employed by the organization sponsoring the study.|A PI may be requested to delay results communications up to 18 months following study conclusion or until a summary of all study results initiated by Sponsor (first publication) has been published. Following first publication embargo, sponsor may review results communications for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor may request a postponement of results communications not to exceed 180 days.
7253|NCT01664039|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7254|NCT01663987|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7255|NCT01663922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7256|NCT01663779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7257|NCT01663727|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7258|NCT01663714|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7259|NCT01663623|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7260|NCT01663532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7261|NCT01663506|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7262|NCT01663363|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreement between the Principal Investigator and the Sponsor (or its agents) restricts the PI's rights to discuss or publish trial results until after the trial is completed and requires prior approval from the sponsor.
7263|NCT01663285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7264|NCT01663233|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7265|NCT01663103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7266|NCT01663012|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7267|NCT01662999|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7268|NCT01662986|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
7269|NCT01662908|Principal Investigators are NOT employed by the organization sponsoring the study.|
7270|NCT01662882|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7271|NCT01662856|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the Study, after providing Sponsor thirty days’ notice prior to submitting a manuscript or other materials related to the Study to any outside party. At Sponsors’ request, Site will remove any Confidential Information (other than Study results), and Site will upon Sponsors’ request, delay publication or presentation for a period of up to one hundred twenty days to allow Sponsor to protect its interests in any Sponsor Inventions.
7272|NCT01662791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7273|NCT01662765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7274|NCT01662648|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7275|NCT01662635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7276|NCT01662583|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7277|NCT01662531|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
7278|NCT01662492|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7279|NCT01662440|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7280|NCT01662362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7281|NCT01662336|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7282|NCT01662310|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator wishes to publish information from study, a copy of the manuscript must be provided to the Sponsor for review at least 60 days before submission for publication or presentation. If requested by the Sponsor, investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application. Investigators will not publish data derived from individual site until Sponsor confirms there will be no multi-center study publication.
7283|NCT01662115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7284|NCT01662102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7285|NCT01662063|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7286|NCT01662024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7288|NCT01661933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7289|NCT01661881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7290|NCT01661790|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7291|NCT01661764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7292|NCT01661621|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7293|NCT01661270|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7294|NCT01661205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7295|NCT01661179|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7296|NCT01661140|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7297|NCT01661114|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7298|NCT01661062|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7299|NCT01660906|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7300|NCT01660893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7301|NCT01660815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7302|NCT01660802|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for at least 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7303|NCT01660763|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7304|NCT01660737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7305|NCT01660698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7306|NCT01660672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7327|NCT01658735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7307|NCT01660451|Principal Investigators are NOT employed by the organization sponsoring the study.|"Contract Partners (PI) shall provide to Bayer any proposed publication or oral presentation relating to the Study or the Results (Publication) at least sixty (60) days prior to the intended submission or presentation of the Publication in order to allow Bayer to review it.~If Bayer does not notify PI within forty-five (45) days of Bayer's receipt of the intended Publication, PI shall remind Bayer. If Bayer does not provide any comments within the sixty day period, PI shall be free to publish."
7308|NCT01660412|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7309|NCT01660334|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7310|NCT01660321|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7311|NCT01660230|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7312|NCT01660191|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7313|NCT01660022|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7314|NCT01659996|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
7315|NCT01659853|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7316|NCT01659736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7317|NCT01659567|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7318|NCT01659554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7319|NCT01659320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7320|NCT01659268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7321|NCT01659125|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7322|NCT01659021|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
7323|NCT01658943|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7324|NCT01658904|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7325|NCT01658839|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7326|NCT01658813|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7328|NCT01658657|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7329|NCT01658579|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7330|NCT01658514|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study may be published by INSTITUTE, however the publication shall not disclose any SPONSOR Confidential Information, the INSTITUTE shall send the SPONSOR a copy of any such proposed publication 90 days prior to submission for publication, the INSTITUTE, on request of the SPONSOR, shall delete any SPONSOR Confidential Information in the proposed publication, and the INSTITUTE shall, on the SPONSOR’s request, delay submission while the SPONSOR files applications for patents.
7331|NCT01658436|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
7332|NCT01658228|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7333|NCT01658072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7334|NCT01658020|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7335|NCT01657903|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7336|NCT01657877|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7337|NCT01657799|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7338|NCT01657461|Principal Investigators are NOT employed by the organization sponsoring the study.|Physician shall not make any publication without providing Sponsor 30 days notice.If Sponsor determines that the proposed publication contains confidential information, Sponsor may require the delay of publication for a period of time not to exceed 90 days and may require that any confidential information be removed from the publication. Sponsor may also require Physician to delay publication until any factual errors or inaccuracies in the publication are corrected.
7339|NCT01657370|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7340|NCT01657305|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires approval of the sponsor without specification of an embargo time period.
7341|NCT01657292|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires approval of the sponsor without specification of an embargo time period.
7342|NCT01657253|Principal Investigators are NOT employed by the organization sponsoring the study.|"All the information is confidential and exclusive property of the sponsor. Information can be revealed only to my staff and regulatory agencies or ethics committee.~All the information from this protocol is confidential and exclusive property of the sponsor, it can not be revealed without written consent from the sponsor."
7343|NCT01657032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7344|NCT01657019|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
7345|NCT01656967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7367|NCT01654666|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7346|NCT01656889|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7347|NCT01656850|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7348|NCT01656772|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7349|NCT01656759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7350|NCT01656486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7351|NCT01656460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7352|NCT01656434|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including slides and texts of oral or other public presentations that report any results of the trial). The Sponsor has the right to review and comment on publications, abstracts, slides, and manuscripts, as well as the data analysis and presentation.
7353|NCT01656408|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
7354|NCT01656304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7355|NCT01656252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7356|NCT01656161|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement restricts the PI from discussing or publishing trial results after the trial is completed.
7357|NCT01656031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7358|NCT01655719|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7359|NCT01655498|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7360|NCT01655381|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7361|NCT01655329|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7362|NCT01655069|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript at least 90 days prior to publication for review and comment. Sponsor may delay the publication temporarily to seek patent protection or permanently withhold the publication.
7363|NCT01655043|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7364|NCT01654887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7365|NCT01654861|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7366|NCT01654796|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7368|NCT01654601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7369|NCT01654549|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7370|NCT01654536|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
7371|NCT01654523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7372|NCT01654302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7373|NCT01654276|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7374|NCT01654263|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7375|NCT01654250|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7376|NCT01654224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7377|NCT01654107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7378|NCT01653964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7379|NCT01653912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7380|NCT01653782|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7381|NCT01653743|Principal Investigators are NOT employed by the organization sponsoring the study.|
7382|NCT01653509|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7383|NCT01653418|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7384|NCT01653262|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7385|NCT01653158|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7386|NCT01653132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7387|NCT01653028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7388|NCT01652885|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7389|NCT01652729|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7390|NCT01652716|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7391|NCT01652703|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
7392|NCT01652690|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
7393|NCT01652664|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7394|NCT01652573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7395|NCT01652495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7396|NCT01652287|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7397|NCT01652040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7398|NCT01652001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7399|NCT01651949|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
7400|NCT01651936|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
7401|NCT01651806|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7402|NCT01651780|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7403|NCT01651351|Principal Investigators are NOT employed by the organization sponsoring the study.|PI may not publish without the prior written consent of Sponsor
7404|NCT01651260|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7405|NCT01651208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7406|NCT01651104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7407|NCT01651039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7408|NCT01651000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7409|NCT01650844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7410|NCT01650831|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7411|NCT01650805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7412|NCT01650779|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7413|NCT01650545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7414|NCT01650519|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7415|NCT01650350|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7416|NCT01650324|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7417|NCT01650285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7418|NCT01650246|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
7419|NCT01649856|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7420|NCT01649804|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7421|NCT01649791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7422|NCT01649609|All Principal Investigators ARE employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7423|NCT01649596|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7424|NCT01649557|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7425|NCT01649505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7426|NCT01649362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7427|NCT01649297|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7428|NCT01649271|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7429|NCT01649232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7430|NCT01649180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7431|NCT01648920|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7432|NCT01648790|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7433|NCT01648699|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7434|NCT01648582|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7435|NCT01648530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7436|NCT01648491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7437|NCT01648452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7438|NCT01648348|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7439|NCT01648322|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7440|NCT01648140|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7441|NCT01648101|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7442|NCT01647945|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7443|NCT01647737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7444|NCT01647711|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7445|NCT01647542|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7446|NCT01647464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7447|NCT01647438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7448|NCT01647282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7449|NCT01647217|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7450|NCT01646827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is no agreement between PI and sponsor that restricts the PI's right to discuss or publish trial results after the trial is completed.
7451|NCT01646814|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7452|NCT01646762|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7453|NCT01646671|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7454|NCT01646398|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7455|NCT01646385|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7456|NCT01646320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7457|NCT01646268|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
7458|NCT01646255|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
7459|NCT01646216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7460|NCT01646177|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7461|NCT01646151|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7462|NCT01646138|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7463|NCT01646125|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
7464|NCT01646073|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7465|NCT01646021|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
7466|NCT01645735|Principal Investigators are NOT employed by the organization sponsoring the study.|The data generated in this clinical study are the exclusive property of the Sponsor and are confidential. The Sponsor will make all reasonable efforts to publish the results of the study in an appropriate peer-reviewed journal. Authorship on the primary publication of the results from this study will be based on contributions to study design, enrollment, data analysis, and interpretation of results. Publication of results by the PI will be subject to mutual agreement between the PI and Sponsor.
7467|NCT01645709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7468|NCT01645280|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
7469|NCT01645176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7470|NCT01645111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7471|NCT01645098|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7472|NCT01645059|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7473|NCT01644734|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
7474|NCT01644695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7475|NCT01644643|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to use such Confidential study information and not to disclose them to any other third parties, except that the undersigned shall not be prevented from using or disclosing information: (a) which by written records was previously known; (b) which is now public knowledge, (c) which is lawfully obtained by the undersigned from sources who have a lawful right to disclose such information.
7476|NCT01644617|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results without the prior written consent of the sponsor. The Sponsor has the opportunity to review all proposed abstracts, manuscripts, presentations, or data analyses regarding this trial 45 days prior to submission for publication/presentation. The sponsor has the right to review and comment with regard to proprietary information, accuracy, and compliance with FDA regulations.
7477|NCT01644500|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7478|NCT01644474|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7479|NCT01644396|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7480|NCT01644331|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7481|NCT01644292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7482|NCT01644240|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may communicate the trial results generated by the PI, but only after the first publication or presentation of the combined study results generated by all participating sites. The Sponsor can then review trial results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The Sponsor cannot require changes to the communication and cannot extend the embargo.
7483|NCT01644188|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7503|NCT01642238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7484|NCT01644175|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7485|NCT01644058|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7486|NCT01643928|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot extend the embargo. Investigator will, on request, remove any previously undisclosed Confidential Information (other than the Study results themselves) before disclosure.
7487|NCT01643902|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7488|NCT01643876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7489|NCT01643798|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7490|NCT01643668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7491|NCT01643616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7492|NCT01643525|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7493|NCT01643213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7494|NCT01643044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7495|NCT01642914|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this trial will be the property of Forest Research Institute, Inc. and Ironwood Pharmaceuticals, Inc. An integrated clinical and statistical report will be prepared at the completion of the trial.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator, Ironwood Pharmaceuticals, Inc., and Forest Research Institute, Inc."
7496|NCT01642732|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7497|NCT01642615|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7498|NCT01642602|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7499|NCT01642589|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
7500|NCT01642485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7501|NCT01642407|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7502|NCT01642277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7504|NCT01642212|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
7505|NCT01642147|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7506|NCT01642082|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7507|NCT01642004|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7508|NCT01641991|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7509|NCT01641978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7510|NCT01641952|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7511|NCT01641939|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7512|NCT01641926|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts.
7513|NCT01641900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7514|NCT01641861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7515|NCT01641835|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7516|NCT01641822|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
7517|NCT01641692|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7518|NCT01641653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7519|NCT01641640|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
7520|NCT01641471|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7521|NCT01641367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7522|NCT01641237|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7523|NCT01641159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7524|NCT01641133|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7525|NCT01641120|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7526|NCT01641081|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the PI will be subject to mutual agreement between the PI and sponsor.
7527|NCT01641042|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7528|NCT01640964|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7529|NCT01640951|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
7530|NCT01640925|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7531|NCT01640548|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7532|NCT01640379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7533|NCT01640353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the site is that the sponsor can review results communications prior to public release and must have at least 30 days to do so.
7534|NCT01640340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7535|NCT01640327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7536|NCT01640314|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7537|NCT01640197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7538|NCT01640184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7539|NCT01640171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7540|NCT01640054|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7541|NCT01639833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7542|NCT01639755|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7543|NCT01639742|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7544|NCT01639729|Principal Investigators are NOT employed by the organization sponsoring the study.|requires prior approval
7545|NCT01639703|Principal Investigators are NOT employed by the organization sponsoring the study.|"All written or oral papers and publications must have the joint agreement of the investigator and the sponsor.~Each investigator agrees not to publish/submit/present the results of the study main criterion involving only the patients he/she has included.~Any abstract project will be first submitted to Guerbet at least 10 working days before submission to the congress scientific committee."
7546|NCT01639560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7547|NCT01639495|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
7548|NCT01639469|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7549|NCT01639443|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7550|NCT01639352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7551|NCT01639222|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights therefrom or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
7552|NCT01639157|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7553|NCT01639144|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7554|NCT01639040|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor's request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
7555|NCT01639001|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7556|NCT01638559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7557|NCT01638546|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7558|NCT01638507|Principal Investigators are NOT employed by the organization sponsoring the study.|For any publication or presentation of the Protected Materials or any portion thereof, a manuscript of the paper, abstract or any materials will be provided by Consultant to Sponsor for its approval at least sixty (60days) for manuscripts and thirty (30) days for presentations prior to outside submission. Medtronic shall have the right to request reasonable modifications of any manuscript or other materials to be published or presented.
7559|NCT01638468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7560|NCT01638312|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7561|NCT01638000|Principal Investigators are NOT employed by the organization sponsoring the study.|"Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript 45 days prior to publication for review and comment.~Sponsor may delay the publication to seek patent protection."
7603|NCT01634243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7562|NCT01637961|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7563|NCT01637935|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 45 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7564|NCT01637922|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights..
7565|NCT01637870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7566|NCT01637584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7567|NCT01637272|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
7568|NCT01637246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7569|NCT01637090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7570|NCT01637077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7571|NCT01636986|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7572|NCT01636960|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees not to publish or publicly present any interim results of the trial without prior written consent of the Sponsor. The Investigator further agrees to provide review copies of abstracts or manuscripts (both oral and textual including transmission through any electronic medium). No publication or manuscript shall contain any trade secret information of the Sponsor or any proprietary or confidential information of the Sponsor.
7573|NCT01636947|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation.
7574|NCT01636882|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7575|NCT01636778|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7576|NCT01636765|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7577|NCT01636713|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7578|NCT01636661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7579|NCT01636466|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7580|NCT01636414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7581|NCT01636362|Principal Investigators are NOT employed by the organization sponsoring the study.|
7582|NCT01636258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7583|NCT01636206|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicentre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicentre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
7584|NCT01636102|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7585|NCT01636076|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
7586|NCT01636063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7587|NCT01635933|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7588|NCT01635920|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7589|NCT01635881|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Investigator shall have the right to publish the results, provided that before publishing, Institution and Investigator shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
7590|NCT01635855|Principal Investigators are NOT employed by the organization sponsoring the study.|No manuscripts may be submitted for publication without prior review by the Sponsor. Investigator agrees to accommodate requests by Sponsor to protect proprietary rights/interests. Sponsor will be given full credit/acknowledgment for support provided for any publication resulting from this research. Investigator shall grant to the Sponsor an irrevocable royalty free, non-exclusive right to reproduce, translate, use all such copyrighted material arising from publications from study.
7591|NCT01635764|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
7592|NCT01635504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7593|NCT01635439|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7594|NCT01635244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7595|NCT01635218|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7596|NCT01635062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7597|NCT01634854|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7598|NCT01634659|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7599|NCT01634620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7600|NCT01634555|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
7601|NCT01634360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7602|NCT01634256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7604|NCT01634165|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7605|NCT01634152|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7606|NCT01634139|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7607|NCT01634113|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7608|NCT01634100|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
7609|NCT01633944|Principal Investigators are NOT employed by the organization sponsoring the study.|PI and Institution reserve the right to publish and present the results of the work performed provided that Institution and/or PI submits a copy of any proposed publication to Sponsor's agent for review and comment at least 90 days in advance of its presentation or submission for publication. In addition, if Sponsor's agent requests, Institution and/or PI will withhold publication or presentation for an additional 60 days to allow for establishing and preserving its proprietary rights.
7610|NCT01633892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7611|NCT01633853|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7612|NCT01633827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7613|NCT01633814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7614|NCT01633788|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7615|NCT01633320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7616|NCT01632995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7617|NCT01632904|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
7618|NCT01632878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7619|NCT01632800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7620|NCT01632735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7621|NCT01632709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7622|NCT01632683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7623|NCT01632423|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7624|NCT01632345|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7625|NCT01632280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7626|NCT01632267|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7627|NCT01632215|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7628|NCT01632150|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7629|NCT01632020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7630|NCT01631929|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7631|NCT01631864|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7632|NCT01631825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7633|NCT01631812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7634|NCT01631682|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7635|NCT01631656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7636|NCT01631630|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7637|NCT01631435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7638|NCT01631331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7639|NCT01631227|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7640|NCT01631149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7641|NCT01631110|Principal Investigators are NOT employed by the organization sponsoring the study.|Material for public dissemination will be submitted to the sponsor for review at least ninety (90) days prior to submission for publication, public dissemination, or review by a publication committee.
7642|NCT01631071|Principal Investigators are NOT employed by the organization sponsoring the study.|Material for public dissemination will be submitted to the Sponsor for review at least ninety (90) days prior to submission for publication, public dissemination, or review by a publication committee.
7643|NCT01630811|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7644|NCT01630694|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7645|NCT01630616|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
7646|NCT01630135|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7647|NCT01630109|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7648|NCT01629953|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7649|NCT01629862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7650|NCT01629823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7651|NCT01629797|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7652|NCT01629784|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7653|NCT01629771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7654|NCT01629706|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7655|NCT01629693|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7656|NCT01629667|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
7657|NCT01629589|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
7658|NCT01629290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7659|NCT01629134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7660|NCT01628965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7661|NCT01628926|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7662|NCT01628913|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
7663|NCT01628848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7664|NCT01628692|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7665|NCT01628614|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7666|NCT01628601|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7667|NCT01628588|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7668|NCT01628510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7669|NCT01628367|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7670|NCT01628250|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7671|NCT01628198|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7672|NCT01628042|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
7673|NCT01627860|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7674|NCT01627782|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
7675|NCT01627561|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7676|NCT01627340|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7677|NCT01627327|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7678|NCT01627249|Principal Investigators are NOT employed by the organization sponsoring the study.|Trial results can not be discussed until they have been made available to the public.
7679|NCT01627002|Principal Investigators are NOT employed by the organization sponsoring the study.|After completion of the study, the Investigator may prepare a joint publication with the Sponsor. The Investigator must undertake not to submit any part of the individual data from this protocol for publication without prior consent of the Sponsor at a mutually agreed time.
7680|NCT01626820|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7681|NCT01626690|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7682|NCT01626456|Principal Investigators are NOT employed by the organization sponsoring the study.|Should an Investigator desire to disclose study results, Sponsor will review the results disclosure prior to public release and can embargo the disclosure for a period of at least 60 days. Revisions to the disclosure will be negotiated in good faith. For a multicenter study the Investigators agree to publish/ publicly present the results together with the other sites for the 12 month period after study results are available unless Sponsor grants written permission in advance.
7683|NCT01626391|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7684|NCT01626352|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
7685|NCT01626118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7686|NCT01626092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7687|NCT01625910|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7688|NCT01625845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7689|NCT01625689|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7690|NCT01625507|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7691|NCT01625455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7692|NCT01625416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7693|NCT01625377|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7694|NCT01625338|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
7695|NCT01625221|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7696|NCT01625182|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7697|NCT01625169|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7698|NCT01625104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7699|NCT01625091|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7700|NCT01624948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7701|NCT01624740|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7702|NCT01624467|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7703|NCT01624363|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7704|NCT01624350|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7705|NCT01624259|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7706|NCT01624233|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7707|NCT01624168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7708|NCT01623869|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7709|NCT01623830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7710|NCT01623739|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7711|NCT01623596|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
7712|NCT01623479|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7713|NCT01623466|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be reviewed and approved by sponsor
7714|NCT01623323|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7715|NCT01623310|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreement is described in the CTA between sponsor and PI
7716|NCT01623271|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7717|NCT01623154|Principal Investigators are NOT employed by the organization sponsoring the study.|Central/Principal Investigator may publish the results of the study. However, at least 60 days prior to submitting to a publisher or a public presentation, a copy of the manuscript will be provided to the Sponsor for review. PI understands and agrees that as such, participation in the study involves a commitment to publish the data from the study in a cooperative publication prior to publication or oral presentation of efficacy/safety results on an individual basis.
7718|NCT01623115|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7719|NCT01623050|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7720|NCT01622673|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
7721|NCT01622660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7722|NCT01622348|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7723|NCT01622296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7724|NCT01622257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7725|NCT01622231|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7726|NCT01621802|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7727|NCT01621776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7728|NCT01621672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7729|NCT01621633|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7730|NCT01621477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7731|NCT01621191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7732|NCT01621178|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7733|NCT01621126|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7734|NCT01621009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7735|NCT01620762|Principal Investigators are NOT employed by the organization sponsoring the study.|To avoid disclosures that may affect the proprietary rights of the Sponsor, the Investigator agrees to allow Circassia the opportunity to review all manuscripts and abstracts 60 days prior to submission for publication. Circassia reserves the right to include the report of this study in any regulatory documentation or submission or in any informational materials.
7736|NCT01620593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7737|NCT01620489|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
7738|NCT01620255|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7739|NCT01620177|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7740|NCT01620138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7741|NCT01620086|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7742|NCT01620060|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
7743|NCT01620047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7744|NCT01619982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7745|NCT01619878|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7746|NCT01619800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7747|NCT01619787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7748|NCT01619774|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7749|NCT01619579|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7750|NCT01619059|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7751|NCT01618968|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7752|NCT01618955|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7753|NCT01618942|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7754|NCT01618864|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right to remove all Confidential Information from any publications or presentations to protect its intellectual property rights.
7755|NCT01618838|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7756|NCT01618708|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7757|NCT01618669|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or 18 months after data-lock, whichever is first. Sponsor must receive a site’s manuscript at least 45 days prior to publication for review and comment. Sponsor may delay the publication for up to 60 days to seek patent protection.
7758|NCT01618422|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7759|NCT01618344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7760|NCT01618266|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7761|NCT01618240|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7762|NCT01618227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7763|NCT01618214|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Novo Nordisk reserves the right to prior review of such publications and to ask for delay of publication of individual site results until after the primary manuscript is accepted for publication.
7764|NCT01618162|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone pubication and/or communication for up to 60 days to protect intellectual property.
7765|NCT01618019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7766|NCT01617681|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­ site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
7767|NCT01617668|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
7787|NCT01615822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7768|NCT01617655|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
7769|NCT01617629|Principal Investigators are NOT employed by the organization sponsoring the study.|For study centers in Australia, no publication of the study results may be made until publication of the results of the study from all centers or until 2 years after study completion, whichever is sooner. For study centers in the USA, no submission for publication or public disclosure of the results by will be made until the results from all centers have been received and analyzed by the sponsor, or the multi-center study has been terminated or abandoned at all centers.
7770|NCT01617603|Principal Investigators are NOT employed by the organization sponsoring the study.|
7771|NCT01617577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7772|NCT01617460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7773|NCT01617447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7774|NCT01617434|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager before submission for comments. Comments will be given within four weeks from receipt of the planned communication.
7775|NCT01617369|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7776|NCT01617187|Principal Investigators are NOT employed by the organization sponsoring the study.|It is planned to first publish/present trial results together with the other sites, unless permission is obtained from Sponsor to publish separate results. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. If there is disagreement concerning appropriateness of the materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve disagreement prior to submission for publication.
7777|NCT01617083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7778|NCT01617070|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7779|NCT01617005|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7780|NCT01616953|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7781|NCT01616771|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7782|NCT01616576|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees to submit any publication to Sponsor (S) at least 30 days prior to submission. Within 30 days of its receipt, S advises PI in writing of any information contained therein which is Confidential Information (CI) (other than Study Data) or which may impair the availability of patent protection for Inventions. S has the right to require PI to remove specifically identified CI and/or to delay the publication for an additional 60 days to enable S to seek patent protection for Inventions.
7783|NCT01616459|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7784|NCT01616173|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7785|NCT01616056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7786|NCT01615939|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7788|NCT01615809|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7789|NCT01615731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7790|NCT01615484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7791|NCT01615367|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7792|NCT01615328|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7793|NCT01615263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7794|NCT01615198|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7795|NCT01615029|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
7796|NCT01614886|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
7797|NCT01614795|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7798|NCT01614769|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
7799|NCT01614613|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7800|NCT01614600|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7801|NCT01614574|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication
7802|NCT01614509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7803|NCT01614470|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
7804|NCT01614457|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
7805|NCT01614249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7806|NCT01614210|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7807|NCT01614093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7808|NCT01613716|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7809|NCT01613599|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7810|NCT01613417|Principal Investigators are NOT employed by the organization sponsoring the study.|Study results may be presented at scientific symposia or published in a peer-review journal after review by sponsor in accordance with the guidelines set forth in the applicable publication or financial agreement
7811|NCT01613378|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7812|NCT01613339|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7813|NCT01613326|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
7814|NCT01613313|Principal Investigators are NOT employed by the organization sponsoring the study.|
7815|NCT01613248|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7816|NCT01613131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7817|NCT01613027|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7818|NCT01613014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7819|NCT01612884|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7820|NCT01612858|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7821|NCT01612767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7822|NCT01612702|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7823|NCT01612676|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
7824|NCT01612546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7825|NCT01612494|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7826|NCT01612351|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7827|NCT01612221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7828|NCT01612156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7829|NCT01612000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7830|NCT01611974|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
7831|NCT01611948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7832|NCT01611883|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
7833|NCT01611857|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
7834|NCT01611792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7835|NCT01611779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7836|NCT01611662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7837|NCT01611571|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7838|NCT01611558|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
7839|NCT01611259|Principal Investigators are NOT employed by the organization sponsoring the study.|
7840|NCT01610791|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7841|NCT01610713|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7842|NCT01610700|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7843|NCT01610687|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7844|NCT01610596|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor has first right to publish pooled study data. In the event that such manuscript has not been submitted for publication within 12 months from study completion/termination at all participating sites, the PI shall have the right to single center publications provided they submit any data for presentation, oral or written, to the Sponsor for review 30 days prior to public disclosure. The PI may not disclose previously undisclosed confidential information other than study results.
7845|NCT01610570|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7846|NCT01610557|Principal Investigators are NOT employed by the organization sponsoring the study.|No outcome data should be presented until after a manuscript is accepted for publication.
7885|NCT01607320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7847|NCT01610492|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7848|NCT01610453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7849|NCT01610414|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7850|NCT01610297|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7851|NCT01610167|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7852|NCT01610154|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7853|NCT01610076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7854|NCT01610063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7855|NCT01610037|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7856|NCT01610011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7857|NCT01609790|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7858|NCT01609582|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7859|NCT01609543|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
7860|NCT01609478|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
7861|NCT01609348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7862|NCT01609257|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7863|NCT01609062|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot publish any data prior to multi-centre publication. If publication related to sub-sets of data it shall make reference to the relevant multi-centre publication. PI agrees to submit material to Sponsor for review up to 60 days prior to publication and incorporate all reasonable comments. During review, Sponsor may request that publication be delayed for up to 6 months from date of first submission to Sponsor in order for Sponsor to take steps to protect its proprietary information.
7864|NCT01609023|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7865|NCT01609010|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
7866|NCT01608971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7867|NCT01608815|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
7868|NCT01608724|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7869|NCT01608672|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7870|NCT01608659|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7871|NCT01608490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7872|NCT01608321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7873|NCT01608308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7874|NCT01608295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7875|NCT01608100|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7876|NCT01607853|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is entitled to review and comment on publications prior to submission or presentation. Upon request of the sponsor, the investigator shall delay publication or presentation to allow for protection of the sponsors inventions and other intellectual property.
7877|NCT01607645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7878|NCT01607593|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7879|NCT01607554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7880|NCT01607476|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7881|NCT01607450|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7882|NCT01607411|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7883|NCT01607398|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7884|NCT01607346|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7886|NCT01607203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7887|NCT01607112|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7888|NCT01606852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7889|NCT01606800|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc) that report any results of the trial.
7890|NCT01606761|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
7891|NCT01606748|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7892|NCT01606735|Principal Investigators are NOT employed by the organization sponsoring the study.|All information related to this study is considered confidential information belonging to Icon Bioscience, Inc. Data on the use of the study drug and results of all clinical and laboratory studies are considered private and confidential. None of the details, results, or other information for this study shall be published or made known to a third party without written consent from Icon Bioscience, Inc., except for disclosure to regulatory agencies if required by law.
7893|NCT01606670|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7894|NCT01606319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7895|NCT01606306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7896|NCT01606254|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7897|NCT01606228|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7898|NCT01606202|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7899|NCT01606189|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7900|NCT01606176|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7901|NCT01606150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7902|NCT01606137|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7903|NCT01606124|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7904|NCT01606007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7946|NCT01602380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7905|NCT01605942|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7906|NCT01605916|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AZ approval before this study was completed.
7907|NCT01605903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7908|NCT01605877|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7909|NCT01605825|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has the right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
7910|NCT01605799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7911|NCT01605669|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7912|NCT01605617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7913|NCT01605552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7914|NCT01605539|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7915|NCT01605461|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
7916|NCT01605370|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7917|NCT01605292|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7918|NCT01605227|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements with investigators vary; constant is our right to review results communications prior to public release, and embargo communications for a period of ≤60 days from submittal for review. We do not prohibit investigators from publishing, but we may require previously undisclosed confidential information, other than study results, to be removed from publications, and single-center publications are postponed until after publication of the trial’s primary multicenter publication.
7919|NCT01604941|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
7920|NCT01604850|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
7921|NCT01604772|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7922|NCT01604408|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7923|NCT01604343|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
7924|NCT01604278|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7925|NCT01604265|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7926|NCT01604122|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7927|NCT01604109|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7928|NCT01603940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7929|NCT01603875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7930|NCT01603459|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study information usually requires agreement with the sponsor. In case of justified doubts by the sponsor, the Investigator will consider these doubts in the publication as long as the scientific neutrality is not affected.
7931|NCT01603420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7932|NCT01603394|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7933|NCT01603277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7934|NCT01603121|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7935|NCT01603082|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AstraZeneca (AZ) for review at least 60 days in advance of the submission for publication. The Investigators in the Multi-Center (MC) study agree to postpone MC publications until the earlier of the first AZ-authorized publication or up to 18 months from study completion at all sites.
7936|NCT01603056|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to review and comment any manuscript within 30 days of receipt, but cannot prevent publications of findings. Sponsor will review the communications for accuracy (thus avoiding potential discrepancies with submissions to health authorities), verify that the confidential information is not being inadvertently divulged and provide any relevant supplementary information.
7937|NCT01603043|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
7938|NCT01602965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7939|NCT01602744|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7940|NCT01602731|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7941|NCT01602562|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7942|NCT01602549|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7943|NCT01602510|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
7944|NCT01602484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7945|NCT01602471|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7947|NCT01602341|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7948|NCT01602315|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data all sites) in the clinical trial.
7949|NCT01602198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7950|NCT01602068|Principal Investigators are NOT employed by the organization sponsoring the study.|
7951|NCT01602016|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7952|NCT01601977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7953|NCT01601821|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
7954|NCT01601782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7955|NCT01601704|Principal Investigators are NOT employed by the organization sponsoring the study.|If not already published by Sponsor as part of a multi-center publication, 24 months after conclusion, abandonment or termination of the study or notification that there will be no such multi-center publication, PI may publish the results for PI's study center individually. Prior to such publication, PI must provide Sponsor with at least 90 days to review and comment on the proposed publication. Sponsor may delay publication for up to an additional 6-month period to file for patent protection.
7956|NCT01601691|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7957|NCT01601626|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
7958|NCT01601470|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
7959|NCT01601236|Principal Investigators are NOT employed by the organization sponsoring the study.|A sole participant institution shall not, without Sponsor’s prior written consent, independently publish or otherwise disclose any results of this multicenter study prior to a “multicenter” publication, or 12 months after completion of the study, whichever occurs first. Institution and Principal Investigator shall have the right to publish and present the results of Institution’s and Principal Investigator’s activities solely in accordance with the Sponsor’s written provisions.
7960|NCT01601132|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
7961|NCT01600950|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7962|NCT01600885|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7963|NCT01600729|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7964|NCT01600716|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
7965|NCT01600703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7966|NCT01600677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7967|NCT01600586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7968|NCT01600495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7969|NCT01600482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7970|NCT01600326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7971|NCT01600287|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7972|NCT01600222|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
7973|NCT01600092|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
7974|NCT01600053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7975|NCT01600014|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
7976|NCT01599832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7977|NCT01599806|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator submits the proposed publication and /or presentation to AZAB for review at least 60 days prior to proposed publication and/or presentation. If AZAB, requests in writing, then PI shall withhold publication and/or presentation for an additional 90 days to allow AZAB to protect its intellectual rights.
7978|NCT01599741|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7979|NCT01599650|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
7980|NCT01599637|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
7981|NCT01599585|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7982|NCT01599325|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally sixty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
7983|NCT01599234|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
7984|NCT01599104|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8007|NCT01597479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7985|NCT01598987|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
7986|NCT01598779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7987|NCT01598740|Principal Investigators are NOT employed by the organization sponsoring the study.|
7988|NCT01598610|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7989|NCT01598545|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7990|NCT01598532|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7991|NCT01598506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7992|NCT01598428|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7993|NCT01598350|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7994|NCT01598311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7995|NCT01598298|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7996|NCT01598207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7997|NCT01598129|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
7998|NCT01598064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
7999|NCT01598025|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8000|NCT01597908|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8001|NCT01597843|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8002|NCT01597791|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8003|NCT01597635|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8004|NCT01597596|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
8005|NCT01597505|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8006|NCT01597492|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8008|NCT01597440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8009|NCT01597245|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8010|NCT01597141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8011|NCT01597128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8012|NCT01597050|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8013|NCT01596972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8014|NCT01596842|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8015|NCT01596582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8016|NCT01596504|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the Investigator can present or publish results. The investigator provides the sponsor with a copy of the presentation or publication for review and comment at least 30 days in advance of its submission.~The sponsor can delay the submission for a period not exceeding 90 days to allow for filing a patent application or such other measures as sponsor deems appropriate to establish and preserve its proprietary rights."
8017|NCT01596283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8018|NCT01596231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8019|NCT01596127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8020|NCT01596088|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8021|NCT01596062|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8022|NCT01595854|All Principal Investigators ARE employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
8023|NCT01595646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8024|NCT01595438|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator submits the proposed publication and /or presentation to AZAB for review at least 60 days prior to proposed publication and/or presentation. If AZAB, requests in writing, then PI shall withhold publication and/or presentation for an additional 90 days to allow AZAB to protect its intellectual rights.
8025|NCT01595386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8026|NCT01595282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8027|NCT01594970|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8048|NCT01592695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8028|NCT01594762|Principal Investigators are NOT employed by the organization sponsoring the study.|If no multi-site publication within 18 months of study completion, Site shall have right to publish subject to: 1) Prior to submitting/presenting, Site shall provide Sponsor a copy; Sponsor shall have 60 days to review/comment. 2) Site shall remove any Confidential Information prior to submitting/presenting the materials. 3) Site shall further delay publication/presentation for up to 120 days to allow Sponsor to protect its interests in any Sponsor Inventions described in any such materials.
8029|NCT01594749|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
8030|NCT01594515|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8031|NCT01594424|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8032|NCT01594411|Principal Investigators are NOT employed by the organization sponsoring the study.|CardioDx will provide a copy of the proposed publication to Collaborator for prior review for a thirty (30)-day period, during which period any Collaborator personnel listed as authors may either (a) elect to opt out from being listed as an author, or (b) suggest modifications to the proposed publication, and if they do not elect either (a) or (b) within that period, they will be deemed to have consented to publication as an author.
8033|NCT01594385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8034|NCT01594294|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
8035|NCT01594125|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8036|NCT01593852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8037|NCT01593787|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8038|NCT01593722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8039|NCT01593670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8040|NCT01593592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8041|NCT01593215|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8042|NCT01592864|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8043|NCT01592851|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8044|NCT01592786|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study are the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
8045|NCT01592773|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the PI will be subject to mutual agreement between the PI and Forest Research Institute, Inc."
8046|NCT01592760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8047|NCT01592708|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8049|NCT01592435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8050|NCT01592396|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The Principal Investigator (PIs) also agree for data to be presented first as a joint, multi-center publication.
8051|NCT01592344|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8052|NCT01592292|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8053|NCT01592240|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results
8054|NCT01592071|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8055|NCT01592045|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the Study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed, except as provided below. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
8056|NCT01592006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8057|NCT01591954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8058|NCT01591863|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication or other public presentation of results from this study requires prior review and written approval of the Sponsor. Draft abstracts, manuscripts, and materials for presentation at scientific meetings should be provided to the Sponsor at least 30 working days prior to submission deadlines. Authorship of publications resulting from this study will be based on generally accepted criteria for major medical journals.
8059|NCT01591837|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
8060|NCT01591733|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8061|NCT01591681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8062|NCT01591616|Principal Investigators are NOT employed by the organization sponsoring the study.|The subject study was a post-approval requirement related to the approval of NDA 21-451 to evaluate the pharmacokinetics and safety of the Oraqix gel in pediatric patients. As the purpose of the study was solely to fulfill a post approval regulatory requirement, the information is considered proprietary to the sponsor (Dentsply International, Inc.) and disclosure by the Investigators to any third party (unless such disclosure was required by government regulations or laws) was prohibited.
8063|NCT01591499|Principal Investigators are NOT employed by the organization sponsoring the study.|"All the information collected during this study will be considered to be confidential until the analysis has been finalised by the study Sponsor.~All the data collected during this study will remain the property of the study Sponsor and may not be communicated to third parties under any circumstances without the Sponsor's express, written consent.~The results may not be published or passed on (orally or in writing) without the prior consent of the study sponsor."
8064|NCT01591460|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8065|NCT01591408|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8066|NCT01591382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8067|NCT01591317|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8068|NCT01591096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8069|NCT01591044|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8070|NCT01591018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8071|NCT01591005|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8072|NCT01590979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8073|NCT01590888|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8074|NCT01590875|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8075|NCT01590810|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
8076|NCT01590797|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
8077|NCT01590771|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding the study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
8078|NCT01590758|Principal Investigators are NOT employed by the organization sponsoring the study.|If no multi-site publication within 18 months of study completion, Site shall have right to publish subject to: 1) Prior to submitting/presenting, Site shall provide Sponsor a copy; Sponsor shall have 60 days to review/comment. 2) Site shall remove any Confidential Information prior to submitting/presenting the materials. 3) Site shall further delay publication/presentation for up to 120 days to allow Sponsor to protect its interests in any Sponsor Inventions described in any such materials.
8079|NCT01590563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8080|NCT01590550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8081|NCT01590394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8082|NCT01590264|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8083|NCT01590238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8084|NCT01590212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8085|NCT01589978|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8086|NCT01589822|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8087|NCT01589653|Principal Investigators are NOT employed by the organization sponsoring the study.|Individual reports by the investigator should not precede the primary manuscript and should always reference the primary manuscript of the trial. Novo Nordisk reserves the right to prior review of such publications and to ask for deferment of publication of individual site results until after the primary manuscript is accepted for publication.
8088|NCT01589601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8089|NCT01589510|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8090|NCT01589497|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
8091|NCT01589484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8092|NCT01589445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8093|NCT01589237|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8094|NCT01588951|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8095|NCT01588821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8096|NCT01588561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8097|NCT01588548|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca will manage the publication of the results of the Clinical Trial in partnership with the authors. AstraZeneca recognises that Institutions/Investigators may wish to make publications regarding Clinical Trial results. The Institution/Investigator agrees to collaborate in good faith with AstraZeneca. Prior to any such publication, the Institution/Investigator shall provide AstraZeneca with preliminary data and drafts of proposed publications.
8098|NCT01588496|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
8099|NCT01588470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8100|NCT01588444|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8101|NCT01588418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8102|NCT01588405|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the Study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed, except as provided below. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
8103|NCT01588353|Principal Investigators are NOT employed by the organization sponsoring the study.|Asahi Kasei Pharma Corporation agreements may vary with individual facilities but will not prohibit any investigator from publishing. Asahikasei supports the publication of results from all centers of a multicenter trial but requests that reports based on single site data not precede the primary publication of the entire clinical trial.
8104|NCT01588158|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8105|NCT01588106|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Publications or lectures on the findings of the present clinical trial either as a whole or at individual investigation sites must be approved by the sponsor in advance, and the sponsor reserves the right to review and comment on such documentation before publication.
8106|NCT01587989|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8107|NCT01587963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8108|NCT01587950|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8109|NCT01587924|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8110|NCT01587898|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8111|NCT01587885|Principal Investigators are NOT employed by the organization sponsoring the study.|MERCK retains the title to and exclusive right to publish all documentation, research data, records, raw data, other work product, data, and/or results generated with respect to the Services and/or the Study (“Work Product”). Such Work Product will be retained in the CRO archive in compliance with regulatory requirements.
8112|NCT01587651|Principal Investigators are NOT employed by the organization sponsoring the study.|Consultants may not publish in any way without the prior written consent of Daiichi Sankyo Inc., which consent may be witheld by DSI in its sole discretion, any material or manuscript relating to Consultant's work hereunder and/or any information or materials that Consultant received in connection with or pursuant to this Agreement or Consultant's relationship established with DSI.
8113|NCT01587118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8114|NCT01587105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8115|NCT01587079|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
8116|NCT01587027|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8117|NCT01587014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8118|NCT01587001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8119|NCT01586975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8120|NCT01586962|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
8121|NCT01586897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8122|NCT01586819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8123|NCT01586806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8124|NCT01586364|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
8144|NCT01585038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8125|NCT01586338|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
8126|NCT01586312|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor must review results communications prior to public release.
8127|NCT01586195|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8128|NCT01586156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8129|NCT01586026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8130|NCT01585987|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
8131|NCT01585961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present, or publish trial results after the trial is completed. Please contact Biosense Webster for additional information.
8132|NCT01585779|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8133|NCT01585597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8134|NCT01585584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8135|NCT01585558|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
8136|NCT01585441|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8137|NCT01585428|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8138|NCT01585324|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8139|NCT01585272|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8140|NCT01585246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8141|NCT01585207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8142|NCT01585168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8143|NCT01585129|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8145|NCT01584843|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8146|NCT01584648|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8147|NCT01584544|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8148|NCT01584518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8149|NCT01584479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8150|NCT01584388|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8151|NCT01584232|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8152|NCT01583894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8153|NCT01583647|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
8154|NCT01583543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8155|NCT01583530|Principal Investigators are NOT employed by the organization sponsoring the study.|For multi-center trials, no investigator will be authorized to publish study results from an individual center until the earlier of the multi-center trial results are published or 12 months after the end or termination of the multi-center trial at all sites. All manuscripts and abstracts must be submitted to the sponsor for review at least 30 days prior to submission for publication or for presentation at a scientific meeting. The sponsor may delay publication for up to 3 months.
8156|NCT01583452|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8157|NCT01583374|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally sixty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
8158|NCT01583218|Principal Investigators are NOT employed by the organization sponsoring the study.|Due to multi centers, studies and countries this varies.
8159|NCT01583101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8160|NCT01582971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8161|NCT01582945|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8162|NCT01582880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8163|NCT01582854|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
8164|NCT01582789|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor. Assuming that the product is marketed, it is the intention of the sponsor to publish the results of the study.
8165|NCT01582490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8166|NCT01582477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8167|NCT01582451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8168|NCT01582308|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
8169|NCT01582282|Principal Investigators are NOT employed by the organization sponsoring the study.|Data, calculations, interpretations, opinions, and recommendations are the property of P&GP
8170|NCT01582243|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8171|NCT01582178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8172|NCT01582139|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8173|NCT01582100|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8174|NCT01582009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8175|NCT01581931|All Principal Investigators ARE employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
8176|NCT01581710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8177|NCT01581684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8178|NCT01581658|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
8179|NCT01581619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8180|NCT01581541|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8181|NCT01581437|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8182|NCT01581307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8183|NCT01581281|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8184|NCT01581021|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8185|NCT01581008|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8186|NCT01580995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8187|NCT01580904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8188|NCT01580618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8189|NCT01580592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8190|NCT01580488|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is entitled to review and comment on publications prior to submission or presentation. Upon request of the sponsor, the investigator shall delay publication or presentation to allow for protection of the sponsors inventions and other intellectual property.
8191|NCT01580423|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8192|NCT01580410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8193|NCT01580306|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8194|NCT01580098|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8195|NCT01580072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8196|NCT01580020|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
8197|NCT01579916|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
8198|NCT01579812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8199|NCT01579747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8200|NCT01579669|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8201|NCT01579578|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8202|NCT01579565|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agreed not to publish or otherwise to disclose Study data without prior written consent from the sponsor for a period of 24 months following Study completion or until data are published in a combined publication (whichever occurs first). The sponsor can review communications containing results prior to public release and embargo those communications for a period that is no longer than 60 days from the date of receipt of the non-public communication. The sponsor cannot extend the embargo.
8203|NCT01579474|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8204|NCT01579318|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8205|NCT01579305|Principal Investigators are NOT employed by the organization sponsoring the study.|Allergan, as the Sponsor, has proprietary interest in this study. Authorship and manuscript composition will reflect joint cooperation between multiple Investigators and sites and Allergan personnel. Authorship will be established prior to the writing of the manuscript. As this study involves multiple centers, no individual publications will be allowed prior to completion of the final report of the multicenter study except as agreed with Allergan.
8206|NCT01579214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8207|NCT01579084|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8208|NCT01579045|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8209|NCT01579006|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8210|NCT01578993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8211|NCT01578980|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8212|NCT01578967|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8213|NCT01578850|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8214|NCT01578785|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
8215|NCT01578772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8216|NCT01578707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8217|NCT01578499|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
8218|NCT01578486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8219|NCT01578330|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
8220|NCT01578239|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8221|NCT01578187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8222|NCT01578044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8223|NCT01578031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8224|NCT01577966|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8225|NCT01577758|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
8226|NCT01577745|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
8227|NCT01577732|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8228|NCT01577706|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8229|NCT01577628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8230|NCT01577381|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8231|NCT01577329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8232|NCT01577186|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8233|NCT01577160|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8234|NCT01577108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8235|NCT01576952|Principal Investigators are NOT employed by the organization sponsoring the study.|
8236|NCT01576939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8237|NCT01576809|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
8238|NCT01576718|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
8239|NCT01576549|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8240|NCT01576471|Principal Investigators are NOT employed by the organization sponsoring the study.|As specified in each clinical trial agreement
8241|NCT01576367|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8242|NCT01576341|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to the first publication or presentation of the results of the study which is intended to be a joint, multi-center publication of the study results. Following the first publication, institutions and/or Principal Investigators may publish or present data or results from the study per the terms of the clinical trial agreement.
8243|NCT01576276|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8244|NCT01576159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8245|NCT01576146|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
8246|NCT01576120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8247|NCT01576055|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8248|NCT01576042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8249|NCT01575912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8250|NCT01575899|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8251|NCT01575808|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8252|NCT01575769|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8253|NCT01575756|Principal Investigators are NOT employed by the organization sponsoring the study.|Octapharma agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Octapharma supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. Octapharma also reserves the right to review data prior to publishing and provide comments/changes within a certain time period.
8254|NCT01575561|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
8255|NCT01575522|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8256|NCT01575197|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8257|NCT01575106|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8258|NCT01575080|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8259|NCT01575054|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8260|NCT01575028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8261|NCT01574703|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8262|NCT01574651|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
8263|NCT01574612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8264|NCT01574326|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
8265|NCT01574248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8266|NCT01574183|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8267|NCT01574105|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8268|NCT01574079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8269|NCT01573910|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
8270|NCT01573767|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8271|NCT01573624|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8272|NCT01573325|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8273|NCT01573260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8274|NCT01573000|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8275|NCT01572948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8276|NCT01572844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8277|NCT01572792|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the Principal Investigator (PI) will be subject to mutual agreement between the PI and the sponsor
8278|NCT01572740|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk Trial Manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
8279|NCT01572727|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
8280|NCT01572675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8281|NCT01572389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8282|NCT01572298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8283|NCT01572207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8284|NCT01571557|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8285|NCT01571453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8286|NCT01571362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8326|NCT01567826|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8287|NCT01571284|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
8288|NCT01571232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8289|NCT01570751|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
8290|NCT01570686|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8291|NCT01570634|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8292|NCT01570309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8293|NCT01570244|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8294|NCT01570192|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8295|NCT01569841|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to Novo Nordisk before submission for comments. Comments will be given within four weeks from receipt of the planned communication.
8296|NCT01569828|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
8297|NCT01569815|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
8298|NCT01569763|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator has the right to publish their research for non-profit and academic purposes, provided the 1st publication of results shall be in conjunction with results from all centers in this Study. If Investigator desires to publish/present data obtained by Investigator, following completion of the Study at all sites, Investigator may do so, provided a copy of proposed publication/presentation is received by Company for review/comment at least 15 days in advance of submission for publication.
8299|NCT01569607|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8300|NCT01569568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8301|NCT01569529|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8302|NCT01569464|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
8303|NCT01569438|Principal Investigators are NOT employed by the organization sponsoring the study.|60 days prior to the submission of any results, the PI shall submit to SPONSOR any proposed PUBLICATION, which period may be extended for an additional 30 days if requested by SPONSOR. If any Confidential Information should be redacted or patent applications relating to an Invention should be filed prior to PUBLICATION, then PUBLICATION will be delayed until patent application has been filed. Delay of a PUBLICATION shall not exceed 24 months from the date of such notice to the PI.
8304|NCT01569295|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8305|NCT01569191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8306|NCT01569152|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
8307|NCT01569126|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8308|NCT01569087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8309|NCT01569074|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8310|NCT01569022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8311|NCT01568905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8312|NCT01568892|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8313|NCT01568866|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
8314|NCT01568827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8315|NCT01568593|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever from without prior written agreement of THEA
8316|NCT01568424|Principal Investigators are NOT employed by the organization sponsoring the study.|
8317|NCT01568112|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
8318|NCT01568073|Principal Investigators are NOT employed by the organization sponsoring the study.|
8319|NCT01568047|Principal Investigators are NOT employed by the organization sponsoring the study.|
8320|NCT01568034|Principal Investigators are NOT employed by the organization sponsoring the study.|
8321|NCT01568021|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8322|NCT01568008|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8323|NCT01567943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8324|NCT01567852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8325|NCT01567839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8327|NCT01567462|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8328|NCT01567371|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8329|NCT01567163|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
8330|NCT01567150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8331|NCT01567020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8332|NCT01566981|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8333|NCT01566838|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8334|NCT01566773|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
8335|NCT01566721|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8336|NCT01566630|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8337|NCT01566604|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8338|NCT01566539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8339|NCT01566526|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8340|NCT01566500|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8341|NCT01566461|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8342|NCT01566435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8343|NCT01566409|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8344|NCT01566370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8345|NCT01566331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8383|NCT01563406|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8346|NCT01566162|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS agreement between Principal Investigator and Sponsor that restricts PI's rights to discuss or publish trial results after trial is completed.~In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication provided, if a multicenter publication is not forthcoming within 24 months post completion of study at all sites, PI shall be free to publish."
8347|NCT01566149|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
8348|NCT01566084|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8349|NCT01565993|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8350|NCT01565980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8351|NCT01565941|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8352|NCT01565902|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
8353|NCT01565889|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8354|NCT01565850|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8355|NCT01565707|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript at least 90 days prior to publication for review and comment. Sponsor may delay the publication temporarily to seek patent protection or permanently withhold the publication.
8356|NCT01565616|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8357|NCT01565564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8358|NCT01565551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8359|NCT01565538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8360|NCT01565382|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8361|NCT01565369|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8362|NCT01565356|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8363|NCT01565343|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8364|NCT01565330|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8365|NCT01565291|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8366|NCT01565148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8367|NCT01565083|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8368|NCT01564953|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8369|NCT01564862|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
8370|NCT01564784|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. Investigators will, on request, remove any previously undisclosed Confidential Information (other than the Study results themselves) before disclosure.
8371|NCT01564758|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8372|NCT01564732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8373|NCT01564706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8374|NCT01564693|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8375|NCT01564537|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor's confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
8376|NCT01564459|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
8377|NCT01564407|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8378|NCT01564394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8379|NCT01564277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8380|NCT01563978|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review and comment on results communications prior to publication or presentation. Sponsor will be allowed a review period of at least 60 days from submission but can request that the submission be delayed for an additional 90 days from the date of Sponsor’s request.
8381|NCT01563913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8382|NCT01563536|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
8384|NCT01563198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8385|NCT01563185|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8386|NCT01563172|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8387|NCT01563081|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8388|NCT01563055|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8389|NCT01563029|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8390|NCT01563003|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8391|NCT01562886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8392|NCT01562873|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8393|NCT01562756|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8394|NCT01562743|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8395|NCT01562678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8396|NCT01562613|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8397|NCT01562548|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8398|NCT01562327|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8399|NCT01562314|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
8400|NCT01562275|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8401|NCT01562132|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8402|NCT01561976|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8403|NCT01561898|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
8404|NCT01561755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8405|NCT01561716|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8406|NCT01561703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8407|NCT01561560|Principal Investigators are NOT employed by the organization sponsoring the study.|Study data should not be disclosed to any third party for a period of three years after the termination of the study without prior written consent.
8408|NCT01561469|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8409|NCT01561430|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8410|NCT01561313|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
8411|NCT01561300|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8412|NCT01561079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8413|NCT01560988|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8414|NCT01560975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8415|NCT01560819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8416|NCT01560507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8417|NCT01560429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8418|NCT01560403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8419|NCT01560260|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8420|NCT01560234|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication (e.g., in a scientific journal) based on the results of this study is envisaged, approval from AstraZeneca will be obtained and a draft manuscript will be submitted to AstraZeneca for scrutiny and comment. The choice of conduit will be mutually agreed on by the Principal Investigator and AstraZeneca.
8421|NCT01560143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8422|NCT01559935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8423|NCT01559922|Principal Investigators are NOT employed by the organization sponsoring the study.|Suneva, as the Sponsor, has a proprietary interest in this study. Authorship and manuscript composition will reflect joint cooperation among multiple investigators and sites and Suneva personnel. Authorship will be established prior to the writing of the manuscript. As this study involves multiple centers, no individual publications will be allowed prior to completion of the final report of the multi-center study except as agreed with Suneva.
8424|NCT01559857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8425|NCT01559844|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8426|NCT01559675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8427|NCT01559649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8428|NCT01559506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8429|NCT01559454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8430|NCT01559311|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8431|NCT01559116|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8432|NCT01559064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8433|NCT01559012|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8434|NCT01558791|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8435|NCT01558739|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
8436|NCT01558700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8437|NCT01558674|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
8438|NCT01558661|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8439|NCT01558596|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8440|NCT01558492|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8441|NCT01558297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8442|NCT01558271|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8443|NCT01558128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8444|NCT01558089|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8445|NCT01557959|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8446|NCT01557946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8447|NCT01557920|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8448|NCT01557894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8449|NCT01557868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8450|NCT01557842|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI’s rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
8451|NCT01557751|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8452|NCT01557699|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8453|NCT01557595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8454|NCT01557582|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8455|NCT01557569|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8456|NCT01557504|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
8457|NCT01557348|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
8458|NCT01557322|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8459|NCT01557283|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8460|NCT01557166|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in the protocol. Novo Nordisk reserves the right to prior review of such publications and to ask for deferment of publication of individual site results until after the primary manuscript is accepted for publication.
8461|NCT01556997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8462|NCT01556932|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8463|NCT01556906|Principal Investigators are NOT employed by the organization sponsoring the study.|Information is unavailable.
8464|NCT01556763|Principal Investigators are NOT employed by the organization sponsoring the study.|
8465|NCT01556724|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8486|NCT01554241|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8466|NCT01556633|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8467|NCT01556594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8468|NCT01556451|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
8469|NCT01556425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8470|NCT01556204|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8471|NCT01556165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8472|NCT01556100|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8473|NCT01556061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8474|NCT01555983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8475|NCT01555931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8476|NCT01555567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8477|NCT01555463|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may publish study results of their own patients only after review/comment by the sponsor. At least 60 days prior to submitting a manuscript to a publisher, a copy of the manuscript will be provided to the sponsor for review. No publication of confidential information shall be made without the sponsor’s prior written consent. The PI agrees to delete any confidential information which would prejudice the securing of adequate intellectual property protection from the proposed publication.
8478|NCT01555164|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8479|NCT01555151|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
8480|NCT01555138|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
8481|NCT01555073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8482|NCT01554982|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8483|NCT01554904|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8484|NCT01554891|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8485|NCT01554579|Principal Investigators are NOT employed by the organization sponsoring the study.|60 days prior to the submission of any results, the PI shall submit to SPONSOR any proposed PUBLICATION, which period may be extended for an additional 30 days if requested by SPONSOR. If any Confidential Information should be redacted or patent applications relating to an Invention should be filed prior to PUBLICATION, then PUBLICATION will be delayed until patent application has been filed. Delay of a PUBLICATION shall not exceed 24 months from the date of such notice to the PI.
8531|NCT01549977|Principal Investigators are NOT employed by the organization sponsoring the study.|Insufficient data to publish.
8487|NCT01554176|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
8488|NCT01554163|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
8489|NCT01553916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8490|NCT01553851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8491|NCT01553708|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8492|NCT01553539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8493|NCT01553318|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8494|NCT01553292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8495|NCT01553240|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8496|NCT01553136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8497|NCT01553058|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8498|NCT01552954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8499|NCT01552928|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
8500|NCT01552915|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
8501|NCT01552902|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
8502|NCT01552889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8503|NCT01552876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8504|NCT01552772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8505|NCT01552694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8506|NCT01552681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8507|NCT01552603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8508|NCT01552343|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
8509|NCT01552057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8510|NCT01551979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8511|NCT01551888|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the PI will be subject to mutual agreement between the PI and sponsor.
8512|NCT01551758|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8513|NCT01551745|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8514|NCT01551693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8515|NCT01551355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8516|NCT01551303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8517|NCT01551199|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8518|NCT01551173|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
8519|NCT01551095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8520|NCT01551082|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8521|NCT01551056|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8522|NCT01550965|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
8523|NCT01550952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8524|NCT01550809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8525|NCT01550757|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8526|NCT01550744|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
8527|NCT01550705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8528|NCT01550549|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8529|NCT01550302|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8530|NCT01550289|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
8532|NCT01549964|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
8533|NCT01549951|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
8534|NCT01549925|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8535|NCT01549873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8536|NCT01549860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8537|NCT01549613|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8538|NCT01549405|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8539|NCT01549392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8540|NCT01549340|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall be notified and have a right to timely and prior review of public disclosures of the results, including without limitation, disclosures at research seminars, lectures and professional meetings and submission of papers for publication.
8541|NCT01549275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8542|NCT01549223|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8543|NCT01549041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8544|NCT01549002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8545|NCT01548885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8546|NCT01548833|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
8547|NCT01548742|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8548|NCT01548638|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8549|NCT01548573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8550|NCT01548417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8551|NCT01548287|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8552|NCT01548040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8553|NCT01547806|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8554|NCT01547728|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8555|NCT01547715|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8556|NCT01547598|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8557|NCT01547390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8558|NCT01547299|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees not to independently publish the results before the publication of the multi-center PI paper. Sponsor shall review and comment 30 days prior to submission or disclosure. If publication or disclosure contains Sponsor Confidential Information, other than study data, PI agrees to remove Confidential Information from publication or disclosure. Sponsor may request that PI delay such publication for an additional 60 days to protect the patentability of any invention described.
8559|NCT01547286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8560|NCT01547247|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8561|NCT01547130|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8562|NCT01546922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8563|NCT01546883|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8564|NCT01546688|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8565|NCT01546675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8566|NCT01546649|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
8567|NCT01546636|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8568|NCT01546623|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
8569|NCT01546519|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
8570|NCT01546454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8571|NCT01546402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8572|NCT01546285|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor cannot require changes to the PI’s disclosure, with the exception of requesting the removal of sponsor’s confidential information. The study results themselves are not considered confidential information. Sponsor cannot extend the embargo beyond 60 days unless the PI’s disclosure contains patentable subject matter, in which an embargo beyond 60 days may be necessary to allow for the filing of a patent application
8573|NCT01546207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8574|NCT01546194|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8575|NCT01546168|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8576|NCT01546155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8577|NCT01546142|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
8578|NCT01546038|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8579|NCT01545843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8580|NCT01545765|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor to review and approval at least 2 months prior to the date of intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
8581|NCT01545700|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8582|NCT01545518|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8583|NCT01545388|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.~Any information identified by the sponsor as confidential must be deleted prior to submission."
8584|NCT01545375|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8585|NCT01545336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8586|NCT01545232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8587|NCT01545193|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8588|NCT01544998|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8589|NCT01544920|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
8590|NCT01544582|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
8591|NCT01544478|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
8592|NCT01544361|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
8613|NCT01542684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8593|NCT01544348|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
8594|NCT01544309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8595|NCT01544179|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8596|NCT01544166|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is interested in the publication of the results of every study it performs. All relevant aspects regarding publication will be part of the contract between the sponsor and the investigator/institution.
8597|NCT01544153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8598|NCT01544114|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights .
8599|NCT01544062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8600|NCT01544023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8601|NCT01543958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8602|NCT01543828|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
8603|NCT01543685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8604|NCT01543607|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8605|NCT01543581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8606|NCT01543568|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8607|NCT01543503|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8608|NCT01543204|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
8609|NCT01543178|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8610|NCT01543074|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8611|NCT01542957|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8612|NCT01542788|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8614|NCT01542645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8615|NCT01542632|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights from or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
8616|NCT01542541|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8617|NCT01542528|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8618|NCT01542502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8619|NCT01542372|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8620|NCT01542307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8621|NCT01542255|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8622|NCT01542125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8623|NCT01542034|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
8624|NCT01541969|Principal Investigators are NOT employed by the organization sponsoring the study.|The manufacturer acknowledges and accepts the right of the investigator to publish the results of the research, however, the Investigator shall send a draft manuscript of the publication or abstract of the study findings to the manufacturer 30 days in advance of submission to a scientific journal for approval. Adaptive Neuromodulation GmbH was the manufacturer at the start of the trial, subsequently passing to NeuroTherapies Reset (Brook Henderson Group) during open-label extension.
8625|NCT01541930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8626|NCT01541917|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8627|NCT01541865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8628|NCT01541826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8629|NCT01541735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8630|NCT01541644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8631|NCT01541553|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor is entitled to review and comment on publications prior to submission or presentation.~Upon request of the sponsor, the investigator shall delay publication or presentation to allow for protection of the sponsors inventions and other intellectual property."
8632|NCT01541397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8633|NCT01541384|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8634|NCT01541371|Principal Investigators are NOT employed by the organization sponsoring the study.|
8635|NCT01541358|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8657|NCT01539083|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
8636|NCT01541254|Principal Investigators are NOT employed by the organization sponsoring the study.|As part of a multi-center study the results of the national Trial shall be published by a National Principal Investigator within 12 months of completion of last study site. If no publication within that time frame, Principal Investigator is free to publish. Copies of proposed publication must be submitted to Sponsor at least 30 days in advance to ensure removal of proprietary or confidential information.
8637|NCT01540981|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8638|NCT01540851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8639|NCT01540825|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8640|NCT01540773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8641|NCT01540513|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8642|NCT01540487|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
8643|NCT01540370|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8644|NCT01540266|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8645|NCT01540162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8646|NCT01540045|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8647|NCT01539980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8648|NCT01539811|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8649|NCT01539759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8650|NCT01539642|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8651|NCT01539590|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8652|NCT01539538|Principal Investigators are NOT employed by the organization sponsoring the study.|prior review and approval required
8653|NCT01539525|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8654|NCT01539512|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8655|NCT01539317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8656|NCT01539135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8658|NCT01539070|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8659|NCT01538862|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8660|NCT01538719|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8661|NCT01538615|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8662|NCT01538472|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8663|NCT01538199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8664|NCT01537900|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
8665|NCT01537835|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8666|NCT01537783|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8667|NCT01537666|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI cannot at any time during or after the Study make any announcement, oral presentation or publication relating to the Study, or any of the methods, results of, or conclusions from, the Study without the prior written consent of the Sponsor.
8668|NCT01537549|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8669|NCT01537432|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8670|NCT01537419|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8671|NCT01537393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8672|NCT01537367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8673|NCT01537315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8674|NCT01537302|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the earliest of (a)publication of results, (b)receipt of notice stating that Study has been terminated or (c)18 months after completion or termination, Institution/Investigator (IN) shall have right to publish information & data collected or produced, provided that drafts are provided to Sponsor (SP) at least 60 days prior to the first submission. SP shall comment within 45 days. IN shall delay publication/presentation to enable SP to secure patent or other proprietary protection.
8675|NCT01537198|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
8676|NCT01537185|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8677|NCT01537133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8678|NCT01537120|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
8698|NCT01536171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8679|NCT01537081|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8680|NCT01537068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8681|NCT01537042|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
8682|NCT01536951|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8683|NCT01536938|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
8684|NCT01536886|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
8685|NCT01536860|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8686|NCT01536704|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8687|NCT01536587|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8688|NCT01536574|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8689|NCT01536561|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8690|NCT01536496|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8691|NCT01536418|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8692|NCT01536405|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
8693|NCT01536379|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8694|NCT01536366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8695|NCT01536262|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8696|NCT01536197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8697|NCT01536184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8699|NCT01536145|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8700|NCT01536119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8701|NCT01536093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8702|NCT01536067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8703|NCT01536015|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8704|NCT01535976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8705|NCT01535807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8706|NCT01535729|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
8707|NCT01535664|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
8708|NCT01535638|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8709|NCT01535599|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
8710|NCT01535560|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
8711|NCT01535365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8712|NCT01535326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8713|NCT01535261|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
8714|NCT01535235|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8715|NCT01535222|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release. Sponsor will complete review within 60 days. If Sponsor believes proposed publication contains patentable information, disclosure shall be delayed to 90 days to permit patent filing. If additional time is required an extension shall be granted not to exceed an additional 90 days. If Sponsor believes proposed publication contains confidential information, site shall delete such information.
8716|NCT01535118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8717|NCT01535040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8718|NCT01535001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8719|NCT01534975|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8720|NCT01534962|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8721|NCT01534910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8722|NCT01534897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8723|NCT01534689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8724|NCT01534676|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8725|NCT01534637|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8726|NCT01534533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8727|NCT01534520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8728|NCT01534416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8729|NCT01534351|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
8730|NCT01534208|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
8731|NCT01534182|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8732|NCT01534143|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8733|NCT01534078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8734|NCT01534052|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. The sponsor must receive a site's manuscript prior to publication for review and comment as specified in the Investigator Agreement.
8735|NCT01533974|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8736|NCT01533948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8737|NCT01533935|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8738|NCT01533922|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8739|NCT01533753|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8740|NCT01533597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8741|NCT01533493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8742|NCT01533428|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish or present trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
8743|NCT01533259|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
8744|NCT01533246|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8745|NCT01533181|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8746|NCT01533116|Principal Investigators are NOT employed by the organization sponsoring the study.|
8747|NCT01533077|Principal Investigators are NOT employed by the organization sponsoring the study.|
8748|NCT01533038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8749|NCT01532999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8750|NCT01532973|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
8751|NCT01532934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8752|NCT01532869|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8753|NCT01532830|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8754|NCT01532817|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8755|NCT01532635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8756|NCT01532570|Principal Investigators are NOT employed by the organization sponsoring the study.|
8757|NCT01532453|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator is granted a right to publish and present Trial Results together with other investigators of Trial and to be referred to in publications containing such results. However, investigator shall not publish or present Trial Results unless Investigator has submitted to Spirig a draft of the intended publication or presentation for review and approval.
8758|NCT01532414|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall submit a copy of proposed publication. Sponsor shall have sixty (60) days (or such longer period as Sponsor shall determine is necessary) to review the proposed publication and, upon request, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication.
8759|NCT01532362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8760|NCT01532349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8761|NCT01532141|Principal Investigators are NOT employed by the organization sponsoring the study.|
8762|NCT01532128|Principal Investigators are NOT employed by the organization sponsoring the study.|
8763|NCT01531998|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8764|NCT01531725|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8765|NCT01531673|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: PI is free to publish results of the study after (1)first multi-center publication, (2)if sponsor elects not to publish the results, or(3)18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
8766|NCT01531387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8767|NCT01531374|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8768|NCT01531335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8769|NCT01531205|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8770|NCT01530997|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8771|NCT01530880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8772|NCT01530477|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8773|NCT01530464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8774|NCT01530399|Principal Investigators are NOT employed by the organization sponsoring the study.|After initial multicenter results communications are published, or after 12 months from study closure (whichever occurs first), sponsor can review results communications prior to submission and can embargo submissions for a period of 45 days from the time submitted to the sponsor for review, agreeing to resolve differences of opinion or interpretation through scientific debate. Sponsor can request further delay for an additional 90 days to file any patent applications if deemed necessary
8775|NCT01530334|Principal Investigators are NOT employed by the organization sponsoring the study.|
8776|NCT01530243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8777|NCT01530087|Principal Investigators are NOT employed by the organization sponsoring the study.|
8778|NCT01529827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8779|NCT01529645|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8780|NCT01529632|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
8781|NCT01529515|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. if requested in writing, such publication will be withheld for up to an additional 60 days.
8782|NCT01529502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8783|NCT01529450|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8784|NCT01529385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8785|NCT01529268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8786|NCT01529203|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8787|NCT01529112|Principal Investigators are NOT employed by the organization sponsoring the study.|
8788|NCT01528969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8789|NCT01528891|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8790|NCT01528878|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8791|NCT01528787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8792|NCT01528735|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8793|NCT01528696|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8794|NCT01528605|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8795|NCT01528592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8796|NCT01528345|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
8797|NCT01528332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8798|NCT01528319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8799|NCT01528293|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release but cannot embargo communications regarding trial results unless those communications are found inaccurate, contain Confidential Information, or would hinder seeking patent protection.
8800|NCT01528215|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8801|NCT01528150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8802|NCT01527942|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8803|NCT01527513|Principal Investigators are NOT employed by the organization sponsoring the study.|
8804|NCT01527487|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
8805|NCT01527370|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
8806|NCT01527162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8807|NCT01527110|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8808|NCT01527006|Principal Investigators are NOT employed by the organization sponsoring the study.|
8809|NCT01526902|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8810|NCT01526785|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
8811|NCT01526733|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained as a result of this study or during the conduct of this study will be regarded as confidential. The Investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless prior written permission from the Sponsor (Halozyme) is obtained.
8812|NCT01526629|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8813|NCT01526551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8814|NCT01526538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8815|NCT01526343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8816|NCT01526213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8817|NCT01526148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8818|NCT01525927|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8819|NCT01525849|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8820|NCT01525745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8821|NCT01525667|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8822|NCT01525641|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8823|NCT01525628|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8824|NCT01525615|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
8825|NCT01525563|Principal Investigators are NOT employed by the organization sponsoring the study.|
8826|NCT01525550|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8827|NCT01525420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8828|NCT01525407|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8829|NCT01525238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8830|NCT01525225|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
8831|NCT01525173|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8832|NCT01524978|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8833|NCT01524913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8834|NCT01524900|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8835|NCT01524887|Principal Investigators are NOT employed by the organization sponsoring the study.|For this study, PIs are restricted from independently publishing results before completion of a single multicenter publication or one year after study completion, whichever occurs first. Baxter requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (eg, for intellectual property protection).
8836|NCT01524796|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8837|NCT01524783|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
8838|NCT01524770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8839|NCT01524692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8840|NCT01524627|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8841|NCT01524302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8842|NCT01524198|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8843|NCT01524133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8844|NCT01523964|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8845|NCT01523899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8846|NCT01523886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8847|NCT01523873|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8848|NCT01523756|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8849|NCT01523743|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8850|NCT01523613|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8851|NCT01523587|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
8852|NCT01523496|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8853|NCT01523457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8854|NCT01523392|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AstraZeneca (AZ) for review at least 60 days in advance of the submission for publication. The Investigators in the Multi-Center (MC) study agree to postpone MC publications until the earlier of the first AstraZeneca-authorized publication or up to eighteen months from study completion at all sites.
8855|NCT01523366|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AstraZeneca (AZ) for review at least 60 days in advance of the submission for publication. The Investigators in the Multi-Center (MC) study agree to postpone MC publications until the earlier of the first AZ-authorized publication or up to 18 months from study completion at all sites.
8856|NCT01523301|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
8857|NCT01522976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8858|NCT01522963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8859|NCT01522937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8860|NCT01522924|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8861|NCT01522703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8862|NCT01522456|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8863|NCT01522443|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements with investigators vary; constant is our right to review results communications prior to public release, and embargo communications for a period of ≤60 days from submittal for review. We do not prohibit investigators from publishing, but we may require previously undisclosed confidential information, other than study results, to be removed from publications, and single-center publications are postponed until after publication of the trial’s primary multicenter publication.
8864|NCT01522339|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8865|NCT01522235|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8866|NCT01522131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8867|NCT01521923|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8868|NCT01521897|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8869|NCT01521884|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8870|NCT01521871|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8871|NCT01521845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8872|NCT01521780|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
8873|NCT01521559|Principal Investigators are NOT employed by the organization sponsoring the study.|Without the prior written agreement of the Sponsor, the Institution (I) shall not publish, submit or present for publication, directly or indirectly, any Manuscript (M) prior to publication of an article in a peer-reviewed scientific journal summarizing data generated by all Study centers, unless no such article is so published before the first anniversary of the finalization of the clinical study report, in which case the (I) may publish or submit for publication a (M) without further delay.
8874|NCT01521546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8875|NCT01521507|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review communications for at least 30 days prior to public release with an extension for up to 45 additional days, if the Sponsor notifies the Investigator that the publication contains patentable material or Proprietary Information other than the study results. Upon Sponsor's written request, Investigator agrees to delete any Proprietary Information.
8876|NCT01521364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8877|NCT01521260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8878|NCT01521143|Principal Investigators are NOT employed by the organization sponsoring the study.|For study centers in Australia, no publication of the study results may be made until publication of the results of the study from all centers or until 2 years after study completion, whichever is sooner. For study centers in the USA, no submission for publication or public disclosure of the results by will be made until the results from all centers have been received and analyzed by the sponsor, or the multi-center study has been terminated or abandoned at all centers.
8879|NCT01521026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8880|NCT01520987|Principal Investigators are NOT employed by the organization sponsoring the study.|
8881|NCT01520922|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8882|NCT01520909|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8883|NCT01520727|Principal Investigators are NOT employed by the organization sponsoring the study.|
8884|NCT01520714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8885|NCT01520558|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement is specific to clinical trial agreement
8886|NCT01520532|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8887|NCT01520506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results without permission of the sponsor.
8888|NCT01520454|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8889|NCT01520402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8890|NCT01520207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8891|NCT01519960|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8892|NCT01519934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8893|NCT01519921|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8894|NCT01519882|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8895|NCT01519817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8896|NCT01519791|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8897|NCT01519778|Principal Investigators are NOT employed by the organization sponsoring the study.|Trius intends to pursue publication of the results of the study in cooperation with a lead Investigator, subject to the terms and conditions of the clinical study agreement between Trius and Investigators. Trius written approval is required for publication of any data subsets. Final authorship will be determined in accordance with the International Conference of Medical Journal Editors definition of authorship.
8898|NCT01519765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8899|NCT01519713|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
8900|NCT01519700|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall provide Sponsor with any presentation at least 15 working days prior to disclosure and any other publication at least 45 working days prior to disclosure. Sponsor may require amendments on reasonable grounds: (a) accuracy of publication; (b) confidentiality of proprietary information; (c) intellectual property protection; (d) to enable further information to be provided. Sponsor may require publications or presentations to be delayed up to four (4) months to enable patent application.
8901|NCT01519674|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Novo Nordisk reserves the right to prior review of such publications and to ask for delay of publication of individual site results until after the primary manuscript is accepted for publication.
8902|NCT01519661|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8903|NCT01519648|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8904|NCT01519518|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8905|NCT01519466|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8906|NCT01519427|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8907|NCT01519323|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
8908|NCT01519284|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8909|NCT01519271|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8910|NCT01519245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8911|NCT01519206|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8912|NCT01519167|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator may not submit the results of the study for publication without the prior written consent of Hospira.
8913|NCT01519089|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8914|NCT01518946|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
8915|NCT01518530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8916|NCT01518322|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8917|NCT01518270|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8918|NCT01518257|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
8919|NCT01518244|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
8920|NCT01518192|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8921|NCT01518153|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8922|NCT01517984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8923|NCT01517893|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8924|NCT01517867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8925|NCT01517750|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8926|NCT01517529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9008|NCT01511081|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8927|NCT01517412|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
8928|NCT01517373|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8929|NCT01517295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8930|NCT01517282|Principal Investigators are NOT employed by the organization sponsoring the study.|All information supplied by MorphoSys is considered confidential until publication and shall not be disclosed without prior written consent from MorphoSys. No data can be published in any format without prior approval of MorphoSys, which has final decision on approving submissions for publication. In the event of disagreement in the content of a publication, both the Author’s and MorphoSys’ opinion will be fairly and sufficiently represented in the publication.
8931|NCT01517178|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8932|NCT01517074|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8933|NCT01516970|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
8934|NCT01516892|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that results publication or presentations be submitted for sponsor review no less than 90 days in advance, during which the sponsor can embargo such communications prior to public release. The embargo may be extended for up to 90 days for the sponsor to preserve its proprietary rights. PI will not publish study results prior to release of a multicenter manuscript including data from all study centers. The sponsor cannot require changes to the communication.
8935|NCT01516879|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
8936|NCT01516749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8937|NCT01516736|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8938|NCT01516632|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8939|NCT01516437|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
8940|NCT01516268|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8941|NCT01516034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8942|NCT01516008|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8943|NCT01515956|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8944|NCT01515943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8945|NCT01515891|Principal Investigators are NOT employed by the organization sponsoring the study.|
8946|NCT01515865|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
8947|NCT01515696|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8948|NCT01515657|Principal Investigators are NOT employed by the organization sponsoring the study.|Standard confidentiality agreement
8949|NCT01515566|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8950|NCT01515540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8951|NCT01515488|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8952|NCT01515423|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
8953|NCT01515410|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees that sponsor shall have the right to the first publication of the study results which is intended to be a joint, multi-center publication. Following the first publication, the PI may publish study data or results, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may remove any information that is considered confidential and/or proprietary other than study data.
8954|NCT01515345|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8955|NCT01515306|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
8956|NCT01515189|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
8957|NCT01515176|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8958|NCT01515072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8959|NCT01515046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8960|NCT01514864|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
8961|NCT01514786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8962|NCT01514760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8963|NCT01514734|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
8964|NCT01514682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8965|NCT01514630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8966|NCT01514513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8967|NCT01514461|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8968|NCT01514448|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8969|NCT01514422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8970|NCT01514357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8971|NCT01514318|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8972|NCT01514292|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8973|NCT01514240|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AZ approval before this study was completed.
8974|NCT01514162|Principal Investigators are NOT employed by the organization sponsoring the study.|
8975|NCT01514149|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8976|NCT01514136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8977|NCT01513902|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8978|NCT01513590|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
8979|NCT01513538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8980|NCT01513473|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of plans by any investigator to publish and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to Novo Nordisk before submission for comments. Comments will be given within four weeks from receipt of the planned communication.
8981|NCT01513460|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
8982|NCT01513447|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8983|NCT01513330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8984|NCT01513317|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8985|NCT01513291|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
8986|NCT01513239|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
8987|NCT01513148|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8988|NCT01513122|Principal Investigators are NOT employed by the organization sponsoring the study.|"There is a Clinical Trial Agreement signed with each PI detailing the publication policy and disclosure of study's information, in summary:~The Institution, its personnel and the Principal Investigator must not Publish or present any aspect of the Study without the prior written approval of the sponsor, except for the purposes of internal training Publications or presentations of results from the Study will follow the agreement's publication/presentation guidelines"
8989|NCT01512979|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
8990|NCT01512849|Principal Investigators are NOT employed by the organization sponsoring the study.|
8991|NCT01512797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8992|NCT01512745|Principal Investigators are NOT employed by the organization sponsoring the study.|
8993|NCT01512693|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8994|NCT01512667|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
8995|NCT01512368|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8996|NCT01512251|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8997|NCT01512225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
8998|NCT01512160|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
8999|NCT01512108|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Novo Nordisk reserves the right to prior review of such publications and ask for delay of publication of individual site results until after the primary manuscript is accepted for publication.
9000|NCT01511978|Principal Investigators are NOT employed by the organization sponsoring the study.|"The first publication shall be a multicenter publication submitted after conclusion of the Study at all sites. If a multicenter publication is not submitted within 12 months, PIs may use results.~The only other disclosure restriction on the PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of 30 days for confidential review. This period may be extended by 60 days at Sponsor’s request."
9001|NCT01511939|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9002|NCT01511809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9003|NCT01511536|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
9004|NCT01511445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9005|NCT01511315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9006|NCT01511250|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9007|NCT01511107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9009|NCT01511016|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9010|NCT01510912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9011|NCT01510834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9012|NCT01510769|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
9013|NCT01510756|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9014|NCT01510717|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9015|NCT01510704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9016|NCT01510652|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9017|NCT01510457|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9018|NCT01510379|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9019|NCT01510327|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least 45 days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
9020|NCT01510158|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
9021|NCT01510145|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9022|NCT01509807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9023|NCT01509664|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9024|NCT01509638|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9025|NCT01509625|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9026|NCT01509586|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9027|NCT01509183|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9028|NCT01509105|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9029|NCT01509079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9030|NCT01509053|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9031|NCT01509040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9032|NCT01508936|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
9033|NCT01508910|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, results may not be published without prior written approval of Sponsor.
9034|NCT01508832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9035|NCT01508702|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
9036|NCT01508676|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9037|NCT01508455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9038|NCT01508325|Principal Investigators are NOT employed by the organization sponsoring the study.|
9039|NCT01508169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9040|NCT01508130|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9041|NCT01508117|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9042|NCT01508052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9043|NCT01508013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9044|NCT01507896|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, results may not be published without prior written approval of the Sponsor.
9045|NCT01507831|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
9046|NCT01507662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9047|NCT01507493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9048|NCT01507246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9049|NCT01507233|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9050|NCT01507220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9051|NCT01507181|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9052|NCT01507155|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9053|NCT01507103|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Investigator will inform the Sponsor in advance about any plans to publish or present data from the trial. Any publications and presentations of the results (abstracts in journals or newspapers, oral presentations, etc.), either in whole or in part, by Investigators or their representatives will require pre-submission review by the Sponsor.~The Sponsor will not suppress or veto publications, but maintains the right to delay publication in order to protect intellectual property rights."
9054|NCT01507090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9055|NCT01507051|Principal Investigators are NOT employed by the organization sponsoring the study.|Any disclosure of study results by the Principal Investigator or investigators has to be in agreement with the sponsor.
9056|NCT01506960|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9057|NCT01506947|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9058|NCT01506908|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9059|NCT01506882|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9060|NCT01506726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9061|NCT01506596|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution/PI may use Institution/PI derived Study results in a Publication provided Publication does not disclose Vector Confidential Information unnecessary to publish Study results. Institution/PI will submit to Vector for review/comment proposed Publication and data necessary for meaningful review at least 30 days prior to submission. Vector may request delay of submission up to 60 days in order to file patent applications relating to an Invention.
9062|NCT01506479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9063|NCT01506362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9064|NCT01506323|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9065|NCT01506193|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9066|NCT01505881|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
9067|NCT01505764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9068|NCT01505673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9069|NCT01505647|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
9070|NCT01505608|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9071|NCT01505465|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9072|NCT01505387|Principal Investigators are NOT employed by the organization sponsoring the study.|
9073|NCT01505374|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9074|NCT01505166|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9075|NCT01505114|Principal Investigators are NOT employed by the organization sponsoring the study.|All study abstracts and publications are subject to HPTN Publication and Public Information Policies and Clinical Trial Agreements between NIAID (DAIDS) and company collaborators. The publication or other disclosure can be delayed for up to thirty additional business days for manuscripts & five business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
9076|NCT01504997|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9077|NCT01504971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9078|NCT01504958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9079|NCT01504867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9080|NCT01504854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9081|NCT01504204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9082|NCT01503749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9083|NCT01503164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9084|NCT01503021|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9085|NCT01502956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9086|NCT01502787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9087|NCT01502761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9088|NCT01502709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9089|NCT01502644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9090|NCT01502423|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9091|NCT01502410|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9092|NCT01502371|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
9093|NCT01502332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9094|NCT01502228|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9095|NCT01502033|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9096|NCT01501162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9097|NCT01501110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9098|NCT01500772|Principal Investigators are NOT employed by the organization sponsoring the study.|
9099|NCT01500746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9100|NCT01500720|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
9101|NCT01500694|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9102|NCT01500629|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to publish results without PI approval. PI has right to present and/or publish research results and related background information, but must provide publication to Sponsor in advance with at least 30 days for review. Sponsor confidential information cannot be submitted for publication without Sponsor’s written consent. Sponsor cannot require changes or extend the embargo. If requested, the PI will withhold the publication for ≤60 days to allow for patent application.
9103|NCT01500434|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
9104|NCT01500382|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts,or presentations regarding this study 60 days prior to submission for publication/presentation.
9105|NCT01500317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9106|NCT01500278|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9107|NCT01500252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9108|NCT01500226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9109|NCT01500213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9110|NCT01500135|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9111|NCT01500109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9112|NCT01500083|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of this study will be published. Authors of the primary publication based on this study must fulfil the criteria defined by the International Committee of Medical Journal Editors (ICMJE). The primary publication must be published before any secondary publications are submitted for publication.
9113|NCT01500057|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9114|NCT01500031|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least 45 days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
9115|NCT01499862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9116|NCT01499849|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9117|NCT01499810|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9118|NCT01499667|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
9119|NCT01499654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9120|NCT01499576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9121|NCT01499498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9122|NCT01499355|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
9123|NCT01499303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9124|NCT01499290|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall not publish results until the earliest of (i) date of the 1st study publication (joint between PI, sponsor and study sites) (ii) 18 months after study completion, or (iii) sponsor notification that no multi-center publication is to be made. The PI submits the publication for review 60 days before submission. Sponsor may embargo for a further 90 days to protect IP rights. Sponsor may request removal of confidential and/or proprietry information.
9125|NCT01499277|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to use such Confidential study information and not to disclose them to any other third parties, except that the undersigned shall not be prevented from using or disclosing information: (a) which by written records was previously known; (b) which is now public knowledge, (c) which is lawfully obtained by the undersigned from sources who have a lawful right to disclose such information.
9126|NCT01499199|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9127|NCT01499173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9128|NCT01499160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9129|NCT01499147|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9130|NCT01499134|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9131|NCT01499095|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
9132|NCT01499082|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
9133|NCT01498978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9134|NCT01498822|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9135|NCT01498744|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9136|NCT01498692|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to the Sponsor for review at least 45 days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
9137|NCT01498679|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9138|NCT01498653|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9139|NCT01498640|Principal Investigators are NOT employed by the organization sponsoring the study.|
9140|NCT01498601|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9141|NCT01498588|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9142|NCT01498575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9143|NCT01498549|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9144|NCT01498458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9145|NCT01498419|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator or any Sub-Investigator shall submit any oral or written publication or abstract concerning this study to the Sponsor not less than thirty (30) days prior to submission to any journal, other publication or meeting, for review and removal of confidential information.
9146|NCT01498185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9147|NCT01498120|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9148|NCT01498068|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9149|NCT01497938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9150|NCT01497899|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9151|NCT01497756|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9152|NCT01497665|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9153|NCT01497613|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9154|NCT01497366|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9155|NCT01497275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9156|NCT01497262|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
9157|NCT01497197|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9158|NCT01497171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9159|NCT01496846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9160|NCT01496807|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9161|NCT01496469|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9162|NCT01496456|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9163|NCT01496430|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9164|NCT01496352|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9165|NCT01496313|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
9166|NCT01496287|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9167|NCT01496274|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
9168|NCT01496248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9169|NCT01496183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9170|NCT01496131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9171|NCT01496066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9172|NCT01495988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9173|NCT01495975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9174|NCT01495923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9175|NCT01495858|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9176|NCT01495793|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9177|NCT01495702|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9178|NCT01495689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9179|NCT01495585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9180|NCT01495572|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9181|NCT01495481|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9182|NCT01495286|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9183|NCT01495000|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9184|NCT01494987|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9185|NCT01494818|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9186|NCT01494753|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever form without prior written agreement of THEA.
9187|NCT01494649|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9188|NCT01494610|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9189|NCT01494584|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9190|NCT01494545|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9191|NCT01494532|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9192|NCT01494506|Principal Investigators are NOT employed by the organization sponsoring the study.|Authorship/contents of any publication is determined by site and provides sponsor a publication prior to submission. Sponsor has 60 days to review and avoid editorial changes but may request site delete confidential data. If publication contains patentable matter, site agrees to delay publication for 60 days. If study is part of multicenter protocol, site agrees not to independently publish. If multicenter publication is not forthcoming in 18 months after study end, site may proceed accordingly.
9193|NCT01494467|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty (60) days prior to submission for publication, presentation or use, the Institution and the Investigator shall submit in writing to the Contract Research Organization and Sponsor for review and comment any proposed oral or written publication, which period may be extended for an additional thirty (30) days if requested in writing by Contract Research Organization and Sponsor.
9194|NCT01494350|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9255|NCT01488097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9195|NCT01494298|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9196|NCT01493960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9197|NCT01493947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9198|NCT01493687|Principal Investigators are NOT employed by the organization sponsoring the study.|At least sixty (60) days prior to submission for publication, presentation or use, the Institution and the Investigator shall submit in writing to the Contract Research Organization and Sponsor for review and comment any proposed oral or written publication, which period may be extended for an additional thirty (30) days if requested in writing by Contract Research Organization and Sponsor.
9199|NCT01493557|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
9200|NCT01493531|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor's request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
9201|NCT01493427|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9202|NCT01493284|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9203|NCT01493180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9204|NCT01493167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9205|NCT01493089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9206|NCT01492439|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9207|NCT01492426|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9208|NCT01492400|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9209|NCT01492309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9210|NCT01492088|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
9211|NCT01491984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9212|NCT01491958|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9213|NCT01491919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9214|NCT01491802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9215|NCT01491737|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
9216|NCT01491672|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
9217|NCT01491633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9218|NCT01491607|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor is responsible for public disclosure of study data. Any proposed publication is subject to review agreed between Biomedical Advanced Research and Development Authority (BARDA)and Emergent; between Emergent and the contract research organizations (CROs)/vendors; and between the CROs and the site Principal Investigator. Data are the property of the sponsor and cannot be published without prior authorization from the sponsor, but data and publication thereof will not be unduly withheld.
9219|NCT01491490|Principal Investigators are NOT employed by the organization sponsoring the study.|"All publications must be submitted to GW for corporate review before release. The principal investigators must then incorporate all reasonable comments made by GW into the publication.~GW also reserve the right to delay the submission of such information by up to six months from the date of first submission to them in order to allow them to take steps to protect proprietary information where applicable."
9220|NCT01491178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9221|NCT01491113|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9222|NCT01491035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9223|NCT01491022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9224|NCT01490931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9225|NCT01490866|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
9226|NCT01490840|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
9227|NCT01490697|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9228|NCT01490632|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9229|NCT01490359|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9230|NCT01490294|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9231|NCT01490190|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator agrees not to publish or publicly present interim results of the Study without prior written consent of sponsor, agrees to provide 45 days written notice to sponsor prior to submission for publication or presentation, and permits sponsor to review copies of abstracts and manuscripts for publication, and slides and text of oral presentations and text of any electronically transmitted media such as the Internet, World Wide Web, etc.
9232|NCT01490151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9233|NCT01490125|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
9234|NCT01490086|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9235|NCT01490060|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9236|NCT01489956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9237|NCT01489891|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9238|NCT01489826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigator and the Sponsor (or is agents) that restricts the PIs rights to discuss or publish trial results after the trial is completed.
9239|NCT01489670|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9240|NCT01489527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9241|NCT01489358|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9242|NCT01489254|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Synthon's agreements with its investigators may vary. However, Synthon BV does not prohibit any investigator from publishing. Any publication from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
9243|NCT01489189|Principal Investigators are NOT employed by the organization sponsoring the study.|Trial results can not be discussed until they have been made available to the public.
9244|NCT01488994|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per individual PI, but contain common elements. For this study, PIs may be restricted from independently publishing results without prior approval.
9245|NCT01488877|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9246|NCT01488708|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9247|NCT01488578|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9248|NCT01488487|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9249|NCT01488448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9250|NCT01488409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9251|NCT01488370|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9252|NCT01488318|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9253|NCT01488279|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9254|NCT01488188|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9256|NCT01488071|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of this study will be published. Authors of the primary publication based on this study must fulfil the criteria defined by the International Committee of Medical Journal Editors (ICMJE). The primary publication must be published before any secondary publications are submitted for publication.
9257|NCT01488019|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9258|NCT01487954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9259|NCT01487863|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentations relating to the Study will be coordinated by Dendreon in communication with institutions contributing patients to the Study.
9260|NCT01487668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9261|NCT01487577|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9262|NCT01487525|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9263|NCT01487499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9264|NCT01487265|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
9265|NCT01487161|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9266|NCT01486966|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones, for example, when the clinical trial report is available. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
9267|NCT01486927|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
9268|NCT01486758|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9269|NCT01486615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9270|NCT01486446|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9271|NCT01486238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9272|NCT01486199|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9273|NCT01486043|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9274|NCT01485991|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
9275|NCT01485887|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9297|NCT01484028|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9276|NCT01485796|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 12 months after study completion. Baxalta requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxalta may request an additional delay of ≤60 days eg, for intellectual property protection.
9277|NCT01485640|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS agreement between Principal Investigator and Sponsor that restricts PI's rights to discuss or publish trial results after trial is completed.~In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication provided, if a multicenter publication is not forthcoming within 24 months post completion of study at all sites, PI shall be free to publish."
9278|NCT01485536|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9279|NCT01485380|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9280|NCT01485354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9281|NCT01485172|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9282|NCT01485094|Principal Investigators are NOT employed by the organization sponsoring the study.|Joint publications are only possible if both parties agree. All editorial decisions will be jointly taken by the sponsor and the international coordinating investigator. The sponsor reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
9283|NCT01484977|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
9284|NCT01484951|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right to review the results communication prior to its public release.
9285|NCT01484938|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
9286|NCT01484912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9287|NCT01484873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9288|NCT01484834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9289|NCT01484652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9290|NCT01484561|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9291|NCT01484496|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9292|NCT01484314|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9293|NCT01484197|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
9294|NCT01484132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9295|NCT01484054|Principal Investigators are NOT employed by the organization sponsoring the study.|
9296|NCT01484041|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9298|NCT01483963|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9299|NCT01483937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9300|NCT01483924|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9301|NCT01483820|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9302|NCT01483651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9303|NCT01483625|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
9304|NCT01483599|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
9305|NCT01483378|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9306|NCT01483352|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9307|NCT01483209|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9308|NCT01483183|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9309|NCT01483118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9310|NCT01482910|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9311|NCT01482884|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9312|NCT01482819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9313|NCT01482767|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9314|NCT01482429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9315|NCT01482325|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9316|NCT01482312|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
9317|NCT01482221|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9318|NCT01482169|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9319|NCT01482091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9320|NCT01482065|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9321|NCT01481935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9322|NCT01481896|Principal Investigators are NOT employed by the organization sponsoring the study.|Any paper drafted regarding the results of the study shall be sent to Depuy Clinical Research for review and comment at least thirty (30) days before being submitted for publication; the same shall apply to abstracts, except the time for review by DePuy shall be ten (10) days. DePuy will promptly inform the authors of any changes deemed necessary to preserve the confidentiality of proprietary information or to ensure scientific accuracy.
9323|NCT01481779|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9324|NCT01481740|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9325|NCT01481558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9326|NCT01481376|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9327|NCT01481324|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9328|NCT01481129|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9329|NCT01481116|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9330|NCT01480843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9331|NCT01480674|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9332|NCT01480596|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9333|NCT01480297|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9334|NCT01480284|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9335|NCT01480232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9336|NCT01480219|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9337|NCT01480089|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9338|NCT01480076|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
9339|NCT01479868|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9340|NCT01479777|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9341|NCT01479764|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication and slides and texts of oral or other presentations that report any results of the trial.
9342|NCT01479725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9343|NCT01479621|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
9344|NCT01479595|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
9345|NCT01479543|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release.
9346|NCT01479530|Principal Investigators are NOT employed by the organization sponsoring the study.|"The results of this study will be published. Authors of the primary publication based on this study must fulfil the criteria defined by the International Committee of Medical Journal Editors (ICMJE).~The primary publication must be published before any secondary publications are submitted for publication."
9347|NCT01479517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9348|NCT01479374|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9349|NCT01479127|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9350|NCT01479010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9351|NCT01478971|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9352|NCT01478958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9353|NCT01478828|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9354|NCT01478620|Principal Investigators are NOT employed by the organization sponsoring the study.|Each Party acknowledges that it shall not publish any results of the trial,without the prior written authorization of the other Party. If SPONSOR (S.) requests INVESTIGATOR (I.)to publish any results obtained from the study, I. shall prepare and accomplish such publication at the expense of S. after review by S. and subject to written approval of the S. prior to publication. I. must be mentioned as co-author in any kind of publication resulting from such a request by S. to I. to publish.
9355|NCT01478594|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or after 18 months after database lock, whichever comes first. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication for up to 60 days to seek patent protection.
9356|NCT01478373|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
9357|NCT01478360|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
9358|NCT01478347|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement: the terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial
9359|NCT01478256|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9360|NCT01478113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9361|NCT01478087|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall provide the sponsor with a copy of any proposed publication for review at least 60 days prior to submission to a publisher. The sponsor may request that any confidential information or intellectual property contained be removed, redacted, or modified. If the PI do not agree to such deletion or modification, they shall notify the sponsor and agree to postpone such submission for an additional 60 days to allow sponsor to file the appropriate applications or seek protective remedies.
9362|NCT01478048|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9363|NCT01478009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9364|NCT01477892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9365|NCT01477853|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
9366|NCT01477762|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9367|NCT01477749|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentations relating to the study will be coordinated by Dendreon in communication with institutions contributing patients to the study.
9368|NCT01477710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9369|NCT01477567|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9370|NCT01477463|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9371|NCT01477450|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9372|NCT01477333|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed, except as provided below. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
9373|NCT01477320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9374|NCT01476748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9375|NCT01476722|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9376|NCT01476696|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9377|NCT01476475|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
9378|NCT01476345|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
9379|NCT01476202|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9380|NCT01475955|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of results from multi-center trial will be made by the Sponsor. If publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from the site individually, subject to compliance with the other terms of the clinical trial agreement, including a requirement that the PI provide a draft of the publication for the sponsor's review 60 days before publication so that sponsor can review the publication for confidential information.
9381|NCT01475851|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9382|NCT01475838|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9383|NCT01475734|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9384|NCT01475721|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9385|NCT01475487|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9386|NCT01475474|Principal Investigators are NOT employed by the organization sponsoring the study.|
9387|NCT01475461|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9388|NCT01475331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9389|NCT01475305|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
9390|NCT01475253|Principal Investigators are NOT employed by the organization sponsoring the study.|
9391|NCT01475214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9392|NCT01475175|Principal Investigators are NOT employed by the organization sponsoring the study.|In most cases, contracts allow investigators to publish study results per the protocol and publication plan following Medtronic's review to determine whether confidential information (CI) is disclosed. Any such CI is deleted prior to publication/presentation. Medtronic may not censor/interfere with the publication except as described. Investigators may not publish any single-site publications until the main multi-site study publication has occurred.
9393|NCT01475097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9394|NCT01475071|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreement covered by contract.
9395|NCT01474993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9396|NCT01474915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9397|NCT01474876|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9398|NCT01474863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9399|NCT01474772|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9400|NCT01474746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9401|NCT01474681|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
9402|NCT01474590|Principal Investigators are NOT employed by the organization sponsoring the study.|
9403|NCT01474551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9404|NCT01474538|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9405|NCT01474512|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9406|NCT01474434|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
9407|NCT01474317|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9408|NCT01474291|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
9409|NCT01474239|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9410|NCT01474213|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9411|NCT01474200|Principal Investigators are NOT employed by the organization sponsoring the study.|
9412|NCT01474122|Principal Investigators are NOT employed by the organization sponsoring the study.|
9413|NCT01474109|Principal Investigators are NOT employed by the organization sponsoring the study.|
9414|NCT01473992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9415|NCT01473953|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
9416|NCT01473836|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9417|NCT01473758|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9418|NCT01473745|Principal Investigators are NOT employed by the organization sponsoring the study.|no financial PI disclosure
9419|NCT01473602|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9420|NCT01473589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9421|NCT01473563|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9422|NCT01473524|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators must wait 18 months after the study ends to publish their results and a multi-center publication must come first. The sponsor has a 45 day review period with the option to extend to an additional 90 days.
9423|NCT01473394|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
9424|NCT01473381|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
9425|NCT01473368|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9426|NCT01473160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9427|NCT01472965|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9428|NCT01472939|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9429|NCT01472874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9430|NCT01472835|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9431|NCT01472822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9432|NCT01472562|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9433|NCT01472432|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9434|NCT01472380|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9435|NCT01472341|Principal Investigators are NOT employed by the organization sponsoring the study.|Each site can publish its own results without the results of other sites after the publication of the study or after 24 months from completion of publication. The author list will be established with the participating sites before the layout of the text to be published. The company will need to evaluate all the proposed summaries, manuscripts or presentations 60 days prior to publication. The revision made by Company could be accelerated in order to satisfy the guidelines concerning publication.
9436|NCT01472289|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9437|NCT01472185|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9438|NCT01471782|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
9439|NCT01471691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9440|NCT01471379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9441|NCT01471353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9442|NCT01471340|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor, and to provide the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication which report any trial results. The sponsor has the right to review and comment on publications, abstracts, slides, and manuscripts, and to review and comment on data analysis and presentation.
9443|NCT01471639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9444|NCT01471626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9445|NCT01471574|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9446|NCT01471197|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9447|NCT01471171|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
9448|NCT01471041|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9449|NCT01471015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9450|NCT01470859|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9451|NCT01470651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9452|NCT01470599|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9453|NCT01470469|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9454|NCT01470417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9455|NCT01470248|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9456|NCT01470196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9457|NCT01470170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9458|NCT01470144|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9459|NCT01470118|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
9460|NCT01470027|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9461|NCT01470001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9462|NCT01469819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9463|NCT01469767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9464|NCT01469715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9465|NCT01469637|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9466|NCT01469546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9467|NCT01469377|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc.
9468|NCT01469364|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9469|NCT01469234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9470|NCT01469221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9471|NCT01469182|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor for review 45 days prior to submission for publication or presentation copies of abstracts or manuscripts that report any results of the trial. If the parties disagree concerning the sponsor's confidential information the investigator agrees to meet with the sponsor's representative, prior to submission for publication, to discuss and resolve any issues or disagreement.
9472|NCT01469065|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9473|NCT01469052|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9493|NCT01467882|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication or scientific communication related to this study can only take place once the agreement between the Sponsor and the Investigator has been reached.
9474|NCT01469039|Principal Investigators are NOT employed by the organization sponsoring the study.|Should an Investigator desire to disclose study results, Sponsor will review the results disclosure prior to public release and can embargo the disclosure for a period of at least 60 days. Revisions to the disclosure will be negotiated in good faith. For a multicenter study the Investigators agree to publish/publicly present the results together with the other sites for the 12 month period after study results are available unless Sponsor grants written permission in advance.
9475|NCT01469000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9476|NCT01468987|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9477|NCT01468896|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9478|NCT01468818|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9479|NCT01468675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9480|NCT01468584|Principal Investigators are NOT employed by the organization sponsoring the study.|
9481|NCT01468558|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9482|NCT01468350|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has the right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
9483|NCT01468337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9484|NCT01468311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9485|NCT01468233|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9486|NCT01468207|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9487|NCT01468181|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9488|NCT01468077|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9489|NCT01468012|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9490|NCT01467960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9491|NCT01467947|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
9492|NCT01467934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9494|NCT01467713|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9495|NCT01467700|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9496|NCT01467661|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9497|NCT01467583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9498|NCT01467570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9499|NCT01467557|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9500|NCT01467505|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
9501|NCT01467492|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
9502|NCT01467479|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
9503|NCT01467427|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
9504|NCT01467076|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators must adhere to the Neonatal Research Network Publication policies.
9505|NCT01467037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9506|NCT01466881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9507|NCT01466790|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9508|NCT01466764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9509|NCT01466673|Principal Investigators are NOT employed by the organization sponsoring the study.|If Institution & Principal Investigator wish to publish information from Clinical Trial, a copy of manuscript must be provided to Sponsor at least 60 days prior to submission for publication/presentation and will arrange expedited reviews for the same. No paper with confidential information will be submitted without Sponsor’s prior consent. If requested, Institution and Principal Investigator will hold such publication for up to additional 60 days to allow filing of patent application.
9510|NCT01466660|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
9511|NCT01466595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9512|NCT01466491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9513|NCT01466387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9514|NCT01466361|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9515|NCT01466348|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9516|NCT01466270|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9517|NCT01466192|Principal Investigators are NOT employed by the organization sponsoring the study.|
9518|NCT01466179|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
9519|NCT01466153|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
9520|NCT01466127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9521|NCT01466075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9522|NCT01466062|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9523|NCT01465997|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9524|NCT01465958|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9525|NCT01465802|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9526|NCT01465763|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9527|NCT01465412|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with regard to proprietary information; the accuracy of the information; and to ensure that the presentation is fairly balanced and in compliance with Food and Drug Administration (FDA) regulations.
9528|NCT01465386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9529|NCT01465347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9530|NCT01465230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9531|NCT01465178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9532|NCT01465048|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9533|NCT01465022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9534|NCT01464996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9535|NCT01464931|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
9536|NCT01464879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is a restriction on joint publications prepared in collaboration between investigator and sponsor as Ferring reserves the right to be involved in this decision. In the event of any disagreement in the content of any publication both investigator’s and Ferring´s opinion will be fairly and sufficiently represented in the publication.
9537|NCT01464840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9538|NCT01464827|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9539|NCT01464788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9540|NCT01464619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9541|NCT01464424|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9542|NCT01464359|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9543|NCT01464346|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9544|NCT01464307|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study information usually requires agreement with the sponsor. In case of justified doubts by the sponsor, the Investigator will consider these doubts in the publication as long as the scientific neutrality is not affected.
9545|NCT01464255|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor. This restriction will apply for a period of five years from completion of the study.
9546|NCT01464229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9547|NCT01464190|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may not present or publish partial or complete study results individually. Any manuscript or abstract proposed by the Investigators must be reviewed and approved in writing by Vifor Pharma before submission for publication. Names of all Investigators participating in the study will be included in the publication.
9548|NCT01464021|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9549|NCT01463982|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator will complete the report on this study through discussion with Hanmi Pharmaceutical Co., Ltd. after the study is completed. If the report is to be published, prior agreement in writing should be made between the two parties.
9550|NCT01463878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9551|NCT01463696|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
9552|NCT01463683|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
9553|NCT01463527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9554|NCT01463384|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9555|NCT01463293|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9556|NCT01463202|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9557|NCT01463111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9558|NCT01463033|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9559|NCT01463007|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9560|NCT01462942|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication and/or presentation whether complete or partial, of any part of the data or results of this trial will not be allowed until global publication and study results disclosure by the sponsor as per EUDRACT/FDA regulatory compliance obligations, and only after mutual agreement between the investigator and sponsor
9561|NCT01462929|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
9562|NCT01462877|Principal Investigators are NOT employed by the organization sponsoring the study.|
9563|NCT01462812|Principal Investigators are NOT employed by the organization sponsoring the study.|Found in PI contract.
9564|NCT01462773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9565|NCT01462695|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9566|NCT01462565|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9567|NCT01462435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9568|NCT01462370|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. The sponsor review can be expedited to meet publication timelines.
9569|NCT01462357|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9570|NCT01462344|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9571|NCT01462318|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
9572|NCT01462292|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9573|NCT01462279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9574|NCT01462266|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
9575|NCT01462227|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9576|NCT01462162|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
9577|NCT01462084|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9578|NCT01462045|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9579|NCT01461993|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9580|NCT01461980|Principal Investigators are NOT employed by the organization sponsoring the study.|
9581|NCT01461824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9582|NCT01461811|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
9583|NCT01461733|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9584|NCT01461707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9585|NCT01461668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9586|NCT01461655|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting or presenting a manuscript, the investigator shall provide to LEO Pharma a copy of all such manuscripts, and LEO Pharma shall have rights to review and comment. Upon the request of LEO Pharma the investigator shall remove any confidential information prior to submitting or presenting the manuscripts. The investigator shall, upon the request of LEO Pharma, delay publication or presentation to allow LEO Pharma to protect its inventions and other intellectual property rights.
9587|NCT01461551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9588|NCT01461538|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9589|NCT01461499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9590|NCT01461473|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9591|NCT01461369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9610|NCT01459016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9592|NCT01461096|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
9593|NCT01461057|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9594|NCT01461044|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9595|NCT01460940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9596|NCT01460927|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall have the right to publish the results of the Trial provided Sponsor has given it prior written approval. Sponsor reserves the right to remove all Confidential Information from any communications, or if Sponsor deems that such removal does not sufficiently protect its intellectual property rights, to require that Investigator refrain from making such communications.
9597|NCT01460732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9598|NCT01460628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9599|NCT01460446|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9600|NCT01460342|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9601|NCT01460303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9602|NCT01460290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9603|NCT01459913|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
9604|NCT01459796|Principal Investigators are NOT employed by the organization sponsoring the study.|PI/Institution will provide a copy of any publication to Sponsor prior to submission for review. Sponsor may request to remove confidential information from submission, provided that removal does not preclude the complete and accurate presentation and interpretation of the study results.
9605|NCT01459783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9606|NCT01459705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9607|NCT01459653|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor is the sole owner of all data, results and any work summarizing the Study to which this agreement refers, and it should be noted that the Investigator agrees to their publication by Sponsor in any scientific or medical journal chosen by Sponsor. It should be noted that the Investigator may not make any communications or publications relating to the Study which forms the basis of this agreement, without the prior written agreement of the Sponsor.
9608|NCT01459588|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9609|NCT01459068|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9611|NCT01458990|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9612|NCT01458951|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9613|NCT01458639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9614|NCT01458587|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of results from multi-center trial will be made by the Sponsor. If publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from the site individually, subject to compliance with the other terms of the clinical trial agreement, including a requirement that the PI provide a draft of the publication for the sponsor's review 60 days before publication so that sponsor can review the publication for confidential information.
9615|NCT01458574|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9616|NCT01458561|Principal Investigators are NOT employed by the organization sponsoring the study.|Authorship of 1st publication (Primary Paper) determined by Sponsor. If Primary Paper not sub. for publication within 18 months of study completion, Investigator may publish individual publication/presentation - proposal must be provided to Sponsor for review and comment at least 30 days prior to submission date/public disclosure. Sponsor to review within 30 days of receipt and can remove proprietary/confidential info and/or require delay in publication or public disclosure for up to 30 days.
9617|NCT01458535|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
9618|NCT01458392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9619|NCT01458288|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9620|NCT01458275|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
9621|NCT01458249|Principal Investigators are NOT employed by the organization sponsoring the study.|
9622|NCT01458210|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9623|NCT01458171|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
9624|NCT01458106|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
9625|NCT01457950|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9626|NCT01457924|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9627|NCT01457885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9687|NCT01453075|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9628|NCT01457846|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9629|NCT01457703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9630|NCT01457573|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9631|NCT01457521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9632|NCT01457430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9633|NCT01457417|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results shall not be made before the publication by Sponsor. If there is no multi-site publication within 18 months after the Study completion/termination at all sites, the Site shall have the right to publish its results. Prior to submitting to public release the Sponsor has 60 days from receipt to review and comment. The Site shall, upon Sponsor's request, further delay publication/presentation for up to 120 days to allow Sponsor to protect its interests.
9634|NCT01457339|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9635|NCT01457053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9636|NCT01457014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9637|NCT01456962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9638|NCT01456936|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study participating sites. Investigator may not disclose previously undisclosed confidential other than study results.
9639|NCT01456780|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9640|NCT01456299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9641|NCT01456195|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9642|NCT01456169|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9643|NCT01456143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9644|NCT01456130|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9645|NCT01456052|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution must provide any proposed publication or presentation to Sponsor for Sponsor’s review, comment and approval at least sixty (60) days prior to the proposed submission for publication date or the proposed presentation date. Sponsor shall have the right to have deleted from the final version of the publication any information to which Sponsor objects, any Confidential Information, proprietary information or patentable subject matter.
9729|NCT01449955|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9646|NCT01456039|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; the Investigators shall not disclose any material/information disclosed by the Sponsor (Celgene KK) with the clinical trial or information obtained by conducting the clinical trial to third parties without Sponsor’s prior written approval.
9647|NCT01456000|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9648|NCT01455545|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9649|NCT01455519|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9650|NCT01455428|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9651|NCT01455415|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9652|NCT01455220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9653|NCT01455194|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9654|NCT01455181|Principal Investigators are NOT employed by the organization sponsoring the study.|
9655|NCT01455064|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9656|NCT01455012|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9657|NCT01454947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9658|NCT01454934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9659|NCT01454830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9660|NCT01454791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9661|NCT01454778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9662|NCT01454726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9663|NCT01454583|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9664|NCT01454531|Principal Investigators are NOT employed by the organization sponsoring the study.|All presentations/publications must be approved by ALK prior to public presentation/submission. Investigators agree not to present data gathered from one trial centre or a small group of trial centres before the full publication unless formally agreed by all other investigators and ALK. ALK has the right to review and comment any manuscript within 30 days of receipt, but cannot prevent publications of findings.
9665|NCT01454505|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9666|NCT01454414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9667|NCT01454401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9668|NCT01454284|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9669|NCT01454258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9670|NCT01454076|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
9671|NCT01454063|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agreed not to publish or otherwise to disclose Study data without prior written consent from the sponsor for a period of 24 months following Study completion or until data are published in a combined publication (whichever occurs first). The sponsor can review communications containing results prior to public release and embargo those communications for a period that is no longer than 60 days from the date of receipt of the non-public communication. The sponsor cannot extend the embargo.
9672|NCT01453998|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9673|NCT01453946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9674|NCT01453894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9675|NCT01453855|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9676|NCT01453725|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including slides and texts of oral or other public presentations and texts of any transmission through any electronic media) that report any results of the trial.
9677|NCT01453595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9678|NCT01453569|Principal Investigators are NOT employed by the organization sponsoring the study.|
9679|NCT01453413|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9680|NCT01453387|Principal Investigators are NOT employed by the organization sponsoring the study.|The study as a whole will be published prior to any individual investigator publications. It is required that copies of all papers, abstracts, articles, etc. that contain study data are to be forward to the Sponsor for review 30 days prior to submission for publication.
9681|NCT01453374|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of such disclosure must be given to Alkermes for review at least 60 days prior to submission for publication. Revision to such disclosure will be negotiated in good faith by the Institution, Principal Investigator, and Alkermes. The disclosure may be submitted for publication or presented by the Institution and Principal Investigator only following receipt of written notice from an authorized representative of Alkermes stating that the disclosure has been reviewed and approved.
9682|NCT01453361|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9683|NCT01453348|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9684|NCT01453296|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9685|NCT01453205|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises on-going studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
9686|NCT01453166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9688|NCT01453049|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9689|NCT01453036|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9690|NCT01453023|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9691|NCT01452854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9692|NCT01452529|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9693|NCT01452425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9694|NCT01452347|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
9695|NCT01452269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9696|NCT01452152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9697|NCT01452126|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9698|NCT01451996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9699|NCT01451983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9700|NCT01451931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9701|NCT01451814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9702|NCT01451775|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9703|NCT01451762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9704|NCT01451749|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9705|NCT01451723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9706|NCT01451645|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor’s request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
9707|NCT01451632|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9708|NCT01451606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9709|NCT01451554|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9710|NCT01451541|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish
9711|NCT01451463|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9712|NCT01451437|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the Sponsor. The Investigator further agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
9713|NCT01451424|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
9714|NCT01451411|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can publish data generated at their study site after multi-center study data have already been published, or after 18 months have elapsed following database lock, whichever comes first. The sponsor may review manuscripts before submission and delay publication by an additional 60 days, if necessary.
9715|NCT01451398|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
9716|NCT01451203|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for to seek patent protection.
9717|NCT01450813|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9718|NCT01450800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9719|NCT01450787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9720|NCT01450761|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9721|NCT01450696|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9722|NCT01450683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9723|NCT01450631|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9724|NCT01450397|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9725|NCT01450319|Principal Investigators are NOT employed by the organization sponsoring the study.|
9726|NCT01450306|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9727|NCT01450189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9728|NCT01450007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9730|NCT01449929|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9731|NCT01449812|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9732|NCT01449747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9733|NCT01449734|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9734|NCT01449721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9735|NCT01449708|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9736|NCT01449682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9737|NCT01449539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9738|NCT01449526|Principal Investigators are NOT employed by the organization sponsoring the study.|
9739|NCT01449513|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review at least 30 days prior to the same paper being submitted for publication or presentation. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
9740|NCT01449461|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
9741|NCT01449370|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
9742|NCT01449305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9743|NCT01449279|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9744|NCT01449266|Principal Investigators are NOT employed by the organization sponsoring the study.|"No unpublished data given to the investigator may be transmitted to a third party without approval by the sponsor. The data are the exclusive property of Guerbet.~The investigator undertakes to submit to Guerbet any articles or papers related to this study within 30 days of their submission to journals or congresses.~All publications must have the joint agreement of the investigator and the sponsor.~The investigator remains independent with no relationship of subordination with Guerbet."
9745|NCT01449240|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9746|NCT01449006|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9747|NCT01448850|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
9748|NCT01448707|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days. The sponsor will not mandate modifications to scientific content and does not have the right to suppress information.
9749|NCT01448616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9750|NCT01448525|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9751|NCT01448486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9752|NCT01448356|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9753|NCT01448213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9754|NCT01448057|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
9755|NCT01448044|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9756|NCT01447927|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9757|NCT01447914|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9758|NCT01447849|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9759|NCT01447719|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9760|NCT01447706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9761|NCT01447576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9762|NCT01447511|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9763|NCT01447446|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
9764|NCT01447433|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9765|NCT01447420|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
9766|NCT01447225|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9767|NCT01447121|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9787|NCT01444924|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9768|NCT01447017|Principal Investigators are NOT employed by the organization sponsoring the study.|"The following disclosure restriction on the PI was included in clinical study protocol:~If an Investigator wishes to publish results from this clinical study, written permission to publish must be obtained from the Sponsor in advance. As some of the information regarding the IP and development activities at the Sponsor may be of a strictly confidential nature, the Sponsor must first review any publication manuscript prior to their submission to journals, meetings or conferences."
9769|NCT01446796|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9770|NCT01446705|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9771|NCT01446419|Principal Investigators are NOT employed by the organization sponsoring the study.|Individual PIs will not publish any study results until completion of study and publication of the multi-center results in a peer-reviewed journal, which shall occur within one year after study completion. Thereafter, PIs may publish individual site experience. Sponsor can review results communications prior to public release and can embargo communications regarding results for a period that is less than or equal to 60 days from the time submitted to sponsor for review.
9772|NCT01446289|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
9773|NCT01446250|Principal Investigators are NOT employed by the organization sponsoring the study.|
9774|NCT01446237|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9775|NCT01446003|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
9776|NCT01445951|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
9777|NCT01445873|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9778|NCT01445847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9779|NCT01445769|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
9780|NCT01445678|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator(s) must undertake not to submit any part of the data from this protocol for publication without the prior consent of Cubist Pharmaceuticals, Inc.
9781|NCT01445652|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9782|NCT01445626|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9783|NCT01445613|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9784|NCT01445548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9785|NCT01445301|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9786|NCT01445028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9885|NCT01437878|Principal Investigators are NOT employed by the organization sponsoring the study.|
9788|NCT01444911|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9789|NCT01444898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9790|NCT01444781|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
9791|NCT01444742|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9792|NCT01444651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9793|NCT01444456|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
9794|NCT01444430|Principal Investigators are NOT employed by the organization sponsoring the study.|≥ 60 days prior to submission of material for publication/presentation, Institution and PI shall jointly provide AZ with material for review. No publication/presentation may include any of AZ’s Confidential Information without AZ’s written approval. AZ can request Inst. and PI to withhold material from submission for publication/presentation for an additional 90 days to allow AZ to establish and preserve its proprietary rights in the material being submitted for publication or presentation.
9795|NCT01444417|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
9796|NCT01444391|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9797|NCT01444378|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9798|NCT01444300|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9799|NCT01444287|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9800|NCT01444092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9801|NCT01444027|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9802|NCT01443923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9803|NCT01443858|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9804|NCT01443845|Principal Investigators are NOT employed by the organization sponsoring the study.|
9805|NCT01443494|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9806|NCT01443403|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
9807|NCT01443364|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9808|NCT01443130|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9809|NCT01443078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9810|NCT01443026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9811|NCT01442844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9812|NCT01442779|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9813|NCT01442714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9814|NCT01442688|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9815|NCT01442675|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
9816|NCT01442493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9817|NCT01442376|Principal Investigators are NOT employed by the organization sponsoring the study.|If Sponsor does not submit a publication regarding the study to a journal within 12 months from study data analysis completion, the Investigator may publish an analysis of the study data collected as a result of the conduct of the study by the Investigator. The Investigator shall ensure that at least 60 days prior to submitting/presenting a manuscript/material relating to study to publishers a copy of all manuscripts/materials is provided to the Sponsor to allow the Sponsor sixty days to review.
9818|NCT01442181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9819|NCT01442155|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
9820|NCT01442129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9821|NCT01442103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9822|NCT01442064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9823|NCT01442038|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9824|NCT01441973|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9825|NCT01441960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9886|NCT01437540|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the principal investigator (PI) will be subject to mutual agreement between the PI and sponsor
9826|NCT01441882|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9827|NCT01441843|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9828|NCT01441765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9829|NCT01441596|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
9830|NCT01441570|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9831|NCT01441466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9832|NCT01441440|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9833|NCT01441414|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9834|NCT01441401|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9835|NCT01441245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9836|NCT01441180|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9837|NCT01441102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9838|NCT01441076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9839|NCT01440972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9840|NCT01440959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9841|NCT01440946|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
9842|NCT01440881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9843|NCT01440816|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9844|NCT01440764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9845|NCT01440647|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9846|NCT01440634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9847|NCT01440595|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
9848|NCT01440569|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
9849|NCT01440543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9850|NCT01440517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9851|NCT01440387|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9852|NCT01440374|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
9853|NCT01440322|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
9854|NCT01440283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9855|NCT01440101|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
9856|NCT01440049|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9857|NCT01439971|Principal Investigators are NOT employed by the organization sponsoring the study.|Catalyst Biosciences has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9858|NCT01439945|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9859|NCT01439867|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
9860|NCT01439724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9861|NCT01439711|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9862|NCT01439672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9863|NCT01439373|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9864|NCT01439360|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9865|NCT01439282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9866|NCT01439204|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9867|NCT01439165|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
9868|NCT01439126|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
9869|NCT01439074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9870|NCT01438996|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event that no publication of the Study results has been made by NVGH within twelve (12) months of Study database lock and no proposed publication is under discussion by the publication committee, Principal Investigator may publish its own Study results, provided that he furnishes NVGH with a copy of the proposed publication for NVGH's review and comment, at least 1 month prior to submission to a publisher or disclosure to any third party.
9871|NCT01438840|Principal Investigators are NOT employed by the organization sponsoring the study.|
9872|NCT01438814|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
9873|NCT01438710|Principal Investigators are NOT employed by the organization sponsoring the study.|
9874|NCT01438541|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9875|NCT01438489|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
9876|NCT01438424|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
9877|NCT01438307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9878|NCT01438294|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9879|NCT01438229|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9880|NCT01438177|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9881|NCT01438151|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9882|NCT01438060|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
9883|NCT01437995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9884|NCT01437943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9887|NCT01437501|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9888|NCT01437488|All Principal Investigators ARE employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9889|NCT01437423|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
9890|NCT01437397|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the Investigator will be subject to mutual agreement between the investigator and sponsor.
9891|NCT01437319|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9892|NCT01437267|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event that no publication of the Study results has been made by NVGH within twelve (12) months of Study database lock and no proposed publication is under discussion by the publication committee, Principal Investigator may publish its own Study results.
9893|NCT01437124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9894|NCT01437111|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to allow the Sponsor to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Investigators have also agreed that any information identified by the SPONSOR as confidential must be deleted prior to submission.
9895|NCT01437098|Principal Investigators are NOT employed by the organization sponsoring the study.|It is not required per Japan GCP. There is an agreement with the site, but not the individual investigator at the site.
9896|NCT01436799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9897|NCT01436643|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
9898|NCT01436526|Principal Investigators are NOT employed by the organization sponsoring the study.|Any disclosure of study results by the Principal Investigator or investigators has to be in agreement with the sponsor.
9899|NCT01436500|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can publish data generated at their study site after multi=center study data have already been published, or after 18 months have elapsed following database lock. The sponsor may review manuscripts before submission and delay publication by an additional 60 days, if necessary.
9900|NCT01436435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9901|NCT01436370|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9902|NCT01436305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9903|NCT01436279|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9904|NCT01436266|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9905|NCT01436253|Principal Investigators are NOT employed by the organization sponsoring the study.|No Investigator may publish or disclose any study information without permission from the Sponsor.
9906|NCT01436201|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9907|NCT01436175|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multi-centre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multi-centre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9908|NCT01436162|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9909|NCT01436149|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9910|NCT01436110|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9911|NCT01436084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9912|NCT01436071|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9913|NCT01436045|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9914|NCT01436006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9915|NCT01435928|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
9916|NCT01435798|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9917|NCT01435772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9918|NCT01435759|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
9919|NCT01435655|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9920|NCT01435616|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9921|NCT01435603|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9922|NCT01435577|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
9923|NCT01435460|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s)after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
9924|NCT01435304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9925|NCT01435265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9926|NCT01435174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9927|NCT01435122|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9928|NCT01435031|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9929|NCT01434823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9930|NCT01434693|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9931|NCT01434680|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
9932|NCT01434654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9933|NCT01434641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9934|NCT01434511|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 12 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥30 days prior to submission or communication. Baxter may request an additional delay of ≤30 days(e.g., for intellectual property protection)
9935|NCT01434342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9936|NCT01434290|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
9937|NCT01434186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9938|NCT01434121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9939|NCT01434030|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9940|NCT01433978|Principal Investigators are NOT employed by the organization sponsoring the study.|
9941|NCT01433913|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9942|NCT01433731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9943|NCT01433549|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
9944|NCT01433471|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9945|NCT01433354|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­ site are postponed until the publication of the pooled data (i.e, data from all sites) in the clinical trial.
9946|NCT01433263|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
9947|NCT01433250|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
9948|NCT01433172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9949|NCT01433159|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9950|NCT01433107|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
9951|NCT01433081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9952|NCT01433055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9953|NCT01433042|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9954|NCT01433016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9955|NCT01432938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9956|NCT01432886|Principal Investigators are NOT employed by the organization sponsoring the study.|
9957|NCT01432756|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9958|NCT01432626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9959|NCT01432600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9960|NCT01432574|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9961|NCT01432561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9962|NCT01432535|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the Sponsor. The Investigator further agrees to provide review copies of abstracts or manuscripts for publication that report any results of the trial to the Sponsor 45 days prior to submission for publication or presentation. The Sponsor shall have the right to review and comment.
9963|NCT01432457|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9964|NCT01432444|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9965|NCT01432405|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9966|NCT01432379|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
9967|NCT01432366|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9968|NCT01432327|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9969|NCT01432275|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9970|NCT01432262|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9988|NCT01431170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9971|NCT01432236|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9972|NCT01432015|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9973|NCT01431989|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9974|NCT01431976|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9975|NCT01431963|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9976|NCT01431950|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9977|NCT01431846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9978|NCT01431755|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication or presentation by PI shall be submitted to Q-Med for review no less than 60 days before submission for publication or presentation. Q-Med will provide any comments to Principal Investigator within thirty (30) days following receipt of the proposed publication/presentation. PI agrees to consider, discuss and give reasonable considerations to comments by Q-Med. Q-Med may also request that the Company name or Q-Med employee name appear or not appear in such publication.
9979|NCT01431716|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9980|NCT01431703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9981|NCT01431521|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/ presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
9982|NCT01431508|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
9983|NCT01431391|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentations relating to the Study will be coordinated by Dendreon in communication with institutions contributing patients to the Study.
9984|NCT01431339|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI will provide Durata an opportunity to review any proposed publication or other type of disclosure at least 30 days before they are submitted. If any patent action is required to protect intellectual property rights, the Investigator agrees to delay the disclosure for a period not to exceed an additional 60 days. If the study is part of a multi-center study, the Investigator agrees that the first publication is to be a joint publication covering all centers.
9985|NCT01431300|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9986|NCT01431287|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
9987|NCT01431274|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
9989|NCT01431144|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9990|NCT01431131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9991|NCT01431079|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
9992|NCT01431014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9993|NCT01430819|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
9994|NCT01430754|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9995|NCT01430741|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9996|NCT01430624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
9997|NCT01430611|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
9998|NCT01430585|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
9999|NCT01430468|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10000|NCT01430455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10001|NCT01430403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10002|NCT01430325|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10003|NCT01430299|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10004|NCT01430182|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10005|NCT01430169|Principal Investigators are NOT employed by the organization sponsoring the study.|
10006|NCT01430130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10007|NCT01430104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10008|NCT01430091|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10009|NCT01429987|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10010|NCT01429623|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10011|NCT01429584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10012|NCT01429532|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10013|NCT01429441|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall have the right to the 1st publication of the Study results (joint, multi-center publication in conjunction with PI). Following the 1st publication, PI may publish data/results from the Study; provided that PI submits the proposed publication to Sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may request that Confidential/Proprietary Information be deleted and/or publication be postponed to protect Sponsor's intellectual property rights.
10014|NCT01429298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10015|NCT01429285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10016|NCT01429272|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10017|NCT01429259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10018|NCT01429077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10019|NCT01429064|Principal Investigators are NOT employed by the organization sponsoring the study.|
10020|NCT01429051|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
10021|NCT01428882|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10022|NCT01428765|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10023|NCT01428713|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10024|NCT01428661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10025|NCT01428583|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10026|NCT01428336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10027|NCT01428258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10028|NCT01428219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10029|NCT01428128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10030|NCT01428115|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10031|NCT01428076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10032|NCT01428063|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10033|NCT01427933|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
10034|NCT01427920|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Novo Nordisk reserves the right to prior review of such publications and to ask for delay of publication of individual site results until after the primary manuscript is accepted for publication.
10035|NCT01427907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10036|NCT01427881|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10037|NCT01427803|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10038|NCT01427751|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 120 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10039|NCT01427738|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10040|NCT01427517|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10041|NCT01427504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10042|NCT01427309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10043|NCT01427296|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10044|NCT01426958|All Principal Investigators ARE employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10045|NCT01426867|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
10046|NCT01426854|Principal Investigators are NOT employed by the organization sponsoring the study.|Results, materials of research, relevant intellectual property, and trial materials may not be used, disclosed, revealed, or published in any form without Sponsor's prior written consent.
10047|NCT01426789|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10048|NCT01426763|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to Sponsor for pre-review. If Sponsor requests, PI must delete Sponsor confidential information before publication and/or delay publication for 60 days so Sponsor can file for patents or take other action to protect its patent rights.
10049|NCT01426555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10050|NCT01426516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10051|NCT01426438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10052|NCT01426425|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, the contract allows the principal investigator to publish their data per the publication strategy/Clinical Investigational Plan following Medtronic's review for (a) disclosure of confidential information (CI), (b) technical correctness and (c) selection and order of publications by the publications committee. Any such CI and/or item identified as not technically correct is deleted prior to publication/presentation. Medtronic may not otherwise interfere with the publication."
10053|NCT01426373|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical study agreement requires that the investigator or institution obtain written consent from Kythera Biopharmaceuticals, Inc. prior to presenting and/or publishing results of this study.
10054|NCT01426360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10055|NCT01426347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10056|NCT01426269|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10057|NCT01426230|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: The PI agrees that sponsor shall have the right to the first publication of the study results which is intended to be a joint, multi-center publication. Following the first publication, the PI may publish study data or results, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may remove any information that is considered confidential and/or proprietary other than study data.
10058|NCT01426113|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10059|NCT01426009|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the study is part of a multi-center study. The first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
10060|NCT01425879|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10061|NCT01425853|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10062|NCT01425814|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subjected to revision and written agreement between the investigator and Sponsor
10063|NCT01425801|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication and/or presentation whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and sponsor
10064|NCT01425749|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10065|NCT01425632|Principal Investigators are NOT employed by the organization sponsoring the study.|
10066|NCT01425528|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10067|NCT01425463|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10068|NCT01425359|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
10069|NCT01425307|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10070|NCT01425268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10071|NCT01425229|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10072|NCT01425203|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees not to publish or publicly present any interim results of trial without prior written consent of Sponsor. Investigator further agrees to provide to Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. Sponsor has right to review and comment with respect to publications, abstracts, slides, data analysis and presentation
10073|NCT01425190|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication.
10074|NCT01424943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10075|NCT01424930|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10076|NCT01424813|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
10077|NCT01424644|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10078|NCT01424566|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10079|NCT01424514|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10080|NCT01424501|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10081|NCT01424306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10082|NCT01424228|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10083|NCT01424189|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
10084|NCT01424072|All Principal Investigators ARE employed by the organization sponsoring the study.|The copyright of the search results are the exclusive property of Latin American Journal of Nursing, barring any reproduction, in whole or in part in any form or means of printed or electronic, without the prior and necessary authorization is requested.
10085|NCT01424033|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10086|NCT01423916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10087|NCT01423812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10088|NCT01423773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10089|NCT01423760|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator will inform the Sponsor in advance about any plans to publish or present data from the trial. Any publications and presentations of the results (abstracts in journals or newspapers, oral presentations, etc.), either in whole or in part, by Investigators or their representatives will require pre-submission review by the Sponsor.The Sponsor will not suppress or veto publications, but maintains the right to delay publication in order to protect intellectual property rights.
10090|NCT01423617|Principal Investigators are NOT employed by the organization sponsoring the study.|
10207|NCT01412710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10091|NCT01423604|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study; provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
10092|NCT01423253|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS agreement between Principal Investigator and Sponsor that restricts PI's rights to discuss or publish trial results after trial is completed.~In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication provided, if a multicenter publication is not forthcoming within 24 months post completion of study at all sites, PI shall be free to publish."
10093|NCT01423162|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 18 months from the time submitted to the sponsor for review.
10094|NCT01423084|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10095|NCT01422915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10096|NCT01422889|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10097|NCT01422876|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
10098|NCT01422850|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10099|NCT01422824|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
10100|NCT01422720|Principal Investigators are NOT employed by the organization sponsoring the study.|
10101|NCT01422538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10102|NCT01422434|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
10103|NCT01422408|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10104|NCT01422382|Principal Investigators are NOT employed by the organization sponsoring the study.|May not publish.
10105|NCT01422369|Principal Investigators are NOT employed by the organization sponsoring the study.|May not publish.
10106|NCT01422356|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10107|NCT01422304|Principal Investigators are NOT employed by the organization sponsoring the study.|Initial public presentation of the Investigator's results will occur only together with the other sites unless permission is obtained from Sponsor. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. In case of disagreement concerning appropriateness of materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues, prior to submission for publication/presentation.
10108|NCT01422239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10109|NCT01422226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10228|NCT01411085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10110|NCT01422213|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of this study will be published. Authors of the primary publication based on this study must fulfil the criteria defined by the International Committee of Medical Journal Editors (ICMJE). The primary publication must be published before any secondary publications are submitted for publication.
10111|NCT01422187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10112|NCT01422070|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10113|NCT01421719|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10114|NCT01421667|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10115|NCT01421654|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10116|NCT01421641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10117|NCT01421589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10118|NCT01421511|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor intends to pursue publication of the results of the study in cooperation with a lead Investigator, subject to the terms and conditions of the clinical study agreement between the Sponsor and Investigators. Sponsor approval in writing is required for publication of any data subsets. Final authorship will be determined in accordance with the International Committee of Medical Journal Editors definition of authorship.
10119|NCT01421498|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicentre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicentre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10120|NCT01421472|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10121|NCT01421459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10122|NCT01421355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10123|NCT01421342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10124|NCT01421303|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10125|NCT01421277|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
10126|NCT01421147|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10127|NCT01421134|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS agreement between Principal Investigator and Sponsor that restricts PI's rights to discuss or publish trial results after trial is completed.~In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication provided, if a multicenter publication is not forthcoming within 24 months post completion of study at all sites, PI shall be free to publish."
10229|NCT01410773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10128|NCT01420926|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10129|NCT01420848|All Principal Investigators ARE employed by the organization sponsoring the study.|The copyright of the search results are the exclusive property of the Journal of School Nursing, University of Saint Paul, barring any reproduction, in whole or in part in any form or means of printed or electronic, without the prior and necessary authorization is requested.
10130|NCT01420289|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10131|NCT01420146|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10132|NCT01420081|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10133|NCT01419977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10134|NCT01419795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10135|NCT01419769|Principal Investigators are NOT employed by the organization sponsoring the study.|"PI must wait 9 months after close of study for Sponsor to present collaborative publication. If Sponsor does not publish within 9 months after close of study, PI is free to publish institution's results at that time.~Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of 6 months from the date the PI receives the objection. The Sponsor cannot require changes to the communication and cannot extend the embargo."
10136|NCT01419639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10137|NCT01419314|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10138|NCT01419275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10139|NCT01419249|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor does not object to trial results publication by Investigator. Investigator will provide sponsor proposed publication/disclosure for review before submission. In multi-center trial, Investigator agree on first publication to be joint involving all sites. Investigator can decline to be part of joint publication. If joint manuscript has not submitted for publication within 12 months of trial completion/termination at all sites, Investigator can publish separately, subject to this agreement.
10140|NCT01419236|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10141|NCT01419197|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10142|NCT01419184|Principal Investigators are NOT employed by the organization sponsoring the study.|
10143|NCT01419171|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Investigator shall have the right to publish the results, provided that before publishing, Institution and Investigator shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
10144|NCT01419028|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in a multicenter study involves a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis. Therefore, PIs are subject to certain disclosure and publication limitations.
10145|NCT01418937|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10146|NCT01418703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10147|NCT01418482|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10148|NCT01418365|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10149|NCT01418209|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10150|NCT01418001|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10151|NCT01417936|Principal Investigators are NOT employed by the organization sponsoring the study.|
10152|NCT01417481|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10153|NCT01417455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10154|NCT01417377|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10155|NCT01417195|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
10156|NCT01417156|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
10157|NCT01417104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10158|NCT01417078|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has right to review at least forty-five (45) days prior to the date of submission for publication or of public disclosure. Multi-center trials; publication shall be delayed until a publication of the multi-center results or until twelve (12) months have elapsed since the completion of the study, whichever occurs first.
10159|NCT01417026|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10160|NCT01417000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10161|NCT01416610|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10162|NCT01416584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10163|NCT01416571|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10164|NCT01416389|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10165|NCT01416272|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10230|NCT01410604|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10166|NCT01416181|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
10167|NCT01416155|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
10168|NCT01416142|Principal Investigators are NOT employed by the organization sponsoring the study.|
10169|NCT01416129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10170|NCT01416025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10171|NCT01415986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10172|NCT01415960|Principal Investigators are NOT employed by the organization sponsoring the study.|All information from the trial is property of the Sponsor and the PI has no right on it except the prior writing authorization of the sponsor
10173|NCT01415921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10174|NCT01415908|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10175|NCT01415583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10176|NCT01415531|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc
10177|NCT01415518|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish any results until the earlier of (i) the date of the first Study results publication authorized by AZ and (ii) the end of the 18 month period following the completion of the Study. PI shall provide AZ with such material for review, at least 60 days prior to submission for publication. If requested in writing by AZ, PI shall withhold material from submission for publication for an additional 90 days from the date of AZ's request.
10178|NCT01415453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10179|NCT01415427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10180|NCT01415401|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
10181|NCT01415349|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10182|NCT01415232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10183|NCT01414855|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10184|NCT01414634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10185|NCT01414413|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10186|NCT01414244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10187|NCT01414205|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10188|NCT01414192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10189|NCT01414166|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
10190|NCT01414153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10191|NCT01414114|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10192|NCT01414036|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10193|NCT01414010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10194|NCT01413958|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Sponsor must have the opportunity to review all proposed abstracts,~manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines."
10195|NCT01413750|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10196|NCT01413542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10197|NCT01413516|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10198|NCT01413360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10199|NCT01413204|Principal Investigators are NOT employed by the organization sponsoring the study.|
10200|NCT01413191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10201|NCT01412983|Principal Investigators are NOT employed by the organization sponsoring the study.|
10202|NCT01412957|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10203|NCT01412944|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10204|NCT01412918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10205|NCT01412879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10206|NCT01412801|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
10208|NCT01412541|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10209|NCT01412424|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study cannot be published for a period of up to 150 days, 60 days for sponsor review and 90 days for patent protection. In addition, the first publication may only occur after the first multi-center publication or, if no such multi-center publication is made, 12-18 months after completion of the study at all study sites.
10210|NCT01412333|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10211|NCT01412281|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 90 days from the time submitted to the sponsor for review. The sponsor can make a reasoned request that publication be delayed for up to 3 months from the date of first submission to the sponsor in order to enable the sponsor to protect proprietary information, Intellectual Property, etc.
10212|NCT01412229|Principal Investigators are NOT employed by the organization sponsoring the study.|
10213|NCT01412164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10214|NCT01412151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10215|NCT01412086|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10216|NCT01411995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10217|NCT01411891|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10218|NCT01411852|Principal Investigators are NOT employed by the organization sponsoring the study.|Research activities of the Resuscitation Outcomes Consortium (ROC) are intended to contribute applicable knowledge to the field of Resuscitative Medicine. Definitive contributions are made through publications in peer-reviewed literature. No participating institution may present or publish individual findings from work performed on study protocols without approval of the Publications Subcommittee (PS).
10219|NCT01411839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10220|NCT01411774|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10221|NCT01411696|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10222|NCT01411592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10223|NCT01411501|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10224|NCT01411488|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10225|NCT01411228|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10226|NCT01411215|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10227|NCT01411137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10231|NCT01410565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10232|NCT01410552|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10233|NCT01410474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10234|NCT01410448|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10235|NCT01410409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10236|NCT01410357|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10237|NCT01410344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10238|NCT01410240|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥30 days prior to submission or communication. Baxter may request an additional delay of ≤60 days(e.g., for intellectual property protection)
10239|NCT01410227|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or ≥12 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥40 days prior to submission or communication. Baxter may request an additional delay of ≤45 days eg, for intellectual property protection.
10240|NCT01410110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10241|NCT01410097|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10242|NCT01409993|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10243|NCT01409837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10244|NCT01409707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10245|NCT01409564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10246|NCT01409434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10247|NCT01409382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10248|NCT01409291|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10249|NCT01409239|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10250|NCT01409213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10251|NCT01409096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10252|NCT01408992|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10253|NCT01408914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10254|NCT01408888|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10255|NCT01408862|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10256|NCT01408732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10257|NCT01408719|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10258|NCT01408706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10259|NCT01408641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10260|NCT01408628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10261|NCT01408537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10262|NCT01408485|Principal Investigators are NOT employed by the organization sponsoring the study.|
10263|NCT01408329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10264|NCT01408303|Principal Investigators are NOT employed by the organization sponsoring the study.|Individual investigators may publish data arising from their own subjects. The PI will provide the Sponsor with copies of written publications (including abstracts and posters)at least 60 days in advance of submission. Data will be reviewed by all participating investigators prior to publication. The Sponsor will have 60 days to review all definitive publications, such as manuscripts and book chapters, and a minimum of 30 days to review all abstracts.
10265|NCT01408277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10266|NCT01407575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10267|NCT01407523|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10268|NCT01407354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10269|NCT01407276|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
10270|NCT01407068|Principal Investigators are NOT employed by the organization sponsoring the study.|
10271|NCT01406990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10272|NCT01406938|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
10273|NCT01406873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10274|NCT01406860|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10275|NCT01406795|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10276|NCT01406574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10277|NCT01406223|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10278|NCT01406015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10279|NCT01405950|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
10280|NCT01405937|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
10281|NCT01405924|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
10282|NCT01405898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10283|NCT01405820|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
10284|NCT01405794|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10285|NCT01405768|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10286|NCT01405742|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10287|NCT01405560|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
10288|NCT01405508|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10289|NCT01405469|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10290|NCT01405456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10291|NCT01405313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10292|NCT01405196|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10293|NCT01405027|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10294|NCT01404988|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10295|NCT01404936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10296|NCT01404923|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10297|NCT01404832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10298|NCT01404650|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
10299|NCT01404611|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor does not object to publication by Institution of the results of the Trial based on information collected or generated by Institution, whether or not the results are favorable to the Sponsor Drug. However, to ensure against inadvertent disclosure of Confidential Information or unprotected Inventions, Institution will provide Sponsor an opportunity to review any proposed publication or other type of disclosure before it is submitted or otherwise disclosed.
10300|NCT01404572|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10301|NCT01404559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10302|NCT01404429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10303|NCT01404260|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10304|NCT01404234|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
10305|NCT01404208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10306|NCT01404078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10307|NCT01404039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10308|NCT01403987|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10309|NCT01403805|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10310|NCT01403441|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10311|NCT01403376|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the Investigator can present or publish results. The Investigator provides the Sponsor with a copy of the presentation or publication for review and comment at least 30 days in advance of its submission.~The Sponsor can delay the submission for a period not exceeding 90 days to allow for filing a patent application or such other measures as the Sponsor deems appropriate to establish and preserve its proprietary rights."
10312|NCT01403194|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10313|NCT01403090|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10314|NCT01403051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10315|NCT01402986|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
10316|NCT01402947|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10317|NCT01402869|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10318|NCT01402817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10319|NCT01402700|Principal Investigators are NOT employed by the organization sponsoring the study.|"There is an agreement between the Principal Investigator and Sponsor [or its agents] that restricts PI's rights to discuss or publish trial results without permission of the Sponsor.~Trial is still ongoing."
10320|NCT01402570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10321|NCT01402427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10322|NCT01402375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10323|NCT01402284|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10324|NCT01402141|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10325|NCT01402128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10326|NCT01402115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10327|NCT01402102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10328|NCT01402063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10329|NCT01401959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10330|NCT01401907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10331|NCT01401842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10332|NCT01401647|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10333|NCT01401595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10334|NCT01401582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10335|NCT01401517|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10336|NCT01401478|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10337|NCT01401465|Principal Investigators are NOT employed by the organization sponsoring the study.|
10377|NCT01399047|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10338|NCT01401452|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10339|NCT01401361|Principal Investigators are NOT employed by the organization sponsoring the study.|
10340|NCT01401322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10341|NCT01401283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10342|NCT01401257|Principal Investigators are NOT employed by the organization sponsoring the study.|"No individual publication (paper, abstract, poster, oral presentation) is allowed until results of the complete study have been published.~The Investigator agrees that any proposed publication, presentation or use of results arising from the Investigation will be submitted to Pharnext for review and written agreement prior to submission."
10343|NCT01401166|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10344|NCT01401153|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10345|NCT01401101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10346|NCT01401062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10347|NCT01401049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10348|NCT01401023|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10349|NCT01401010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10350|NCT01400958|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10351|NCT01400932|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10352|NCT01400919|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results without permission of the sponsor.~Trial is still ongoing"
10353|NCT01400906|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10354|NCT01400893|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10355|NCT01400880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10356|NCT01400841|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication by the investigator was not allowed until completion of the trial. All proposed publications must be cleared by unanimous vote of a publication committee consisting of the sponsor and representatives of the study investigators. Publication materials must be submitted for review at least 60 day in advance of publication. The Sponsor may embargo publication for 60 additional days to allow for patent filing or may prevent publication if filling of such application would be premature.
10357|NCT01400698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10358|NCT01400516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10359|NCT01400503|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
10360|NCT01400451|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10361|NCT01400425|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10362|NCT01400412|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
10363|NCT01400243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10364|NCT01400139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10365|NCT01400113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10366|NCT01399866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10367|NCT01399788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10368|NCT01399723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10369|NCT01399697|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10370|NCT01399619|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
10371|NCT01399593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10372|NCT01399268|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10373|NCT01399229|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs may publish or present results of the study after the expiration of 12 months from completion. Publications or presentations are subject to the protection of confidential information or patentable information.
10374|NCT01399190|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10375|NCT01399125|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
10376|NCT01399099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10378|NCT01399008|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires the prior written consent of the Sponsor. The Principal Investigator must provide the Sponsor the opportunity to review any proposed abstracts, manuscripts or presentations that relate to any research or clinical results at least 30 days prior to its intended submission for publication.
10379|NCT01398982|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10380|NCT01398956|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10381|NCT01398943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10382|NCT01398852|Principal Investigators are NOT employed by the organization sponsoring the study.|All such Confidential Information shall remain the property of Topcon, as applicable, and Institution agrees that neither it nor Principal Investigator nor any of its employees or Sub-Investigators, if any, shall disclose any of the Confidential Information to third parties, without the prior written consent of Topcon.
10383|NCT01398839|All Principal Investigators ARE employed by the organization sponsoring the study.|All such Confidential Information shall remain the property of Topcon, as applicable, and Institution agrees that neither it nor Principal Investigator nor any of its employees or Sub-Investigators, if any, shall disclose any of the Confidential Information to third parties, without the prior written consent of Topcon.
10384|NCT01398787|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
10385|NCT01398514|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor shall require the PI to furnish the sponsor with a copy of any proposed publication at least 60 days prior to submission. The sponsor shall be entitled to review such proposed publications. The PI shall give due regard to the sponsor's comments on the proposed publication. If the sponsor reasonably believes a patent application claiming an invention should be filed prior to such publication, such submission shall not be submitted until applicable patent applications have been filed.
10386|NCT01398475|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10387|NCT01398410|Principal Investigators are NOT employed by the organization sponsoring the study.|
10388|NCT01398358|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10389|NCT01398176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10390|NCT01397890|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI Disclosure Restriction is indicated in the Clinical Study Agreement, please refer to this document of each PI and country.
10391|NCT01397851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10392|NCT01397825|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
10393|NCT01397786|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10394|NCT01397747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10395|NCT01397617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10396|NCT01397591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10397|NCT01397461|Principal Investigators are NOT employed by the organization sponsoring the study.|Any and all data resulting from the Study will not be presented or published in any form or media by the Institution, Investigator or Research Staff without the prior written consent of Sponsor which consent maybe as directed within the Protocol.
10398|NCT01397448|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.
10399|NCT01397422|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10400|NCT01397409|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10401|NCT01397253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10402|NCT01397084|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AZ approval before this study was completed.
10403|NCT01396525|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10404|NCT01396512|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
10405|NCT01396447|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc.
10406|NCT01396434|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10407|NCT01396421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10408|NCT01396395|Principal Investigators are NOT employed by the organization sponsoring the study.|
10409|NCT01396382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10410|NCT01396317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10411|NCT01396265|All Principal Investigators ARE employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10412|NCT01396239|Principal Investigators are NOT employed by the organization sponsoring the study.|The Non Disclosure Agreement provides that the PI, Dr. Jerry Mendell, cannot disclose any “results of the discussions or evaluation” without our consent, and that the “proprietary information shall not be evaluated by any laboratory or clinical testing or experimentation conducted” without our consent.
10413|NCT01396226|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10414|NCT01396187|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10415|NCT01396161|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10416|NCT01396148|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10417|NCT01396083|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
10418|NCT01396070|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10419|NCT01396057|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
10420|NCT01396044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10421|NCT01396005|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc) that report any results of the trial.
10422|NCT01395966|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor does not object to publication by Institution of the results of the Trial based on information collected or generated by Institution, whether or not the results are favorable to the Sponsor Drug. However, to ensure against inadvertent disclosure of Confidential Information or unprotected Inventions, Institution will provide Sponsor an opportunity to review any proposed publication or other type of disclosure before it is submitted or otherwise disclosed.
10423|NCT01395914|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor intends to publish the complete study results in a timely manner that is appropriate to the project. Separate publication of a portion of the study results by any PI is discouraged.
10424|NCT01395901|Principal Investigators are NOT employed by the organization sponsoring the study.|If Sponsor does not submit a publication regarding the study to a journal within 12 months from study data analysis completion, the Investigator may publish an analysis of the study data collected as a result of the conduct of the study by the Investigator. The Investigator shall ensure that at least 60 days prior to submitting/presenting a manuscript/material relating to study to publishers a copy of all manuscripts/materials is provided to the Sponsor to allow the Sponsor sixty days to review.
10425|NCT01395888|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10426|NCT01395823|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees that the first publication and presentation shall be made by sponsor. If publication is not made within 24 months PI may publish their site data provided that sponsor receives 30 days to review.
10427|NCT01395810|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
10428|NCT01395797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10429|NCT01395784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10430|NCT01395758|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10431|NCT01395524|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10432|NCT01395394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10433|NCT01395368|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10434|NCT01395277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10435|NCT01395043|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10436|NCT01395017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10437|NCT01394991|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10438|NCT01394978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10439|NCT01394926|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10440|NCT01394718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10441|NCT01394692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10442|NCT01394627|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10443|NCT01394614|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10444|NCT01394523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10445|NCT01394510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10446|NCT01394276|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
10447|NCT01394250|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10448|NCT01394185|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10449|NCT01394159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10450|NCT01394081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10451|NCT01393964|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10452|NCT01393899|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10453|NCT01393743|Principal Investigators are NOT employed by the organization sponsoring the study.|
10454|NCT01393730|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10455|NCT01393717|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10456|NCT01393704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10457|NCT01393626|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The PI must remove any previously undisclosed Confidential Information (other than the Study results themselves) before public release.
10458|NCT01393613|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10459|NCT01393600|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the PI has the right to publish results provided such publication does not violate confidentiality or IP provisions within the contract with the Sponsor. Prior to submission for publication or presentation of results, the PI must provide the Sponsor time for review. The Sponsor can request the PI to withhold or remove information from all publications. For a multi-center study, any publication of results by the PI shall not be made before the first multi-center publication.
10460|NCT01393457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10461|NCT01393444|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10462|NCT01393405|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10463|NCT01393132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10464|NCT01393106|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
10465|NCT01392742|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
10466|NCT01392703|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10467|NCT01392677|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
10468|NCT01392625|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10469|NCT01392573|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
10470|NCT01392560|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10471|NCT01392547|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Novo Nordisk reserves the right to prior review of such publications and to ask for delay of publication of individual site results until after the primary manuscript is accepted for publication.
10472|NCT01392495|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10473|NCT01392378|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10474|NCT01392326|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
10475|NCT01392300|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study information usually requires agreement with the sponsor. In case of justified doubts by the sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
10476|NCT01392170|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10477|NCT01392053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10478|NCT01391858|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10479|NCT01391819|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10480|NCT01391663|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
10481|NCT01391611|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10482|NCT01391559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10483|NCT01391546|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators must first obtain written consent from Sponsor. If consent is given, all abstracts manuscripts, texts, or presentation, etc. will be sent to Sponsor for review and approval prior to their publication or presentation. Sponsor shall have sixty days to review these documents and may refuse to give its consent in part or whole for confidential reasons (including but not limited to intellectual property rights, whether patentable or not).
10484|NCT01391507|Principal Investigators are NOT employed by the organization sponsoring the study.|If Sponsor should have justified objections, then Hospital will respond to these objections as the scientific nature of publication are not negatively affected. If no agreement can be reached, they will appeal to an independent body of experts to resolve the points in dispute. It is not permissible to publish study data before overall study results are published without the written consent of Sponsor. However, this applies to a maximum period of 12 months after study has ended or been cancelled.
10485|NCT01391468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10486|NCT01391325|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall submit a copy of the Publication to Sponsor for review at least 45 days prior to its proposed submission. Sponsor reserves the right to delay any such publication for an additional period of 60 days. Upon Sponsor’s request, PI agrees to delete from the proposed publication any Confidential Information. PI agrees not to release any publication without the prior written permission of Sponsor.
10487|NCT01391312|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10488|NCT01391299|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10489|NCT01391286|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10490|NCT01391273|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10491|NCT01391013|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10492|NCT01391000|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10493|NCT01390948|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10494|NCT01390909|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10495|NCT01390870|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10496|NCT01390857|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10497|NCT01390844|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
10498|NCT01390818|Principal Investigators are NOT employed by the organization sponsoring the study.|
10499|NCT01390779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10500|NCT01390649|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
10501|NCT01390441|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/ presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
10502|NCT01390428|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
10503|NCT01390415|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10504|NCT01390402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10505|NCT01390389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10506|NCT01390259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10507|NCT01390246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10508|NCT01390233|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10509|NCT01390181|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10510|NCT01390038|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs are restricted from publishing study results until either 18 months after the study is completed or the primary manuscript has been accepted, whichever comes first.
10511|NCT01389973|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10512|NCT01389882|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10513|NCT01389856|Principal Investigators are NOT employed by the organization sponsoring the study.|
10514|NCT01389817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10515|NCT01389596|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results
10516|NCT01389323|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10517|NCT01389284|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10518|NCT01389102|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall not publish, or seek to publish, either in whole or in part, any results of the Clinical Investigation without the written consent of the Sponsor.
10519|NCT01389076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10520|NCT01388946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10521|NCT01388920|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10522|NCT01388907|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10523|NCT01388816|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10524|NCT01388790|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10525|NCT01388647|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10526|NCT01388530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10527|NCT01388491|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator/Institution must submit proposed publication to Sponsor for review within a prespecified number of days before submission for publication. If Sponsor's review shows that potentially patentable subject matter would be disclosed, publication/public disclosure shall be delayed to enable Sponsor, or Sponsor’s designees, to file necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
10528|NCT01388361|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
10529|NCT01388166|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
10530|NCT01387789|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10531|NCT01387737|Principal Investigators are NOT employed by the organization sponsoring the study.|
10532|NCT01387672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10533|NCT01387594|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10534|NCT01387581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10535|NCT01387542|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to publication and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The paper that incorporates confidential information requires Sponsor’s written consent. PI will withhold publication for up to an additional 60 days to allow for filing of a patent application.
10536|NCT01387464|Principal Investigators are NOT employed by the organization sponsoring the study.|
10537|NCT01387347|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10538|NCT01387282|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor intends to publish the complete study results in a timely manner that is appropriate to the project. Separate publication of a portion of the study results by any PI is discouraged.
10539|NCT01387269|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor intends to publish the complete study results in a timely manner that is appropriate to the project. Separate publication of a portion of the study results by any PI is discouraged.
10540|NCT01387230|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10541|NCT01387178|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10542|NCT01387139|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10543|NCT01387074|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10544|NCT01387022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10545|NCT01386983|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10546|NCT01386944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10547|NCT01386788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10548|NCT01386684|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10549|NCT01386632|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10550|NCT01386606|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights.
10551|NCT01386554|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution/Investigator shall not, without Sponsor's prior written consent, independently publish or otherwise disclose any results of the study until a Multi-Center Publication is published. If a Multi-Center Publication is not submitted for publication within the specified timeframe, Institution and Principal Investigator shall have the right to publish and present the results of Institution's and Principal Investigator's activities solely in accordance with the Sponsor's written provisions.
10552|NCT01386528|Principal Investigators are NOT employed by the organization sponsoring the study.|“At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property”
10553|NCT01386125|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
10554|NCT01386008|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigators are not permitted to publish or make public any of the results without prior written approval from the Sponsor.
10555|NCT01385995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10556|NCT01385748|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10557|NCT01385696|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
10558|NCT01385644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10559|NCT01385579|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10560|NCT01385566|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication or presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
10561|NCT01385371|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the SPONSOR 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
10562|NCT01385293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10563|NCT01385202|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI’s rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
10564|NCT01385189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10565|NCT01385137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10566|NCT01385098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10567|NCT01385033|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
10568|NCT01384760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10569|NCT01384591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10570|NCT01384539|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10571|NCT01384292|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10572|NCT01384019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10573|NCT01383993|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10574|NCT01383954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10575|NCT01383928|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
10576|NCT01383720|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to the Sponsor for review at least 45 days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
10577|NCT01383707|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10578|NCT01383681|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
10579|NCT01383616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10580|NCT01383499|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10581|NCT01383486|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10582|NCT01383447|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10583|NCT01383421|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10584|NCT01383356|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10585|NCT01383317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10586|NCT01383213|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10587|NCT01383200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10588|NCT01383174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10589|NCT01383161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10590|NCT01383096|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10591|NCT01383005|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
10592|NCT01382940|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10593|NCT01382901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10594|NCT01382719|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10595|NCT01382602|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10596|NCT01382446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10597|NCT01382303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10598|NCT01382251|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10599|NCT01382225|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
10600|NCT01382212|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10601|NCT01382186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10602|NCT01382108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10603|NCT01381952|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10604|NCT01381926|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10605|NCT01381900|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10606|NCT01381679|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10607|NCT01381575|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10608|NCT01381562|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10609|NCT01381549|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10610|NCT01381471|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10611|NCT01381406|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10612|NCT01381120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10613|NCT01381016|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10614|NCT01380834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10654|NCT01377467|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10615|NCT01380782|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10616|NCT01380769|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator interested in participating in writing the manuscript should contact the Sponsor. The Investigsator shall not make any Study-related publication or other disclosure without the Sponsor's prior written approval, which may be withheld or granted by the Sponsor, in its sole discretion.
10617|NCT01380730|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10618|NCT01380639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10619|NCT01380379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10620|NCT01380366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10621|NCT01380327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10622|NCT01380197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10623|NCT01380145|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10624|NCT01380093|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10625|NCT01380080|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
10626|NCT01379963|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigators is free to publish in reputed journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10627|NCT01379937|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10628|NCT01379781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10629|NCT01379768|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
10630|NCT01379703|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
10631|NCT01379664|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10632|NCT01379651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10633|NCT01379625|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10634|NCT01379534|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10635|NCT01379521|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10636|NCT01379183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10637|NCT01378988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10638|NCT01378975|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10639|NCT01378962|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10640|NCT01378520|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10641|NCT01378429|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
10642|NCT01378416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10643|NCT01378325|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10644|NCT01378221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10645|NCT01378195|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10646|NCT01378117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10647|NCT01378104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10648|NCT01378065|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10649|NCT01377922|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10650|NCT01377636|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10651|NCT01377623|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10652|NCT01377584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10653|NCT01377480|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts with regard to proprietary information, accuracy, and fair-balance and compliance.
10655|NCT01377441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10656|NCT01377402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10657|NCT01377233|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10658|NCT01377194|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the PI will be patient to mutual agreement between the PI and Forest Research Institute, Inc."
10659|NCT01377012|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10660|NCT01376908|Principal Investigators are NOT employed by the organization sponsoring the study.|
10661|NCT01376804|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10662|NCT01376700|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements may vary with individual PIs, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or up to 2 years after study completion. Baxter requires a review of results communications (eg for confidential information) ≥30 days prior to submission/communication. Baxter may request additional delay of ≤6 months (e.g., for intellectual property protection). Prior authorization may be required
10663|NCT01376557|Principal Investigators are NOT employed by the organization sponsoring the study.|Institutions cannot publish any data generated from the clinical trial until Sponsor publishes such data or until 18 months have elapsed since completion of the clinical trial. Proposed publication must be provided to Sponsor at least 60 days prior to submission for publication and Sponsor has 30 days from receipt to review. Sponsor can delete any info to which it objects, Confidential Information, proprietary information or patentable subject matter from the final version of the publication.
10664|NCT01376388|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10665|NCT01376362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10666|NCT01376349|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10667|NCT01376323|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10668|NCT01376297|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor and investigator(s) agree that no publications discussing trials' results will occur until release of final report. Sponsor has no objections if the investigators publish study results, however the investigator is requested to contact the sponsor before publishing, to prevent premature disclosure of data and is not intended as a restrictive measure concerning results or opinions of investigators.
10669|NCT01376245|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10670|NCT01376167|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10671|NCT01376089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10672|NCT01376050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10673|NCT01376037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10674|NCT01375946|Principal Investigators are NOT employed by the organization sponsoring the study.|Approval by Agile Therapeutics, Inc. of any publication, including oral presentations and abstracts, utilizing data or any information from the ATI-CL16 study is required prior to publication submission.
10675|NCT01375777|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10676|NCT01375764|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10677|NCT01375751|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10678|NCT01375660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10679|NCT01375608|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10680|NCT01375569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10681|NCT01375374|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10682|NCT01375127|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10683|NCT01375049|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
10684|NCT01374971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10685|NCT01374919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10686|NCT01374906|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
10687|NCT01374802|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
10688|NCT01374568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10689|NCT01374451|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
10690|NCT01374438|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10750|NCT01369888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10691|NCT01374425|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10692|NCT01374269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10693|NCT01374178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10694|NCT01374087|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor required reasonable opportunity to review any summary, presentation, or paper before the material was submitted for publication or communicated. This also applied to any amendments that were requested by evaluators or journal directors. The Sponsor committed to comment on the draft documents within a time period agreed in the contractual provisions between the Sponsor and authors or their institutions. Delays were also possible if publication would adversely affect patentability.
10695|NCT01373918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10696|NCT01373671|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10697|NCT01373580|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agreed to hold this information in confidence and not to disclose it to any third parties for a period of three years from the date of this agreement, or until this information becomes a matter of public knowledge or until a formal agreement for that purpose has been entered into by the parties.
10698|NCT01373450|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
10699|NCT01373346|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10700|NCT01373294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10701|NCT01373281|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
10702|NCT01373229|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10703|NCT01373164|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10704|NCT01372995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10705|NCT01372878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10706|NCT01372813|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10707|NCT01372748|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10708|NCT01372618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10709|NCT01372605|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10710|NCT01372501|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10711|NCT01372462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10712|NCT01372410|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10713|NCT01372384|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10714|NCT01372202|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10715|NCT01372150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10716|NCT01371994|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data, or 18 months after data lock, whichever occurs first. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication for up to 60 days to seek patent protection.
10717|NCT01371877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10718|NCT01371851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10719|NCT01371838|Principal Investigators are NOT employed by the organization sponsoring the study.|
10720|NCT01371825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10721|NCT01371786|Principal Investigators are NOT employed by the organization sponsoring the study.|
10722|NCT01371747|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements generally provide that PI cannot publish single site data before publication of the multi-site publication, unless 1 year has elapsed since completion of the study at all sites. Thereafter, PI may publish provided that PI shall: provide a copy of the publication to sponsor at least 60 days in advance of submission for publication; delete sponsor’s confidential information as requested; and delay publication up to an additional 90 days to permit protection of intellectual property.
10723|NCT01371734|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10724|NCT01371721|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The PI must remove any previously undisclosed Confidential Information (other than the Study results themselves) before public release.
10725|NCT01371708|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10726|NCT01371643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10727|NCT01371565|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10728|NCT01371552|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
10729|NCT01371539|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
10730|NCT01371110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10751|NCT01369875|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10731|NCT01371006|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
10732|NCT01370863|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10733|NCT01370837|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10734|NCT01370733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10735|NCT01370694|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
10736|NCT01370655|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
10737|NCT01370642|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
10738|NCT01370616|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
10739|NCT01370603|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
10740|NCT01370590|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
10741|NCT01370538|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10742|NCT01370525|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10743|NCT01370460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10744|NCT01370408|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10745|NCT01370369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is a restriction on joint publications prepared in collaboration between investigator and sponsor as Ferring reserves the right to be involved in this decision. In the event of any disagreement in the content of any publication both investigator’s and Ferring´s opinion will be fairly and sufficiently represented in the publication.
10746|NCT01370356|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10747|NCT01370265|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10748|NCT01370083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10749|NCT01370005|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10752|NCT01369849|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10753|NCT01369784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10754|NCT01369758|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10755|NCT01369745|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10756|NCT01369732|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10757|NCT01369706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10758|NCT01369680|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10759|NCT01369641|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10760|NCT01369615|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10761|NCT01369485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10762|NCT01369355|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
10763|NCT01369342|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
10764|NCT01369329|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
10765|NCT01369225|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10766|NCT01369108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10767|NCT01369030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10768|NCT01368965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10769|NCT01368900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10770|NCT01368874|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10771|NCT01368835|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10772|NCT01368809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10773|NCT01368653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10774|NCT01368536|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10775|NCT01368432|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10776|NCT01368406|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10777|NCT01368276|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10778|NCT01368263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10779|NCT01368211|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10780|NCT01368185|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10781|NCT01368081|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10782|NCT01368042|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10783|NCT01367886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10784|NCT01367860|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10785|NCT01367834|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10786|NCT01367704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10787|NCT01367457|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10788|NCT01367249|Principal Investigators are NOT employed by the organization sponsoring the study.|
10789|NCT01367158|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
10790|NCT01367119|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10791|NCT01367080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10792|NCT01366976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10793|NCT01366885|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10794|NCT01366872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10795|NCT01366846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10796|NCT01366638|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
10797|NCT01366534|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10798|NCT01366521|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10799|NCT01366443|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10800|NCT01366417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10801|NCT01366209|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10802|NCT01366196|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10803|NCT01366092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10804|NCT01365910|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10805|NCT01365845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10806|NCT01365819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10807|NCT01365650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10808|NCT01365624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10809|NCT01365611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10810|NCT01365585|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10811|NCT01365546|Principal Investigators are NOT employed by the organization sponsoring the study.|Octapharma agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Octapharma supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. Octapharma also reserves the right to review data prior to publishing and provide comments/changes within a certain time period.
10812|NCT01365507|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
10813|NCT01365494|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial
10814|NCT01365481|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­ site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
11094|NCT01344161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10815|NCT01365468|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10816|NCT01365455|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
10817|NCT01365273|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor is the owner of the results.
10818|NCT01365130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10819|NCT01365091|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10820|NCT01365052|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10821|NCT01365039|Principal Investigators are NOT employed by the organization sponsoring the study.|
10822|NCT01364922|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
10823|NCT01364896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10824|NCT01364870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10825|NCT01364740|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10826|NCT01364727|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10827|NCT01364649|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
10828|NCT01364558|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10829|NCT01364428|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
10830|NCT01364389|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10831|NCT01364298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10832|NCT01364259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10833|NCT01364207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10834|NCT01364090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11172|NCT01338857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10835|NCT01363986|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10836|NCT01363908|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10837|NCT01363843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10838|NCT01363765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10839|NCT01363713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10840|NCT01363700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10841|NCT01363661|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10842|NCT01363492|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire's agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial's multi-center publication
10843|NCT01363479|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor and investigator(s) agree that no publications discussing trials' results will occur until release of final report. Sponsor has no objections if the investigators publish study results, however the investigator is requested to contact the sponsor before publishing, to prevent premature disclosure of data and is not intended as a restrictive measure concerning results or opinions of investigators.
10844|NCT01363440|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission of any (M)anuscript, (I)nstitution shall, or cause PI to, provide (S)ponsor a copy of (M). (I) to consider comments submitted by (S), & to delete confidential information upon (S) request. At (S)'s request, (I) to delay publication for an additional 60 days to allow filing of patent applications. (I) & PI agree to delay publication, prior to (M) summarizing data from all sites, unless no (M) is published prior to first anniversary of final study report.
10845|NCT01363401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10846|NCT01363349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10847|NCT01363297|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The PI must remove any previously undisclosed Confidential Information (other than the Study results themselves) before public release.
10848|NCT01363076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10849|NCT01363050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10850|NCT01363011|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
10851|NCT01362946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10852|NCT01362907|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
11030|NCT01348854|Principal Investigators are NOT employed by the organization sponsoring the study.|All proposed submissions for publication or presentation of Trial data must be approved by the Sponsor prior to submission. Under no circumstances shall the Investigator(s) publish or disclose data without the Sponsor's written approval.
10853|NCT01362894|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
10854|NCT01362686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10855|NCT01362608|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
10856|NCT01362530|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
10857|NCT01362517|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator to submit all manuscripts/abstracts to the sponsor for review at least 60 days prior to any intended submission.
10858|NCT01362491|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10859|NCT01362439|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10860|NCT01362348|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10861|NCT01362296|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10862|NCT01362244|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10863|NCT01362205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10864|NCT01362192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10865|NCT01362140|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
10866|NCT01362062|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10867|NCT01362049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10868|NCT01361867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10869|NCT01361854|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10870|NCT01361633|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10871|NCT01361620|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10968|NCT01353586|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
10872|NCT01361607|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10873|NCT01361594|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10874|NCT01361568|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10875|NCT01361464|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10876|NCT01361308|Principal Investigators are NOT employed by the organization sponsoring the study.|
10877|NCT01361178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10878|NCT01361126|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
10879|NCT01361113|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10880|NCT01361048|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10881|NCT01361009|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
10882|NCT01360996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10883|NCT01360840|Principal Investigators are NOT employed by the organization sponsoring the study.|
10884|NCT01360645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10885|NCT01360632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10886|NCT01360554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10887|NCT01360450|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10888|NCT01360021|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than less than or equal to 180 days from the date of AZ's request to allow for the filing of a patent app or the taking of such measures as AZ deems appropriate to establish and preserve its proprietary rights in teh material being submitted.
10889|NCT01359943|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10890|NCT01359904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10891|NCT01359748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10892|NCT01359735|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11090|NCT01344538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10893|NCT01359644|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10894|NCT01359449|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
10895|NCT01359410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10896|NCT01359371|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10897|NCT01359254|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10898|NCT01359150|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10899|NCT01359111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10900|NCT01359007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10901|NCT01358877|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
10902|NCT01358864|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
10903|NCT01358825|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10904|NCT01358760|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators shall provide to the SPONSOR 30 days prior to submission all documents for publication, presentation, etc that report any trial results. The SPONSOR shall have editorial rights on documents and the right to review/comment with regard to (1) proprietary information, (2) accuracy of the information, (3) correctness of the scientific evaluation/conclusions and (4) to ensure that the information is fairly balanced and in compliance with regulations.
10905|NCT01358734|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications
10906|NCT01358708|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication after a multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
10907|NCT01358578|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10908|NCT01358526|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10969|NCT01353508|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
10909|NCT01358357|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
10910|NCT01358175|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
10911|NCT01357980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10912|NCT01357915|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10913|NCT01357889|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10914|NCT01357850|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
10915|NCT01357720|Principal Investigators are NOT employed by the organization sponsoring the study.|Any material for public dissemination will be submitted to the Sponsor for review at least ninety (90) days prior to submission for publication, public dissemination, or review by a publication committee
10916|NCT01357655|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10917|NCT01357616|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
10918|NCT01357551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10919|NCT01357512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10920|NCT01357239|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
10921|NCT01357161|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
10922|NCT01357148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10923|NCT01357135|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators cannot disclose any results without sponsor’s agreement, only on request of French Health Authorities as per French law.
10924|NCT01356966|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10925|NCT01356940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10926|NCT01356667|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10927|NCT01356628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10928|NCT01356602|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
11091|NCT01344460|Principal Investigators are NOT employed by the organization sponsoring the study.|
10929|NCT01356589|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10930|NCT01356498|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10931|NCT01356407|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10932|NCT01356147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10933|NCT01355978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10934|NCT01355705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10935|NCT01355679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10936|NCT01355627|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
10937|NCT01355588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10938|NCT01355523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10939|NCT01355484|Principal Investigators are NOT employed by the organization sponsoring the study.|"Provide Sponsor with an advance copy of any proposed results communication at least 60 days prior to the date of the planned submission or presentation and Sponsor shall have 60 days from receipt to request any changes. Sponsor may request a delay of up to 60 additional days.~The PI shall not present data until the earlier of Sponsor’s publication of the results of all investigators participating in the Study or 18 months after completion of the Study at all participating sites."
10940|NCT01355471|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10941|NCT01355458|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10942|NCT01355419|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10943|NCT01355302|Principal Investigators are NOT employed by the organization sponsoring the study.|
10944|NCT01355289|Principal Investigators are NOT employed by the organization sponsoring the study.|
10945|NCT01355224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10946|NCT01355081|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
10947|NCT01355068|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10948|NCT01354990|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11092|NCT01344447|Principal Investigators are NOT employed by the organization sponsoring the study.|
10949|NCT01354938|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
10950|NCT01354899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10951|NCT01354652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10952|NCT01354444|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10953|NCT01354431|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
10954|NCT01354314|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10955|NCT01354223|Principal Investigators are NOT employed by the organization sponsoring the study.|Release of this data (through presentation, publication or other written or oral communication) to other than listed personnel (listed in protocol) requires the prior written permission from the study Sponsor. Study investigators and all office personnel are prohibited from acknowledging participation in the study to individuals and organizations except those listed.
10956|NCT01354197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10957|NCT01354145|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10958|NCT01354132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10959|NCT01354106|Principal Investigators are NOT employed by the organization sponsoring the study.|The proposed disclosure must be reviewed by the sponsor. The sponsor shall complete the review within 30 working days after receipt. The PI will discuss and consider in good faith the sponsor recommendations resulting from the review.
10960|NCT01354028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10961|NCT01354015|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10962|NCT01353976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10963|NCT01353963|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10964|NCT01353911|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
10965|NCT01353898|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
10966|NCT01353859|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10967|NCT01353664|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigator and the Sponsor that restricts the PIs rights to publish trial results after the trial is completed. Upon investigator submission of a publication to Celgene, Celgene will complete its review within 60 days after receipt of the publication. Upon Celgene's request, the publication shall be delayed up to 90 additional days to enable Celgene to secure intellectual property protection that would be affected by such proposed publication.
10970|NCT01353274|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
10971|NCT01353222|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentation relating to the Study will be coordinated by Dendreon in communication with institutions contributing patients to the Study.
10972|NCT01353144|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10973|NCT01353079|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10974|NCT01352845|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10975|NCT01352793|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10976|NCT01352741|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
10977|NCT01352715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10978|NCT01352585|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
10979|NCT01352546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10980|NCT01352507|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10981|NCT01352468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10982|NCT01352442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10983|NCT01352416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10984|NCT01352221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10985|NCT01352117|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
10986|NCT01351623|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10987|NCT01351506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10988|NCT01351480|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11010|NCT01350141|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
10989|NCT01351415|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
10990|NCT01351337|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10991|NCT01351090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10992|NCT01351077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10993|NCT01351064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10994|NCT01351025|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
10995|NCT01350999|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
10996|NCT01350973|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
10997|NCT01350947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
10998|NCT01350934|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
10999|NCT01350804|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11000|NCT01350583|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11001|NCT01350544|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11002|NCT01350479|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11003|NCT01350414|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11004|NCT01350401|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11005|NCT01350388|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11006|NCT01350271|Principal Investigators are NOT employed by the organization sponsoring the study.|Release after two years after completing trial
11007|NCT01350258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11008|NCT01350245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11009|NCT01350232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11093|NCT01344369|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
11011|NCT01350128|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
11012|NCT01350115|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11013|NCT01350102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11014|NCT01349972|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11015|NCT01349959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11016|NCT01349933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11017|NCT01349920|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, and on the presentation with regard to the following: proprietary information; the accuracy of the information; and that the presentation is fairly balanced and in compliance with FDA regulations.
11018|NCT01349907|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication or manuscript shall contain any trade secret information of the sponsor or any proprietary or confidential information of the sponsor, and shall be confined to new discoveries and interpretations of scientific fact.
11019|NCT01349829|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11020|NCT01349816|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
11021|NCT01349803|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
11022|NCT01349790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11023|NCT01349660|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
11024|NCT01349595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11025|NCT01349491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11026|NCT01349465|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
11027|NCT01349231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11028|NCT01349192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11029|NCT01349114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11031|NCT01348789|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11032|NCT01348776|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11033|NCT01348607|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11034|NCT01348425|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11035|NCT01348165|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11036|NCT01348139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11037|NCT01348100|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
11038|NCT01348087|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
11039|NCT01347931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11040|NCT01347879|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11041|NCT01347840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11042|NCT01347788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11043|NCT01347710|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11044|NCT01347632|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11045|NCT01347580|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11046|NCT01347554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11047|NCT01347255|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
11048|NCT01347112|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11049|NCT01347086|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11050|NCT01347073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11051|NCT01347060|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11052|NCT01347034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11053|NCT01347008|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11054|NCT01346852|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11055|NCT01346839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11056|NCT01346774|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11057|NCT01346592|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11058|NCT01346514|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11059|NCT01346501|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11060|NCT01346488|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11061|NCT01346475|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review and comment on any proposed publication, and all Study results and data reasonably necessary for a meaningful review of the proposed publication are submitted to the sponsor for a period of at least thirty (30) days prior to submitting the publication to any third party.
11062|NCT01346410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11063|NCT01346397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11064|NCT01346293|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
11065|NCT01346189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11066|NCT01346176|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11067|NCT01346085|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11068|NCT01346072|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11069|NCT01346059|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11070|NCT01345929|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator(s) must undertake not to submit any part of the data from this protocol for publication without the prior consent of Cubist Pharmaceuticals, Inc.
11071|NCT01345786|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must provide sponsor w/ review copies of abstracts or manuscripts for publication that report any results of the study, 45 days before submission for publication or presentation. The sponsor shall have the right to review/comment on the material. If the parties disagree about the appropriateness of the material, PI must meet with sponsor's representatives before submission for publication, for the purpose of making good faith efforts to discuss and resolve any issues of disagreement.
11072|NCT01345721|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11073|NCT01345682|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11074|NCT01345669|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11075|NCT01345630|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11076|NCT01345591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11077|NCT01345318|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11078|NCT01345292|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
11079|NCT01345253|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11080|NCT01345240|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11081|NCT01345162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11082|NCT01345123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11083|NCT01345058|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11084|NCT01345019|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
11085|NCT01344876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11086|NCT01344824|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11087|NCT01344759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11088|NCT01344629|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11089|NCT01344616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11095|NCT01344057|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
11096|NCT01343901|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
11097|NCT01343888|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11098|NCT01343823|Principal Investigators are NOT employed by the organization sponsoring the study.|Dyax agreements vary, but Dyax will not prohibit any investigator from publishing. Dyax reviews publications prior to public release and can request deferral by up to 60 days beyond the proposed publication date if necessary to preserve its intellectual property. Dyax can request changes to publications to remove non-study-related confidential information. Dyax can also request deferral of single-center publications until after disclosure of the clinical trial's primary publication.
11099|NCT01343667|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11100|NCT01343485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11101|NCT01343368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11102|NCT01343277|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
11103|NCT01343251|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11104|NCT01343095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11105|NCT01343082|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11106|NCT01343056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11107|NCT01343004|Principal Investigators are NOT employed by the organization sponsoring the study.|Results may not be published prior to the Study Report completion. Investigators may publish results, providing a manuscript to the Sponsor =/> 30 days prior to its submission to a publisher. Sponsor will provide manuscript to Investigators =/> 30 days prior to its submission. Investigator shall comply with Sponsor's policy, withholding publication for an additional 60 days to permit the Sponsor to obtain patent or other proprietary rights protection, if deemed necessary.
11108|NCT01342965|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11109|NCT01342926|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11110|NCT01342913|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11111|NCT01342887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11112|NCT01342770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11215|NCT01335750|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11113|NCT01342757|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11114|NCT01342666|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11115|NCT01342640|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11116|NCT01342549|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11117|NCT01342523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11118|NCT01342510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11119|NCT01342484|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11120|NCT01342471|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11121|NCT01342458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11122|NCT01342445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11123|NCT01342341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11124|NCT01342211|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11125|NCT01342172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11126|NCT01342107|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
11127|NCT01342094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11128|NCT01342081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11129|NCT01342029|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11130|NCT01341990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11131|NCT01341977|Principal Investigators are NOT employed by the organization sponsoring the study.|All data and discoveries arising out of the Study shall be the sole property of Alcon or its designated affiliate. Alcon reserves the right of prior review of any publication or presentation of the information related to the Study.
11132|NCT01341912|Principal Investigators are NOT employed by the organization sponsoring the study.|Octapharma agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Octapharma supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. Octapharma also reserves the right to review data prior to publishing and provide comments/changes within a certain time period
11152|NCT01340066|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11133|NCT01341782|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11134|NCT01341600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11135|NCT01341587|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11136|NCT01341444|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11137|NCT01341301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11138|NCT01341067|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11139|NCT01340937|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
11140|NCT01340794|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11141|NCT01340768|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall not publish any article or paper nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations, relating or referring to the following: (a) the study or any results, data or insight there from; (b) the services performed; or (c) any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of the sponsor.
11142|NCT01340664|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. Expedited reviews will be arranged for abstracts, poster presentations, or other materials. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
11143|NCT01340651|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least thirty (30) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
11144|NCT01340625|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
11145|NCT01340586|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
11146|NCT01340573|Principal Investigators are NOT employed by the organization sponsoring the study.|
11147|NCT01340495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11148|NCT01340300|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11149|NCT01340209|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11150|NCT01340196|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11151|NCT01340144|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11216|NCT01335724|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
11153|NCT01340027|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 90 days prior to publication for review and comment.
11154|NCT01340014|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11155|NCT01339936|Principal Investigators are NOT employed by the organization sponsoring the study.|"Publication policy~The investigation data is wholly owned by the Sponsor. The results of the investigation may not be used in publications or presentations without the written permission of the Sponsor."
11156|NCT01339923|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
11157|NCT01339910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11158|NCT01339897|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees with the use of results of the clinical study for the purposes of national and international registration, publication, and information for medical and pharmaceutical professionals. If necessary, the competent authorities will be notified of the investigator’s name, address, qualifications, and extent of involvement. An investigator shall not publish any data (poster, abstract, paper, etc.) without having consulted with the Sponsor in advance.
11159|NCT01339832|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
11160|NCT01339429|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11161|NCT01339416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11162|NCT01339403|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11163|NCT01339390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11164|NCT01339299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11165|NCT01339260|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor and investigator(s) agree that no publications discussing trials' results will occur until release of final report. Sponsor has no objections if the investigators publish study results, however the investigator is requested to contact the sponsor before publishing, to prevent premature disclosure of data and is not intended as a restrictive measure concerning results or opinions of investigators.
11166|NCT01339247|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11167|NCT01339091|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI will provide Durata an opportunity to review any proposed publication or other type of disclosure at least 30 days before they are submitted. If any patent action is required to protect intellectual property rights, the Investigator agrees to delay the disclosure for a period not to exceed an additional 60 days. If the study is part of a multi-center study, the Investigator agrees that the first publication is to be a joint publication covering all centers.
11168|NCT01339052|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11169|NCT01339013|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11170|NCT01339000|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11171|NCT01338870|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11173|NCT01338818|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
11174|NCT01338792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11175|NCT01338649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11176|NCT01338636|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11177|NCT01338610|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11178|NCT01338493|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidential Information shall not be disclosed and shall be property of sponsor during the term of the agreement and for 3 years after agreement termination. Results might be published or presented, however sponsor should receive publication for review at least 90 days prior to submittal. Sponsor shall limit its review to a determination of whether Confidential Information is disclosed, to allow sponsor to protect its rights in copyrightable material, and to check for technical correctness.
11179|NCT01338415|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related article or abstract written independently by investigators must be submitted to Actelion for review at least 60 days prior to submission for publication or presentation.
11180|NCT01338298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11181|NCT01338025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11182|NCT01338012|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study will be published and/or presented in an integrated manner reflecting the results observed across all participating center. Accordingly, decisions on timing and content of publications and presentations relating to the Study will be coordinated by Dendreon in communication with institutions contributing patients to the Study.
11183|NCT01337960|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11184|NCT01337739|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11185|NCT01337674|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission
11186|NCT01337635|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11187|NCT01337609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11188|NCT01337336|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11189|NCT01337297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11190|NCT01337167|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/ presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
11191|NCT01337115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11192|NCT01337089|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11193|NCT01337076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11194|NCT01337050|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11195|NCT01336972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11196|NCT01336894|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11197|NCT01336764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11198|NCT01336738|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11199|NCT01336712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11200|NCT01336647|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11201|NCT01336634|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11202|NCT01336621|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11203|NCT01336608|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11204|NCT01336569|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11205|NCT01336413|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11206|NCT01336296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11207|NCT01336205|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11208|NCT01336140|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11209|NCT01336023|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
11210|NCT01335997|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
11211|NCT01335971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11212|NCT01335932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11213|NCT01335867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11214|NCT01335789|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11217|NCT01335698|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
11218|NCT01335685|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property
11219|NCT01335542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11220|NCT01335477|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11221|NCT01335464|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
11222|NCT01335308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11223|NCT01335230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11224|NCT01335191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11225|NCT01335061|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11226|NCT01334957|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11227|NCT01334944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11228|NCT01334918|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
11229|NCT01334866|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11230|NCT01334723|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11231|NCT01334710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11232|NCT01334606|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11233|NCT01334554|Principal Investigators are NOT employed by the organization sponsoring the study.|
11234|NCT01334515|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
11235|NCT01334229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11236|NCT01334216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11237|NCT01334125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11238|NCT01333956|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11239|NCT01333943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11240|NCT01333865|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11241|NCT01333813|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11242|NCT01333722|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11243|NCT01333592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11244|NCT01333501|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11245|NCT01333488|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must obtain permission from sponsor to publish any data related to this trial.
11246|NCT01333475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11247|NCT01333436|Principal Investigators are NOT employed by the organization sponsoring the study.|Subsequent to the multicenter publication, or 24 months after completion of the study, whichever comes first, an investigator and/or his/her colleagues may publish the results for their study site independently. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
11248|NCT01333397|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11249|NCT01333189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11250|NCT01333111|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
11251|NCT01332994|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11252|NCT01332981|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11253|NCT01332968|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11254|NCT01332721|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11255|NCT01332578|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11256|NCT01332500|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11257|NCT01332487|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11258|NCT01332461|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11259|NCT01332435|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11260|NCT01332357|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11261|NCT01332318|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11262|NCT01332305|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11263|NCT01332292|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11264|NCT01332253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11265|NCT01332227|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
11266|NCT01332188|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11267|NCT01332149|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11268|NCT01332123|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11269|NCT01332071|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11270|NCT01332019|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
11271|NCT01331837|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11272|NCT01331824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11273|NCT01331694|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11274|NCT01331681|Principal Investigators are NOT employed by the organization sponsoring the study.|CONTRACT PARTNERS shall provide to BSP (Bayer Schering Pharma) any proposed publication or oral at least sixty (60) days prior to the intended submission or presentation. If BSP does not notify CONTRACT PARTNERS within sixty (60) days of BSP's receipt of the intended PUBLICATION, CONTRACT PARTNERS shall be free to publish. CONTRACT PARTNERS acknowledge that in case of multi-centre studies the RESULTS of the STUDY are to be published only through coordination by Bayer.
11275|NCT01331304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11276|NCT01331291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11277|NCT01331213|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11278|NCT01331161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11279|NCT01331109|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc.
11280|NCT01331005|Principal Investigators are NOT employed by the organization sponsoring the study.|Members of the Network can not discuss the trial results until the primary outcome has been made publicly available.
11281|NCT01330914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11282|NCT01330628|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11283|NCT01330433|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11284|NCT01330420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11285|NCT01330394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11286|NCT01330381|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
11287|NCT01330355|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of ten years, the PI agrees to keep confidential and not disclose, without the prior written consent of Sponsor, to any third party or use any technology, data, reports, results of clinical studies conducted under this Study or other information received by Sponsor, or any technology, data, reports, study materials, or other information developed by Sponsor unless disclosure by PI is required by law.
11288|NCT01330316|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11289|NCT01330303|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11290|NCT01330290|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11291|NCT01330108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11292|NCT01330043|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11293|NCT01330030|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11294|NCT01330017|All Principal Investigators ARE employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission or publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
11295|NCT01329978|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11296|NCT01329939|Principal Investigators are NOT employed by the organization sponsoring the study.|"You shall have the right to publish the results derived from your performance of the Study. You agree to submit a copy of...Study results (“Publication”) to Merck for comment sixty (60) days prior to its submission for publication. Merck shall have the applicable sixty (60) day period to respond to you with any requested revisions. You agree to delete any confidential information (excluding results) identified by Merck as confidential prior to submitting/presenting the Publication....."
11297|NCT01329848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11298|NCT01329679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11299|NCT01329562|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11300|NCT01329549|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11301|NCT01329419|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11302|NCT01329263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11303|NCT01329198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11304|NCT01329185|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11305|NCT01329029|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
11306|NCT01328964|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11307|NCT01328951|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11308|NCT01328873|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications will need prior written consent from sponsor.
11309|NCT01328782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11310|NCT01328769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11311|NCT01328756|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
11312|NCT01328717|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11313|NCT01328574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11314|NCT01328548|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11315|NCT01328496|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11316|NCT01328444|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11317|NCT01328431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11318|NCT01328405|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11319|NCT01328379|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
11320|NCT01328366|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11321|NCT01328184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11322|NCT01328158|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11323|NCT01328080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11324|NCT01328054|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11325|NCT01328041|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11326|NCT01327989|Principal Investigators are NOT employed by the organization sponsoring the study.|Physician shall not make any publication without providing Sponsor 60 days notice.If Sponsor determines that the proposed publication contains confidential information, Sponsor may require the delay of publication for a period of time not to exceed 90 days and may require that any confidential information be removed from the publication. Sponsor may also require Physician to delay publication until any factual errors or inaccuracies in the publication are corrected.
11327|NCT01327976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11328|NCT01327885|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11329|NCT01327703|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication after a multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor's confidential information be removed from any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
11330|NCT01327677|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11331|NCT01327651|Principal Investigators are NOT employed by the organization sponsoring the study.|All study abstracts and publications are subject to HPTN Publication and Public Information Policies and Clinical Trial Agreements between NIAID (DAIDS) and company collaborators. The publication or other disclosure can be delayed for up to thirty additional business days for manuscripts and five business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
11332|NCT01327599|Principal Investigators are NOT employed by the organization sponsoring the study.|France: All results obtained during this study are the property of the Sponsor. All information given to the investigators must remain confidential and cannot be used outside the framework of this study. Germany: Investigators can publish results 12 months after the Sponsor’s final evaluation of the data. The Sponsor is entitled to request a delay of such publication due to business or operational reasons.
11333|NCT01327547|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11334|NCT01327508|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor shall have the sole right for 12 mo after completion of Study at all sites to arrange for the submission of the multi-center article or presentation~After the 12 mo, upon Sponsor approval or after the multicenter publication occurs, Investigator may publish, present and use for instruction and research, Investigator’s results arising out of its conduct of the Study at the Site. Investigator may not disclose Sponsor Confidential Information, and Sponsor protects its proprietary rights"
11335|NCT01327495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11336|NCT01327482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11337|NCT01327339|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11338|NCT01327313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11339|NCT01327300|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11340|NCT01327274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11341|NCT01327053|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
11342|NCT01326962|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11343|NCT01326910|Principal Investigators are NOT employed by the organization sponsoring the study.|The trial was conducted as work made for hire, and disclosure of results by the investigator is prohibited without the prior written consent of Sponsor.
11344|NCT01326845|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
11345|NCT01326533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11346|NCT01326026|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
11347|NCT01325870|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11348|NCT01325792|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications/public disclosures within 60 days prior to submission will be provided to sponsor for review by Investigator. Sponsor may make modifications to the proposals only as reasonably necessary to ensure the proper use of any references to itself, its trademarks, and trade names. Sponsor may correct inaccuracies in any technical specifications or descriptions of the biosynthetic material.
11349|NCT01325714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11350|NCT01325701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11351|NCT01325623|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11352|NCT01325532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11353|NCT01325493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11354|NCT01325428|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
11355|NCT01325350|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
11356|NCT01325337|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
11357|NCT01325311|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11358|NCT01325181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11359|NCT01324999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11360|NCT01324947|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Celgene with a copy of the papers prior to submission; Celgene shall complete its review within 60 days after receipt. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of patentable material.
11361|NCT01324882|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11362|NCT01324700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11363|NCT01324687|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11364|NCT01324622|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11365|NCT01324570|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11366|NCT01324453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11367|NCT01324440|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11368|NCT01324401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11450|NCT01318538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11369|NCT01324388|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11370|NCT01324349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11371|NCT01324323|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene’s request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation
11372|NCT01324310|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator and the Sponsor that restricts the PIs rights to publish trial results after the trial is completed. Upon investigator submission of a publication to Celgene, Celgene will complete its review within 60 days after receipt of the publication. Upon Celgene's request, the publication shall be delayed up to 90 additional days to enable Celgene to secure intellectual property protection that would be affected by such proposed publication.
11373|NCT01324271|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11374|NCT01324128|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may not present or publish partial or complete study results individually. Any manuscript or abstract proposed by the Investigators must be reviewed and approved in writing by Vifor Pharma before submission for publication. Names of all Investigators participating in the study will be included in the publication.
11375|NCT01324102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11376|NCT01324024|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11377|NCT01323998|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11378|NCT01323972|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11379|NCT01323959|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11380|NCT01323920|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11381|NCT01323855|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
11382|NCT01323790|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11383|NCT01323777|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11384|NCT01323673|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11385|NCT01323660|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11386|NCT01323647|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11492|NCT01315158|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11387|NCT01323634|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11388|NCT01323621|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11389|NCT01323595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11390|NCT01323582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11391|NCT01323517|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11392|NCT01323478|Principal Investigators are NOT employed by the organization sponsoring the study.|The primary publication must be published before any secondary publications. H. Lundbeck A/S will ensure that the authorship of all publications based on this study is in accordance with the criteria defined by the International Committee of Medical Journal Editors (ICMJE).
11393|NCT01323387|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11394|NCT01323270|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11395|NCT01323192|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11396|NCT01323140|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11397|NCT01323010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11398|NCT01322971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11399|NCT01322945|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11400|NCT01322841|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11401|NCT01322815|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11402|NCT01322633|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11403|NCT01322607|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11404|NCT01322594|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
11405|NCT01322386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11406|NCT01322360|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11407|NCT01322347|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11408|NCT01322048|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11409|NCT01322022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11410|NCT01322009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11411|NCT01321749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11412|NCT01321723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11413|NCT01321710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11414|NCT01321697|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11415|NCT01321554|Principal Investigators are NOT employed by the organization sponsoring the study.|
11416|NCT01321073|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11417|NCT01321008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11418|NCT01320943|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11419|NCT01320826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11420|NCT01320735|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11421|NCT01320722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11422|NCT01320683|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11423|NCT01320553|Principal Investigators are NOT employed by the organization sponsoring the study.|
11424|NCT01320293|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11425|NCT01320202|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11426|NCT01320137|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11427|NCT01320072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11472|NCT01316900|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11428|NCT01319877|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11429|NCT01319851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11430|NCT01319812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11431|NCT01319799|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11432|NCT01319773|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
11433|NCT01319721|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11434|NCT01319617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11435|NCT01319552|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11436|NCT01319539|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11437|NCT01319500|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11438|NCT01319422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11439|NCT01319396|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11440|NCT01319383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11441|NCT01319318|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
11442|NCT01319110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11443|NCT01319045|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11444|NCT01318993|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11445|NCT01318967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11446|NCT01318915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11447|NCT01318876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11448|NCT01318733|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11449|NCT01318694|Principal Investigators are NOT employed by the organization sponsoring the study.|
11451|NCT01318512|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11452|NCT01318499|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11453|NCT01318408|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11454|NCT01318382|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide copies of abstracts or manuscripts for publication that report any results of the trial to the Sponsor 45 days prior to submission for publication or presentation.
11455|NCT01318278|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11456|NCT01318135|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
11457|NCT01318122|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
11458|NCT01318109|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
11459|NCT01318083|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
11460|NCT01318070|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
11461|NCT01317901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11462|NCT01317797|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
11463|NCT01317667|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11464|NCT01317641|Principal Investigators are NOT employed by the organization sponsoring the study.|
11465|NCT01317615|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11466|NCT01317160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11467|NCT01317095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11468|NCT01317004|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11469|NCT01316939|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11470|NCT01316926|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11471|NCT01316913|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11473|NCT01316887|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11474|NCT01316692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11475|NCT01316614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11476|NCT01316575|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11477|NCT01316419|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
11478|NCT01316380|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11479|NCT01316341|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11480|NCT01316315|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees with the use of results of the clinical study for the purposes of national and international registration, publication, and information for medical and pharmaceutical professionals. If necessary, the competent authorities will be notified of the investigator’s name, address, qualifications, and extent of involvement. An investigator shall not publish any data (poster, abstract, paper, etc.) without having consulted with the Sponsor in advance.
11481|NCT01316302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11482|NCT01316263|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
11483|NCT01316224|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11484|NCT01316055|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
11485|NCT01316042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11486|NCT01315873|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11487|NCT01315847|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
11488|NCT01315665|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11489|NCT01315574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11490|NCT01315353|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11491|NCT01315249|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
11493|NCT01315145|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11494|NCT01315028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11495|NCT01315002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11496|NCT01314963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11497|NCT01314872|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
11498|NCT01314742|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11499|NCT01314716|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11500|NCT01314703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11501|NCT01314443|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11502|NCT01314417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11503|NCT01314261|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11504|NCT01314118|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days. The sponsor will not mandate modifications to scientific content and does not have the right to suppress information.
11505|NCT01314105|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11506|NCT01314014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11507|NCT01314001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11508|NCT01313936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11509|NCT01313923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11510|NCT01313910|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11511|NCT01313897|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11512|NCT01313884|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11513|NCT01313858|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11514|NCT01313780|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11515|NCT01313728|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11516|NCT01313689|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11517|NCT01313676|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11518|NCT01313663|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11519|NCT01313650|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11520|NCT01313637|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11521|NCT01313624|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11522|NCT01313559|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11523|NCT01313520|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor has the right to review and comment on publications, abstracts, slides and manuscripts and on the data analysis and presentation.
11524|NCT01313507|Principal Investigators are NOT employed by the organization sponsoring the study.|Octapharma agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Octapharma supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. Octapharma also reserves the right to review data prior to publishing and provide comments/changes within a certain time period.
11525|NCT01313494|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
11526|NCT01313312|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11527|NCT01313299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11528|NCT01313273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11529|NCT01313221|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
11530|NCT01313208|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
11531|NCT01313182|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11532|NCT01313117|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11533|NCT01313078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11534|NCT01313039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11535|NCT01312961|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
11536|NCT01312948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11537|NCT01312844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11538|NCT01312818|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11539|NCT01312805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11540|NCT01312766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11541|NCT01312519|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11542|NCT01312467|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11543|NCT01312428|Principal Investigators are NOT employed by the organization sponsoring the study.|To publish, exhibit or lecture, the manuscript, exhibit or speech must be provided to Stryker at least 60 days prior to submission for publication or presentation. The Investigator must receive consent from Stryker prior to publication, exhibition, or disclosure of scientific and clinical data. This review by Stryker is not intended to curtail distribution of scientific and clinical data, but to identify and edit any company confidential material and/or violations of FDA and FTC regulations.
11544|NCT01312272|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11545|NCT01312181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11546|NCT01312129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11547|NCT01312038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11548|NCT01311895|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11549|NCT01311687|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Celgene with a copy of the papers prior to submission; Celgene shall complete its review within 60 days after receipt. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of patentable material.
11550|NCT01311661|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
11551|NCT01311557|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
11552|NCT01311505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11553|NCT01311362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11554|NCT01311102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11555|NCT01311024|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11556|NCT01310868|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results.
11557|NCT01310855|Principal Investigators are NOT employed by the organization sponsoring the study.|"The excerpts below are present on all site agreements between site staff (including PI) and the sponsor:~The Site shall ensure that only those of its employees or officers directly concerned with the conduct of the Trial at the Site shall have access to the Confidential Information relating to the Trial.~The Site agrees it will not publish any information, data or results without the express written permission of the TMG, such permission not to be unreasonably withheld."
11558|NCT01310803|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator shall not publish or present information related to the Study without prior written permission of Sponsor. Sponsor may withhold permission if a publication or presentation is in violation of other agreements, is not consistent with academic standards, is false or misleading, or is for commercial purposes.
11559|NCT01310777|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11560|NCT01310699|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11561|NCT01310582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11562|NCT01310413|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11563|NCT01310400|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release. A time period for this review is not specified in the study protocol.
11564|NCT01310179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11565|NCT01310127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11566|NCT01309997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11567|NCT01309919|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11568|NCT01309893|Principal Investigators are NOT employed by the organization sponsoring the study.|
11569|NCT01309880|Principal Investigators are NOT employed by the organization sponsoring the study.|
11570|NCT01309841|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11571|NCT01309828|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
11572|NCT01309802|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11573|NCT01309737|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11574|NCT01309672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11575|NCT01309659|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11576|NCT01309646|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11577|NCT01309581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11578|NCT01309451|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11579|NCT01309386|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
11580|NCT01309360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11581|NCT01309308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11582|NCT01309282|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11583|NCT01309269|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11584|NCT01309243|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11585|NCT01309204|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11586|NCT01309100|Principal Investigators are NOT employed by the organization sponsoring the study.|
11587|NCT01308918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11588|NCT01308840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11589|NCT01308814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11590|NCT01308788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11591|NCT01308762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11592|NCT01308749|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11593|NCT01308736|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11594|NCT01308619|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11595|NCT01308580|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
11596|NCT01308567|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
11597|NCT01308476|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11598|NCT01308463|Principal Investigators are NOT employed by the organization sponsoring the study.|"A publication which uses data in addition to the authors will be reviewed by all who have contributed data, and all of the contributors will be recognized.~All publications will be reviewed by BIOMET at least 30 days prior to publication."
11599|NCT01308450|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11600|NCT01308424|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11601|NCT01307956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11602|NCT01307891|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11603|NCT01307787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11604|NCT01307631|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11605|NCT01307618|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11606|NCT01307462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11607|NCT01307423|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
11608|NCT01307397|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11609|NCT01307319|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
11610|NCT01307111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11611|NCT01307046|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. The sponsor review can be expedited to meet publication timelines.
11612|NCT01307033|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
11613|NCT01307020|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting the results of this study for publication or presentation, the investigator will allow the Sponsor at least 60 days time to review and comment upon the publication manuscript. It is agreed, that the results of the study will not be submitted for presentation, abstract, poster exhibition, or publication by the investigator until the Sponsor has reviewed/commented and agreed to any publication.
11614|NCT01307007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11615|NCT01306968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11616|NCT01306877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11617|NCT01306643|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11618|NCT01306617|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11619|NCT01306305|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator to submit all manuscripts/abstracts to the sponsor for review at least 6 weeks before submission.
11620|NCT01306292|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11621|NCT01306253|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator to submit all manuscripts/abstracts to the sponsor for review at least 6 weeks before submission.
11622|NCT01306214|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11623|NCT01306201|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11624|NCT01306175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11625|NCT01306162|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11626|NCT01306058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11627|NCT01306032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11628|NCT01305941|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11629|NCT01305811|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11630|NCT01305772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11631|NCT01305655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11632|NCT01305577|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
11633|NCT01305564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11634|NCT01305473|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11635|NCT01305408|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
11636|NCT01305265|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11637|NCT01305252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11638|NCT01305239|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11639|NCT01305213|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11640|NCT01305200|Principal Investigators are NOT employed by the organization sponsoring the study.|
11641|NCT01305044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11642|NCT01304966|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11643|NCT01304706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11644|NCT01304693|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11645|NCT01304641|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11646|NCT01304589|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11647|NCT01304498|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
11648|NCT01304329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11649|NCT01304316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11650|NCT01304277|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
11651|NCT01304238|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11652|NCT01304147|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11653|NCT01304082|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11654|NCT01303861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11655|NCT01303835|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11656|NCT01303744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11657|NCT01303627|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11658|NCT01303510|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator to submit all manuscripts/abstracts to the sponsor for review at least 6 weeks before submission.
11659|NCT01303445|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11660|NCT01303406|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11661|NCT01303380|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data (i.e, data from all sites) in the clinical trial.
11662|NCT01303224|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting the results of this study for publication or presentation, the PI will allow Sponsor at least 60 days time to review and comment upon the publication manuscript. No publication of PI is permitted before the overall publication of the multicentre study made by the Sponsor (or its designee), unless said overall publication is not made within 18 months from the completion of the Final Study Report.
11663|NCT01303159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11664|NCT01302938|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11665|NCT01302899|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11666|NCT01302860|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
11667|NCT01302743|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11668|NCT01302691|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
11669|NCT01302548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11670|NCT01302483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11671|NCT01302444|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11672|NCT01302418|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11673|NCT01302392|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
11674|NCT01302366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11675|NCT01302119|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution or Principal Investigator may only publish Study results after: (i) the results of the multicenter Study in its entirety have been publicly disclosed by the Sponsor in an abstract, manuscript or presentation form, or (ii) two (2) years after conclusion of the Study at all sites, whichever is first to occur.
11676|NCT01302067|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11677|NCT01302054|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11678|NCT01302041|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site. Sponsor must receive a site’s manuscript at least 90 days prior to publication for review and comment.
11679|NCT01301963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11680|NCT01301950|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11681|NCT01301833|Principal Investigators are NOT employed by the organization sponsoring the study.|
11682|NCT01301742|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11683|NCT01301729|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11684|NCT01301508|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11685|NCT01301456|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11686|NCT01301274|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11687|NCT01301092|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11688|NCT01301079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11689|NCT01301066|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall have the right to the first publication of the results of the Study. PI may publish, however PI must submit publication to sponsor for review at least 60 days prior to proposed publication. Sponsor may remove any information that is considered confidential and/or proprietary.
11690|NCT01301027|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11691|NCT01301001|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11692|NCT01300923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11693|NCT01300819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11694|NCT01300767|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
11695|NCT01300741|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
11696|NCT01300728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11697|NCT01300650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11698|NCT01300624|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11699|NCT01300559|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11700|NCT01300546|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11701|NCT01300455|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
11702|NCT01300351|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11703|NCT01300338|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11704|NCT01300286|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11705|NCT01300260|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11706|NCT01300247|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11707|NCT01300234|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11708|NCT01300052|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11709|NCT01299961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11710|NCT01299909|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11711|NCT01299896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11712|NCT01299805|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights therefrom or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
11713|NCT01299610|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11714|NCT01299584|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11812|NCT01292798|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11715|NCT01299571|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11716|NCT01299480|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11717|NCT01299454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11718|NCT01299389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11719|NCT01299376|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
11720|NCT01299285|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11721|NCT01299272|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11722|NCT01299116|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11723|NCT01299103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11724|NCT01299090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11725|NCT01299077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11726|NCT01299025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11727|NCT01298778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11728|NCT01298661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11729|NCT01298648|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11730|NCT01298570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11731|NCT01298544|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11732|NCT01298531|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11733|NCT01298518|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11813|NCT01292746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11734|NCT01298492|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to review disclosures, requesting a delay of up to 60 days. The first publication must be a joint publication covering all centers. However, if a joint manuscript has not been submitted for publication within 12 months of completion or termination of study at all participating sites, Investigator may publish individual site results separately. Investigator may not disclose previously undisclosed confidential information other than study results.
11735|NCT01298362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11736|NCT01298323|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
11737|NCT01298167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11738|NCT01298128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11739|NCT01298063|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11740|NCT01297920|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11741|NCT01297595|All Principal Investigators ARE employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11742|NCT01297517|All Principal Investigators ARE employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11743|NCT01297504|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11744|NCT01297491|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
11745|NCT01297465|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11746|NCT01297348|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11747|NCT01297335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11748|NCT01297322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11749|NCT01297283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11750|NCT01297270|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
11751|NCT01297257|Principal Investigators are NOT employed by the organization sponsoring the study.|For any publication or presentation of the Protected Materials or any portion thereof, a manuscript of the paper, abstract or other materials will be provided by Consultant to Sponsor for its approval at least sixty (60) days for manuscripts and thirty (30) days for presentations prior to outside submission. Medtronic shall have the right to request reasonable modifications of any manuscript or other materials to be published or presented.
11814|NCT01292642|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11752|NCT01297062|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11753|NCT01296841|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11754|NCT01296815|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11755|NCT01296763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11756|NCT01296698|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators agreed not to discuss or publish the details/results of this study.
11757|NCT01296672|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11758|NCT01296646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11759|NCT01296412|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
11760|NCT01296360|Principal Investigators are NOT employed by the organization sponsoring the study.|
11761|NCT01296347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11762|NCT01296152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11763|NCT01296035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11764|NCT01295905|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
11765|NCT01295879|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11766|NCT01295840|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11767|NCT01295814|All Principal Investigators ARE employed by the organization sponsoring the study.|
11768|NCT01295671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11769|NCT01295320|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11770|NCT01295281|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11771|NCT01295216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11772|NCT01295112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11773|NCT01295034|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11774|NCT01294917|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11815|NCT01292629|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11775|NCT01294800|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc) that report any results of the trial.
11776|NCT01294787|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11777|NCT01294748|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11778|NCT01294709|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications derived from this study should include input from the investigator(s), and SPONSOR personnel. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
11779|NCT01294696|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
11780|NCT01294683|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
11781|NCT01294644|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
11782|NCT01294592|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11783|NCT01294553|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11784|NCT01294514|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11785|NCT01294462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11786|NCT01294449|Principal Investigators are NOT employed by the organization sponsoring the study.|The restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor can request changes to the communication.
11787|NCT01294436|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
11788|NCT01294423|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
11789|NCT01294397|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
11790|NCT01294384|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
11816|NCT01292603|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11791|NCT01294371|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11792|NCT01294319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11793|NCT01294306|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11794|NCT01294267|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11795|NCT01294241|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11796|NCT01294228|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11797|NCT01294163|Principal Investigators are NOT employed by the organization sponsoring the study.|
11798|NCT01294150|Principal Investigators are NOT employed by the organization sponsoring the study.|"Investigator agreements restricted data disclosure until written agreement by or publication by Sponsor. The first publication appeared in the Journal of Urology, June 2013. The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia: The L.I.F.T. Study  Claus G. Roehrborn, Steven N. Gange, Neal D. Shore, Jonathan L. Giddens, et al. The Vol. 190, Issue 6, Pages 2161-2167."
11799|NCT01294098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11800|NCT01294046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11801|NCT01293968|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11802|NCT01293825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11803|NCT01293695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11804|NCT01293539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11805|NCT01293240|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
11806|NCT01293084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11807|NCT01293032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11808|NCT01293006|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
11809|NCT01292928|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Investigator shall have the right to publish the Results, provided that before publishing, Institution and Investigator shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any Confidential Information or other proprietary information of Sponsor from the proposed publication or presentation.
11810|NCT01292876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11811|NCT01292837|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11817|NCT01292538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11818|NCT01292486|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11819|NCT01292473|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11820|NCT01292304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11821|NCT01292265|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
11822|NCT01292239|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
11823|NCT01292226|All Principal Investigators ARE employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11824|NCT01292187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11825|NCT01292135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11826|NCT01292070|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11827|NCT01292057|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11828|NCT01292005|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11829|NCT01291836|Principal Investigators are NOT employed by the organization sponsoring the study.|
11830|NCT01291784|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11831|NCT01291498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11832|NCT01291277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11833|NCT01291264|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11834|NCT01291225|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11835|NCT01291173|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
11836|NCT01291160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11837|NCT01291108|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
11838|NCT01291056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11839|NCT01291017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11840|NCT01290978|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction for PI to publish trial results without review and approval by sponsor
11841|NCT01290952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11842|NCT01290913|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11843|NCT01290887|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
11844|NCT01290874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11845|NCT01290822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11846|NCT01290796|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11847|NCT01290757|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11848|NCT01290731|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
11849|NCT01290718|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11850|NCT01290679|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11851|NCT01290666|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11852|NCT01290640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11853|NCT01290627|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11854|NCT01290614|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11855|NCT01290601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11856|NCT01290536|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11857|NCT01290523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11858|NCT01290484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11879|NCT01289210|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11859|NCT01290341|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator agreed not to individually publish or assist other person or entity with any articles, papers, and/or make presentations, speeches referring to the protocol, clinical trial data, the study, or the study drug or any data, results, materials, or information generated or obtained by the Institution or the Principal Investigator without the prior written consent of Merz, which consent may be withheld in the sole discretion of Merz.
11860|NCT01290315|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11861|NCT01290263|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11862|NCT01290237|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11863|NCT01290224|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11864|NCT01290094|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
11865|NCT01290068|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
11866|NCT01290029|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
11867|NCT01289990|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11868|NCT01289912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11869|NCT01289847|Principal Investigators are NOT employed by the organization sponsoring the study.|"There is an agreement between the PI and Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results.~Publication of Study results will be allowed only with prior written approval from Sponsor. At the request of Sponsor, the Institution and/or Investigator shall delete any Confidential Information pertaining to Sponsor's Inventions from any proposed publications prior to submitting or presenting the materials."
11870|NCT01289821|Principal Investigators are NOT employed by the organization sponsoring the study.|PI has to submit a draft manuscript of the publication or abstract to Bayer for review and approval at least 60 days before submission. Possible discrepancies will be discussed to find solution which satifies both parties. Bayer may delay publication for up to three months after analyzing the results.
11871|NCT01289782|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11872|NCT01289639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11873|NCT01289574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11874|NCT01289548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11875|NCT01289522|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11876|NCT01289418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11877|NCT01289392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11878|NCT01289275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11880|NCT01289119|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
11881|NCT01289080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11882|NCT01289067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11883|NCT01289041|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
11884|NCT01289028|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
11885|NCT01289015|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator agreed not to individually publish or assist other person or entity with any articles, papers, and/or make presentations, speeches referring to the protocol, clinical trial data, the study, or the study drug or any data, results, materials, or information generated or obtained by the Institution or the Principal Investigator without the prior written consent of Merz, which consent may be withheld in the sole discretion of Merz.
11886|NCT01288976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11887|NCT01288911|Principal Investigators are NOT employed by the organization sponsoring the study.|Standard Restriction Description: Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or 18 months after data-lock, whichever is first. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication for up to 60 days to seek patent protection.
11888|NCT01288859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11889|NCT01288833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11890|NCT01288781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11891|NCT01288729|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11892|NCT01288612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11893|NCT01288534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11894|NCT01288521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11895|NCT01288469|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
11896|NCT01288443|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
11897|NCT01288287|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11935|NCT01285791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11898|NCT01288209|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
11899|NCT01288079|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11900|NCT01288027|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
11901|NCT01287897|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigators will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11902|NCT01287832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11903|NCT01287754|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11904|NCT01287741|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11905|NCT01287611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11906|NCT01287416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11907|NCT01287403|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11908|NCT01287364|Principal Investigators are NOT employed by the organization sponsoring the study.|
11909|NCT01287221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11910|NCT01287208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11911|NCT01287195|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11912|NCT01287117|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11913|NCT01287065|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11914|NCT01287039|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
11915|NCT01287013|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11936|NCT01285713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11916|NCT01286818|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
11917|NCT01286805|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11918|NCT01286753|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
11919|NCT01286740|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11920|NCT01286558|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
11921|NCT01286493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11922|NCT01286480|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11923|NCT01286454|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11924|NCT01286402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11925|NCT01286324|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11926|NCT01286311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11927|NCT01286207|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
11928|NCT01286168|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11929|NCT01286129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11930|NCT01286077|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the Sponsor for review at least 60 days prior to submission for publication or presentation. No paper that incorporates Confidential Information will be submitted for publication without Sponsor’s prior written consent. If requested in writing, such publication will be withheld for up to an additional 60 calendar days. A publication from the individual Study site data will not be published until the combined results have been published
11931|NCT01286012|Principal Investigators are NOT employed by the organization sponsoring the study.|No study results may be submitted for publication without Sponsor’s prior written consent. Within 60 days from submission to Sponsor’s review, Sponsor may withhold the consent. 1st publication of results is made in conjunction with the presentation of a joint, multicenter publication of results with certain PIs from all sites contributing data.
11932|NCT01285947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11933|NCT01285908|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11934|NCT01285843|Principal Investigators are NOT employed by the organization sponsoring the study.|Both the investigator and Medacta have the right to publish or allow to be published the results of the trial. The investigator recognizes that Medacta has a special interest in the results of the trial and will submit manuscripts to Medacta prior to publication. If Medacta desires changes to be made, these are communicated to the investigator within 60 days.
12058|NCT01276509|Principal Investigators are NOT employed by the organization sponsoring the study.|
11937|NCT01285635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11938|NCT01285609|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
11939|NCT01285518|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11940|NCT01285492|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
11941|NCT01285427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11942|NCT01285401|Principal Investigators are NOT employed by the organization sponsoring the study.|
11943|NCT01285323|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
11944|NCT01285310|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
11945|NCT01285076|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator can publish the study results only following the sponsor's review and approval.
11946|NCT01285050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11947|NCT01285024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11948|NCT01284959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11949|NCT01284634|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
11950|NCT01284621|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11951|NCT01284517|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
11952|NCT01284504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11953|NCT01284491|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11954|NCT01284426|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11955|NCT01284361|Principal Investigators are NOT employed by the organization sponsoring the study.|Variable restriction depends on site.
11956|NCT01284296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11957|NCT01284244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11958|NCT01284140|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11959|NCT01284114|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11960|NCT01284062|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
11961|NCT01283971|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
11962|NCT01283581|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11963|NCT01283555|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators have agreed to provide drug sponsor with a copy of any draft manuscript or abstract for its review and comment at least thirty days prior to submission for publication and provide a copy of any draft presentation at least seven days in advance of any scientific meeting or conference.
11964|NCT01283516|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11965|NCT01283464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11966|NCT01283334|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11967|NCT01283321|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11968|NCT01283282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11969|NCT01283152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11970|NCT01283139|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
11971|NCT01283035|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11972|NCT01283022|Principal Investigators are NOT employed by the organization sponsoring the study.|Any abstract,presentation or manuscript proposed for publication must be submitted to the Sponsor for review at least 30 days prior to submission for any meeting or journal.If deemed necessary by the Sponsor for protection of proprietary information prior to patent filing,the Investigator agrees to a further delay of 60 days before any presentation or publication is submitted.Publications must be in a form that does not reveal technical information that is considered confidential or proprietary.
11973|NCT01282866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11974|NCT01282814|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
11975|NCT01282801|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
11976|NCT01282723|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs may publish or present results of the study after the expiration of 12 months from completion. Publications or presentations are subject to the protection of confidential information or patentable information.
11977|NCT01282710|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs may publish or present results of the study after the expiration of 12 months from completion. Publications or presentations are subject to the protection of confidential information or patentable information.
11978|NCT01282476|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11979|NCT01282424|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
11980|NCT01282372|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
11981|NCT01282294|Principal Investigators are NOT employed by the organization sponsoring the study.|"A single comprehensive publication may be authored on the procedure and outcomes of the trial. Sites that enroll less than five patients will not be included in the publication. Synthes GmbH will have the right to review prior to submission.~Each clinical site that enrolls ten patients will have the option to submit an abstract for publication or presentation at a regional, national, or international conference on their work. Synthes GmbH will have the right to review prior to submission."
11982|NCT01282242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11983|NCT01282229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11984|NCT01282203|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
11985|NCT01282164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11986|NCT01282138|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
11987|NCT01282086|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
11988|NCT01281917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11989|NCT01281865|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11990|NCT01281839|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11991|NCT01281644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11992|NCT01281501|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11993|NCT01281475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11994|NCT01281306|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
11995|NCT01281202|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11996|NCT01281124|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
11997|NCT01281007|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
11998|NCT01280981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
11999|NCT01280968|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12000|NCT01280955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12001|NCT01280942|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12002|NCT01280903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12003|NCT01280695|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12004|NCT01280656|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
12005|NCT01280604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12006|NCT01280591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12007|NCT01280552|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12008|NCT01280357|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12009|NCT01280266|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12010|NCT01280123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12011|NCT01280110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12012|NCT01280058|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12013|NCT01279681|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12014|NCT01279564|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12015|NCT01279447|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12016|NCT01279317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12017|NCT01279265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12018|NCT01279200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12019|NCT01279187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12020|NCT01279109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12021|NCT01279070|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12022|NCT01279044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12023|NCT01278953|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12024|NCT01278927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12025|NCT01278797|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12026|NCT01278745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12027|NCT01278615|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12028|NCT01278485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12029|NCT01278407|Principal Investigators are NOT employed by the organization sponsoring the study.|
12030|NCT01278394|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution or Principal Investigator may only publish Study results after: (i) the results of the multicenter Study in its entirety have been publicly disclosed by the Sponsor in an abstract, manuscript or presentation form, or (ii) two (2) years after conclusion of the Study at all sites, whichever is first to occur.
12031|NCT01278342|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
12032|NCT01278303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12033|NCT01278173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12034|NCT01278160|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones, e.g. when the clinical trial report is available. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
12035|NCT01278030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12036|NCT01277887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12037|NCT01277861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12038|NCT01277822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12039|NCT01277757|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12040|NCT01277718|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12041|NCT01277666|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12042|NCT01277601|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
12043|NCT01277549|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12044|NCT01277523|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BIs intellectual property rights.
12045|NCT01277510|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
12046|NCT01277354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12047|NCT01277302|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12048|NCT01277211|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review and comment on data analysis and presentation for all abstracts, manuscripts, and slide presentations that report any results of this trial 45 days prior to the submission for publication or presentation.
12049|NCT01277159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12050|NCT01277081|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12051|NCT01277042|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12052|NCT01276847|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
12053|NCT01276821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12054|NCT01276756|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12055|NCT01276652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12056|NCT01276639|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12057|NCT01276535|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12059|NCT01276457|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
12060|NCT01276353|Principal Investigators are NOT employed by the organization sponsoring the study.|
12061|NCT01276327|All Principal Investigators ARE employed by the organization sponsoring the study.|
12062|NCT01276314|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12063|NCT01276301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12064|NCT01276288|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12065|NCT01276223|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
12066|NCT01276197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12067|NCT01276171|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12068|NCT01276106|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12069|NCT01276054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12070|NCT01275833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12071|NCT01275755|Principal Investigators are NOT employed by the organization sponsoring the study.|
12072|NCT01275664|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12073|NCT01275625|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12074|NCT01275586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12075|NCT01275430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12076|NCT01275365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12077|NCT01275313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12078|NCT01275196|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
12079|NCT01275131|Principal Investigators are NOT employed by the organization sponsoring the study.|
12080|NCT01275092|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12081|NCT01275066|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12082|NCT01275053|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12083|NCT01274897|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12084|NCT01274715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12085|NCT01274637|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12086|NCT01274611|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12087|NCT01274585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12088|NCT01274559|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
12089|NCT01274533|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12090|NCT01274429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12091|NCT01274182|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to the first publication or presentation of the results of the study which is intended to be a joint, multi-center publication of the study results. Following the first publication, institutions and/or Principal Investigators may publish or present data or results from the study per the terms of the clinical trial agreement.
12092|NCT01273896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12093|NCT01273883|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12094|NCT01273857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12095|NCT01273818|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12096|NCT01273805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12097|NCT01273766|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12098|NCT01273623|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12099|NCT01273597|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
12100|NCT01273519|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12101|NCT01273181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12102|NCT01273064|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12103|NCT01273038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12104|NCT01272960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12105|NCT01272947|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the Principal Investigator
12106|NCT01272934|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
12107|NCT01272921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12108|NCT01272908|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12109|NCT01272882|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12110|NCT01272869|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12111|NCT01272830|Principal Investigators are NOT employed by the organization sponsoring the study.|Published articles to be reviewed/approved by IC-MedTech prior to publication.
12112|NCT01272804|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12113|NCT01272661|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12114|NCT01272635|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12115|NCT01272583|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12116|NCT01272284|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12117|NCT01272245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12118|NCT01272232|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right not to release data until specified milestones are available. This includes the right not to release interim results from clinical trials, as such results may lead to conclusions that are later proven incorrect. At the end of the trial, one or more manuscripts for publication will be prepared in collaboration between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to briefly postpone publication or communication to protect intellectual property.
12119|NCT01272219|Principal Investigators are NOT employed by the organization sponsoring the study.|When the primary results are available, Novo Nordisk plans to discuss the interpretation of these with the principal Investigator, but reserves the right to release results that may impact Novo Nordisk financial expectations (e.g. a press release directly to the public or similar) without prior consultation with the remaining participating Investigators. Novo Nordisk reserves the right not to release data until specified milestones, e.g. a clinical trial report is available.
12120|NCT01272193|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
12121|NCT01272180|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12122|NCT01272141|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12123|NCT01272076|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results until the device is released on the market.
12124|NCT01272011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12125|NCT01271946|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication or presentation, the Institution will provide the Sponsor with at least sixty (60) days for review of a manuscript. If requested in writing,The Institution and Principal Investigator will withhold such publication for up to an additional sixty (60) days to allow for filing of a patent application.
12126|NCT01271907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12127|NCT01271855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12128|NCT01271803|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12129|NCT01271712|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12130|NCT01271686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12131|NCT01271543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12132|NCT01271452|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 30 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication and can extend the embargo
12133|NCT01271413|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12134|NCT01271244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12135|NCT01271036|Principal Investigators are NOT employed by the organization sponsoring the study.|Study is considered a work made for hire and the Sponsor retains all rights to publish results.
12136|NCT01271010|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12137|NCT01270971|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution or Principal Investigator may only publish Study results after: (i) the results of the multicenter Study in its entirety have been publicly disclosed by the Sponsor in an abstract, manuscript or presentation form, or (ii) two (2) years after conclusion of the Study at all sites, whichever is first to occur.
12138|NCT01270958|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12139|NCT01270919|Principal Investigators are NOT employed by the organization sponsoring the study.|
12140|NCT01270880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12141|NCT01270867|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12142|NCT01270841|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights.
12143|NCT01270828|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12144|NCT01270802|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12145|NCT01270711|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12146|NCT01270659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12147|NCT01270620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12148|NCT01270581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12149|NCT01270555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12150|NCT01270542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12151|NCT01270529|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12152|NCT01270503|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
12153|NCT01270464|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
12154|NCT01270256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12155|NCT01270139|All Principal Investigators ARE employed by the organization sponsoring the study.|This project and manuscript were not prepared or funded in any part by a commercial organization. Nanoparticles and biomedical facilities were supplied free for the study by the non-profit Agiko Foundation (Yekaterinburg, Russia). All rights of authors are reserved by the Russian Law. The access of the non-russian international and alien academic and governmental organizations to the essential and primary documents of the trial is restricted by the Russian government.
12156|NCT01270126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12157|NCT01269918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12158|NCT01269801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12159|NCT01269749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12160|NCT01269736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12161|NCT01269710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12162|NCT01269346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12163|NCT01269125|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12164|NCT01269047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12165|NCT01268943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12166|NCT01268891|Principal Investigators are NOT employed by the organization sponsoring the study.|"The results of this study will be published at the discretion of H. Lundbeck A/S. H. Lundbeck A/S will ensure that the authorship of all publications based on this study is in accordance with the criteria defined by the International Committee of Medical Journal Editors (ICMJE).~The primary publication must be published before any secondary publications."
12167|NCT01268683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12168|NCT01268566|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
12169|NCT01268553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12170|NCT01268501|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
12171|NCT01268488|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12172|NCT01268306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12173|NCT01268293|Principal Investigators are NOT employed by the organization sponsoring the study.|
12174|NCT01268267|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12175|NCT01268189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12176|NCT01268150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12177|NCT01268111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12178|NCT01268098|Principal Investigators are NOT employed by the organization sponsoring the study.|
12179|NCT01267994|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12180|NCT01267929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12181|NCT01267422|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12182|NCT01267292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12183|NCT01267266|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12184|NCT01267253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12185|NCT01267240|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12186|NCT01267227|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure of the submitted materials approved per contractual agreement.
12187|NCT01267201|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12208|NCT01265875|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12188|NCT01267175|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12189|NCT01267136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12190|NCT01267045|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12191|NCT01267019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12192|NCT01266967|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12193|NCT01266876|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission for publication or presentation, the Institution shall, or cause the Principal Investigator to, provide the Sponsor with a copy of the Manuscript. The Institution shall consider in good faith any comments from the Sponsor regarding the content, and shall delete Confidential Information upon written request of the Sponsor. At the Sponsor's request, the Institution shall delay publication for an additional 60 days to allow patent applications to be filed.
12194|NCT01266850|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12195|NCT01266824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12196|NCT01266447|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12197|NCT01266317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12198|NCT01266291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12199|NCT01266265|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12200|NCT01266148|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
12201|NCT01266122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12202|NCT01266070|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12203|NCT01266031|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12204|NCT01266018|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12205|NCT01265992|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12206|NCT01265966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12207|NCT01265953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12209|NCT01265823|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12210|NCT01265797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12211|NCT01265784|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 60 days prior to submitting or presenting a manuscript, poster, presentation, abstract or other materials relating to the Trial, the PI shall provide to Sponsor all such manuscripts and materials, and Sponsor shall have 60 days to review and comment. If requested, the PI shall remove Confidential lnformation prior to submitting or presenting the materials, and shall delay publication or presentation for up to 90 days to allow Sponsor to protect its interests in any such materials.
12212|NCT01265667|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12213|NCT01265615|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12214|NCT01265563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12215|NCT01265550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12216|NCT01265524|Principal Investigators are NOT employed by the organization sponsoring the study.|A standard confidentiality agreement is in place.
12217|NCT01265511|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12218|NCT01265498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12219|NCT01265459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12220|NCT01265446|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
12221|NCT01265420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12222|NCT01265394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12223|NCT01265056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12224|NCT01264952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12225|NCT01264939|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12226|NCT01264887|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
12227|NCT01264835|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12228|NCT01264770|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review and comment on results communications prior to publication. Sponsor will be allowed a review period of at least 60 days from submission but can request that publication be delayed for a period up to 6 months. Any reasonable comments made by the sponsor will be incorporated by the PI into the publication.
12248|NCT01263301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12229|NCT01264679|Principal Investigators are NOT employed by the organization sponsoring the study.|If there is no multi-site publication within 18 months after the Study has been completed or terminated at all Study sites, and all data has been received by Sponsor, the Site and SMO shall have the right to publish its results from the Study for non-commercial purposes, if submitted to Sponsor for review 60 days prior to submission of publication. Publication must remove all confidential information and may be delayed by up to 120 days to allow Sponsor to protect its interests.
12230|NCT01264614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12231|NCT01264601|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12232|NCT01264380|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
12233|NCT01264081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12234|NCT01264016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12235|NCT01263925|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12236|NCT01263873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12237|NCT01263717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12238|NCT01263704|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12239|NCT01263691|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor is responsible for public disclosure of study data. Any proposed publication is subject to review agreed between National Institute of Allergy and Infectious Disease (NIAID) and Emergent; between Emergent and the contract research organizations (CROs)/vendors; and between the CROs and the site Principal Investigator. Data are the property of the sponsor and cannot be published without prior authorization from the sponsor, but data and publication thereof will not be unduly withheld.
12240|NCT01263665|Principal Investigators are NOT employed by the organization sponsoring the study.|Before the single-center publication is submitted or presented, the > Investigator will provide a copy to the Sponsor and allow the Sponsor 30 days to review and > comment. The Sponsor will review the publication for data accuracy only and not the > conclusions or interpretations. If the Sponsor requests, the publication will be delayed an > additional ninety (90) days, to allow Sponsor to ensure the protection of inventions or other > property of Sponsor.
12241|NCT01263639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12242|NCT01263561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12243|NCT01263509|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
12244|NCT01263496|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
12245|NCT01263483|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
12246|NCT01263470|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
12247|NCT01263444|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
12249|NCT01263132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12250|NCT01263054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12251|NCT01263028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12252|NCT01263015|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12253|NCT01262989|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12254|NCT01262898|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12255|NCT01262872|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12256|NCT01262846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12257|NCT01262820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12258|NCT01262755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12259|NCT01262651|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12260|NCT01262599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12261|NCT01262573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12262|NCT01262560|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
12263|NCT01262547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12264|NCT01262456|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
12265|NCT01262352|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
12266|NCT01262339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12267|NCT01262287|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12268|NCT01262131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12269|NCT01262118|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12270|NCT01262105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12271|NCT01262092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12272|NCT01262027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12273|NCT01261975|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
12274|NCT01261780|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12275|NCT01261624|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12276|NCT01261559|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12277|NCT01261507|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12278|NCT01261390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12279|NCT01261325|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
12280|NCT01261247|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12281|NCT01261052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12282|NCT01261000|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12283|NCT01260948|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
12284|NCT01260922|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
12285|NCT01260896|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
12286|NCT01260883|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12287|NCT01260701|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12288|NCT01260688|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12289|NCT01260662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12290|NCT01260649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12291|NCT01260584|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor reflects the following restrictive language in the Clinical Study Agreements: If Daiichi Sankyo Inc. (DSI) identifies any of its confidential information as defined herein, it shall be deleted … Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by the Study Site."
12292|NCT01260493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12293|NCT01260467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12294|NCT01260454|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12295|NCT01260350|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
12296|NCT01260324|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12297|NCT01260311|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12298|NCT01260272|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12299|NCT01260194|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12300|NCT01260142|Principal Investigators are NOT employed by the organization sponsoring the study.|
12301|NCT01259726|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
12302|NCT01259713|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
12303|NCT01259596|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12304|NCT01259492|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
12305|NCT01259466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12306|NCT01259440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12307|NCT01259427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12308|NCT01259401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12309|NCT01259375|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12310|NCT01259297|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
12311|NCT01259284|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12312|NCT01259245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12313|NCT01259115|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12314|NCT01259102|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12315|NCT01259063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12316|NCT01259024|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12317|NCT01259011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12318|NCT01258998|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12319|NCT01258985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12320|NCT01258803|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
12321|NCT01258790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12322|NCT01258738|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12323|NCT01258660|Principal Investigators are NOT employed by the organization sponsoring the study.|PI (principal investigator) of CRO (contract research organization) will refrain from publishing any data or information generated or derived as a result of the performance of the Services.
12324|NCT01258595|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
12325|NCT01258582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12326|NCT01258504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12327|NCT01258387|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has the right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
12328|NCT01258153|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study cannot be submitted for presentation, abstract, poster exhibition, or publication by the investigator until Menarini Ricerche S.p.A. has reviewed/commented and agreed to any publication.
12329|NCT01258101|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
12330|NCT01258049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12331|NCT01257880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12332|NCT01257802|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12333|NCT01257750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12334|NCT01257737|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights.
12335|NCT01257581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12336|NCT01257542|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12337|NCT01257503|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12338|NCT01257438|Principal Investigators are NOT employed by the organization sponsoring the study.|
12339|NCT01257425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12340|NCT01257347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12341|NCT01257230|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
12342|NCT01257217|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
12343|NCT01257204|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
12344|NCT01256983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12345|NCT01256944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12346|NCT01256918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12347|NCT01256840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12348|NCT01256684|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators shall provide to the SPONSOR 30 days prior to submission all documents for publication, presentation, etc that report any trial results. The SPONSOR shall have editorial rights on documents and the right to review/comment with regard to (1) proprietary information, (2) accuracy of the information, (3) correctness of the scientific evaluation/conclusions and (4) to ensure that the information is fairly balanced and in compliance with regulations.
12349|NCT01256671|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators shall provide to the SPONSOR 30 days prior to submission all documents for publication, presentation, etc that report any trial results. The SPONSOR shall have editorial rights on documents and the right to review/comment with regard to (1) proprietary information, (2) accuracy of the information, (3) correctness of the scientific evaluation/conclusions and (4) to ensure that the information is fairly balanced and in compliance with regulations.
12350|NCT01256658|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
12351|NCT01256567|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
12352|NCT01256502|Principal Investigators are NOT employed by the organization sponsoring the study.|As this study involves multiple centers, no individual publications will be allowed prior to completion of the final report of the multicenter study except as agreed with Allergan.
12353|NCT01256476|Principal Investigators are NOT employed by the organization sponsoring the study.|May not publish.
12354|NCT01256450|Principal Investigators are NOT employed by the organization sponsoring the study.|The oral or written use of study results by the Investigator is not permitted without the express written consent from the Sponsor.
12355|NCT01256424|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12356|NCT01256411|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
12357|NCT01256385|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12358|NCT01256294|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
12359|NCT01256281|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12360|NCT01256190|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators will be part of the primary publication. Each investigator may publish on the data from subjects enrolled at their site after the initial publication has been submitted.
12361|NCT01256177|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator shall not publish or present any such results until the earlier of (i) the date of the first Study results publication, or in case of a Multi-Centre Study the first Multi-Centre Results publication, authorized by AstraZeneca and (ii) the end of the eighteen (18) month period following the completion, or early termination, of the Study at all participating sites.
12362|NCT01256164|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators were part of the primary publication. Each investigator may publish on the data from subjects enrolled at their site after the initial publication has been submitted.
12363|NCT01256086|Principal Investigators are NOT employed by the organization sponsoring the study.|INSTITUTION shall have the right to publish the results of its part of the study either independently or in collaboration with SPONSOR.In either case, INSTITUTION agrees to submit a copy of any manuscript and/or abstract to SPONSOR for review and comment sixty (60) days prior to its submission for publication. SPONSOR shall have said sixty (60) day period to respond to INSTITUTION with any requested revisions. INSTITUTION agrees to delete information identified by SPONSOR as confidential.
12364|NCT01256060|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12365|NCT01256034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12366|NCT01256008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12367|NCT01255904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12368|NCT01255787|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
12369|NCT01255761|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
12370|NCT01255722|Principal Investigators are NOT employed by the organization sponsoring the study.|"No unpublished data given to the investigator may be transmitted to a third party without prior approval of the sponsor in writing. The data are the exclusive property of Guerbet.~The investigator undertakes to submit to Guerbet any draft articles or papers related to this study within 30 days of their submission to the scientific review or the congress scientific committee.~All written or oral papers and publications must have the joint agreement of the investigator and the sponsor."
12371|NCT01255631|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12372|NCT01255592|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12373|NCT01255449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12374|NCT01255436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12375|NCT01255423|Principal Investigators are NOT employed by the organization sponsoring the study.|Preliminary agreement between Novartis Consumer Health and the investigator
12376|NCT01255306|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12377|NCT01255163|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12378|NCT01255137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12379|NCT01254890|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12380|NCT01254877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12381|NCT01254851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12382|NCT01254760|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
12383|NCT01254747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12384|NCT01254721|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12385|NCT01254669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12386|NCT01254656|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12387|NCT01254643|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines
12388|NCT01254630|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
12389|NCT01254604|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish results for his/her study site after publication of results of entire multicenter trial, or after public disclosure of the results online if a multicenter manuscript is not planned. Sponsor must be able to review all proposed results communications regarding study 60 days prior to submission for publication/presentation. Information identified by the Sponsor as confidential must be deleted prior to submission.
12390|NCT01254565|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
12391|NCT01254409|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agree that the first public presentation of data will be a joint, multicentre publication of results. If this does not occur within 12 months after conclusion of the study, investigator may publish the results, provided that the complete manuscript or other publication is submitted to the sponsor for review 30 days prior to submission.
12392|NCT01254396|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12393|NCT01254344|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
12394|NCT01254331|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12395|NCT01254318|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator and Institution agree to provide 45 days written notice to Sponsor prior to submission for publication or presentation to permit Sponsor to review drafts of abstracts and manuscripts for publication which report any results arising out of the Study.
12396|NCT01254305|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
12397|NCT01254292|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12398|NCT01254214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12399|NCT01254188|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
12400|NCT01254045|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12401|NCT01253980|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12402|NCT01253902|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
12403|NCT01253824|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the sponsor and PI that no restricts the PI's right but need to discuss the timing of publish date of trial results after the trial is completed.
12404|NCT01253811|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
12405|NCT01253642|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12406|NCT01253577|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12407|NCT01253564|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
12408|NCT01253525|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
12409|NCT01253447|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12410|NCT01253421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12411|NCT01253408|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12412|NCT01253369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12413|NCT01253343|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12414|NCT01253317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12415|NCT01253304|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12416|NCT01253265|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12417|NCT01253200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12418|NCT01253187|Principal Investigators are NOT employed by the organization sponsoring the study.|PI (principal investigator) of CRO (contract research organization) will refrain from publishing any data or information generated or derived as a result of the performance of the Services.
12419|NCT01253174|Principal Investigators are NOT employed by the organization sponsoring the study.|PI (principal investigator) of CRO (contract research organization) will refrain from publishing any data or information generated or derived as a result of the performance of the Services.
12420|NCT01253148|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12421|NCT01253135|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12422|NCT01253070|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12423|NCT01253044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12424|NCT01253018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12425|NCT01252966|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12426|NCT01252953|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12427|NCT01252940|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
12428|NCT01252810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12429|NCT01252745|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12430|NCT01252355|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
12431|NCT01252290|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12432|NCT01252277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12433|NCT01252251|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12434|NCT01252238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12435|NCT01252186|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
12436|NCT01252147|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
12437|NCT01252134|Principal Investigators are NOT employed by the organization sponsoring the study.|
12438|NCT01252095|Principal Investigators are NOT employed by the organization sponsoring the study.|No data may be published or presented from the study except with the prior written consent of Progen. Progen reserves the right to a 30-day review and approval of all manuscripts related to the study prior to publication.
12439|NCT01251978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12440|NCT01251952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12441|NCT01251770|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12442|NCT01251757|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12443|NCT01251653|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
12444|NCT01251614|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12445|NCT01251588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12446|NCT01251380|Principal Investigators are NOT employed by the organization sponsoring the study.|A plan for scientific publication and presentation of the results could be agreed and implemented by the study investigators or a steering committee. The sponsor required that reasonable opportunity be given to review the content and conclusions of any abstract, presentation, or paper before the material was submitted for publication or communicated. This condition also applied to any amendments that were subsequently requested by referees or journal editors.
12447|NCT01251367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12448|NCT01251354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12449|NCT01251315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12450|NCT01251276|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study sixty (60) days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
12451|NCT01251146|Principal Investigators are NOT employed by the organization sponsoring the study.|
12452|NCT01251120|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12453|NCT01251042|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12454|NCT01250990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12455|NCT01250925|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12456|NCT01250899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12457|NCT01250834|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12458|NCT01250769|Principal Investigators are NOT employed by the organization sponsoring the study.|Philips shall have the final authority to determine whether or not to publish study results.
12459|NCT01250756|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12460|NCT01250730|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12461|NCT01250717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12462|NCT01250509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12463|NCT01250418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12464|NCT01250379|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12465|NCT01250184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12466|NCT01250171|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
12467|NCT01250145|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12468|NCT01250119|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12469|NCT01250054|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12470|NCT01250002|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12471|NCT01249872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12472|NCT01249833|Principal Investigators are NOT employed by the organization sponsoring the study.|If Sponsor has not submitted a manuscript for publication for this multi-center study within 12 months of study completion/termination, the PI will be free to publish separately. Sponsor can review results communications prior to public release and can embargo communications for up to 90 days if the proposed publication contains information relating to patentable items. If Sponsor believes proposed communications contain any confidential information, Sponsor has the right to remove it.
12473|NCT01249664|Principal Investigators are NOT employed by the organization sponsoring the study.|
12474|NCT01249651|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AZ approval before this study was completed.
12475|NCT01249417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12476|NCT01249404|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12477|NCT01249274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12478|NCT01249261|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12479|NCT01249157|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12480|NCT01249131|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
12481|NCT01249118|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12482|NCT01249092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12483|NCT01248949|Principal Investigators are NOT employed by the organization sponsoring the study.|“MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome” in the agreement description.
12484|NCT01248936|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
12485|NCT01248884|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12486|NCT01248793|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12487|NCT01248780|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12488|NCT01248728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12489|NCT01248715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12532|NCT01245283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12490|NCT01248468|Principal Investigators are NOT employed by the organization sponsoring the study.|Data of &/or resulting from the performance of the Clinical Trial (CT) shall be pooled with the data from other centers & analyzed as stipulated in the Protocol.Without the consent of the steering committee of the multi-center CT, no presentation/publication of the results obtained from datasets other than the final pooled dataset shall be made prior to the presentation/ publication based on the final pooled dataset.
12491|NCT01248455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12492|NCT01248364|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
12493|NCT01248221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12494|NCT01248130|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12495|NCT01248065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12496|NCT01248013|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12497|NCT01247974|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multi-site publication is not submitted within twenty-four (24) months after conclusion of the Study at all sites, Institution and/or the Principal Investigator may publish the results from Institution’s site individually, subject to Sponsor’s rights
12498|NCT01247922|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication for an additional to 60 days to seek patent protection.
12499|NCT01247675|Principal Investigators are NOT employed by the organization sponsoring the study.|
12500|NCT01247571|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12501|NCT01247428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12502|NCT01247350|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12503|NCT01247324|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12504|NCT01247298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12505|NCT01247285|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
12506|NCT01247272|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
12507|NCT01247220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12508|NCT01247090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12509|NCT01247064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12510|NCT01246999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12511|NCT01246973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12512|NCT01246960|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
12513|NCT01246895|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12514|NCT01246791|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the sponsor and PI that no restricts the PI's right but need to discuss the timing of publish date of trial results after the trial is completed.
12515|NCT01246713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12516|NCT01246479|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12517|NCT01246401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12518|NCT01246349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12519|NCT01246258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12520|NCT01246206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12521|NCT01246076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12522|NCT01246011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12523|NCT01245764|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
12524|NCT01245751|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
12525|NCT01245738|Principal Investigators are NOT employed by the organization sponsoring the study.|The scientific information generated from this study will be publically disclosed in forms of peer reviewed publication and scientific presentations and may even be actively disseminated amongst the practicing medical community in appropriate scientific platforms.
12526|NCT01245647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12527|NCT01245595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12528|NCT01245439|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12529|NCT01245413|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12530|NCT01245387|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12531|NCT01245374|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones, including the right to not release interim results of clinical trials. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
12533|NCT01245270|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12534|NCT01245140|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12535|NCT01245101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12536|NCT01245062|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12537|NCT01245049|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12538|NCT01244984|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12539|NCT01244906|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12540|NCT01244893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12541|NCT01244828|Principal Investigators are NOT employed by the organization sponsoring the study.|Initial public presentation of the Investigator's results will occur only together with the other sites unless permission is obtained from Sponsor. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. In case of disagreement concerning appropriateness of materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues, prior to submission for publication/presentation.
12542|NCT01244815|Principal Investigators are NOT employed by the organization sponsoring the study.|It is planned to first publish/present trial results together with the other sites, unless permission is obtained from Sponsor to publish separate results. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. If there is disagreement concerning appropriateness of the materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve disagreement prior to submission for publication.
12543|NCT01244724|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12544|NCT01244711|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12545|NCT01244633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12546|NCT01244620|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12547|NCT01244529|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written authorization from Sponsor.
12548|NCT01244516|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication required agreement and written authorization from the Sponsor.
12549|NCT01244503|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12550|NCT01244490|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
12551|NCT01244477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12552|NCT01244425|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., for intellectual property protection)
12553|NCT01244412|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12554|NCT01244243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12555|NCT01244126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12556|NCT01244061|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12557|NCT01243944|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
12558|NCT01243892|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12559|NCT01243775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12560|NCT01243762|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation and can delete information identified as confidential prior to submission.
12561|NCT01243671|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12562|NCT01243619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12563|NCT01243580|Principal Investigators are NOT employed by the organization sponsoring the study.|Approval by Agile Therapeutics, Inc. of any publication, including oral presentations and abstracts, utilizing data or any information from the ATI-CL14 study is required prior to publication submission.
12564|NCT01243567|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
12565|NCT01243450|Principal Investigators are NOT employed by the organization sponsoring the study.|
12566|NCT01243411|Principal Investigators are NOT employed by the organization sponsoring the study.|
12567|NCT01243320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12568|NCT01243294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12569|NCT01243242|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12570|NCT01243177|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12571|NCT01243112|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12572|NCT01242813|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
12573|NCT01242748|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
12574|NCT01242527|Principal Investigators are NOT employed by the organization sponsoring the study.|Individual investigators may publish data arising from their own subjects. The PI will provide the Sponsor with copies of written publications (including abstracts and posters)at least 60 days in advance of submission. Data will be reviewed by all participating investigators prior to publication. The Sponsor will have 60 days to review all definitive publications, such as manuscripts and book chapters, and a minimum of 30 days to review all abstracts.
12575|NCT01242514|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review and comment on results communications prior to publication. Sponsor will be allowed a review period of at least 60 days from submission but can request that publication be delayed for a period up to 6 months. Any reasonable comments made by the sponsor will be incorporated by the PI into the publication.
12576|NCT01242371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12577|NCT01242176|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12578|NCT01242111|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot publish any data prior to multi-centre publication. If publication related to sub-sets of data it shall make reference to the relevant multi-centre publication. PI agrees to submit material to Sponsor for review at least 60 days prior to publication and incorporate all reasonable comments. During review, Sponsor may request that publication be delayed for up to 6 months from date of first submission to Sponsor in order for Sponsor to take steps to protect its proprietary information.
12579|NCT01242085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12580|NCT01242020|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12581|NCT01241916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12582|NCT01241903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12583|NCT01241760|Principal Investigators are NOT employed by the organization sponsoring the study.|If the PI (Investigator) wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
12584|NCT01241591|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12585|NCT01241565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12586|NCT01241552|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
12587|NCT01241539|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12588|NCT01241513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12589|NCT01241448|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12590|NCT01241292|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
12655|NCT01236170|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12591|NCT01241279|Principal Investigators are NOT employed by the organization sponsoring the study.|Study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
12592|NCT01241240|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release. No documents containing confidential information from the sponsor or information developed will be submitted for publication without prior written authorization from the sponsor.
12593|NCT01240915|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12594|NCT01240902|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12595|NCT01240863|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
12596|NCT01240811|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12597|NCT01240785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12598|NCT01240746|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
12599|NCT01240590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12600|NCT01240551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12601|NCT01240382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12602|NCT01240356|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12603|NCT01240330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12604|NCT01240200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12605|NCT01240135|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
12606|NCT01240122|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12607|NCT01239992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12608|NCT01239797|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
12609|NCT01239745|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12630|NCT01238536|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12610|NCT01239732|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12611|NCT01239680|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12612|NCT01239511|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12613|NCT01239394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12614|NCT01239381|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12615|NCT01239355|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12616|NCT01239342|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12617|NCT01239316|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12618|NCT01239212|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12619|NCT01239121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12620|NCT01239056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12621|NCT01239043|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
12622|NCT01238991|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12623|NCT01238900|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12624|NCT01238861|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
12625|NCT01238848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12626|NCT01238822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12627|NCT01238640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12628|NCT01238588|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12629|NCT01238575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12631|NCT01238471|All Principal Investigators ARE employed by the organization sponsoring the study.|
12632|NCT01238341|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12633|NCT01238211|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12634|NCT01237678|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12635|NCT01237613|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12636|NCT01237353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12637|NCT01237340|Principal Investigators are NOT employed by the organization sponsoring the study.|
12638|NCT01237327|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12639|NCT01237301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12640|NCT01237223|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
12641|NCT01237197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12642|NCT01237080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12643|NCT01237054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12644|NCT01236768|Principal Investigators are NOT employed by the organization sponsoring the study.|Review and approval by Agile Therapeutics, Inc. of any publication, including oral presentations and abstracts, utilizing data or any information from the ATI-CL13 study is required prior to publication submission.
12645|NCT01236742|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12646|NCT01236573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12647|NCT01236534|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12648|NCT01236391|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12649|NCT01236378|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12650|NCT01236365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12651|NCT01236339|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
12652|NCT01236326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12653|NCT01236300|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12654|NCT01236196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12656|NCT01236118|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12657|NCT01236105|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12658|NCT01236053|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12659|NCT01236001|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
12660|NCT01235975|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12661|NCT01235923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12662|NCT01235910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12663|NCT01235897|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12664|NCT01235741|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
12665|NCT01235728|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
12666|NCT01235715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12667|NCT01235689|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12668|NCT01235598|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12669|NCT01235546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12670|NCT01235507|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12671|NCT01235442|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
12672|NCT01235403|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12673|NCT01235377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12674|NCT01235338|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
12675|NCT01235234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12676|NCT01235195|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12677|NCT01234922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12678|NCT01234883|Principal Investigators are NOT employed by the organization sponsoring the study.|
12679|NCT01234870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12680|NCT01234831|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12681|NCT01234766|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12682|NCT01234714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12683|NCT01234675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12684|NCT01234467|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12685|NCT01234337|Principal Investigators are NOT employed by the organization sponsoring the study.|"Bayer will have up to 30/45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable).~No publication of single center data should be done prior to publication of multi-center data."
12686|NCT01234207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12687|NCT01234103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12688|NCT01233999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12689|NCT01233921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12690|NCT01233869|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12691|NCT01233817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12692|NCT01233726|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12693|NCT01233687|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12694|NCT01233609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12695|NCT01233284|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12877|NCT01221285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12696|NCT01233258|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12697|NCT01233232|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12698|NCT01233076|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
12699|NCT01233050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12700|NCT01232920|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12701|NCT01232894|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
12702|NCT01232868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12703|NCT01232829|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12704|NCT01232790|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12705|NCT01232738|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12706|NCT01232569|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12707|NCT01232504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12708|NCT01232491|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
12709|NCT01232465|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12710|NCT01232296|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
12711|NCT01232283|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
12712|NCT01232205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12713|NCT01232127|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
12814|NCT01225822|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12714|NCT01231984|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI and Clinical Center will not publish the results pursuant to the Protocol without sponsor review and opportunity to comment on the publication or oral presentation. Abstracts and synopsis of oral presentations must be received by sponsor 30 days, and journal submissions 60 days, prior to submission. The data generated pursuant to the Protocol will be the property of the sponsor and may be used in any manner by the sponsor as it may determine in its sole discretion.
12715|NCT01231841|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12716|NCT01231750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12717|NCT01231646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12718|NCT01231633|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12719|NCT01231620|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12720|NCT01231607|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12721|NCT01231581|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12722|NCT01231555|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12723|NCT01231516|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12724|NCT01231503|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12725|NCT01231464|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12726|NCT01231412|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12727|NCT01231399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12728|NCT01231373|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12729|NCT01231334|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
12730|NCT01231321|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
12731|NCT01231230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12732|NCT01230892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12733|NCT01230827|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12734|NCT01230814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12735|NCT01230788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12736|NCT01230749|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12737|NCT01230710|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12738|NCT01230502|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI, or his designee, must notify the sponsor at least (10) days, if possible, or as soon as possible, prior to submitting this information.
12739|NCT01230424|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12740|NCT01230307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12741|NCT01230177|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12742|NCT01230060|Principal Investigators are NOT employed by the organization sponsoring the study.|
12743|NCT01230021|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk (NN) reserves the right not to release data until after specified milestones, e.g., finalisation of clinical trial report. This includes the right not to release interim results of clinical trials, as release of such information can invalidate the trial results. At end of trial, one or more manuscripts will be prepared collaboratively between Investigator(s) and NN. NN reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
12744|NCT01229943|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12745|NCT01229891|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12746|NCT01229735|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12747|NCT01229722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12748|NCT01229527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12749|NCT01229462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12750|NCT01229436|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12751|NCT01229423|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12752|NCT01229410|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
12753|NCT01229397|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 60 days from the time submitted to the sponsor for review. The sponsor reserves the right to remove any proprietary or confidential information and to require that publication be delayed for up to 60 additional days to enable the sponsor to prepare and file patent applications.
12754|NCT01229371|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period between 30 to 90 days (depending on the complexitiy of the work) from the time submitted to the sponsor for review.
12755|NCT01229254|Principal Investigators are NOT employed by the organization sponsoring the study.|Due to multiple studies, centers and countries this may vary.
12756|NCT01229228|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12757|NCT01229176|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event that no publication of the Study results has been made by NVGH within twelve (12) months of Study database lock and no proposed publication is under discussion by the publication committee, Principal Investigator may publish its own Study results.
12758|NCT01229150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12759|NCT01229111|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12760|NCT01228968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12761|NCT01228929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12762|NCT01228903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12763|NCT01228747|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12764|NCT01228734|Principal Investigators are NOT employed by the organization sponsoring the study.|
12765|NCT01228591|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12766|NCT01228435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12767|NCT01228175|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12768|NCT01228149|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12769|NCT01228084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12770|NCT01228071|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12771|NCT01228019|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication must be approved by the Sponsor.
12772|NCT01227993|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12773|NCT01227980|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12774|NCT01227967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12775|NCT01227954|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
12776|NCT01227928|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12777|NCT01227902|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12778|NCT01227889|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12779|NCT01227824|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12780|NCT01227785|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall be provided with copy of all Trial-related manuscripts and reports for review and comment
12781|NCT01227707|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12782|NCT01227681|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12783|NCT01227668|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
12784|NCT01227655|Principal Investigators are NOT employed by the organization sponsoring the study.|
12785|NCT01227629|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12786|NCT01227577|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
12787|NCT01227564|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12788|NCT01227551|Principal Investigators are NOT employed by the organization sponsoring the study.|
12789|NCT01227512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12790|NCT01227434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12791|NCT01227421|Principal Investigators are NOT employed by the organization sponsoring the study.|Presentation and/or publication is encouraged provided the Sponsor is notified in advance and given the opportunity to review the manuscript or abstract 30 days prior to its submission for presentation at a scientific meeting or for publication in a scientific journal. The investigators will have complete autonomy regarding the content and wording including the decision of whether or not to publish.
12792|NCT01227395|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12793|NCT01227382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12794|NCT01227278|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
12853|NCT01222572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12795|NCT01227265|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
12796|NCT01227057|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12797|NCT01227018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12798|NCT01227005|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12799|NCT01226745|Principal Investigators are NOT employed by the organization sponsoring the study.|
12800|NCT01226732|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
12801|NCT01226719|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
12802|NCT01226706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12803|NCT01226511|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12804|NCT01226459|Principal Investigators are NOT employed by the organization sponsoring the study.|Multi-Center Publication will be the first publication to present the results of the Study. Upon such Multi-Center Publication, or the earlier of (a) Sponsor's confirmation that there will be no Multi-Center Publication or presentation, or (b) 12 months after the completion of the entire multi-center study, Institution and Investigator may publish or present Study data and results generated in their performance of the Study in accordance with the terms of this Article.
12805|NCT01226420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12806|NCT01226121|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12807|NCT01226095|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection
12808|NCT01226043|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
12809|NCT01225991|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12810|NCT01225952|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s)after the review by, and in consultation and agreement with the Sponsor.
12811|NCT01225926|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
12812|NCT01225887|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12813|NCT01225835|Principal Investigators are NOT employed by the organization sponsoring the study.|"The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor.~Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention."
12815|NCT01225731|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the Sponsor. The investigator further agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication in any media that report any results of the trial. The Sponsor shall have the right to review and comment on the data analysis and presentation.
12816|NCT01225562|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12817|NCT01225549|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish any results until (i) the date of the first Study results publication, or in case of a Multi-Centre Study the first Multi-Centre Results publication, agreed by the participating sites, and (ii) the end of the eighteen (18) month period following the completion or early termination of the Study at all participating sites.
12818|NCT01225354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12819|NCT01225289|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12820|NCT01225263|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12821|NCT01225211|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
12822|NCT01225159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12823|NCT01225146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12824|NCT01225068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12825|NCT01225055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12826|NCT01225029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12827|NCT01224821|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12828|NCT01224782|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12829|NCT01224639|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
12830|NCT01224626|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12831|NCT01224444|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12832|NCT01224431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12833|NCT01224236|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12854|NCT01222533|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
12834|NCT01224171|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
12835|NCT01224015|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
12836|NCT01223963|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12837|NCT01223937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
12838|NCT01223703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12839|NCT01223469|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12840|NCT01223404|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12841|NCT01223365|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
12842|NCT01223352|Principal Investigators are NOT employed by the organization sponsoring the study.|The only agreement between the sponsor and the investigators is that any study-related article or abstract written independently by investigators must be submitted to the sponsor for review at least 60 days prior to submission for publication or presentation.
12843|NCT01223235|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12844|NCT01223196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12845|NCT01223183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12846|NCT01223027|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
12847|NCT01223001|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12848|NCT01222884|Principal Investigators are NOT employed by the organization sponsoring the study.|If Pharmacosmos or its agents has not prepared a draft for submission to a peer reviewed journal prior to 1 year following completion of the study report, the investigators have the right to publish the results. Such publications are to be submitted to Pharmacosmos for comment 30 days prior to submission for publication.
12849|NCT01222832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12850|NCT01222715|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12851|NCT01222689|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12852|NCT01222585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12855|NCT01222520|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12856|NCT01222507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12857|NCT01222416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12858|NCT01222403|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12859|NCT01222390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12860|NCT01222286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12861|NCT01222273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12862|NCT01222234|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12863|NCT01222195|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12864|NCT01222117|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the study, after providing sponsor 30 days’ notice prior to submitting a manuscript or other materials related to the study to any outside party. At sponsor's request, site will remove any confidential information (other than study results), and site will upon sponsor's request delay publication or presentation for a period of up to 60 days to allow sponsor to protect its interests in any sponsor inventions
12865|NCT01222104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12866|NCT01222078|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12867|NCT01221948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12868|NCT01221753|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12869|NCT01221727|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
12870|NCT01221623|Principal Investigators are NOT employed by the organization sponsoring the study.|
12871|NCT01221597|Principal Investigators are NOT employed by the organization sponsoring the study.|
12872|NCT01221441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12873|NCT01221363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12874|NCT01221350|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12875|NCT01221311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12876|NCT01221298|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
12878|NCT01221272|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
12879|NCT01221090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12880|NCT01220973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12881|NCT01220869|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
12882|NCT01220739|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12883|NCT01220609|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12884|NCT01220557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12885|NCT01220466|Principal Investigators are NOT employed by the organization sponsoring the study.|
12886|NCT01220414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12887|NCT01220401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12888|NCT01220297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12889|NCT01220180|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12890|NCT01220128|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12891|NCT01219985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12892|NCT01219933|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12893|NCT01219881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12894|NCT01219855|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12895|NCT01219777|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12896|NCT01219738|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12897|NCT01219673|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12934|NCT01216943|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
12898|NCT01218997|Principal Investigators are NOT employed by the organization sponsoring the study.|Should a PI wish to disclose results, the Sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days prior to the submission, for review and approval. Revisions will be negotiated in good faith by the Investigator and Sponsor and may be submitted for publication or disclosed by the Investigator only following receipt of written approval from the Sponsor.
12899|NCT01218984|Principal Investigators are NOT employed by the organization sponsoring the study.|Should a PI wish to disclose results, the Sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days prior to the submission, for review and approval. Revisions will be negotiated in good faith by the Investigator and Sponsor and may be submitted for publication or disclosed by the Investigator only following receipt of written approval from the Sponsor.
12900|NCT01218971|Principal Investigators are NOT employed by the organization sponsoring the study.|Should a PI wish to disclose results, the Sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days prior to the submission, for review and approval. Revisions will be negotiated in good faith by the Investigator and Sponsor and may be submitted for publication or disclosed by the Investigator only following receipt of written approval from the Sponsor.
12901|NCT01218958|Principal Investigators are NOT employed by the organization sponsoring the study.|Should a PI wish to disclose results, the Sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days prior to the submission, for review and approval. Revisions will be negotiated in good faith by the Investigator and Sponsor and may be submitted for publication or disclosed by the Investigator only following receipt of written approval from the Sponsor.
12902|NCT01218867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12903|NCT01218802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12904|NCT01218646|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
12905|NCT01218594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12906|NCT01218477|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
12907|NCT01218438|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or ≤15 months after study completion. Baxalta requires a review of results communications (eg, for confidential information) ≥30 days prior to submission or communication. Baxalta may request an additional delay of ≤60 days eg, for intellectual property protection.
12908|NCT01218399|Principal Investigators are NOT employed by the organization sponsoring the study.|Please contact the sponsor Astra Zeneca for the agreement
12909|NCT01218308|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12910|NCT01218243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12911|NCT01218204|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12912|NCT01218126|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12913|NCT01218113|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
12914|NCT01218100|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
12915|NCT01218087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12916|NCT01218009|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data
12917|NCT01217957|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
12918|NCT01217944|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
12919|NCT01217892|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
12920|NCT01217840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12921|NCT01217827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12922|NCT01217814|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
12923|NCT01217801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12924|NCT01217749|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12925|NCT01217606|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
12926|NCT01217515|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12927|NCT01217476|Principal Investigators are NOT employed by the organization sponsoring the study.|PI have no implicit or explicit rights to publish study data and results of their services.
12928|NCT01217463|Principal Investigators are NOT employed by the organization sponsoring the study.|PI have no implicit or explicit rights to publish study data and results of their services.
12929|NCT01217411|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12930|NCT01217307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12931|NCT01217229|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12932|NCT01217112|Principal Investigators are NOT employed by the organization sponsoring the study.|GW Pharmaceuticals Ltd (GW) will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
12933|NCT01217073|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
12935|NCT01216761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12936|NCT01216748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12937|NCT01216735|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12938|NCT01216631|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12939|NCT01216410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12940|NCT01216397|All Principal Investigators ARE employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12941|NCT01216319|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12942|NCT01216241|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12943|NCT01216163|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12944|NCT01216072|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
12945|NCT01215981|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12946|NCT01215968|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12947|NCT01215955|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12948|NCT01215929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12949|NCT01215851|Principal Investigators are NOT employed by the organization sponsoring the study.|All unpublished information given to the Investigator by the Sponsor shall not be published/disclosed to a third party, other than to IEC/IRB, within the understanding of the confidentiality, without the prior written consent of the Sponsor. Results of this research will be submitted for publication as soon as feasible upon completion of the study in the form of a joint publication(s) between the Sponsor and Investigator(s), including site clinical and laboratory investigators, as appropriate.
12950|NCT01215786|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
12951|NCT01215734|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12952|NCT01215721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12953|NCT01215695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12954|NCT01215643|Principal Investigators are NOT employed by the organization sponsoring the study.|
12955|NCT01215513|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
12956|NCT01215435|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol.
12957|NCT01215422|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12958|NCT01215357|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12959|NCT01215344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12960|NCT01215292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12961|NCT01215279|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institutions or Investigators were permitted to publish or present the study results from their site (or the overall results), providing the article or presentation was submitted to and approved by AstraZeneca beforehand.
12962|NCT01215227|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc) that report any results of the trial.
12963|NCT01215123|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12964|NCT01215110|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator or any Sub-Investigator shall submit any oral or written publication or abstract concerning this study to the Sponsor not less than thirty (30) days prior to submission to any journal, other publication or meeting, for review and removal of confidential information.
12965|NCT01215097|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12966|NCT01215032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12967|NCT01214980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12968|NCT01214915|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
12969|NCT01214850|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12970|NCT01214837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12971|NCT01214824|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12972|NCT01214811|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12973|NCT01214759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12974|NCT01214720|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
12975|NCT01214616|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12976|NCT01214434|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12977|NCT01214395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12978|NCT01214330|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12979|NCT01214252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12980|NCT01214239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12981|NCT01214187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12982|NCT01214174|Principal Investigators are NOT employed by the organization sponsoring the study.|All information related to this study is considered confidential information belonging to Icon Bioscience, Inc. Data on the use of the study drug and results of all clinical and laboratory studies are considered private and confidential. None of the details, results, or other information for this study shall be published or made known to a third party without written consent from Icon Bioscience, Inc., except for disclosure to regulatory agencies if required by law.
12983|NCT01214161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12984|NCT01214109|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
12985|NCT01214083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12986|NCT01213966|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12987|NCT01213836|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12988|NCT01213823|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
12989|NCT01213706|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12990|NCT01213589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12991|NCT01213576|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12992|NCT01213329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12993|NCT01213316|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of this study will be published by the sponsor according to the current guidelines for publication. The Contract Research Organization will assist the sponsor with initial publication. Further details will be laid down in the financial agreement between the sponsor and the Contract Research Organization.
12994|NCT01213264|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from Investigator’s site will initially only be published/presented with results from the other sites, unless permission is obtained to publish separate results. Investigator will not publish interim results. Sponsor must be able to review all proposed study results communications 45 days prior to submission for publication/presentation. If parties disagree concerning appropriateness of proposed content, Investigator will meet with Sponsor's representatives to discuss/resolve any issues.
12995|NCT01213251|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12996|NCT01213199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
12997|NCT01213173|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
12998|NCT01213043|Principal Investigators are NOT employed by the organization sponsoring the study.|
12999|NCT01212991|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees not to independently publish the results before the publication of the multi-center PI paper. Sponsor shall review and comment 30 days prior to submission or disclosure. If publication or disclosure contains Sponsor Confidential Information, other than study data, PI agrees to remove Confidential Information from publication or disclosure. Sponsor may request that PI delay such publication for an additional 60 days to protect the patentability of any invention described.
13000|NCT01212874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13001|NCT01212770|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
13002|NCT01212757|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
13003|NCT01212627|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13004|NCT01212484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13005|NCT01212445|Principal Investigators are NOT employed by the organization sponsoring the study.|Schering-Plough HealthCare Products, Inc. reserves all publication and presentation rights.
13006|NCT01212302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13007|NCT01212185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13008|NCT01212172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13009|NCT01212159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13010|NCT01212094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13011|NCT01211873|Principal Investigators are NOT employed by the organization sponsoring the study.|"No unpublished data given to the investigator may be transmitted to a third party without prior approval of the sponsor in writing. The data are the exclusive property of Guerbet.~The investigator undertakes to submit to Guerbet any draft articles or papers related to this study within 30 days of their submission to the scientific review or the congress scientific committee.~All written or oral papers and publications must have the joint agreement of the investigator and the sponsor."
13012|NCT01211769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13013|NCT01211730|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13014|NCT01211665|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
13015|NCT01211613|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13016|NCT01211535|Principal Investigators are NOT employed by the organization sponsoring the study.|
13017|NCT01211340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13018|NCT01211197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13019|NCT01211184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13020|NCT01211145|Principal Investigators are NOT employed by the organization sponsoring the study.|
13021|NCT01211106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13022|NCT01210820|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 1 month prior to any proposed submission for publication or presentation of Trial data or other findings related to the Trial, the Institution will provide the Sponsor with a manuscript for review, comment, and approval. Under no circumstances shall the Institution or PI publish or disclose the Sponsor's confidential Information without the Sponsor's prior written approval.The manner in which the publication will be generated will be negotiated between the Sponsor and PI.
13023|NCT01210807|Principal Investigators are NOT employed by the organization sponsoring the study.|
13024|NCT01210716|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of data and/or information derived from the study requires prior review and approval by Sponsor.
13025|NCT01210690|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13026|NCT01210651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13027|NCT01210495|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13028|NCT01210443|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13029|NCT01210222|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13030|NCT01210170|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13031|NCT01210144|Principal Investigators are NOT employed by the organization sponsoring the study.|
13032|NCT01210118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13033|NCT01210079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13034|NCT01210001|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13035|NCT01209949|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
13036|NCT01209780|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13037|NCT01209767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13038|NCT01209702|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13039|NCT01209689|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13040|NCT01209624|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13041|NCT01209598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13042|NCT01209520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13043|NCT01209286|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
13044|NCT01209260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13045|NCT01209195|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13046|NCT01209143|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13047|NCT01209078|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13048|NCT01208961|Principal Investigators are NOT employed by the organization sponsoring the study.|Individual investigators may publish data arising from their own subjects. The PI will provide the Sponsor with copies of written publications (including abstracts and posters)at least 60 days in advance of submission. Data will be reviewed by all participating investigators prior to publication. The Sponsor will have 60 days to review all definitive publications, such as manuscripts and book chapters, and a minimum of 30 days to review all abstracts.
13049|NCT01208870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13050|NCT01208415|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13051|NCT01208402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13052|NCT01208337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13053|NCT01208233|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13054|NCT01208220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13055|NCT01208207|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
13056|NCT01208181|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
13057|NCT01207934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13058|NCT01207765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13059|NCT01207687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13060|NCT01207648|Principal Investigators are NOT employed by the organization sponsoring the study.|
13061|NCT01207596|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13062|NCT01207583|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13063|NCT01207570|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13064|NCT01207492|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13065|NCT01207466|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
13066|NCT01207453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13067|NCT01207427|Principal Investigators are NOT employed by the organization sponsoring the study.|
13068|NCT01207414|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
13069|NCT01207401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13070|NCT01207388|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
13071|NCT01207219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13072|NCT01207102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13073|NCT01206777|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13074|NCT01206738|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13075|NCT01206660|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13076|NCT01206608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13077|NCT01206595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13078|NCT01206582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13100|NCT01205165|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13079|NCT01206517|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may not publish/publicly present interim results without prior consent of Sponsor. Any materials that report results of the study must be sent to Sponsor 45 days prior to submission for publication/presentation. Sponsor has right to review and comment. In case of any disagreements concerning appropriateness of the materials, investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues or disagreement, prior to submission for publication/presentation.
13080|NCT01206478|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13081|NCT01206452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13082|NCT01206439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13083|NCT01206387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13084|NCT01206322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13085|NCT01206140|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13086|NCT01206101|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
13087|NCT01206062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13088|NCT01205828|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13089|NCT01205776|Principal Investigators are NOT employed by the organization sponsoring the study.|
13090|NCT01205685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13091|NCT01205646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13092|NCT01205581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13093|NCT01205568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13094|NCT01205529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13095|NCT01205503|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13096|NCT01205451|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13097|NCT01205399|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13098|NCT01205269|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites. AZ has the right to request delays: up to 60 days for confidential information, and an additional 90 days to protect intellectual property.
13099|NCT01205230|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13101|NCT01205152|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13102|NCT01205126|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13103|NCT01205035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13104|NCT01204918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13105|NCT01204853|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13106|NCT01204788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13107|NCT01204775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13108|NCT01204736|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13109|NCT01204697|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13110|NCT01204671|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13111|NCT01204658|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13112|NCT01204398|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13113|NCT01204294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13114|NCT01204255|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13115|NCT01204203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13116|NCT01203956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13117|NCT01203930|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
13118|NCT01203917|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13119|NCT01203878|Principal Investigators are NOT employed by the organization sponsoring the study.|Up to 30 days to review presentations and/or manuscripts. Up to an additional 60 days, if applicable, to file patent applications.
13120|NCT01203852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13121|NCT01203826|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13122|NCT01203787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13123|NCT01203644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13124|NCT01203319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13125|NCT01203189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13126|NCT01203098|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
13127|NCT01203072|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
13128|NCT01203046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13129|NCT01202994|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13130|NCT01202955|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13131|NCT01202903|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
13132|NCT01202877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13133|NCT01202773|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13134|NCT01202760|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13135|NCT01202747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13136|NCT01202656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13137|NCT01202643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13138|NCT01202591|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13139|NCT01202578|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13140|NCT01202565|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13141|NCT01202279|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13142|NCT01202253|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13143|NCT01202227|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13144|NCT01202188|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
13145|NCT01202162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13146|NCT01202110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13147|NCT01202071|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13148|NCT01201967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13149|NCT01201915|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13150|NCT01201811|Principal Investigators are NOT employed by the organization sponsoring the study.|Multicenter publication must include input from all Investigators involved in the study and Sponsor before its publication; it has priority over subset (single center) publication during 1 year after study completion; Each Investigator has publication rights after multicenter publication is submitted or 1 year after study completion. Sponsor has the right to comment on the publication and ask for a 90-day delay to protect its intellectual property and/or deletion of any confidential information.
13151|NCT01201798|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
13152|NCT01201785|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13153|NCT01201772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13154|NCT01201759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13155|NCT01201629|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13156|NCT01201486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13157|NCT01201343|Principal Investigators are NOT employed by the organization sponsoring the study.|
13158|NCT01201317|Principal Investigators are NOT employed by the organization sponsoring the study.|No such publication or presentation may include any of AstraZeneca’s Confidential Information without AstraZeneca’s prior written approval. AZ should have 60 days for review and can extend time until submission up to 90 days.
13159|NCT01201265|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13160|NCT01200992|Principal Investigators are NOT employed by the organization sponsoring the study.|
13161|NCT01200875|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13162|NCT01200810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13201|NCT01198366|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13163|NCT01200797|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13164|NCT01200758|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13165|NCT01200602|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13166|NCT01200589|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13167|NCT01200524|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreement restricts the PI's rights to discuss or publish trial results after the trial is completed. No publication or presentation may include any of AZ's Confidential Information without AZ's prior written approval. AZ should have 60 days for review and can extend time until submission up to 90 days.
13168|NCT01200511|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
13169|NCT01200498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13170|NCT01200433|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13171|NCT01200368|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13172|NCT01200355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13173|NCT01200342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13174|NCT01200290|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13175|NCT01200160|Principal Investigators are NOT employed by the organization sponsoring the study.|An agreement is in place that includes a clause of keeping Abbott´s information confidential and that any publication would be performed under agreement with Abbott.
13176|NCT01200069|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13177|NCT01199965|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13178|NCT01199939|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13179|NCT01199926|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13180|NCT01199861|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
13181|NCT01199822|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
13202|NCT01198327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13182|NCT01199744|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13183|NCT01199731|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13184|NCT01199705|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
13185|NCT01199601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13186|NCT01199471|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
13187|NCT01199237|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13188|NCT01199146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13189|NCT01199042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13190|NCT01199016|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13191|NCT01198977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13192|NCT01198873|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the Investigator can present or publish trial results. A copy is submitted to the Sponsor for review and comment at least 30 days in advance of any presentation or submission for publication.~The Sponsor can require to delay the communication for a period not exceeding 90 days to allow for filing a patent application or such other measures as Sponsor deems appropriate to establish and preserve its proprietary rights."
13193|NCT01198795|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
13194|NCT01198769|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13195|NCT01198756|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13196|NCT01198691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13197|NCT01198600|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
13198|NCT01198574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13199|NCT01198548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13200|NCT01198509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13203|NCT01198275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13204|NCT01198145|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13205|NCT01198132|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication will be publication of results of the analysis of primary endpoint(s) that will include data from all trial centers. Any publications and presentations of results, either in whole or in part, by investigators or their representatives will require pre-submission review by the sponsor/CRO. Sponsor will not suppress or veto publications, but maintains right to delay publication in order to protect intellectual property rights.
13206|NCT01198002|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13207|NCT01197911|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13208|NCT01197898|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release.
13209|NCT01197833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13210|NCT01197794|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13211|NCT01197755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13212|NCT01197612|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13213|NCT01197560|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
13214|NCT01197547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13215|NCT01197534|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13216|NCT01197521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13217|NCT01197508|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13218|NCT01197495|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13219|NCT01197417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13220|NCT01197326|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13221|NCT01196988|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13222|NCT01196975|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13223|NCT01196923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13224|NCT01196819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13225|NCT01196741|Principal Investigators are NOT employed by the organization sponsoring the study.|Participating sites may not publish trial results without prior written consent from the Trial Management Group
13226|NCT01196442|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13227|NCT01196429|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13228|NCT01196416|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13229|NCT01196377|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13230|NCT01196104|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
13231|NCT01196078|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13232|NCT01196052|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13233|NCT01196026|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13234|NCT01195948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13235|NCT01195922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13236|NCT01195844|Principal Investigators are NOT employed by the organization sponsoring the study.|"The initial publication of this study will be multicenter, comprising data from all sites involved. After the multicenter publication, or 24 months after the end of the study, each site involved may publish its own results in an independent fashion.~The sponsor will also have the opportunity to review all the proposed abstracts,~manuscripts or lectures related to this study 60 days before submission for~publication/presentation."
13237|NCT01195831|Principal Investigators are NOT employed by the organization sponsoring the study.|The company acknowledges the investigators' right to publish the results of the trial. The company retains the right to have any publication submitted to the company for review at least 30 days prior to the proposed submission or presentation date. Investigators must undertake not to submit any part of their individual data for publication without prior consent of LEO.
13238|NCT01195779|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13239|NCT01195701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13240|NCT01195675|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13241|NCT01195662|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
13242|NCT01195636|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13243|NCT01195623|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13244|NCT01195597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13245|NCT01195584|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13246|NCT01195467|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13247|NCT01195415|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13248|NCT01195363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13249|NCT01195272|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but only after the first publication or presentation that involves the overall study. The sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the sponsor's intellectual property rights.
13250|NCT01195116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13251|NCT01195103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13252|NCT01195090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13253|NCT01195025|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13254|NCT01194999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13255|NCT01194973|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this multicenter study involved a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis.
13256|NCT01194908|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13257|NCT01194869|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13258|NCT01194856|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13259|NCT01194830|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13260|NCT01194674|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13261|NCT01194570|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13262|NCT01194531|Principal Investigators are NOT employed by the organization sponsoring the study.|"Each PI signed an agreement that all data, analyses, information and materials prepared or derived as a direct result of the Study are required to be provided to the sponsor and in accordance with the Protocol, whether preliminary or final (the Study Results) shall be property of the sponsor. Site may utilize the Study Results for patient care and for it's own internal education purposes."
13263|NCT01194479|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13264|NCT01194453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13265|NCT01194440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13266|NCT01194427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13267|NCT01194414|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13268|NCT01194297|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13269|NCT01194258|Principal Investigators are NOT employed by the organization sponsoring the study.|
13270|NCT01194245|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained as a result of this study or during the conduct of this study will be regarded as confidential. The Investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless written permission from the sponsor (Halozyme) is obtained.
13271|NCT01194219|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
13272|NCT01194154|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13273|NCT01194089|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13274|NCT01193920|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement: the terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
13275|NCT01193907|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event that no publication of the Study results has been made by NVGH within twelve (12) months of Study database lock and no proposed publication is under discussion by the publication committee, Principal Investigator may publish its own Study results.
13276|NCT01193868|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13277|NCT01193686|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13278|NCT01193660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13279|NCT01193608|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13280|NCT01193582|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13300|NCT01192282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13281|NCT01193556|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13282|NCT01193348|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this multicenter study involved a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis.
13283|NCT01193335|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13284|NCT01193283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13285|NCT01193244|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
13286|NCT01193218|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13287|NCT01193153|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 60 days prior to submitting a manuscript the Site shall provide to Sponsor a copy of all such manuscripts and materials,and allow Sponsor 60 days to review and comment on them. If Sponsor requests, the Site shall remove any Confidential Information prior to submitting the materials.The Site agrees that if Study is part of a multi-center study,any publication by the Institution of results of the Study conducted at the Site shall not be made before the first multi-center publication.
13288|NCT01193127|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agreed not to publish or otherwise to disclose Study data without prior written consent from the sponsor for a period of 24 months following Study completion or until data are published in a combined publication (whichever occurs first). The sponsor can review communications containing results prior to public release and embargo those communications for a period that is no longer than 60 days from the date of receipt of the non-public communication. The sponsor cannot extend the embargo.
13289|NCT01193114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13290|NCT01193101|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13291|NCT01193049|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
13292|NCT01192776|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators must adhere to the Neonatal Research Network Publication policies.
13293|NCT01192698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13294|NCT01192542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13295|NCT01192516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13296|NCT01192412|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13297|NCT01192399|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13298|NCT01192347|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
13299|NCT01192295|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13301|NCT01192204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13302|NCT01192191|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13303|NCT01192178|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13304|NCT01192152|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
13305|NCT01192139|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
13306|NCT01192126|Principal Investigators are NOT employed by the organization sponsoring the study.|
13307|NCT01192022|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
13308|NCT01191944|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13309|NCT01191840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13310|NCT01191827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13311|NCT01191801|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13312|NCT01191788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13313|NCT01191762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13314|NCT01191749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13315|NCT01191736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13316|NCT01191723|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13317|NCT01191476|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
13318|NCT01191411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13319|NCT01191398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13320|NCT01191333|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13321|NCT01191320|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights.
13322|NCT01191268|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13323|NCT01191255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13324|NCT01191242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13325|NCT01191190|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13326|NCT01191086|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13327|NCT01191008|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13328|NCT01190891|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13329|NCT01190878|Principal Investigators are NOT employed by the organization sponsoring the study.|
13330|NCT01190865|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13331|NCT01190839|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
13332|NCT01190813|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13333|NCT01190566|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13334|NCT01190527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13335|NCT01190514|All Principal Investigators ARE employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13336|NCT01190475|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs must seek written permission from the sponsor prior to publication of any trial results.
13337|NCT01190436|Principal Investigators are NOT employed by the organization sponsoring the study.|"PI shall make no press release, advertising or other promotional written or oral statements to public in connection with any reference to Sponsor’s name of any member of Sponsor's staff, or PI, without prior approval of Sponsor or designated agent.~PI and/or Co-I shall not publish any information related to study data/results without first obtaining prior written consent of Sponsor and agrees to submit to Sponsor for review, a copy of any proposed publication resulting from completed study."
13338|NCT01190306|Principal Investigators are NOT employed by the organization sponsoring the study.|All such Confidential Information shall remain the property of Topcon, as applicable, and Institution agrees that neither it nor Principal Investigator nor any of its employees or Sub-Investigators, if any, shall disclose any of the Confidential Information to third parties, without the prior written consent of Topcon.
13339|NCT01190267|Principal Investigators are NOT employed by the organization sponsoring the study.|It is planned to first publish/present trial results together with the other sites, unless permission is obtained from Sponsor to publish separate results. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. If there is disagreement concerning appropriateness of the materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve disagreement prior to submission for publication.
13358|NCT01189370|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13340|NCT01190254|Principal Investigators are NOT employed by the organization sponsoring the study.|It is planned to first publish/present trial results together with the other sites, unless permission is obtained from Sponsor to publish separate results. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. If there is disagreement concerning appropriateness of the materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve disagreement prior to submission for publication.
13341|NCT01190228|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
13342|NCT01190215|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13343|NCT01190150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
13344|NCT01190124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13345|NCT01190098|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13346|NCT01190085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13347|NCT01190007|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13348|NCT01189890|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish results for his/her study site after publication of results of entire multicenter trial, or after public disclosure of the results online if a multicenter manuscript is not planned. Sponsor must be able to review all proposed results communications regarding study 60 days prior to submission for publication/presentation. Information identified by the Sponsor as confidential must be deleted prior to submission.
13349|NCT01189812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13350|NCT01189760|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13351|NCT01189747|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13352|NCT01189617|Principal Investigators are NOT employed by the organization sponsoring the study.|Study is considered a work made for hire and the Sponsor retains all rights to publish results.
13353|NCT01189604|Principal Investigators are NOT employed by the organization sponsoring the study.|If the PI wants to publish the results, the PI must send the English documents to AZ beforehand. And AZ can review and revise the documents, after that, AZ will give the approval to the PI about the publication of the results.
13354|NCT01189500|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13355|NCT01189487|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13356|NCT01189461|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13357|NCT01189435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13359|NCT01189292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13360|NCT01189279|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13361|NCT01189240|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13362|NCT01189227|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13363|NCT01189201|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
13364|NCT01189136|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13365|NCT01189123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13366|NCT01189110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13367|NCT01189071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13368|NCT01189032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13369|NCT01188967|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13370|NCT01188928|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting or presenting a manuscript relating to the clinical trial to a publisher, reviewer, or other outside person, the Investigator shall provide to LEO a copy of all such manuscripts, and LEO shall have rights to review and comment. Upon the request of LEO the Investigator shall remove any confidential information (other than results generated by the Investigator) prior to submitting or presenting the manuscripts.
13371|NCT01188876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13372|NCT01188811|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13373|NCT01188798|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13374|NCT01188772|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
13375|NCT01188694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13376|NCT01188681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13377|NCT01188668|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13423|NCT01185561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13378|NCT01188655|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13379|NCT01188603|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Sprout Pharmaceuticals publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13380|NCT01188577|Principal Investigators are NOT employed by the organization sponsoring the study.|
13381|NCT01188564|Principal Investigators are NOT employed by the organization sponsoring the study.|To ensure against inadvertent disclosure of confidential information, the PI will provide Sponsor an opportunity to review any proposed publication/disclosure before it is submitted or otherwise disclosed. The PI will submit proposed manuscript, publication or disclosure to the Sponsor for comment at least 60 days prior to its submission/disclosure. If requested, the publishing party shall remove any Information (other than Study results) prior to submitting or disclosing the materials.
13382|NCT01188551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13383|NCT01188538|Principal Investigators are NOT employed by the organization sponsoring the study.|
13384|NCT01188499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13385|NCT01188460|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13386|NCT01188447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13387|NCT01188421|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13388|NCT01188343|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
13389|NCT01188226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13390|NCT01188109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13391|NCT01187953|Principal Investigators are NOT employed by the organization sponsoring the study.|
13392|NCT01187914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13393|NCT01187901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13394|NCT01187771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13395|NCT01187550|Principal Investigators are NOT employed by the organization sponsoring the study.|
13396|NCT01187511|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13397|NCT01187498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13398|NCT01187446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13399|NCT01187433|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
13400|NCT01187407|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13443|NCT01184053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13401|NCT01187381|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13402|NCT01187355|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
13403|NCT01187043|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
13404|NCT01187017|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13405|NCT01187004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13406|NCT01186939|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (30) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
13407|NCT01186848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13408|NCT01186796|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13409|NCT01186744|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13410|NCT01186705|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13411|NCT01186692|Principal Investigators are NOT employed by the organization sponsoring the study.|A publication committee is in place for this study.
13412|NCT01186562|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13413|NCT01186458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13414|NCT01186419|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
13415|NCT01186406|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13416|NCT01186250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13417|NCT01185964|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13418|NCT01185834|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
13419|NCT01185821|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
13420|NCT01185782|Principal Investigators are NOT employed by the organization sponsoring the study.|
13421|NCT01185704|Principal Investigators are NOT employed by the organization sponsoring the study.|
13422|NCT01185600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13424|NCT01185522|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13425|NCT01185509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13426|NCT01185353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13427|NCT01185340|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13428|NCT01185301|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13429|NCT01185288|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13430|NCT01185249|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13431|NCT01185080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between PI and Sponsor (AZ) or its agents that restricts the PI's right to discuss/publish trial results after the trial is completed. The PI agrees to collaborate in good faith with AZ with regards to content and formation of any publication or disclosure to be made by PI and to pay due consideration to opinions offered by AZ
13432|NCT01185028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13433|NCT01184989|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13434|NCT01184898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13435|NCT01184885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13436|NCT01184872|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13437|NCT01184859|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
13438|NCT01184846|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
13439|NCT01184755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13440|NCT01184417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13441|NCT01184118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13442|NCT01184079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13444|NCT01184014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13445|NCT01183975|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13446|NCT01183858|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13447|NCT01183780|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
13448|NCT01183728|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13449|NCT01183689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13450|NCT01183650|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13451|NCT01183546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13452|NCT01183533|Principal Investigators are NOT employed by the organization sponsoring the study.|The study PI will submit the manuscript of any proposed publication to the sponsor at least 45 days before publication, and the sponsor shall have the right to review and comment upon the publication. The sponsor shall provide any comments to investigator within 30 days of receipt of the proposed publication or presentation. At the end of the 30 day period, the PI shall be free to proceed with the publication or presentation provided he or she has complied with the sponsor's feedback.
13453|NCT01183481|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13454|NCT01183468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13455|NCT01183390|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13456|NCT01183312|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13457|NCT01183260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13458|NCT01183234|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually
13459|NCT01183169|Principal Investigators are NOT employed by the organization sponsoring the study.|
13460|NCT01183143|All Principal Investigators ARE employed by the organization sponsoring the study.|
13461|NCT01183104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13462|NCT01183065|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13463|NCT01183013|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13464|NCT01182805|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13465|NCT01182727|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13466|NCT01182675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13467|NCT01182610|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication or presentation of Sponsored Research results, Researcher agrees to provide Amgen 60 days to review a manuscript and 15 days to review any poster presentation, abstract or other written or oral materials derived from a Study. If Amgen requests in writing, the Researcher shall withhold material an additional 60 days. Amgen reserves the right to remove confidential information from any publications. The Researcher shall reference Amgen's support of the Study in any material.
13468|NCT01182493|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13469|NCT01182480|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13470|NCT01182428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13471|NCT01182415|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13472|NCT01182376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13473|NCT01182337|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Investigators may freely present or publish results of the Clinical Investigation in a manner which fairly sets forth the conclusions reached by the Clinical Investigators, but only after the Sponsor has been given the opportunity of reviewing the proposed presentation or publication at least 60 days prior to the intended submission, presentation, or publication date.
13474|NCT01182298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13475|NCT01182285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13476|NCT01182207|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13477|NCT01182194|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13478|NCT01182181|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13479|NCT01182103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13480|NCT01181986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13481|NCT01181947|Principal Investigators are NOT employed by the organization sponsoring the study.|Medical Center or Investigator may, at his/her discretion, publish and/or present publicly the results of the work of Medical Center and/or Investigator performed under this Agreement. However, should Medical Center or Investigator contemplate publishing and/or presenting publicly such results, the Investigator shall provide copies of any abstracts, papers, or manuscripts to Medtronic for review at least 90 (ninety) days prior to submittal for publication or presentation.
13482|NCT01181921|Principal Investigators are NOT employed by the organization sponsoring the study.|Study results as well as all reports or publications related to the study, belong to the sponsor exclusively. If the investigator would like to public results in journals or scientific magazines, it has to be in agreement with the sponsor and according to the protocol.
13483|NCT01181895|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13484|NCT01181804|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication. The sponsor shall have the right to review and comment.
13485|NCT01181778|Principal Investigators are NOT employed by the organization sponsoring the study.|"Investigators have accepted and committed not to disclose~information herein contained. Investigators will not to publish or disclose any results pertaining to the study without written authorization by the Sponsor.~Investigators accept that the Sponsor will review any manuscript or abstract 30 days before submission for a publication or presentation (including oral~presentations) containing data derived from the present study."
13486|NCT01181726|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13487|NCT01181609|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13488|NCT01181531|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
13489|NCT01181492|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13490|NCT01181349|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may not publish/publicly present interim results without prior consent of Sponsor. Any materials that report results of the study must be sent to Sponsor 45 days prior to submission for publication/presentation. Sponsor has right to review and comment. In case of any disagreements concerning appropriateness of the materials, investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues or disagreement, prior to submission for publication/presentation.
13491|NCT01181323|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13492|NCT01181271|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13493|NCT01181258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13494|NCT01181167|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
13495|NCT01181141|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
13496|NCT01181128|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
13497|NCT01181102|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
13498|NCT01181050|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to defer data release until specified milestones, e.g. availability of a clinical trial report. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property. Novo Nordisk reserves the right to prior review of site-specific publications and to ask for deferment of publication of individual site results until after the primary manuscript is accepted for publication.
13499|NCT01181011|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13500|NCT01180998|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication required agreement and written authorization from the Sponsor.
13501|NCT01180985|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written consent from the Sponsor.
13502|NCT01180894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13503|NCT01180790|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting/presenting a manuscript or materials relating to a Study to a publisher, reviewer, or outside person, the Institution shall provide to Achillion a copy of all such manuscripts or materials, and Achillion shall have sixty (60) days to review and comment. The Institution shall, upon Achillion's request, further delay publication or presentation for a period of up to one hundred twenty (120) days to allow Achillion to protect its interests in any Achillion Inventions.
13504|NCT01180777|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written authorization from the Sponsor
13505|NCT01180660|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13506|NCT01180647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13507|NCT01180478|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13508|NCT01180400|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13509|NCT01180296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13510|NCT01180244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13511|NCT01180127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13512|NCT01180049|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13513|NCT01179984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13514|NCT01179919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13515|NCT01179737|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
13516|NCT01179672|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13517|NCT01179568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13518|NCT01179516|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
13519|NCT01179490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13520|NCT01179399|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13521|NCT01179347|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13522|NCT01179334|Principal Investigators are NOT employed by the organization sponsoring the study.|The embargo can be up to 6 months (equal to the 180 days), moreover if it is necessary the embargo period can be prolonged to expiry of priority year.
13523|NCT01179217|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees that any INFORMATION submitted to it by EMMAUS shall be maintained in secrecy for a period of seven (7) years from each disclosure of INFORMATION. PI will use the up most due diligence to prevent disclosure by it except to its employees, agents, and contractors necessary for evaluation, all of whom shall be bound by similar written obligations of confidentiality, and who agree not to use the INFORMATION for any purpose other than for evaluation purposes.
13524|NCT01179191|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13525|NCT01179113|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13526|NCT01179048|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
13527|NCT01178944|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13528|NCT01178853|Principal Investigators are NOT employed by the organization sponsoring the study.|May not publish
13529|NCT01178827|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13530|NCT01178762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13531|NCT01178671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13532|NCT01178528|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13533|NCT01178385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13534|NCT01178333|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications and presentations resulting from studies from the TMH Network must be approved by the Publications and Presentations Committee before submission. The Sponsor (NERI) and funding agency (NHLBI) both are represented on the P&P Committee along with Network Investigators. Members of the P&P Committee can recommend changes to publications.
13535|NCT01178294|Principal Investigators are NOT employed by the organization sponsoring the study.|For this study, PIs are restricted from independently publishing results before completion of a single multicenter publication or one year after study completion, whichever occurs first. Baxter requires a review of results communications (eg, for confidential information) ≥30 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (eg, if a patentable invention is disclosed).
13536|NCT01178281|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then Investigator can publish if the manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides a publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
13537|NCT01178268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13538|NCT01178138|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13539|NCT01178125|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator/Institution must submit proposed publication to Sponsor for review within a prespecified number of days before submission for publication. If Sponsor's review shows that potentially patentable subject matter would be disclosed, publication/public disclosure shall be delayed to enable Sponsor, or Sponsor’s designees, to file necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
13540|NCT01178099|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13541|NCT01178073|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13542|NCT01177969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13543|NCT01177956|Principal Investigators are NOT employed by the organization sponsoring the study.|All submissions by the PI for publication require the written permission from the sponsor. The PI commits to forward to the sponsor all documents intended for publication which contains data or results generated in connection with the study. Documents must be available at least 60 days before the planned submission date to allow for review. Any publication should follow the policy in the protocol. The PI shall not publish results derived from the study until the study has been reported in full.
13544|NCT01177943|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13545|NCT01177813|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13546|NCT01177800|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13547|NCT01177735|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13548|NCT01177722|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
13549|NCT01177709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13550|NCT01177670|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13551|NCT01177553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13552|NCT01177410|Principal Investigators are NOT employed by the organization sponsoring the study.|INVESTIGATOR shall not publish the results of the Study conducted at the INSTITUTION, unless they (i) obtain the prior written consent of SALIX for the publication; or (ii) withhold any publication for a period of two (2) years following the Completion of the Study by all participating institutions and investigators
13553|NCT01177384|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
13554|NCT01177293|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13555|NCT01177228|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
13556|NCT01177098|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13557|NCT01177007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13558|NCT01176968|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13559|NCT01176955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13560|NCT01176877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13561|NCT01176773|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 120 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13562|NCT01176617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13563|NCT01176565|Principal Investigators are NOT employed by the organization sponsoring the study.|The overall Principal Investigator IS, but the Data Coordination Unit (statistical) Principal Investigator IS NOT employed by the sponsor. Prior to release of a public-use data set, any study PIs/other collaborators may submit a proposal requesting data access, assistance with statistical analyses, and publication of additional results. All proposals are reviewed by a Publications Committee that includes the primary study PI, the statistical PI, the NINDS project scientist, and appointed others.
13564|NCT01176513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13565|NCT01176448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13566|NCT01176435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13567|NCT01176292|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13568|NCT01176266|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13569|NCT01176240|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13570|NCT01176058|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13571|NCT01176032|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
13572|NCT01175902|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13573|NCT01175850|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13574|NCT01175824|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13575|NCT01175811|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13576|NCT01175798|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13577|NCT01175707|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If First Publication not published within 1 year of Study conclusion or termination, Investigator has right to publish and disclose the Data. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
13578|NCT01175668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13579|NCT01175590|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed. Prior to publication or presentation, a copy of the final text should be forwarded by the Investigator(s) to the Sponsor or its designee, for comment.
13580|NCT01175473|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
13581|NCT01175434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13582|NCT01175395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13583|NCT01175382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13584|NCT01175369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13585|NCT01175356|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior approval.
13586|NCT01175343|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13587|NCT01175317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13588|NCT01175226|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13589|NCT01175213|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxalta's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 12 months after study completion. Baxalta requires a review of results communications (e.g., for confidential information) ≥45 days prior to submission or communication. Baxalta may request an additional delay of ≤60 days eg, for intellectual property protection.
13590|NCT01175148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13591|NCT01175135|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13592|NCT01175031|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13593|NCT01175018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13594|NCT01175005|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13595|NCT01174784|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13596|NCT01174576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13597|NCT01174550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13598|NCT01174459|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13599|NCT01174446|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements may vary with individual PIs, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or up to 3 years after study completion. Baxter requires a review of results communications (eg for confidential information) ≥60 days prior to submission/communication. Baxter may request additional delay of ≤180 days(e.g., for intellectual property protection). Prior authorization may be required.
13600|NCT01174342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13601|NCT01174264|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13602|NCT01174186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13603|NCT01174173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13604|NCT01174160|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to submit a copy of a 'Publication' to CRO/Sponsor for review and comment 60 days prior to submission for publication and / or disclosure. Sponsor has the applicable 60 day period to respond to PI with any requested revisions. PI agrees to delete any confidential information (excluding results) identified by Sponsor as confidential prior to submitting/presenting the publication.
13605|NCT01174043|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13606|NCT01174030|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13607|NCT01174004|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish the study results, relative to his/her own patients, only after review, comment and approval by the sponsor. No publication of confidential information shall be made without the sponsor’s prior written consent. At least 60 days prior to submitting a manuscript or prior to any public presentation, a copy of the manuscript or presentation will be provided to the sponsor for review and comment. The sponsor has 60 days to review and comment.
13608|NCT01173874|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13609|NCT01173848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13610|NCT01173718|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
13611|NCT01173679|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13612|NCT01173653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13613|NCT01173601|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13614|NCT01173523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13615|NCT01173471|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor recognises that the Trust and Investigator have a responsibility under the Research Governance Framework for Health and Social Care to ensure that results of scientific interest arising from the Clinical Trial are appropriately published and disseminated. Such data will be submitted to the Sponsor for review and comment prior to publication. The Trust agrees, and shall ensure that the Investigator agrees, that all reasonable comments made by the Sponsor will be incorporated.
13616|NCT01173211|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13617|NCT01173120|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
13618|NCT01173055|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13619|NCT01173029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13620|NCT01172938|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
13621|NCT01172873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13622|NCT01172847|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13623|NCT01172821|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13624|NCT01172808|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13625|NCT01172600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13626|NCT01172535|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and seven (7) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
13627|NCT01172522|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13628|NCT01172418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13629|NCT01172353|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13630|NCT01172288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13631|NCT01172197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13632|NCT01172184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13633|NCT01172145|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13634|NCT01171989|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13635|NCT01171976|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until publication of the pooled data (i.e. data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13636|NCT01171963|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13637|NCT01171924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13638|NCT01171820|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13639|NCT01171794|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13640|NCT01171690|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13641|NCT01171677|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13642|NCT01171612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13643|NCT01171534|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13644|NCT01171521|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13645|NCT01171183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13646|NCT01171118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13647|NCT01170962|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
13648|NCT01170949|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13649|NCT01170884|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
13650|NCT01170754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13651|NCT01170663|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
13652|NCT01170598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13653|NCT01170546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13654|NCT01170533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13655|NCT01170390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13656|NCT01170364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13657|NCT01170273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13658|NCT01170247|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13659|NCT01170221|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor intends to pursue publication of results in cooperation with a lead Investigator, subject to the terms and conditions of the clinical study agreement between the Sponsor and Investigators. Sponsor approval is required for publication of any data subsets. Final authorship will be determined in accordance with the International Committee of Medical Journal Editors definition of authorship.
13660|NCT01170208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13661|NCT01170117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13662|NCT01170091|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13663|NCT01170039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13664|NCT01169987|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13706|NCT01167192|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13665|NCT01169779|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
13666|NCT01169753|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13667|NCT01169701|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13668|NCT01169675|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13669|NCT01169649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13670|NCT01169610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13671|NCT01169558|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13672|NCT01169519|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13673|NCT01169493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13674|NCT01169467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13675|NCT01169350|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13676|NCT01169311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13677|NCT01169103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13678|NCT01169064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13679|NCT01169038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13680|NCT01168999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13681|NCT01168986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13682|NCT01168973|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
13683|NCT01168934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13684|NCT01168908|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13707|NCT01167179|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13685|NCT01168856|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13686|NCT01168726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13687|NCT01168687|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13688|NCT01168674|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13689|NCT01168596|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13690|NCT01168427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13691|NCT01168349|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13692|NCT01168232|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13693|NCT01168219|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13694|NCT01168024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13695|NCT01167907|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13696|NCT01167881|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13697|NCT01167829|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13698|NCT01167712|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13699|NCT01167634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13700|NCT01167608|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13701|NCT01167582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13702|NCT01167504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13703|NCT01167452|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13704|NCT01167426|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data
13705|NCT01167257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13708|NCT01167153|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13709|NCT01167140|Principal Investigators are NOT employed by the organization sponsoring the study.|
13710|NCT01167023|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13711|NCT01166997|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13712|NCT01166971|Principal Investigators are NOT employed by the organization sponsoring the study.|The existence of this clinical study is confidential and should not be discussed with persons outside of the study. You shall hold confidential, and not disclose directly or indirectly to any third party other than those persons involved in the study who have a need to know, the protocol, the data arising out of the study, and any other information related to the study or to Alcon’s products or research programs that is provided by Alcon to you (the “Confidential Information”).
13713|NCT01166958|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13714|NCT01166763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13715|NCT01166750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13716|NCT01166724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13717|NCT01166659|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
13718|NCT01166646|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor has first right to publish pooled study data. In the event that such manuscript has not been submitted for publication within 12 months from study completion/termination at all participating sites, the PI shall have the right to single center publications provided they submit any data for presentation, oral or written, to the Sponsor for review 30 days prior to public dissemination. The PI may not disclose previously undisclosed confidential information other than study results.
13719|NCT01166438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13720|NCT01166347|Principal Investigators are NOT employed by the organization sponsoring the study.|In most cases, the contract allows the principal investigator to publish their data after the release of the multi-center publication (or one year after the conclusion of the study if no multi-center publication is submitted) following the sponsor review for (a) disclosure of confidential information, and (b) information that would impair the sponsor’s ability to obtain patent protection.
13721|NCT01166282|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13722|NCT01166230|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13723|NCT01166178|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
13724|NCT01166139|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13725|NCT01166126|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13726|NCT01165996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13764|NCT01163604|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13727|NCT01165983|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13728|NCT01165840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13729|NCT01165775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13730|NCT01165684|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Novo Nordisk reserves the right to prior review of such publications and to ask for delay of publication of individual site results until after the primary manuscript is accepted for publication.
13731|NCT01165554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13732|NCT01165541|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13733|NCT01165450|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13734|NCT01165424|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, reveiw copies of abstracts or manuscripts for publication that report any results of the trial. The Sponsor shall have the right to reveiw and comment with respect to publications, abstracts, slides, and manuscripts and the right to reveiw and comment on the data analysis and presentation.
13735|NCT01165320|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to publication or presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
13736|NCT01165307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13737|NCT01165281|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. Expedited reviews will be arranged for abstracts, poster presentations, or other materials. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
13738|NCT01165242|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13739|NCT01165229|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13740|NCT01165216|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
13741|NCT01165203|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13742|NCT01165177|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13743|NCT01165138|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13744|NCT01165112|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13745|NCT01165047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13746|NCT01165021|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13747|NCT01164891|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13748|NCT01164865|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
13749|NCT01164722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13750|NCT01164644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13751|NCT01164579|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13752|NCT01164501|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13753|NCT01164475|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
13754|NCT01164137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13755|NCT01164007|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13756|NCT01163955|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13757|NCT01163916|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
13758|NCT01163851|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13759|NCT01163760|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
13760|NCT01163747|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13761|NCT01163721|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
13762|NCT01163656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13763|NCT01163617|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13765|NCT01163474|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13766|NCT01163461|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13767|NCT01163318|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13768|NCT01163292|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13769|NCT01163279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13770|NCT01163266|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
13771|NCT01163253|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13772|NCT01163214|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13773|NCT01163162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13774|NCT01163149|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13775|NCT01163097|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 90 days). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
13776|NCT01163032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13777|NCT01162863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13778|NCT01162733|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13779|NCT01162499|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13780|NCT01162473|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13781|NCT01162421|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13782|NCT01162343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13783|NCT01162317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13784|NCT01162304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13785|NCT01162135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13786|NCT01162122|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13787|NCT01162096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13788|NCT01161862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13789|NCT01161771|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
13790|NCT01161628|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13791|NCT01161563|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13792|NCT01161537|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
13793|NCT01161498|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
13794|NCT01161472|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13795|NCT01161446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13796|NCT01161420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13797|NCT01161407|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13798|NCT01161329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13799|NCT01161225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13800|NCT01161173|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
13801|NCT01161160|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13802|NCT01161121|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13803|NCT01160848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13804|NCT01160822|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
13805|NCT01160770|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review and approve all proposed abstracts, manuscripts, or presentations regarding this study prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
13806|NCT01160744|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
13807|NCT01160640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13808|NCT01160614|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13809|NCT01160484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13810|NCT01160458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13811|NCT01160445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13812|NCT01160380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13813|NCT01160237|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13814|NCT01160198|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13815|NCT01159938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13816|NCT01159912|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13817|NCT01159769|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
13818|NCT01159743|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
13819|NCT01159691|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13820|NCT01159665|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13821|NCT01159600|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13844|NCT01157182|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13822|NCT01159574|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13823|NCT01159535|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13824|NCT01159431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13825|NCT01159262|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13826|NCT01159171|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13827|NCT01159054|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13828|NCT01158976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13829|NCT01158924|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Investigators may freely present or publish results of the Clinical Investigation in a manner which fairly sets forth the conclusions reached by the Clinical Investigators, but only after the Sponsor has been given the opportunity of reviewing the proposed presentation or publication at least 60 days prior to the intended submission, presentation, or publication date.
13830|NCT01158716|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13831|NCT01158703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13832|NCT01158573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13833|NCT01158534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13834|NCT01158378|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13835|NCT01158261|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13836|NCT01158118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13837|NCT01157845|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13838|NCT01157533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13839|NCT01157429|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13840|NCT01157416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13841|NCT01157377|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13842|NCT01157351|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13843|NCT01157234|All Principal Investigators ARE employed by the organization sponsoring the study.|
13846|NCT01157117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13847|NCT01157078|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13848|NCT01157065|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
13849|NCT01156987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13850|NCT01156844|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
13851|NCT01156792|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13852|NCT01156701|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13853|NCT01156675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13854|NCT01156597|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13855|NCT01156571|Principal Investigators are NOT employed by the organization sponsoring the study.|"In general, PI communications regarding trial results are prohibited until after the communication and publication of the multi-center results by Sponsor, but no more than 12 months after conclusion of the trial at all sites.~PI must submit results communications to sponsor for review at least 45 days prior to submission for publication and Sponsor may embargo such communications for a period that is less than or equal to 135 days solely to seek appropriate patent protection."
13856|NCT01156532|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13857|NCT01156480|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13858|NCT01156376|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
13859|NCT01156363|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13860|NCT01156311|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
13861|NCT01156142|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13862|NCT01156116|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13863|NCT01156051|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13864|NCT01156012|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever form without prior written agreement of THEA.
13865|NCT01155999|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever form without prior written agreement of THEA.
13866|NCT01155869|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13867|NCT01155830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13868|NCT01155726|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
13869|NCT01155661|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13870|NCT01155570|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
13871|NCT01155531|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13872|NCT01155479|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The Investigator further agrees to provide the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment.
13873|NCT01155466|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation with regard to proprietary information, accuracy, fair balance, and compliance.
13874|NCT01155388|Principal Investigators are NOT employed by the organization sponsoring the study.|If there is no multi-site publication within 18 months after the Study has been completed or terminated at all Study sites, and all data has been received by Sponsor, the Site and SMO shall have the right to publish its results from the Study for non-commercial purposes, if submitted to Sponsor for review 60 days prior to submission of publication. Publication must remove all confidential information and may be delayed by up to 120 days to allow Sponsor to protect its interests.
13875|NCT01155375|Principal Investigators are NOT employed by the organization sponsoring the study.|If there is no multi-site publication within 18 months after the Study has been completed or terminated at all Study sites, and all data have been received by Sponsor, the Site, and SMO shall have the right to publish its results from the Study for non-commercial purposes, if submitted to Sponsor for review 60 days prior to submission of publication. Publication must remove all confidential information and may be delayed by up to 120 days to allow Sponsor to protect its interests.
13876|NCT01155336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13877|NCT01155323|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may not be published or publicly presented without prior written approval of the sponsor. If the investigator wishes to publish or present any study findings, investigator shall contact sponsor to discuss publication plan.
13878|NCT01155284|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13879|NCT01155219|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever form without prior written agreement of THEA.
13880|NCT01155180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13881|NCT01155167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13882|NCT01155154|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13883|NCT01155141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13884|NCT01155063|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13885|NCT01155024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13886|NCT01155011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13887|NCT01154985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13888|NCT01154816|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
13889|NCT01154751|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13890|NCT01154699|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13891|NCT01154673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13892|NCT01154634|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13893|NCT01154452|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13894|NCT01154335|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
13895|NCT01154322|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13896|NCT01154296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13897|NCT01154283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13898|NCT01154231|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13899|NCT01154218|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13900|NCT01154166|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13901|NCT01154153|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication for review and comment at least 45 days (for abstracts -20 days) in advance of any submission for publication. The Sponsor may request for the publication to be delayed for a limited time, not to exceed 90 days to preserve its proprietary rights.
13902|NCT01154140|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13903|NCT01154127|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13925|NCT01153321|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institutions or Investigators were permitted to publish or present the study results from their site (or the overall results), providing the article or presentation was submitted to and approved by AstraZeneca beforehand.
13904|NCT01154101|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13905|NCT01154036|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
13906|NCT01154010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13907|NCT01153984|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13908|NCT01153971|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
13909|NCT01153958|Principal Investigators are NOT employed by the organization sponsoring the study.|
13910|NCT01153893|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13911|NCT01153841|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13912|NCT01153815|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13913|NCT01153763|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13914|NCT01153724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13915|NCT01153711|All Principal Investigators ARE employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13916|NCT01153698|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13917|NCT01153685|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
13918|NCT01153672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13919|NCT01153633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13920|NCT01153620|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13921|NCT01153581|All Principal Investigators ARE employed by the organization sponsoring the study.|
13922|NCT01153503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13923|NCT01153425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13924|NCT01153347|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13926|NCT01153269|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
13927|NCT01153009|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
13928|NCT01152996|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
13929|NCT01152814|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
13930|NCT01152788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13931|NCT01152697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13932|NCT01152580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13933|NCT01152554|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13934|NCT01152450|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13935|NCT01152437|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
13936|NCT01152385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13937|NCT01152359|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13938|NCT01152307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13939|NCT01152294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13940|NCT01152190|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13941|NCT01152112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13942|NCT01151904|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
13943|NCT01151852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13944|NCT01151761|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13945|NCT01151579|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13946|NCT01151553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13947|NCT01151449|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13948|NCT01151436|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor to review and approval at least 2 months prior to the date of intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
13949|NCT01151410|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­ site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
13950|NCT01151371|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must provide written approval for any publication.
13951|NCT01151345|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13952|NCT01151280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13953|NCT01151215|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13954|NCT01151189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13955|NCT01151137|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the investigator can present or publish trial results. A copy is submitted to the sponsor for review and comment at least 30 days in advance of any presentation or submission for publication.~The sponsor can require to delay the communication for a period not exceeding 90 days to allow for filing a patent application or such other measures as sponsor deems appropriate to establish and preserve its proprietary rights."
13956|NCT01151098|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13957|NCT01151085|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13958|NCT01151046|Principal Investigators are NOT employed by the organization sponsoring the study.|If no overall study publication has occurred by the Sponsor within 12 months of the completion of this Study, the Investigator shall have the right to publish or present independently the results of this Study subject to the review procedure set forth herein. The Investigator will provide the Sponsor with a copy of any such presentation or publication derived from the Study for review, and the Sponsor may delay publication for up to 90 days to preserve patent activities and proprietary rights.
13959|NCT01151020|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13960|NCT01150981|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13961|NCT01150903|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13962|NCT01150760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13963|NCT01150500|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13964|NCT01150474|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13965|NCT01150461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13966|NCT01150409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13967|NCT01150357|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single­site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
13968|NCT01150123|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13969|NCT01150097|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
13970|NCT01149876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13971|NCT01149863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13972|NCT01149785|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
13973|NCT01149772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13974|NCT01149759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13975|NCT01149733|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
13976|NCT01149655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13977|NCT01149616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13978|NCT01149538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13979|NCT01149512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13980|NCT01149486|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13981|NCT01149473|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
13982|NCT01149460|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
13983|NCT01149434|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13984|NCT01149421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13985|NCT01149148|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13986|NCT01149057|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
13987|NCT01148979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13988|NCT01148862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13989|NCT01148836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13990|NCT01148771|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13991|NCT01148745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13992|NCT01148693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13993|NCT01148563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13994|NCT01148537|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13995|NCT01148524|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
13996|NCT01148511|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
13997|NCT01148420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13998|NCT01148056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
13999|NCT01148017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14000|NCT01147926|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14001|NCT01147900|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14002|NCT01147874|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14003|NCT01147848|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14004|NCT01147822|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14005|NCT01147809|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14006|NCT01147744|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14007|NCT01147653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14008|NCT01147640|Principal Investigators are NOT employed by the organization sponsoring the study.|The data generated in this clinical study are the exclusive property of the Sponsor and are confidential. Authorship on any primary publication of the results from this study will be based on contributions to study design, enrollment, data analysis, and interpretation of results. All investigators who enroll at least one subject will be acknowledged in any journal publication.
14009|NCT01147627|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14010|NCT01147601|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14011|NCT01147497|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14012|NCT01147471|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14013|NCT01147458|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14014|NCT01147406|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees with the use of results of the clinical study for the purposes of national and international registration, publication, and information for medical and pharmaceutical professionals. If necessary, the competent authorities will be notified of the investigator’s name, address, qualifications, and extent of involvement. An investigator shall not publish any data (poster, abstract, paper, etc.) without having consulted with the Sponsor in advance.
14015|NCT01147393|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14016|NCT01147380|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14017|NCT01147341|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14018|NCT01147302|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14019|NCT01147250|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
14020|NCT01147172|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14021|NCT01147068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14022|NCT01147055|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14023|NCT01147042|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14024|NCT01146951|Principal Investigators are NOT employed by the organization sponsoring the study.|
14025|NCT01146912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14026|NCT01146873|Principal Investigators are NOT employed by the organization sponsoring the study.|
14027|NCT01146860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14028|NCT01146808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14029|NCT01146782|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14030|NCT01146613|Principal Investigators are NOT employed by the organization sponsoring the study.|The NIAAA Project Officer is responsible for overseeing the preparation of the main paper summarizing the main findings of the completed Study (the “Main Paper”). No single site data will be published or otherwise disseminated without first consulting and coordinating any such publication or dissemination with the investigators from all stakeholders. Additional manuscripts published after the publication of the Main Paper may be initiated and primarily authored by NIAAA.
14031|NCT01146600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14032|NCT01146457|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14033|NCT01146418|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc) that report any results of the trial.
14034|NCT01146379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14035|NCT01146288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14036|NCT01146275|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14037|NCT01146054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14038|NCT01145898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14039|NCT01145755|Principal Investigators are NOT employed by the organization sponsoring the study.|"No publication or presentation of results until the earlier of 1) the date of the first study results publication or 2) 18 months after completion or termination of the study.~AZ review 60 days prior submission and AZ has the possibility to further delay publication for an additional 90 days"
14040|NCT01145638|Principal Investigators are NOT employed by the organization sponsoring the study.|If Pharmacosmos or its agents has not prepared a draft for submission to a peer reviewed journal prior to 1 year following completion of the study report, the investigators have the right to publish the results. Such publications are to be submitted to Pharmacosmos for comment 30 days prior to submission for publication.
14041|NCT01145625|Principal Investigators are NOT employed by the organization sponsoring the study.|Multi-Center Publication will be the first publication to present the results of the Study. Upon such Multi-Center Publication, or the earlier of (a) Sponsor's confirmation that there will be no Multi-Center Publication or presentation, or (b) 12 months after the completion of the entire multi-center study, Institution and Investigator may publish or present Study data and results generated in their performance of the Study in accordance with the terms of this Article.
14042|NCT01145560|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14043|NCT01145547|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14044|NCT01145508|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14045|NCT01145495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14046|NCT01145482|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14047|NCT01145417|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14048|NCT01145391|Principal Investigators are NOT employed by the organization sponsoring the study.|The study funder, Novartis Pharmaceuticals Corporation, had no role in the data analysis or manuscript preparation; however, as part of the study agreement Novartis approved the investigators’ study design and final manuscript.
14049|NCT01145352|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14050|NCT01145053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14051|NCT01145001|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14052|NCT01144949|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14053|NCT01144715|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14054|NCT01144624|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14055|NCT01144598|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14056|NCT01144455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14057|NCT01144442|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14058|NCT01144416|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agreed not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agreed to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report(s) any results of the trial.
14059|NCT01144403|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
14060|NCT01144377|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14061|NCT01144364|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14062|NCT01144299|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14063|NCT01144286|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review publications and/or presentations (results communications) prior to public release and communications regarding trial results for a period that is 60 days from the time submitted to the sponsor for review. The sponsor may require changes to the publication and /or presentation regarding its content or the time of release.
14064|NCT01144182|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14065|NCT01144143|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14066|NCT01144052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14067|NCT01144026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14068|NCT01143896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14069|NCT01143883|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14070|NCT01143870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14071|NCT01143818|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14072|NCT01143792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14073|NCT01143766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14074|NCT01143727|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release.
14075|NCT01143714|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release.
14076|NCT01143701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14077|NCT01143688|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14078|NCT01143649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14079|NCT01143636|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14080|NCT01143610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14081|NCT01143402|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14082|NCT01143389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14083|NCT01143337|Principal Investigators are NOT employed by the organization sponsoring the study.|
14084|NCT01143324|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidential Disclosure Agreements were signed by all investigators. The information had to be kept confidential and investigators agreed not to disclose information to any third party.
14085|NCT01143272|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14086|NCT01143259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14087|NCT01143207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14088|NCT01143142|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14089|NCT01143090|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
14090|NCT01143077|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
14091|NCT01143051|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is to maintain all information, data, inventions and discoveries disclosed by the Sponsor in confidence unless that information was in public domain at time of disclosure or becomes part of the public domain or is published through no fault of the PI or Institution, or was in the possession of the PI or Institution at time of disclosure and was not acquired from Sponsor under any obligation of confidentiality or is produced pursuant to a validly issued subpoena.
14092|NCT01143038|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
14093|NCT01142908|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14094|NCT01142726|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
14095|NCT01142661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14096|NCT01142596|Principal Investigators are NOT employed by the organization sponsoring the study.|It is planned to first publish/present trial results together with the other sites, unless permission is obtained from Sponsor to publish separate results. Sponsor must be able to review all proposed results communications regarding study 45 days prior to submission for publication/presentation. If there is disagreement concerning appropriateness of the materials, Investigator and Sponsor must meet to make a good faith effort to discuss/resolve disagreement prior to submission for publication.
14097|NCT01142466|Principal Investigators are NOT employed by the organization sponsoring the study.|
14098|NCT01142388|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14099|NCT01142336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14100|NCT01142323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14101|NCT01142297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14102|NCT01142193|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14103|NCT01142128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14104|NCT01142115|Principal Investigators are NOT employed by the organization sponsoring the study.|
14105|NCT01142089|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator will provide Sponsor an opportunity of at least 30 days to review and comment on any proposed publication before it is disclosed and Sponsor shall have the right to require the removal of any Confidential Information. Sponsor shall have the right to require the publication be delayed for an additional period not to exceed 60 days to permit the filing of patent applications or to seek intellectual property protection related to information contained in such publication.
14106|NCT01141725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14107|NCT01141712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14108|NCT01141660|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14109|NCT01141647|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14110|NCT01141595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14111|NCT01141569|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14112|NCT01141491|Principal Investigators are NOT employed by the organization sponsoring the study.|Site shall withhold publication of Site’s individual Study results for a period of 18 months following completion of the Study at all sites, or until after Sponsor’s written confirmation that Sponsor will not publish a joint, multicenter publication, whichever occurs first.
14113|NCT01141374|All Principal Investigators ARE employed by the organization sponsoring the study.|The copyright of the search results are the exclusive property of the Journal of School Nursing, University of Saint Paul, barring any reproduction, in whole or in part in any form or means of printed or electronic, without the prior and necessary authorization is requested.
14114|NCT01141283|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14115|NCT01141205|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14116|NCT01140906|Principal Investigators are NOT employed by the organization sponsoring the study.|"The results of this study will be published at the discretion of H. Lundbeck A/S. H. Lundbeck A/S will ensure that the authorship of all publications based on this study is in accordance with the criteria defined by the International Committee of Medical Journal Editors (ICMJE).~The primary publication must be published before any secondary publications."
14117|NCT01140880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14118|NCT01140867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14119|NCT01140815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14120|NCT01140646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14121|NCT01140503|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14122|NCT01140477|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of ten years, the PI agrees to keep confidential and not disclose, without the prior written consent of Sponsor, to any third party or use any technology, data, reports, results of clinical studies conducted under this Study or other information received by Sponsor, or any technology, data, reports, study materials, or other information developed by Sponsor unless disclosure by PI is required by law.
14123|NCT01140360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14124|NCT01140347|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
14125|NCT01140295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14126|NCT01140191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14127|NCT01140061|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
14128|NCT01140048|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
14129|NCT01139996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14130|NCT01139879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14131|NCT01139814|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14132|NCT01139775|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14133|NCT01139762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14134|NCT01139658|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14135|NCT01139580|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14136|NCT01139515|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14137|NCT01139450|Principal Investigators are NOT employed by the organization sponsoring the study.|
14138|NCT01139411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14139|NCT01139294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14140|NCT01139190|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14141|NCT01139164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14142|NCT01139125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14143|NCT01139047|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
14144|NCT01139021|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
14145|NCT01139008|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
14146|NCT01138995|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14147|NCT01138969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14148|NCT01138826|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14149|NCT01138735|Principal Investigators are NOT employed by the organization sponsoring the study.|
14150|NCT01138657|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14151|NCT01138514|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14152|NCT01138501|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol.
14153|NCT01138475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14154|NCT01138150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14155|NCT01138124|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14156|NCT01138111|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14157|NCT01138098|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14158|NCT01138046|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14159|NCT01138007|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14160|NCT01137890|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14161|NCT01137812|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
14162|NCT01137786|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14163|NCT01137773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14164|NCT01137682|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14165|NCT01137604|Principal Investigators are NOT employed by the organization sponsoring the study.|
14166|NCT01137578|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
14167|NCT01137539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14168|NCT01137474|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
14169|NCT01137435|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
14170|NCT01137396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14171|NCT01137370|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14172|NCT01137292|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14173|NCT01137071|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14174|NCT01137032|Principal Investigators are NOT employed by the organization sponsoring the study.|
14175|NCT01136967|Principal Investigators are NOT employed by the organization sponsoring the study.|
14176|NCT01136954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14177|NCT01136915|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14178|NCT01136876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14179|NCT01136785|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14180|NCT01136772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14181|NCT01136746|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14182|NCT01136655|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14183|NCT01136486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14184|NCT01136408|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
14185|NCT01136382|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14186|NCT01136356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14187|NCT01136291|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14188|NCT01136226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14189|NCT01136174|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
14190|NCT01135992|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
14252|NCT01131884|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14191|NCT01135914|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until publication of the pooled data (i.e. data from all sites) in the clinical trial or dislcosure of trial results in their entirety.
14192|NCT01135524|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14193|NCT01135511|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14194|NCT01135498|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14195|NCT01135420|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14196|NCT01135381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14197|NCT01135368|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
14198|NCT01135186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14199|NCT01135134|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The Sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
14200|NCT01135069|Principal Investigators are NOT employed by the organization sponsoring the study.|
14201|NCT01135017|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the Investigator can present or publish trial results. A copy is submitted to the Sponsor for review and comment at least 45 days in advance of the submission to journal (20 days for abstracts).~The Sponsor can require to delay the communication for a period not exceeding 90 days to allow for filing a patent application or such other measures as Sponsor deems appropriate to establish and preserve its proprietary rights."
14202|NCT01134952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14203|NCT01134939|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
14204|NCT01134900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14205|NCT01134887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14206|NCT01134783|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14207|NCT01134731|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14208|NCT01134705|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
14209|NCT01134627|Principal Investigators are NOT employed by the organization sponsoring the study.|
14210|NCT01134614|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14211|NCT01134562|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
14212|NCT01134549|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
14213|NCT01134510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14214|NCT01134393|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14215|NCT01134328|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14216|NCT01134315|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14217|NCT01134276|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14218|NCT01134107|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14219|NCT01134081|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14220|NCT01134055|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14221|NCT01134042|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14222|NCT01134016|Principal Investigators are NOT employed by the organization sponsoring the study.|All the PI should grand sponcer's agree to discuss or publish trial results after the trial is completed.
14223|NCT01133977|Principal Investigators are NOT employed by the organization sponsoring the study.|
14224|NCT01133860|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14225|NCT01133847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14226|NCT01133821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14227|NCT01133756|Principal Investigators are NOT employed by the organization sponsoring the study.|
14228|NCT01133704|Principal Investigators are NOT employed by the organization sponsoring the study.|A provision provides for sponsor review up to 45 days with the right to request modification based on disclosure of confidential information; extendable by 60 days to file a patent application.
14229|NCT01133665|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14230|NCT01133626|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
14231|NCT01133522|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
14232|NCT01133418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14233|NCT01133392|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14234|NCT01133379|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
14235|NCT01133288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14236|NCT01133275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14237|NCT01133171|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14238|NCT01132846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14239|NCT01132820|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14240|NCT01132690|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14241|NCT01132664|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
14242|NCT01132651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14243|NCT01132612|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14244|NCT01132547|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14245|NCT01132508|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14246|NCT01132495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14247|NCT01132378|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14248|NCT01132326|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14249|NCT01132313|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
14250|NCT01132144|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14251|NCT01132118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14253|NCT01131676|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
14254|NCT01131585|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14255|NCT01131520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14256|NCT01131507|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication after a multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
14257|NCT01131494|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14258|NCT01131455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14259|NCT01131299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14260|NCT01131182|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
14261|NCT01131130|Principal Investigators are NOT employed by the organization sponsoring the study.|
14262|NCT01131104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14263|NCT01131078|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14264|NCT01131065|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the Study, after providing Sponsor thirty days’ notice prior to submitting a manuscript or other materials related to the Study to any outside party. At Sponsor’s request, Site will remove any Confidential Information (other than Study results), and Site will upon Sponsor’s request, delay publication or presentation for a period of up to one hundred twenty days to allow Sponsor to protect its interests in any Sponsor’s Inventions.
14265|NCT01131052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14266|NCT01130974|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor,and such that confidential or proprietary information is not disclosed.
14267|NCT01130883|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14268|NCT01130844|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14269|NCT01130831|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14270|NCT01130740|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14271|NCT01130597|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements generally provide that PI cannot publish single site data before publication of the multi-site publication, unless 1 year has elapsed since completion of the study at all sites. Thereafter, PI may publish provided that PI shall: provide a copy of the publication to sponsor at least 60 days in advance of submission for publication; delete sponsor’s confidential information as requested; and delay publication up to an additional 90 days to permit protection of intellectual property.
14272|NCT01130532|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14273|NCT01130493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14274|NCT01130337|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
14275|NCT01130168|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines
14276|NCT01130103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14277|NCT01130051|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14278|NCT01129960|Principal Investigators are NOT employed by the organization sponsoring the study.|
14279|NCT01129921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14280|NCT01129778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14281|NCT01129765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14282|NCT01129622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14283|NCT01129583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14284|NCT01129557|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14285|NCT01129531|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14286|NCT01129336|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
14287|NCT01129284|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14288|NCT01129245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14289|NCT01129206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14290|NCT01129141|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14291|NCT01129128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14292|NCT01129115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14293|NCT01129102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the sponsor and PI that no restricts the PI's right but need to discuss the timing of publish date of trial results after the trial is completed.
14294|NCT01129011|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees that the first publication will be a multi-center publication of the study results. Following this multi-center publication, PI can publish, present or use any non-confidential study results following Sponsor review and comment.
14295|NCT01128972|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14296|NCT01128959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14297|NCT01128946|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14298|NCT01128894|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14299|NCT01128829|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14300|NCT01128738|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14301|NCT01128621|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14302|NCT01128595|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14303|NCT01128569|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14304|NCT01128543|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14305|NCT01128426|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14306|NCT01128413|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14307|NCT01128400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14308|NCT01128387|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14309|NCT01128361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14310|NCT01128296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14311|NCT01128270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14312|NCT01128244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14313|NCT01128192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14314|NCT01128179|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14315|NCT01128153|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 60 days prior to submission of any material for publication or presentation, PI shall provide Sponsor with such material for review. If requested in writing by Sponsor, PI shall withhold material from submission for publication or presentation for an additional 90 days from the date of Sponsor's request.
14316|NCT01128114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14317|NCT01128049|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor review required before publishing results.
14318|NCT01127763|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14319|NCT01127737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14320|NCT01127659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14321|NCT01127646|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14322|NCT01127633|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14323|NCT01127607|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14324|NCT01127581|Principal Investigators are NOT employed by the organization sponsoring the study.|Any abstract,presentation or manuscript proposed for publication must be submitted to the Sponsor for review at least 30 days prior to submission for any meeting or journal.If deemed necessary by the Sponsor for protection of proprietary information prior to patent filing,the Investigator agrees to a further delay of 60 days before any presentation or publication is submitted.Publications must be in a form that does not reveal technical information that is considered confidential or proprietary.
14325|NCT01127503|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14326|NCT01127438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14327|NCT01127321|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
14328|NCT01127256|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14329|NCT01127165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14330|NCT01127139|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14331|NCT01127087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14332|NCT01126957|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14333|NCT01126801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14334|NCT01126723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14335|NCT01126671|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14336|NCT01126619|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14337|NCT01126593|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14338|NCT01126580|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14339|NCT01126541|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14340|NCT01126437|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14341|NCT01126424|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may not publish trial data generated at their specific study site without prior written approval of the Sponsor.
14342|NCT01126359|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14343|NCT01126268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14344|NCT01126099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14345|NCT01126060|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14346|NCT01125930|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14347|NCT01125917|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14348|NCT01125813|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14349|NCT01125800|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-­site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
14350|NCT01125774|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
14351|NCT01125748|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14352|NCT01125722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14353|NCT01125605|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14354|NCT01125566|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.>
14355|NCT01125514|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14356|NCT01125202|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14357|NCT01125189|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
14358|NCT01125098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14359|NCT01124955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14360|NCT01124916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14361|NCT01124864|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
14362|NCT01124838|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14363|NCT01124786|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 120 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14364|NCT01124643|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information(excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
14365|NCT01124617|Principal Investigators are NOT employed by the organization sponsoring the study.|
14366|NCT01124604|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
14367|NCT01124448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14368|NCT01124422|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14369|NCT01124370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14370|NCT01124305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14371|NCT01124292|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14372|NCT01124188|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14375|NCT01124149|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14376|NCT01124097|Principal Investigators are NOT employed by the organization sponsoring the study.|
14377|NCT01124045|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
14378|NCT01124006|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Investigators may freely present or publish results of the Clinical Investigation in a manner which fairly sets forth the conclusions reached by the Clinical Investigators, but only after the Sponsor has been given the opportunity of reviewing the proposed presentation or publication at least 60 days prior to the intended submission, presentation, or publication date.
14379|NCT01123980|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right not to release data until specified milestones. This includes the right not to release interim results from clinical trials. At the end of the trial, one or more manuscripts for publication will be prepared in collaboration between Investigator(s) and Novo Nordisk. Novo Nordisk will not suppress or veto publications; however Novo Nordisk reserves the right to postpone publication and/or communication for a short time to protect intellectual property.
14380|NCT01123941|Principal Investigators are NOT employed by the organization sponsoring the study.|
14381|NCT01123928|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14382|NCT01123889|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14383|NCT01123850|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14384|NCT01123642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14385|NCT01123512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14386|NCT01123395|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14387|NCT01123382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14388|NCT01123356|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14389|NCT01123200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14390|NCT01123161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14391|NCT01123148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14392|NCT01123083|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14393|NCT01122927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14394|NCT01122901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14395|NCT01122862|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14396|NCT01122849|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14397|NCT01122680|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14398|NCT01122576|Principal Investigators are NOT employed by the organization sponsoring the study.|
14399|NCT01122511|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14400|NCT01122394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14401|NCT01122381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14402|NCT01122264|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14403|NCT01122238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14404|NCT01122160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14405|NCT01122108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14406|NCT01122030|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
14407|NCT01121991|Principal Investigators are NOT employed by the organization sponsoring the study.|
14408|NCT01121939|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
14409|NCT01121926|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication based on the results of this study is envisaged, approval from the Sponsor will be obtained and a draft manuscript will be submitted to the sponsor for scrutiny and comment. The choice of scientific journal will be mutually agreed on by the principal investigator and the sponsor.
14410|NCT01121913|Principal Investigators are NOT employed by the organization sponsoring the study.|The scientific results from this study are the property of the Sponsors, ie, Labopharm Inc., Canada and A.C.R.A.F. S.p.A., Italy. No data reported in the final integrated clinical trial report of this study will be used for publication in scientific journals and/or for presentation at scientific meetings without a previous agreed written consent between the Sponsors.
14411|NCT01121900|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication based on the results of this study is envisaged, approval from the Sponsor will be obtained and a draft manuscript will be submitted to the sponsor for scrutiny and comment. The choice of scientific journal will be mutually agreed on by the principal investigator and the sponsor.
14412|NCT01121757|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14413|NCT01121666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14414|NCT01121575|Principal Investigators are NOT employed by the organization sponsoring the study.|"Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites.~Investigator may not disclose previously undisclosed confidential information other than study results."
14415|NCT01121562|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14416|NCT01121549|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14417|NCT01121536|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
14418|NCT01121484|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14419|NCT01121406|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
14420|NCT01121393|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
14421|NCT01121263|Principal Investigators are NOT employed by the organization sponsoring the study.|MSSM and sites shall cooperate in the submission of manuscript(s) for publication of the study results and sites shall not submit manuscripts for publication without express written permission of the Operations Committee. After dissolution of the Operations committee or one year after the completion of the agreement, whichever occurs first, no such permission shall be required.
14422|NCT01121224|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14423|NCT01121211|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14424|NCT01121185|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14425|NCT01121172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14426|NCT01121146|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor requires at least 30 days to review and comment on manuscripts before submission. For abstracts, the time frame for review is at least 10 days before submission. The sponsor will inform the investigator of any changes deemed necessary to preserve the confidentiality of proprietary information or to ensure scientific accuracy.
14427|NCT01120990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14428|NCT01120899|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14429|NCT01120834|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14430|NCT01120808|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14431|NCT01120782|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written authorization from Sponsor.
14432|NCT01120717|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
14433|NCT01120704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14434|NCT01120691|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14435|NCT01120626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14436|NCT01120600|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
14437|NCT01120405|Principal Investigators are NOT employed by the organization sponsoring the study.|Air Liquide Sante International may delay publication or disclosure for a term not exceeding eighteen (18) months with effect from the request in the event that Air Liquide Sante International wishes to seek protection of the results of the Trial by industrial property rights.
14438|NCT01120379|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14439|NCT01120275|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14440|NCT01120236|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14441|NCT01120223|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators’ right to publish the results of the trial, irrespective of outcome. Pubs/presentations by investigator(s) shall not be made before the results of a joint publication is public. LEO retains the right to have any publication submitted to LEO for review at least 30 days prior to this paper being submitted for publication/presentation. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
14442|NCT01120210|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator wishes to publish information from the study, a copy of the manuscript must be provided to the Sponsor for review at least 60 days before submission for publication or presentation. Expedited reviews will be arranged for abstracts, poster presentations, or other materials. If requested by the Sponsor in writing, the Investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
14443|NCT01120197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14444|NCT01120184|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14445|NCT01120093|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
14446|NCT01120067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14447|NCT01119963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14448|NCT01119950|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14449|NCT01119937|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
14450|NCT01119859|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14451|NCT01119846|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14452|NCT01119794|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14453|NCT01119768|Principal Investigators are NOT employed by the organization sponsoring the study.|
14454|NCT01119755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14455|NCT01119716|Principal Investigators are NOT employed by the organization sponsoring the study.|The Scientific Committee for the study has the authority to make all decisions related to design, conduct, data interpretation and dissemination of study results.
14456|NCT01119703|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
14457|NCT01119625|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14458|NCT01119443|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14459|NCT01119287|Principal Investigators are NOT employed by the organization sponsoring the study.|
14460|NCT01119222|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14461|NCT01119131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14462|NCT01119118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14463|NCT01119040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14464|NCT01119001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14465|NCT01118988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14466|NCT01118975|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14467|NCT01118962|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
14468|NCT01118949|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14469|NCT01118845|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14470|NCT01118780|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14471|NCT01118741|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14472|NCT01118728|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
14473|NCT01118663|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14474|NCT01118624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14475|NCT01118455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14476|NCT01118377|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14477|NCT01118325|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14478|NCT01118312|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14479|NCT01118273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14480|NCT01118221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14481|NCT01118143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14482|NCT01118117|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14483|NCT01118091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14484|NCT01118052|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14485|NCT01118013|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14486|NCT01117987|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
14487|NCT01117948|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14488|NCT01117870|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14489|NCT01117857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14490|NCT01117766|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14491|NCT01117727|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14492|NCT01117623|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14493|NCT01117480|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14494|NCT01117454|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14495|NCT01117428|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14496|NCT01117350|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any abstract/manuscript for comment at least 20/45 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
14497|NCT01117337|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14498|NCT01117311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14499|NCT01117181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14500|NCT01117090|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14501|NCT01117051|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14502|NCT01117012|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14503|NCT01116986|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14504|NCT01116934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14505|NCT01116921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14506|NCT01116882|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14507|NCT01116687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14508|NCT01116466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14509|NCT01116427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14510|NCT01116401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14511|NCT01116232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14512|NCT01116102|Principal Investigators are NOT employed by the organization sponsoring the study.|For this study, Baxter requires a review of any planned PI results communications (eg, for confidential information) up to 30 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (eg, to allow for intellectual property protection).
14513|NCT01116037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14514|NCT01116024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14515|NCT01115998|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14516|NCT01115933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14517|NCT01115855|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14518|NCT01115738|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14519|NCT01115699|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14520|NCT01115673|Principal Investigators are NOT employed by the organization sponsoring the study.|The results may not be published or referred to at research seminars, lectures or professional meetings, in whole or in part, without the prior written consent of McNeil Consumer Healthcare, to be given or withheld at McNeil Consumer Healthcare’s sole and absolute discretion
14521|NCT01115660|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14522|NCT01115582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14523|NCT01115569|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14524|NCT01115556|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14525|NCT01115517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14526|NCT01115491|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14527|NCT01115452|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14528|NCT01115244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14529|NCT01115166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14530|NCT01115101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14531|NCT01114997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14532|NCT01114945|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14533|NCT01114893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14534|NCT01114880|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14535|NCT01114828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14536|NCT01114737|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14537|NCT01114724|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) and institution agree not to publish the results of the study until after the earliest of the following: a)conclusion of the study, b)the early termination of the study, c)at discretion and approval of the sponsor, or d)after sponsor confirms there will be no multicenter study publication, whichever occurs first. PI and institution further agree to submit to sponsor copies of any proposed publication or public presentation at least sixty days before dissemination.
14538|NCT01114672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14539|NCT01114620|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14540|NCT01114581|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14541|NCT01114529|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing any publications from a single-site are postponed until publication of the pooled data (i.e., data from all sites) in the clinical trial.
14542|NCT01114516|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14543|NCT01114503|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14544|NCT01114438|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14545|NCT01114373|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14546|NCT01114360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14547|NCT01114334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14548|NCT01113931|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14549|NCT01113801|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14550|NCT01113749|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14551|NCT01113723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14552|NCT01113710|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
14553|NCT01113632|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
14554|NCT01113580|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
14555|NCT01113541|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14556|NCT01113463|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14557|NCT01113398|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14558|NCT01113385|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14559|NCT01113008|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14560|NCT01112917|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14561|NCT01112865|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14562|NCT01112696|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14563|NCT01112683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14564|NCT01112670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14565|NCT01112579|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14566|NCT01112514|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14567|NCT01112267|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot provide the any trial related information to external parties’ without mutual agreement with the sponsor. This is valid even after the contract is canceled.
14568|NCT01112241|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14569|NCT01112059|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14570|NCT01111851|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
14571|NCT01111838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14572|NCT01111825|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14573|NCT01111526|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14574|NCT01111461|Principal Investigators are NOT employed by the organization sponsoring the study.|
14575|NCT01111370|Principal Investigators are NOT employed by the organization sponsoring the study.|
14576|NCT01111331|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14577|NCT01111318|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14578|NCT01111305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14579|NCT01111292|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14580|NCT01111240|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14581|NCT01111162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14582|NCT01111149|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14583|NCT01111123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14584|NCT01111110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14585|NCT01110967|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidential Information shall not be disclosed and shall be sole property of sponsor during the term of the agreement and for 3 years after agreement termination. Results might be published or presented, however sponsor should receive publication for review at least 7 days prior to submittal. Sponsor shall limit its review to a determination of whether Confidential Information is disclosed, to allow sponsor to protect its rights in copyrightable material, and to check for technical correctness.
14586|NCT01110915|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and Participating Institutions will provide any publication of Study Data generated by PI and/or Participating Institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
14587|NCT01110707|Principal Investigators are NOT employed by the organization sponsoring the study.|
14588|NCT01110499|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14589|NCT01110421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14590|NCT01110408|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14591|NCT01110382|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14592|NCT01110330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14593|NCT01110252|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14594|NCT01110239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14595|NCT01110200|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14596|NCT01110187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14597|NCT01110135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14598|NCT01110005|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14599|NCT01109979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14600|NCT01109849|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14601|NCT01109602|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14602|NCT01109576|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14603|NCT01109524|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
14604|NCT01109381|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14605|NCT01109316|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14606|NCT01109173|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
14607|NCT01109147|Principal Investigators are NOT employed by the organization sponsoring the study.|All results and publications are reviewed by the sponsor and the principle Investigator. None could be released without accordance from both parts.
14608|NCT01109108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14609|NCT01109056|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14610|NCT01108835|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14611|NCT01108809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14612|NCT01108796|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
14613|NCT01108757|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14614|NCT01108731|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14615|NCT01108718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14616|NCT01108523|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14617|NCT01108510|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
14618|NCT01108458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14619|NCT01108445|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14620|NCT01108406|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14621|NCT01108341|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
14622|NCT01108263|Principal Investigators are NOT employed by the organization sponsoring the study.|
14623|NCT01108237|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14624|NCT01108185|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14625|NCT01108081|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14626|NCT01108068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14627|NCT01108055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14628|NCT01108003|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14629|NCT01107964|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14630|NCT01107925|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14631|NCT01107912|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14632|NCT01107899|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14633|NCT01107886|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca’s Publication Policy, data disclosure and transparency are available at the website: http://www.astrazeneca.com/responsibility/code-and-policies/policies?itemId=4861823&nav=yes. All papers or abstracts must be submitted to the Steering Committee and the SPONSOR, through BRIGHAM, for review of its appropriateness and scientific merit at least six weeks prior to submission to any publication.
14634|NCT01107834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14635|NCT01107743|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14636|NCT01107730|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14637|NCT01107535|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14638|NCT01107457|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14639|NCT01107418|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14640|NCT01107405|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to any presentation of results, draft versions of manuscripts will be made available to co-authors and to the Sponsor for review and comment. At least 30 days in the case of abstracts or 60 days in the case of full papers should be allowed for comments prior to submission for consideration of acceptance of presentation or publication.
14641|NCT01107392|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14642|NCT01107379|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14643|NCT01107353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14644|NCT01107197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14645|NCT01107015|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14646|NCT01106976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14647|NCT01106950|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14648|NCT01106911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14649|NCT01106898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14650|NCT01106859|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor agrees to review manuscripts within a reasonable period of time. If sponsor determines the publication included patentable subject matter, sponsor will be granted no less than 120 days to prepare patent applications.
14651|NCT01106846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14652|NCT01106690|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
14653|NCT01106677|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
14654|NCT01106651|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
14655|NCT01106625|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
14656|NCT01106586|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
14657|NCT01106534|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14658|NCT01106456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14659|NCT01106430|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14660|NCT01106404|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14661|NCT01106391|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14662|NCT01106352|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14663|NCT01106326|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14664|NCT01106287|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
14665|NCT01106248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14666|NCT01106157|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14667|NCT01106092|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14668|NCT01106040|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall not submit a publication to journals or professional societies without the prior written approval of the Sponsor.
14669|NCT01106027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14670|NCT01106014|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14671|NCT01105975|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14672|NCT01105936|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14673|NCT01105767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14674|NCT01105754|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14675|NCT01105702|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14676|NCT01105650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14677|NCT01105533|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14698|NCT01104207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14678|NCT01105377|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14679|NCT01105312|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14680|NCT01105247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14681|NCT01105130|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14682|NCT01105117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14683|NCT01105091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14684|NCT01105065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14685|NCT01104870|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the Study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed, except as provided below. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
14686|NCT01104701|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
14687|NCT01104662|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If first publication not published within 1 year of study conclusion or termination, Investigator has right to publish and disclose the data. Prior to any submission for publication, presentation, or communication of results or information arising from the study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
14688|NCT01104636|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14689|NCT01104584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14690|NCT01104558|Principal Investigators are NOT employed by the organization sponsoring the study.|
14691|NCT01104493|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
14692|NCT01104415|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution must provide any proposed publication or presentation to Sponsor for Sponsor's review, comment and approval at least thirty (30) days prior to the proposed submission for publication date or the proposed presentation date. Sponsor shall have the right to have deleted from the final version of the publication any confidential information, proprietary information, or patentable subject matter.
14693|NCT01104402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14694|NCT01104376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14695|NCT01104311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14696|NCT01104285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14697|NCT01104246|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14700|NCT01104116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14701|NCT01104103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14702|NCT01103973|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14703|NCT01103960|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14704|NCT01103934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14705|NCT01103713|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14706|NCT01103492|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14707|NCT01103479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14708|NCT01103466|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14709|NCT01103440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14710|NCT01103414|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14711|NCT01103362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14712|NCT01103323|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreed point of publication is 12-18 months after database lock at the earliest. Bayer will have 30-45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable). No publication of single center data should be done prior of publication if multi-center data.
14713|NCT01103284|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall submit any paper or presentation to the Sponsor for review and comments at least 60 days prior to submitting the same to a third party. Upon receiving any request from the Sponsor to delete any Confidential Information or request to delay in publication up to 90 days to allow the filing of any Sponsor application, the Investigator shall take the request action. Investigator shall not be restricted after 18 months from completion of their site's performance in the study.
14714|NCT01103271|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14715|NCT01103232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14716|NCT01103141|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14717|NCT01103063|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14718|NCT01102972|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14719|NCT01102894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14720|NCT01102803|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14721|NCT01102777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14722|NCT01102764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14723|NCT01102491|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14724|NCT01102413|Principal Investigators are NOT employed by the organization sponsoring the study.|If Pharmacosmos or its agents has not prepared a draft for submission to a peer reviewed journal prior to 1 year following completion of the study report, the investigators have the right to publish the results. Such publications are to be submitted to Pharmacosmos for comment 30 days prior to submision for publication.
14725|NCT01102374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14726|NCT01102270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14727|NCT01102257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14728|NCT01102218|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor’s (S) publication (pub) of multi-center pub,Institution (I) and/or Principal Investigator (PI) may publish data/results from Study based solely upon Study conducted by I/PI,provided that I/PI submits pub to S for review/comment > 60 days before date of proposed pub.S may review in advance contents of pub.If pub is not submitted within 12 months after termination of Study at all sites,or if S confirms there will be no pub,the I/PI may publish Study results.
14729|NCT01102140|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14730|NCT01101971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14731|NCT01101958|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14732|NCT01101880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14733|NCT01101867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14734|NCT01101841|Principal Investigators are NOT employed by the organization sponsoring the study.|
14735|NCT01101542|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14736|NCT01101477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14737|NCT01101464|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be based on data validated by Organon. Any such communication will first be submitted to Organon, at least 6 weeks ahead of time for written consent. Organon shall have the right to make its consent conditional upon proper representation of the interpretation of both Organon and the investigator. In any communication concerning this trial, the authors of this protocol will be included in the list of authors.
14738|NCT01101321|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14739|NCT01101308|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14740|NCT01101191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14741|NCT01101178|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14742|NCT01101165|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14743|NCT01101022|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14744|NCT01100944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14745|NCT01100931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14746|NCT01100853|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14747|NCT01100762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14748|NCT01100723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14749|NCT01100658|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14750|NCT01100606|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication after a multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor's confidential information be removed from any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
14751|NCT01100567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14752|NCT01100502|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14753|NCT01100437|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14754|NCT01100320|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14755|NCT01100307|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14756|NCT01100268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14757|NCT01100255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14758|NCT01100242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14759|NCT01100112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14760|NCT01100086|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14761|NCT01100073|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
14762|NCT01099917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14763|NCT01099774|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
14764|NCT01099761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14765|NCT01099709|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14766|NCT01099618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14767|NCT01099579|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
14768|NCT01099475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14769|NCT01099397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14770|NCT01099358|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14771|NCT01099267|Principal Investigators are NOT employed by the organization sponsoring the study.|Unless approved by Celgene, single center data will not be published before multicenter data, unless more than 1 year has elapsed since completion of the Study. Thereafter, Investigator may publish single center data provided that Investigator shall: i) provide a copy of the publication to Celgene at least 60 days in advance of submission for publication; ii) delete Celgene Confidential Information and; iii) delay submission up to 90 additional days to permit intellectual property filings.
14772|NCT01099215|Principal Investigators are NOT employed by the organization sponsoring the study.|Company-specific confidentiality agreement
14773|NCT01099202|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14774|NCT01099111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14775|NCT01098851|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14776|NCT01098812|Principal Investigators are NOT employed by the organization sponsoring the study.|Study results may be published by PI upon written approval by sponsor (AMO). Any proposed submission for publication or presentation of study data must be provided to AMO 90 days prior to submission for review, comment and approval. Sponsor may delay or withhold submission as necessary (ongoing study activities, patents pending, etc.).
14777|NCT01098747|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14778|NCT01098578|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14779|NCT01098539|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14780|NCT01098500|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14862|NCT01092910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14781|NCT01098487|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14782|NCT01098461|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14783|NCT01098318|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14784|NCT01098305|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14785|NCT01098253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14786|NCT01098240|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14787|NCT01098162|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14788|NCT01098110|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts, and to review and comment on the data analysis and presentation.
14789|NCT01098097|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts. Investigator agrees to meet with sponsor's representatives prior to submission for publication to discuss and resolve any disagreements.
14790|NCT01098071|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator and his co-workers agree not to publish or publicly present any results of the study without the prior written consent and approval of the sponsor.
14791|NCT01098032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14792|NCT01098006|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14793|NCT01097915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14794|NCT01097863|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussion, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
14795|NCT01097785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14796|NCT01097694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14797|NCT01097668|Principal Investigators are NOT employed by the organization sponsoring the study.|If the Investigator drafts a publication, he/she agrees to send it to Apitope for review and comment before its submission to the journal. If Apitope considers that the proposed publication contains patentable material or information which should be protected as valuable confidential information, Apitope reserves the right to delay submission to the journal until patent applications have been filed and/or require the deletion of the confidential information from the proposed publication.
14798|NCT01097655|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14820|NCT01096056|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14799|NCT01097629|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish results for his/her study site after publication of results of entire multicenter trial, or after public disclosure of the results online if a multicenter manuscript is not planned. Sponsor must be able to review all proposed results communications regarding study 60 days prior to submission for publication/presentation. Information identified by the Sponsor as confidential must be deleted prior to submission.
14800|NCT01097616|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish results for his/her study site after publication of results of entire multicenter trial, or after public disclosure of the results online if a multicenter manuscript is not planned. Sponsor must be able to review all proposed results communications regarding study 60 days prior to submission for publication/presentation. Information identified by the Sponsor as confidential must be deleted prior to submission.
14801|NCT01097460|Principal Investigators are NOT employed by the organization sponsoring the study.|
14802|NCT01097421|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14803|NCT01097343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14804|NCT01097304|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14805|NCT01097057|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14806|NCT01097005|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators will be granted by sponsor.
14807|NCT01096875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14808|NCT01096823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14809|NCT01096810|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14810|NCT01096784|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14811|NCT01096771|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14812|NCT01096680|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
14813|NCT01096667|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator will provide manuscripts, abstracts, or the full text of any other intended disclosure (poster presentation, invited speaker or guest lecturer presentation, etc.) to the sponsor at least 30 days before they are submitted for publication or otherwise disclosed. If any patent action is required to protect intellectual property rights, Investigator agrees to delay the disclosure for a period not to exceed an additional 60 days.
14814|NCT01096589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14815|NCT01096550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14816|NCT01096446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14817|NCT01096342|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14818|NCT01096316|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14819|NCT01096186|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results of the Study conducted at the Site shall not be made before the first multi-site publication by Sponsor.
14821|NCT01096017|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14822|NCT01095978|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection
14823|NCT01095887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14824|NCT01095835|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14825|NCT01095796|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
14826|NCT01095757|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14827|NCT01095666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14828|NCT01095653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14829|NCT01095510|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Trial Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to Sponsor for pre-review. If Sponsor requests, PI must delete Sponsor confidential information before publication and/or delay publication for 60 days so Sponsor can file for patents or take other action to protect its patent rights.
14830|NCT01095497|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to Sponsor for pre-review. If Sponsor requests, PI must delete Sponsor confidential information before publication and/or delay publication for 60 days so Sponsor can file for patents or take other action to protect its patent rights.
14831|NCT01095250|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
14832|NCT01095094|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14833|NCT01094886|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14834|NCT01094808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14835|NCT01094743|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written consent from the Sponsor.
14836|NCT01094730|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires the agreement and written authorization of the Sponsor.
14837|NCT01094704|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14838|NCT01094574|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14839|NCT01094561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14840|NCT01094548|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publications of the results, either in part or in total (abstracts in journals or newspapers, oral presentations, etc.) by Investigators or their representatives will require pre-submission review by the Sponsor. The Sponsor is entitled to delay publication in order to obtain patent protection.
14841|NCT01094522|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14842|NCT01094184|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14843|NCT01094171|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14844|NCT01094119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14845|NCT01093976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14846|NCT01093846|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
14847|NCT01093794|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication guidelines.
14848|NCT01093755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14849|NCT01093690|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14850|NCT01093651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14851|NCT01093625|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication required agreement and written authorization from the Sponsor
14852|NCT01093599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14853|NCT01093534|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 60 days prior to publication for review and comment. Sponsor may delay the publication for up to 6 months to seek patent protection.
14854|NCT01093521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14855|NCT01093482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14856|NCT01093469|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14857|NCT01093417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14858|NCT01093222|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14859|NCT01093027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14860|NCT01093014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14861|NCT01092923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14863|NCT01092832|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. PI will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. PI may not disclose previously undisclosed confidential information other than study results.
14864|NCT01092780|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
14865|NCT01092767|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) and institution agree not to publish the results of the study until after the earliest of the following: a)conclusion of the study, b)the early termination of the study, c)at discretion and approval of the sponsor, or d)after sponsor confirms there will be no multicenter study publication, whichever occurs first. PI and institution further agree to submit to sponsor copies of any proposed publication or public presentation at least sixty days before dissemination.
14866|NCT01092728|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14867|NCT01092702|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14868|NCT01092663|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14869|NCT01092637|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14870|NCT01092559|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14871|NCT01092546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14872|NCT01092507|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
14873|NCT01092442|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI can not publish any results or data arising from the study except with the institution's approval and sponsor's written consent.
14874|NCT01092416|Principal Investigators are NOT employed by the organization sponsoring the study.|Any previously unpublished information provided to the Investigators by the Sponsor is confidential and will remain the sole property of the Sponsor. The Investigator agrees to use this information only in accomplishing this study not use it for other purposes without the Sponsor’s written consent. An Investigator can generate additional publication ideas based on the trial data. The Sponsor reserves the right to review the manuscript prior to submission in order to verify accuracy of the data.
14875|NCT01092364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14876|NCT01092338|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14877|NCT01091974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14878|NCT01091948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14879|NCT01091675|Principal Investigators are NOT employed by the organization sponsoring the study.|
14880|NCT01091662|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
14881|NCT01091519|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14882|NCT01091454|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14883|NCT01091259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14884|NCT01091246|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
14885|NCT01091155|Principal Investigators are NOT employed by the organization sponsoring the study.|14.1 Review. Institution may publish the results of the Study, based on information collected or generated by Institution and Principal Investigator within the framework thereof, subject to the provisions of this section. In any event, however, no publication, presentation in any forum or any other form of disclosure with respect to the Study or the results thereof will be made prior to the publication of the Joint Publication without Sponsor’s prior written consent.
14886|NCT01091116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14887|NCT01091103|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees not to independently publish the results before the publication of the multi-center PI paper. Sponsor shall review and comment 30 days prior to submission or disclosure. If publication or disclosure contains Sponsor Confidential Information, other than Study Data, PI agrees to remove Confidential Information from publication or disclosure. Sponsor may request that PI delay such publication for an additional 60 days to protect the patentability of any Invention described.
14888|NCT01090973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14889|NCT01090765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14890|NCT01090752|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14891|NCT01090739|Principal Investigators are NOT employed by the organization sponsoring the study.|"After the primary or the combined data article has been published, an Investigator may publish the study experience from his/her site. However, the Sponsor reserves the right to review the manuscript prior to submission in order to verify accuracy of the data.~All publications will be reviewed by the sponsor in order to assure that no confidential information is disclosed. Such confidential information is not allowed for publishing."
14892|NCT01090492|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14893|NCT01090479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14894|NCT01090453|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14895|NCT01090427|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14896|NCT01090323|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
14897|NCT01090310|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
14898|NCT01090180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14899|NCT01090102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14900|NCT01090076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14901|NCT01090063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14902|NCT01090050|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14903|NCT01090011|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14904|NCT01089751|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14905|NCT01089608|Principal Investigators are NOT employed by the organization sponsoring the study.|All the results of the Trial are the sole and exclusive property of THEA, and cannot be used in whatever form without prior written agreement of THEA.
14906|NCT01089595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14907|NCT01089582|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
14908|NCT01089569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14909|NCT01089556|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14910|NCT01089543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14911|NCT01089517|Principal Investigators are NOT employed by the organization sponsoring the study.|No individual site or investigator may publish or present any results from the trial until a joint, multi center publication of the trial results is made by Sponsor in conjunction with various participating investigators and appropriate sites contributing data and comments. Subsequently, individual investigators may request to publish or present results from the trial; however, approval will be at the sole discretion of the Sponsor.
14912|NCT01089504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14913|NCT01089413|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
14914|NCT01089361|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14915|NCT01089231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14916|NCT01089127|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
14917|NCT01089062|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14918|NCT01089023|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14919|NCT01088997|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14920|NCT01088984|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator/Institution must submit proposed publication to Sponsor for review within a prespecified number of days before submission for publication. If Sponsor's review shows that potentially patentable subject matter would be disclosed, publication/public disclosure shall be delayed to enable Sponsor, or Sponsor's designees, to file necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
14959|NCT01085968|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14921|NCT01088711|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
14922|NCT01088672|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14923|NCT01088646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14924|NCT01088529|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14925|NCT01088503|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14926|NCT01088464|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study completion or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
14927|NCT01088438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14928|NCT01088399|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14929|NCT01088295|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14930|NCT01088243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14931|NCT01087996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14932|NCT01087970|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14933|NCT01087957|Principal Investigators are NOT employed by the organization sponsoring the study.|(b) Publication- Investigator and Institution agree not to publish the results of the Trial until after the conclusion of the Trial. Investigator agrees to submit to Sponsor copies of any proposed publication at least sixty (60) calendar days in advance of dissemination. Sponsor agrees to review and comment in a timely manner after receipt . All proprietary and/or confidential information of Sponsor must be removed from the Proposed Publication.
14934|NCT01087944|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
14935|NCT01087918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14936|NCT01087905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14937|NCT01087814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14938|NCT01087801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14939|NCT01087788|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14940|NCT01087762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14941|NCT01087736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14942|NCT01087723|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14943|NCT01087541|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14944|NCT01087528|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14945|NCT01087502|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14946|NCT01087489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14947|NCT01086969|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
14948|NCT01086852|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14949|NCT01086761|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
14950|NCT01086605|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14951|NCT01086475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14952|NCT01086423|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14953|NCT01086410|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14954|NCT01086384|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
14955|NCT01086358|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14956|NCT01086228|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14957|NCT01086215|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14958|NCT01086033|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14960|NCT01085903|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14961|NCT01085825|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14962|NCT01085786|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14963|NCT01085760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14964|NCT01085734|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14965|NCT01085682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14966|NCT01085643|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14967|NCT01085591|Principal Investigators are NOT employed by the organization sponsoring the study.|
14968|NCT01085539|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14969|NCT01085513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14970|NCT01085500|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14971|NCT01085357|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
14972|NCT01085331|Principal Investigators are NOT employed by the organization sponsoring the study.|
14973|NCT01085318|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither Institution nor any Principal Investigators shall publish or present any results from such Study to any third parties until: (i) EMD Serono publishes the results from all sites participating in such Study; (ii) Institution receives notification from EMD Serono that publication of the multi-site results is no longer planned; or (iii) twenty-four (24) months following the completion of the multi-site study at all sites, whichever occurs first.
14974|NCT01085214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14975|NCT01085201|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14976|NCT01085136|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
14977|NCT01085045|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
14978|NCT01085006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14979|NCT01084759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14980|NCT01084707|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15000|NCT01083706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14981|NCT01084668|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14982|NCT01084603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14983|NCT01084551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14984|NCT01084538|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14985|NCT01084278|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
14986|NCT01084265|Principal Investigators are NOT employed by the organization sponsoring the study.|
14987|NCT01084239|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14988|NCT01084174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14989|NCT01084148|Principal Investigators are NOT employed by the organization sponsoring the study.|Mutual agreement
14990|NCT01084135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14991|NCT01084083|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
14992|NCT01084005|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
14993|NCT01083979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14994|NCT01083901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14995|NCT01083849|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
14996|NCT01083810|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
14997|NCT01083771|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
14998|NCT01083758|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators’ right to publish the results of the trial, irrespective of outcome. Pubs/presentations by investigator(s) shall not be made before the results of a joint publication is public. LEO retains the right to have any publication submitted to LEO for review at least 30 days prior to this paper being submitted for publication/presentation. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
14999|NCT01083732|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
15001|NCT01083693|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15002|NCT01083680|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15003|NCT01083667|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15004|NCT01083654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15005|NCT01083641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15006|NCT01083602|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
15007|NCT01083576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15008|NCT01083485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15009|NCT01083472|Principal Investigators are NOT employed by the organization sponsoring the study.|
15010|NCT01083316|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15011|NCT01083199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15012|NCT01083186|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15013|NCT01083173|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15014|NCT01083160|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection
15015|NCT01083121|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15016|NCT01082965|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15017|NCT01082952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15018|NCT01082939|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15019|NCT01082874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15020|NCT01082640|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
15021|NCT01082614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15022|NCT01082588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15023|NCT01082575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15024|NCT01082380|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15025|NCT01082367|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15026|NCT01082328|Principal Investigators are NOT employed by the organization sponsoring the study.|
15027|NCT01082211|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
15028|NCT01082159|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15029|NCT01082081|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15030|NCT01081951|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15031|NCT01081912|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15032|NCT01081886|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15033|NCT01081873|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15034|NCT01081834|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
15035|NCT01081795|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
15036|NCT01081769|Principal Investigators are NOT employed by the organization sponsoring the study.|"A copy of the manuscript must be provided to the Sponsor for review at least 60 days prior to submission for publication or presentation.~No paper that incorporates Confidential Information will be submitted for publication without Sponsor’s prior written consent. If requested in writing, such publication will be withheld for up to an additional 60 calendar days. A publication from the individual Study site data will not be published until the combined results have been published."
15037|NCT01081665|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15038|NCT01081626|Principal Investigators are NOT employed by the organization sponsoring the study.|
15039|NCT01081301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15040|NCT01081249|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15041|NCT01081145|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
15042|NCT01081132|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
15043|NCT01081041|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15044|NCT01080976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15045|NCT01080807|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15046|NCT01080794|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15047|NCT01080768|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15048|NCT01080677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15049|NCT01080625|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15050|NCT01080391|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
15051|NCT01080326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15052|NCT01080300|Principal Investigators are NOT employed by the organization sponsoring the study.|"The PI agrees that sponsor shall have the right to first publication of study results which is intended to be a joint, multi-center publication. Following first publication, the PI may publish study data or results, provided however PI submits proposed publication to sponsor for review at least 60 days prior to the date of proposed publication. Sponsor may remove any information that is considered confidential and/or proprietary other than study data.~ACCEPTED FOR PUBLICATION IN MENOPAUSE."
15053|NCT01080261|Principal Investigators are NOT employed by the organization sponsoring the study.|In Japan, the study agreement was executed between the head of hospital (not PI) and Boston Scientific Japan. The site must get written approval before they publish any study data/information to an outside community such as a scientific society.
15054|NCT01080248|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15055|NCT01080209|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
15056|NCT01080196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15057|NCT01080131|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
15058|NCT01080118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15059|NCT01079988|Principal Investigators are NOT employed by the organization sponsoring the study.|
15060|NCT01079962|Principal Investigators are NOT employed by the organization sponsoring the study.|
15062|NCT01079936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15063|NCT01079832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15064|NCT01079806|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
15065|NCT01079741|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15066|NCT01079598|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15067|NCT01079390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15068|NCT01079299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15069|NCT01079234|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15070|NCT01079195|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15071|NCT01079182|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15072|NCT01079143|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
15073|NCT01079130|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15074|NCT01078974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15075|NCT01078922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15076|NCT01078909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15077|NCT01078844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15078|NCT01078805|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15079|NCT01078753|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention
15080|NCT01078675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15081|NCT01078662|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15082|NCT01078623|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication and/or presentation whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and sponsor
15083|NCT01078584|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15084|NCT01078571|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15085|NCT01078545|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection
15086|NCT01078454|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15087|NCT01078441|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15088|NCT01078402|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15089|NCT01078389|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
15090|NCT01078376|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be made without Sponsor’s prior written approval. Any proposed publication or presentation will be submitted to Sponsor for review 60 days in advance of publication. Institution will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for an additional 60 days to preserve intellectual property.
15091|NCT01078363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15092|NCT01078298|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15093|NCT01078246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15094|NCT01078233|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15095|NCT01078220|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
15096|NCT01078207|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15097|NCT01078168|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15098|NCT01078155|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15099|NCT01078116|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15100|NCT01078090|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15101|NCT01077973|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15102|NCT01077960|Principal Investigators are NOT employed by the organization sponsoring the study.|
15103|NCT01077921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15104|NCT01077856|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
15105|NCT01077830|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
15106|NCT01077817|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15107|NCT01077804|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission, it being understood that the results of this study are not to be considered confidential. The sponsor review can be expedited to meet publication guidelines.
15108|NCT01077739|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15109|NCT01077713|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15110|NCT01077622|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15111|NCT01077596|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15112|NCT01077544|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
15113|NCT01077401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15114|NCT01077375|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
15115|NCT01077362|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
15116|NCT01077323|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15117|NCT01077310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15118|NCT01077284|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
15119|NCT01077271|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15120|NCT01077258|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15121|NCT01077193|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed that the first publication should be made in conjunction with the presentation of a joint, multicenter publication with the PIs from all sites contributing data, analyses, and comments. If this publication was not submitted within 12 months after conclusion of the Study at all sites, termination of the Study at all sites, or after Sponsor confirmed there would be no multicenter Study publication, whichever is first, the PIs could publish the results from their individual sites.
15122|NCT01077128|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15123|NCT01077076|Principal Investigators are NOT employed by the organization sponsoring the study.|Schering-Plough HealthCare Products, Inc. reserves all publication and presentation rights.
15124|NCT01077063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15125|NCT01077050|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15126|NCT01077024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15127|NCT01076985|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15128|NCT01076972|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15129|NCT01076959|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15130|NCT01076686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15131|NCT01076647|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15132|NCT01076504|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
15133|NCT01076452|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15134|NCT01076400|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
15135|NCT01076361|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15136|NCT01076348|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15137|NCT01076335|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15138|NCT01076296|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15139|NCT01076283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15140|NCT01076270|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15141|NCT01076244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15142|NCT01076192|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15143|NCT01076179|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15144|NCT01076166|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15145|NCT01076153|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15146|NCT01076088|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
15147|NCT01076075|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
15148|NCT01076036|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15149|NCT01075984|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts.
15150|NCT01075971|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's representative will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
15151|NCT01075958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15152|NCT01075815|Principal Investigators are NOT employed by the organization sponsoring the study.|
15153|NCT01075763|Principal Investigators are NOT employed by the organization sponsoring the study.|
15154|NCT01075685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15155|NCT01075646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15156|NCT01075412|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15157|NCT01075399|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15158|NCT01075347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15159|NCT01075282|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15160|NCT01075256|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15161|NCT01075243|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15162|NCT01075217|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. For one site, there is a Clinical Trial Cooperative Research and Development Agreement (CRADA) with a restriction of 180 days after pooled data set is published by the sponsor or 180 after data lock of the complete data.
15163|NCT01075204|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15164|NCT01075191|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15165|NCT01075178|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15166|NCT01075152|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15167|NCT01075100|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15168|NCT01075087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15169|NCT01075074|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15170|NCT01074944|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
15171|NCT01074931|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15172|NCT01074658|Principal Investigators are NOT employed by the organization sponsoring the study.|PI will provide results to sponsor for review and approval at least 60 days prior to submittal for publication or presentation. Review will be limited to determination whether Confidential Information is disclosed and not to censor or interfere with presentation or conclusions beyond the extent necessary to protect Confidential Information, to allow the sponsor to protect its rights in patentable or copyrightable material, and to check for technical correctness of sponsor information.
15173|NCT01074554|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15174|NCT01074502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15175|NCT01074463|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
15176|NCT01074450|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
15177|NCT01074437|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15178|NCT01074307|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator commits him/her to forward to sponsor all papers, manuscripts or conference abstracts intended for publication or presentation that contain data or results generated in connection with the study. Papers and abstracts must be available at sponsor’s site in time before the planned submission date to allow for review and comments. Submission for publication need expressed written permission from the sponsor. Any publication should follow publication policy as described in protocol.
15179|NCT01074268|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15180|NCT01074255|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator intends to publish trial results in an academic journal, prior consent of the sponsor must be obtained.
15181|NCT01074242|Principal Investigators are NOT employed by the organization sponsoring the study.|In regard to surveillance results, any publication should be agreed by the sponsor in advance
15182|NCT01074229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15183|NCT01074216|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15184|NCT01074177|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15185|NCT01074164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15186|NCT01074125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15187|NCT01074099|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15188|NCT01074047|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation 60 days in advance of the submission and (ii) delete any confidential information of the sponsor and (iii) delay submission for up to 90 days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
15189|NCT01074034|Principal Investigators are NOT employed by the organization sponsoring the study.|
15190|NCT01074008|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15191|NCT01073943|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
15192|NCT01073930|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
15193|NCT01073865|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs cannot disclose trial results without prior approval in writing by the sponsor.
15194|NCT01073657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15195|NCT01073631|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15196|NCT01073618|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15197|NCT01073605|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15198|NCT01073566|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15199|NCT01073462|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15200|NCT01073449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15201|NCT01073293|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
15202|NCT01073267|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15203|NCT01073163|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator/Institution must submit proposed publication to Sponsor for review within a prespecified number of days before submission for publication. If Sponsor's review shows that potentially patentable subject matter would be disclosed, publication/public disclosure shall be delayed to enable Sponsor, or Sponsor's designees, to file necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
15204|NCT01072929|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
15205|NCT01072877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15206|NCT01072773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15207|NCT01072669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15208|NCT01072656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15209|NCT01072643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15210|NCT01072630|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
15211|NCT01072617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15212|NCT01072539|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15213|NCT01072526|All Principal Investigators ARE employed by the organization sponsoring the study.|This study had no external sponsors. It was supported by the University of Missouri, my employer. The University of Missouri can review the data at anytime.
15214|NCT01072500|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15215|NCT01072448|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
15216|NCT01072409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15217|NCT01072396|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
15218|NCT01072357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15219|NCT01072344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15220|NCT01072331|Principal Investigators are NOT employed by the organization sponsoring the study.|
15221|NCT01072201|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15222|NCT01072188|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15223|NCT01072175|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15224|NCT01072149|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15225|NCT01072136|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15226|NCT01072032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15227|NCT01072006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15228|NCT01071993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15229|NCT01071915|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
15230|NCT01071798|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15231|NCT01071538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15232|NCT01071512|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15233|NCT01071395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15234|NCT01071356|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15235|NCT01071278|Principal Investigators are NOT employed by the organization sponsoring the study.|MSD SHARP & DOHME GmbH and its comarketing companies have exclusive rights to the use and evaluation of the data collected in this study.
15236|NCT01071252|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15237|NCT01071200|Principal Investigators are NOT employed by the organization sponsoring the study.|
15238|NCT01071096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15239|NCT01071083|Principal Investigators are NOT employed by the organization sponsoring the study.|The provisions of our agreement are subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
15240|NCT01071070|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15241|NCT01071044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15242|NCT01070979|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15243|NCT01070966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15244|NCT01070953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15245|NCT01070888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15246|NCT01070810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15247|NCT01070784|Principal Investigators are NOT employed by the organization sponsoring the study.|
15248|NCT01070771|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15249|NCT01070693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15250|NCT01070550|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15251|NCT01070394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15252|NCT01070381|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
15253|NCT01070329|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15254|NCT01070316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15255|NCT01070303|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
15256|NCT01070173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15257|NCT01070043|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15258|NCT01069939|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AZ approval before this study was completed.
15259|NCT01069900|Principal Investigators are NOT employed by the organization sponsoring the study.|"The agreed point of publication is 12/18 months after database lock at the earliest.~Bayer will have up to 30/45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable).~No publication of single center data should be done prior of publication if multi-center data."
15260|NCT01069861|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15261|NCT01069627|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15262|NCT01069562|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15263|NCT01069523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15264|NCT01069484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15265|NCT01069419|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15266|NCT01069354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15267|NCT01069341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15268|NCT01069289|Principal Investigators are NOT employed by the organization sponsoring the study.|
15269|NCT01069185|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15270|NCT01069172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the PI and the sponsor (or its agents) that restricts the PI's rights to publish trial results, but does not prohibit publication provided that prior written permission from the sponsor has been granted.
15271|NCT01069120|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
15272|NCT01069003|Principal Investigators are NOT employed by the organization sponsoring the study.|
15273|NCT01068964|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
15274|NCT01068912|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15275|NCT01068860|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15276|NCT01068821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15277|NCT01068769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15278|NCT01068743|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period of <= 60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trail's primary publication.
15279|NCT01068730|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
15280|NCT01068717|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
15281|NCT01068678|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15282|NCT01068665|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15283|NCT01068652|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15284|NCT01068626|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications during 3 months prior to public release and can embargo communications regarding trial results for an additional period of 3 months from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
15285|NCT01068600|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15286|NCT01068548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15287|NCT01068509|Principal Investigators are NOT employed by the organization sponsoring the study.|For study centers in Australia, no publication of the study results may be made until publication of the results of the study from all centers or until 2 years after study completion, whichever is sooner. For study centers in the USA, no submission for publication or public disclosure of the results by will be made until the results from all centers have been received and analyzed by the sponsor, or the multi-center study has been terminated or abandoned at all centers.
15288|NCT01068418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15289|NCT01068262|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR has the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
15290|NCT01068158|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
15291|NCT01067976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15292|NCT01067846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15293|NCT01067781|Principal Investigators are NOT employed by the organization sponsoring the study.|
15294|NCT01067768|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15295|NCT01067716|Principal Investigators are NOT employed by the organization sponsoring the study.|At least ninety (90) days prior to any proposed submission for publication or presentation of Study Data or other findings related to the Study, Institution will provide Sponsor with a manuscript of such submission(s) for review, comment, and approval. For greater certainty, neither Institution nor Principal Investigator shall have any right to publish any information or results concerning the Study without the express written consent of Sponsor.
15296|NCT01067456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15297|NCT01067352|Principal Investigators are NOT employed by the organization sponsoring the study.|
15298|NCT01067339|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15299|NCT01067326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15300|NCT01067105|Principal Investigators are NOT employed by the organization sponsoring the study.|
15301|NCT01066923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15302|NCT01066897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15303|NCT01066871|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor can with reasonable grounds require changes to the communication which do not change the scientific statement or neutrality of the communication.
15304|NCT01066819|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15305|NCT01066793|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15306|NCT01066780|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 60 days before submission for publication, presentation or use, Institution or Principal Investigator will submit to Sponsor for review and comment any proposed oral or written Publication. Sponsor will have the right to request any modification of any Publication if in Sponsor's reasonable opinion that Publication would jeopardize a patent application or patent.
15307|NCT01066624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15308|NCT01066585|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
15309|NCT01066546|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15310|NCT01066520|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15311|NCT01066156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15312|NCT01066143|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15313|NCT01066104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15314|NCT01066039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15315|NCT01066000|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15316|NCT01065844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15317|NCT01065818|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15318|NCT01065779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15319|NCT01065766|Principal Investigators are NOT employed by the organization sponsoring the study.|In regard to surveillance result, any publication should be agreed by sponsor in advance.
15320|NCT01065714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15321|NCT01065597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15322|NCT01065558|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15323|NCT01065506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15324|NCT01065480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15325|NCT01065454|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigative Site, Institution and/or Principal Investigator shall furnish the Sponsor with a copy of any proposed publication of material at least sixty (60) days in advance of the date of submission for publication or presentation.
15326|NCT01065428|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15327|NCT01065350|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15365|NCT01062308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15328|NCT01065051|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigative Site, Institution and/or Principal Investigator shall furnish the Sponsor with a copy of any proposed publication of material described in Clinical Trial Agreement at least sixty (60) days in advance of the date of submission for publication or presentation. Within sixty (60) day period, the Sponsor shall: review such proposed publication for any patentable subject matter or designated Confidential Information, which the Sponsor may have furnished to facilitate the study.
15329|NCT01064947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15330|NCT01064882|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
15331|NCT01064856|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15332|NCT01064830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15333|NCT01064817|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15334|NCT01064739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15335|NCT01064687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15336|NCT01064622|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15337|NCT01064414|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
15338|NCT01064401|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
15339|NCT01064362|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15340|NCT01064323|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15341|NCT01064310|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15342|NCT01064297|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15343|NCT01064284|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15344|NCT01064167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15345|NCT01064076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15366|NCT01062269|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15346|NCT01063907|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15347|NCT01063881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15348|NCT01063868|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15349|NCT01063855|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15350|NCT01063829|Principal Investigators are NOT employed by the organization sponsoring the study.|Every Publication, disclosure or other use of Information conveyed to the Institution and the Investigator in relation to the Trial and of data and results derived from the Performance of the Trial requires the express written consent of Sponsor.
15351|NCT01063764|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15352|NCT01063712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15353|NCT01063595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15354|NCT01063517|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15355|NCT01063348|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15356|NCT01063153|Principal Investigators are NOT employed by the organization sponsoring the study.|Brain Network Analysis [the primary analysis of EEG data related to BAFPA (Brain Activity Flow Patterns Analysis) and functional connectivity networks] is still in progress by the Sponsor, and there is an agreement between the Sponsor and the Principal Investigator preventing the PI from disclosing EEG results from this trial until the data has been published. We are, however, at liberty to report adverse events from the open-label clinical trial and have done so here.
15357|NCT01063075|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15358|NCT01063062|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15359|NCT01063049|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15360|NCT01063036|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
15361|NCT01062841|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15362|NCT01062763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15363|NCT01062425|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
15364|NCT01062399|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
15367|NCT01062256|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15368|NCT01062230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15369|NCT01062165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15370|NCT01062113|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15371|NCT01062074|Principal Investigators are NOT employed by the organization sponsoring the study.|With regard to surveillance results, any publication should be agreed by the sponsor in advance
15372|NCT01062061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15373|NCT01061866|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15374|NCT01061775|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15375|NCT01061736|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
15376|NCT01061723|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
15377|NCT01061710|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15378|NCT01061671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15379|NCT01061606|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15380|NCT01061567|All Principal Investigators ARE employed by the organization sponsoring the study.|There was no PI assigned for the overall study
15381|NCT01061476|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15382|NCT01061385|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall furnish a copy of any proposed publication or disclosure at least 60 days prior to submission so that Sponsor may have the opportunity to protect its proprietary rights to information, inventions, or products developed under the Clinical Study. If such publication or disclosure contains Confidential Information, the PI agrees to remove such Confidential Information upon the Sponsor's request.
15383|NCT01061359|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15384|NCT01061333|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, subsequent to the multicenter publication, an investigator and colleagues may publish their data independently. Limitations of single site observations should always be described in such a manuscript. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
15385|NCT01061177|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15386|NCT01061151|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
15387|NCT01061034|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15388|NCT01061008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15389|NCT01060670|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall not publicly disclose any results/information pertaining to the trial until a multi-center publication is released under sponsor's direction; however, if a multi-center publication is not released within 18 months after completion of analysis of all study data from all studies conducted within the multi center trial, Investigator may publish results at their institution as long as they have given sponsor 30 days to review.
15390|NCT01060592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15391|NCT01060553|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15392|NCT01060540|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15393|NCT01060150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15394|NCT01060124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15395|NCT01060111|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot provide any trial related information to external parties’ without mutual agreement with the Sponsor. This is valid even after the contract is cancelled.
15396|NCT01060072|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
15397|NCT01060059|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15398|NCT01060020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15399|NCT01060007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15400|NCT01059994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15401|NCT01059903|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
15402|NCT01059864|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15403|NCT01059851|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
15404|NCT01059825|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator will provide manuscripts, abstracts, or the full text of any other intended disclosure (poster presentation, invited speaker or guest lecturer presentation, etc.) to the Sponsor at least 30-days before they are submitted for publication or otherwise disclosed. If any patent action is required to protect intellectual property rights, Investigator agrees to delay the disclosure for a period not to exceed an additional 60 days.
15422|NCT01058655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15405|NCT01059812|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15406|NCT01059799|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15407|NCT01059773|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the Sponsor for review at least 60 days prior to submission for publication or presentation. No paper that incorporates Confidential Information will be submitted for publication without Sponsor’s prior written consent. If requested in writing, such publication will be withheld for up to an additional 60 calendar days. A publication from the individual Study site data will not be published until the combined results have been published.
15408|NCT01059760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15409|NCT01059643|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15410|NCT01059630|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15411|NCT01059617|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15412|NCT01059565|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
15413|NCT01059526|Principal Investigators are NOT employed by the organization sponsoring the study.|Dyax agreements vary, but Dyax will not prohibit any investigator from publishing. Dyax reviews publications prior to public release and can request deferral by up to 60 days beyond the proposed publication date if necessary to preserve its intellectual property. Dyax can request changes to publications to remove non-study-related confidential information. Dyax can also request deferral of single-center publications until after disclosure of the clinical trial's primary publication.
15414|NCT01059344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15415|NCT01059305|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15416|NCT01059175|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15417|NCT01059071|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15418|NCT01058993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15419|NCT01058941|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15420|NCT01058863|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
15421|NCT01058668|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
15423|NCT01058642|Principal Investigators are NOT employed by the organization sponsoring the study.|
15424|NCT01058421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15425|NCT01058356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15426|NCT01058304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15427|NCT01058265|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15428|NCT01058239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15429|NCT01058096|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
15430|NCT01058070|Principal Investigators are NOT employed by the organization sponsoring the study.|
15431|NCT01058005|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
15432|NCT01057901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15433|NCT01057888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15434|NCT01057862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15435|NCT01057810|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
15436|NCT01057693|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15437|NCT01057589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15438|NCT01057433|Principal Investigators are NOT employed by the organization sponsoring the study.|May not publish.
15439|NCT01057394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15440|NCT01057277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15441|NCT01057251|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
15442|NCT01057225|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15443|NCT01057121|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15444|NCT01057017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15445|NCT01056913|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15446|NCT01056822|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety.
15447|NCT01056718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15448|NCT01056653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15449|NCT01056640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15450|NCT01056601|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15451|NCT01056523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15452|NCT01056510|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15453|NCT01056484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15454|NCT01056380|Principal Investigators are NOT employed by the organization sponsoring the study.|Presentation and/or publication is encouraged provided the Sponsor is notified in advance and given the opportunity to review the manuscript or abstract 30 days prior to its submission for presentation at a scientific meeting or for publication in a scientific journal. The investigators will have complete autonomy regarding the content and wording including the decision of whether or not to publish.
15455|NCT01056341|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigators can reserve the right to publish or present study data; provided that the sponsor reviews the abstract or manuscript at least 60 days prior to the expected date of submission to the intended publisher or planned presentation.~Publication of study results by each site shall be made only after completion and finalisation of the study by all sites and first publication by the Sponsor."
15456|NCT01056328|Principal Investigators are NOT employed by the organization sponsoring the study.|
15457|NCT01056315|Principal Investigators are NOT employed by the organization sponsoring the study.|It is the Institution and Principal Investigator's obligation not to publish any information declaration, invention or whatsoever which is in connection with this Agreement without the prior written consent of the Sponsor.
15458|NCT01056289|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15459|NCT01056276|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
15460|NCT01056263|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15461|NCT01056198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15462|NCT01056107|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15463|NCT01056016|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15464|NCT01055886|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15465|NCT01055834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15466|NCT01055782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15467|NCT01055769|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15468|NCT01055704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15469|NCT01055639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15470|NCT01055613|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15471|NCT01055457|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15472|NCT01055314|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15473|NCT01055262|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15474|NCT01055223|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15475|NCT01055197|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
15476|NCT01055184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15477|NCT01055171|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15478|NCT01055132|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications require agreement and written approval from Sponsor.
15479|NCT01055028|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15480|NCT01054976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release (time limit not indicated).
15481|NCT01054911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15482|NCT01054885|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15483|NCT01054846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15484|NCT01054820|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15485|NCT01054742|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to provide forty-five (45) days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of abstracts or manuscripts for publication (including, without limitation, slides and text of oral or other public presentations and text of any transmission through any electronic media), which report any results of the Study. The sponsor shall have the right to review and comment on any presentation including editorial rights.
15504|NCT01053507|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15486|NCT01054729|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
15487|NCT01054703|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator shall not issue or disseminate any press release or statement, nor initiate or cause to be initiated any communication of information regarding the clinical trial (written or oral) to the communications media or third parties without the prior written consent of Sponsor.
15488|NCT01054625|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site and the PI may be required to withhold the publication for up to 90 days. Subject to a reasoned request from the sponsor, the publication may be further delayed for a period up to 6 months from the date of first submission to the sponsor.~The sponsor has the right to require deletion of any trade secret, proprietary, or confidential information supplied by the sponsor to the site or the PI. The sponsor shall not otherwise have the right to censor publications."
15489|NCT01054599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15490|NCT01054586|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15491|NCT01054573|Principal Investigators are NOT employed by the organization sponsoring the study.|It is the policy of the sponsor not to allow the investigators to publish their results or findings prior to the sponsor’s publication of the overall trial results. The investigator agrees that before he/she publishes any results of this trial, he/she shall allow at least 45 days for the sponsor to review the prepublication manuscript prior to submission of the manuscript to the publisher as specified in the Clinical Trial Agreement between institution/investigator and sponsor.
15492|NCT01054560|Principal Investigators are NOT employed by the organization sponsoring the study.|Physician shall not make any publication without providing Sponsor 30 days notice.If Sponsor determines that the proposed publication contains confidential information, Sponsor may require the delay of publication for a period of time not to exceed 90 days and may require that any confidential information be removed from the publication. Sponsor may also require Physician to delay publication until any factual errors or inaccuracies in the publication are corrected.
15493|NCT01054404|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15494|NCT01054339|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15495|NCT01054222|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15496|NCT01054183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15497|NCT01054170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15498|NCT01054079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15499|NCT01053988|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15500|NCT01053897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15501|NCT01053819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15502|NCT01053741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15503|NCT01053663|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15505|NCT01053429|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15506|NCT01053312|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15507|NCT01053247|Principal Investigators are NOT employed by the organization sponsoring the study.|
15508|NCT01053156|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15509|NCT01053078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15510|NCT01053000|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15511|NCT01052948|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15512|NCT01052844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15513|NCT01052831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15514|NCT01052779|Principal Investigators are NOT employed by the organization sponsoring the study.|If there is no multi-site publication within 18 months after the Study has been completed or terminated at all Study sites, and all data has been received by Sponsor, the Site and SMO shall have the right to publish its results from the Study for non-commercial purposes, if submitted to Sponsor for review 60 days prior to submission of publication. Publication must remove all confidential information and may be delayed by up to 180 days to allow Sponsor to protect its interests.
15515|NCT01052714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15516|NCT01052701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15517|NCT01052662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15518|NCT01052545|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15519|NCT01052480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15520|NCT01052428|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15521|NCT01052272|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15522|NCT01052207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15523|NCT01052116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15524|NCT01052077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15525|NCT01052038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15526|NCT01051986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15527|NCT01051921|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15528|NCT01051856|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15529|NCT01051817|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
15530|NCT01051791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15531|NCT01051778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15532|NCT01051739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15533|NCT01051570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15534|NCT01051557|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15535|NCT01051466|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15536|NCT01051440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15537|NCT01051323|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15538|NCT01050998|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
15539|NCT01050946|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15540|NCT01050816|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15541|NCT01050790|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15542|NCT01050764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15543|NCT01050673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15544|NCT01050660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15545|NCT01050647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15546|NCT01050634|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15547|NCT01050582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15548|NCT01050569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15549|NCT01050543|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor shall have the right to review and comment with respect to publications with regard to the following concerns: proprietary information; accuracy of the information; and to ensure that the presentation is fairly balanced and in compliance with FDA regulations.~The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial."
15550|NCT01050530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15551|NCT01050257|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15552|NCT01050218|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
15553|NCT01050205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15554|NCT01050153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15555|NCT01050062|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15556|NCT01049984|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. Sponsor may remove information that is considered confidential and/or proprietary other than Study data and results.
15557|NCT01049945|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15558|NCT01049802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15559|NCT01049776|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15560|NCT01049581|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15561|NCT01049503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15562|NCT01049412|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15563|NCT01049373|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15564|NCT01049360|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the Investigator will be subject to mutual agreement between the investigator and sponsor.
15565|NCT01049334|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15566|NCT01049308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15567|NCT01049243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15568|NCT01049217|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15569|NCT01049009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15570|NCT01048944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15571|NCT01048879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15572|NCT01048866|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15573|NCT01048788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15574|NCT01048723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15575|NCT01048697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15576|NCT01048671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15577|NCT01048658|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15578|NCT01048606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15579|NCT01048593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15580|NCT01048541|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15581|NCT01048502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15582|NCT01048424|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15583|NCT01048333|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15584|NCT01048242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15585|NCT01048125|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15586|NCT01048099|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
15587|NCT01047839|Principal Investigators are NOT employed by the organization sponsoring the study.|
15588|NCT01047709|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15589|NCT01047553|Principal Investigators are NOT employed by the organization sponsoring the study.|
15590|NCT01047527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15591|NCT01047475|Principal Investigators are NOT employed by the organization sponsoring the study.|
15592|NCT01047436|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI was restricted from publishing results for 6 months from the end of the trial. This has now passed and the PI is free to publish the results without restriction
15593|NCT01047358|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15594|NCT01047345|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
15595|NCT01047332|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15596|NCT01047306|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire's agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial's multi-center publication.
15597|NCT01047293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15598|NCT01047241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15599|NCT01047189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15600|NCT01046903|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15601|NCT01046877|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15602|NCT01046695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15603|NCT01046682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15604|NCT01046643|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15605|NCT01046565|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
15606|NCT01046396|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
15607|NCT01046253|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
15608|NCT01046136|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15609|NCT01046110|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15610|NCT01046084|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
15611|NCT01045993|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after the disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15612|NCT01045967|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
15613|NCT01045798|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
15614|NCT01045707|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15615|NCT01045694|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15616|NCT01045551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15617|NCT01045447|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
15618|NCT01045421|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review in advance of publication.
15619|NCT01045265|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15620|NCT01045187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15621|NCT01045161|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
15622|NCT01045122|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15623|NCT01045096|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights therefrom or any data, information or materials obtained or generated in the performance of it’s obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
15624|NCT01045057|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15625|NCT01045031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15626|NCT01044862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15627|NCT01044771|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15628|NCT01044758|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15629|NCT01044732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15630|NCT01044706|Principal Investigators are NOT employed by the organization sponsoring the study.|This document contains trade secrets and commercial information that is confidential and may not be disclosed to third parties. Persons to whom this study protocol is disclosed must be informed that all the information herein is confidential and may not be further divulged. These restrictions will apply as well to all future communications if deemed privileged or confidential. Publication of the study results may only be allowed with written permission from the Sponsor.
15631|NCT01044693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15632|NCT01044589|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15633|NCT01044537|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15634|NCT01044498|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15635|NCT01044459|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc.
15636|NCT01044303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15637|NCT01044290|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15638|NCT01044264|Principal Investigators are NOT employed by the organization sponsoring the study.|
15639|NCT01044212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15640|NCT01044056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15641|NCT01044030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15642|NCT01043939|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15643|NCT01043926|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
15644|NCT01043874|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
15645|NCT01043705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15646|NCT01043653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15647|NCT01043640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15648|NCT01043562|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15649|NCT01043523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15650|NCT01043432|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15651|NCT01043393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15652|NCT01043185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between PI and Sponsor (AZ) or its agents that restricts the PI's right to discuss/publish trial results after the trial is completed.The PI agrees to collaborate in good faith with AZ with regards to content and formation of any publication or disclosure to be made by PI and to pay due consideration to opinions offered by AZ.
15653|NCT01043146|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI can discuss and publish trial results upon review of results communication by the sponsor. The sponsor can require changes to the communication.
15654|NCT01043133|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15655|NCT01043094|Principal Investigators are NOT employed by the organization sponsoring the study.|PI not to publish.
15656|NCT01042977|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
15657|NCT01042938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15658|NCT01042795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15659|NCT01042678|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
15660|NCT01042613|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15661|NCT01042600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15662|NCT01042535|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15663|NCT01042509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15664|NCT01042496|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15665|NCT01042392|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15666|NCT01042366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15667|NCT01042288|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
15668|NCT01042236|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15669|NCT01042158|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15670|NCT01042145|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15671|NCT01042093|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15672|NCT01041976|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15673|NCT01041859|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
15674|NCT01041638|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15675|NCT01041573|Principal Investigators are NOT employed by the organization sponsoring the study.|
15676|NCT01041417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15677|NCT01041404|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15678|NCT01041287|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15679|NCT01041209|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15680|NCT01040871|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15681|NCT01040858|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15682|NCT01040845|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15683|NCT01040832|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15684|NCT01040819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15685|NCT01040793|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
15686|NCT01040780|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15687|NCT01040728|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
15688|NCT01040689|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
15689|NCT01040624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15690|NCT01040403|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
15691|NCT01040351|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15692|NCT01040260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15693|NCT01040208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15694|NCT01040169|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15695|NCT01040130|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
15696|NCT01040052|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
15697|NCT01039792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15698|NCT01039688|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15699|NCT01039675|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15700|NCT01039584|Principal Investigators are NOT employed by the organization sponsoring the study.|
15701|NCT01039519|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right, 60 days before submission for publication, to review disclosures and require deletion of its confidential information, excluding the study results. Public disclosure shall be delayed for up to 60 additional days in order for the Sponsor to file a patent application, if needed. Single center publications will be postponed until after disclosure of pooled data (all sites), or, for a period of 18 months from study completion/termination at all participating sites.
15702|NCT01039428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15703|NCT01039376|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15704|NCT01039207|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15705|NCT01038921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15706|NCT01038869|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15707|NCT01038856|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15708|NCT01038752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15709|NCT01038713|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15710|NCT01038635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15711|NCT01038609|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15712|NCT01038336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15713|NCT01038323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15714|NCT01038128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15715|NCT01037452|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15716|NCT01037309|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15717|NCT01037244|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15718|NCT01037218|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15719|NCT01037192|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15720|NCT01037127|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15721|NCT01037114|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15722|NCT01037088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15723|NCT01036802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15724|NCT01036763|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
15725|NCT01036724|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15726|NCT01036529|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15727|NCT01036490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15728|NCT01036438|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15729|NCT01036321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15730|NCT01036165|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither Institution nor any Principal Investigators shall publish or present any results from such Study to any third parties until: (i) EMD Serono publishes the results from all sites participating in such Study; (ii) Institution receives notification from EMD Serono that publication of the multi-site results is no longer planned; or (iii) twenty-four (24) months following the completion of the multi-site study at all sites, whichever occurs first.
15731|NCT01036022|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15732|NCT01036009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15733|NCT01035944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15734|NCT01035905|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
15735|NCT01035788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15736|NCT01035749|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15737|NCT01035658|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
15738|NCT01035606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15739|NCT01035346|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15740|NCT01035333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15741|NCT01035255|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15742|NCT01035229|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15743|NCT01035138|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15744|NCT01035060|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15745|NCT01035047|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15746|NCT01034709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15747|NCT01034657|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15748|NCT01034631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15749|NCT01034592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15750|NCT01034579|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs have to submit any publication for internal review and approval by EMD Serono before it can be publicly disclosed.
15751|NCT01034553|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15752|NCT01034540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15753|NCT01034462|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
15754|NCT01034397|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15755|NCT01034358|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15756|NCT01034306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15757|NCT01034176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15758|NCT01034163|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15777|NCT01032915|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
15759|NCT01034137|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15760|NCT01034111|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor shall have the opportunity to review all abstracts, drafts or proposed presentations regarding this study 60 days prior to submission for publication/presentation. Any information that the sponsor identifies as confidential should be deleted prior to submission.
15761|NCT01033942|Principal Investigators are NOT employed by the organization sponsoring the study.|The Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by the protocol team and AMLG.
15762|NCT01033864|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15763|NCT01033851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15764|NCT01033825|Principal Investigators are NOT employed by the organization sponsoring the study.|
15765|NCT01033747|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15766|NCT01033734|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15767|NCT01033565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15768|NCT01033487|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15769|NCT01033448|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
15770|NCT01033383|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15771|NCT01033227|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15772|NCT01033071|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
15773|NCT01033032|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from the date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish results until 18 mos. after the trial has been completed at all sites.
15774|NCT01033019|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15775|NCT01032993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15776|NCT01032928|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15778|NCT01032889|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
15779|NCT01032850|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15780|NCT01032837|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15781|NCT01032759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15782|NCT01032733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15783|NCT01032694|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15784|NCT01032538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15785|NCT01032382|Principal Investigators are NOT employed by the organization sponsoring the study.|Parties agree to keep Referenced Information in strict confidence and not to disclose it to any other party or use Referenced Information for any purpose, other than for the performance of the clinical studies herein described, without prior written consent of the providing party. Parties may disclose the Referenced Information to their employees and consultants, and employees and consultants of their affiliates, who have a need to know such Referenced Information.
15786|NCT01032291|Principal Investigators are NOT employed by the organization sponsoring the study.|"Multicenter publication must include input from investigators and Celgene, agreement to be established before publication~Multicenter publication has priority over subset (single center) publication, for duration of 1 year after study completion~Individual investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. In this case, Celgene has the right to comment and right to ask delay of publication for 90 days"
15787|NCT01032265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15788|NCT01032239|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15789|NCT01032200|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15790|NCT01032174|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15791|NCT01032135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15792|NCT01032070|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
15793|NCT01032044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15794|NCT01032018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15795|NCT01031979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15796|NCT01031953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15797|NCT01031914|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15798|NCT01031810|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15799|NCT01031706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15800|NCT01031680|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
15801|NCT01031628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15802|NCT01031550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15803|NCT01031498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15804|NCT01031446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15805|NCT01031381|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15806|NCT01031134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15807|NCT01031095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15808|NCT01031043|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15809|NCT01031004|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
15810|NCT01030965|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15811|NCT01030952|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15812|NCT01030822|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15813|NCT01030757|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15814|NCT01030718|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
15815|NCT01030666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15816|NCT01030653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15817|NCT01030536|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
15818|NCT01030458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15819|NCT01029925|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15820|NCT01029912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15821|NCT01029886|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15822|NCT01029795|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15823|NCT01029730|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
15824|NCT01029704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15825|NCT01029691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15826|NCT01029652|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
15827|NCT01029535|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 120 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
15828|NCT01029405|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15829|NCT01029392|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15830|NCT01029366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15831|NCT01029340|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15832|NCT01029262|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 12 months since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
15833|NCT01029054|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15834|NCT01028911|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15835|NCT01028820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15836|NCT01028677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15837|NCT01028651|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and/or Principal Investigator agree not to publish or publicly present any interim results of the Study without the prior written consent of Sponsor, not to be unreasonably withheld or delayed, except as provided below. Institution and/or Principal Investigator further agree to provide Sponsor with drafts of any such publication or presentation for review and approval no less than 30 days prior to submission for publication or the date of public presentation.
15838|NCT01028391|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15839|NCT01028378|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15840|NCT01028352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15841|NCT01028300|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Investigators may freely present or publish results of the Clinical Investigation in a manner which fairly sets forth the conclusions reached by the Clinical Investigators, but only after the Sponsor has been given the opportunity of reviewing the proposed presentation or publication prior to the intended submission, presentation, or publication date
15842|NCT01028222|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15843|NCT01028131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15844|NCT01028053|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15845|NCT01028027|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
15846|NCT01028014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15847|NCT01027910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15848|NCT01027897|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15849|NCT01027884|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15850|NCT01027819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15851|NCT01027780|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15852|NCT01027702|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15853|NCT01027650|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
15854|NCT01027598|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
15855|NCT01027468|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15856|NCT01027416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15857|NCT01027364|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
15858|NCT01027351|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15859|NCT01027286|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15860|NCT01027273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15861|NCT01027195|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15862|NCT01027000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15863|NCT01026974|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15864|NCT01026948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15865|NCT01026909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15866|NCT01026844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15867|NCT01026831|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15868|NCT01026818|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15869|NCT01026805|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15870|NCT01026792|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15871|NCT01026493|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
15872|NCT01026454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15873|NCT01026402|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15874|NCT01026389|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15875|NCT01026324|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15876|NCT01026220|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
15877|NCT01026194|Principal Investigators are NOT employed by the organization sponsoring the study.|
15878|NCT01026181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15899|NCT01024855|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15879|NCT01026142|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
15880|NCT01026103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15881|NCT01026038|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15882|NCT01026012|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15883|NCT01025843|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts,or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
15884|NCT01025830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15885|NCT01025817|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety.
15886|NCT01025635|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish the results of Study only after review, comment and approval by Intendis. At least sixty (60) days prior to submitting a manuscript to a publisher or other outside persons (i.e., reviewer(s)) or prior to any public presentation), a copy of the manuscript or presentation will be provided to Intendis by the Investigator for review and comment. No publication of confidential information shall be made without Intendis' prior written consent.
15887|NCT01025492|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15888|NCT01025336|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15889|NCT01025284|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15890|NCT01025271|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15891|NCT01025232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15892|NCT01025193|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15893|NCT01025154|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15894|NCT01025076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15895|NCT01025037|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15896|NCT01024972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15897|NCT01024959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15898|NCT01024946|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15900|NCT01024751|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor.
15901|NCT01024738|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15902|NCT01024608|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
15903|NCT01024465|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon study conclusion, the PI has the right to use the study data for educational purposes, scientific conferences and publications. The sponsor will have a period of 15 days (for abstracts) and 30 days (for scientific publications) to review the proposal for disclosure / publication for the sole purpose of protecting any confidential information. If such disclosure contains Confidential Information, the PI agrees to remove such Confidential Information.
15904|NCT01024387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15905|NCT01024335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15906|NCT01024309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15907|NCT01024296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15908|NCT01024244|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15909|NCT01024036|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15910|NCT01023958|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
15911|NCT01023841|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
15912|NCT01023815|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15913|NCT01023789|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15914|NCT01023776|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15915|NCT01023724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15916|NCT01023711|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15917|NCT01023672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15918|NCT01023659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15919|NCT01023581|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
15920|NCT01023568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15921|NCT01023516|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15922|NCT01023308|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
15923|NCT01023256|Principal Investigators are NOT employed by the organization sponsoring the study.|All information supplied by MorphoSys is considered confidential until publication and shall not be disclosed without prior written consent from MorphoSys. No data can be published in any format without prior approval of the MSC-1001 Publication Committee, which has final decision on approving submissions for publication. In the event of disagreement in the content of a publication, both the Author’s and MorphoSys’ opinion will be fairly and sufficiently represented in the publication.
15924|NCT01023217|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15925|NCT01023178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15926|NCT01023074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15927|NCT01023061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15928|NCT01023035|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts.
15929|NCT01023022|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15930|NCT01022996|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
15931|NCT01022762|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones, e.g. when the clinical trial report is available. This includes the right to not release interim results of clinical trials. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
15932|NCT01022567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15933|NCT01022502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15934|NCT01022398|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15935|NCT01022307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15936|NCT01022242|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15937|NCT01022203|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15938|NCT01022190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15940|NCT01022073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15941|NCT01021878|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15942|NCT01021852|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15943|NCT01021813|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
15944|NCT01021761|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15945|NCT01021683|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot provide any trial related information to external parties without mutual agreement with the Sponsor. This is valid even after the contract is cancelled.
15946|NCT01021618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15947|NCT01021553|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15948|NCT01021423|Principal Investigators are NOT employed by the organization sponsoring the study.|"Multicenter publication must include input from investigators and Celgene, agreement to be established before publication.~Multicenter publication has priority over subset (single center) publication, for duration of 1 year after study completion.~Individual investigators have publication right after multicenter publication is complete or 1 year after study completion, whichever is first. Celgene has the right to comment and right to ask delay of publication for up to 90 days."
15949|NCT01021332|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principle Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript at least 90 days prior to publication for review and comment. Sponsor may delay the publication to seek patent approval.
15950|NCT01021306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15951|NCT01021293|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15952|NCT01021215|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15953|NCT01021111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15954|NCT01021020|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15955|NCT01021007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15956|NCT01020981|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15957|NCT01020903|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15958|NCT01020877|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
15959|NCT01020838|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15960|NCT01020812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15961|NCT01020799|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication or presentation of results until the earlier of the publication of the first multi-center publication and the second anniversary of the completion of the multi-center study at all sites. Sponsor must receive a copy of proposed manuscript for review and comment at least 60 days prior to its submission for publication or presentation.
15962|NCT01020786|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15963|NCT01020773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15964|NCT01020747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15965|NCT01020591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15966|NCT01020526|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study participating sites. Investigator may not disclose previously undisclosed confidential other than study results.
15967|NCT01020474|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
15968|NCT01020448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15969|NCT01020435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15970|NCT01020305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15971|NCT01020123|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15972|NCT01020019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15973|NCT01020006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15974|NCT01019980|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
15975|NCT01019928|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15976|NCT01019707|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15977|NCT01019694|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
15978|NCT01019486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15979|NCT01019369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15980|NCT01019317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15981|NCT01019135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15982|NCT01018992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15983|NCT01018979|Principal Investigators are NOT employed by the organization sponsoring the study.|PI needs to inform sponsor and asks for permission before he/she discusses or publishes trial results after the trial is completed.
15984|NCT01018953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15985|NCT01018862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15986|NCT01018810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15987|NCT01018732|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15988|NCT01018680|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15989|NCT01020487|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
15990|NCT01018511|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 3 months prior to publication for review and comment. Sponsor may delay the publication to seek patent protection.
15991|NCT01018420|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
15992|NCT01018394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15993|NCT01018264|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15994|NCT01018186|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15995|NCT01018134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15996|NCT01018095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15997|NCT01018056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
15998|NCT01018030|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
15999|NCT01017952|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16000|NCT01017874|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16020|NCT01016873|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and the Principal Investigator agree not to publish or issue a press release or authorize the publication or presentation of any Study Results without obtaining Oraya’s prior written approval.
16001|NCT01017731|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
16002|NCT01017653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16003|NCT01017601|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16004|NCT01017575|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single center publications until after disclosure of the clinical trial's primary publication.
16005|NCT01017549|Principal Investigators are NOT employed by the organization sponsoring the study.|The results are published; therefore the disclosure agreement is no longer in effect. The site investigators were to ask permission to publish single center results if they chose to publish prior to the entire study results were published.
16006|NCT01017536|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16007|NCT01017497|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16008|NCT01017263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16009|NCT01017250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16010|NCT01017237|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16011|NCT01017146|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16012|NCT01017120|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16013|NCT01017042|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16014|NCT01017029|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
16015|NCT01017003|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16016|NCT01016977|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16017|NCT01016964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16018|NCT01016938|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16019|NCT01016912|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single center publications until after disclosure of the clinical trial's primary publication.
16021|NCT01016847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16022|NCT01016834|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16023|NCT01016691|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires written consent of the sponsor.
16024|NCT01016678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16025|NCT01016652|Principal Investigators are NOT employed by the organization sponsoring the study.|Written authorization by the Sponsor is required for publication.
16026|NCT01016600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16027|NCT01016483|Principal Investigators are NOT employed by the organization sponsoring the study.|
16028|NCT01016353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16029|NCT01016132|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
16030|NCT01016106|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16031|NCT01016067|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16032|NCT01016015|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16033|NCT01015976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16034|NCT01015833|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16035|NCT01015820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16036|NCT01015807|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16037|NCT01015781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16038|NCT01015703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16039|NCT01015677|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
16040|NCT01015638|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16041|NCT01015560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16042|NCT01015534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16043|NCT01015443|Principal Investigators are NOT employed by the organization sponsoring the study.|
16044|NCT01015326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16045|NCT01015287|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16046|NCT01015170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16047|NCT01015131|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
16048|NCT01015118|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
16049|NCT01014988|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16050|NCT01014975|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the study, after providing sponsor 30 days’ notice prior to submitting a manuscript or other materials related to the study to any outside party. At sponsor's request, site will remove any confidential information (other than study results), and site will upon sponsor's request delay publication or presentation for a period of up to 120 days to allow sponsor to protect its interests in any sponsor inventions.
16051|NCT01014936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16052|NCT01014910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16053|NCT01014871|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreement in full force and effect for a period of 10 years.
16054|NCT01014741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16055|NCT01014728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16056|NCT01014689|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreement in full force and effect for a period of 10 years.
16057|NCT01014624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16058|NCT01014585|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this study is the property of Forest Research Institute, Inc. An integrated clinical and statistical report was prepared at the completion of the study. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc.
16059|NCT01014533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16060|NCT01014455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16061|NCT01014442|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16062|NCT01014351|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
16063|NCT01014208|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16064|NCT01014169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16065|NCT01014143|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16066|NCT01014091|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16067|NCT01014013|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16068|NCT01013961|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16069|NCT01013883|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16070|NCT01013870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16071|NCT01013844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16072|NCT01013792|Principal Investigators are NOT employed by the organization sponsoring the study.|
16073|NCT01013753|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
16074|NCT01013740|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
16075|NCT01013701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16076|NCT01013597|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16077|NCT01013207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16078|NCT01013194|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16079|NCT01012999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16080|NCT01012973|Principal Investigators are NOT employed by the organization sponsoring the study.|Publishing of result communication only after Bayer´s written approval. Manuscript to Bayer sixty days before public release. If no written Bayer comment within 60 days consider approval given. If multi-site study, principal investigator (PI) not do independently publish results before publication of the multi-site paper, but PI not restricted from 24 months from study to completion onwards.
16081|NCT01012947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16082|NCT01012921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16083|NCT01012765|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
16084|NCT01012739|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
16085|NCT01012713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16086|NCT01012674|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16087|NCT01012661|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves right to review/comment on any manuscript for publication/presentation presenting data from the trial. No manuscript may be submitted for publication without prior review. Investigator agrees to accommodate reasonable requests to protect propriety rights/interests. Investigator must ensure accuracy of results. Investigator shall grant Sponsor right to reproduce/translate/use all copyrighted material from study publications.
16088|NCT01012622|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator cannot provide any trial related information to external parties’ without mutual agreement with the sponsor. This is valid even after the contract is cancelled.
16089|NCT01012492|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16090|NCT01012440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16091|NCT01012414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16092|NCT01012388|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves right to review/comment on manuscript intended for publication/presentation which presents trial data. No manuscripts may be submitted for publication without prior review/comment by Sponsor. Title, right to determine disposition of any copyrights, or copyrightable material, first produced/composed in the performance of this research shall remain with PI, provided that PI grants Sponsor irrevocable right to reproduce/translate/use all such copyrighted material for own purposes.
16093|NCT01012362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16094|NCT01012336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16095|NCT01012323|Principal Investigators are NOT employed by the organization sponsoring the study.|Octapharma agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Octapharma supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. Octapharma also reserves the right to review data prior to publishing and provide comments/changes within a certain time period.
16096|NCT01012297|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16097|NCT01012258|Principal Investigators are NOT employed by the organization sponsoring the study.|All submissions by the PI for publication require the written permission from the sponsor. The PI commits to forward to the sponsor all documents intended for publication which contains data or results generated in connection with the study. Documents must be available at least 60 days before the planned submission date to allow for review. Any publication should follow the policy in the protocol. The PI shall not publish results derived from the study until the study has been reported in full.
16098|NCT01012245|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16099|NCT01012219|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication timelines.
16100|NCT01012167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16101|NCT01012037|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16102|NCT01011946|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16103|NCT01011933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16104|NCT01011907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16105|NCT01011894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16106|NCT01011868|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16107|NCT01011829|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16108|NCT01011816|Principal Investigators are NOT employed by the organization sponsoring the study.|"Disclosure restrictions:~Sponsor can review results communication prior to public release and can embargo communications regarding trial results for up to 30 days from the time submitted for review.~If the communication contains patentable invention information, disclosure may be delayed up to 6 months for patent application filing.~If the communication contains confidential information, Sponsor will notify the PI to remove the confidential information prior to release."
16109|NCT01011738|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
16110|NCT01011673|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16111|NCT01011634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16112|NCT01011556|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16113|NCT01011465|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16114|NCT01011387|Principal Investigators are NOT employed by the organization sponsoring the study.|The Coordinating Investigator will be the lead author for the mail (primary) publication from this Investigation. For any abstract and/or manuscript the Investigators will be given at least 14 days review time before the intended submission of the document.
16115|NCT01011335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16116|NCT01011309|Principal Investigators are NOT employed by the organization sponsoring the study.|IDRI encourages publication in peer-reviewed medical journals and will not unduly withhold permission to publish. However, all proposed publications, papers, abstracts or written materials related to the study or an outline of any oral presentation, shall be submitted to and coordinated by IDRI to assure that no proprietary information is presented and that authorship is fairly represented.
16117|NCT01011283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16118|NCT01011179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16119|NCT01011153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16120|NCT01011075|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16121|NCT01011049|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
16122|NCT01010971|Principal Investigators are NOT employed by the organization sponsoring the study.|
16123|NCT01010932|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16124|NCT01010906|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
16125|NCT01010867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16126|NCT01010854|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16127|NCT01010776|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The Sponsor can require changes to the communication and can extend the embargo.
16128|NCT01010750|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
16129|NCT01010633|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s)after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
16130|NCT01010568|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16131|NCT01010555|Principal Investigators are NOT employed by the organization sponsoring the study.|No distribution of trial-specific information without express written permission of Director of Centre for Contact Lens Research.
16132|NCT01010503|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
16133|NCT01010477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16134|NCT01010399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16135|NCT01010282|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
16136|NCT01010230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16137|NCT01010204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16138|NCT01010061|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16139|NCT01010009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16140|NCT01009983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16141|NCT01009931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16142|NCT01009840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16143|NCT01009762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16144|NCT01009645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16145|NCT01009619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16167|NCT01008553|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the Sponsor requires.
16168|NCT01008475|Principal Investigators are NOT employed by the organization sponsoring the study.|
16146|NCT01009580|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
16147|NCT01009554|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator agreed not to publish the study results without prior sponsor approval.
16148|NCT01009515|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16149|NCT01009463|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16150|NCT01009346|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16151|NCT01009333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16152|NCT01009203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16153|NCT01009138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16154|NCT01009099|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16155|NCT01009086|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
16156|NCT01009060|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16157|NCT01009047|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator wishes to publish information from the study, a copy of the manuscript must be provided to the Sponsor for review at least 60 days before submission for publication. If requested by the Sponsor, the Investigator will withhold it up to an additional 60 days to allow for filing of a patent application. The Sponsor will not change or suppress the scientific content. For multi-center study, results may not be published before the primary endpoints of a study have been published.
16158|NCT01009034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16159|NCT01008995|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16160|NCT01008969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16161|NCT01008943|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16162|NCT01008904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16163|NCT01008722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16164|NCT01008696|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16165|NCT01008618|Principal Investigators are NOT employed by the organization sponsoring the study.|
16166|NCT01008605|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16169|NCT01008449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16170|NCT01008319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16171|NCT01008280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16172|NCT01007916|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
16173|NCT01007942|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
16174|NCT01007838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16175|NCT01007812|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
16176|NCT01007656|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16177|NCT01007643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16178|NCT01007552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16179|NCT01007435|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16180|NCT01007396|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16181|NCT01007253|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16182|NCT01007149|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
16183|NCT01007123|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16184|NCT01007110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16185|NCT01007071|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16186|NCT01006980|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16187|NCT01006889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16188|NCT01006707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16189|NCT01006655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16190|NCT01006629|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
16191|NCT01006616|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, e.g., any computer access system such as the Internet, World Wide Web, etc.) that report any results of the study.
16192|NCT01006603|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication or presentation may include any of AZ’s confidential information without AZ’s prior written approval.
16193|NCT01006590|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16194|NCT01006356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16195|NCT01006291|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
16196|NCT01006135|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16197|NCT01006122|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16198|NCT01006018|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16199|NCT01005966|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16200|NCT01005914|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16201|NCT01005901|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
16202|NCT01005888|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to sponsor for pre-review. If sponsor requests, PI must delete sponsor confidential information before publication and/or delay publication for 90 days so sponsor can file for patents or take other action to protect its patent rights.
16203|NCT01005875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16204|NCT01005745|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16205|NCT01005732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16206|NCT01005719|Principal Investigators are NOT employed by the organization sponsoring the study.|
16207|NCT01005706|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16208|NCT01005680|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16209|NCT01005602|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16210|NCT01005576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16211|NCT01005459|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16212|NCT01005407|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16213|NCT01005355|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
16214|NCT01005329|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16215|NCT01005316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16216|NCT01005290|Principal Investigators are NOT employed by the organization sponsoring the study.|Communications and publication must be agreed between sponsor and PI
16217|NCT01005251|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between PI and Sponsor (AZ) or its agents that restricts the PI's right to discuss/publish trial results after the trial is completed.The PI agrees to collaborate in good faith with AZ with regards to content and formation of any publication or disclosure to be made by PI and to pay due consideration to opinions offered by AZ.
16218|NCT01004991|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16219|NCT01004939|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16220|NCT01004874|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16221|NCT01004848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16222|NCT01004822|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16223|NCT01004770|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16224|NCT01004705|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication must be agreed upon with the sponsor.
16225|NCT01004614|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16226|NCT01004510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16227|NCT01004432|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16228|NCT01004393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16229|NCT01004354|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16250|NCT01002989|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16230|NCT01004263|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees to delay publication of study results until Food and Drug Administration (FDA) grants pediatric exclusivity on the study drug. Investigator may publish results for his/her study site after primary publication of results of entire multicenter trial. Sponsor must be able to review all proposed results communications regarding study 60 days prior to submission for publication/presentation. Information identified by the Sponsor as confidential must be deleted prior to submission.
16231|NCT01004250|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16232|NCT01004185|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16233|NCT01004172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16234|NCT01004159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16235|NCT01004146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16236|NCT01004003|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
16237|NCT01003990|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16238|NCT01003938|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16239|NCT01003899|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16240|NCT01003886|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16241|NCT01003301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16242|NCT01003288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16243|NCT01003275|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16244|NCT01003249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16245|NCT01003210|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16246|NCT01003184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16247|NCT01003106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16248|NCT01003080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16249|NCT01003067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16251|NCT01002742|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16252|NCT01002573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16253|NCT01002482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16254|NCT01002456|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16255|NCT01002339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16256|NCT01002287|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16257|NCT01002118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16258|NCT01002105|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16259|NCT01001988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16260|NCT01001975|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that no information based on the conduct (including the protocol, the data resulting from this study or the fact that this study is being conducted) will be released without prior written consent of the sponsor, unless this requirement is superceded by the State or Federal law.
16261|NCT01001832|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16262|NCT01001806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16263|NCT01001767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16264|NCT01001702|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16265|NCT01001572|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
16266|NCT01001559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16267|NCT01001546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16268|NCT01001520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16269|NCT01001494|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
16270|NCT01001442|Principal Investigators are NOT employed by the organization sponsoring the study.|Part of CTA:The Investigator or any Site employee, consultant or admitting physician to the Site or Study Team member is not allowed to make any publication of any Study Data, information, results, or similar information without the review and comment of SPONSOR. As the Study is part of a multi-center trial, and the Investigator/site agree that no publication by Site/Investigator of the results of the Study conducted at the Site shall be made before the first multi-centre publication.
16271|NCT01001429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16272|NCT01001403|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16273|NCT01001390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16274|NCT01001377|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
16275|NCT01001325|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16276|NCT01001299|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16277|NCT01001234|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees to delay publication of study results until Food and Drug Administration (FDA) grants pediatric exclusivity on the study drug. Investigator may publish results for his/her study site after primary publication of results of entire multicenter trial. Sponsor must be able to review all proposed results communications regarding study 60 days prior to submission for publication/presentation. Information identified by the Sponsor as confidential must be deleted prior to submission.
16278|NCT01001221|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 45 days in advance of proposed submission, the Investigator should forward a copy of the manuscript or abstract for review by the sponsor, and, if necessary, delay publication or communication for a limited time in order to protect the confidentiality or proprietary nature of any information contained therein.
16279|NCT01001208|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial resul
16280|NCT01001195|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
16281|NCT01001169|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16282|NCT01001104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16283|NCT01001078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16284|NCT01001052|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16285|NCT01000987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16286|NCT01000974|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16287|NCT01000961|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may publish or disclose study data, with the restriction that sponsor may embargo such communications for a period up to 60 days from the time submitted to sponsor. As a multi-center study, first publication of results will take place in conjunction with all investigators. If such a multi-center publication is not forthcoming within 18 months of study completion, individual investigators may publish as restricted according to limitations expressed above (60 day embargo).
16288|NCT01000818|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
16289|NCT01000805|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16290|NCT01000727|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16291|NCT01000662|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16292|NCT01000649|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
16293|NCT01000610|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16294|NCT01000506|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16295|NCT01000493|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16296|NCT01000480|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16297|NCT01000376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16298|NCT01000337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16299|NCT01000324|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16300|NCT01000311|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16301|NCT01000285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16302|NCT01000155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16303|NCT01000064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16304|NCT01000025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16305|NCT00999921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16306|NCT00999908|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
16307|NCT00999830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16308|NCT00999804|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16309|NCT00999713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16310|NCT00999687|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16311|NCT00999661|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed that the first publication of results should be made in conjunction with the presentation of a joint, multicenter publication of the results with the PIs from all sites contributing data, analyses, and comments. If this publication was not submitted within 12 months after conclusion of the Study at all sites, or after Sponsor confirmed there would be no multicenter Study publication, whichever is first, the PIs could have published the results from their individual sites.
16312|NCT00999609|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16313|NCT00999596|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16314|NCT00999544|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16315|NCT00999466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between PI and Sponsor (AZ) or its agents that restricts the PI's right to discuss/publish trial results after the trial is completed. The PI agrees to collaborate in good faith with AZ with regards to content and formation of any publication or disclosure to be made by PI and to pay due consideration to opinions offered by AZ
16316|NCT00999167|Principal Investigators are NOT employed by the organization sponsoring the study.|
16317|NCT00999141|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter’s agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., for intellectual property protection)
16318|NCT00999037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16319|NCT00998985|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
16320|NCT00998881|Principal Investigators are NOT employed by the organization sponsoring the study.|
16321|NCT00998868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16322|NCT00998764|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16323|NCT00998738|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16324|NCT00998660|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor will review results communications prior to public release to determine whether Confidential Information is disclosed and will not censor or in any way interfere with presentation or conclusions beyond the extent necessary to protect Confidential Information. PIs are required to provide results communications for review at least 60 days prior to submission or presentation. When requested by Sponsor, PI will delay publication up to an additional 90 days.
16325|NCT00998582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16326|NCT00998517|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16327|NCT00998426|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16328|NCT00998374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16329|NCT00998335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16330|NCT00998309|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16353|NCT00997035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16331|NCT00998296|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
16332|NCT00998205|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16333|NCT00998049|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16334|NCT00998023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16335|NCT00997984|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
16336|NCT00997932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16337|NCT00997672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16338|NCT00997620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16339|NCT00997594|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16340|NCT00997555|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16341|NCT00997516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16342|NCT00997503|Principal Investigators are NOT employed by the organization sponsoring the study.|During the term of the agreement and for a period of one year thereafter, the PI must submit to Boston Scientific each paper, summary, abstract or outline that he intends to present or publish relating to the study, and will not submit or present any proposed publication to a publisher or other party prior to the expiration of 45 days from the date such Proposed Publication is submitted to Boston Scientific.
16343|NCT00997438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16344|NCT00997425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16345|NCT00997373|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16346|NCT00997334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16347|NCT00997321|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16348|NCT00997243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16349|NCT00997204|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16350|NCT00997139|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16351|NCT00997126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16352|NCT00997113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16354|NCT00996996|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16355|NCT00996944|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16356|NCT00996931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16357|NCT00996918|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16358|NCT00996892|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
16359|NCT00996840|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16360|NCT00996801|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16361|NCT00996775|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16362|NCT00996736|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16363|NCT00996658|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16364|NCT00996632|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16365|NCT00996606|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16366|NCT00996593|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16367|NCT00996580|Principal Investigators are NOT employed by the organization sponsoring the study.|Details of the study and its results shall not be publicized or published in any form to cooperative publication without prior, written consent of sponsor. Such approval is necessary to prevent premature disclosure of trade secrets and other confidential information.
16368|NCT00996502|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16369|NCT00996476|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
16370|NCT00996437|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16371|NCT00996372|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16372|NCT00996346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16373|NCT00996333|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16374|NCT00996307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16375|NCT00996281|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
16376|NCT00996216|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16377|NCT00996203|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
16378|NCT00996164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16379|NCT00996125|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16380|NCT00996034|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor has 30 days to approve anything that PI would like to publish and/or present
16381|NCT00995930|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
16382|NCT00995904|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
16383|NCT00995865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16384|NCT00995774|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16385|NCT00995761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16386|NCT00995722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16387|NCT00995709|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
16388|NCT00995670|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16389|NCT00995566|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16390|NCT00995553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16391|NCT00995501|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16392|NCT00995488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16393|NCT00995449|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor has right of first publication of trial results, which will be a joint, multi-center publication of the study results from all appropriate sites contributing data, analysis and comments.
16394|NCT00995436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16395|NCT00995410|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description: PI agrees that the first publication will be a multi-center publication of the study results. Following this multi-center publication, PI can publish, present or use any non-confidential study results following Sponsor review and comment.
16396|NCT00995371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16397|NCT00995345|Principal Investigators are NOT employed by the organization sponsoring the study.|No explicit limitations on discussion by PI. PI may not publish results before a coordinated multicenter publication has been submitted for publication, marketing approval obtained, or until 7 years after the study has ended, whichever occurs first. Thereafter, the study site will have the opportunity to publish the results of the study, provided that the Sponsor has had the opportunity to review and comment on the study site’s proposed publication prior to it being submitted for publication.
16398|NCT00995085|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16399|NCT00995020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16400|NCT00995007|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16401|NCT00994929|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16402|NCT00994760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16403|NCT00994682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16404|NCT00994643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16405|NCT00994604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16406|NCT00994461|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16407|NCT00994448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16408|NCT00994422|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
16409|NCT00994318|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may not present or publish partial or complete study results individually. Any manuscript or abstract proposed by the Investigators must be reviewed and approved in writing by Vifor Pharma before submission for publication. Names of all Investigators participating in the study will be included in the publication.
16410|NCT00994279|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16411|NCT00994240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16412|NCT00994214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16413|NCT00994175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16414|NCT00994123|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16415|NCT00994110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16416|NCT00993967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16417|NCT00993954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16418|NCT00993928|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16419|NCT00993915|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16420|NCT00993824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16421|NCT00993668|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
16422|NCT00993655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16423|NCT00993616|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16424|NCT00993499|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
16425|NCT00993473|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
16426|NCT00993447|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
16427|NCT00993421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16428|NCT00993317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16429|NCT00993291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16430|NCT00993265|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16431|NCT00993200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16432|NCT00993187|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
16433|NCT00993148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16434|NCT00993044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16435|NCT00993031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16436|NCT00992992|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16437|NCT00992927|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16438|NCT00992836|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16439|NCT00992784|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16440|NCT00992719|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16441|NCT00992602|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16442|NCT00992589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16443|NCT00992459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16444|NCT00992446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16445|NCT00992433|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16446|NCT00992407|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16447|NCT00992394|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16448|NCT00992264|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16449|NCT00992186|Principal Investigators are NOT employed by the organization sponsoring the study.|If Investigator wishes to publish information from study, a copy of manuscript must be provided to Sponsor for review at least 60 days before publication. Expedited reviews will be arranged for abstracts, poster presentations. If requested by Sponsor in writing, Investigator will withhold such publication for up to additional 60 days to allow for patent filing. If the issues arise regarding scientific integrity or regulatory compliance, Sponsor will review them with Investigator.
16450|NCT00992108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16451|NCT00992056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16452|NCT00992017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16453|NCT00991952|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16454|NCT00991939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16455|NCT00991887|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16456|NCT00991809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16457|NCT00991510|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
16458|NCT00991458|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
16459|NCT00991341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16460|NCT00991302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16461|NCT00991289|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
16462|NCT00991276|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16463|NCT00991185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16464|NCT00991081|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16465|NCT00990964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16466|NCT00990821|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16467|NCT00990782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16468|NCT00990769|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16469|NCT00990704|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
16470|NCT00990652|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16471|NCT00990561|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16472|NCT00990509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16473|NCT00990340|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
16474|NCT00990288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16475|NCT00990184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16476|NCT00990106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16477|NCT00990093|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16478|NCT00989989|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
16479|NCT00989950|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16480|NCT00989911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16481|NCT00989833|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16482|NCT00989781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16483|NCT00989768|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16484|NCT00989664|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16485|NCT00989586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16486|NCT00989287|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16487|NCT00989235|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16488|NCT00989196|Principal Investigators are NOT employed by the organization sponsoring the study.|Octapharma agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Octapharma supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. Octapharma also reserves the right to review data prior to publishing and provide comments/changes within a certain time period.
16489|NCT00989157|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16490|NCT00989092|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
16491|NCT00989014|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16492|NCT00988884|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
16493|NCT00988858|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16494|NCT00988832|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor recognises the right of the investigator to publish the study results. The investigator is asked to send a draft of the publication/abstract to the Sponsor 30 days in advance of submission in order to obtain approval prior to submission. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion, the contents of the publication will be discussed in order to find a solution which satisfies both parties.
16495|NCT00988637|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
16496|NCT00988533|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
16497|NCT00988442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16498|NCT00988429|Principal Investigators are NOT employed by the organization sponsoring the study.|
16499|NCT00988351|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16500|NCT00988325|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
16501|NCT00988247|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
16502|NCT00988221|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16503|NCT00988208|Principal Investigators are NOT employed by the organization sponsoring the study.|Multicenter publication must include input from investigators and Celgene, agreement to be established before publication. It has priority over subset (single center) publication, for duration of 24 months after study completion. Individual investigators have publication rights after multicenter publication is complete (or 24 months after study completion), whichever is first. In this case, Celgene has the right to comment and right to ask delay of publication for 60 days.
16504|NCT00988169|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16505|NCT00988156|All Principal Investigators ARE employed by the organization sponsoring the study.|
16506|NCT00988143|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
16507|NCT00988117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16508|NCT00988091|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
16509|NCT00988065|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may not publish/publicly present interim results without prior consent of Sponsor. Any materials that report results of the study must be sent to Sponsor 45 days prior to submission for publication/presentation. Sponsor has right to review and comment. In case of any disagreements concerning appropriateness of the materials, investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues or disagreement, prior to submission for publication/presentation.
16510|NCT00987948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16511|NCT00987935|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
16512|NCT00987831|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16513|NCT00987727|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 30 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication and can extend the embargo
16514|NCT00987623|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
16515|NCT00987558|Principal Investigators are NOT employed by the organization sponsoring the study.|
16516|NCT00987467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16517|NCT00987415|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16518|NCT00987402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16519|NCT00987337|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16520|NCT00986999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16521|NCT00986986|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16522|NCT00986973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16523|NCT00986960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16524|NCT00986947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16525|NCT00986921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16526|NCT00986856|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16527|NCT00986674|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16528|NCT00986583|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16529|NCT00986570|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16530|NCT00986544|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16531|NCT00986479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16532|NCT00986453|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16533|NCT00986427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16534|NCT00986401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16535|NCT00986362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16536|NCT00986349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16537|NCT00986258|Principal Investigators are NOT employed by the organization sponsoring the study.|Grünenthal reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
16538|NCT00986245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16539|NCT00986232|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16540|NCT00986180|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16541|NCT00986154|Principal Investigators are NOT employed by the organization sponsoring the study.|A study site may not publish results of a study until after a coordinated multicenter publication has been submitted for publication or until one year after the study has ended, whichever occurs first. The study site will have the opportunity to publish results of the study, provided Daiichi Sankyo has had the opportunity to review and comment on the study site’s proposed publication prior to being submitted for publication with the advice of patent council and need for subject protection.
16542|NCT00986102|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16543|NCT00985985|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16544|NCT00985959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16545|NCT00985946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16546|NCT00985829|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16547|NCT00985790|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16548|NCT00985751|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16549|NCT00985738|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16550|NCT00985725|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
16551|NCT00985712|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16552|NCT00985686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16553|NCT00985673|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16554|NCT00985543|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall not publish or otherwise disseminate the conclusions of the Study, including all or any part of the Results without the prior written consent of the Sponsor, such consent not to be unreasonably withheld or delayed. Any publication or other dissemination of the conclusions of the Study by the PI shall not occur until the Sponsor has published the conclusions of the Study.
16555|NCT00985504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16556|NCT00985491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16557|NCT00985439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16558|NCT00985257|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16559|NCT00985231|Principal Investigators are NOT employed by the organization sponsoring the study.|Study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s)after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
16560|NCT00985192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16561|NCT00985166|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16562|NCT00985153|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16563|NCT00985140|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16564|NCT00985114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16565|NCT00985088|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16566|NCT00985010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16567|NCT00984867|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
16568|NCT00984815|Principal Investigators are NOT employed by the organization sponsoring the study.|PI may disclose data resulting from the study upon the earliest of: a) publication of a multi-center publication coordinated by Sponsor, b) submission of the data by Sponsor to the FDA, and c) 18 months after the study is completed at all sites if a multi-center publication is not submitted by Sponsor for publication provided PI submits proposed publication at least 60 days in advance for review of any Sponsor Confidential Information.
16569|NCT00984698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16570|NCT00984659|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16628|NCT00982189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16571|NCT00984620|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
16572|NCT00984594|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16573|NCT00984568|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide the sponsor 45 days prior to publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial. The sponsor has the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis with respect to: proprietary information, accuracy, and fair balance.
16574|NCT00984542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16575|NCT00984490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16576|NCT00984334|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16577|NCT00984308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16578|NCT00984295|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16579|NCT00984282|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must discuss any publication with the sponsor prior to release and obtain written consent of the sponsor on the intended publication. He/she must send a draft manuscript of the publication 30 days in advance of submission in order to obtain approval prior to submission of the final version for publication. In case of a difference of opinion, the contents will be discussed in order to find a solution which satisfies both parties.
16580|NCT00984256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16581|NCT00984204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16582|NCT00984165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16583|NCT00984139|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16584|NCT00984126|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
16585|NCT00984061|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16586|NCT00984022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16587|NCT00984009|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16588|NCT00983983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16589|NCT00983957|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16590|NCT00983931|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16591|NCT00983918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16592|NCT00983905|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16593|NCT00983892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16594|NCT00983853|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16595|NCT00983827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16596|NCT00983801|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16597|NCT00983749|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16598|NCT00983645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16599|NCT00983580|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16600|NCT00983541|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16601|NCT00983515|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16602|NCT00983489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16603|NCT00983476|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16604|NCT00983437|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
16605|NCT00983385|Principal Investigators are NOT employed by the organization sponsoring the study.|Grünenthal reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
16606|NCT00983372|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16607|NCT00983359|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16608|NCT00983346|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16609|NCT00983307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16669|NCT00979953|Principal Investigators are NOT employed by the organization sponsoring the study.|
16610|NCT00983294|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16611|NCT00983281|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16612|NCT00983242|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16613|NCT00983216|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16614|NCT00983073|Principal Investigators are NOT employed by the organization sponsoring the study.|Grünenthal reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
16615|NCT00982995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16616|NCT00982735|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16617|NCT00982657|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16618|NCT00982644|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
16619|NCT00982592|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16620|NCT00982553|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16621|NCT00982488|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16622|NCT00982423|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16623|NCT00982410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16624|NCT00982397|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PIs may not publish single-site data until the main multi-site publication has occurred."
16625|NCT00982345|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16626|NCT00982280|Principal Investigators are NOT employed by the organization sponsoring the study.|Grünenthal reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
16627|NCT00982228|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
16629|NCT00982137|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
16630|NCT00982111|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16631|NCT00982033|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16632|NCT00982020|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16633|NCT00982007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16634|NCT00981825|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16635|NCT00981812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16636|NCT00981669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16637|NCT00981630|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
16638|NCT00981461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16639|NCT00981435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16640|NCT00981409|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16641|NCT00981370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16642|NCT00981305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16643|NCT00981292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16644|NCT00981253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16645|NCT00981227|Principal Investigators are NOT employed by the organization sponsoring the study.|
16646|NCT00981214|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication after a multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
16647|NCT00981175|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
16648|NCT00981149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16649|NCT00981084|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16650|NCT00981058|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16651|NCT00981045|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16652|NCT00981019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16653|NCT00980980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16654|NCT00980798|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16655|NCT00980746|Principal Investigators are NOT employed by the organization sponsoring the study.|
16656|NCT00980681|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16657|NCT00980655|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16658|NCT00980642|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16659|NCT00980590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16660|NCT00980343|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16661|NCT00980330|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16662|NCT00980278|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16663|NCT00980200|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16664|NCT00980174|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
16665|NCT00980148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16666|NCT00980044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16667|NCT00980005|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16668|NCT00979992|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16670|NCT00979940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16671|NCT00979901|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16672|NCT00979875|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16673|NCT00979654|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
16674|NCT00979628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16675|NCT00979615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16676|NCT00979602|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16677|NCT00979576|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
16678|NCT00979550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16679|NCT00979459|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
16680|NCT00979420|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16681|NCT00979303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16682|NCT00979212|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
16683|NCT00979199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16684|NCT00979121|Principal Investigators are NOT employed by the organization sponsoring the study.|sponsor can review results communications prior to public release and can embargo communications regarding trial results until presented at the American Thoracic Society international meeting.
16685|NCT00979069|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16686|NCT00979017|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16687|NCT00978757|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16688|NCT00978731|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16689|NCT00978627|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
16690|NCT00978562|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16691|NCT00978445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16692|NCT00978432|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16693|NCT00978380|Principal Investigators are NOT employed by the organization sponsoring the study.|At the end of the trial, one or more scientific publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
16694|NCT00978341|Principal Investigators are NOT employed by the organization sponsoring the study.|
16695|NCT00978120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16696|NCT00978042|Principal Investigators are NOT employed by the organization sponsoring the study.|As this study involves multiple centers, no individual publications will be allowed prior to completion of the final report of the multicenter study except as agreed with Allergan.
16697|NCT00978029|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor for review 45 days prior to submission for publication or presentation, copies of abstracts or manuscripts for publication that report any results of the trial. If the parties disagree concerning the sponsor's confidential information, the investigator agrees to meet with the sponsor's representative, prior to submission for publication, in order to make good faith efforts to discuss and resolve any issues or disagreements.
16698|NCT00977938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16699|NCT00977808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16700|NCT00977769|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16701|NCT00977704|Principal Investigators are NOT employed by the organization sponsoring the study.|Researcher agree to submit to Medicis for Medicis' prior review and written approval, which approval shall not be unreasonably withheld, any written publication utilizing results or other data generated from this study at least ninety days, or, for abstracts, at least thirty days before such publication is presented or submitted for publication.
16702|NCT00977665|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
16703|NCT00977613|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16704|NCT00977574|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16705|NCT00977561|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16706|NCT00977548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16707|NCT00977470|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16708|NCT00977379|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
16709|NCT00977314|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16710|NCT00977197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16711|NCT00977184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16712|NCT00977171|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16713|NCT00977106|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16714|NCT00977080|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
16715|NCT00976989|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16716|NCT00976950|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
16717|NCT00976937|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
16718|NCT00976911|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16719|NCT00976898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16720|NCT00976820|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16721|NCT00976716|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16722|NCT00976703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16723|NCT00976677|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16724|NCT00976664|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16725|NCT00976599|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16726|NCT00976573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16727|NCT00976560|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16749|NCT00975611|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16728|NCT00976521|Principal Investigators are NOT employed by the organization sponsoring the study.|Any proposed manuscript or publication will be submitted to Sponsor and Lead PI for comment at least 60 days prior to release of that manuscript or publication. There will be no publicizing of any data or results without the Sponsor’s prior written permission. The publishing party will make every reasonable attempt to incorporate comments received from the Sponsor during such 60-day period.
16729|NCT00976508|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16730|NCT00976495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16731|NCT00976482|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16732|NCT00976456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16733|NCT00976404|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16734|NCT00976391|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16735|NCT00976352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16736|NCT00976339|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16737|NCT00976274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16738|NCT00976248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16739|NCT00976209|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16740|NCT00976183|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16741|NCT00976027|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
16742|NCT00975975|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16743|NCT00975923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16744|NCT00975806|Principal Investigators are NOT employed by the organization sponsoring the study.|Multicenter publications must include input from investigators and Celgene, and agreement be established before publication. Results from a center cannot be submitted for publication prior to a multicenter publication unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene ≤ 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to ≤ 90 days.
16745|NCT00975780|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16746|NCT00975715|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
16747|NCT00975689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16748|NCT00975637|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16750|NCT00975585|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication or presentation, the PI will provide SPONSOR with at least sixty (60) days for review of a manuscript. Notwithstanding the foregoing, no paper that incorporates SPONSOR Confidential Information will be submitted for publication without SPONSOR’s prior written consent. If requested in writing, the PI will withhold such publication for up to an additional sixty (60) days to allow for filing of a patent application.
16751|NCT00975507|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16752|NCT00975481|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16753|NCT00975416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16754|NCT00975286|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
16755|NCT00975221|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
16756|NCT00975195|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
16757|NCT00975156|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16758|NCT00975143|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16759|NCT00975130|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator is granted the right to use the results of all work under this study including but not limited to, the results of tests and any raw data and statistical data generated for investigator's own teaching, research, and publication purposes only. Investigator/Institution agrees, on behalf of itself and its employees, officers, trustees, and agents, not to cause said results to be knowingly used for any commercial purpose whatsoever except as authorized by the sponsor in writing.
16760|NCT00975000|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
16761|NCT00974974|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results of the Study conducted at the Site shall not be made before the first multi-site publication by Sponsor.
16762|NCT00974922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16763|NCT00974818|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16764|NCT00974675|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
16765|NCT00974571|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16766|NCT00974480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16767|NCT00974376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16768|NCT00974363|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16769|NCT00974311|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16770|NCT00974246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16771|NCT00974233|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16772|NCT00974220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16773|NCT00974142|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16774|NCT00974090|Principal Investigators are NOT employed by the organization sponsoring the study.|
16775|NCT00974051|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16776|NCT00973921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16777|NCT00973765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16778|NCT00973752|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16779|NCT00973739|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16780|NCT00973700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16781|NCT00973622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16782|NCT00973479|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16783|NCT00973362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16784|NCT00973349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16785|NCT00972959|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16786|NCT00972816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16787|NCT00972777|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
16788|NCT00972738|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16789|NCT00972725|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16790|NCT00972621|Principal Investigators are NOT employed by the organization sponsoring the study.|At least ninety (90) days prior to any proposed submission for publication or presentation of Study Data or other findings related to the Study, Institution will provide Sponsor with a manuscript of such submission(s) for review, comment, and approval.
16791|NCT00972595|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16792|NCT00972543|Principal Investigators are NOT employed by the organization sponsoring the study.|
16793|NCT00972530|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16794|NCT00972504|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16795|NCT00972478|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16796|NCT00972439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16797|NCT00972374|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
16798|NCT00972335|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
16799|NCT00972322|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
16800|NCT00972283|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
16801|NCT00972244|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
16802|NCT00972205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16803|NCT00972153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16804|NCT00972088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16805|NCT00972023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16806|NCT00971997|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16807|NCT00971932|Principal Investigators are NOT employed by the organization sponsoring the study.|
16830|NCT00970307|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16808|NCT00971841|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
16809|NCT00971789|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16810|NCT00971750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16811|NCT00971633|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16812|NCT00971620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16813|NCT00971425|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16814|NCT00971295|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16815|NCT00971282|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor for review and approval at least 2 months prior to the date of the intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
16816|NCT00971243|Principal Investigators are NOT employed by the organization sponsoring the study.|
16817|NCT00971204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16818|NCT00971048|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16819|NCT00970944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16820|NCT00970853|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16821|NCT00970814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16822|NCT00970736|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16823|NCT00970684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16824|NCT00970632|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16825|NCT00970606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16826|NCT00970502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16827|NCT00970489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16828|NCT00970359|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16829|NCT00970320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16831|NCT00970294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16832|NCT00970281|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16833|NCT00970268|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
16834|NCT00970216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16835|NCT00969878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16836|NCT00969709|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
16837|NCT00969618|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16838|NCT00969540|Principal Investigators are NOT employed by the organization sponsoring the study.|
16839|NCT00969501|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16840|NCT00969436|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16841|NCT00969280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16842|NCT00969228|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16843|NCT00969150|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
16844|NCT00969124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16845|NCT00968981|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16846|NCT00968890|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16847|NCT00968864|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16848|NCT00968838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16849|NCT00968812|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
16850|NCT00968799|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16871|NCT00967044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16851|NCT00968708|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
16852|NCT00968669|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
16853|NCT00968617|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
16854|NCT00968539|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16855|NCT00968253|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16856|NCT00968227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16857|NCT00968201|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16858|NCT00968149|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16859|NCT00968071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16860|NCT00968032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16861|NCT00968019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16862|NCT00967993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16863|NCT00967694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16864|NCT00967668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16865|NCT00967551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16866|NCT00967486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16867|NCT00967473|Principal Investigators are NOT employed by the organization sponsoring the study.|Per clinical protocol confidentiality/study publication specifications all data discoveries arising out of the study, patentable of nonpatentable, shall be the sole property of Alcon Inc. Alcon reserves the right of prior review of any publication or presentation of information related to the study.
16868|NCT00967447|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the results of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
16869|NCT00967330|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
16870|NCT00967226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16872|NCT00967018|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
16873|NCT00967005|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16874|NCT00966992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16875|NCT00966953|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16876|NCT00966940|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16877|NCT00966875|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16878|NCT00966823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16879|NCT00966654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16880|NCT00966641|Principal Investigators are NOT employed by the organization sponsoring the study.|Standard Confidentiality Agreement
16881|NCT00966550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16882|NCT00966446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16883|NCT00966355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16884|NCT00966277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16885|NCT00966264|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16886|NCT00966238|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16887|NCT00966186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16888|NCT00965848|Principal Investigators are NOT employed by the organization sponsoring the study.|If the Institution & Principal Investigator wish to publish information from Clinical Trial, a copy of manuscript must be provided to Sponsor at least 60 days prior to submission for publication/presentation & will arrange expedited reviews for the same. No paper with confidential Information will be submitted without Sponsor’s prior consent. If requested, Institution & Principal Investigator will hold such publication for up to additional 60 days to allow filing of patent application.
16889|NCT00965757|Principal Investigators are NOT employed by the organization sponsoring the study.|
16890|NCT00965731|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16891|NCT00965718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16892|NCT00965562|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16893|NCT00965523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16894|NCT00965497|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16895|NCT00965484|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16896|NCT00965458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16897|NCT00965419|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16898|NCT00965341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16899|NCT00965263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16900|NCT00965250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16901|NCT00965237|Principal Investigators are NOT employed by the organization sponsoring the study.|No distribution of trial-specific information without express written permission of director.
16902|NCT00965185|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16903|NCT00965146|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI to publish results of this Clinical Study or the results of the activities hereunder, any abstract, manuscript, presentation or other communication shall be submitted to sponsor for review and approval at least 60 days prior to submission for publication. The sponsor retains the right to deny publication or, at its sole option, to revise the manuscript to delete proprietary or other confidential commercial information.
16904|NCT00965094|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
16905|NCT00965081|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16906|NCT00964886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16907|NCT00964860|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16908|NCT00964795|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator (PI) may publish results provided a copy of oral/ written publication is received by sponsor at least 45 days in advance for review & comment. If the parties disagree, PI agrees to meet with sponsor prior to submission to resolve any disagreement. Sponsor reserves the right to remove confidential information from such submission. It is also agreed that publication of results shall be made only as part of a publication of the results obtained by all sites performing the study.
16909|NCT00964743|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16910|NCT00964678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16911|NCT00964548|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16912|NCT00964496|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16913|NCT00964444|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16914|NCT00964431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16915|NCT00964392|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
16916|NCT00964366|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16917|NCT00964223|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16918|NCT00964158|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16919|NCT00964119|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16920|NCT00964028|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16921|NCT00963937|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16922|NCT00963924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16923|NCT00963872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16924|NCT00963859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16925|NCT00963820|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish clinical data after the earlier of publication by Sponsor or 12 months after early termination or database lock. Proposed publication copy should be provided to Sponsor at least 30 days prior to submission/disclosure. If requested, Sponsor's confidential information must be removed and publication delayed if Sponsor intends to file a related patent application.
16926|NCT00963807|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16927|NCT00963677|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16928|NCT00963638|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16929|NCT00963599|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16930|NCT00963560|Principal Investigators are NOT employed by the organization sponsoring the study.|All data and discoveries arising out of the study, patentable or nonpatentable, shall be the sole property of Alcon Laboratories, Inc. Alcon reserves the right of prior review of any publication or presentation of information related to the study. Alcon may use these data now and in the future for presentation or publication at Alcon’s discretion or for submission to government regulatory agencies.
16931|NCT00963508|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16932|NCT00963482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16933|NCT00963469|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16934|NCT00963430|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16935|NCT00963235|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16936|NCT00963157|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16937|NCT00962871|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
16938|NCT00962780|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16939|NCT00962754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16940|NCT00962741|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16941|NCT00962650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16942|NCT00962598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16943|NCT00962585|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16944|NCT00962390|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16945|NCT00962247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16946|NCT00962208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16947|NCT00962104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16948|NCT00962065|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor requires that written permission be given before the PI can release any data publicly.
16949|NCT00962013|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center’s results at the completion of the study.These manuscripts and abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the Sponsor for review at least 60 days prior to submission of publication.The Sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.
16950|NCT00962000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16951|NCT00961896|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
16952|NCT00961805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16953|NCT00961662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16954|NCT00961649|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
16955|NCT00961636|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications derived from this study should include input from the investigator(s) and Sponsor personnel. Subsequent to the multicenter publication, or 24 months after completion of the study, whichever comes first, an investigator and/or his/her colleagues may publish the results for their study site independently. The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
16956|NCT00961571|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16957|NCT00961532|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16958|NCT00961441|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
16959|NCT00961415|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
16960|NCT00961402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16961|NCT00961350|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees that the first publication will be a multi-center publication of the study results. Following this multi-center publication, PI can publish, present or use any non-confidential study results following Sponsor review and comment.
16962|NCT00961311|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator and or Participating lnstitution may publish the results of work performed in accordance with the Publication Strategy described in the Clinical Investigational Plan; provided, however, that any such publication or presentation shall be at a time determined by Medtronic and shall be provided to Medtronic for review at least 60 days prior to submission or presentation, for a determination by Medtronic of whether Confidential lnformation is disclosed.
16963|NCT00961298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16964|NCT00961259|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16965|NCT00961233|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16966|NCT00961220|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16967|NCT00961181|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16968|NCT00961116|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16969|NCT00961051|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to publication release and can embargo communications regarding trials results for a period that is more than 90 days but less than or equal to 18 months from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
16970|NCT00960999|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
16971|NCT00960986|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16972|NCT00960934|Principal Investigators are NOT employed by the organization sponsoring the study.|Subsequent to the multicenter publication, or 24 months after completion of the study, whichever comes first, an investigator and/or his/her colleagues may publish the results of the study associated with their study site independently.
16973|NCT00960869|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees that the first publication will be a multi-center publication of the study results. Following this multi-center publication, PI can publish, present or use any non-confidential study results following Sponsor review and comment.
16974|NCT00960856|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16975|NCT00960843|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16976|NCT00960687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16977|NCT00960661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16978|NCT00960622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16979|NCT00960570|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16980|NCT00960531|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16981|NCT00960440|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16982|NCT00960375|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16983|NCT00960323|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16984|NCT00960297|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
16985|NCT00960206|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI to publish results of this Clinical Study or the results of the activities hereunder, any abstract, manuscript, presentation or other communication shall be submitted to sponsor for review and approval at least 60 days prior to submission for publication. The sponsor retains the right to deny publication or, at its sole option, to revise the manuscript to delete proprietary or other confidential commercial information.
16986|NCT00960193|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16987|NCT00960154|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
16988|NCT00960141|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
16989|NCT00960115|Principal Investigators are NOT employed by the organization sponsoring the study.|
16990|NCT00960076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16991|NCT00960063|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
16992|NCT00959985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16993|NCT00959946|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
16994|NCT00959920|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16995|NCT00959907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16996|NCT00959894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16997|NCT00959764|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
16998|NCT00959751|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor may request Investigator or Institution not to publish or disclose information related to the clinical study.
16999|NCT00959699|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator must provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc.) that report any results of the trial. The sponsor shall have the right to review and comment.
17000|NCT00959660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17001|NCT00959647|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17002|NCT00959374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17003|NCT00959192|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17004|NCT00959049|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17005|NCT00958919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17006|NCT00958893|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
17007|NCT00958880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17008|NCT00958841|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
17009|NCT00958828|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
17050|NCT00957008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17010|NCT00958789|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center's results at the completion of the study.These manuscripts & abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the sponsor for review at least 60 days prior to the submission for publication.The sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.
17011|NCT00958776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17012|NCT00958724|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17013|NCT00958581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17014|NCT00958568|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17015|NCT00958477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17016|NCT00958438|Principal Investigators are NOT employed by the organization sponsoring the study.|PI/Institution will provide a copy of any publication to Sponsor prior to submission for review. Sponsor may request to remove confidential information from submission, provided that removal does not preclude the complete and accurate presentation and interpretation of the study results.
17017|NCT00958360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17018|NCT00958347|Principal Investigators are NOT employed by the organization sponsoring the study.|"For 7 years from and after termination date of the agreement, prior to submission for publication of abstracts, manuscripts, presentations or other communications describing the results of any aspect of the Study (Manuscript), You and the Institution shall send Stryker Orthopaedics a copy of the Manuscript to be submitted, and allow Stryker Orthopaedics sixty (60) days from the date of receipt to review the Manuscript."
17019|NCT00958334|Principal Investigators are NOT employed by the organization sponsoring the study.|
17020|NCT00958308|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17021|NCT00958282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17022|NCT00958256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17023|NCT00958243|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17024|NCT00958217|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17025|NCT00958191|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center's results at the completion of the study.These manuscripts and abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the sponsor for review at least 60 days prior to submission for publication.The sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.
17026|NCT00958165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17027|NCT00958126|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
17028|NCT00958074|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17051|NCT00956943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17029|NCT00958035|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
17030|NCT00958009|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither Institution nor any Principal Investigators shall publish or present any results from such Study to any third parties until: (i) EMD Serono publishes the results from all sites participating in such Study; (ii) Institution receives notification from EMD Serono that publication of the multi-site results is no longer planned; or (iii) twenty-four (24) months following the completion of the multi-site study at all sites, whichever occurs first.
17031|NCT00957996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17032|NCT00957944|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
17033|NCT00957905|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17034|NCT00957801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17035|NCT00957723|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center’s results at the completion of the study. These manuscripts and abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the sponsor for review at least 60 days prior to submission for publication.The sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.
17036|NCT00957684|Principal Investigators are NOT employed by the organization sponsoring the study.|
17037|NCT00957671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17038|NCT00957658|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center’s results at the completion of the study. These manuscripts and abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the sponsor for review at least 60 days prior to submission for publication.The sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.
17039|NCT00957593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17040|NCT00957580|Principal Investigators are NOT employed by the organization sponsoring the study.|
17041|NCT00957528|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17042|NCT00957424|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17043|NCT00957372|Principal Investigators are NOT employed by the organization sponsoring the study.|
17044|NCT00957333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17045|NCT00957268|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers, nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data, or insights therefrom or any data, information, or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
17046|NCT00957242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17047|NCT00957047|Principal Investigators are NOT employed by the organization sponsoring the study.|
17048|NCT00957034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17049|NCT00957021|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center’s results at the completion of the study. These manuscripts and abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the sponsor for review at least 60 days prior to submission for publication.The sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.
17052|NCT00956839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17053|NCT00956813|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17054|NCT00956761|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
17055|NCT00956709|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17056|NCT00956657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17057|NCT00956631|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17058|NCT00956592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17059|NCT00956540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17060|NCT00956293|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
17061|NCT00956254|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17062|NCT00956085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17063|NCT00956020|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17064|NCT00955968|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
17065|NCT00955955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17066|NCT00955916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17067|NCT00955903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17068|NCT00955825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17069|NCT00955747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17070|NCT00955721|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17071|NCT00955617|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17072|NCT00955513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17073|NCT00955487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17074|NCT00955474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17075|NCT00955357|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17076|NCT00955305|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17077|NCT00955279|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17078|NCT00955266|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17079|NCT00955110|Principal Investigators are NOT employed by the organization sponsoring the study.|Any analysis and/or publication of any data generated or arising from the study is not permitted without the prior written consent of Endo Pharmaceuticals Inc.
17080|NCT00955032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17081|NCT00954993|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
17082|NCT00954941|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17083|NCT00954915|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17084|NCT00954824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17085|NCT00954733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17086|NCT00954707|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17087|NCT00954681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17088|NCT00954538|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
17089|NCT00954512|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
17090|NCT00954447|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17091|NCT00954421|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17092|NCT00954356|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17093|NCT00954187|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17094|NCT00954122|Principal Investigators are NOT employed by the organization sponsoring the study.|
17095|NCT00954109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17096|NCT00953927|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restrictions on the PI include submission of study data as an Investigator’s Brochure prior to publication, sponsor’s review (for a period of 60-180 days from the time submission to the sponsor for review), correction of factual errors, accommodation of reasonable comments of sponsor relating to regulatory submissions/interpretation of the Study Data (including assertion of safety and efficacy).
17097|NCT00953862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17098|NCT00953849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17099|NCT00953745|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17100|NCT00953719|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17101|NCT00953706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17102|NCT00953680|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17103|NCT00953667|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17104|NCT00953654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17105|NCT00953615|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17106|NCT00953524|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
17107|NCT00953407|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
17108|NCT00953329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17109|NCT00953290|Principal Investigators are NOT employed by the organization sponsoring the study.|Prepare the study results for publication and presentation in cooperation with Cutera. The Doctor will not publish or present the results of the Study, or speak publicly about it, unless Cutera has first had a reasonable opportunity to review and comment on the contents of the proposed presentation or publication.
17110|NCT00953225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17111|NCT00953212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17112|NCT00953199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17113|NCT00953173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17114|NCT00953160|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Doctor will not publish or present the results of the Study, or speak publicly about it, unless Cutera has first had a reasonable opportunity to review and comment on the contents of the proposed presentation or publication."
17115|NCT00953147|Principal Investigators are NOT employed by the organization sponsoring the study.|
17116|NCT00953121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17117|NCT00953056|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/ presentation. SPONSOR review can be expedited to meet publication guidelines.
17118|NCT00953043|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17119|NCT00953017|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17120|NCT00952848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17121|NCT00952822|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs vary per individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) up to 90 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (e.g., to allow for intellectual property protection).
17122|NCT00952731|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17123|NCT00952705|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
17124|NCT00952653|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17125|NCT00952614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17126|NCT00952588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17127|NCT00952523|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17128|NCT00952484|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17129|NCT00952419|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
17130|NCT00952393|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17131|NCT00952367|Principal Investigators are NOT employed by the organization sponsoring the study.|Wyeth has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17132|NCT00952341|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
17133|NCT00952289|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
17134|NCT00952276|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
17135|NCT00952211|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17136|NCT00952133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17137|NCT00952120|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17138|NCT00952081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17139|NCT00952068|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 30 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm's ability to patent any invention related to the study, the publication or disclosure will be modified or delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm's confidential information.
17140|NCT00951912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17141|NCT00951899|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17142|NCT00951821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17143|NCT00951808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17144|NCT00951665|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
17145|NCT00951561|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees not to originate or use the name of Another Way Products, LLC and/or VIPON, or any of its employees, in any publicity, news release or other public announcement, written or oral, whether to the public, press or otherwise, relating to this protocol, to any amendment herto, or to the performance here under, without the prior written consent of Another Way Products, LLC
17146|NCT00951509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17147|NCT00951496|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17148|NCT00951483|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17149|NCT00951379|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17150|NCT00951275|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but only after the first publication or presentation that involves the overall study. The sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17151|NCT00951171|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17152|NCT00951093|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17153|NCT00951015|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17154|NCT00950963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17155|NCT00950937|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17156|NCT00950911|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
17157|NCT00950872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17158|NCT00950859|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17159|NCT00950833|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17160|NCT00950807|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17161|NCT00950755|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17162|NCT00950742|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
17163|NCT00950729|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17164|NCT00950690|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
17165|NCT00950664|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17166|NCT00950651|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 30 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm's ability to patent any invention related to the study, the publication or disclosure will be modified or delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm's confidential information
17167|NCT00950612|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17168|NCT00950599|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
17169|NCT00950352|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17170|NCT00950300|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17171|NCT00950235|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17172|NCT00950183|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17173|NCT00949975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17174|NCT00949910|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17175|NCT00949884|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor reflects the following restrictive language in the Clinical Study Agreements: If identified by DSI, any of DSI's confidential information as defined herein shall be deleted…Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by the Study Site."
17176|NCT00949715|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17177|NCT00949702|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17178|NCT00949650|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
17179|NCT00949533|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
17180|NCT00949234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17181|NCT00949117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17182|NCT00949078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17183|NCT00948896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17184|NCT00948857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17185|NCT00948818|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this trial will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the trial. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc.
17186|NCT00948792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17187|NCT00948766|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
17188|NCT00948688|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17189|NCT00948675|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17190|NCT00948610|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17191|NCT00948506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17192|NCT00948441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17193|NCT00948389|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
17194|NCT00948246|Principal Investigators are NOT employed by the organization sponsoring the study.|At least one month prior to any proposed submission for publication or presentation of trial data, the PI will provide the Sponsor the manuscript for review, comment, and approval. No confidential information may be disclosed without Sponsor’s written approval. If it is a multi-center trial, the first publication of the results shall be made in conjunction with the results from other Investigators at other centers.
17195|NCT00948155|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17196|NCT00948090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17197|NCT00948064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17198|NCT00947882|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
17199|NCT00947856|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
17200|NCT00947791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17201|NCT00947765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17202|NCT00947752|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
17203|NCT00947661|Principal Investigators are NOT employed by the organization sponsoring the study.|
17204|NCT00947544|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17205|NCT00947531|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17206|NCT00947518|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17207|NCT00947505|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17208|NCT00947427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17209|NCT00947349|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
17210|NCT00947310|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17211|NCT00947297|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17212|NCT00947284|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17213|NCT00947271|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17214|NCT00947219|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17215|NCT00947167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17216|NCT00947154|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17217|NCT00947115|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17218|NCT00947011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17219|NCT00946998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17220|NCT00946985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17221|NCT00946920|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
17222|NCT00946881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17223|NCT00946530|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17224|NCT00946478|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17225|NCT00946348|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17226|NCT00946322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17227|NCT00946309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17228|NCT00946296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17229|NCT00946114|Principal Investigators are NOT employed by the organization sponsoring the study.|
17230|NCT00946101|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
17231|NCT00946088|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17232|NCT00945958|Principal Investigators are NOT employed by the organization sponsoring the study.|
17233|NCT00945945|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17234|NCT00945906|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
17235|NCT00945893|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
17236|NCT00945854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17237|NCT00945815|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17238|NCT00945750|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by Merck as confidential must be deleted prior to submission.
17239|NCT00945555|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17240|NCT00945477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17241|NCT00945334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17242|NCT00945321|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17243|NCT00945295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17244|NCT00945256|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17245|NCT00945243|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17246|NCT00945139|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17247|NCT00945100|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17248|NCT00945035|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17249|NCT00944749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17250|NCT00944710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17251|NCT00944697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17252|NCT00944671|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17253|NCT00944645|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17254|NCT00944554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17255|NCT00944450|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17256|NCT00944229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17257|NCT00944125|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17258|NCT00944073|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17259|NCT00944047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17260|NCT00944034|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
17261|NCT00944021|Principal Investigators are NOT employed by the organization sponsoring the study.|
17262|NCT00943917|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to submit multicenter results within 12 months after completion of the study. Thereafter, PI may publish the results of its data after submitting advance copy of the planned publication to sponsor. PI to agree to sponsor changes regarding deletion of confidential information, reasonable changes, or a delay of up to 90 days for patent purposes.
17263|NCT00943878|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17264|NCT00943852|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17265|NCT00943826|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17266|NCT00943787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17267|NCT00943761|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
17268|NCT00943735|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17269|NCT00943722|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
17270|NCT00943683|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17271|NCT00943670|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17272|NCT00943631|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17273|NCT00943605|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17274|NCT00943592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17275|NCT00943579|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17276|NCT00943488|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17277|NCT00943436|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17278|NCT00943397|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17279|NCT00943384|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17280|NCT00943306|Principal Investigators are NOT employed by the organization sponsoring the study.|The CTAs generally envision a multisite publication, with the PI’s right to publish individually if the pooled publication does not occur within 12 months of study completion. Sponsor has a 45 to 60 day review/approval period to request deletion of confidential information or to request limited deferral to protect its proprietary technology. In one case, the publication provision is more general, specifying that the Sponsor and clinical site will agree on the manner/terms of publication.
17281|NCT00943202|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17282|NCT00943150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17283|NCT00943124|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17284|NCT00943111|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
17285|NCT00943098|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17286|NCT00943072|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI, after completion of the trial and multi-center publication, is that the sponsor can review results communications prior to public release & may have the right to embargo communications regarding results for a period between 60 & 180 days from the time submitted to the sponsor for review; provided that the sponsor can remove confidential/proprietary information. The sponsor cannot require other changes to the communication and cannot extend the embargo.
17287|NCT00942994|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
17288|NCT00942968|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17289|NCT00942903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17290|NCT00942890|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17291|NCT00942851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17292|NCT00942825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17293|NCT00942786|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17294|NCT00942734|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17295|NCT00942604|Principal Investigators are NOT employed by the organization sponsoring the study.|"For US sites: The institution and investigator agree not to publish the results of this study without prior written consent of the Sponsor. As used herein, the term publish shall include oral presentations,written abstracts, written manuscripts, etc."
17296|NCT00942448|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17297|NCT00942422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17298|NCT00942409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17299|NCT00942266|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17300|NCT00942188|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17301|NCT00942175|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights therefrom or any data, information or materials obtained or generated in the performance of it’s obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
17302|NCT00942149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17303|NCT00942084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17304|NCT00941993|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17305|NCT00941928|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17306|NCT00941889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17307|NCT00941863|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor recognizes right of principle investigator (PI) to publish results on completion of study, however, PI must provide draft of the communication to sponsor for approval 30 days prior to submission for publication. In case of difference of opinion between sponsor and PI, the parties will seek a solution satisfactory to both.
17308|NCT00941798|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
17309|NCT00941733|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17310|NCT00941720|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17311|NCT00941681|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor intends to publish the results of the trial in collaboration with the Investigators.
17312|NCT00941668|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17313|NCT00941655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17314|NCT00941603|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
17315|NCT00941330|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17316|NCT00941304|Principal Investigators are NOT employed by the organization sponsoring the study.|
17317|NCT00941070|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17318|NCT00941031|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
17319|NCT00940992|Principal Investigators are NOT employed by the organization sponsoring the study.|
17320|NCT00940927|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17321|NCT00940901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17322|NCT00940888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17323|NCT00940875|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17324|NCT00940823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17325|NCT00940576|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17326|NCT00940537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17327|NCT00940485|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
17328|NCT00940446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17329|NCT00940290|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17330|NCT00940108|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
17331|NCT00940017|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17332|NCT00939991|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17333|NCT00939952|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17334|NCT00939900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17454|NCT00932828|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17335|NCT00939874|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution, its personnel and the Principal Investigator must not Publish or present any aspect of the Study without the prior written approval of the sponsor. This includes periodic information releases and announcements to the news media or a third party regarding the progress of this Study.
17336|NCT00939809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17337|NCT00939796|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17338|NCT00939783|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17339|NCT00939731|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17340|NCT00939705|Principal Investigators are NOT employed by the organization sponsoring the study.|
17341|NCT00939692|Principal Investigators are NOT employed by the organization sponsoring the study.|
17342|NCT00939627|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17343|NCT00939562|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17344|NCT00939536|Principal Investigators are NOT employed by the organization sponsoring the study.|
17345|NCT00939510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17346|NCT00939484|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17347|NCT00939471|Principal Investigators are NOT employed by the organization sponsoring the study.|Scientific Publications Reporting results initiated only by SPONSOR. Sites may not publish single center results before aggregate results. Drafts of abstracts, etc. must be submitted to SPONSOR for review at least sixty (60) days prior to submission for publication. Investigator(s) shall delay submission for up to 90 days to permit patent application filing or shall redact paper to remove language detrimental to SPONSOR’s intellectual property interests.
17348|NCT00939393|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17349|NCT00939367|Principal Investigators are NOT employed by the organization sponsoring the study.|
17350|NCT00939341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17351|NCT00939211|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites. AZ has the right to request delays: up to 60 days for confidential information, and an additional 90 days to protect intellectual property.
17352|NCT00939185|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17353|NCT00939159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17354|NCT00939120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17355|NCT00939107|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17455|NCT00932659|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17356|NCT00939094|Principal Investigators are NOT employed by the organization sponsoring the study.|"No publication or presentation with respect to the study until the earlier of 1) publication of the first Multi-Center Publication and 2) the second anniversary of the completion, or termination of the study.~Sponsor to review at least 60 days prior submission. Sponsor can withhold material for submission for additional 90 days"
17357|NCT00939055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17358|NCT00939029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17359|NCT00939003|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
17360|NCT00938964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17361|NCT00938886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17362|NCT00938860|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
17363|NCT00938782|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17364|NCT00938717|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that publication cannot be made for 24 months from the date of final data lock of the study, the sponsor can review the publication prior to public release, sponsor requires a minimum 60 day review period for each publication, sponsor can request removal of confidential information of sponsor (not including results of trial), and sponsor can request an additional delay period of 60 days in order to protect potentially patentable information.
17365|NCT00938704|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
17366|NCT00938639|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
17367|NCT00938548|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17368|NCT00938470|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17369|NCT00938457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17370|NCT00938431|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
17371|NCT00938392|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17372|NCT00938366|Principal Investigators are NOT employed by the organization sponsoring the study.|
17373|NCT00938327|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17374|NCT00938314|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17375|NCT00938041|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17376|NCT00938015|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17377|NCT00937950|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17378|NCT00937937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17379|NCT00937833|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17380|NCT00937794|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
17381|NCT00937768|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17382|NCT00937560|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17383|NCT00937547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17384|NCT00937521|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17385|NCT00937495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17386|NCT00937391|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17387|NCT00937326|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17388|NCT00937235|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17389|NCT00937157|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17390|NCT00937118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17391|NCT00937105|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17392|NCT00937040|Principal Investigators are NOT employed by the organization sponsoring the study.|PI has the right to publish results of research and background information provided by SPONSOR necessary to include in publication of research results or for others to verify results. PI shall include a statement that creation of data was supported by SPONSOR. Prior to submission for publication/presentation, the INSTITUTION shall provide SPONSOR at least sixty (60) days for review.
17393|NCT00936975|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17394|NCT00936910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17395|NCT00936897|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
17396|NCT00936741|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17397|NCT00936715|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
17398|NCT00936702|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17399|NCT00936663|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17400|NCT00936598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17401|NCT00936585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17402|NCT00936481|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17403|NCT00936455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17404|NCT00936377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17405|NCT00936351|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17406|NCT00936221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17407|NCT00936208|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17408|NCT00936117|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17409|NCT00936065|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17410|NCT00935883|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17411|NCT00935857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17412|NCT00935818|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17413|NCT00935792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17414|NCT00935766|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall furnish copies of any proposed publication or presentation to the Sponsor for review at least thirty (30) days in advance of the submission of such proposed publication or presentation to a journal, editor or other third party. The sponsor shall have thirty (30) days after receipt of said copies, to object to such proposed presentation or proposed publication.
17415|NCT00935701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17416|NCT00935649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17417|NCT00935584|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17418|NCT00935532|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17419|NCT00935493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17420|NCT00935311|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
17421|NCT00935272|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17422|NCT00935259|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications should include input from the investigator(s), and Sponsor personnel. Such input should be reflected in publication authorship. The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
17423|NCT00935220|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17424|NCT00935064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17425|NCT00934947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17426|NCT00934921|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
17427|NCT00934856|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
17428|NCT00934843|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17429|NCT00934791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17430|NCT00934661|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17431|NCT00934648|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17432|NCT00934635|Principal Investigators are NOT employed by the organization sponsoring the study.|"Publication of study data will be coordinated by the Sponsor, but written by the Investigator.~The Medical Institution will not be entitled to publish any data unless the Sponsor has received the manuscript within 3 months after the Clinical Study Report for review (within 30 days) to ensure that the publication does not reveal secret information. If the Sponsor suggests changes, these changes must be incorporated unless they compromise the scientific nature of the publication."
17433|NCT00934622|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17434|NCT00934596|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17435|NCT00934544|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
17436|NCT00934440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17437|NCT00934375|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17438|NCT00934362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17439|NCT00934180|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
17440|NCT00934141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17441|NCT00934128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17442|NCT00934102|Principal Investigators are NOT employed by the organization sponsoring the study.|No distribution of trial-specific information without express written permission of director.
17443|NCT00934050|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17444|NCT00933933|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator (PI) must provide copy of any proposed publication/presentation at least 30 days prior to submission for sponsor review/approval. PI must incorporate changes as the sponosr requires in order to protect the sponsor's proprietary rights and interests. Sponsor may require the PI to include acknowledgement of sponosr's role in the study. PI may be requested to delay publication/presentation an extra 60 days to enable sponor to secure patent or other proprietary protection.
17445|NCT00933686|Principal Investigators are NOT employed by the organization sponsoring the study.|
17446|NCT00933608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17447|NCT00933543|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17448|NCT00933491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17449|NCT00933335|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17450|NCT00933270|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17451|NCT00933244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17452|NCT00933166|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor’s written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
17453|NCT00932893|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17456|NCT00932646|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
17457|NCT00932620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17458|NCT00932477|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
17459|NCT00932451|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17460|NCT00932425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17461|NCT00932399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17462|NCT00932373|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17463|NCT00932321|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17464|NCT00932282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17465|NCT00932165|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
17466|NCT00932152|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17467|NCT00932126|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17468|NCT00932113|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17469|NCT00932035|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17470|NCT00932022|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
17471|NCT00931996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17472|NCT00931918|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
17473|NCT00931879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17474|NCT00931801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17475|NCT00931723|Principal Investigators are NOT employed by the organization sponsoring the study.|
17476|NCT00931710|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
17477|NCT00931632|Principal Investigators are NOT employed by the organization sponsoring the study.|Site shall use Confidential Information solely for the purposes of preforming its obligations under the Clinical Study Agreement and shall not, without Sponsor’s prior written consent, publish, disseminate or otherwise disclose to any third party (including any of its affiliates) any Confidential Information. These obligations shall survive and continue for ten years after the termination or expiration of the Agreement or such longer period as required by Applicable Law.
17478|NCT00931528|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
17479|NCT00931515|Principal Investigators are NOT employed by the organization sponsoring the study.|Research parties agree not to make any publications of results until notified in writing by Sponsor that study is complete and results published in peer-reviewed journal; however if not published within 18 months, Research parties may pursue publication of individual results. Research parties must submit communication to Sponsor for review/approval at least 30 days prior to submission. Sponsor can require the modification of the manuscript or delay of publication.
17480|NCT00931489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17481|NCT00931463|Principal Investigators are NOT employed by the organization sponsoring the study.|"There is a Clinical Trial Agreement signed with each PI detailing the publication policy and disclosure of study's information, in summary:~The Institution, its personnel and the Principal Investigator must not Publish or present any aspect of the Study without the prior written approval of the sponsor, except for the purposes of internal training~Publications or presentations of results from the Study will follow the agreement's publication/presentation guidelines"
17482|NCT00931411|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17483|NCT00931385|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
17484|NCT00931359|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17485|NCT00931307|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
17486|NCT00931268|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17487|NCT00931255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17488|NCT00931242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17489|NCT00931164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17490|NCT00930982|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor 30 days in advance of submission in order to obtain written approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion, the contents of the publication will be discussed in order to find a solution that satisfies both parties.
17491|NCT00930969|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigational Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication."
17492|NCT00930930|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17493|NCT00930813|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17494|NCT00930787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17495|NCT00930774|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17496|NCT00930761|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17497|NCT00930722|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17498|NCT00930644|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of NPS Pharmaceuticals agreements with its investigators may vary. However, NPS does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e. data from all sites) in the clinical trial.
17499|NCT00930553|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
17500|NCT00930293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17501|NCT00930176|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17502|NCT00929981|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17503|NCT00929864|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
17504|NCT00929773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17505|NCT00929734|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17506|NCT00929708|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites. AZ has the right to request delays: up to 60 days for confidential information, and an additional 90 days to protect intellectual property.
17507|NCT00929695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17508|NCT00929669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17509|NCT00929656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17510|NCT00929643|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17511|NCT00929578|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17512|NCT00929526|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17513|NCT00929500|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17514|NCT00929474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17515|NCT00929383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17516|NCT00929357|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17517|NCT00929344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17518|NCT00929331|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17519|NCT00929305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17520|NCT00929240|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17521|NCT00929201|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17522|NCT00929162|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca can review results communications prior to public release and may within 60 days of receipt require amendments to be made. AstraZeneca can also require that submission or disclosure be delayed to allow for the filing of a patent application.
17523|NCT00929110|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
17524|NCT00929071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17525|NCT00928954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17526|NCT00928889|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
17527|NCT00928772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17528|NCT00928746|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17529|NCT00928720|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17530|NCT00928694|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17531|NCT00928668|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
17532|NCT00928642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17533|NCT00928512|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
17534|NCT00928486|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements varied; the Investigators shall not disclose any material/information disclosed by the Sponsor (Celgene KK) with the clinical trial or information obtained by conducting the clinical trial to third parties without Sponsor's prior written approval.
17535|NCT00928434|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
17536|NCT00928421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17537|NCT00928408|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
17538|NCT00928395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17539|NCT00928304|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17540|NCT00928252|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17541|NCT00928187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17542|NCT00928174|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17543|NCT00928083|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17544|NCT00928070|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17545|NCT00928057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17546|NCT00928018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17547|NCT00927992|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17548|NCT00927953|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17549|NCT00927940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17550|NCT00927927|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to defer data release until specified milestones, e.g. availability of a clinical trial report. Novo Nordisk reserves the right to postpone publication and/or communication for short period to protect intellectual property. Novo Nordisk reserves the right to prior review of site-specific publications and to ask for deferment of publication of individual site results until after the primary manuscript is accepted for publication.
17551|NCT00927901|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
17552|NCT00927888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17553|NCT00927862|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17554|NCT00927849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17555|NCT00927823|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17556|NCT00927758|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Sandoz's agreements with its investigators may vary. However, Sandoz does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
17557|NCT00927589|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17558|NCT00927576|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17559|NCT00927563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17560|NCT00927472|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17561|NCT00927394|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
17562|NCT00927368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17563|NCT00927355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17564|NCT00927264|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17565|NCT00927251|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Medtronic reviews publications to determine if confidential information (CI) is included. Any such CI is deleted before publication. Medtronic may not censor/interfere with the publication. Investigators may publish single-site publications after a decision by Medtronic that no multi-site study publication will be done or 12 months after the study is closed, whichever is earlier."
17566|NCT00927186|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17567|NCT00927160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17568|NCT00927095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17569|NCT00927082|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17570|NCT00927069|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17571|NCT00926952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17572|NCT00926887|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17573|NCT00926796|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17574|NCT00926783|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is allowed to publish but must submit draft pubs to Biosense Webster, Inc. at least 30 days prior to submission for publication or presentation.
17575|NCT00926588|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17576|NCT00926575|Principal Investigators are NOT employed by the organization sponsoring the study.|
17577|NCT00926536|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17578|NCT00926497|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17579|NCT00926393|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to collaborate in good faith with AstraZeneca with regards to the contents and formation of any publication or disclosure to be made by the PI and to pay due consideration to the comments, views and opinions offered by AstraZeneca
17580|NCT00926380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17581|NCT00926367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17582|NCT00926328|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17583|NCT00926289|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17584|NCT00926263|All Principal Investigators ARE employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17585|NCT00926211|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17586|NCT00926185|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicentre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicentre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
17587|NCT00926029|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17588|NCT00925990|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17589|NCT00925938|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications resulting from the clinical trial must be in a form that does not reveal technical information that the Sponsor considers confidential or proprietary. A copy of any abstract, presentation or manuscript proposed for publication must be submitted to the Sponsor for review at least 30 days before its submission. If deemed necessary for protection of proprietary information prior to patent filing, a further delay of 60 days is required before any publication is submitted.
17590|NCT00925899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17591|NCT00925782|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution/PI shall submit to the Sponsor for comment, any manuscript or public release of information at least 90 days prior to its submission or release. If the Sponsor requires additional time in order to protect the results of the Study by patenting or otherwise, Institution agrees to delay submitting the Publication to any third party for up to an additional 90 days after the request by Sponsor. Such request, however, must be received by Institution during the 90-day review period.
17592|NCT00925769|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17593|NCT00925704|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
17594|NCT00925600|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
17595|NCT00925587|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
17596|NCT00925548|Principal Investigators are NOT employed by the organization sponsoring the study.|
17597|NCT00925522|Principal Investigators are NOT employed by the organization sponsoring the study.|Approval from St. Jude Medical prior to any publication.
17598|NCT00925353|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17599|NCT00925288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17600|NCT00925132|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17601|NCT00925119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17602|NCT00925015|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
17603|NCT00924950|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17604|NCT00924898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17605|NCT00924833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17606|NCT00924807|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17607|NCT00924781|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
17608|NCT00924729|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17609|NCT00924651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17610|NCT00924638|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17611|NCT00924560|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
17612|NCT00924508|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17613|NCT00924482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17614|NCT00924469|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor will retain the right to review all material prior to presentation or submission for publication and neither institution(s) nor Study Co-Chairs/Principal Investigator(s) is/are permitted to publish/present the results of the study, in part or in their entirety, without the written authorization of the Sponsor. The review is aimed at complying with 21CFR312.7 (non promotion of investigational drugs) as well as the intellectual property rights and commercial interests of the Sponsor.
17615|NCT00924443|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI) and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. In multi-site studies, PI can publish after sponsor publishes or 18 months after study completion. PI gives sponsor a draft 60 days before publication. Sponsor can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application.
17616|NCT00924404|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17617|NCT00924352|Principal Investigators are NOT employed by the organization sponsoring the study.|The funder will be provided with a copy of the proposed publication at least 30 days prior to its submission or presentation. The funder may request the presentation/submission be delayed for an additional 90 days to allow the funder to seek patent protection. The funder can require the deletion of information deemed as confidential.
17618|NCT00924313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17619|NCT00924287|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17620|NCT00924209|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17621|NCT00924170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17622|NCT00924118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17623|NCT00924066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17624|NCT00924053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17625|NCT00924040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17626|NCT00924001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17627|NCT00923975|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17628|NCT00923949|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17629|NCT00923936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17630|NCT00923910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17631|NCT00923845|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17632|NCT00923481|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17633|NCT00923364|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17634|NCT00923351|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17635|NCT00923273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17636|NCT00923260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17637|NCT00923247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17638|NCT00923195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17639|NCT00923156|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
17640|NCT00923130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17641|NCT00923117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17642|NCT00923091|Principal Investigators are NOT employed by the organization sponsoring the study.|A site may not publish results until after a coordinated multicentre publication has been submitted for publication or until one year after the study has ended, whichever occurs first. Then, the site will have the opportunity to publish the results, provided that DSE has had the opportunity to review and comment on the site’s proposed publication prior to its being submitted for publication with the advice of company patent council and in accord with needs for subject protection.
17643|NCT00923078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17644|NCT00922987|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17645|NCT00922935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17646|NCT00922779|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17647|NCT00922766|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17648|NCT00922701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17649|NCT00922636|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17650|NCT00922623|Principal Investigators are NOT employed by the organization sponsoring the study.|Any proposed press release, announcement, disclosure for publication, whether or not in writing, prepared by or on behalf of Consultant as part of services under this Agreement or that relates to the work performed hereunder must be reviewed and approved in writing by Merz prior to dissemination.
17651|NCT00922480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17652|NCT00922441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17653|NCT00922428|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17654|NCT00922272|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
17655|NCT00922233|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17656|NCT00922207|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17657|NCT00922194|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17658|NCT00922116|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
17659|NCT00921947|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17660|NCT00921934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17661|NCT00921895|Principal Investigators are NOT employed by the organization sponsoring the study.|Results to be published or presented shall be submitted to RPS for review and comment at least 30 days prior to submission for publication or presentation. Institution and/or PI may publish or present the results and data from the Institution's site individually (i) 12 months after conclusion, abandonment or termination of study at all sites, or (ii) after RPS confirms there will be no multicenter study publication, whichever occurs first.
17662|NCT00921687|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17663|NCT00921557|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
17664|NCT00921518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17665|NCT00921310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17666|NCT00921115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17667|NCT00921024|Principal Investigators are NOT employed by the organization sponsoring the study.|The data generated in this clinical study are the exclusive property of the Sponsor and are confidential. Authorship on any primary publication of the results from this study will be based on contributions to study design, enrollment, data analysis, and interpretation of results.
17668|NCT00920907|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
17669|NCT00920855|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
17670|NCT00920816|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17671|NCT00920790|Principal Investigators are NOT employed by the organization sponsoring the study.|
17672|NCT00920699|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17673|NCT00920686|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor may request the Investigator or Institution not to publish or disclose information related to the clinical study.
17694|NCT00919191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17674|NCT00920647|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information(excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
17675|NCT00920621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17676|NCT00920439|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17677|NCT00920426|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17678|NCT00920374|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17679|NCT00920309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17680|NCT00920231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17681|NCT00920218|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17682|NCT00920140|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17683|NCT00920075|All Principal Investigators ARE employed by the organization sponsoring the study.|Agreement with Merck: to submit a copy of any proposed abstract, manuscript and/or press release to Merck for review and comment at least 30 days prior to submission for publication or presentation.
17684|NCT00920023|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17685|NCT00919932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17686|NCT00919893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17687|NCT00919867|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
17688|NCT00919854|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17689|NCT00919802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17690|NCT00919763|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17691|NCT00919724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17692|NCT00919711|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
17693|NCT00919633|Principal Investigators are NOT employed by the organization sponsoring the study.|
17771|NCT00913770|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17695|NCT00919126|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17696|NCT00919113|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17697|NCT00919061|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17698|NCT00919035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17699|NCT00918957|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
17700|NCT00918931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17701|NCT00918879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17702|NCT00918866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17703|NCT00918749|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17704|NCT00918736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17705|NCT00918723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17706|NCT00918684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17707|NCT00918671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17708|NCT00918645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17709|NCT00918580|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17710|NCT00918385|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17711|NCT00918346|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor respects the investigators' wish to publish results of the study, and will not unnecessarily restrict the spreading of information of scientific interest. However, the study may involve confidential information affecting the company's business, such as aspects related to patent application. Therefore, the investigators agree to allow the sponsor to review any manuscripts and to negotiate timing and forum of publication.
17712|NCT00918333|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17713|NCT00918281|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17714|NCT00918255|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
17792|NCT00912301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17715|NCT00918203|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17716|NCT00918138|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
17717|NCT00918125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17718|NCT00917865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17719|NCT00917852|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
17720|NCT00917735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17721|NCT00917644|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17722|NCT00917579|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17723|NCT00917501|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17724|NCT00917384|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study completion or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
17725|NCT00917267|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17726|NCT00917124|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17727|NCT00916929|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17728|NCT00916721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17729|NCT00916643|Principal Investigators are NOT employed by the organization sponsoring the study.|Client may use the results of the study for its own teaching,research,education,clinical and publication purposes without the payment of royalties or other fees.Client shall submit to Sponsor for review, a copy of any proposed publication resulting from the Study at least thirty(30)days prior to the estimated date of publication, and if no response is received within thirty(30)days of the date submitted to Sponsor,it will be conclusively presumed that the publication may proceed without delay.
17730|NCT00916617|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17731|NCT00916539|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17732|NCT00916383|Principal Investigators are NOT employed by the organization sponsoring the study.|An Institution Publication may be published provided that it does not disclose Confidential Information other than the study results from the Institution’s study data. The proposed Institution Publication shall be submitted to sponsor for review and comment at least 30 days prior to submitting it to a third party. If sponsor requests a delay in order to file patent applications, the Institution Publication may be delayed for submission to a third party for up to 120 days after sponsor request.
17733|NCT00916370|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication except to delay any proposed publication or presentation to enable the Sponsor to secure patent or other protection of proprietary rights.
17734|NCT00916357|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17735|NCT00916344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17736|NCT00916305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17737|NCT00916279|Principal Investigators are NOT employed by the organization sponsoring the study.|
17738|NCT00916136|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17739|NCT00916032|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication of the main/primary endpoint or ≤24 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) prior to submission for publication, and shall review and if necessary amend the manuscript in ≤30 days
17740|NCT00916006|Principal Investigators are NOT employed by the organization sponsoring the study.|"For US sites: The institution and investigator agree not to publish the results of this study without prior written consent of the Sponsor. As used herein, the term publish shall include oral presentations,written abstracts, written manuscripts, etc."
17741|NCT00915902|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17742|NCT00915876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17743|NCT00915798|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17744|NCT00915772|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17745|NCT00915759|Principal Investigators are NOT employed by the organization sponsoring the study.|
17746|NCT00915655|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor will not unreasonably withhold consent to publish the data generated in this trial. However, it is the policy of the Sponsor not to allow the investigators to publish their results or findings prior to the Sponsor’s publication of the overall trial results. The investigator agrees that before he/she publishes any results of this trial, he/she shall allow at least 45 days for the Sponsor to review the prepublication manuscript prior to submission of the manuscript to the publisher.
17747|NCT00915603|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from the date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish results until 18 mos. after the trial has been completed at all sites.
17748|NCT00915590|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17749|NCT00915551|Principal Investigators are NOT employed by the organization sponsoring the study.|"For US sites: The institution and investigator agree not to publish the results of this study without prior written consent of the Sponsor. As used herein, the term publish shall include oral presentations,written abstracts, written manuscripts, etc."
17750|NCT00915525|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
17751|NCT00915499|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17752|NCT00915473|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17753|NCT00915356|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17754|NCT00915343|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicentre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicentre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
17755|NCT00915278|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17756|NCT00915148|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17757|NCT00915018|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17758|NCT00914966|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to Sponsor for pre-review. If Sponsor requests, PI must delete Sponsor confidential information before publication and/or delay publication for 60 days so Sponsor can file for patents or take other action to protect its patent rights.
17759|NCT00914927|Principal Investigators are NOT employed by the organization sponsoring the study.|
17760|NCT00914862|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights therefrom or any data, information or materials obtained or generated in the performance of its obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
17761|NCT00914849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17762|NCT00914810|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17763|NCT00914589|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
17764|NCT00914485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17765|NCT00914459|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17766|NCT00914316|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17767|NCT00914186|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17768|NCT00914069|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigators may publish or present the study results with prior consent of the Sponsor, but will not disclose confidential information. Prior to submission by a Principal Investigator for publication or presentation, the Sponsor will be provided with the opportunity to review the submission for confidential information and accuracy.
17769|NCT00913913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17770|NCT00913835|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
17772|NCT00913744|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and the Principal Investigator (PI) reserve the right to publish only the results of the work performed by the Principal Investigator pursuant to this Agreement; provided, however, that Institution provides Sponsor a copy of any proposed publication, for review and comment at least sixty (60) days in advance of its submission for publication.
17773|NCT00913692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17774|NCT00913627|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17775|NCT00913523|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written consent. The Institution will provide Sponsor with at least sixty (60) days for review of a manuscript, and if requested in writing, the Institution and Principal Investigators will withhold such publication for up to an additional sixty (60) days to allow for filing of a patent application.
17776|NCT00913510|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17777|NCT00913458|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17778|NCT00913380|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17779|NCT00913263|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17780|NCT00913133|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17781|NCT00913081|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17782|NCT00913003|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17783|NCT00912964|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
17784|NCT00912925|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
17785|NCT00912912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17786|NCT00912808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17787|NCT00912795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17788|NCT00912782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17789|NCT00912743|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17790|NCT00912509|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17791|NCT00912405|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17793|NCT00912288|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17794|NCT00912223|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17795|NCT00912158|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17796|NCT00912093|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
17797|NCT00912028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17798|NCT00912015|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 30 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm's ability to patent any invention related to the study, the publication or disclosure will be modified or delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm's confidential information.
17799|NCT00912002|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
17800|NCT00911989|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17801|NCT00911937|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17802|NCT00911898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17803|NCT00911859|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17804|NCT00911820|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17805|NCT00911807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17806|NCT00911768|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17807|NCT00911742|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must agree to maintain the confidentiality of the study at all times, and he cannot reveal any information coming from the protocol, the study results or any documentation related to the study, without permission of the sponsor. Any publication of the results, in whole or in part will require the permission of the sponsor.
17808|NCT00911625|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17809|NCT00911612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17810|NCT00911547|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17811|NCT00911534|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17812|NCT00911495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17813|NCT00911443|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17814|NCT00911326|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall not submit a publication to journals or professional societies without the prior written approval of the Sponsor.
17815|NCT00911300|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17816|NCT00911274|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
17817|NCT00911170|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
17818|NCT00911157|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17819|NCT00911144|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17820|NCT00910988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17821|NCT00910962|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17822|NCT00910910|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 12 months since study completion. Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
17823|NCT00910871|Principal Investigators are NOT employed by the organization sponsoring the study.|It is the policy of the sponsor not to allow the investigators to publish their results or findings prior to the sponsor’s publication of the overall trial results.The investigator agrees that before he/she publishes any results of this trial, he/she shall provide the sponsor with at least 45 days for full review of the prepublication manuscript prior to submission of the manuscript to the publisher.
17824|NCT00910858|Principal Investigators are NOT employed by the organization sponsoring the study.|"Multicenter publication must include input from investigators and Celgene, agreement to be established before publication. It has priority over subset (single center) publication, for duration of 1 year after study completion.~Individual investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. In this case, Celgene has the right to comment and right to ask delay of publication for 60 days."
17825|NCT00910845|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
17826|NCT00910728|Principal Investigators are NOT employed by the organization sponsoring the study.|
17827|NCT00910715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17828|NCT00910689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17829|NCT00910663|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
17830|NCT00910624|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the sponsor, and further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
17875|NCT00908011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17831|NCT00910520|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
17832|NCT00910299|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17833|NCT00910273|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17834|NCT00910091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17835|NCT00910039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17836|NCT00910000|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17837|NCT00909870|Principal Investigators are NOT employed by the organization sponsoring the study.|Company-specific confidentiality agreement
17838|NCT00909857|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17839|NCT00909844|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17840|NCT00909792|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any pre-clinical and/or clinical data or impressions from this trial.
17841|NCT00909779|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish.
17842|NCT00909753|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not allowed to discuss or publish trial results.
17843|NCT00909727|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17844|NCT00909649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17845|NCT00909610|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
17846|NCT00909545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17847|NCT00909532|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17848|NCT00909480|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right not to release data before passing specified milestones. This includes the right not to release interim results that may later be found to be incorrect. At the end of the trial, one or more manuscripts will be prepared in collaboration between Investigator(s) and Novo Nordisk. Novo Nordisk will not suppress or veto publications but will reserve the right to postpone publication and/or communication for a short time to protect intellectual property.
17849|NCT00909428|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17850|NCT00909389|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosures agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.
17876|NCT00907907|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
17851|NCT00909324|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
17852|NCT00909220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17853|NCT00909181|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17854|NCT00909155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17855|NCT00909064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17856|NCT00909038|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17857|NCT00908960|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17858|NCT00908908|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17859|NCT00908895|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17860|NCT00908882|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17861|NCT00908687|Principal Investigators are NOT employed by the organization sponsoring the study.|
17862|NCT00908648|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17863|NCT00908596|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17864|NCT00908583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17865|NCT00908388|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
17866|NCT00908375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17867|NCT00908349|Principal Investigators are NOT employed by the organization sponsoring the study.|
17868|NCT00908310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17869|NCT00908232|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17870|NCT00908141|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17871|NCT00908128|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
17872|NCT00908115|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17873|NCT00908076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17874|NCT00908037|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17877|NCT00907881|Principal Investigators are NOT employed by the organization sponsoring the study.|The study sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the study sponsor as confidential must be deleted prior to submission.
17878|NCT00907803|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI must obtain the sponsor's written consent to publish any study results and must notify the sponsor within 30 working days prior to publishing.
17879|NCT00907777|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17880|NCT00907738|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
17881|NCT00907621|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17882|NCT00907517|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
17883|NCT00907478|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
17884|NCT00907426|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
17885|NCT00907374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17886|NCT00907335|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17887|NCT00907257|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17888|NCT00907218|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17889|NCT00907153|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17890|NCT00907101|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17891|NCT00907088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17892|NCT00906971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17893|NCT00906945|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17894|NCT00906789|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release; review by sponsor must be completed within 60 days. Public release of results cannot occur prior to the completion of the FDA review of submitted results.
17895|NCT00906776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17896|NCT00906698|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17897|NCT00906503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17898|NCT00906425|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17899|NCT00906399|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
17900|NCT00906347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17901|NCT00906282|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
17902|NCT00906243|Principal Investigators are NOT employed by the organization sponsoring the study.|This was a Phase 1 and Phase 2 study. The study was terminated after completion of Phase 1 under terms of a settlement agreement that restricts disclosure to limited Phase 1 results only.
17903|NCT00906204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17904|NCT00906178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17905|NCT00906087|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor wants an opportunity to review the data. I will send a PDF of this record on 3/17/2017.
17906|NCT00906074|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17907|NCT00906035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17908|NCT00905840|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17909|NCT00905827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17910|NCT00905632|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BIs intellectual property rights.
17911|NCT00905606|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
17912|NCT00905580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17913|NCT00905567|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
17914|NCT00905554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17915|NCT00905515|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17916|NCT00905489|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
17917|NCT00905437|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17940|NCT00904488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17918|NCT00905424|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
17919|NCT00905359|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17920|NCT00905346|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
17921|NCT00905307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17922|NCT00905268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17923|NCT00905255|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
17924|NCT00905164|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
17925|NCT00905151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17926|NCT00905125|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17927|NCT00905034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17928|NCT00905021|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17929|NCT00904995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17930|NCT00904982|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17931|NCT00904969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17932|NCT00904943|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
17933|NCT00904917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17934|NCT00904839|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
17935|NCT00904826|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17936|NCT00904748|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17937|NCT00904722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17938|NCT00904670|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17939|NCT00904618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17941|NCT00904423|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17942|NCT00904371|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17943|NCT00904215|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
17944|NCT00904189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17945|NCT00904150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17946|NCT00904007|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17947|NCT00903968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17948|NCT00903929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17949|NCT00903877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17950|NCT00903695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17951|NCT00903682|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the Sponsor for review at least 60 days prior to submission for publication or presentation. No paper that incorporates Confidential Information will be submitted for publication without Sponsor’s prior written consent. If requested in writing, such publication will be withheld for up to an additional 60 calendar days. A publication from the individual Study site data will not be published until the combined results have been published.
17952|NCT00903630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17953|NCT00903617|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17954|NCT00903448|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17955|NCT00903409|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17956|NCT00903396|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17957|NCT00903383|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor requires that written permission be given before the PI can release any data publicly.
17958|NCT00903370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17959|NCT00903357|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17960|NCT00903344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17961|NCT00903331|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18021|NCT00896779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17962|NCT00903201|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
17963|NCT00903175|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
17964|NCT00903162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17965|NCT00903032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17966|NCT00903006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17967|NCT00902850|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17968|NCT00902746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the sponsor and PI that no restricts the PI's right but need to discuss the timing of publish date of trial results after the trial is completed.
17969|NCT00902668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17970|NCT00902564|Principal Investigators are NOT employed by the organization sponsoring the study.|No results can be made public before appropriate steps by Lundbeck to secure patents and/or intellectual property rights. The Investigator shall send any manuscript and/or public presentation to Lundbeck at least 1 month before submission for publication. If Lundbeck finds matters requiring patents or the like, the Investigator shall delay publication and/or public presentation for an additional 3 months.
17971|NCT00902538|Principal Investigators are NOT employed by the organization sponsoring the study.|A site may not publish results until after a multi-center publication has been submitted for publication or until one year after the study has ended, whichever occurs first. Then, the site will have the opportunity to publish the results, provided that Daiichi Sankyo Europe has had the opportunity to review and comment on the site’s proposed publication prior to its being submitted for publication with the advice of company patent council and in accord with needs for subject protection.
17972|NCT00902330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17973|NCT00902304|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
17974|NCT00902278|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17975|NCT00902265|Principal Investigators are NOT employed by the organization sponsoring the study.|PI gives Ferring a draft manuscript 30 days before submission for the final form for to any journal for review and comments. Ferring can ask that confidential information be removed.
17976|NCT00902226|Principal Investigators are NOT employed by the organization sponsoring the study.|No results can be made public before appropriate steps by Lundbeck to secure patents / intellectual property rights. The Investigator shall send any manuscript / public presentation to Lundbeck at least 1 month before submission for publication. If Lundbeck finds matters requiring patents or the like, the Investigator shall delay publication / public presentation for an additional 3 months.
17977|NCT00902174|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
17978|NCT00902161|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
17979|NCT00901901|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI must send a draft manuscript of the publication or abstract to the sponsor 30 days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution which satisfies both parties.
17980|NCT00901628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18022|NCT00896649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17981|NCT00901576|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
17982|NCT00901459|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17983|NCT00901342|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentations relating to the Study will be coordinated by Dendreon in communication with institutions contributing patients to the Study.
17984|NCT00901316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17985|NCT00901225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17986|NCT00901186|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
17987|NCT00901017|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17988|NCT00900822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17989|NCT00900796|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
17990|NCT00900757|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution will provide Eisai with a copy of any manuscript, paper, or poster connected with the study at least 30 days prior to submission to journal/presentation in order for Eisai to review for Eisai's Confidential Information (CI). Should Eisai notify Institution with such 30 day period that materials contain CI, Institution agrees to delay submission/publication/presentation for an additional 60 days to allow Eisai to seek patent or other protection.
17991|NCT00900731|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
17992|NCT00900666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17993|NCT00900627|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17994|NCT00900601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
17995|NCT00900237|Principal Investigators are NOT employed by the organization sponsoring the study.|
17996|NCT00900159|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17997|NCT00900146|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
17998|NCT00900029|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
17999|NCT00899847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18000|NCT00899717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18001|NCT00899678|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18002|NCT00899600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18003|NCT00899574|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18004|NCT00899470|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18005|NCT00899392|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18006|NCT00899379|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18007|NCT00899353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18008|NCT00898937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18009|NCT00898807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18010|NCT00898677|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18011|NCT00898560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18012|NCT00898443|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18013|NCT00898222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18014|NCT00897949|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18015|NCT00897910|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18016|NCT00897897|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18017|NCT00897715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18018|NCT00897676|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18019|NCT00897390|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18020|NCT00897104|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18042|NCT00895622|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
18023|NCT00896454|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
18024|NCT00896441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18025|NCT00896389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18026|NCT00896363|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18027|NCT00896337|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least 45 days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
18028|NCT00896233|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications derived from this study should include input from the investigators and SPONSOR personnel.Such input should be reflected in publication authorship.The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts,or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
18029|NCT00896168|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18030|NCT00896064|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18031|NCT00896051|Principal Investigators are NOT employed by the organization sponsoring the study.|It is the policy of the sponsor not to allow investigators to publish their results or findings from the study prior to the sponsor’s publication of the overall trial results. The investigator agrees that before he/she publishes any results of this trial, he/she shall allow at least 45 days for the sponsor to review the prepublication manuscript prior to submission of the manuscript to the publisher.
18032|NCT00896038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18033|NCT00896025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18034|NCT00895947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18035|NCT00895934|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18036|NCT00895895|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18037|NCT00895843|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18038|NCT00895830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18039|NCT00895817|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18040|NCT00895752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18041|NCT00895661|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18043|NCT00895583|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18044|NCT00895531|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18045|NCT00895453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18046|NCT00895310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18047|NCT00895284|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18048|NCT00895245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18049|NCT00895232|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18050|NCT00895193|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18051|NCT00895180|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the ABTC publication, JHU will submit the draft of any proposed publication to ImClone at least thirty (30) days prior to submission for publication and agrees to withhold any such submission for an additional period, not to exceed ninety (90) days to allow ImClone to file patent applications. If Confidential Information is in the publication, it will notify JHU, which will insure such Confidential Information is redacted.
18052|NCT00895011|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
18053|NCT00894933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18054|NCT00894803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18055|NCT00894790|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18056|NCT00894699|Principal Investigators are NOT employed by the organization sponsoring the study.|
18057|NCT00894647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18058|NCT00894556|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18059|NCT00894543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18060|NCT00894517|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
18061|NCT00894504|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
18062|NCT00894465|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18063|NCT00894387|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
18064|NCT00894361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18065|NCT00894322|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18066|NCT00894244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18067|NCT00894166|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18068|NCT00894127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18069|NCT00893997|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18070|NCT00893971|Principal Investigators are NOT employed by the organization sponsoring the study.|Drafts of any and all publications or presentations of this study must be submitted at least 30 days prior to submission for publication or presentation to Pearl Therapeutics for review, approval, and to ensure consistency. Pearl Therapeutics has the right to request appropriate modification to correct facts and to represent its opinions, or the opinions of the publication committee, if these differ with the proposed publication.
18071|NCT00893789|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
18072|NCT00893763|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18073|NCT00893737|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of Results is specifically authorized, subject to the provisions of STUDY AGREEMENT. INVESTIGATOR is free to publish Results of its part of study in collaboration with other investigators, but in compliance with confidentiality agreement and subsequent to full study publication issued by CLINVEST. INVESTIGATOR agrees to submit a copy of any results communication to CLINVEST for review and comment 60 days prior to submission for publication.
18074|NCT00893464|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
18075|NCT00893152|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18076|NCT00893113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18077|NCT00893074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18078|NCT00892957|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., for intellectual property protection)
18079|NCT00892775|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18080|NCT00892723|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18081|NCT00892710|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
18082|NCT00892697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18083|NCT00892606|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18084|NCT00892437|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
18085|NCT00892281|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
18086|NCT00892177|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18087|NCT00892151|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18088|NCT00892099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18089|NCT00892047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18090|NCT00892008|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18091|NCT00891995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18092|NCT00891982|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18093|NCT00891930|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
18094|NCT00891904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18095|NCT00891839|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
18096|NCT00891813|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
18097|NCT00891774|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written consent. The Institution will provide Sponsor with at least sixty (60) days for review of a manuscript, and if requested in writing, the Institution and Principal Investigators will withhold such publication for up to an additional sixty (60) days to allow for filing of a patent application.
18118|NCT00890656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18098|NCT00891735|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18099|NCT00891657|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18100|NCT00891618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18101|NCT00891527|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18102|NCT00891462|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute."
18103|NCT00891436|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor has the right to review the results prior to publication of the results. But no embargo or time limit was given.
18104|NCT00891371|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18105|NCT00891319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18106|NCT00891293|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18107|NCT00891228|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18108|NCT00891202|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
18109|NCT00891176|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18110|NCT00891046|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data (i.e, data from all sites) in the clinical trial.
18111|NCT00891020|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18112|NCT00890981|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
18113|NCT00890929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18114|NCT00890916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18115|NCT00890721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18116|NCT00890695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18117|NCT00890682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18119|NCT00890591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18120|NCT00890552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18121|NCT00890409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18122|NCT00890201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18123|NCT00890097|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
18124|NCT00890084|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18125|NCT00889928|Principal Investigators are NOT employed by the organization sponsoring the study.|
18126|NCT00889915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18127|NCT00889863|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18128|NCT00889824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18129|NCT00889720|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18130|NCT00889707|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators will take all steps reasonably necessary to hold Protox’s Proprietary Information in trust and confidence, will not use Proprietary Information in any manner or for any purpose not expressly set forth in their Agreement, and will not disclose any such Proprietary Information to any third party without first obtaining Protox’s express written consent.
18131|NCT00889681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18132|NCT00889603|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18133|NCT00889512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18134|NCT00889421|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18135|NCT00889330|Principal Investigators are NOT employed by the organization sponsoring the study.|
18136|NCT00889265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18137|NCT00889252|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees not to publish or publicly present the results of the study without the prior written approval of the sponsor.
18138|NCT00889200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18139|NCT00889187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18140|NCT00888979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18141|NCT00888940|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If the First Publication is not published within 1 year of Study conclusion or termination, Investigator shall have the right to publish and disclose the Data. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
18142|NCT00888849|Principal Investigators are NOT employed by the organization sponsoring the study.|
18143|NCT00888654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18144|NCT00888628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18145|NCT00888459|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18146|NCT00888433|Principal Investigators are NOT employed by the organization sponsoring the study.|The institution agrees that no Publication of the Study Results may be made until Publication of the results of the multi-centre study or 2 years after Study Completion, whichever is sooner.
18147|NCT00888381|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
18148|NCT00888355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18149|NCT00888329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18150|NCT00888238|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18151|NCT00888173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18152|NCT00888134|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18153|NCT00887978|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18154|NCT00887965|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
18155|NCT00887913|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is under a general confidentiality agreement and must have prior written approval by the Sponsor prior to publishing the study results.
18156|NCT00887822|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
18157|NCT00887809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18158|NCT00887744|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Investigator acknowledge that all information affecting or relating to Sponsor’s products that is developed, discovered, or transmitted in connection with the study, including the multi-center data resulting from the study and any inventions or moral rights, shall belong to Sponsor, and nothing shall be construed to confer upon or grant to Institution or Investigator any right, title, or interest therein.
18159|NCT00887679|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18160|NCT00887653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18161|NCT00887640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18162|NCT00887588|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
18163|NCT00887575|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
18164|NCT00887562|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18165|NCT00887549|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18166|NCT00887510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18167|NCT00887484|Principal Investigators are NOT employed by the organization sponsoring the study.|If the Investigator wishes to make any such publication or presentation, the Investigator must first submit such publication or presentation to Stiefel for review at least thirty (30) days prior to the date on which such publication or presentation is proposed to be made.
18168|NCT00887471|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18169|NCT00887458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18170|NCT00887354|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18171|NCT00887341|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18172|NCT00887315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18173|NCT00887289|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18174|NCT00887250|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18175|NCT00887224|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18176|NCT00887198|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the Sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
18177|NCT00887159|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18178|NCT00886938|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18179|NCT00886899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18180|NCT00886834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18181|NCT00886821|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18222|NCT00884611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18182|NCT00886795|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18183|NCT00886769|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until publication of the pooled data (i.e., data from all sites) in the clinical trial or publication of trial results in their entirety.
18184|NCT00886743|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18185|NCT00886704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18186|NCT00886639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18187|NCT00886626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18188|NCT00886613|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, an investigator and his/her colleagues may publish their data independently subsequent to the multicenter publication. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication timelines.
18189|NCT00886600|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18190|NCT00886587|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed not to publish the study results without prior sponsor approval.
18191|NCT00886483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18192|NCT00886340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18193|NCT00886288|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18194|NCT00886145|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18195|NCT00886119|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any pre-clinical and/or clinical data or impressions from this trial.
18196|NCT00886015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18197|NCT00885846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18198|NCT00885768|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18199|NCT00885755|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18200|NCT00885742|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned, before seeking publication review.
18221|NCT00884741|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18201|NCT00885703|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
18202|NCT00885677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18203|NCT00885638|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18204|NCT00885534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18205|NCT00885482|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18206|NCT00885378|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤ 60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18207|NCT00885365|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon PI submission of publication to Sponsor, Sponsor will complete its review within 90 days after receipt. At Sponsor’s request, publication may be delayed up to 120 additional days for Sponsor to file necessary patent applications. In multicenter trials, PIs will postpone single center publications until after multicenter data publication. If no multicenter publication occurs within 12 months of trial completion, PI may publish single center results, subject to review timelines listed above.
18208|NCT00885352|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
18209|NCT00885170|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
18210|NCT00885118|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18211|NCT00885105|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
18212|NCT00885092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18213|NCT00885079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18214|NCT00884949|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot publish any data prior to multi-centre publication. If publication related to sub-sets of data shall make reference to the relevant multi-centre publication. PI agrees to submit data to Sponsor for review and comment 60 days prior to publication. During review period, Sponsor may request that publication be delayed for up to 6 months from date of first submission to Sponsor in order for Sponsor to take steps to protect its proprietary information.
18215|NCT00884910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18216|NCT00884897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18217|NCT00884832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18218|NCT00884806|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
18219|NCT00884793|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18220|NCT00884754|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18223|NCT00884585|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
18224|NCT00884390|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18225|NCT00884377|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18226|NCT00884325|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18227|NCT00884312|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
18228|NCT00884286|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18229|NCT00884273|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
18230|NCT00884221|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the principle investigator (PI) is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
18231|NCT00884117|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18232|NCT00884065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18233|NCT00884039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18234|NCT00883779|Principal Investigators are NOT employed by the organization sponsoring the study.|Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18235|NCT00883753|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18236|NCT00883740|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18237|NCT00883675|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18238|NCT00883558|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained as a result of this study or during the conduct of this study will be regarded as confidential. The investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless written permission from the sponsor (Halozyme) is obtained.
18239|NCT00883493|Principal Investigators are NOT employed by the organization sponsoring the study.|
18240|NCT00883389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18241|NCT00883337|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the Investigator can present or publish results. The investigator provides the sponsor with a copy of the presentation or publication for review and comment at least 30 days in advance of its submission.~The sponsor can delay the submission for a period not exceeding 90 days to allow for filing a patent application or such other measures as sponsor deems appropriate to establish and preserve its proprietary rights."
18242|NCT00883246|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18243|NCT00883233|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor for review and approval at least 2 months prior to the date of the intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
18244|NCT00883181|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
18245|NCT00883168|Principal Investigators are NOT employed by the organization sponsoring the study.|"Investigators participating in multicenter studies must agree not to present data gathered individually or by a subgroup of centers before the full, initial publication, unless this has been agreed to by all other investigators and Meda Pharmaceuticals.~Meda Pharmaceuticals requests that it receive copies of any intended communication reasonably in advance (at least 15 working days for an abstract or oral presentation and 45 working days for a manuscript)"
18246|NCT00883129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18247|NCT00883116|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18248|NCT00883103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18249|NCT00883090|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned, before seeking publication review.
18250|NCT00882921|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
18251|NCT00882908|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18252|NCT00882778|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18253|NCT00882713|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18254|NCT00882687|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
18255|NCT00882661|Principal Investigators are NOT employed by the organization sponsoring the study.|To prevent premature disclosure of information, Investigators agree not to present, publish, or disclose study results or information about the Investigational Device without the express written consent of Sponsor.
18256|NCT00882583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18257|NCT00882557|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If First Publication not published within 1 year of Study conclusion or termination, Investigator has right to publish and disclose the Data. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
18258|NCT00882518|Principal Investigators are NOT employed by the organization sponsoring the study.|
18259|NCT00882440|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18260|NCT00882362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18261|NCT00882310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18262|NCT00882206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18263|NCT00882102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18264|NCT00881959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18265|NCT00881894|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
18266|NCT00881868|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
18267|NCT00881751|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18268|NCT00881712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18269|NCT00881647|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18270|NCT00881621|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18271|NCT00881608|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
18272|NCT00881530|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18273|NCT00881504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18274|NCT00881465|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18275|NCT00881335|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18276|NCT00881205|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
18277|NCT00880919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18278|NCT00880906|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18279|NCT00880763|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
18280|NCT00880750|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
18281|NCT00880698|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
18282|NCT00880685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18283|NCT00880620|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results of the Study conducted at the Site shall not be made before the first multi-site publication by Sponsor.
18284|NCT00880581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18285|NCT00880568|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts,or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
18286|NCT00880555|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18287|NCT00880542|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18288|NCT00880425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18289|NCT00880399|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18290|NCT00880360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18291|NCT00880334|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18292|NCT00880269|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
18293|NCT00880256|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18294|NCT00880230|Principal Investigators are NOT employed by the organization sponsoring the study.|Medtronic has a legitimate interest in ensuring that a multi-center publication is the first publication to be released regarding the completed Study. The Institution agrees that it will not publish or disclose any results of or information pertaining to the study until a multi-center publication is released. If a publication is not released within one year after completion of the study, the Institution will have the right to publish information pertaining to their activities conducted.
18295|NCT00880191|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18296|NCT00880165|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18297|NCT00880100|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication after a multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
18298|NCT00880048|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18299|NCT00880022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18300|NCT00880009|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18301|NCT00879996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18302|NCT00879970|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18303|NCT00879879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18304|NCT00879814|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18305|NCT00879775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18306|NCT00879710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18307|NCT00879697|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18308|NCT00879684|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18309|NCT00879645|Principal Investigators are NOT employed by the organization sponsoring the study.|
18310|NCT00879619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18311|NCT00879411|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18312|NCT00879398|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18313|NCT00879359|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18314|NCT00879333|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
18315|NCT00879255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18316|NCT00879229|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
18317|NCT00879190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18318|NCT00879034|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18319|NCT00878995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18320|NCT00878969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18321|NCT00878878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18322|NCT00878826|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18323|NCT00878800|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18324|NCT00878722|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18325|NCT00878709|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18326|NCT00878644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18327|NCT00878605|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18328|NCT00878553|Principal Investigators are NOT employed by the organization sponsoring the study.|"PROTOCOL CONFIDENTIALITY/COMPLIANCE STATEMENT:~Investigators ...agree not to originate or use the name of Somnus Therapeutics, Inc and/or Zaleplon or SKP-1041, or any of its employees, in any publicity, news release, or other public announcement, written or oral, whether to the public, press, or otherwise, relating to this protocol, to any amendment hereto, or to the performance hereunder, without the prior written consent of Somnus Therapeutics, Inc.~SKP refers to SkyePharma PLC"
18329|NCT00878501|Principal Investigators are NOT employed by the organization sponsoring the study.|
18330|NCT00878436|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18331|NCT00878228|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18332|NCT00878215|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18333|NCT00877929|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18334|NCT00877890|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18335|NCT00877877|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18336|NCT00877799|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18337|NCT00877773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18338|NCT00877604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18357|NCT00875836|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18339|NCT00877487|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
18340|NCT00877448|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18341|NCT00877383|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
18342|NCT00877370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18343|NCT00877071|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18344|NCT00877058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18345|NCT00877032|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18346|NCT00877006|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator/Institution must submit proposed publication to Sponsor for review within a prespecified number of days before submission for publication. If Sponsor's review shows that potentially patentable subject matter would be disclosed, publication/public disclosure shall be delayed to enable Sponsor, or Sponsor's designees, to file necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
18347|NCT00876928|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18348|NCT00876915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18349|NCT00876733|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
18350|NCT00876694|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18351|NCT00876460|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
18352|NCT00876447|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
18353|NCT00876343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18354|NCT00876265|Principal Investigators are NOT employed by the organization sponsoring the study.|Any proposed press release, announcement, disclosure for publication, whether or not in writing, prepared by or on behalf of Consultant as part of services under this Agreement or that relates to the work performed hereunder must be reviewed and approved in writing by Merz prior to dissemination.
18355|NCT00876018|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18356|NCT00875979|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18358|NCT00875810|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release. The sponsor will limit its review to the determination of whether Confidential Information is disclosed and to check for technical correctness.
18359|NCT00875797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18360|NCT00875706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18361|NCT00875615|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18362|NCT00875589|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18363|NCT00875563|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18364|NCT00875550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18365|NCT00875485|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18366|NCT00875433|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18367|NCT00875420|Principal Investigators are NOT employed by the organization sponsoring the study.|Results may not be published prior to Study Report completion. Subsequent to formation of a Publications Committee, Investigators may publish results, providing a manuscript to Sponsor =/> 30 days prior to its submission. Sponsor will provide manuscript to Investigators =/> 30 days prior to its submission. Investigator will comply with Sponsor's policy, withholding publication for another 60 days to permit Sponsor to obtain patent or other proprietary rights protection, if deemed necessary.
18368|NCT00875394|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18369|NCT00875329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18370|NCT00875212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18371|NCT00875017|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
18372|NCT00874939|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
18373|NCT00874887|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
18374|NCT00874848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18375|NCT00874822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18376|NCT00874770|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single center publications until after disclosure of the clinical trial's primary publication.
18377|NCT00874549|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
18378|NCT00874510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18379|NCT00874497|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
18380|NCT00874276|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18381|NCT00874250|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
18382|NCT00874120|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves all publication and presentation rights.
18383|NCT00874094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18384|NCT00874029|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18385|NCT00873912|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
18386|NCT00873873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18387|NCT00873860|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
18388|NCT00873821|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
18389|NCT00873782|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18390|NCT00873730|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
18391|NCT00873457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18392|NCT00873366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18393|NCT00873327|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18394|NCT00873119|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18395|NCT00873093|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18396|NCT00873041|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18397|NCT00873015|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18398|NCT00872989|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18399|NCT00872898|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study are the property of Forest Research Institute. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute."
18400|NCT00872833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18401|NCT00872729|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may publish or disclose study data, with the restriction that sponsor may embargo such communications for a period up to 60 days from the time submitted to sponsor.
18402|NCT00872599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18403|NCT00872534|Principal Investigators are NOT employed by the organization sponsoring the study.|Standard Confidentiality Agreement
18404|NCT00872521|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18405|NCT00872430|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18406|NCT00872339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18407|NCT00872170|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18408|NCT00872079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18409|NCT00872027|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18410|NCT00872001|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator agrees not to publish or publicly present any interim results~of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media that report any study results)."
18411|NCT00871975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18412|NCT00871871|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
18413|NCT00871819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18414|NCT00871780|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
18415|NCT00871741|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18416|NCT00871728|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot provide any trial related information to external parties’ without mutual agreement with the sponsor. This is valid even after the contract is canceled.
18417|NCT00871715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18418|NCT00871689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18419|NCT00871624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18420|NCT00871572|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18421|NCT00871494|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18422|NCT00871429|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18423|NCT00871403|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18424|NCT00871377|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18425|NCT00871351|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish/present any interim results of the study without Sponsor's prior written consent. The investigator further agrees to provide to the sponsor 45 days prior to submission, review copies of abstracts/manuscripts that report any study results. The sponsor has the right to review and comment. If the parties disagree, investigator agrees to meet with the sponsor for the purpose of making good faith efforts to discuss and resolve any such issues or disagreement.
18426|NCT00871338|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18427|NCT00871286|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18428|NCT00871234|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18429|NCT00871169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18430|NCT00871143|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18431|NCT00871117|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18432|NCT00871000|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18433|NCT00870896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18434|NCT00870740|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
18435|NCT00870688|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18436|NCT00870584|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18437|NCT00870545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18461|NCT00869089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18438|NCT00870467|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
18439|NCT00870363|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18440|NCT00870194|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18441|NCT00870103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18442|NCT00869999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18443|NCT00869960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18444|NCT00869947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18445|NCT00869791|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18446|NCT00869778|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators can't publish articles relevant to the study unless the sponsor permits.
18447|NCT00869622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18448|NCT00869609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18449|NCT00869557|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
18450|NCT00869518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18451|NCT00869414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18452|NCT00869401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18453|NCT00869375|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18454|NCT00869362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18455|NCT00869349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18456|NCT00869323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18457|NCT00869258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18458|NCT00869167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18459|NCT00869141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18460|NCT00869128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18462|NCT00869050|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18463|NCT00868998|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18464|NCT00868959|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
18465|NCT00868790|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR has the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
18466|NCT00868751|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18467|NCT00868712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18468|NCT00868699|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
18469|NCT00868608|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18470|NCT00868530|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18471|NCT00868517|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18472|NCT00868452|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
18473|NCT00868439|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreements generally provide that PI cannot publish single site data before publication of the multi-site publication, unless 1 year has elapsed since completion of the study at all sites. Thereafter, PI may publish provided that PI shall: provide a copy of the publication to sponsor at least 60 days in advance of submission for publication; delete sponsor’s confidential information as requested; and delay publication up to an additional 90 days to permit protection of intellectual property.
18474|NCT00868374|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18475|NCT00868348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18476|NCT00868309|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18477|NCT00868296|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
18478|NCT00868231|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
18479|NCT00868218|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18480|NCT00868192|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18481|NCT00868140|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18482|NCT00868101|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18483|NCT00867659|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18484|NCT00867568|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18485|NCT00867529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18486|NCT00867503|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18487|NCT00867490|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18488|NCT00867451|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18489|NCT00867360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18490|NCT00867321|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18491|NCT00867217|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18492|NCT00867165|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agreed not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agreed to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
18493|NCT00867139|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18494|NCT00867113|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial
18495|NCT00867087|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18496|NCT00867035|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18497|NCT00867009|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18498|NCT00866918|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
18499|NCT00866905|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from the date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish results until 18 mos. after the trial has been completed at all sites.
18500|NCT00866814|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18501|NCT00866788|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."
18502|NCT00866775|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish
18503|NCT00866723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18504|NCT00866697|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
18505|NCT00866658|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
18506|NCT00866606|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18507|NCT00866359|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 45 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential data before submission or defer publication to permit patent applications.
18508|NCT00866320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18509|NCT00866307|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
18510|NCT00866294|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18511|NCT00866281|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data (i.e, data from all sites) in the clinical trial.
18512|NCT00866177|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18513|NCT00866047|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18514|NCT00866034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18515|NCT00865904|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is free to publish results of the study after (1) the first multi-center publication, (2) if the sponsor elects not to publish the results, or (3) 18 months after close of the study, whichever occurs first. Proposed publications are to be submitted to the sponsor for review and comment for a period of at least 45 days (which may be extended under certain circumstances related to protection of intellectual property); the sponsor cannot require changes to the proposed publications.
18516|NCT00865709|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18517|NCT00865514|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18518|NCT00865345|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18519|NCT00865306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18520|NCT00865202|Principal Investigators are NOT employed by the organization sponsoring the study.|The manuscript has been accepted by the Journal of the American Geriatrics Society for publication.
18521|NCT00865189|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18522|NCT00865124|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18523|NCT00865098|Principal Investigators are NOT employed by the organization sponsoring the study.|
18524|NCT00865046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18525|NCT00865020|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18526|NCT00864916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18527|NCT00864851|Principal Investigators are NOT employed by the organization sponsoring the study.|
18528|NCT00864708|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are employed by the Department of Veterans Affairs (DVA) which funded the study; the Alfred P. Mann Foundation (AMF) provided the technology that was tested.~There was an agreement between the Principal Investigators of the DVA and the AMF that the AMF would be provided a period of time to review any manuscript for publication and provide input. There was no restriction regarding PI’s rights to discuss or publish the results."
18529|NCT00864682|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18530|NCT00864539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18531|NCT00864513|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18532|NCT00864383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18533|NCT00864253|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Celgene with a copy of the papers prior to submission; Celgene shall complete its review within 60 days. Institution shall review comments from Celgene. Upon Celgene's request, proposed publication will be delayed up to 60 additional days to allow Celgene to secure adequate intellectual property protection of patentable material.
18534|NCT00864227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18535|NCT00864123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18536|NCT00864084|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18537|NCT00864032|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18538|NCT00863798|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18539|NCT00863746|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must discuss and obtain written consent of the sponsor on the intended publication. The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of the submission in order to obtain approval.
18577|NCT00861471|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18540|NCT00863707|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
18541|NCT00863655|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data in the clinical trial.
18542|NCT00863551|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
18543|NCT00863512|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18544|NCT00863434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18545|NCT00863356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18546|NCT00863343|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18547|NCT00863330|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18548|NCT00863317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18549|NCT00863109|Principal Investigators are NOT employed by the organization sponsoring the study.|The study data/results may not be published or disseminated without prior consent from the study sponsor. All publications arising from the study will cite all the participating researchers.
18550|NCT00863057|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
18551|NCT00862940|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and H. Lundbeck A/S. Manuscripts and abstracts must be sent to H. Lundbeck A/S at least one month prior to submission for publication or presentation.
18552|NCT00862849|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained as a result of this study or during the conduct of this study will be regarded as confidential. The investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless written permission from the sponsor (Halozyme) is obtained.
18553|NCT00862836|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
18554|NCT00862823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18555|NCT00862810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18556|NCT00862784|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
18557|NCT00862745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18558|NCT00862719|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18559|NCT00862654|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor to review and approval at least 2 months prior to the date of intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
18560|NCT00862641|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
18561|NCT00862563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18562|NCT00862537|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18563|NCT00862459|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of results will be a group publication. Sites with recruitment of >= 6 valid patients will contribute. There will be one author from each site having contributed >= 6 valid patients. Authorship listed according to recruitment. Sponsor will appoint up to 3 persons as co-authors. Main author of publication may be announced by site with most valid patients enrolled. In case more than 1 center reaches maximum patient No., main author will be from the center with fastest recruitment
18564|NCT00862277|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
18565|NCT00862251|Principal Investigators are NOT employed by the organization sponsoring the study.|An investigator and/or his/her colleagues may publish the results for their study site independently after the multicenter publication, or 24 months after completion of the study, whichever comes first. The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
18566|NCT00862186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18567|NCT00862134|Principal Investigators are NOT employed by the organization sponsoring the study.|Single site data may be published/presented prior to the publication of multi-center data from overall study if agreed to by the sponsor in writing, or 12 months have elapsed following termination or completion of the study, whichever comes first.
18568|NCT00862121|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
18569|NCT00862082|Principal Investigators are NOT employed by the organization sponsoring the study.|Single site data may be published/presented prior to the publication of multi-center data from overall study if agreed to by the sponsor in writing, or 12 months have elapsed following termination or completion of the study, whichever comes first.
18570|NCT00861913|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18571|NCT00861757|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18572|NCT00861744|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18573|NCT00861705|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18574|NCT00861692|Principal Investigators are NOT employed by the organization sponsoring the study.|
18575|NCT00861614|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18576|NCT00861601|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18578|NCT00861341|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18579|NCT00861263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18580|NCT00861198|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18581|NCT00861146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18582|NCT00860951|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18583|NCT00860847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18584|NCT00860795|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18585|NCT00860743|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18586|NCT00860535|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18587|NCT00860470|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18588|NCT00860457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18589|NCT00860405|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications are subject to a prior review of Fresenius Kabi and may only be made in a neutral and anonymous form within the respective circles of experts. Fresenius Kabi shall give its comments, if applicable, within 30 days after having received the respective manuscript. Manuscripts should be submitted for publication within 2 years following the final report.
18590|NCT00860314|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18591|NCT00860262|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18592|NCT00860249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18593|NCT00860171|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18594|NCT00860158|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18595|NCT00860067|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
18596|NCT00860028|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18597|NCT00859950|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18598|NCT00859937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18599|NCT00859898|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18600|NCT00859833|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18601|NCT00859651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18602|NCT00859638|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18603|NCT00859586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18604|NCT00859573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18605|NCT00859547|Principal Investigators are NOT employed by the organization sponsoring the study.|ZymoGenetics (ZG) agreements vary by trial, but each states that presentation/publication (p/p) cannot disclose Confidential Information (CI), excluding trial results; p/p may not begin until the earlier of 18 months after study end, ZG/lead investigator publishes, or ZG notification that multicenter publication is not planned; ZG has specified time for draft review before submission/presentation and may delay or modify content, require CI removal, and delay p/p for patent application filing.
18606|NCT00859521|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18607|NCT00859508|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18608|NCT00859469|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18609|NCT00859430|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18610|NCT00859339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18611|NCT00859313|Principal Investigators are NOT employed by the organization sponsoring the study.|no publication without prior written consent
18612|NCT00859222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18613|NCT00859131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18614|NCT00859053|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18615|NCT00859040|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18616|NCT00859027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18617|NCT00859014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18618|NCT00858962|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18619|NCT00858858|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18620|NCT00858845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18621|NCT00858832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18622|NCT00858780|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18623|NCT00858702|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18624|NCT00858689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18625|NCT00858637|Principal Investigators are NOT employed by the organization sponsoring the study.|
18626|NCT00858507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18627|NCT00858494|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18628|NCT00858468|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
18629|NCT00858442|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18630|NCT00858403|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18631|NCT00858390|Principal Investigators are NOT employed by the organization sponsoring the study.|"This work was supported by the Department of Health and Human Services Health Resources and Services Administration Award Number 1R38OT10585-01-00 and, in part, by Public Health Service Grant DK56338.~Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the PHS or HHS."
18632|NCT00858247|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18633|NCT00858208|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18634|NCT00858143|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
18635|NCT00858130|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18636|NCT00858013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18637|NCT00857961|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18638|NCT00857948|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
18639|NCT00857896|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18640|NCT00857857|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18641|NCT00857818|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
18642|NCT00857792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18643|NCT00857766|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18644|NCT00857714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18645|NCT00857649|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and H. Lundbeck A/S. Manuscripts and abstracts must be sent to H. Lundbeck A/S at least one month prior to submission for publication or presentation.
18646|NCT00857623|Principal Investigators are NOT employed by the organization sponsoring the study.|
18647|NCT00857584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18648|NCT00857545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18649|NCT00857532|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18650|NCT00857506|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18651|NCT00857454|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18652|NCT00857415|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18653|NCT00857311|Principal Investigators are NOT employed by the organization sponsoring the study.|"As this study is part of a multicenter trial, publications derived from this study should include input from the principal investigator, his/her colleagues, the other investigators in this trial, and SPONSOR personnel.~The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication guidelines."
18654|NCT00857285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18655|NCT00857272|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extend the embargo.
18656|NCT00857259|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety.
18657|NCT00857246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18658|NCT00857233|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub-publications. Order of authors has to be established. Publication of the results by the investigator will be subject to mutual agreement between the investigator and H. Lundbeck A/S. Manuscripts and abstracts must be sent to H. Lundbeck A/S at least one month prior to submission for publication or presentation.
18659|NCT00857220|Principal Investigators are NOT employed by the organization sponsoring the study.|
18660|NCT00856986|Principal Investigators are NOT employed by the organization sponsoring the study.|"Novo Nordisk reserves the right not to release data until specified milestones, e.g. a clinical trial report is available. This includes the right not to release interim results from clinical trials.~At the end of the trial, one or more manuscripts for publication will be prepared in collaboration between Investigator(s) and Novo Nordisk. Novo Nordisk will not suppress or veto publications. Novo Nordisk reserves the right to postpone publication for a short time to protect intellectual property."
18661|NCT00856973|Principal Investigators are NOT employed by the organization sponsoring the study.|
18662|NCT00856934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18663|NCT00856908|Principal Investigators are NOT employed by the organization sponsoring the study.|CONTRACT RESEARCH ORGANIZATION AGREEMENT by and between ASTRAZENECA AB and the CRO. CRO agrees that AstraZeneca shall have the exclusive right to publish the results of the Study, including all Work Product, and that such results may not be published or otherwise disseminated by CRO without the prior written approval of AstraZeneca.
18664|NCT00856843|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extend the embargo.
18665|NCT00856830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18666|NCT00856791|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigators agree to inform the Sponsor of any publication or presentations on the study. All manuscripts, abstracts or presentations (in outline form with copies of slides if available) will be submitted to the Sponsor at least 30 days prior to the submission of the data for publication in order for the Sponsor to protect proprietary information. The Sponsor will review the submitted material within a reasonable period of time and will not unreasonably withhold publication permission.
18667|NCT00856778|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18668|NCT00856739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18669|NCT00856726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18670|NCT00856661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18671|NCT00856635|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
18672|NCT00856609|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18673|NCT00856583|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the investigator will be subject to mutual agreement between the investigator and H. Lundbeck A/S.
18674|NCT00856557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18675|NCT00856544|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18676|NCT00856518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18677|NCT00856492|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18678|NCT00856414|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
18679|NCT00856388|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18680|NCT00856349|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Investigators and Participating Institutions will provide any publication of Study Data generated by PI and/or Participating Institution to Medtronic for review prior to submission to determine if confidential information (CI) is included and to check for technical correctness. Medtronic may not censor/interfere with the publication beyond the extent necessary to protect CI."
18681|NCT00856323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18701|NCT00855465|Principal Investigators are NOT employed by the organization sponsoring the study.|The embargo can be up to 6 months (equal to the 180 days), moreover if it is necessary the embargo period can be prolonged to expiry of priority year.
18682|NCT00856297|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18683|NCT00856284|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
18684|NCT00856245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18685|NCT00856232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18686|NCT00856206|Principal Investigators are NOT employed by the organization sponsoring the study.|PI/Institution will provide a copy of any publication to Sponsor prior to submission for review. Sponsor may request to remove confidential information from submission, provided that removal does not preclude the complete and accurate presentation and interpretation of the study results.
18687|NCT00856193|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18688|NCT00856180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18689|NCT00856050|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18690|NCT00856024|Principal Investigators are NOT employed by the organization sponsoring the study.|The text of the article that will be submitted to the journal shall be defined in common accord between the Investigators and the Sponsor. The principal investigators also agree to not publish and/or present interim results of the study without due written authorization of the Sponsor.
18691|NCT00855959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18692|NCT00855933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18693|NCT00855920|Principal Investigators are NOT employed by the organization sponsoring the study.|PI/Institution will provide a copy of any publication to Sponsor prior to submission for review. Sponsor may request to remove confidential information from submission, provided that removal does not preclude the complete and accurate presentation and interpretation of the study results.
18694|NCT00855894|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18695|NCT00855868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18696|NCT00855842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18697|NCT00855816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18698|NCT00855738|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18699|NCT00855595|Principal Investigators are NOT employed by the organization sponsoring the study.|A) Investigator shall provide Sponsor with intended publication 60 days upfront publication date, Sponsor has 30 d to comment, recommended changes shall not be unreasonably refused B) Sponsor has the right to ask Investigator to delay publication for a maximum of 90 days C) Investigative data will be pooled and published by Sponsor - no other publication without the consent of all parties prior to publication of the pooled data, or within 12 months after LPLV, whatever comes first
18700|NCT00855582|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18702|NCT00855439|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18703|NCT00855413|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18704|NCT00855335|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
18705|NCT00855309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18706|NCT00855218|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must discuss and obtain written consent of the sponsor on the intended publication. The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of the submission inorder to obtain approval.
18707|NCT00855166|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
18708|NCT00855062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18709|NCT00855010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18710|NCT00854906|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18711|NCT00854724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18712|NCT00854620|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18713|NCT00854607|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
18714|NCT00854594|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18715|NCT00854581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18716|NCT00854373|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18717|NCT00854360|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
18718|NCT00854308|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18719|NCT00854113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18720|NCT00854087|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18721|NCT00853996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18722|NCT00853970|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the PI will provide to the sponsor a copy of proposed publication information for review, comment and approval following completion of the study and at least sixty (60) days prior to submission of the publication. If sponsor requests in writing, the PI will withhold publication until written permission is given by Sponsor.
18723|NCT00853957|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
18724|NCT00853905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18725|NCT00853840|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
18726|NCT00853827|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
18727|NCT00853762|Principal Investigators are NOT employed by the organization sponsoring the study.|The study as a whole will be published prior to any individual investigator publications. It is required that copies of all papers, abstracts, articles, etc. that contain study data are to be forward to the Sponsor for review 30 days prior to submission for publication.
18728|NCT00853749|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18729|NCT00853723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18730|NCT00853658|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
18731|NCT00853606|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
18732|NCT00853593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18733|NCT00853580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18734|NCT00853567|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
18735|NCT00853489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18736|NCT00853385|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18737|NCT00853333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18738|NCT00853307|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
18758|NCT00852241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18739|NCT00853242|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
18740|NCT00853229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18741|NCT00853151|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18742|NCT00853112|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18743|NCT00853099|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
18744|NCT00853073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18745|NCT00853021|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18746|NCT00852995|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18747|NCT00852969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18748|NCT00852930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18749|NCT00852917|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 30 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm’s ability to patent any invention related to the study, the publication or disclosure will be modified or delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm’s confidential information
18750|NCT00852761|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18751|NCT00852644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18752|NCT00852631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18753|NCT00852592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18754|NCT00852540|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18755|NCT00852527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18756|NCT00852475|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18757|NCT00852397|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18796|NCT00850031|Principal Investigators are NOT employed by the organization sponsoring the study.|
18759|NCT00852137|Principal Investigators are NOT employed by the organization sponsoring the study.|Evaluator and Principal Investigator agree not to individually publish the result of the study, but rather, to participate in a joint publication of the Study results coordinated by sponsor, who shall have the first righ to publish. If such joint publication is not submitted for publication within 1 year of study completion at all sites Evaluator and Principal Investigator have the right to individually produce and submit a proposed publication, subject to the prior review of sponsor.
18760|NCT00852124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18761|NCT00851903|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 45 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
18762|NCT00851890|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
18763|NCT00851799|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
18764|NCT00851786|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
18765|NCT00851747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18766|NCT00851721|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study: PIs may require prior written approval, or be restricted from independently publishing results until the earlier of the primary multicenter publication or ≤36 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) prior to submission for publication, and shall review and if necessary amend the manuscript in ≤60 days
18767|NCT00851682|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18768|NCT00851643|Principal Investigators are NOT employed by the organization sponsoring the study.|As this study is part of a multicenter trial, the SPONSOR does not recommend separate publication of individual study site results due to scientific concerns. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
18769|NCT00851630|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18770|NCT00851591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18771|NCT00851552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18772|NCT00851409|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to its submission or disclosure. The sponsor may request to delete information identified by sponsor as confidential information prior to submitting such manuscript and/or abstract for publication. For a multi-center study, the investigator must wait (i) at least 24 months after the study is completed at all sites or (ii) until after the multi-center publication.
18773|NCT00851318|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication to seek patent protection.
18774|NCT00851279|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18861|NCT00846885|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
18775|NCT00851253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18776|NCT00851084|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission to a journal, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
18777|NCT00851006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18778|NCT00850993|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18779|NCT00850889|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
18780|NCT00850759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18781|NCT00850720|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18782|NCT00850642|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18783|NCT00850603|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
18784|NCT00850564|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18785|NCT00850538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18786|NCT00850499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18787|NCT00850460|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18788|NCT00850421|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18789|NCT00850395|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18790|NCT00850343|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication to seek patent protection.
18791|NCT00850200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18792|NCT00850174|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18793|NCT00850135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18794|NCT00850096|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither the complete nor any part of the results of the study carried out under this protocol, nor any of the information provided by the sponsor for the purposes of performing the study, will be published or passed on to any third party without the consent of the study sponsor.
18795|NCT00850070|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18797|NCT00849940|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18798|NCT00849901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18799|NCT00849875|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18800|NCT00849862|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18801|NCT00849810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18802|NCT00849797|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18803|NCT00849693|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18804|NCT00849680|Principal Investigators are NOT employed by the organization sponsoring the study.|"As this study is part of a multicenter trial, publications derived from this study should include input from the principal investigator, his/her colleagues, the other investigators in this trial, and SPONSOR personnel.~The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication guidelines."
18805|NCT00849524|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18806|NCT00849485|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18807|NCT00849472|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18808|NCT00849381|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18809|NCT00849290|Principal Investigators are NOT employed by the organization sponsoring the study.|A provision provides for sponsor review up to 45 days with the right to request modification based on disclosure of confidential information; extendable by 60 days to file a patent application.
18810|NCT00849251|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18811|NCT00849212|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18812|NCT00849186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18813|NCT00849147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18814|NCT00849121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18815|NCT00849108|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18816|NCT00849056|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18817|NCT00849017|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18818|NCT00848965|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18819|NCT00848926|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18820|NCT00848783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18821|NCT00848744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18822|NCT00848549|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18823|NCT00848536|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18824|NCT00848510|Principal Investigators are NOT employed by the organization sponsoring the study.|
18825|NCT00848497|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18826|NCT00848484|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18827|NCT00848367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18828|NCT00848354|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18829|NCT00848250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18830|NCT00848237|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18831|NCT00848211|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18832|NCT00848198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18833|NCT00848185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18834|NCT00848172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18835|NCT00848120|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18836|NCT00848107|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18837|NCT00848081|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18838|NCT00848042|Principal Investigators are NOT employed by the organization sponsoring the study.|
18839|NCT00848016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18840|NCT00847912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18841|NCT00847886|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor requires that written permission be given before the investigator can release any data publicly.
18842|NCT00847808|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
18843|NCT00847704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18844|NCT00847665|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18845|NCT00847626|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
18846|NCT00847613|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18847|NCT00847587|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18848|NCT00847561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18849|NCT00847535|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18850|NCT00847522|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18851|NCT00847509|Principal Investigators are NOT employed by the organization sponsoring the study.|The restriction on the PI is that the sponsor can review results communication prior to public release and can embargo communications regarding trial results.
18852|NCT00847405|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
18853|NCT00847301|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18854|NCT00847288|Principal Investigators are NOT employed by the organization sponsoring the study.|
18855|NCT00847210|Principal Investigators are NOT employed by the organization sponsoring the study.|Research Organization shall not publish any articles or papers nor make any presentations, nor assist any other person in publishing any articles or papers or in making any presentations relating or referring to the Study or any results, data or insights therefrom or any data, information or materials obtained or generated in the performance of it’s obligations without the prior written consent of Takeda, which consent may be granted or withheld in Takeda’s sole discretion.
18856|NCT00847197|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18857|NCT00847145|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18858|NCT00847132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18859|NCT00847015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18860|NCT00847002|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18862|NCT00846846|Principal Investigators are NOT employed by the organization sponsoring the study.|For any publication or presentation of the Protected Materials or any portion thereof, a maunscript of the paper, abstract or any materials will be provided by Consultant to Sponsor for its approval at least sixty (60days) for manuscripts and thirty (30) days for presentations prior to outside submission. Medtronic shall have the right to request reasonable modifications of any manuscript or other materials to be published or presented.
18863|NCT00846807|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18864|NCT00846768|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18865|NCT00846651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18866|NCT00846586|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
18867|NCT00846573|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18868|NCT00846547|Principal Investigators are NOT employed by the organization sponsoring the study.|Seaside Therapeutics agreements with investigators vary; constant is our right to restrict communications regarding trial results prior to public release for ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
18869|NCT00846521|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18870|NCT00846495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18871|NCT00846391|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18872|NCT00846365|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
18873|NCT00846287|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18874|NCT00846066|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18875|NCT00846027|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18876|NCT00845975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18877|NCT00845897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18878|NCT00845858|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18879|NCT00845845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18899|NCT00844753|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18880|NCT00845832|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
18881|NCT00845728|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
18882|NCT00845702|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18883|NCT00845676|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18884|NCT00845663|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
18885|NCT00845507|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18886|NCT00845481|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO retains the right to publish the results of this clinical trial
18887|NCT00845429|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
18888|NCT00845195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18889|NCT00845182|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18890|NCT00845130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18891|NCT00845065|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees not to present any interim results of study without prior written consent of sponsor. Investigator agrees to provide sponsor 45 days prior to submission publication, review copies of abstracts/manuscripts that report any results of the study. Sponsor shall have the right to review/comment on data analysis. If parties disagree investigator agrees to meet with sponsor's representatives at clinical study site for purpose of making good faith efforts to resolve any such issues.
18892|NCT00845000|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the trial.
18893|NCT00844896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18894|NCT00844883|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18895|NCT00844857|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18896|NCT00844844|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this multicenter study involved a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis.
18897|NCT00844831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18898|NCT00844805|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media. The sponsor shall have the right to review and comment with respect to data analysis and presentation with regard to protected proprietary information, data accuracy, and fair balance.
18900|NCT00844714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18901|NCT00844649|Principal Investigators are NOT employed by the organization sponsoring the study.|Authorship/contents of any publication is determined by site and provides sponsor a publication prior to submission. Sponsor has 60 days to review and avoid editorial changes but may request site delete confidential data. If publication contains patentable matter, site agrees to delay publication for 60 days. If study is part of multicenter protocol, site agrees not to independently publish. If multicenter publication is not forthcoming in 18 months after study end, site may proceed accordingly.
18902|NCT00844597|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI required written permission to publish any information relating to the trial and if given permission to acknowledge the sponsor's contribution and ownership of the materials.
18903|NCT00844558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18904|NCT00844545|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this multicenter study involved a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis.
18905|NCT00844532|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18906|NCT00844519|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18907|NCT00844480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18908|NCT00844428|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this multicenter study involved a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis.
18909|NCT00844415|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18910|NCT00844376|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18911|NCT00844298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18912|NCT00844194|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
18913|NCT00844090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18914|NCT00844051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18915|NCT00843986|All Principal Investigators ARE employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
18916|NCT00843843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18917|NCT00843830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18918|NCT00843778|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18919|NCT00843713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18920|NCT00843635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18921|NCT00843622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18922|NCT00843518|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18923|NCT00843492|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18924|NCT00843479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18925|NCT00843466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18926|NCT00843349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18927|NCT00843310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18928|NCT00843284|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
18929|NCT00843193|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18930|NCT00843180|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18931|NCT00843167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18932|NCT00843115|Principal Investigators are NOT employed by the organization sponsoring the study.|
18933|NCT00843050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18934|NCT00843024|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18935|NCT00842985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18936|NCT00842946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18937|NCT00842829|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
18938|NCT00842751|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18939|NCT00842712|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18940|NCT00842608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18941|NCT00842543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18965|NCT00841204|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18942|NCT00842361|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
18943|NCT00842348|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor required reasonable opportunity to review any abstract, presentation, or paper before the material is submitted for publication or communicated. This also applied to any amendments that are requested by referees or journal editors. The Sponsor committed to comment on the draft documents within a time period agreed in the contractual arrangements between the Sponsor and authors or their institution. Delays were also possible if publication would adversely affect patentability.
18944|NCT00842335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18945|NCT00842296|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18946|NCT00842257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18947|NCT00842244|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
18948|NCT00842231|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor confidential information will be submitted for publication without Sponsor's prior written agreement.
18949|NCT00842153|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18950|NCT00842075|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18951|NCT00842023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18952|NCT00841971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18953|NCT00841906|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18954|NCT00841815|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18955|NCT00841776|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18956|NCT00841763|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18957|NCT00841698|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18958|NCT00841672|Principal Investigators are NOT employed by the organization sponsoring the study.|
18959|NCT00841659|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18960|NCT00841555|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18961|NCT00841542|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18962|NCT00841412|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18963|NCT00841321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18964|NCT00841269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18966|NCT00841087|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
18967|NCT00841035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18968|NCT00840996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18969|NCT00840879|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18970|NCT00840866|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
18971|NCT00840840|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
18972|NCT00840658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18973|NCT00840632|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18974|NCT00840476|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18975|NCT00840450|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18976|NCT00840411|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18977|NCT00840307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18978|NCT00840294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18979|NCT00840281|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
18980|NCT00840216|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18981|NCT00840203|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18982|NCT00840099|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
18983|NCT00840086|Principal Investigators are NOT employed by the organization sponsoring the study.|The information obtained during the conduct of this trial is considered confidential and can be used by Novo Nordisk for regulatory purposes and for the general development of the trial product. The information obtained during this trial may be made available to other physicians who are conducting other clinical trials with the trial product, if deemed necessary by Novo Nordisk.
18984|NCT00840073|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18985|NCT00840060|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18986|NCT00840034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18987|NCT00839982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18988|NCT00839956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18989|NCT00839930|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
18990|NCT00839917|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
18991|NCT00839800|Principal Investigators are NOT employed by the organization sponsoring the study.|
18992|NCT00839540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19114|NCT00834639|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
18993|NCT00839527|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
18994|NCT00839436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18995|NCT00839423|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub publication. The investigators shall obtain Lundbeck's written approval before publishing any publication relating to Vortioxetine, the Study, the Protocol and/or the results recorded during the Study.
18996|NCT00839332|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
18997|NCT00839319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18998|NCT00839306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
18999|NCT00839241|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19000|NCT00839098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19001|NCT00839072|Principal Investigators are NOT employed by the organization sponsoring the study.|Approval from the sponsor will be required prior to publication of the results of this study and a draft manuscript will be submitted to the sponsor for scrutiny and comment. The choice of scientific journal will be mutually agreed on by the investigator and the sponsor.
19002|NCT00838981|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19003|NCT00838929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19004|NCT00838916|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19005|NCT00838903|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19006|NCT00838682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19007|NCT00838630|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19008|NCT00838578|Principal Investigators are NOT employed by the organization sponsoring the study.|
19009|NCT00838539|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19010|NCT00838526|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19011|NCT00838513|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this multicenter study involved a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis.
19012|NCT00838331|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19013|NCT00838279|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19014|NCT00838201|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
19143|NCT00833937|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19015|NCT00838162|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19016|NCT00838136|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19017|NCT00838110|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19018|NCT00838097|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
19019|NCT00837967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19020|NCT00837876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19021|NCT00837824|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
19022|NCT00837811|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19023|NCT00837759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19024|NCT00837616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19025|NCT00837577|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor must have the opportunity to review all communications regarding trial results for 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
19026|NCT00837512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19027|NCT00837486|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restrictions on the PI allow for the sponsor to review results communications prior to public release and to embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to sponsor for review. The sponsor is also allowed to require changes for technical correctness and to protect confidential information, copyrightable or patentable material; and when reasonably requested, extend the embargo up to an additional 90 days.
19028|NCT00837473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19029|NCT00837447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19030|NCT00837434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19031|NCT00837330|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19032|NCT00837252|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19033|NCT00837213|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19034|NCT00837200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19035|NCT00837161|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19036|NCT00837148|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19037|NCT00837031|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
19038|NCT00836953|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
19039|NCT00836927|Principal Investigators are NOT employed by the organization sponsoring the study.|All unpublished information that the Sponsor gives to the Investigator shall be kept confidential and shall not be published or disclosed to a third party without the prior written consent of the Sponsor.
19040|NCT00836901|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19041|NCT00836875|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19042|NCT00836810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19043|NCT00836745|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19044|NCT00836719|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19045|NCT00836706|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19046|NCT00836693|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19047|NCT00836641|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19048|NCT00836498|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19049|NCT00836472|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19050|NCT00836433|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19051|NCT00836407|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19052|NCT00836355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19053|NCT00836342|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19054|NCT00836277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19055|NCT00836095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19056|NCT00836056|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19057|NCT00836017|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
19058|NCT00836004|Principal Investigators are NOT employed by the organization sponsoring the study.|Prinicipal Investigator is not permitted to discuss or publish trial results.
19059|NCT00835991|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19060|NCT00835978|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19061|NCT00835926|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
19062|NCT00835900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19063|NCT00835861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19064|NCT00835796|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19065|NCT00835731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19066|NCT00835705|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19067|NCT00835692|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19068|NCT00835679|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19069|NCT00835666|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19070|NCT00835640|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19071|NCT00835614|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19072|NCT00835588|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19073|NCT00835575|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19074|NCT00835549|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19075|NCT00835536|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19076|NCT00835510|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19077|NCT00835497|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19078|NCT00835484|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19079|NCT00835406|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19080|NCT00835380|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19081|NCT00835367|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
19082|NCT00835354|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19083|NCT00835341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19084|NCT00835276|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19085|NCT00835263|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19086|NCT00835237|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19087|NCT00835224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19088|NCT00835211|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19089|NCT00835198|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19090|NCT00835185|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
19091|NCT00835172|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19092|NCT00835159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19093|NCT00835146|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19094|NCT00835120|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19095|NCT00835081|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19096|NCT00835068|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19097|NCT00835042|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19098|NCT00835003|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19099|NCT00834990|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19100|NCT00834977|Principal Investigators are NOT employed by the organization sponsoring the study.|PI is not permitted to discuss or publish trial results.
19101|NCT00834964|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19102|NCT00834912|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the study results may only be allowed with written permission from the sponsor.
19103|NCT00834899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19104|NCT00834886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19105|NCT00834873|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19106|NCT00834834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19107|NCT00834808|Principal Investigators are NOT employed by the organization sponsoring the study.|The publication of the results obtained will be authorized, after prior agreement between the various recipients [investigator and sponsor].
19108|NCT00834795|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19109|NCT00834756|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19110|NCT00834743|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19111|NCT00834717|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19112|NCT00834678|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19113|NCT00834652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19115|NCT00834626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19116|NCT00834613|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19117|NCT00834587|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19118|NCT00834574|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19119|NCT00834561|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19120|NCT00834535|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19121|NCT00834522|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19122|NCT00834483|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19123|NCT00834444|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19124|NCT00834431|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19125|NCT00834418|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19126|NCT00834405|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19127|NCT00834366|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication based on the results of this study is envisaged, approval from the sponsor will be obtained and a draft manuscript will be submitted to the sponsor for scrutiny and comment.
19128|NCT00834340|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19129|NCT00834288|Principal Investigators are NOT employed by the organization sponsoring the study.|If a publication based on the results of this study is envisaged, approval from the sponsor will be obtained and a draft manuscript will be submitted to the sponsor for scrutiny and comment.
19130|NCT00834275|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19131|NCT00834249|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19132|NCT00834236|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19133|NCT00834210|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19134|NCT00834197|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19135|NCT00834171|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19136|NCT00834132|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19137|NCT00834106|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
19138|NCT00834080|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of such disclosure must be given to Alkermes for review at least sixty (60) days prior to submission for publication, presentation or delivery to any other party. Revisions to such disclosure will be negotiated in good faith by the Institution, Principal Investigator and Alkermes. Expedited reviews for abstracts or poster presentations may be arranged if mutually agreeable to Alkermes and the Institution.
19139|NCT00834067|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19140|NCT00834041|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
19141|NCT00833989|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19142|NCT00833976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19144|NCT00833924|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19145|NCT00833911|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 30 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm’s ability to patent any invention related to the study, the publication or disclosure will be modified or delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm’s confidential information.
19146|NCT00833898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19147|NCT00833859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19148|NCT00833833|Principal Investigators are NOT employed by the organization sponsoring the study.|"Multicenter publication must include input from investigators and Celgene, and has priority over subset (single center) publication, for 1 year after study completion.~Investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. Celgene has 45 days to review and comment on draft manuscript/presentation, and may ask for an additional delay (not to exceed 90 days total) to address intellectual property issues."
19149|NCT00833794|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 30 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm’s ability to patent any invention related to the study, the publication or disclosure will be modified or delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm’s confidential information.
19150|NCT00833781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19151|NCT00833755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19152|NCT00833703|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months after trial completion, the Investigator can publish the results. Prior to publication, the sponsor shall review the manuscript and can request changes, provided they do not jeopardize the accuracy and/or the scientific value of the publication. The approval is given in writing by the sponsor, not exceeding 90 days.
19153|NCT00833690|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19154|NCT00833664|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19155|NCT00833638|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19156|NCT00833586|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19157|NCT00833560|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19158|NCT00833547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19159|NCT00833521|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19160|NCT00833482|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
19161|NCT00833469|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19162|NCT00833443|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19202|NCT00831480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19163|NCT00833417|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19164|NCT00833365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19165|NCT00833248|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
19166|NCT00833092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19167|NCT00833053|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19168|NCT00833040|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication without prior written consent
19169|NCT00833027|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19170|NCT00832975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19171|NCT00832871|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19172|NCT00832819|Principal Investigators are NOT employed by the organization sponsoring the study.|
19173|NCT00832780|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19174|NCT00832767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19175|NCT00832650|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19176|NCT00832637|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19177|NCT00832624|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19178|NCT00832598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19179|NCT00832585|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19180|NCT00832572|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
19181|NCT00832520|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19182|NCT00832455|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19221|NCT00830375|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19183|NCT00832416|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 30 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm’s ability to patent any invention related to the study, the publication or disclosure will be modified or delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm’s confidential information.
19184|NCT00832390|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19185|NCT00832377|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19186|NCT00832338|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19187|NCT00832299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19188|NCT00832260|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19189|NCT00832130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19190|NCT00832117|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
19191|NCT00832091|Principal Investigators are NOT employed by the organization sponsoring the study.|RegeneRx/Sigma-Tau agreements may vary with individual investigators, but will not prohibit any investigator from publishing. RegeneRx/Sigma-Tau support the publication of results from all centers of a multi-center trial but requests that reports based on a single-site data not precede the primary publication of the entire clinical trial.
19192|NCT00832078|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19193|NCT00832000|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19194|NCT00831987|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
19195|NCT00831844|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19196|NCT00831779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19197|NCT00831766|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19198|NCT00831753|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
19199|NCT00831701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19200|NCT00831675|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
19201|NCT00831493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19203|NCT00831441|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
19204|NCT00831428|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19205|NCT00831415|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19206|NCT00831389|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19207|NCT00831311|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
19208|NCT00831272|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19209|NCT00831233|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
19210|NCT00831181|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19211|NCT00831129|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19212|NCT00830960|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19213|NCT00830947|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19214|NCT00830804|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
19215|NCT00830791|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19216|NCT00830765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19217|NCT00830596|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19218|NCT00830518|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
19219|NCT00830440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19220|NCT00830388|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19249|NCT00829504|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19222|NCT00830362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19223|NCT00830336|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19224|NCT00830310|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19225|NCT00830284|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19226|NCT00830258|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19227|NCT00830232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19228|NCT00830219|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19229|NCT00830206|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19230|NCT00830167|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19231|NCT00830128|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19232|NCT00830115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19233|NCT00830076|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
19234|NCT00830037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19235|NCT00830024|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19236|NCT00829998|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19237|NCT00829985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19238|NCT00829933|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall not publish the results of the Study at any time without the prior written approval of Sponsor.
19239|NCT00829868|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19240|NCT00829829|Principal Investigators are NOT employed by the organization sponsoring the study.|PI/Institution will provide a copy of any publication to Sponsor prior to submission for review. Sponsor may request to remove confidential information from submission, provided that removal does not preclude the complete and accurate presentation and interpretation of the study results.
19241|NCT00829790|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19242|NCT00829764|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19243|NCT00829738|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19244|NCT00829712|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19245|NCT00829686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19246|NCT00829673|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19247|NCT00829621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19248|NCT00829530|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19251|NCT00829439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19252|NCT00829426|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19253|NCT00829387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19254|NCT00829309|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator is not permitted to discuss or publish trial results.
19255|NCT00829296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19256|NCT00829283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19257|NCT00829244|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall submit any results communication to the sponsor for review and comment at least 30 business days prior to submission. The sponsor shall have the right to request the PI to delete or modify any of sponsor’s proprietary information contained therein. If the PI does not agree to the deletion or appropriate modification of such information, it shall postpone submission for publication or presentation for 60 days from the date the PI notifies the sponsor.
19258|NCT00829179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19259|NCT00829166|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19260|NCT00829049|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19261|NCT00829036|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19262|NCT00829010|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19263|NCT00828984|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19264|NCT00828945|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19265|NCT00828841|Principal Investigators are NOT employed by the organization sponsoring the study.|The study funder will be provided with a copy of any results communication at least 30 days prior to its submission to a scientific journal or presentation at a scientific meeting to allow review of the publication for confidential information. If confidential information is being disclosed, it may be required to be redacted. Upon request by the study funder, the PI may be asked to withhold disclosure for an additional 90 days to allow the study funder to seek patent protection.
19266|NCT00828750|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19267|NCT00828711|Principal Investigators are NOT employed by the organization sponsoring the study.|Any abstract,presentation or manuscript proposed for publication must be submitted to the Sponsor for review at least 30 days prior to submission for any meeting or journal.If deemed necessary by the Sponsor for protection of proprietary information prior to patent filing,the Investigator agrees to a further delay of 60 days before any presentation or publication is submitted.Publications must be in a form that does not reveal technical information that is considered confidential or proprietary.
19268|NCT00828568|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19269|NCT00828542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19270|NCT00828516|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19271|NCT00828464|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19272|NCT00828451|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19273|NCT00828412|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19274|NCT00828347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19275|NCT00828321|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator is not permitted to discuss or publish trial results.
19276|NCT00828308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19277|NCT00828295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19278|NCT00828204|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
19279|NCT00828191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19280|NCT00828178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19281|NCT00828139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19282|NCT00828113|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19283|NCT00828074|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19284|NCT00828061|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19285|NCT00827983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19286|NCT00827944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19287|NCT00827931|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19288|NCT00827918|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
19289|NCT00827827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19290|NCT00827632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19291|NCT00827606|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19292|NCT00827567|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19293|NCT00827541|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19294|NCT00827502|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19295|NCT00827372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19296|NCT00827255|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19297|NCT00827242|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19298|NCT00827112|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19299|NCT00827099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19300|NCT00827073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19301|NCT00826943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19302|NCT00826800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19303|NCT00826748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19304|NCT00826618|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19305|NCT00826540|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19306|NCT00826449|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19307|NCT00826280|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
19308|NCT00826267|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19309|NCT00826228|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19310|NCT00826202|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19332|NCT00824993|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19311|NCT00826176|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may not publish/publicly present interim results without prior consent of Sponsor. Any materials that report results of the study must be sent to Sponsor 45 days prior to submission for publication/presentation. Sponsor has right to review and comment. In case of any disagreements concerning appropriateness of the materials, investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues or disagreement, prior to submission for publication/presentation.
19312|NCT00826111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19313|NCT00826007|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19314|NCT00825994|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19315|NCT00825916|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19316|NCT00825825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19317|NCT00825812|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI must not publish/publicly present any interim results without prior written consent of sponsor. The PI must provide copies of material for sponsor to review, 45 days prior to submission for publication/presentation. The sponsor may review/comment. If the parties disagree on the appropriateness of the data analysis and presentation, the PI must agree to meet prior to submission for publication/presentation to make good faith efforts to discuss and resolve any issues or disagreement.
19318|NCT00825786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19319|NCT00825734|Principal Investigators are NOT employed by the organization sponsoring the study.|
19320|NCT00825682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19321|NCT00825630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19322|NCT00825565|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19323|NCT00825500|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19324|NCT00825370|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19325|NCT00825344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19326|NCT00825318|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19327|NCT00825305|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19328|NCT00825266|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19329|NCT00825227|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19330|NCT00825175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19331|NCT00825162|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19333|NCT00824850|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19334|NCT00824824|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19335|NCT00824772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19336|NCT00824746|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19337|NCT00824733|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19338|NCT00824720|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication or presentation, the PI will provide the Sponsor 60 days for review of the manuscript. The Sponsor may request that the PI withhold the publication for an additional 60 days.
19339|NCT00824655|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19340|NCT00824616|Principal Investigators are NOT employed by the organization sponsoring the study.|After multicenter publication or 24 months after study completion, whichever comes first, an investigator may publish the results for their study site only. Sponsor can review publications 60 days prior to submission.
19341|NCT00824564|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19342|NCT00824538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19343|NCT00824512|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19344|NCT00824473|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, joint publication is required to assure that the initial publication is based on all data from all sites and investigators participating in these studies agree not to present data gathered individually or by subgroup centers before the initial publication unless jointly agreed by all other investigators and the sponsor. authorship will be determined by mutual agreement.
19345|NCT00824460|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may not present or publish partial or complete study results individually. Any manuscript or abstract proposed by the Investigators must be reviewed and approved in writing by Vifor Pharma before submission for publication. Names of all Investigators participating in the study will be included in the publication.
19346|NCT00824434|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least 40 days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
19347|NCT00824421|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19348|NCT00824408|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
19349|NCT00824382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19350|NCT00824369|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19351|NCT00824291|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
19352|NCT00824265|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
19353|NCT00824161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19354|NCT00824070|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s)after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
19355|NCT00824044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19356|NCT00824005|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19357|NCT00823979|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19358|NCT00823966|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19359|NCT00823901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19360|NCT00823836|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19361|NCT00823823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19362|NCT00823797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19363|NCT00823719|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19364|NCT00823615|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any pre-clinical and/or clinical data or impressions from this trial.
19365|NCT00823472|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19366|NCT00823303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19367|NCT00823264|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19368|NCT00823212|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least 45 days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
19369|NCT00823199|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19370|NCT00823095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19454|NCT00818168|Principal Investigators are NOT employed by the organization sponsoring the study.|Trial results belong to the SPONSOR only, all investigators are not allowed to publish trial results without permission of the SPONSOR.
19371|NCT00823082|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the Study, after providing Sponsor thirty days’ notice prior to submitting a manuscript or other materials related to the Study to any outside party. At Sponsor’s request, Site will remove any Confidential Information (other than Study results), and Site will upon Sponsor’s request, delay publication or presentation for a period of up to one hundred twenty days to allow Sponsor to protect its interests in any Sponsor’s Inventions.
19372|NCT00823069|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19373|NCT00823043|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication or presentation, the PI will provide the Sponsor with at least 60 days for review of a manuscript. If requested in writing, the PI will withhold publication for up to an additional 60 days.
19374|NCT00822926|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19375|NCT00822900|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19376|NCT00822770|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19377|NCT00822757|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19378|NCT00822692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19379|NCT00822679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19380|NCT00822588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19381|NCT00822523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19382|NCT00822510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19383|NCT00822354|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19384|NCT00822328|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19385|NCT00822237|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
19386|NCT00822185|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to defer data release until specified milestones, e.g. availability of a clinical trial report. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property. Novo Nordisk reserves the right to prior review of site-specific publications and to ask for deferment of publication of individual site results until after the primary manuscript is accepted for publication.
19387|NCT00822172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19388|NCT00822120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19389|NCT00822094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19390|NCT00821964|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19391|NCT00821951|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19455|NCT00818116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19392|NCT00821886|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
19393|NCT00821873|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19394|NCT00821821|Principal Investigators are NOT employed by the organization sponsoring the study.|
19395|NCT00821678|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19396|NCT00821587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19397|NCT00821509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19398|NCT00821431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19399|NCT00821327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19400|NCT00821236|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19401|NCT00821184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19402|NCT00821119|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19403|NCT00821093|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
19404|NCT00821041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19405|NCT00820898|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19406|NCT00820872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19407|NCT00820755|Principal Investigators are NOT employed by the organization sponsoring the study.|
19408|NCT00820664|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19409|NCT00820612|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19410|NCT00820573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19411|NCT00820534|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19412|NCT00820443|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19413|NCT00820248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19414|NCT00820222|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
19415|NCT00819910|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19416|NCT00819832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19417|NCT00819780|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
19418|NCT00819767|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
19419|NCT00819741|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones, e.g. when the clinical trial report is available. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
19420|NCT00819637|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19421|NCT00819585|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19422|NCT00819507|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19423|NCT00819403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19424|NCT00819390|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19425|NCT00819286|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator may publish his/her own results from the study provided such publication does not include or disclose any confidential information. Principal investigator may also participate in joint publications. All proposed publications shall be submitted to Biomet for review. Biomet will have 30 days to review the proposed publication.
19426|NCT00819260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19427|NCT00819247|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
19428|NCT00819234|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
19429|NCT00819182|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19430|NCT00819156|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
19431|NCT00819091|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19432|NCT00819052|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19433|NCT00819039|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
19434|NCT00819013|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
19435|NCT00818961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19436|NCT00818883|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
19437|NCT00818805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19438|NCT00818779|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19439|NCT00818766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19440|NCT00818753|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19441|NCT00818662|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication (by USCD) or 12 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥45 days prior to submission or communication. Baxter may request an additional delay of ≤45 days(e.g., for intellectual property protection)
19442|NCT00818649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19443|NCT00818623|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
19444|NCT00818519|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19445|NCT00818454|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19446|NCT00818441|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19447|NCT00818389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19448|NCT00818337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19449|NCT00818324|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19450|NCT00818272|Principal Investigators are NOT employed by the organization sponsoring the study.|Trial results belong to the SPONSOR only, all investigators are not allowed to publish trial results without permission of the SPONSOR.
19451|NCT00818259|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
19452|NCT00818246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19453|NCT00818207|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19456|NCT00817999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19457|NCT00817843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19458|NCT00817804|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19459|NCT00817778|Principal Investigators are NOT employed by the organization sponsoring the study.|CONTRACT RESEARCH ORGANIZATION AGREEMENT by and between ASTRAZENECA AB and the CRO. CRO agrees that AstraZeneca shall have the exclusive right to publish the results of the Study, including all Work Product, and that such results may not be published or otherwise disseminated by CRO without the prior written approval of AstraZeneca.
19460|NCT00817596|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19461|NCT00817531|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19462|NCT00817479|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19463|NCT00817336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19464|NCT00817219|Principal Investigators are NOT employed by the organization sponsoring the study.|LEO acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. LEO retains the right to have any publication submitted to LEO for review at least 30 days prior to the same paper being submitted for publication or presentation. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
19465|NCT00817206|Principal Investigators are NOT employed by the organization sponsoring the study.|
19466|NCT00817063|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19467|NCT00816907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19468|NCT00816829|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review.
19469|NCT00816777|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19470|NCT00816595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19471|NCT00816556|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19472|NCT00816400|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
19473|NCT00816348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19474|NCT00816166|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19475|NCT00816101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19476|NCT00816062|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor can require deletion of confidential information.The sponsor cannot require changes beyond those necessary to protect confidential information. The sponsor cannot extend the embargo.
19477|NCT00816036|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19478|NCT00816023|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If the First Publication is not published within 1 year of Study conclusion or termination, Investigator shall have the right to publish and disclose the Data. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
19479|NCT00815919|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19480|NCT00815776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19481|NCT00815698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19482|NCT00815685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19483|NCT00815659|Principal Investigators are NOT employed by the organization sponsoring the study.|
19484|NCT00815633|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19485|NCT00815516|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or 18 months after data-lock, whichever is first. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication for up to 60 days to seek patent protection.
19486|NCT00815490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19487|NCT00815360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19488|NCT00815347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19489|NCT00815308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19490|NCT00815295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19491|NCT00815191|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19492|NCT00815087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19493|NCT00815035|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19494|NCT00814983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19495|NCT00814970|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19496|NCT00814892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19497|NCT00814879|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19498|NCT00814801|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
19499|NCT00814788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19500|NCT00814775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19501|NCT00814710|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19502|NCT00814697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19503|NCT00814671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19504|NCT00814658|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication and can extend the embargo.
19505|NCT00814632|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19506|NCT00814580|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19507|NCT00814502|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19508|NCT00814489|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19509|NCT00814463|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19510|NCT00814346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19511|NCT00814333|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19512|NCT00814320|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 12 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥30 days prior to submission or communication. Baxter may request an additional delay of ≤60 days eg, for intellectual property protection
19513|NCT00814307|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19514|NCT00814255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19515|NCT00814177|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19516|NCT00814164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19517|NCT00814138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19518|NCT00813995|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the multicenter publication or 24 months after study completion, whichever comes first, an investigator may publish the results for their study site independently. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
19519|NCT00813982|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any pre-clinical and/or clinical data or impressions from this trial.
19520|NCT00813943|Principal Investigators are NOT employed by the organization sponsoring the study.|All manuscripts and materials relating to Study shall be submitted to Sponsor at least 60 days prior to submitting/presenting and allow Sponsor 60 days for review. If Sponsor requests, any confidential information shall be removed. In multi-center study, any publication shall not be made before the first multi-center publication; provided, however, that if no multi-center publication is made within 1 year from database lock, then Site may publish individually in accordance with this provision.
19521|NCT00813917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19522|NCT00813904|Principal Investigators are NOT employed by the organization sponsoring the study.|ZymoGenetics (ZG) agreements vary by trial, but each states that presentation/publication (p/p) cannot disclose Confidential Information (CI), excluding trial results; p/p may not begin until the earlier of 18 months after study end, ZG/lead investigator publishes, or ZG notification that multicenter publication is not planned; ZG has specified time for draft review before submission/presentation and may delay or modify content, require CI removal, and delay p/p for patent application filing.
19523|NCT00813813|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Investigators may freely present or publish results of the Clinical Investigation in a manner which fairly sets forth the conclusions reached by the Clinical Investigators, but only after the Sponsor has been given the opportunity of reviewing the proposed presentation or publication at least 60 days prior to the intended submission, presentation, or publication date.
19524|NCT00813800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19525|NCT00813761|Principal Investigators are NOT employed by the organization sponsoring the study.|Written consent of the sponsor is required for publication.
19526|NCT00813748|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
19527|NCT00813709|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to publish any results communication in connection with the study. The PI shall submit any communications including study results to the sponsor for review 30 working days prior to communication submission. The sponsor can request the PI to modify or delete any sponsor's proprietary information. If the PI refuses the modification, the submission shall be postponed for 60 days from PI refusal, to provide the sponsor the opportunity to file a patent or seek legal remedies.
19528|NCT00813592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19529|NCT00813488|Principal Investigators are NOT employed by the organization sponsoring the study.|All unpublished information given to an investigator by Cephalon shall not be published or disclosed to a third party without the prior written consent of Cephalon.
19530|NCT00813319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19531|NCT00813150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19532|NCT00813111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19533|NCT00813098|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor requires that written permission be given before the PI can release any data publicly.
19534|NCT00812981|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19535|NCT00812968|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; the Investigators shall not disclose any material/information disclosed by the Sponsor (Celgene KK) with the clinical trial or information obtained by conducting the clinical trial to third parties without Sponsor’s prior written approval.
19536|NCT00812955|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
19537|NCT00812929|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19538|NCT00812916|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI's rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
19539|NCT00812877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19540|NCT00812812|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19541|NCT00812604|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19542|NCT00812565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19543|NCT00812487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19544|NCT00812461|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub publication. The investigators shall obtain Lundbeck's written approval before publishing any publication relating to nalmefene, the Study, the Protocol and/or the results recorded during the Study.
19545|NCT00812331|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19546|NCT00812253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19547|NCT00812110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19548|NCT00812097|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator and his/her collaborators are free to publish the background, methods, and results of their own research without restraint. Prior review of any proposed manuscript or abstract will be provided to the sponsor to prevent premature disclosure of trade secrets or proprietary information. The review will occur 30 days prior to submission of manuscript or abstract for consideration of publication or to a conference. Sponsor reserves right to publish or present the overall study results.
19549|NCT00812006|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19550|NCT00811954|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
19551|NCT00811941|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub publication. The investigators shall obtain Lundbeck's written approval before publishing any publication relating to nalmefene, the Study, the Protocol and/or the results recorded during the Study.
19552|NCT00811928|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Principal Investigator agrees not to publish or publicly present any interim results of the Protocol study without the prior written consent of the SPONSOR. The Principal Investigator further agrees to provide to the~SPONSOR thirty (30) days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the Protocol study."
19553|NCT00811850|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19554|NCT00811798|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19555|NCT00811733|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19556|NCT00811720|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub publication. The investigators shall obtain Lundbeck's written approval before publishing any publication relating to nalmefene, the Study, the Protocol and/or the results recorded during the Study.
19557|NCT00811655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19558|NCT00811642|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) agrees not to publish or publicly present any interim results of the Protocol study without the prior written consent of the Sponsor. PI further agrees to provide to the Sponsor thirty (30) days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the Protocol study. The sponsor shall have editorial rights with respect to publications, abstracts, slides, and manuscripts.
19559|NCT00811590|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19560|NCT00811577|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19561|NCT00811564|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19562|NCT00811473|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19563|NCT00811434|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19564|NCT00811395|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the Investigator can publish the results. Prior to publication, the sponsor shall review the manuscript and can request changes, provided they do not jeopardize the accuracy and/or the scientific value of the publication. The approval is given in writing by the sponsor, not exceeding 90 days.~To protect by property right the sponsor can postpone the publication of any information, for a period not exceeding 18 months."
19565|NCT00811382|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19566|NCT00811317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19567|NCT00811252|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub-publications. H. Lundbeck A/S follows the Vancouver declaration with respect to authorship.
19568|NCT00811174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19569|NCT00811135|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19570|NCT00811070|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19571|NCT00811057|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19572|NCT00811018|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19573|NCT00810901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19574|NCT00810888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19575|NCT00810810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19576|NCT00810771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19577|NCT00810719|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19578|NCT00810693|Principal Investigators are NOT employed by the organization sponsoring the study.|The embargo can be up to 6 months (equal to the 180 days), moreover if it is necessary the embargo period can be prolonged to expiry of priority year.
19579|NCT00810641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19580|NCT00810602|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19581|NCT00810576|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19582|NCT00810511|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
19583|NCT00810394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19584|NCT00810368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19585|NCT00810355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19586|NCT00810342|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19587|NCT00810303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19588|NCT00810277|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19589|NCT00810199|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19590|NCT00810108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19591|NCT00810095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19592|NCT00810082|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19593|NCT00810069|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19594|NCT00810043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19595|NCT00809965|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
19596|NCT00809926|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19597|NCT00809848|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
19598|NCT00809835|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19599|NCT00809809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19600|NCT00809757|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish
19601|NCT00809614|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
19602|NCT00809523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19603|NCT00809471|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
19604|NCT00809458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19605|NCT00809445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19606|NCT00809328|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19607|NCT00809276|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19608|NCT00809185|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19609|NCT00809159|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
19610|NCT00809146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19611|NCT00809133|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
19612|NCT00809094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19613|NCT00809055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19614|NCT00808899|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19615|NCT00808834|Principal Investigators are NOT employed by the organization sponsoring the study.|For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
19616|NCT00808808|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.The principal investigators (PIs) also agree for data to be presented first as a joint, multi-center publication.
19617|NCT00808769|Principal Investigators are NOT employed by the organization sponsoring the study.|
19618|NCT00808665|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19619|NCT00808639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19620|NCT00808509|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
19621|NCT00808483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19622|NCT00808470|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19623|NCT00808444|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19624|NCT00808405|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19625|NCT00808340|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
19626|NCT00808249|Principal Investigators are NOT employed by the organization sponsoring the study.|
19627|NCT00808236|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19628|NCT00808132|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19629|NCT00808080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19630|NCT00808067|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19631|NCT00808028|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19632|NCT00808015|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19633|NCT00807989|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19634|NCT00807937|Principal Investigators are NOT employed by the organization sponsoring the study.|
19635|NCT00807885|Principal Investigators are NOT employed by the organization sponsoring the study.|For this study, Baxter requires a review of any planned PI results communications (eg, for confidential information) up to 90 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (eg, to allow for intellectual property protection).
19636|NCT00807846|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19637|NCT00807768|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19638|NCT00807664|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19639|NCT00807573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19640|NCT00807560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19641|NCT00807495|Principal Investigators are NOT employed by the organization sponsoring the study.|In general, Investigators may publish clinical data after the earlier of (i) publication by the Sponsor or (ii) 12 months following the abandonment, early termination or database lock; provided a copy of the publication provided to Sponsor at least 30 days ahead of publication, the Sponsor’s confidential information is removed as may be requested by Sponsor and Investigator defers publication for up to 60 days in the event Sponsor provides notice that it intends to file a patent application.
19642|NCT00807456|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19643|NCT00807365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19644|NCT00807248|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub-publications.
19645|NCT00807235|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19646|NCT00807209|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19647|NCT00807092|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones. This includes the right to not release interim results of clinical trials. At the end of the trial, manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
19648|NCT00807040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19649|NCT00807014|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19650|NCT00807001|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the PI that permits the sponsor to review results communications prior to public release and embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor may request the PI to remove the sponsor's confidential information prior to such publication.
19651|NCT00806988|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19652|NCT00806819|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
19653|NCT00806676|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19654|NCT00806624|Principal Investigators are NOT employed by the organization sponsoring the study.|Korea study sites agree that any results of the study are not to be published individually or collectively in whole or part by study site, its employees or agents until after the coordinated multicenter publication or one year after the termination of the study, whichever occurs fist.
19655|NCT00806598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19656|NCT00806585|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
19657|NCT00806546|Principal Investigators are NOT employed by the organization sponsoring the study.|Per the study agreement, Investigators shall have the right to publish or present information and/or data arising from the study, provided the text of any such publication or presentation is submitted for review at least thirty days prior to submission for publication or other disclosure and NuPathe shall have the right to request the removal of any confidential information
19658|NCT00806494|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19659|NCT00806442|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19660|NCT00806416|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19661|NCT00806403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19662|NCT00806390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19663|NCT00806351|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19664|NCT00806260|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
19665|NCT00806234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19666|NCT00806221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19667|NCT00806195|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19668|NCT00806078|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19669|NCT00806026|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19670|NCT00805961|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
19671|NCT00805935|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
19672|NCT00805870|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19673|NCT00805792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19674|NCT00805766|Principal Investigators are NOT employed by the organization sponsoring the study.|
19675|NCT00805740|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19676|NCT00805675|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19677|NCT00805545|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19678|NCT00805493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19679|NCT00805480|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
19680|NCT00805467|Principal Investigators are NOT employed by the organization sponsoring the study.|
19681|NCT00805441|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19682|NCT00805389|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19683|NCT00805285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19684|NCT00805194|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
19685|NCT00805142|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
19686|NCT00805038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19687|NCT00805025|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
19688|NCT00804999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19689|NCT00804986|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19690|NCT00804908|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
19691|NCT00804843|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications derived from the study should include input from the investigator(s) and SPONSOR. After to the multicenter publication, or 24 months after completion of the study, whichever comes first, an investigator may publish the results for the study site independently. The SPONSOR must have the opportunity to review all proposed publications 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
19692|NCT00804713|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19693|NCT00804687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19694|NCT00804648|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication or presentation, the PI will provide the Sponsor with at least 60 days for review of a manuscript. If requested in writing, the PI will withhold publication for up to an additional 60 days.
19695|NCT00804609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19696|NCT00804596|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19697|NCT00804570|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19698|NCT00804193|Principal Investigators are NOT employed by the organization sponsoring the study.|
19699|NCT00803959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19700|NCT00803790|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication timelines.
19701|NCT00803777|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19702|NCT00803751|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19703|NCT00803738|Principal Investigators are NOT employed by the organization sponsoring the study.|
19704|NCT00803712|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
19705|NCT00803686|Principal Investigators are NOT employed by the organization sponsoring the study.|Except as provided herein or as required by applicable law, you agree that you shall keep such Unigene Information confidential and that you shall not, without our prior written consent, transmit, publish, or otherwise disclose to any person or entity either (i) the Unigene Information, (ii) the fact of our disclosure of the Unigene Information to you, or (iii) the existence or terms of any negotiations or discussions between us regarding your potential engagement.
19706|NCT00803647|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19707|NCT00803634|Principal Investigators are NOT employed by the organization sponsoring the study.|After initial multicenter results communications are published, or after 12 months from study closure (whichever occurs first), sponsor can review results communications prior to submission and can embargo submissions for a period of 45 days from the time submitted to the sponsor for review, agreeing to resolve differences of opinion or interpretation through scientific debate. Sponsor can request further delay for an additional 90 days to file any patent applications if deemed necessary.
19708|NCT00803595|Principal Investigators are NOT employed by the organization sponsoring the study.|Principle investigator shall not publish the results of the study at any time without the prior written approval of Sponsor.
19709|NCT00803543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19710|NCT00803517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19711|NCT00803452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19712|NCT00803413|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19713|NCT00803400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19714|NCT00803361|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19715|NCT00803283|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19716|NCT00803270|Principal Investigators are NOT employed by the organization sponsoring the study.|
19717|NCT00803244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19718|NCT00803179|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19719|NCT00803114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19720|NCT00803101|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
19721|NCT00803062|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19722|NCT00803049|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
19723|NCT00803023|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19724|NCT00803010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19725|NCT00802997|Principal Investigators are NOT employed by the organization sponsoring the study.|The results communications must be provided to the Sponsor for review 30 days prior to public release. The Sponsor has the right to review materials for the purposes of preserving confidentiality of Sponsor’s proprietary information, which may be removed at the Sponsor’s request, and for identification of patentable inventions. The Investigator has no obligation to address any additional comments provided during the review and has final control and approval of publication content.
19726|NCT00802919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19727|NCT00802893|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19728|NCT00802880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19729|NCT00802867|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
19730|NCT00802854|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19731|NCT00802841|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
19732|NCT00802737|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19733|NCT00802685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19734|NCT00802672|Principal Investigators are NOT employed by the organization sponsoring the study.|
19735|NCT00802659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19736|NCT00802633|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19737|NCT00802529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19738|NCT00802503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19739|NCT00802464|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19740|NCT00802438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19741|NCT00802412|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19742|NCT00802360|Principal Investigators are NOT employed by the organization sponsoring the study.|"The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor.~Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention."
19743|NCT00802204|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19744|NCT00802178|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19745|NCT00802100|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19746|NCT00802074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19747|NCT00801983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19748|NCT00801892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19749|NCT00801827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19750|NCT00801801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19751|NCT00801684|Principal Investigators are NOT employed by the organization sponsoring the study.|No individual Investigator may publish results without written agreement from Alkermes. Should an Investigator wish to publish or present the data at a meeting, a copy of the manuscript or abstract must be provided to the Sponsor at least 30 days prior to the submission for review and approval. Any revisions will be negotiated in good faith by the Investigator and Sponsor.
19752|NCT00801632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19753|NCT00801242|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
19754|NCT00801229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19755|NCT00801138|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19756|NCT00801099|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19757|NCT00800982|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19758|NCT00800865|Principal Investigators are NOT employed by the organization sponsoring the study.|This is an exploratory study to develop data for possible future studies. It is not intended to be published, unless important new information or data concerning the safety of a marketed product is obtained. The Sponsor must have the opportunity to review all abstracts, manuscripts, or presentations 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. Sponsor review can be expedited.
19759|NCT00800839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19760|NCT00800735|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19761|NCT00800683|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19762|NCT00800540|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
19763|NCT00800436|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
19764|NCT00800384|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19765|NCT00800345|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19766|NCT00800254|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19767|NCT00800202|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19768|NCT00799903|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19769|NCT00799825|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19770|NCT00799773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19771|NCT00799708|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19772|NCT00799643|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19773|NCT00799617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19774|NCT00799604|Principal Investigators are NOT employed by the organization sponsoring the study.|The site agrees that publication of Study results at the site is not permitted until after the presentation and publication of the multi-center results or an affirmative decision is made by Sponsor not to proceed with such publication. In such a case, Sponsor shall provide access to all Study site data to the academic Study Coordination Center, or upon request Sponsor will provide access to all Study site data to Institution. The site will adhere to terms for Sponsor review prior to submission.
19775|NCT00799591|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19776|NCT00799578|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19777|NCT00799487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19778|NCT00799474|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19779|NCT00799435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19780|NCT00799422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19781|NCT00799409|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19782|NCT00799396|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19783|NCT00799383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19784|NCT00799292|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19785|NCT00799227|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
19786|NCT00798967|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of NPS Pharmaceuticals agreements with its investigators may vary. However, NPS does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19787|NCT00798889|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19788|NCT00798759|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
19789|NCT00798720|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19790|NCT00798707|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19791|NCT00798655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19792|NCT00798603|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19793|NCT00798590|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19794|NCT00798577|Principal Investigators are NOT employed by the organization sponsoring the study.|All presentations/publications of study results are subject to Alcon approval.
19795|NCT00798486|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19796|NCT00798434|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19797|NCT00798369|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19798|NCT00798317|Principal Investigators are NOT employed by the organization sponsoring the study.|Varying agreements. The most restrictive is as follows: The Centre and Investigator agree to neither publish nor make public any of the results of the Study without the prior written consent from Sponsor, which consent shall not be unreasonably withheld.
19799|NCT00798304|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19800|NCT00798161|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19801|NCT00798135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19802|NCT00798096|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AstraZeneca for review at least 30 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AstraZeneca authorized MC publication or a period up to 18 months from study completi
19803|NCT00798018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19804|NCT00797966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19805|NCT00797862|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with it's investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until publication of pooled data (i.e., data from all sites) in the clinical trial.
19806|NCT00797823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19807|NCT00797797|Principal Investigators are NOT employed by the organization sponsoring the study.|
19808|NCT00797732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19809|NCT00797667|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
19810|NCT00797563|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19811|NCT00797511|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
19812|NCT00797459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19813|NCT00797316|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19814|NCT00797277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19815|NCT00797212|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19816|NCT00797108|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19817|NCT00796991|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
19818|NCT00796926|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19819|NCT00796861|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19820|NCT00796822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19821|NCT00796757|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
19822|NCT00796744|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor prepared an integrated clinical/statistical report. As this was a multicenter study, any publication/presentation of data was to include the entire study population. Publication/presentation of data from individual study centers is not allowed without explicit permission from US Biotest.
19823|NCT00796718|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
19824|NCT00796705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19825|NCT00796666|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19826|NCT00796653|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
19827|NCT00796627|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19828|NCT00796614|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
19829|NCT00796549|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19830|NCT00796523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19831|NCT00796510|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19832|NCT00796419|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19833|NCT00796367|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
19834|NCT00796328|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19835|NCT00796315|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator and Sub-Investigators agree that all data, calculations, interpretations, opinions, and recommendations regarding the study will be the property of the Sponsor. The Investigator agrees to consider the results as information subject to confidentiality and use restrictions.
19836|NCT00796302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19858|NCT00794963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19837|NCT00796224|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19838|NCT00796120|Principal Investigators are NOT employed by the organization sponsoring the study.|Before Investigators of this study publicly disclose information, PharmaMar must be provided with at least 60 days to review and approve disclosure in order to ensure that confidential and proprietary data are protected. If PharmaMar determines that patentable patient matter is disclosed in the proposed disclosure, the latter shall be withheld for period of time considered convenient.
19839|NCT00796003|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19840|NCT00795951|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19841|NCT00795886|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19842|NCT00795821|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19843|NCT00795769|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19844|NCT00795717|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19845|NCT00795704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19846|NCT00795639|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19847|NCT00795600|Principal Investigators are NOT employed by the organization sponsoring the study.|
19848|NCT00795535|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19849|NCT00795509|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19850|NCT00795366|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19851|NCT00795340|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19852|NCT00795288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19853|NCT00795210|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19854|NCT00795184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19855|NCT00795145|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19856|NCT00795132|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19857|NCT00795002|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19859|NCT00794924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19860|NCT00794820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19861|NCT00794677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19862|NCT00794664|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish site data after a multi-centered publication or 12 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 6 months (contracts have variable timeframes) upon notifying PI that it will file a patent application on inventions contained in the draft.
19863|NCT00794560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19864|NCT00794547|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19865|NCT00794508|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19866|NCT00794469|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19867|NCT00794365|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19868|NCT00794313|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19869|NCT00794196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19870|NCT00794170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19871|NCT00794157|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
19872|NCT00794144|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves the right of prior review of any publication or presentation of information related to the study.
19873|NCT00794118|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19874|NCT00793910|Principal Investigators are NOT employed by the organization sponsoring the study.|All materials that reflects the WRAMC affiliation must be approved and properly cleared before the material is submitted for public dissemination and publication. All publications whereby WRAMC is cited in the bylines will state on the cover page the following sample disclaimer: “The views expressed in this [article, book chapter, speech, presentation, etc.] are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or U.S. Government.”
19875|NCT00793871|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19876|NCT00793819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19877|NCT00793793|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
19878|NCT00793780|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19879|NCT00793650|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19880|NCT00793624|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
19881|NCT00793611|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19882|NCT00793585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19883|NCT00793572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19884|NCT00793546|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19885|NCT00793520|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19886|NCT00793455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19887|NCT00793403|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19888|NCT00793325|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19889|NCT00793182|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19890|NCT00793169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19891|NCT00793104|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19892|NCT00792948|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19893|NCT00792935|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
19894|NCT00792922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19895|NCT00792909|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19896|NCT00792805|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
19897|NCT00792701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19898|NCT00792688|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of up to 90 days. The sponsor can require changes to the communication to remove any confidential information.
19899|NCT00792636|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19900|NCT00792623|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19901|NCT00792610|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19902|NCT00792428|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19903|NCT00792298|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
19904|NCT00792259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19905|NCT00792116|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19906|NCT00792103|Principal Investigators are NOT employed by the organization sponsoring the study.|Per the study agreement, Investigators have the right to publish or present information and/or data arising from the study, provided the text of any such publication or presentation is submitted for review at least thirty days prior to submission for publication or other disclosure and NuPathe shall have the right to request the removal of any confidential information.
19907|NCT00791999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19908|NCT00791973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19909|NCT00791934|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19910|NCT00791921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19911|NCT00791908|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19912|NCT00791817|Principal Investigators are NOT employed by the organization sponsoring the study.|Data, calculations, interpretations, opinions, and recommendations are the property of P&GP. In the event study results are published in the scientific literature by P&GP, acknowledgment will be made to the Investigator(s) in the accepted style, as appropriate.
19913|NCT00791778|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19914|NCT00791765|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
19915|NCT00791700|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study participating sites. Investigator may not disclose previously undisclosed confidential other than study results.
19916|NCT00791661|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
19917|NCT00791648|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19918|NCT00791557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19919|NCT00791518|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19920|NCT00791492|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
19921|NCT00791479|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19922|NCT00791388|Principal Investigators are NOT employed by the organization sponsoring the study.|Data, calculations, interpretations, opinions, and recommendations are the property of P&GP. In the event study results are published in the scientific literature by P&GP, acknowledgment will be made to the Investigator(s) in the accepted style, as appropriate.
19923|NCT00791336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19924|NCT00791323|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
19925|NCT00791258|Principal Investigators are NOT employed by the organization sponsoring the study.|"As stated in the clinical study agreement, If identified by DSI, any of DSI's confidential information as defined herein shall be deleted...Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publicartion prepared by the Study Site."
19926|NCT00791128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19927|NCT00791102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19928|NCT00791089|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19929|NCT00791076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19930|NCT00791037|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19931|NCT00790907|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19932|NCT00790868|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19933|NCT00790855|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19934|NCT00790803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19935|NCT00790790|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19936|NCT00790751|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
19937|NCT00790738|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19938|NCT00790673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19939|NCT00790647|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19940|NCT00790569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19941|NCT00790556|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19942|NCT00790452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19943|NCT00790400|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19944|NCT00790335|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19945|NCT00790296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19946|NCT00790270|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19947|NCT00790218|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19948|NCT00790205|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study at least 30 days prior to submission for publication/presentation or at least 14 calendar days prior to submission for abstracts.
19949|NCT00790192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19950|NCT00790062|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19951|NCT00790036|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
19952|NCT00790023|Principal Investigators are NOT employed by the organization sponsoring the study.|
19953|NCT00789997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19954|NCT00789958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19955|NCT00789880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19956|NCT00789854|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19957|NCT00789828|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
19958|NCT00789815|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19959|NCT00789802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19960|NCT00789750|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees to wait until after coordinated multicenter publication or one year after the trial is over, whichever occurs first. After such time, Study Site will submit any publication to DSI for CCI review and comment at least forty-five (45) days prior to submission. Site agrees to delay publication for an additional sixty (60) days for legal (e.g., patent) concerns. Nothing shall be taken as giving DSI any right of editorial control over any publication prepared by Study Site.
19980|NCT00788775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19961|NCT00789737|Principal Investigators are NOT employed by the organization sponsoring the study.|Until coordinated multicenter publication or one year after the study termination, whichever occurs first. After that, submit for Daiichi Sankyo, Inc. (DSI) review and comment at least 45 days before submission. DSI may ask up to 60 additional days, if patentable material is identified.
19962|NCT00789724|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19963|NCT00789698|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
19964|NCT00789685|Principal Investigators are NOT employed by the organization sponsoring the study.|Review by sponsor of related publication & communications
19965|NCT00789672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19966|NCT00789581|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
19967|NCT00789555|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
19968|NCT00789529|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19969|NCT00789477|Principal Investigators are NOT employed by the organization sponsoring the study.|Not less than 45 days prior to submission of a publication (S)ponsor shall be provided with a copy of the publication. The parties shall discuss any comments submitted by S regarding content, & Institution & PI shall delete any confidential information that S requests to be deleted. In addition, since the study is being conducted at multiple sites, parties agreed that publication of results shall be made only as part of a publication of the results obtained by all sites performing the study.
19970|NCT00789438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19971|NCT00789373|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19972|NCT00789321|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
19973|NCT00789256|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19974|NCT00789191|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right not to release data before passing specified milestones. This includes the right not to release interim results that may later be found to be incorrect. At the end of the trial, one or more manuscripts will be prepared in collaboration between Investigator(s) and Novo Nordisk. Novo Nordisk will not suppress or veto publications but will reserve the right to postpone publication and/or communication for a short time to protect intellectual property.
19975|NCT00789113|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19976|NCT00789074|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19977|NCT00789035|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
19978|NCT00788957|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
19979|NCT00788892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19981|NCT00788710|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
19982|NCT00788697|Principal Investigators are NOT employed by the organization sponsoring the study.|Study results may be presented at scientific symposia or published in a peer-review journal after review by sponsor in accordance with the guidelines set forth in the applicable publication or financial agreement
19983|NCT00788593|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication after a multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
19984|NCT00788372|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the Sponsor requires.
19985|NCT00788255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19986|NCT00788073|Principal Investigators are NOT employed by the organization sponsoring the study.|Seaside Therapeutics agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
19987|NCT00788008|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19988|NCT00787943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19989|NCT00787930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19990|NCT00787917|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis's agreements with it's investigators vary. However, Novartis does not prohibit any investigator from publishing. Any publication from a single-center site are postponed until the publication of the pooled data ( i.e. data from all sites) in the clinical trial.
19991|NCT00787904|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19992|NCT00787891|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19993|NCT00787852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19994|NCT00787839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19995|NCT00787800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19996|NCT00787787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19997|NCT00787761|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
19998|NCT00787644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
19999|NCT00787618|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
20000|NCT00787605|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or the publication of the trial results in their entirety.
20001|NCT00787566|Principal Investigators are NOT employed by the organization sponsoring the study.|SNBL and investigators agreed that SNBL would retain the exclusive right to disseminate data arising from the study through either publication or presentation, including study results, and that SNBL would retain exclusive editorial rights over manuscripts or presentations.
20002|NCT00787527|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20003|NCT00787332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20004|NCT00787319|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20005|NCT00787267|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20006|NCT00787254|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
20007|NCT00787241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20008|NCT00787202|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20009|NCT00787189|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20010|NCT00787150|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20011|NCT00787137|Principal Investigators are NOT employed by the organization sponsoring the study.|An investigator shall not publish any data (poster, abstract, paper etc) without having consulted with the Sponsor in advance.
20012|NCT00787124|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20013|NCT00787020|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20014|NCT00786994|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement on publication prior to disclosure
20015|NCT00786916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20016|NCT00786864|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20017|NCT00786838|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20018|NCT00786799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20019|NCT00786682|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20020|NCT00786643|Principal Investigators are NOT employed by the organization sponsoring the study.|If the Investigator wishes to make a submission for a presentation or publication, the Investigator shall submit all such materials to InterMune at least 60 days prior to the date on which such submission is proposed to be made, and InterMune shall provide timely review of such materials. InterMune may cause the presentation or submission to be delayed for up to 60 additional days if patentable material or proprietary information is identified.
20021|NCT00786565|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20022|NCT00786487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20023|NCT00786474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20024|NCT00786422|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator, whilst free to utilize data derived from the study for scientific purposes, must discuss any publication with Bayer prior to release and obtain written consent of Bayer on the intended publication. The investigator must send a draft manuscript of the publication or abstract to Bayer thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication.
20025|NCT00786409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20026|NCT00786188|Principal Investigators are NOT employed by the organization sponsoring the study.|
20027|NCT00786032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20028|NCT00785980|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20029|NCT00785798|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20030|NCT00785785|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
20031|NCT00785772|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20032|NCT00785707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20033|NCT00785629|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20034|NCT00785577|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20035|NCT00785512|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 60 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential information. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in the publication. On sponsor's request, PI shall delay submission for any pub while sponsor files patent applications. Any publication will give recognition to Sponsor's support.
20036|NCT00785486|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20037|NCT00785356|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
20038|NCT00785291|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20039|NCT00785213|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20040|NCT00785044|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI and/or institution is that the Sponsor can review results communications prior to public release and can restrict communications regarding trial results for a period that is more than 30 days (publications/abstracts) but not to exceed 90 days (patent related issues) from the time submitted to the Sponsor to review. The PI may be asked to remove any Sponsor confidential information and/or delay publication to protect any proprietary information.
20041|NCT00784979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20042|NCT00784927|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20043|NCT00784875|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20044|NCT00784849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20045|NCT00784836|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
20046|NCT00784810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20047|NCT00784784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20048|NCT00784719|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20049|NCT00784654|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20050|NCT00784563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20051|NCT00784550|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20052|NCT00784459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20053|NCT00784368|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
20054|NCT00784277|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20055|NCT00784238|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20056|NCT00784147|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20057|NCT00784134|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20058|NCT00784095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20059|NCT00784043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20060|NCT00784030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20061|NCT00783965|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20062|NCT00783952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20063|NCT00783835|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication and can extend the embargo.
20064|NCT00783796|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20065|NCT00783718|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
20066|NCT00783705|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20067|NCT00783692|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
20068|NCT00783614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20069|NCT00783432|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, joint publication is required to assure that the initial publication is based on all data from all sites and investigators participating in these studies agree not to present data gathered individually or by subgroup centers before the initial publication unless jointly agreed by all other investigators and the Sponsor. Authorship will be determined by mutual agreement.
20070|NCT00783302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20071|NCT00783263|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20072|NCT00783224|Principal Investigators are NOT employed by the organization sponsoring the study.|The only restriction on the PI is that the PI needs to get approval from the sponsor for publication of the trial results prior to public release.
20073|NCT00783198|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
20074|NCT00783094|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20075|NCT00782834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20076|NCT00782821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20077|NCT00782795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20078|NCT00782756|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20079|NCT00782717|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right to review study related information prior to presentation or publication
20080|NCT00782639|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be presented during scientific symposia or published in a scientific journal only after review by Bracco in accordance with the guidelines set forth in the applicable publication or financial agreement.
20081|NCT00782626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20082|NCT00782509|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
20083|NCT00782496|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20084|NCT00782483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20085|NCT00782418|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20086|NCT00782379|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20087|NCT00782340|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20088|NCT00782288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20089|NCT00782275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20090|NCT00782210|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
20091|NCT00782184|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
20092|NCT00782171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20093|NCT00782067|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
20094|NCT00781963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20095|NCT00781950|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20096|NCT00781937|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones, e.g. a clinical trial report is available, including right to not release interim trial results, because this may lead to conclusions later shown to be incorrect. At trial end, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for a short time to protect intellectual property.
20097|NCT00781911|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20098|NCT00781898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20099|NCT00781859|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20100|NCT00781599|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20101|NCT00781508|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20102|NCT00781456|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
20103|NCT00781391|Principal Investigators are NOT employed by the organization sponsoring the study.|A study site may not publish results of a study until after a coordinated multicenter publication has been submitted for publication or until one year after the study has ended, whichever occurs first. The study site will have the opportunity to publish results of the study, provided Daiichi Sankyo has had the opportunity to review and comment on the study site’s proposed publication prior to being submitted for publication with the advice of patent council and need for subject protection.
20104|NCT00781365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20105|NCT00781326|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20106|NCT00781274|Principal Investigators are NOT employed by the organization sponsoring the study.|
20107|NCT00781079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20108|NCT00780962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20109|NCT00780910|Principal Investigators are NOT employed by the organization sponsoring the study.|
20110|NCT00780741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20111|NCT00780715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20112|NCT00780676|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20113|NCT00780572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20114|NCT00780481|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20115|NCT00780455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20116|NCT00780416|Principal Investigators are NOT employed by the organization sponsoring the study.|
20117|NCT00780403|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's representative will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
20118|NCT00780338|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20119|NCT00780273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20120|NCT00780026|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20121|NCT00779909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20122|NCT00779857|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor can review communications prior to public release and can embargo communication regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the tim submitted to the sponsor for review. The sponsor can redact or modify the proposed publication to remove any language the sponsor believes would be detrimental to intellectual property or inaccurately reflect the results of the study.
20123|NCT00779779|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20124|NCT00779766|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20125|NCT00779701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20126|NCT00779675|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data.
20127|NCT00779584|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
20128|NCT00779558|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20129|NCT00779506|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20130|NCT00779467|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20131|NCT00779402|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentations relating to the Study will be coordinated by Dendreon in communication with institutions contributing patients to the Study.
20132|NCT00779311|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication or presentation of Sponsored Research results, Researcher agrees to provide Bayer with such presentation, abstract, or manuscript at least 30 days prior to its presentation or submission for the sole purpose of allowing Bayer to redact Confidential Information and protect any existing or future patents.
20133|NCT00779285|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal investigator agrees not to publish/publicly present any~interim results without prior Sponsor written consent and agrees to provide 30 days written notice prior to submission to permit review of abstracts/manuscripts which report any results. Sponsor has the right to review/comment/edit to ensure confidentiality, information accuracy, and that the presentation is fairly balanced. If the parties disagree, the investigator agrees to meet with Sponsor to discuss/resolve any disagreement."
20134|NCT00779259|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20135|NCT00779246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20136|NCT00779155|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20137|NCT00779142|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20138|NCT00779116|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's representative will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
20139|NCT00779038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20140|NCT00779025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20141|NCT00778999|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor recognizes the right of the investigator(s) to publish, but all communication concerning the clinical trial must be based on data validated and released and will first be submitted to the Sponsor for written consent, which shall not be withheld unreasonably. Sponsor is free to use the data for publication. The investigator(s) may be invited to be co‑author(s). In any communication concerning this clinical trial, the author(s) of this protocol will be included in the list of authors.
20142|NCT00778921|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20143|NCT00778895|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20144|NCT00778869|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator (PI) agrees not to publish or publicly present any interim results of study without prior written consent of sponsor. PI further agrees to provide 30 days written notice to sponsor prior to submission for publication or presentation to permit sponsor to review copies of abstracts or manuscripts for publication including without limitation slides and texts of oral or other public presentations and text of any transmission through any electronic media which report results.
20145|NCT00778830|Principal Investigators are NOT employed by the organization sponsoring the study.|
20146|NCT00778817|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20147|NCT00778648|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20148|NCT00778622|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
20149|NCT00778375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20150|NCT00778336|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20151|NCT00778310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20152|NCT00778258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20153|NCT00778167|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20154|NCT00778102|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20155|NCT00777946|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20156|NCT00777855|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20157|NCT00777803|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 wks before submission. Sponsor to give written opinion within 30 d. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
20158|NCT00777790|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20159|NCT00777764|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20160|NCT00777634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20161|NCT00777608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20162|NCT00777556|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
20163|NCT00777335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20164|NCT00777257|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20165|NCT00777205|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20166|NCT00777179|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20167|NCT00777153|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
20168|NCT00777101|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20169|NCT00777062|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20170|NCT00777049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20171|NCT00777036|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
20172|NCT00777023|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees that the sponsor shall have the right to the first publication of the results of the study which is intended to be a joint, multi-center publication. Following the first publication, the PI may publish data or results from the study, provide however PI submits the proposed publication to sponsor for review at least 60 days prior to the date of the proposed publication. Sponsor may remove any information that is considered confidential and/or proprietary other than study data.
20173|NCT00776997|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20174|NCT00776984|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20175|NCT00776919|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20176|NCT00776789|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20177|NCT00776659|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20178|NCT00776594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20301|NCT00769119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20179|NCT00776555|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20180|NCT00776295|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20181|NCT00776230|Principal Investigators are NOT employed by the organization sponsoring the study.|
20182|NCT00776100|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20183|NCT00776009|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20184|NCT00775983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20185|NCT00775944|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20186|NCT00775684|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20187|NCT00775671|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20188|NCT00775658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20189|NCT00775645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20190|NCT00775606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20191|NCT00775593|Principal Investigators are NOT employed by the organization sponsoring the study.|Results are analyzed together with the sponsor, being the present study a fully independent not-for-profit trial.
20192|NCT00775528|Principal Investigators are NOT employed by the organization sponsoring the study.|At 60 days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy and allow Sponsor 60 days to review and comment.
20193|NCT00775463|Principal Investigators are NOT employed by the organization sponsoring the study.|
20194|NCT00775450|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20195|NCT00775437|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
20196|NCT00775411|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
20197|NCT00775346|Principal Investigators are NOT employed by the organization sponsoring the study.|
20198|NCT00775229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20199|NCT00775203|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting results communications, the investigator shall allow Labopharm at least 60 days to review the proposed communication. If the proposed publication/disclosure risks Labopharm’s ability to patent any invention related to the study, the publication or disclosure will be modified/delayed to allow Labopharm to seek patent protection. This statement does not give Labopharm any editorial rights other than to restrict the disclosure of Labopharm’s confidential information.
20200|NCT00775190|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20201|NCT00775021|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
20202|NCT00774995|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20203|NCT00774930|Principal Investigators are NOT employed by the organization sponsoring the study.|With permission from the Sponsor, each investigator may have published or reported data from their own subjects. The study data in aggregate are the property of the Sponsor and may not be published without permission of the Sponsor. The Sponsor is the final arbitrator of issues relating to the publication or presentation of the aggregate data.
20204|NCT00774852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20205|NCT00774800|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained as a result of this study or during the conduct of this study will be regarded as confidential. The Investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless prior written permission from the Sponsor (Halozyme) is obtained.
20206|NCT00774787|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs must agree on communication of complete results, but may discuss individual site results. Collaborator can review complete results communications prior to public release and can embargo communications regarding trial results, if patents are to be pursued, for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the collaborator for review. The collaborator cannot require changes to the communication and cannot extend the embargo.
20207|NCT00774748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20208|NCT00774397|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
20209|NCT00774306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20210|NCT00774267|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20211|NCT00774163|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20212|NCT00774046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20213|NCT00773968|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
20214|NCT00773955|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20215|NCT00773786|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20216|NCT00773734|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
20217|NCT00773474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20218|NCT00773461|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20219|NCT00773422|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20220|NCT00773383|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20221|NCT00773370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20222|NCT00773279|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right not to release data until specified milestones, eg a clinical trial report is available. This includes the right not to release interim results from clinical trials, because such results may lead to conclusions that are later shown to be incorrect. Novo Nordisk will not suppress or veto publications; however Novo Nordisk reserves the right to postpone publication and/or communication for a short time to protect intellectual property.
20223|NCT00773253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20224|NCT00773136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20225|NCT00773097|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20226|NCT00772967|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20227|NCT00772954|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
20228|NCT00772941|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20229|NCT00772928|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20230|NCT00772915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20231|NCT00772889|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20232|NCT00772772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20233|NCT00772707|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
20234|NCT00772668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20235|NCT00772629|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20236|NCT00772603|Principal Investigators are NOT employed by the organization sponsoring the study.|
20237|NCT00772590|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20238|NCT00772577|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20239|NCT00772538|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20240|NCT00772447|Principal Investigators are NOT employed by the organization sponsoring the study.|
20241|NCT00772382|Principal Investigators are NOT employed by the organization sponsoring the study.|
20242|NCT00772369|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20243|NCT00772304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20244|NCT00772148|Principal Investigators are NOT employed by the organization sponsoring the study.|
20245|NCT00772109|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20246|NCT00772070|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20247|NCT00772031|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20248|NCT00772005|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20249|NCT00771953|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20250|NCT00771927|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20251|NCT00771914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20252|NCT00771901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20253|NCT00771875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20254|NCT00771849|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20255|NCT00771810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20256|NCT00771758|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20257|NCT00771745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20258|NCT00771667|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20259|NCT00771615|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20260|NCT00771602|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20261|NCT00771537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20262|NCT00771472|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
20263|NCT00771407|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20264|NCT00771316|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20265|NCT00771277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20266|NCT00771264|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20267|NCT00771238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20268|NCT00771173|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20269|NCT00771056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20270|NCT00770991|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20271|NCT00770965|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
20272|NCT00770913|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20273|NCT00770861|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 60 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential information. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in the publication. On sponsor's request, PI shall delay submission for any pub while sponsor files patent applications. Any publication will give recognition to Sponsor's support.
20274|NCT00770809|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20275|NCT00770770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20276|NCT00770757|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20277|NCT00770692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20278|NCT00770679|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20279|NCT00770653|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 14 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
20280|NCT00770588|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees to collaborate in good faith with AZ regard to contents and formation of any publication and to pay due consideration to the comments, views and opinions offered by AZ. AZ shall have a period of 30 days from receipt of the proposed final manuscript to review and may require submission be delayed in order for AZ to file patent application
20300|NCT00769132|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20281|NCT00770562|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
20282|NCT00770510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20283|NCT00770484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20284|NCT00770432|Principal Investigators are NOT employed by the organization sponsoring the study.|
20285|NCT00770367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20286|NCT00770341|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
20287|NCT00770328|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20288|NCT00770315|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
20289|NCT00770289|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20290|NCT00770211|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 wks before submission. Sponsor to give written opinion within 30 d. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
20291|NCT00770146|Principal Investigators are NOT employed by the organization sponsoring the study.|After the multicenter publication or 12 months after completion of the study the PI may publish the results of his/her data from the study. The PI shall provide the sponsor with an advance copy at least 60 days prior to planned submission and the Sponsor shall have 60 days to review (contracts have variable timeframes; maximum times are stated here). The sponsor may request the deletion of any confidential information, or a delay in submission for an additional period not to exceed 90 days.
20292|NCT00770120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20293|NCT00770029|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 wks before submission. Sponsor to give written opinion within 30 d. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
20294|NCT00769860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20295|NCT00769704|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
20296|NCT00769652|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20297|NCT00769561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20298|NCT00769314|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20299|NCT00769184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20302|NCT00769067|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20303|NCT00769015|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20304|NCT00768989|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
20305|NCT00768898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20306|NCT00768755|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20307|NCT00768651|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20308|NCT00768599|Principal Investigators are NOT employed by the organization sponsoring the study.|
20309|NCT00768560|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20310|NCT00768521|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20311|NCT00768430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20312|NCT00768300|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
20313|NCT00768222|Principal Investigators are NOT employed by the organization sponsoring the study.|
20314|NCT00768144|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20315|NCT00768118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20316|NCT00768066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20317|NCT00768053|Principal Investigators are NOT employed by the organization sponsoring the study.|Wyeth has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20318|NCT00768040|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20319|NCT00767806|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20320|NCT00767767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20321|NCT00767676|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20322|NCT00767624|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20323|NCT00767572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20324|NCT00767520|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
20325|NCT00767507|Principal Investigators are NOT employed by the organization sponsoring the study.|"In general, PI communications regarding trial results are prohibited until after the communication and publication of the multi-center results by Sponsor, but no more than 12 months after conclusion of the trial at all sites.~PI must submit results communications to sponsor for review at least 60 days prior to submission for publication and Sponsor may embargo such communications for a period that is less than or equal to 150 days solely to seek appropriate patent protection."
20326|NCT00767455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20327|NCT00767364|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20328|NCT00767338|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20329|NCT00767325|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
20330|NCT00767104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20331|NCT00767039|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20332|NCT00767000|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
20333|NCT00766831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20334|NCT00766753|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20335|NCT00766675|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20336|NCT00766649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20337|NCT00766636|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20338|NCT00766597|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
20339|NCT00766532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20340|NCT00766506|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20341|NCT00766493|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
20342|NCT00766467|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20343|NCT00766415|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20344|NCT00766376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20345|NCT00766363|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted for review. At the sponsor’s request, the PI will delete confidential information other than trial data and will delay publication or disclosure for up to 90 days to allow patent filings. The PI agrees that the first publication shall be a joint publication.
20346|NCT00766090|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20347|NCT00766051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20348|NCT00765947|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20349|NCT00765895|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20350|NCT00765882|Principal Investigators are NOT employed by the organization sponsoring the study.|All data generated in this study will be the property of Forest Research Institute. An integrated clinical and statistical report will be prepared at the completion of the trial. Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute
20351|NCT00765843|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20352|NCT00765817|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20353|NCT00765765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20354|NCT00765726|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20355|NCT00765674|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
20356|NCT00765661|Principal Investigators are NOT employed by the organization sponsoring the study.|The study is a multicenter collaborative investigation and the clinical trial results are to be published as a collaborative manuscript. Authorship will reflect varying levels of individual contribution to the study by the individual PIs.
20357|NCT00765648|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20358|NCT00765570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20359|NCT00765388|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish the Inventions subject to the prior written consent of Sponsor. The Investigator shall submit the manuscript to Sponsor for approval, provided however that the Investigator will submit the manuscript at least thirty (30) days before disclosure for such proposed publication. If Sponsor wishes to file patent applications on Inventions Sponsor is allowed to delay the publication upon to a maximum period of 6 months since he above-mentioned submission.
20360|NCT00765375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20361|NCT00765362|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20362|NCT00765336|Principal Investigators are NOT employed by the organization sponsoring the study.|Specific restrictions and agreements are specified in each investigator's contract.
20363|NCT00765245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20364|NCT00765232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20365|NCT00765206|Principal Investigators are NOT employed by the organization sponsoring the study.|"Schering-Plough HealthCare Products, Inc. reserves all publication and~presentation rights."
20366|NCT00765193|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20367|NCT00765128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20368|NCT00765102|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation
20369|NCT00765076|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20370|NCT00765063|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20371|NCT00765037|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20372|NCT00764946|Principal Investigators are NOT employed by the organization sponsoring the study.|Twenty-four months after completion of this study or after publication of the multicenter results, an investigator may publish the results for their study site independently. The sponsor must have the opportunity to review all proposed publications or presentations regarding the study 60 days before submission.
20373|NCT00764881|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution must ensure Discloser gives 40 days notice of proposed Publication to Sponsor who may within 40-day period: provide comments, Institution must consider such comments but is not bound to follow them; request delay of Publication for 120 days to allow Sponsor to file patent applications or take other measures to preserve its proprietary rights, Institution must abide by request; request Discloser remove specified Confidential Information, Institution must remove such Information.
20374|NCT00764868|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20375|NCT00764790|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20376|NCT00764699|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20377|NCT00764673|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20378|NCT00764660|Principal Investigators are NOT employed by the organization sponsoring the study.|In case the proposed publication contains reference to an invention owned by Organon or to which Organon otherwise has rights, Organon may request a reasonable suspension of the publication in order to be able to file a patent application protecting such invention.
20379|NCT00764517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20380|NCT00764504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20381|NCT00764478|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc) that report any results of the trial.
20382|NCT00764465|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20383|NCT00764361|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20384|NCT00764322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20385|NCT00764309|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
20386|NCT00763971|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20387|NCT00763958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20388|NCT00763919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20389|NCT00763867|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20390|NCT00763815|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20391|NCT00763750|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20392|NCT00763698|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20393|NCT00763490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20394|NCT00763451|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20395|NCT00763412|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20396|NCT00763386|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20397|NCT00763360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20418|NCT00762528|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20398|NCT00763321|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
20399|NCT00763282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20400|NCT00763269|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20401|NCT00763256|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20402|NCT00763243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20403|NCT00763139|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20404|NCT00763061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20405|NCT00763048|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20406|NCT00763009|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20407|NCT00762996|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
20408|NCT00762970|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20409|NCT00762931|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20410|NCT00762892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20411|NCT00762853|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20412|NCT00762788|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20413|NCT00762762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20414|NCT00762723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20415|NCT00762645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20416|NCT00762619|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20417|NCT00762606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20477|NCT00760383|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20419|NCT00762515|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20420|NCT00762502|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written consent from the Sponsor.
20421|NCT00762476|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period 1 year after study completion.
20422|NCT00762463|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20423|NCT00762450|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20424|NCT00762424|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20425|NCT00762411|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20426|NCT00762385|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
20427|NCT00762359|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical trial contract states that information should never be disclosed without prior consent of the sponsor, although it does not specify the number of days during which disclosure of information is limited.
20428|NCT00762320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20429|NCT00762268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20430|NCT00762229|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20431|NCT00762216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20432|NCT00762177|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20433|NCT00762164|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20434|NCT00762086|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20435|NCT00762073|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20436|NCT00762034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20437|NCT00762021|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications relating to the study should not be made without the Sponsor’s prior written consent and not prior to the completion of the study. The sponsor shall be notified in writing at least 60 days prior to submission of any intention on the part of the Investigator to publish and shall provide the sponsor an opportunity to comment on any proposed publications.
20438|NCT00761969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20439|NCT00761956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20519|NCT00758667|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20440|NCT00761930|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20441|NCT00761865|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20442|NCT00761813|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20443|NCT00761774|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20444|NCT00761761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20445|NCT00761748|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20446|NCT00761735|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor shall have editorial rights with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation with regard to (1) proprietary information that is protected, (2) the accuracy of the information contained in the publication, and (3) to ensure that the presentation is fairly balanced and in compliance with FDA regulations.
20447|NCT00761631|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20448|NCT00761605|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20449|NCT00761592|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20450|NCT00761579|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20451|NCT00761527|Principal Investigators are NOT employed by the organization sponsoring the study.|SPONSOR is the owner of all the data in the record forms including subsequent reports relating to this study. The prescribing physicians & investigators agree only to use such information to conduct the study & will not be able to publish the results of any part of this study without previous written authorization from SPONSOR. By signing the protocol, the investigator accepts that the results may be used in written publications & for the purpose of providing information to health professionals.
20452|NCT00761514|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall provide Abbott at least sixty (60) days prior to publication or presentation, with a draft of the same for Abbott's review and comment, to ascertain whether any patentable subject matter or Abbott confidential infromariont are disclosed therin. Abbott shall return comment within sixty (60) days after receipt of the draft.
20453|NCT00761462|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20454|NCT00761345|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20455|NCT00761319|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
20456|NCT00761306|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub-publications. H. Lundbeck A/S follows the Vancouver declaration with respect to authorship.
20457|NCT00761280|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator and Sponsor both have publication / presentation privileges. Investigator abstracts or publications had to be reviewed and approved by the Sponsor prior to submission or presentation. The Clinic/Investigator agrees to delete information or defer publication or presentation, if (i) publication would hinder or delay the development of the investigational product or (ii) necessary to permit the filing of any desired patent applications by the Sponsor.
20577|NCT00755131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20458|NCT00761215|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor intends to pursue publication of the results of the study in cooperation with a lead Investigator, subject to the terms and conditions of the clinical trial agreement between Sponsor and Investigators. Sponsor approval is required for publication of any data subsets. Final authorship will be determined by contributions to study design, enrollment, data analysis, and/or interpretation of the results.
20459|NCT00761202|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20460|NCT00761189|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20461|NCT00761176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20462|NCT00761150|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
20463|NCT00761137|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20464|NCT00761007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20465|NCT00760877|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
20466|NCT00760838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20467|NCT00760747|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20468|NCT00760669|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) cannot provide any trial related information to external parties’ without mutual agreement with the Sponsor. This is valid even after the contract is canceled.
20469|NCT00760617|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20470|NCT00760578|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20471|NCT00760552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20472|NCT00760526|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20473|NCT00760487|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Condfidential information will be submitted for publication without Sponsor’s prior written agreement.
20474|NCT00760474|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20475|NCT00760461|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20476|NCT00760435|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20478|NCT00760266|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20479|NCT00760214|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
20480|NCT00760084|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20481|NCT00760019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20482|NCT00760006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20483|NCT00759967|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20484|NCT00759954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20485|NCT00759941|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
20486|NCT00759915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20487|NCT00759902|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20488|NCT00759863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20489|NCT00759811|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20490|NCT00759785|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation and can delete information identified as confidential prior to submission.
20491|NCT00759772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20492|NCT00759759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20493|NCT00759707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20494|NCT00759681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20495|NCT00759668|Principal Investigators are NOT employed by the organization sponsoring the study.|Any formal presentation of data publication from this study has to be a joint presentation from both the Investigators and the Sponsor. Being the study multicentric, it is mandatory that the first publication is based on data from all the centres, analysed according to the protocol. Data from a single Centre can not be presented, unless there is a formal agreement from the other Investigators and Alcon.
20496|NCT00759655|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20497|NCT00759642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20498|NCT00759603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20499|NCT00759577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20500|NCT00759564|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20501|NCT00759525|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20502|NCT00759473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20503|NCT00759395|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20504|NCT00759356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20505|NCT00759330|Principal Investigators are NOT employed by the organization sponsoring the study.|An Institution Publication may be published provided that it does not disclose Confidential Information other than the study results from Institution’s study data. The proposed Institution Publication shall be submitted to sponsor for review and comment at least 30 days prior to submitting it to a third party. If sponsor requests a delay in order to file patent applications, the Institution Publication may be delayed for submission to a third party for up to 120 days after sponsor request.
20506|NCT00759187|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20507|NCT00759174|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20508|NCT00759161|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20509|NCT00759148|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right to review study related information prior to presentation or publication.
20510|NCT00759109|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the principal investigator (PI) is that the PI agrees not to publish or publicly present any results of the study without the prior written permission of the sponsor. The PI further agrees to allow the sponsor to review, 30 days prior to submission for publication or presentation, copies of abstracts or manuscripts for publication (including texts of oral presentations) which report any results of the study.
20511|NCT00759096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20512|NCT00759031|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20513|NCT00758836|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
20514|NCT00758771|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20515|NCT00758758|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20516|NCT00758745|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data is held confidential and not be disclosed to a 3rd party without written consent from Alcon Laboratories for a period of 3 years.
20517|NCT00758706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20518|NCT00758680|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
20520|NCT00758602|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20521|NCT00758589|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20522|NCT00758576|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20523|NCT00758563|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20524|NCT00758550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20525|NCT00758498|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20526|NCT00758485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20527|NCT00758459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20528|NCT00758420|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20529|NCT00758394|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20530|NCT00758342|All Principal Investigators ARE employed by the organization sponsoring the study.|Confidentiality agreement
20531|NCT00758290|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20532|NCT00758264|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20533|NCT00758160|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20534|NCT00758069|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20535|NCT00758043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20536|NCT00757848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20537|NCT00757822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20538|NCT00757783|Principal Investigators are NOT employed by the organization sponsoring the study.|If TTCA does not publish within 12 months after study conclusion or after TTCA confirms there will be no multicenter publication, Institution may publish their results from their site individually, provided TTCA has 60 day review for confidentiality and additional 60 day delay for patent application.
20539|NCT00757705|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20540|NCT00757666|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the results shall be made a joint, multi-center publication.
20541|NCT00757627|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20542|NCT00757601|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
20543|NCT00757588|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
20544|NCT00757484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20545|NCT00757237|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other scholarly media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years."
20546|NCT00757172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20547|NCT00757003|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20548|NCT00756977|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extent the embargo.
20549|NCT00756964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20550|NCT00756938|Principal Investigators are NOT employed by the organization sponsoring the study.|Subsequent to the multicenter publication, or 24 months after completion of the study, whichever comes first, an investigator and/or his/her colleagues may publish the results for their study site independently. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
20551|NCT00756886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20552|NCT00756730|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20553|NCT00756678|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
20554|NCT00756574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20555|NCT00756561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20556|NCT00756548|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extent the embargo.
20557|NCT00756470|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20558|NCT00756457|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20559|NCT00756444|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
20560|NCT00756314|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20561|NCT00756275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20562|NCT00756236|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20563|NCT00756093|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study. Alcon reserves the right of prior review of any publication or presentation of information related to the study.
20564|NCT00756002|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release; such communications can be embargoed for a period up to 150 days to permit actions necessary to preserve sponsor's intellectual property. Sponsor can request changes to the results communication only for the purpose of removing non study related information that is proprietary and confidential to sponsor. Sponsor can require delay of a results communication until the study has been completed at all participating sites.
20565|NCT00755937|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20566|NCT00755911|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20567|NCT00755846|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
20568|NCT00755807|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20569|NCT00755755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20570|NCT00755716|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20571|NCT00755417|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agree that the sponsor shall have the right to the first publication of the results of the study which is intended to be joint, multi-center publication. Following the first publication, the PI may publish data or results from the study, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the data of the proposed publication.Sponsor may remove any information that is considered confidential and or proprietary other than study data.
20572|NCT00755274|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
20573|NCT00755261|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20574|NCT00755235|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20575|NCT00755222|Principal Investigators are NOT employed by the organization sponsoring the study.|"Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~Auxilium Pharmaceuticals, Inc. agreements may vary with individual investigators but will not prohibit any investigator from publishing. Auxilium supports the publication of results from all centers of a multicenter trial but requests that reports based on single site data not preceed the primary publication of the entire clinical trial."
20576|NCT00755196|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20578|NCT00755105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20579|NCT00755079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20580|NCT00755040|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20581|NCT00754923|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20582|NCT00754832|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20583|NCT00754793|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20584|NCT00754767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20585|NCT00754741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20586|NCT00754650|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20587|NCT00754624|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
20588|NCT00754572|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20589|NCT00754559|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
20590|NCT00754546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20591|NCT00754494|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20592|NCT00754468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20593|NCT00754442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20594|NCT00754390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20595|NCT00754377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20596|NCT00754338|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20616|NCT00753545|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20597|NCT00754325|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
20598|NCT00754234|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20599|NCT00754208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20600|NCT00754156|Principal Investigators are NOT employed by the organization sponsoring the study.|
20601|NCT00754130|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
20602|NCT00754065|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution and/or Principal Investigator shall furnish the Sponsor with a copy of any proposed publication material at least sixty (60) days in advance of the date of submission for publication or presentation so that the proposed publication may be edited appropriately to remove any confidential information before publication or the Sponsor shall have sufficient additional time (not to exceed sixty (60) days) to file a patent application for such Confidential Information.
20603|NCT00754052|Principal Investigators are NOT employed by the organization sponsoring the study.|
20604|NCT00754013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20605|NCT00753948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20606|NCT00753935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20607|NCT00753922|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor acknowledges that the Investigator and his/her collaborators shall be free to publish the background, methods and results of their own research without restraint. Prior review of any proposed manuscript or abstract will be provided to Sponsor to prevent premature disclosure of trade secrets or proprietary information. The Investigator acknowledges that the Sponsor reserves the right to publish and present the overall study results, including assigning authorship.
20608|NCT00753896|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20609|NCT00753766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20610|NCT00753714|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20611|NCT00753688|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20612|NCT00753675|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20613|NCT00753649|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20614|NCT00753636|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20615|NCT00753623|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20617|NCT00753519|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20618|NCT00753506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20619|NCT00753454|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
20620|NCT00753415|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
20621|NCT00753363|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20622|NCT00753337|Principal Investigators are NOT employed by the organization sponsoring the study.|Medtronic has a legitimate interest in ensuring that a multi-center publication is the first publication to be released regarding the completed Study. The Institution agrees that it will not publish or disclose any results of or information pertaining to the study until a multi-center publication is released. If a publication is not released within one year after completion of the study, the Institution will have the right to publish information pertaining to their activities conducted.
20623|NCT00753298|Principal Investigators are NOT employed by the organization sponsoring the study.|Astra Tech shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time require that submission for publication or disclosure of the manuscript be delayed in order for Astra Tech to file patent applications.
20624|NCT00753272|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20625|NCT00753220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20626|NCT00753142|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20627|NCT00753012|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20628|NCT00752986|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20629|NCT00752973|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20630|NCT00752895|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20631|NCT00752791|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
20632|NCT00752726|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20633|NCT00752622|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission for publication of results obtained in this study, written permission is required. Draft manuscripts, abstracts & presentations should be submitted for review & approval. Schering-Plough Canada will retain the ownership of the data obtained in this study. Authorship of publications resulting from this study should accurately reflect the academic contribution of individuals to the design and implementation of the study, analysis of the data and preparation of the manuscript.
20634|NCT00752609|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
20635|NCT00752232|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20637|NCT00752102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20638|NCT00752089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20639|NCT00751998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20640|NCT00751972|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20641|NCT00751933|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20642|NCT00751881|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the Investigator can present or publish results. The investigator provides the sponsor with a copy of the presentation or publication for review and comment at least 30 days in advance of its submission.~The sponsor can delay the submission for a period not exceeding 90 days to allow for filing a patent application or such other measures as sponsor deems appropriate to establish and preserve its proprietary rights."
20643|NCT00751790|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication or scientific communication related to this study can only take place once the agreement between the Sponsor and the Investigator has been reached.
20644|NCT00751777|Principal Investigators are NOT employed by the organization sponsoring the study.|
20645|NCT00751634|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20646|NCT00751621|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
20647|NCT00751530|Principal Investigators are NOT employed by the organization sponsoring the study.|Site Investigators (PIs) agree not to individually publish the results of the study. They may participate in a joint publication of the study results with the sponsor.
20648|NCT00751400|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20649|NCT00751348|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20650|NCT00751296|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20651|NCT00751179|Principal Investigators are NOT employed by the organization sponsoring the study.|If a proposed publication contains reference to an invention owned by the Sponsor or to which the Sponsor otherwise has rights, the Sponsor may request a reasonable suspension of the publication in order to be able to file a patent application protecting such invention.
20652|NCT00751140|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20653|NCT00751114|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 45 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20654|NCT00751036|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
20655|NCT00750919|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20656|NCT00750893|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20657|NCT00750880|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20658|NCT00750867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20659|NCT00750815|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20660|NCT00750737|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20661|NCT00750373|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20662|NCT00750360|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20663|NCT00750308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20664|NCT00750282|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20665|NCT00750269|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
20666|NCT00750204|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20667|NCT00750191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20668|NCT00750152|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator agree not to individually publish the results of the Study. Institution and Principal Investigator may, however, upon written notice to Merz participate in a joint, multicenter publication of the Study results with other investigators and/or institutions, provided that the manuscript or abstract is first reviewed by Merz.
20669|NCT00750139|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator agree not to individually publish the results of the Study. Institution and Principal Investigator may, however, upon written notice to Merz participate in a joint, multicenter publication of the Study results with other investigators and/or institutions, provided that the manuscript or abstract is first reviewed by Merz.
20670|NCT00750061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20671|NCT00749996|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20672|NCT00749957|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20673|NCT00749944|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20674|NCT00749931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20675|NCT00749775|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20676|NCT00749684|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20677|NCT00749671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20678|NCT00749606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20679|NCT00749580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20680|NCT00749476|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
20681|NCT00749463|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20682|NCT00749398|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication or presentation (abstract, poster, oral communication and any other support existing or future), a copy of the final text should be forwarded by the Investigator(s) to the sponsor, for comment and authorization. Such comments and authorization shall aim to ensure the scientific content of the proposed publication and/or presentations and shall ensure that data and the material referring to the sponsor activities receive fair, accurate, and reasonable presentation.
20683|NCT00749268|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20684|NCT00749203|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20685|NCT00749190|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20686|NCT00749073|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20687|NCT00748982|All Principal Investigators ARE employed by the organization sponsoring the study.|The PI was employed at AstraZeneca and had therefore to follow AZ policy.
20688|NCT00748969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20689|NCT00748956|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20690|NCT00748865|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study. Alcon reserves the right of prior review of any publication or presentation of information related to the study.
20691|NCT00748826|Principal Investigators are NOT employed by the organization sponsoring the study.|Trial results belong to the SPONSOR only, all investigators are not allowed to publish trial results without permission of the SPONSOR.
20692|NCT00748709|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
20693|NCT00748657|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20694|NCT00748579|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor's intention was to publish the results of the trial in collaboration with the Investigators.
20695|NCT00748566|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20696|NCT00748553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20718|NCT00746954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20697|NCT00748410|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20698|NCT00748241|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20699|NCT00748189|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
20700|NCT00748098|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20701|NCT00748085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20702|NCT00748072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20703|NCT00747916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20704|NCT00747812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20705|NCT00747747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20706|NCT00747643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20707|NCT00747617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20708|NCT00747565|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs may not publish or disclose study data without Sponsor's prior written approval.
20709|NCT00747552|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20710|NCT00747474|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20711|NCT00747461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20712|NCT00747435|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall not publish until after the multi center publication, provided that the multi center publication is submitted within 12 months after conclusion of the study.
20713|NCT00747344|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20714|NCT00747227|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs may not publish or disclose study data without Sponsor's prior written approval.
20715|NCT00747214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20716|NCT00747149|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time require that submission for publication or disclosure of the manuscript be delayed in order for AstraZeneca to file patent applications.
20717|NCT00747006|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
20719|NCT00746941|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 45 to 60 days as agreed within their clinical trial agreement to review any manuscript for a proposed publication and must delay publication for up to an additional 60 to 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
20720|NCT00746889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20721|NCT00746863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20722|NCT00746798|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
20723|NCT00746785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20724|NCT00746733|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20725|NCT00746694|Principal Investigators are NOT employed by the organization sponsoring the study.|"Study data may be used in general publications or at conferences. Authorship will be attributed to those responsible for preparing the report and/or those who had a relevant part in designing the study. Whenever publication rules allow, all investigators will be listed individually.~Investigators may publish their data individually. In this case investigators will notify the study sponsor, including the communication/manuscript to be published, at least 30 days before submission."
20726|NCT00746668|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20727|NCT00746590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20728|NCT00746564|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20729|NCT00746551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20730|NCT00746512|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20731|NCT00746421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20732|NCT00746395|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20733|NCT00746356|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20734|NCT00746330|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20735|NCT00746252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20736|NCT00746239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20737|NCT00746187|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20738|NCT00746096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the sponsor and PI that no restricts the PI's right but need to discuss the timing of publish date of trial results after the trial is completed.
20739|NCT00746018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20740|NCT00745940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20741|NCT00745901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20742|NCT00745875|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca can review results communications prior to public release and may within 60 days of receipt require amendments to be made. AstraZeneca can also require that submission or disclosure be delayed for 90 days to allow for the filing of a patent application.
20743|NCT00745823|Principal Investigators are NOT employed by the organization sponsoring the study.|Twenty-four months after completion of this study or after publication of the multicenter results, an investigator may publish the results for their study site independently. The sponsor must have the opportunity to review all proposed publications or presentations regarding the study 60 days before submission.
20744|NCT00745498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20745|NCT00745420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20746|NCT00745368|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20747|NCT00745290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20748|NCT00745251|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
20749|NCT00745095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20750|NCT00745030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20751|NCT00744978|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20752|NCT00744939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20753|NCT00744874|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20754|NCT00744848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20755|NCT00744757|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20756|NCT00744692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20757|NCT00744653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20758|NCT00744627|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
20759|NCT00744523|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20760|NCT00744497|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
20761|NCT00744380|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20762|NCT00744328|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20763|NCT00744263|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20764|NCT00744237|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute."
20765|NCT00744211|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20766|NCT00744055|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20767|NCT00744042|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20768|NCT00743730|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20769|NCT00743717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20770|NCT00743652|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20771|NCT00743574|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20772|NCT00743509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20773|NCT00743483|Principal Investigators are NOT employed by the organization sponsoring the study.|
20774|NCT00743444|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between PI and Sponsor (AZ) or its agents that restricts the PI's right to discuss/publish trial results after the trial is completed. The PI agrees to collaborate in good faith with AZ with regards to content and formation of any publication or disclosure to be made by PI and to pay due consideration to opinions offered by AZ.
20775|NCT00743431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20776|NCT00743366|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20777|NCT00743340|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
20778|NCT00743288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20800|NCT00742235|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20779|NCT00743275|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
20780|NCT00743262|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20781|NCT00743249|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
20782|NCT00743197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20783|NCT00743119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20784|NCT00743106|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20785|NCT00743093|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20786|NCT00742963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20787|NCT00742924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20788|NCT00742885|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20789|NCT00742872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20790|NCT00742859|Principal Investigators are NOT employed by the organization sponsoring the study.|Due to multiple studies, centers and countries this may vary.
20791|NCT00742781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20792|NCT00742625|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20793|NCT00742560|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
20794|NCT00742508|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20795|NCT00742417|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators are free to publish the results after signing the final report. When several papers are published, each one will be mainly prepared by the more experienced investigator who will appear as first author. The rest of co-authors will appear in the order considered opportune by the principal investigator. Sponsor will receive a copy of the manuscript for review at least 30 days prior to submission for publication or presentation of the abstract at some scientific meeting.
20796|NCT00742391|Principal Investigators are NOT employed by the organization sponsoring the study.|After the Study is completed, Institution shall have the right to publish their own data resulting from the Study upon the earlier of (a) publication of a multi-center publication coordinated by Sponsor or (b) the date of submission of the data resulting from the Study by Sponsor to the FDA. Institution shall furnish Sponsor with a copy of any proposed publication or release at least 90 days in advance of the proposed submission or presentation date.
20797|NCT00742326|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20798|NCT00742313|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20799|NCT00742274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20801|NCT00742209|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20802|NCT00742183|Principal Investigators are NOT employed by the organization sponsoring the study.|The Coordinating Investigator will be the lead author for the mail (primary) publication from this Investigation. For any abstract and/or manuscript the Investigators will be given at least 14 days review time before the intended submission of the document.
20803|NCT00742170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20804|NCT00742079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20805|NCT00742053|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20806|NCT00741988|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
20807|NCT00741936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20808|NCT00741858|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20809|NCT00741819|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20810|NCT00741611|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release at least 60 days prior to publication and that the multi-center results should be published prior to any individual site results unless the multi-center results are not published 2 years after the trial is complete. The only embargo that the sponsor can impose is on the release of confidential information.
20811|NCT00741598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20812|NCT00741468|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
20813|NCT00741390|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20814|NCT00741338|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
20815|NCT00741286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20816|NCT00741273|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
20817|NCT00741260|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20818|NCT00741156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20840|NCT00739973|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20819|NCT00741104|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees not to publish/publicly present any interim results of the Study. PI further agrees to provide 45 days written notice to Sponsor prior to submission for publication/presentation to permit Sponsor to review drafts of any material before publication which report any results arising out of the Study. Sponsor shall have the right to review and comment.
20820|NCT00741091|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the Sponsor can review results communications prior to public release and can embargo communication regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the Sponsor for review. The Sponsor can require changes to the communication to remove any confidential information or other proprietary information of Sponsor.
20821|NCT00741039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20822|NCT00741026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20823|NCT00741013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20824|NCT00740870|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20825|NCT00740857|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agreed to allow the sponsor 30 days to review and approve abstracts and 60 days to review and approve manuscripts prior to submission to protect against disclosure of confidential information.
20826|NCT00740831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20827|NCT00740792|Principal Investigators are NOT employed by the organization sponsoring the study.|"Investigators participating in multicenter studies must agree not to present data gathered individually or by a subgroup of centers before the full, initial publication, unless this has been agreed to by all other investigators and Meda Pharmaceuticals.~Meda Pharmaceuticals requests that it receive copies of any intended communication reasonably in advance (at least 15 working days for an abstract or oral presentation and 45 working days for a manuscript)"
20828|NCT00740779|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20829|NCT00740727|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20830|NCT00740714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20831|NCT00740636|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20832|NCT00740597|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20833|NCT00740584|Principal Investigators are NOT employed by the organization sponsoring the study.|No disclosure without SPL consent.
20834|NCT00740480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20835|NCT00740220|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20836|NCT00740207|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be presented during scientific symposia or published in a scientific journal only after review by Bracco in accordance with the guidelines set forth in the applicable publication or financial agreement.
20837|NCT00740181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20838|NCT00740051|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20839|NCT00739999|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20841|NCT00739934|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20842|NCT00739908|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators were informed that the first publication or disclosure of study results shall be a complete, joint multicenter publication or disclosure coordinated by CeNeRx. Thereafter, any secondary publications will reference the original publication(s).
20843|NCT00739882|Principal Investigators are NOT employed by the organization sponsoring the study.|
20844|NCT00739765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20845|NCT00739752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20846|NCT00739674|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20847|NCT00739661|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20848|NCT00739648|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20849|NCT00739596|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
20850|NCT00739583|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20851|NCT00739336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20852|NCT00739310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20853|NCT00739297|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20854|NCT00739102|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20855|NCT00739063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20856|NCT00739050|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20857|NCT00739024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20858|NCT00738972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20859|NCT00738881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20860|NCT00738699|Principal Investigators are NOT employed by the organization sponsoring the study.|
20861|NCT00738673|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
20862|NCT00738543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20863|NCT00738530|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
20864|NCT00738426|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20865|NCT00738400|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20866|NCT00738374|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20867|NCT00738361|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20868|NCT00738283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20869|NCT00738062|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20870|NCT00738049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20871|NCT00738023|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20872|NCT00737737|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20873|NCT00737711|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20874|NCT00737672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20875|NCT00737633|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
20876|NCT00737594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20877|NCT00737568|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
20878|NCT00737529|Principal Investigators are NOT employed by the organization sponsoring the study.|Single center publications may not be submitted until after multicenter publication is submitted (or 1 year after study completion), whichever comes first. The investigator may then publish results provided that Celgene receive a copy of any proposed publication/presentation at least 30 days in advance of submission, delete any confidential information & delay the submission for up to 60 additional days for patent filing. Multicenter publications must include input from investigators & Celgene.
20879|NCT00737477|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20880|NCT00737464|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
20881|NCT00737438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20882|NCT00737360|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20883|NCT00737282|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
20884|NCT00737243|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
20885|NCT00737204|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20886|NCT00737178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20887|NCT00737100|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20888|NCT00737061|Principal Investigators are NOT employed by the organization sponsoring the study.|"All publications must be submitted for review and approval at least (30) days before the date on which it is to be submitted.~No publication of data wil be permitted prior to the submission and publication of the entire clinical trial."
20889|NCT00737048|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the Principal Investigator is that the Sponsor can review results communications prior to public release.
20890|NCT00736996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20891|NCT00736957|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release.
20892|NCT00736944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20893|NCT00736879|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
20894|NCT00736853|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PIs is that the Sponsor can review results communications prior to public release.
20895|NCT00736840|Principal Investigators are NOT employed by the organization sponsoring the study.|Any manuscript, abstract or other publication or presentation of results or information arising from the study (including ancillary studies involving trial patients) must be prepared in conjunction with Exalenz. Such materials must be submitted to Exalenz for review and comment at least 30 days prior to submission for publication or presentation.
20896|NCT00736723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20897|NCT00736645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20898|NCT00736580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20899|NCT00736502|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20900|NCT00736489|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to any publication or disclosure, the PI provides AstraZeneca with preliminary data and drafts and with the proposed final manuscript. AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript to review it and may within such time frame require that submission for publication or disclosure be delayed.
20901|NCT00736476|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20902|NCT00736385|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20903|NCT00736333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20904|NCT00736255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20905|NCT00736242|Principal Investigators are NOT employed by the organization sponsoring the study.|
20906|NCT00736229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20907|NCT00736190|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may discuss or publish results (without Gilead’s confidential information) after all results have been publicly disclosed by/with consent of Gilead or study has been completed >=2 years. Proposed publication/presentation and destination details must be submitted >=30 days before submission. The investigator agrees to withhold publication or presentation for an additional 60 days in order to obtain patent protection if deemed necessary.
20908|NCT00736125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20909|NCT00736099|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
20910|NCT00736073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20911|NCT00736034|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20912|NCT00735969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20913|NCT00735943|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20914|NCT00735917|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20915|NCT00735904|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20916|NCT00735839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20917|NCT00735787|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
20918|NCT00735709|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
20940|NCT00734734|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
20919|NCT00735696|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
20920|NCT00735670|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20921|NCT00735644|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
20922|NCT00735618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20923|NCT00735553|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
20924|NCT00735475|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20925|NCT00735462|Principal Investigators are NOT employed by the organization sponsoring the study.|a term restricts that PI can publish their trial results within 12 months of completion of the trial.
20926|NCT00735449|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
20927|NCT00735436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20928|NCT00735397|Principal Investigators are NOT employed by the organization sponsoring the study.|
20929|NCT00735371|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20930|NCT00735306|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20931|NCT00735254|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20932|NCT00735072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20933|NCT00735007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20934|NCT00734994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20935|NCT00734968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20936|NCT00734929|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20937|NCT00734851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20938|NCT00734799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20939|NCT00734747|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20941|NCT00734656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20942|NCT00734630|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 60 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential information. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in the publication. On sponsor's request, PI shall delay submission for any pub while sponsor files patent applications. Any publication will give recognition to Sponsor's support.
20943|NCT00734617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20944|NCT00734604|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20945|NCT00734591|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
20946|NCT00734578|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
20947|NCT00734539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20948|NCT00734500|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20949|NCT00734474|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20950|NCT00734409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20951|NCT00734344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20952|NCT00734305|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20953|NCT00734214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20954|NCT00734162|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
20955|NCT00734149|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20956|NCT00734097|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20957|NCT00734071|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
20958|NCT00734032|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20959|NCT00733993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20960|NCT00733980|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20961|NCT00733954|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data results from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
20962|NCT00733824|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20963|NCT00733746|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20964|NCT00733512|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Confidential information will be submitted for publication without Sponsor’s prior written agreement.
20965|NCT00733499|Principal Investigators are NOT employed by the organization sponsoring the study.|DePuy reserves the right to review the contents of publications in advance.The PI may freely disclose the trial results only after DePuy has been given the opportunity of reviewing the proposed results communications at least 30 days prior to the intended release.DePuy will advise the PI of any perceived errors,omissions or corrections but the PI will retain final editorial control.In case of disagreement,DePuy and the PI will make every effort to meet in order to discuss and resolve any issues.
20966|NCT00733421|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20967|NCT00733369|Principal Investigators are NOT employed by the organization sponsoring the study.|DePuy reserves the right to review the contents of publications in advance.The PI may freely disclose the trial results only after DePuy has been given the opportunity of reviewing the proposed results communications at least 30 days prior to the intended release.DePuy will advise the PI of any perceived errors,omissions or corrections but the PI will retain final editorial control.In case of disagreement,DePuy and the PI will make every effort to meet in order to discuss and resolve any issues.
20968|NCT00733356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20969|NCT00733330|Principal Investigators are NOT employed by the organization sponsoring the study.|DePuy reserves the right to review the contents of publications in advance.The PI may freely disclose the trial results only after DePuy has been given the opportunity of reviewing the proposed results communications at least 30 days prior to the intended release.DePuy will advise the PI of any perceived errors,omissions or corrections but the PI will retain final editorial control.In case of disagreement,DePuy and the PI will make every effort to meet in order to discuss and resolve any issues.
20970|NCT00733304|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20971|NCT00733291|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study.
20972|NCT00733278|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20973|NCT00733226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20974|NCT00733135|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can not make any publication concerning the study without providing the sponsor 30 days to review it and provide comments. The Sponsor may require PI to delay publication until any factual errors are corrected. If the sponsor determines the proposed publication contains confidential information, or patentable subject matter that requires protection, the sponsor may require delay of the publication less than or equal to 90 days.
20975|NCT00733096|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20976|NCT00733005|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20977|NCT00732992|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21000|NCT00731783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20978|NCT00732940|Principal Investigators are NOT employed by the organization sponsoring the study.|For multi-center trials,no investigator will be authorized to publish study results from an individual center until the earlier of the multi-center trial results are published or 12 months after the end or termination of the multi-center trial at all sites. All manuscripts and abstracts must be submitted to the sponsor for review least 30 days prior to submission for publication or for presentation at a scientific meeting. The sponsor may delay publication for up to 3 months if indicated.
20979|NCT00732901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20980|NCT00732875|Principal Investigators are NOT employed by the organization sponsoring the study.|All proposed publications/presentations by the investigators or their personnel/associates resulting from/relating to this study must be submitted to SP Korea for review and approval before submission for publication/presentation. If the proposed publication/presentation contains patentable subject matter, which, at SP Korea’s sole discretion, warrants intellectual property protection, SP Korea may delay any publication or presentation for the purpose of pursuing such protection.
20981|NCT00732758|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20982|NCT00732680|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20983|NCT00732654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20984|NCT00732641|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator (PI) agrees not to publish/publicly present any interim study results without the sponsor's prior written consent. The PI further agrees to provide 45 days written notice to the sponsor prior to submission for publication/presentation to permit the sponsor to review copies of abstracts or manuscripts for publication which report any results of the Study. The sponsor shall have the right to review and comment on any presentation, which shall include editorial rights.
20985|NCT00732615|Principal Investigators are NOT employed by the organization sponsoring the study.|
20986|NCT00732472|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
20987|NCT00732381|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
20988|NCT00732303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20989|NCT00732251|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20990|NCT00732238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20991|NCT00732225|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written agreement.
20992|NCT00732212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20993|NCT00732199|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20994|NCT00732160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20995|NCT00732069|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20996|NCT00732030|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written agreement.
20997|NCT00731939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20998|NCT00731874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
20999|NCT00731822|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21001|NCT00731731|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21002|NCT00731692|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
21003|NCT00731679|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21004|NCT00731666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21005|NCT00731653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21006|NCT00731640|Principal Investigators are NOT employed by the organization sponsoring the study.|Specify: No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written agreement.
21007|NCT00731614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21008|NCT00731549|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21009|NCT00731484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21010|NCT00731341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21011|NCT00731211|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
21012|NCT00731198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21013|NCT00731133|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21014|NCT00731120|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
21015|NCT00731094|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21016|NCT00731055|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21017|NCT00731042|Principal Investigators are NOT employed by the organization sponsoring the study.|PI was a test lab, and they do not publish study result. Sponsor can choose to publish.
21018|NCT00730964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21019|NCT00730925|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
21020|NCT00730912|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator (sub-investigator) will disclose the results and knowledge obtained through this study after discussion with the Sponsor and approval is obtained from the Sponsor.~If the investigator (sub-investigator) is to present the results obtained from this study at a medical conference or medical journal, approval of the Sponsor must be obtained beforehand"
21021|NCT00730847|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21022|NCT00730756|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21023|NCT00730730|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator/Institution agree to submit to Sponsor copies of any proposed publication/public presentation (“Proposed Publication”) at least sixty (60) calendar days in advance of dissemination. Sponsor will review/comment within thirty (30) calendar days after receipt thereof. If Sponsor objects to dissemination of any part of the Proposed Publication, Investigator, and Institution shall refrain from disseminating or presenting such Proposed Publication until Sponsor is satisfied.
21024|NCT00730691|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
21025|NCT00730639|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trials primary publication.
21026|NCT00730483|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21027|NCT00730405|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21028|NCT00730353|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21029|NCT00730327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21030|NCT00730275|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
21031|NCT00730236|Principal Investigators are NOT employed by the organization sponsoring the study.|The CTAs generally envision a multisite publication, with the PI’s right to publish individually if the pooled publication does not occur within 12 months of study completion. Sponsor has a 45 to 60 day review/approval period to request deletion of confidential information or to request limited deferral to protect its proprietary technology. In one case, the publication provision is more general, specifying that the Sponsor and clinical site will agree on the manner/terms of publication.
21032|NCT00730171|Principal Investigators are NOT employed by the organization sponsoring the study.|PI may publish or disclose the results of the study 24 months after final data lock provided that sponsor can review the publication prior to public release, sponsor can request removal of confidential information of sponsor (not including results of trial), and sponsor can request a publication delay in order to protect potentially patentable information. Furthermore, if a publication committee is developing an initial publication, PI is to delay disclosure until that publication is published
21033|NCT00730132|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure agreement restricts the rights on publications within 5 years after the document is signed off. The Clinical Trial Agreement restricts the rights on publication within 5 years after the trial completion.
21034|NCT00730041|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agree to submit copies of proposed manuscripts or abstracts to sponsor at least 45 days in advance of public release. If sponsor requests or requires changes, an additional 90 days are allowed for this. Upon completion of the last subject follow-up for the Evaluation, a period of one year shall be reserved for publication of the entire trial results. No individual investigator may publish their individual site results prior to the publication of the group data.
21035|NCT00730028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21036|NCT00730015|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that publication cannot be made for 24 months from the date of final data lock of the study, the sponsor can review the publication prior to public release, sponsor requires a minimum 60 day review period for each publication, sponsor can request removal of confidential information of sponsor (not including results of trial), and sponsor can request an additional delay period of 60 days in order to protect potentially patentable information.
21037|NCT00729937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21038|NCT00729924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21039|NCT00729859|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21040|NCT00729846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21041|NCT00729833|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21042|NCT00729807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21043|NCT00729781|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21044|NCT00729690|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21045|NCT00729677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21046|NCT00729651|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21047|NCT00729612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21048|NCT00729560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21049|NCT00729521|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21050|NCT00729482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21051|NCT00729469|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
21052|NCT00729430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21053|NCT00729378|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21054|NCT00729365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21055|NCT00729326|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21056|NCT00729248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21057|NCT00729183|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
21058|NCT00729157|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21059|NCT00728988|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21060|NCT00728962|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
21061|NCT00728923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21062|NCT00728910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21063|NCT00728884|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
21064|NCT00728845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21065|NCT00728819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21066|NCT00728754|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
21067|NCT00728728|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21068|NCT00728689|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must have sponsor's written consent to publish and must provide information to the sponsor at least 30 working days prior to publication submission deadline.
21069|NCT00728507|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21070|NCT00728494|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information obtained in the course of conducting the study, including all data concerning the study and its results, are confidential and cannot be disclosed to any third parties without the consent of Schering-Plough.
21071|NCT00728481|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21072|NCT00728468|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21073|NCT00728416|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21074|NCT00728260|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
21075|NCT00728182|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator shall have the right to publish any information after prior submittal to NoNO, where NoNO can request a hold for up to 60 days, provided that no publication shall disclose Proprietary Information other than Data containing the results of the Study. Investigators may not publish in the first 18 months after the close of the trial except within a publication representing all participating clinical sites.
21076|NCT00728130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21077|NCT00727961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21078|NCT00727909|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21100|NCT00727025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21079|NCT00727857|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo trial results communications up to 150 days to permit actions necessary to preserve sponsor's intellectual property. Sponsor can request changes to the results communication only for the purpose of removing non study related information that is proprietary and confidential to sponsor. Sponsor can require delay of a results communication until the study has been completed at all participating sites.
21080|NCT00727844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21081|NCT00727740|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21082|NCT00727714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21083|NCT00727649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21084|NCT00727636|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21085|NCT00727597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21086|NCT00727571|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
21087|NCT00727558|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
21088|NCT00727506|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
21089|NCT00727402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21090|NCT00727337|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21091|NCT00727311|Principal Investigators are NOT employed by the organization sponsoring the study.|All rights according to the results belong to Essex, Germany. Publications or transmission of data need a previous written agreement of the company.
21092|NCT00727298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21093|NCT00727272|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21094|NCT00727259|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication or communication (written or oral) could be performed by the Principal Investigator only after written approval from Schering-Plough.
21095|NCT00727246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21096|NCT00727220|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21097|NCT00727194|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21098|NCT00727090|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21099|NCT00727064|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
21101|NCT00726999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21102|NCT00726986|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21103|NCT00726895|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21104|NCT00726882|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
21105|NCT00726830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21106|NCT00726752|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21107|NCT00726739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21108|NCT00726713|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay publication of study results until after multi-center results were published or, a period of up to 20 months had elapsed after termination of the study, whichever shall occur first.
21109|NCT00726661|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
21110|NCT00726622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21111|NCT00726609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21112|NCT00726557|Principal Investigators are NOT employed by the organization sponsoring the study.|Trial results belong to the Sponsor only, all investigators are not allowed to publish trial results without permission of the Sponsor.
21113|NCT00726453|Principal Investigators are NOT employed by the organization sponsoring the study.|
21114|NCT00726414|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21115|NCT00726375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21116|NCT00726323|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21117|NCT00726232|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study; provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
21118|NCT00726180|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21119|NCT00726063|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
21120|NCT00726037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21121|NCT00725985|Principal Investigators are NOT employed by the organization sponsoring the study.|
21122|NCT00725959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21123|NCT00725920|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21124|NCT00725842|Principal Investigators are NOT employed by the organization sponsoring the study.|Study data disclosure is prohibited; data and study results are the exclusive property of the Sponsor.
21125|NCT00725764|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21126|NCT00725751|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21127|NCT00725725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21128|NCT00725712|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21129|NCT00725621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21130|NCT00725608|Principal Investigators are NOT employed by the organization sponsoring the study.|Study results belong to the Sponsor only, all investigators are not allowed to publish study results without permission of the Sponsor.
21131|NCT00725543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21132|NCT00725530|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21133|NCT00725504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21134|NCT00725491|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review any scientific paper, presentation, or other communication concerning the clinical trial at least 6 weeks ahead of estimated publication or presentation. In order to protect its proprietary interests, the sponsor shall have the right to make its consent, which shall not be withheld unreasonably, conditional upon proper representation of the interpretation of both the sponsor and the investigator(s) in the discussion of the data in such communications.
21135|NCT00725452|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21136|NCT00725361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21137|NCT00725322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21138|NCT00725296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21139|NCT00725270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21140|NCT00725205|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators require the SPONSOR'S written permission to publish any information pertaining to the study during and five years after closure of the study.
21141|NCT00725153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21142|NCT00725101|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21143|NCT00725075|Principal Investigators are NOT employed by the organization sponsoring the study.|Any scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the sponsor at least six weeks ahead of estimated publication or presentation, for written consent. The sponsor shall have the right to make its consent of information conditional upon proper representation of the interpretation of both the sponsor and the investigator(s) in the discussion of the data in such communications.
21144|NCT00725049|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
21145|NCT00725010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21146|NCT00724984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21147|NCT00724958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21148|NCT00724945|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
21149|NCT00724932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21150|NCT00724893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21151|NCT00724867|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21152|NCT00724854|Principal Investigators are NOT employed by the organization sponsoring the study.|Whenever a Principal Investigator wishes to use the results of the study, he/she should contact the sponsor to obtain the authorization.
21153|NCT00724815|Principal Investigators are NOT employed by the organization sponsoring the study.|Per the study agreement, Investigators have the right to publish or present information and/or data arising from the study, provided the text of any such publication or presentation is submitted for review at least thirty days prior to submission for publication or other disclosure and NuPathe shall have the right to request the removal of any confidential information.
21154|NCT00724750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21155|NCT00724711|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
21156|NCT00724698|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agree only to use such information to conduct the study and will not be able to publish the results of any part of the study without previous writeen authorization from Schering-Plough.
21157|NCT00724594|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21158|NCT00724568|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21159|NCT00724477|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of this non-interventional study can be published or presented by members of the scientific committee after revision and agreement by Schering-Plough, and in such a way that the confidential information and industrial property are not revealed. Before publication or presentation, a copy of the final text must be sent by the member(s) of the scientific committee to Schering-Plough for comment.
21160|NCT00724464|Principal Investigators are NOT employed by the organization sponsoring the study.|"The principal investigator agrees not to publish or publicly present any interim results of the Study without prior written consent of the SPONSOR. The principal investigator further agrees to provide forty-five (45) days written notice to the SPONSOR prior to submission for publication or presentation~to permit the SPONSOR to review copies of abstracts or manuscripts for publication which report any results of the Study. The SPONSOR shall have the right to review & comment on any presentation."
21161|NCT00724451|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator agrees not to publish or publicly present any interim results of the Study without prior written consent of the sponsor. The principal investigator further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of abstracts or manuscripts for publication.
21162|NCT00724373|Principal Investigators are NOT employed by the organization sponsoring the study.|All data will be the property of the Sponsor. Although under no obligation, it is asked that the investigator discuss any publication with the sponsor prior to release and obtain written consent. The sponsor recognises the right of the investigator to publish the results upon study completion. However, it is asked that the investigator send a draft to the sponsor 30 days in advance of submission in order to obtain approval.
21163|NCT00724347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21164|NCT00724308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21165|NCT00724282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21166|NCT00724243|Principal Investigators are NOT employed by the organization sponsoring the study.|Contractor agrees to acknowledge his contractual relationship with Sponsor in his lecturing or publication activities in relation to subject matter and/or in relation to any other matter concerning Sponsor. However, unless Sponsor’s prior consent was given, Contractor shall not specify in more detail the content or subject matter of his contract. Contractor shall not publish or provide to 3rd parties for publication purposes any results of his activities without Sponsor’s prior written consent.
21167|NCT00724152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21168|NCT00724126|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21169|NCT00724061|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21170|NCT00724009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21171|NCT00723957|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
21172|NCT00723944|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
21173|NCT00723931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21174|NCT00723892|Principal Investigators are NOT employed by the organization sponsoring the study.|Data publishing of the observational study is forbidden. Data and results of the observational study are the exclusive property of the Sponsor.
21175|NCT00723840|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the principal investigator (PI) is that the PI agrees not to publish or publicly present any results of the study without the prior written permission of the sponsor. The PI further agrees to allow the sponsor to review, 30 days prior to submission for publication or presentation, copies of abstracts or manuscripts for publication (including texts of oral presentations) which report any results of the study.
21176|NCT00723827|Principal Investigators are NOT employed by the organization sponsoring the study.|The institution has the right to publish/present the study results. The institution agrees not to publish/present any interim results of the Study without the Sponsor's prior written consent. The institution further agrees to provide the Sponsor 30 days written notice prior to submission. The Sponsor has the right to review and comment. If the parties disagree, the institution agrees to meet with the Sponsor, prior to submission, to discuss and resolve any such issues or disagreement.
21177|NCT00723801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21178|NCT00723788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21179|NCT00723749|Principal Investigators are NOT employed by the organization sponsoring the study.|Trial results belong to the Sponsor only, all investigators are not allowed to publish trial results without permission of the Sponsor.
21180|NCT00723736|Principal Investigators are NOT employed by the organization sponsoring the study.|Any trial related information may be released by the PI to third party only after written consent is obtained from the sponsor. This restriction is valid until 5 years after study closure.
21181|NCT00723710|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21182|NCT00723697|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication (abstract, poster, communication...) can be made without the agreement of SCHERING-PLOUGH.
21183|NCT00723645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21184|NCT00723632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21185|NCT00723606|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21186|NCT00723580|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21187|NCT00723554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21188|NCT00723528|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on Principle investigator is that the sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the sponsor requires.
21189|NCT00723489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21190|NCT00723450|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21191|NCT00723294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21192|NCT00723255|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21193|NCT00723229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21194|NCT00723203|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21195|NCT00723190|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
21196|NCT00723177|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21197|NCT00723125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21198|NCT00723073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21199|NCT00723021|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21200|NCT00723008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21201|NCT00722865|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21202|NCT00722800|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21203|NCT00722761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21204|NCT00722722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21205|NCT00722566|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21226|NCT00721357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21206|NCT00722553|Principal Investigators are NOT employed by the organization sponsoring the study.|Allos agreements with investigators (PIs) may vary. The PI may publish/make public data from the trial after the earlier of publication by Allos or 18 months after study completion. Allos can review results communications prior to public release and can embargo communications regarding trial results for a period less than or equal to 90 days from submission for review. Allos can request changes to the communication related to confidential or patent information, or to ensure accuracy.
21207|NCT00722436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21208|NCT00722423|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21209|NCT00722371|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
21210|NCT00722137|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
21211|NCT00722124|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21212|NCT00722111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21213|NCT00722072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21214|NCT00722020|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21215|NCT00721968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21216|NCT00721955|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21217|NCT00721799|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21218|NCT00721734|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
21219|NCT00721630|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21220|NCT00721617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21221|NCT00721578|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21222|NCT00721539|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21223|NCT00721500|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
21224|NCT00721409|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21225|NCT00721396|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21227|NCT00721279|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
21228|NCT00721253|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Condfidential information will be submitted for publication without Sponsor’s prior written agreement.
21229|NCT00721227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21230|NCT00721214|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21231|NCT00721188|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21232|NCT00721175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21233|NCT00721162|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
21234|NCT00721149|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is allowed to publish but must submit draft publication(s) to Biosense Webster, Inc. at least 30 days prior to submission for publication or presentation.
21235|NCT00721136|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21236|NCT00721123|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21237|NCT00721110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21238|NCT00720941|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
21239|NCT00720798|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21240|NCT00720759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21241|NCT00720629|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21242|NCT00720499|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
21243|NCT00720473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21244|NCT00720434|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21245|NCT00720382|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, joint publication is required to assure that the initial publication is based on all data from all sites and investigators participating in these studies agree not to present data gathered individually or by subgroup centers before the initial publication unless jointly agreed by all other investigators and the sponsor. Authorship will be determined by mutual agreement.
21246|NCT00720369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21247|NCT00720343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21248|NCT00720330|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21249|NCT00720278|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, joint publication is required to assure that the initial publication is based on all data from all sites and investigators participating in these studies agree not to present data gathered individually or by subgroup centers before the initial publication unless jointly agreed by all other investigators and the sponsor. authorship will be determined by mutual agreement.
21250|NCT00720226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21251|NCT00720122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21252|NCT00720109|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21253|NCT00720096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21254|NCT00720083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21255|NCT00720057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21256|NCT00719953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21257|NCT00719914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21258|NCT00719901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21259|NCT00719862|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, joint publication is required to assure that the initial publication is based on all data from all sites and investigators participating in these studies agree not to present data gathered individually or by subgroup centers before the initial publication unless jointly agreed by all other investigators and the sponsor. authorship will be determined by mutual agreement.
21260|NCT00719849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21261|NCT00719810|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor retains control of all publication rights.
21262|NCT00719732|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Condfidential information will be submitted for publication without Sponsor’s prior written agreement.
21263|NCT00719706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21264|NCT00719680|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21265|NCT00719615|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21266|NCT00719576|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21267|NCT00719563|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21268|NCT00719537|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21269|NCT00719472|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21270|NCT00719355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21271|NCT00719329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21272|NCT00719264|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
21273|NCT00719212|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21274|NCT00719186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21275|NCT00719160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21276|NCT00719134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21277|NCT00719043|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21278|NCT00718887|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
21279|NCT00718861|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
21280|NCT00718809|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21281|NCT00718770|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21282|NCT00718718|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
21283|NCT00718640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21284|NCT00718523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21285|NCT00718510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21286|NCT00718328|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21287|NCT00718315|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21288|NCT00718302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21289|NCT00718237|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21290|NCT00718120|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21291|NCT00718094|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21292|NCT00718081|Principal Investigators are NOT employed by the organization sponsoring the study.|requires prior consent
21293|NCT00718042|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI must provide a copy of any proposed publication/presentation at least 30 days prior to submission for sponsor's review/approval. The PI must incorporate changes as the sponsor requires in order to protect the sponsor's proprietary rights and interests. The sponsor may require the PI to include acknowledgement of the sponsor’s role in the study. The PI may be requested to delay publication/presentation an extra 60 days to enable sponsor to secure patent or other proprietary protection.
21294|NCT00717977|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21295|NCT00717912|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21296|NCT00717886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21297|NCT00717873|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21298|NCT00717860|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
21299|NCT00717756|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21300|NCT00717574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21301|NCT00717522|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene’s request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation.
21302|NCT00717418|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
21303|NCT00717405|Principal Investigators are NOT employed by the organization sponsoring the study.|Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21304|NCT00717366|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21305|NCT00717314|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21306|NCT00717288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21307|NCT00717275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21308|NCT00717249|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21309|NCT00717236|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
21310|NCT00717197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21311|NCT00717093|Principal Investigators are NOT employed by the organization sponsoring the study.|
21312|NCT00717067|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21313|NCT00717054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21314|NCT00717041|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21315|NCT00716976|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
21316|NCT00716963|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21317|NCT00716859|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21318|NCT00716820|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21319|NCT00716807|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21320|NCT00716742|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
21321|NCT00716625|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21322|NCT00716482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21323|NCT00716456|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21324|NCT00716443|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
21325|NCT00716417|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
21326|NCT00716274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21327|NCT00716144|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21328|NCT00716092|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
21329|NCT00716079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21330|NCT00715962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21331|NCT00715949|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21332|NCT00715910|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21333|NCT00715884|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21334|NCT00715793|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21335|NCT00715754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21336|NCT00715741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21337|NCT00715676|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21338|NCT00715650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21339|NCT00715624|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21340|NCT00715559|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21341|NCT00715520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21342|NCT00715403|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
21343|NCT00715390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21344|NCT00715299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21345|NCT00715208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21346|NCT00715117|Principal Investigators are NOT employed by the organization sponsoring the study.|No restrictions by the sponsor. The PI may disclose results after the manuscript has been published.
21347|NCT00715104|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentations relating to the study will be coordinated by Dendreon in communication with institutions contributing patients to the study.
21348|NCT00715078|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the Study will be published and/or presented in an integrated manner reflecting the results observed across all participating centers. Accordingly, decisions on timing and content of publications and presentations relating to the Study will be coordinated by Dendreon in communication with institutions contributing patients to the Study.
21349|NCT00715026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21350|NCT00714948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21351|NCT00714870|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21352|NCT00714792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21353|NCT00714714|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21354|NCT00714688|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21355|NCT00714571|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21356|NCT00714493|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21357|NCT00714389|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21358|NCT00714311|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21359|NCT00714285|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21360|NCT00714259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21361|NCT00714233|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21362|NCT00714168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21363|NCT00714051|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21364|NCT00713830|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21365|NCT00713817|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21366|NCT00713700|Principal Investigators are NOT employed by the organization sponsoring the study.|
21367|NCT00713661|Principal Investigators are NOT employed by the organization sponsoring the study.|After publication of the results or 24 months after Clinical Trial Report has been finalised, whichever comes first, Nycomed acknowledge the Investigator's rights to publish results from this trial. Any such scientific paper, presentation, communication, or other information concerning the investigation described in this protocol, must be submitted to Nycomed prior to submission for publication/presentation for review. Review comments will be given within a month from receipt of the manuscript.
21386|NCT00712543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21368|NCT00713648|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk (NN) reserves the right not to release data until after specified milestones, e.g., finalisation of clinical trial report. This includes the right not to release interim results of clinical trials, as release of such information can invalidate the trial results. At end of trial, one or more manuscripts will be prepared collaboratively between Investigator(s) and NN. NN reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.
21369|NCT00713609|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21370|NCT00713596|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21371|NCT00713583|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21372|NCT00713544|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21373|NCT00713479|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21374|NCT00713349|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21375|NCT00713323|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21376|NCT00713310|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21377|NCT00713258|Principal Investigators are NOT employed by the organization sponsoring the study.|After publication of the results or 24 months after Clinical Trial Report has been finalised, whichever comes first, Nycomed acknowledge the Investigator's rights to publish results from this trial. Any such scientific paper, presentation, communication or other information concerning the trial described in this protocol must be submitted to Nycomed for review prior to submission for publication/presentation. Review comments will be given within a month from receipt of the manuscript.
21378|NCT00713219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21379|NCT00713206|Principal Investigators are NOT employed by the organization sponsoring the study.|PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.
21380|NCT00712985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21381|NCT00712959|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
21382|NCT00712933|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21383|NCT00712920|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, joint publication is required to assure that the initial publication is based on all data from all sites and investigators participating in these studies agree not to present data gathered individually or by subgroup centers before the initial publication unless jointly agreed by all other investigators and the sponsor. authorship will be determined by mutual agreement.
21384|NCT00712725|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21385|NCT00712673|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21387|NCT00712530|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21388|NCT00712348|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21389|NCT00712335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21390|NCT00712244|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written agreement.
21391|NCT00712179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21392|NCT00712166|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other scholarly media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years."
21393|NCT00712075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21394|NCT00712010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21395|NCT00711997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21396|NCT00711971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21397|NCT00711958|Principal Investigators are NOT employed by the organization sponsoring the study.|Results stemming from the present trial can only be published if both the Coordinating investigator and the sponsor give their consent. Publications of subcollectives or center specific data are only possible if the whole study results have already been published.
21398|NCT00711880|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21399|NCT00711867|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21400|NCT00711828|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21401|NCT00711802|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21402|NCT00711646|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21403|NCT00711594|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
21404|NCT00711555|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21405|NCT00711529|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21406|NCT00711516|Principal Investigators are NOT employed by the organization sponsoring the study.|
21407|NCT00711490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21408|NCT00711477|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon completion or termination of the CRADA, a final report including a list of inventions must be prepared and delivered to the Dept. of Energy Office of Scientific and Technical Information. Each party must provide the other with up to 45 days to review any proposed publication associated with the CRADA results. Approval of the planned publication will not be unreasonably withheld.
21409|NCT00711464|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21410|NCT00711425|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21411|NCT00711347|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written agreement.
21412|NCT00711191|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21413|NCT00711113|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21414|NCT00711100|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21415|NCT00711087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21416|NCT00711022|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21417|NCT00711009|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
21418|NCT00710996|Principal Investigators are NOT employed by the organization sponsoring the study.|No paper that incorporates Sponsor Condfidential information will be submitted for publication without Sponsor’s prior written agreement.
21419|NCT00710970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21420|NCT00710944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21421|NCT00710931|Principal Investigators are NOT employed by the organization sponsoring the study.|When a clinical study report or manuscript, in lieu of a final report, is completed, Alcon will provide the summary findings of the study to the investigator.
21422|NCT00710905|Principal Investigators are NOT employed by the organization sponsoring the study.|When a clinical study report or manuscript, in lieu of a final report, is completed, Alcon will provide the summary findings of the study to the investigator.
21423|NCT00710879|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
21424|NCT00710866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21425|NCT00710840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21426|NCT00710814|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21427|NCT00710762|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
21428|NCT00710749|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21429|NCT00710684|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21430|NCT00710606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21431|NCT00710593|Principal Investigators are NOT employed by the organization sponsoring the study.|The Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by the protocol team and AMLG.
21432|NCT00710554|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21433|NCT00710424|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21434|NCT00710385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21435|NCT00710203|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21436|NCT00710034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21437|NCT00710021|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21438|NCT00709956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21439|NCT00709891|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21440|NCT00709878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21441|NCT00709852|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is interested in the publication of the results of every study it performs. All relevant aspects regarding publication will be part of the contract between the sponsor and the investigator/institution. The sponsor has committed to the global industry position on disclosure of information about clinical trials. The information regarding the study protocol is made publicly available on the internet at www.clinicaltrials.gov.
21442|NCT00709826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21443|NCT00709761|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
21444|NCT00709735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21445|NCT00709722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21446|NCT00709696|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21447|NCT00709618|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21448|NCT00709592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21449|NCT00709319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21450|NCT00709306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21451|NCT00709228|Principal Investigators are NOT employed by the organization sponsoring the study.|Lead investigator agrees not to publish or publicly present any interim results of the Study without prior written consent of the sponsor. Lead investigator further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of abstracts or manuscripts for publication, which report any results of the Study. Sponsor shall have the right to review and comment on any presentation, including editorial rights.
21452|NCT00709124|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21453|NCT00709111|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
21454|NCT00709098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21455|NCT00709059|Principal Investigators are NOT employed by the organization sponsoring the study.|"The participating physician (PP) agrees not to publish/present any~interim results of the Survey without prior written consent of Schering-~Plough (SP). The PP further agrees to provide 30 days written notice to SP prior to submission for publication or presentation to permit SP to review and comment on any presentation, which right shall include editorial rights. If the parties disagree, the PP agrees to meet with SP to discuss and resolve any such issues or disagreement."
21456|NCT00708942|Principal Investigators are NOT employed by the organization sponsoring the study.|"The PI may publish the results from his/her site, provided that the publication does not disclose confidential information or interfere with sponsor’s efforts to obtain patent protection for inventions. The sponsor must receive material for review not less than sixty (60) days prior to their proposed submission.~In this multi center study, collective publications are anticipated. The PI must not independently publish the results of the Study before the first collective publication."
21457|NCT00708877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21458|NCT00708851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21459|NCT00708734|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21460|NCT00708721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21461|NCT00708708|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21462|NCT00708682|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21463|NCT00708643|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
21464|NCT00708552|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21465|NCT00708526|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21466|NCT00708500|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may not publish/publicly present interim results without prior consent of Sponsor. Any materials that report results of the study must be sent to Sponsor 45 days prior to submission for publication/presentation. Sponsor has right to review and comment. In case of any disagreements concerning appropriateness of the materials, investigator and Sponsor must meet to make a good faith effort to discuss/resolve the issues or disagreement, prior to submission for publication/presentation.
21467|NCT00708461|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21468|NCT00708435|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
21469|NCT00708422|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
21470|NCT00708305|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21471|NCT00708227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21472|NCT00708214|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
21473|NCT00708201|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21474|NCT00708175|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
21475|NCT00708162|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
21476|NCT00708123|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21477|NCT00708110|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21478|NCT00708097|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21479|NCT00708071|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter’s agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., for intellectual property protection)
21480|NCT00708032|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written consent from the Sponsor.
21481|NCT00708019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21482|NCT00707993|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
21483|NCT00707980|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
21484|NCT00707967|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21485|NCT00707954|Principal Investigators are NOT employed by the organization sponsoring the study.|
21486|NCT00707915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21487|NCT00707863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21488|NCT00707759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21489|NCT00707746|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution will submit for review a proposed publication or presentation at least 90 days prior to submission date. Sponsor has the right to delay publication or presentation for not more than 6 months to address patent applications. Sponsor also has the right to demand in writing the deletion of confidential information. Investigator will not make public raw study data, detailed subject cases, or information identifying any subject.
21490|NCT00707655|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site and the PI may be required to withhold the publication for up to 90 days. Subject to a reasoned request from the sponsor, the publication may be further delayed for a period up to 6 months from the date of first submission to the sponsor.~The sponsor has the right to require deletion of any trade secret, proprietary, or confidential information supplied by the sponsor to the site or the PI. The sponsor shall not otherwise have the right to censor publications."
21491|NCT00707577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21492|NCT00707486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21493|NCT00707447|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21494|NCT00707343|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21495|NCT00707239|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21496|NCT00707174|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21497|NCT00707161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21498|NCT00707057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21499|NCT00707031|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21500|NCT00706992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21501|NCT00706979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21502|NCT00706966|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21503|NCT00706914|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and sponsor.
21504|NCT00706901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21505|NCT00706849|Principal Investigators are NOT employed by the organization sponsoring the study.|After the multicenter publication or 12 months after completion of the study the PI may publish the results of his/her data from the study. The PI shall provide the sponsor with an advance copy at least 60 days prior to planned submission and the Sponsor shall have 60 days to review (contracts have variable timeframes; maximum times are stated here). The sponsor may request the deletion of any confidential information, or a delay in submission for an additional period not to exceed 90 days.
21506|NCT00706836|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21507|NCT00706823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21508|NCT00706810|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21509|NCT00706797|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21510|NCT00706784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21511|NCT00706719|Principal Investigators are NOT employed by the organization sponsoring the study.|
21512|NCT00706706|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21513|NCT00706654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21514|NCT00706641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21515|NCT00706628|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
21516|NCT00706589|Principal Investigators are NOT employed by the organization sponsoring the study.|
21517|NCT00706563|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21518|NCT00706550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21519|NCT00706485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21520|NCT00706446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21521|NCT00706433|Principal Investigators are NOT employed by the organization sponsoring the study.|A multi-center publication will be prepared at the end of the Study under the direction of the Sponsor. In the event that such manuscript has not been submitted for publication within twelve (12) months after the date of the final study report, the INVESTIGATOR shall have the right to individually publish the results of his/her Study. Sponsor can review and comment on results communications prior to public release and can delete confidential information contained in results communication.
21522|NCT00706407|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21523|NCT00706355|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21524|NCT00706342|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21525|NCT00706329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21526|NCT00706134|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
21527|NCT00706121|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21528|NCT00706095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21529|NCT00706030|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21530|NCT00706004|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21531|NCT00705939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21532|NCT00705874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21533|NCT00705783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21534|NCT00705757|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21535|NCT00705718|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of single site experience is not allowed until the Multicenter results are published. The Multicenter manuscript will be made available to all authors & Medtronic prior to submission. Final analysis and review on the multicenter manuscript will require Medtronic approval.
21536|NCT00705679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21537|NCT00705666|Principal Investigators are NOT employed by the organization sponsoring the study.|Any published results concerning the data of the non-interventional study is forbidden. Study data and results are exclusive property of the sponsor.
21538|NCT00705653|Principal Investigators are NOT employed by the organization sponsoring the study.|Any formal presentation or publication of data collected from this trial will be considered as a joint publication by the investigator(s) and the appropriate personnel of Progen. Authorship will be determined by mutual agreement.
21539|NCT00705614|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor shall have editorial rights with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
21540|NCT00705575|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
21541|NCT00705536|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained as a result of this study or during the conduct of this study will be regarded as confidential. The investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless written permission from the sponsor (Halozyme) is obtained.
21542|NCT00705523|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21543|NCT00705432|Principal Investigators are NOT employed by the organization sponsoring the study.|"In this multicenter trial, initially, the investigator may only publish study results together with the other sites, unless specific written permission is obtained in advance from the sponsor.~The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a 45 day period from the time submitted to the sponsor for review."
21544|NCT00705406|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21545|NCT00705367|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
21546|NCT00705341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21569|NCT00704405|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
21547|NCT00705289|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and the sponsor's representative will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
21548|NCT00705263|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21549|NCT00705250|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21550|NCT00705224|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees for a period of five years following the Effective Date to retain the Disclosure made to the SPONSOR or on behalf of SPONSOR, in confidence and not disclose it to any third party.
21551|NCT00705159|Principal Investigators are NOT employed by the organization sponsoring the study.|All study data generated as a result of this study will be regarded as confidential, until appropriate analysis and review by the Sponsor or its designee and the Investigator(s) are completed. The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
21552|NCT00705146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21553|NCT00705107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21554|NCT00705081|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21555|NCT00705016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21556|NCT00705003|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21557|NCT00704964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21558|NCT00704938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21559|NCT00704912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21560|NCT00704847|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21561|NCT00704808|Principal Investigators are NOT employed by the organization sponsoring the study.|Publishing or dissemination of study results requires a written approval of the sponsor.
21562|NCT00704769|Principal Investigators are NOT employed by the organization sponsoring the study.|
21563|NCT00704730|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs may publish trial results generated at his/ her site with sponsor’s prior written consent and only after results of the trial from all participating sites have been released in a multi-center publication coordinated by the sponsor.
21564|NCT00704717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21565|NCT00704535|Principal Investigators are NOT employed by the organization sponsoring the study.|The prescribing physicians and investigators of this trial will not publish the results of any part of the study without previous written authorization from the sponsor.
21566|NCT00704522|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21567|NCT00704496|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21568|NCT00704418|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the PI will provide to the sponsor a copy of proposed publication information for review, comment and approval following completion of the study and at least sixty (60) days prior to submission of the publication. If sponsor requests in writing, the PI will withhold publication until written permission is given by sponsor.
21570|NCT00704379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21571|NCT00704353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21572|NCT00704340|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21573|NCT00704184|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
21574|NCT00704171|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Investigator agree to submit the draft of any proposed publication to Sponsor at least 30 dyas prior to submission for publication, presentation, or use, and agrees, at the request of the Sponsor, to withhold any such submission for an additional period, not to exceed 90 days to allow Sponsor to file patent applications. The first publication of the results shall be made in conjunction with the presentation of a joint, multi-center publication.
21575|NCT00704132|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
21576|NCT00704028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21577|NCT00703976|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21578|NCT00703963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21579|NCT00703937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21580|NCT00703924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21581|NCT00703911|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to Novo Nordisk for review at least 60 days before submission for publication or presentation. The investigator will recognize the integrity of a multi-centre study by not publishing data derived from the individual site until the combined results from the completed registry have been published in full, or the sponsor confirms there will be no multi-centre registry publication.
21582|NCT00703885|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21583|NCT00703846|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21584|NCT00703820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21585|NCT00703781|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the PI will provide to the sponsor a copy of proposed publication information for review, comment and approval following completion of the study and at least sixty (60) days prior to submission of the publication. If sponsor requests in writing, the PI will withhold publication until written permission is given by sponsor.
21586|NCT00703729|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21587|NCT00703677|Principal Investigators are NOT employed by the organization sponsoring the study.|The Publication Policy for the National Institute of Neurological Disorders and Stroke (NINDS) Pilot Therapeutic Trials Network (NPTUNE) outlines procedures for the development and review of concept sheets, abstracts, publications, presentations. Investigators must submit an application to the NPTUNE Publications Committee for the use of data. A Writing Committee, appointed by the Publications Committee, is responsible for initiating, coordinating, and approving publications and presentations.
21623|NCT00702208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21588|NCT00703534|Principal Investigators are NOT employed by the organization sponsoring the study.|AZ shall have 30 days from the proposed final manuscript for any disclosure to review it and may within such time require that submission for publication/disclosure be delayed in order for AZ to file patent applications. If study site/investigator requests permission to publish data(incl oral presentations) it is to be agreed with AZ prior to publ.
21589|NCT00703508|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21590|NCT00703391|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21591|NCT00703339|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21592|NCT00703326|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
21593|NCT00703261|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
21594|NCT00703157|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21595|NCT00703118|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21596|NCT00703092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21597|NCT00703053|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21598|NCT00703014|Principal Investigators are NOT employed by the organization sponsoring the study.|Any scientific paper, presentation, or other communication concerning the clinical trial will first be presented to the Sponsor, at least six weeks ahead of estimated publication or presentation, for written consent. The Sponsor shall have the right to make its consent conditional upon proper representation of the interpretation of both the Sponsor and the investigator(s) in the discussion of the data in such communications.
21599|NCT00702949|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21600|NCT00702923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21601|NCT00702884|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21602|NCT00702845|Principal Investigators are NOT employed by the organization sponsoring the study.|Any scientific paper, presentation, or other communication concerning the clinical trial described in this protocol will first be submitted to the sponsor, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
21603|NCT00702780|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21604|NCT00702754|Principal Investigators are NOT employed by the organization sponsoring the study.|No individual PI can disclose results until after a group manuscript is published.
21605|NCT00702715|Principal Investigators are NOT employed by the organization sponsoring the study.|All published results will be based on validated data released by the sponsor and must include one sponsor author. There may be one author from each investigational site, provided that the criteria for authorship are met. In case the proposed publication contains reference to an invention owned by sponsor or to which sponsor otherwise has rights, the sponsor may request a reasonable suspension of the publication in order to be able to file a patent application protecting such invention.
21624|NCT00702143|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21606|NCT00702702|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
21607|NCT00702689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21608|NCT00702650|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21609|NCT00702624|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial described in this protocol will first be submitted to Sponsor, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
21610|NCT00702546|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial described in this protocol will first be submitted to Sponsor, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
21611|NCT00702520|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial described in this protocol will first be submitted to the sponsor, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
21612|NCT00702507|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21613|NCT00702468|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications for example, manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21614|NCT00702403|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21615|NCT00702377|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study. Alcon reserves the right of prior review of any publication or presentation of information related to the study.
21616|NCT00702364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21617|NCT00702338|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial described in the protocol will first be submitted to the Sponsor, at least 6 weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
21618|NCT00702325|Principal Investigators are NOT employed by the organization sponsoring the study.|If Sponsor does not publish within 2 years after study completion, PI is permitted to publish, with confidential information removed from manuscript. Sponsor will have opportunity to review and approve publication at least 60 days pior to being submitted/disclosed. Sponsor can request, in writing, an additional 90 day embargo.
21619|NCT00702299|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21620|NCT00702273|Principal Investigators are NOT employed by the organization sponsoring the study.|Any scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the Sponsor, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably. The Sponsor shall have the right to make its consent conditional upon proper representation of the interpretation of both the Sponsor and the investigator(s) in the discussion of the data in such communications.
21621|NCT00702234|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications must be based on data validated and released by the Sponsor. Any scientific paper, presentation, or other communication concerning the study must first be submitted to the Sponsor, at least 6 weeks prior to estimated publication or presentation, for written consent. Sponsor has the right to make its consent conditional upon proper representation of the interpretation of both the Sponsor and the Investigator in the discussion of the data in such communications.
21622|NCT00702221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21625|NCT00701935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21626|NCT00701805|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
21627|NCT00701779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21628|NCT00701727|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21629|NCT00701714|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to the first publication or presentation of the results of the study which is intended to be a joint, multi-center publication of the study results. Following the first publication, institutions and/or Principal Investigators may publish or present data or results from the study per the terms of the clinical trial agreement.
21630|NCT00701675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21631|NCT00701662|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
21632|NCT00701636|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21633|NCT00701558|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
21634|NCT00701441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21635|NCT00701415|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21636|NCT00701389|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
21637|NCT00701363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21638|NCT00701311|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21639|NCT00701129|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21640|NCT00701103|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
21641|NCT00701090|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21642|NCT00701064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21643|NCT00701051|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21644|NCT00701038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21645|NCT00700999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21646|NCT00700973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21647|NCT00700817|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
21648|NCT00700804|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21649|NCT00700752|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
21650|NCT00700739|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Investigators may freely present or publish results of the Clinical Investigation in a manner which fairly sets forth the conclusions reached by the Clinical Investigators, but only after DePuy has been given the opportunity of reviewing the proposed presentation or publication at least 30 days prior to the intended submission, presentation, or publication date.
21651|NCT00700713|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
21652|NCT00700635|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
21653|NCT00700622|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the study results subject to MNKD rights herein.
21654|NCT00700570|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21655|NCT00700440|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21656|NCT00700427|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21657|NCT00700401|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
21658|NCT00700375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21659|NCT00700310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21660|NCT00700271|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or publication of the trial results in their entirety.
21661|NCT00700180|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21662|NCT00700141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21663|NCT00700115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21664|NCT00700102|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21665|NCT00700063|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution and Investigator agree not to publish the results of this study without the prior written consent of Sponsor. As used herein, the term 'publish' shall include oral presentations, written abstracts, written manuscripts, etc.
21666|NCT00700011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21667|NCT00699998|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21668|NCT00699972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21669|NCT00699907|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21670|NCT00699842|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21671|NCT00699816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21672|NCT00699751|Principal Investigators are NOT employed by the organization sponsoring the study.|No PI may disclose or publish information from the trial before publication of the principal and first communication arising from the trial, unless 12 months has elapsed after completion of the trial. There is restriction on the PI that the sponsor can review results communication prior to public release and can embargo regarding trial results for a period that is less/or equal to 60 days from the time submitted to the sponsor for review. Sponsor cannot require changes or extend the embargo.
21673|NCT00699699|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
21674|NCT00699660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21675|NCT00699608|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21676|NCT00699582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21677|NCT00699556|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21678|NCT00699491|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21679|NCT00699413|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21680|NCT00699400|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator may disclose confidential information to the extent required by law or court order, provided that they promptly provide to EMD Serono prior notice of such disclosure and provide assistance in obtaining an order protecting Confidential Information from public disclosure.
21681|NCT00699374|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21682|NCT00699348|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21683|NCT00699335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21684|NCT00699283|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21685|NCT00699192|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
21686|NCT00699153|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with, the Sponsor and such that confidential or proprietary information is not disclosed. Prior to publication or presentation, a copy of the final text should be forwarded by the Investigator(s) to the Sponsor or its designee for comment.
21687|NCT00699140|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21688|NCT00698932|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator undertakes to provide AstraZeneca as soon as possible with preliminary data and drafts of proposed publications and disclosures, whether oral or in writing, and as soon as available, with the proposed final manuscript. AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time require that submission for publication or disclosure of the manuscript be delayed
21689|NCT00698867|Principal Investigators are NOT employed by the organization sponsoring the study.|A publication which uses data in addition to the authors will be reviewed by all who have contributed data, and all of the contributors will be recognized. All publications will be reviewed by BIOMET at least 30 days prior to publication.
21690|NCT00698841|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
21691|NCT00698815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21692|NCT00698685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21693|NCT00698646|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
21694|NCT00698581|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21695|NCT00698516|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21696|NCT00698451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21697|NCT00698204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21698|NCT00698139|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21699|NCT00698035|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21718|NCT00696761|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21700|NCT00698022|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21701|NCT00698009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21702|NCT00697827|Principal Investigators are NOT employed by the organization sponsoring the study.|All unpublished information given to the investigator by Synthes Spine shall not be published or disclosed to a third party without the prior written consent of Synthes Spine. All information concerning In-Space, Synthes Spine operations, patent application drawings, manufacturing processes, basic scientific data and design information, supplied by the sponsor to the investigator and not previously published, is considered confidential and remains the sole property of Synthes Spine.
21703|NCT00697801|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
21704|NCT00697788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21705|NCT00697697|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
21706|NCT00697619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21707|NCT00697593|Principal Investigators are NOT employed by the organization sponsoring the study.|
21708|NCT00697541|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21709|NCT00697515|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
21710|NCT00697255|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial described in the protocol will first be submitted to the Sponsor, at least 6 weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
21711|NCT00697190|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
21712|NCT00697112|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21713|NCT00697073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21714|NCT00696878|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications must be based on data validated and released by the Sponsor. Any scientific paper, presentation, or other communication concerning the study must first be submitted to the Sponsor, at least 6 weeks prior to estimated publication or presentation, for written consent. Sponsor has the right to make its consent conditional upon proper representation of the interpretation of both the Sponsor and the Investigator in the discussion of the data in such communications.
21715|NCT00696800|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be based on data validated and released by the Sponsor. Any scientific paper, presentation or other communication concerning this clinical trial will first be submitted to the Sponsor at least six weeks before publication or presentation. The Sponsor shall have the right to make its consent conditional upon proper representation of the interpretation of both the Sponsor and the investigator(s) in the discussion of the data in such communications.
21716|NCT00696787|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
21717|NCT00696774|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21719|NCT00696696|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21720|NCT00696618|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21721|NCT00696488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21722|NCT00696449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21723|NCT00696436|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
21724|NCT00696423|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21725|NCT00696410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21726|NCT00696384|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
21727|NCT00696293|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21728|NCT00696241|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
21729|NCT00696072|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
21730|NCT00696020|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
21731|NCT00695955|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
21732|NCT00695903|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If first publication not published within 1 year of study conclusion or termination, Investigator has right to publish and disclose the data. Prior to any submission for publication, presentation, or communication of results or information arising from the study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
21733|NCT00695864|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21734|NCT00695669|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21735|NCT00695565|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator may not publish or present any study information without the express written approval of the Sponsor. The Sponsor may withhold approval for publication or presentation.
21736|NCT00695500|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21737|NCT00695435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21738|NCT00695396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21739|NCT00695318|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21740|NCT00695292|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
21741|NCT00695188|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21742|NCT00695136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21743|NCT00695097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21744|NCT00695019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21745|NCT00694603|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21746|NCT00694564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21747|NCT00694551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21748|NCT00694473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21749|NCT00694369|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21750|NCT00694356|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
21751|NCT00694304|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub-publications. H. Lundbeck A/S follows the Vancouver declaration with respect to authorship.
21752|NCT00694161|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21753|NCT00694122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21754|NCT00694109|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21755|NCT00694096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21756|NCT00694070|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21757|NCT00694018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21758|NCT00693992|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21759|NCT00693784|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21760|NCT00693719|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21761|NCT00693706|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21762|NCT00693693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21763|NCT00693654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21764|NCT00693628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21765|NCT00693498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21766|NCT00693485|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
21767|NCT00693472|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the Sponsor. The investigator further agrees to provide to the Sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
21768|NCT00693420|Principal Investigators are NOT employed by the organization sponsoring the study.|At least ninety (90) days prior to any proposed submission for publication or presentation of Study data or other findings related to the Study, the Institution will provide the Sponsor with a manuscript of such submission(s) for review and comment.
21769|NCT00693303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21770|NCT00693238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21771|NCT00693225|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21772|NCT00693160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21773|NCT00693017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21774|NCT00692913|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts,or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
21775|NCT00692770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21776|NCT00692692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21777|NCT00692419|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21778|NCT00692406|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21779|NCT00692341|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21780|NCT00692237|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21781|NCT00692211|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21782|NCT00692198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21783|NCT00692185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21784|NCT00692003|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21785|NCT00691938|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21786|NCT00691808|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor requires that written permission be given before the investigator can release any data publicly.
21787|NCT00691704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21788|NCT00691665|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21789|NCT00691652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21790|NCT00691483|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21791|NCT00691327|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
21792|NCT00691301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21793|NCT00691210|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21794|NCT00691197|Principal Investigators are NOT employed by the organization sponsoring the study.|"A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 90 days from the time submitted to the sponsor for review.~The sponsor cannot require changes to the communication and cannot extend the embargo."
21795|NCT00691132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21796|NCT00691093|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21797|NCT00691054|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21798|NCT00691028|Principal Investigators are NOT employed by the organization sponsoring the study.|
21799|NCT00691015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21800|NCT00690924|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21801|NCT00690898|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21802|NCT00690833|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21803|NCT00690820|Principal Investigators are NOT employed by the organization sponsoring the study.|At 60 days prior to submitting or presenting a manuscript or other materials relating to the study to a publisher, reviewer or outside persons, the Site shall provide to Sponsor a copy and allow Sponsor 60 days to review and comment.
21804|NCT00690794|Principal Investigators are NOT employed by the organization sponsoring the study.|Alcon reserves the right of prior review of any publication or presentation of information related to the study.
21805|NCT00690755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21806|NCT00690612|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21807|NCT00690573|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; the Medical Institution shall not disclose any material/information disclosed by Abbott Japan in connection with the Clinical Research or information obtained by conducting the Clinical Research to third parties without Abbott Japan's prior written approval. When Medical Institution intends to publish information obtained by conducting Clinical Research, Institution shall obtain Abbott Japan's prior written approval.
21808|NCT00690495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21809|NCT00690482|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21810|NCT00690443|Principal Investigators are NOT employed by the organization sponsoring the study.|Information is unavailable.
21811|NCT00690430|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
21812|NCT00690378|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
21813|NCT00690339|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
21814|NCT00690040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21815|NCT00689936|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than one year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to ninety days; Investigator must delete confidential information before submission or defer publication to permit patent applications
21816|NCT00689884|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21817|NCT00689871|Principal Investigators are NOT employed by the organization sponsoring the study.|The timing of separate presentation or publication of the study by the PI is subject to mutual agreement in advance between the Sponsor and PI.
21818|NCT00689819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21819|NCT00689793|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21820|NCT00689611|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21821|NCT00689481|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21822|NCT00689390|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) agrees to provide to the sponsor 30 days prior to submission for publication or presentation, review results communications. Sponsor shall have editorial rights with respect to results communications and the right to review and comment on the data analysis and presentation with regard to proprietary information, the accuracy of the information contained in the publication, and to ensure that the presentation is fairly balanced and in compliance with FDA regulations.
21823|NCT00689351|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21824|NCT00689338|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21825|NCT00689299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21826|NCT00689260|Principal Investigators are NOT employed by the organization sponsoring the study.|The institution or Principal Investigator can publish or present any results to a third party until (i) EMD Serono publishes the results (ii) Institution receives notification from EMD Serono that publication is no longer planned (iii) 18 months following the completion of the study whichever occurs first. Prior to publishing or presenting results, the Principal Investigator needs to provide EMD Serono with a copy of the presentation for review and approval.
21827|NCT00689221|Principal Investigators are NOT employed by the organization sponsoring the study.|All manuscripts and materials relating to Study shall be submitted to Sponsor at least 60 days prior to submitting/presenting and allow Sponsor 60 days for review. If Sponsor requests, any confidential information shall be removed. In multi-center study, any publication shall not be made before the first multi-center publication; provided, however, that if no multi-center publication is made within 1 year from database lock, then Site may publish individually in accordance with this provision.
21828|NCT00689117|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21829|NCT00689104|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Primary publication of the multi-center data. Sponsor must receive a site’s manuscript at least 45 days prior to planned submission to ensure that no confidential information of Sponsor is included in the document. Sponsor will respond within 30 days and may request changes or delay the publication to seek patent protection.
21830|NCT00689091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21831|NCT00689052|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
21832|NCT00689026|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21833|NCT00688870|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21834|NCT00688844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21835|NCT00688753|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
21836|NCT00688740|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication of the study will be made without approval of the advisory board of the Breast Cancer International Research Group and Rhone- Poulenc Rorer.
21837|NCT00688701|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21838|NCT00688688|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
21839|NCT00688662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21840|NCT00688636|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21841|NCT00688545|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21842|NCT00688519|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21843|NCT00688467|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
21844|NCT00688324|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21845|NCT00688259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21846|NCT00688155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21847|NCT00688103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21848|NCT00688064|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor for review and approval at least 2 months prior to the date of the intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
21849|NCT00687973|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However,Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
21850|NCT00687908|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor for review and approval at least 2 months prior to the date of the intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
21851|NCT00687856|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21852|NCT00687830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21853|NCT00687804|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
21854|NCT00687713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21855|NCT00687674|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21856|NCT00687609|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21857|NCT00687544|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator agrees not to publish/present any interim results without sponsor's prior written consent and agrees to provide sponsor 45 days written notice prior to submission for publication/presentation to permit the sponsor to review copies. The sponsor shall have the right to review and comment, including editing.
21877|NCT00686803|Principal Investigators are NOT employed by the organization sponsoring the study.|PI was an employed by Palatin, as he was/is an employee of the CRO hired by Palatin to conduct the study. All confidentiality agreed upon between Palatin and the CRO applies.
21858|NCT00687531|Principal Investigators are NOT employed by the organization sponsoring the study.|30 days written notice is required prior to submission of study results for publication/presentation so that Sponsor can review the material to be submitted. Sponsor has the right to review/comment on the material & if the parties have any disagreement concerning the appropriateness of the material, the PI and Sponsor must meet to discuss/resolve any issues/disagreement prior to submission. Interim results of the Study may not be published/presented without prior written consent of Sponsor.
21859|NCT00687453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21860|NCT00687440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21861|NCT00687401|Principal Investigators are NOT employed by the organization sponsoring the study.|No specific time period restrictions. If the parties disagree concerning the accuracy and appropriateness of the data analysis and presentation, and/or confidentiality of information, the Sponsor and the Investigator will make good faith efforts to resolve any issues or disagreement.
21862|NCT00687362|Principal Investigators are NOT employed by the organization sponsoring the study.|"The PI agrees not to publish/publicly present any interim results of the Study without prior written consent of Sponsor. The PI further agrees to~provide 30 days written notice to Sponsor prior to submission for publication/presentation to allow Sponsor to review materials which report any results of the Study. Sponsor shall have the right to review/comment on~any presentation, which include editorial rights to ensure protection of confidential information, accuracy, and fair balance."
21863|NCT00687323|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study Chair agrees not to publish/present any interim results without the Sponsor's prior written consent. The Principal Investigators (PIs) agree to provide 30 days prior to submission to the Sponsor to review copies of abstracts/manuscripts. The Sponsor shall have proper representation on publications and editorial rights with regard to data analysis, presentation, proprietary information, and accuracy. If the parties disagree, the PIs agree to meet with the Sponsor to discuss/resolve.
21864|NCT00687297|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21865|NCT00687219|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21866|NCT00687193|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21867|NCT00687167|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21868|NCT00687102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21869|NCT00687076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21870|NCT00686998|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21871|NCT00686972|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21872|NCT00686959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21873|NCT00686894|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees not to publish or publicly present any interim results of the study without prior written consent of the sponsor. The PI further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of abstracts or manuscripts for publication which report any results of the study. The sponsor shall have the right to review and comment on any presentation.
21874|NCT00686881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21875|NCT00686855|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21876|NCT00686842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21878|NCT00686790|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review.
21879|NCT00686777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21880|NCT00686725|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution and Principal Investigator (PI) have the right to publish/present study results. PI and Institution agree not to publish/present any interim study results. PI and Institution further agree to provide 30 days written notice to Sponsor prior to submission for publication or presentation to permit Sponsor to review drafts of abstracts and manuscripts for publication which report any study results. Sponsor shall have the right to review and comment on any Public Presentation.
21881|NCT00686712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21882|NCT00686699|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator agrees to provide to the sponsor 30 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
21883|NCT00686686|Principal Investigators are NOT employed by the organization sponsoring the study.|"All proposed publications/presentations by the investigators or their personnel resulting from or relating to this study must be submitted to Sponsor for review 60 days before submission for publication or presentation. If the proposed publication/presentation contains patentable subject matter which, at~Sponsor’s sole discretion, warrants intellectual property protection, the Sponsor may delay any publication or presentation for up to 60 days for the purpose of pursuing such protection."
21884|NCT00686647|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submission, the Sponsor, Institution, and Site Investigators will review and authorize the publication. A review period of 15 days for Presentational materials and abstracts; and 30 days for manuscripts is required for the Sponsor's review. Sponsor review does not include editorial privileges but can protect proprietary information and correct errors in data reporting or analysis if the Investigator agrees that there is an error.
21885|NCT00686634|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21886|NCT00686595|Principal Investigators are NOT employed by the organization sponsoring the study.|"Investigator agrees not to publish or publicly present any of the~study results without prior written authorization from sponsor, except than for the dispositions provided in the Minister’s Decree and Ministerial Circular. Investigator agrees to provide 45 days written notice to sponsor prior to submission for publication or presentation to permit sponsor to review copies of abstracts/manuscripts for publication (including text for oral presentations) which report any study results."
21887|NCT00686543|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor and investigator will publish/present study results together with other study sites, unless written permission is obtained. The investigator provides to the sponsor 45 days prior to submission for publication/presentation, copies of abstracts or manuscripts reporting any study results. The sponsor has the right to review/comment on the data analysis and presentation regarding proprietary information, accuracy and fair blance of the information, and compliance with FDA regulations.
21888|NCT00686517|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publish or present any results of the study without the prior written permission of Schering-Plough The principal investigator further agrees to allow the Sponsor to review, 30 days prior to submission for publication or presentation, copies of abstracts or manuscripts for publication (including texts of oral presentations) which report any results of the study.
21889|NCT00686374|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
21890|NCT00686335|Principal Investigators are NOT employed by the organization sponsoring the study.|Anything concerning publication, information and communication is described under law number R5121-13 of the French Code de la Santé Publique. Any information about results cannot be given without the accordance of Horizon Pharma (formerly Nitec Pharma).
21891|NCT00686257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21892|NCT00686231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21893|NCT00686205|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI must provide a copy of any proposed publication or presentation at least 30 days prior to submission for sponsor's review/approval. The PI must incorporate changes as the sponsor requires in order to protect the sponsor's proprietary rights and interests. The sponsor may require the PI to include acknowledgement of the sponsor's role in the study. The PI may be requested to delay publication/presentation an extra 60 days to enable sponsor to secure patent or other proprietary protection.
21894|NCT00686166|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21895|NCT00686127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21896|NCT00686075|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
21897|NCT00686036|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
21898|NCT00685945|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21899|NCT00685932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21900|NCT00685880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21901|NCT00685802|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21902|NCT00685763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21903|NCT00685698|Principal Investigators are NOT employed by the organization sponsoring the study.|PI needs to inform sponsor and asks for permission before he/she discusses or publishes trial results after the trial is completed.
21904|NCT00685685|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21905|NCT00685659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21906|NCT00685516|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21907|NCT00685477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21908|NCT00685399|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
21909|NCT00685373|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
21910|NCT00685334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21911|NCT00685295|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21912|NCT00685178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21913|NCT00685165|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21914|NCT00685139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21915|NCT00685035|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21916|NCT00684996|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21917|NCT00684983|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21918|NCT00684814|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21919|NCT00684788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21920|NCT00684775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21921|NCT00684762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21922|NCT00684749|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21923|NCT00684723|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21924|NCT00684671|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21925|NCT00684645|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21926|NCT00684593|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation with regard to (1) proprietary information that is protected, (2) the accuracy of the information contained in the publication, and (3) to ensure that the presentation is fairly balanced and in compliance with FDA regulations.
21927|NCT00684567|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21928|NCT00684554|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21929|NCT00684541|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21930|NCT00684515|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior approval by the Sponsor is required before the results obtained in the clinical study can be made public by the investigator (sub-investigator) in a publication or at a medical meeting.
21931|NCT00684424|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21932|NCT00684411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21933|NCT00684320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21934|NCT00684307|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21935|NCT00684255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21936|NCT00684242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21937|NCT00684203|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior approval by the Sponsor is required before the results obtained in the clinical study can be made public by the investigator (sub-investigator) in a publication or at a medical meeting.
21938|NCT00684177|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21939|NCT00684138|Principal Investigators are NOT employed by the organization sponsoring the study.|
21940|NCT00684073|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor agreement is always necessary before PI publishing or communications. The sponsor can review the communication project during 28 days. The sponsor can require changes to the communication and can extend the embargo.
21941|NCT00684060|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21942|NCT00684047|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the Study, after providing Sponsor at least thirty days’ notice prior to submitting a manuscript or other materials related to the Study to any outside party. At Sponsor’s request, Site will remove any Confidential Information (other than Study results), and incorporate all reasonable comments by Sponsor, or delay publication or presentation for a period of up to one hundred twenty days to allow Sponsor to protect its interests in any Sponsor’s Inventions.
21943|NCT00684021|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21944|NCT00683930|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
21945|NCT00683917|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
21946|NCT00683904|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
21947|NCT00683878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21948|NCT00683852|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21949|NCT00683826|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21950|NCT00683800|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21951|NCT00683787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21952|NCT00683774|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21953|NCT00683696|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21954|NCT00683657|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
21995|NCT00680953|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator shall not publish the results of the Study at any time without the prior written approval of Sponsor.
21955|NCT00683644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21956|NCT00683618|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21957|NCT00683592|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators have the right to publish or permit the publication of any information or material relating to or arising out of this protocol after prior submission to PGxHealth provided that, if PGxHealth requests, the investigator will delay publication for a maximum of six months to enable PGxHealth to protect their rights in such information or material.
21958|NCT00683475|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
21959|NCT00683449|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21960|NCT00683410|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21961|NCT00683384|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21962|NCT00683332|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
21963|NCT00683293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21964|NCT00683163|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21965|NCT00683085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21966|NCT00683046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21967|NCT00683020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21968|NCT00682929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21969|NCT00682890|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21970|NCT00682851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21971|NCT00682838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21972|NCT00682786|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21973|NCT00682734|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21974|NCT00682643|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21975|NCT00682565|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor intends to publish the results of the trial in collaboration with the Investigators.
21976|NCT00682539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21977|NCT00682461|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21978|NCT00682357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21979|NCT00681889|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21980|NCT00681863|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
21981|NCT00681824|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 12 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥45 days prior to submission or communication. Baxter may request an additional delay of ≤60 days e.g., for intellectual property protection)
21982|NCT00681811|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21983|NCT00681668|Principal Investigators are NOT employed by the organization sponsoring the study.|Site has to inform sponsor about a publication at least 60 day in advance and 10 days before submission of an abstract or presenation. Change requests by the sponsor are recognized unless the scientific character or the objectivity is on risk. If the sponsor plans a patent applicaion the publication has to be postponed up to 120 days.
21984|NCT00681629|Principal Investigators are NOT employed by the organization sponsoring the study.|Site has to inform sponsor about a publication at least 60 day in advance and 10 days before submission of an abstract or presentation. Change requests by the sponsor are recognized unless the scientific character or the objectivity is on risk. If the sponsor plans a patent application the publication has to be postponed up to 120 days.
21985|NCT00681590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21986|NCT00681564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21987|NCT00681538|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications for example, manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
21988|NCT00681473|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21989|NCT00681291|Principal Investigators are NOT employed by the organization sponsoring the study.|Should Institution/PI/coPI/other staff want to publish information, data, or orally communicate,a complete copy of information/data will be provided to the Sponsor for review and comment at least 30 days prior to 1st submission. If Sponsor determines proposed publication/oral communication contains patentable or proprietary subject matter (requiring protection),Institution will delay for at least 90 days following the Sponsor's receipt of such copy for the purpose of filing patent applications.
21990|NCT00681265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21991|NCT00681187|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
21992|NCT00681109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21993|NCT00681044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21994|NCT00681031|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall send to Sanofi Pasteur MSD for approval any of the publication and/or communication draft, in whatever forms (abstracts, manuscripts, texts). Sanofi Pasteur MSD shall have 60 (sixty) days to review the draft, have reserves if any, and formulate its refusal to the draft in whole or in part if the draft contains confidential data, may prejudice to Sanofi Pasteur MSD patent/intellectual property rights and/or is not compliant with the study results.
21996|NCT00680914|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
21997|NCT00680901|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
21998|NCT00680862|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
21999|NCT00680836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22000|NCT00680823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22001|NCT00680797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22002|NCT00680771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22003|NCT00680745|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
22004|NCT00680706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22005|NCT00680628|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22006|NCT00680524|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22007|NCT00680459|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22008|NCT00680407|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22009|NCT00680368|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22010|NCT00680316|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22011|NCT00680225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22012|NCT00680186|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22013|NCT00680121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22014|NCT00680056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22015|NCT00680043|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the primary safety and efficacy results will include data from all appropriate study sites. Either after the first multicenter publication, or following 36 months after the completion of the study, Investigators are free to publish; such publications may not contain Sponsor Confidential Information and may be subject to Sponsor review 60 days prior to submission for publication.
22034|NCT00678899|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22016|NCT00680017|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
22017|NCT00679952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22018|NCT00679939|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22019|NCT00679913|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22020|NCT00679783|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22021|NCT00679627|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
22022|NCT00679432|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22023|NCT00679380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22024|NCT00679367|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22025|NCT00679354|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22026|NCT00679341|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22027|NCT00679302|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22028|NCT00679289|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22029|NCT00679263|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22030|NCT00679211|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22031|NCT00679172|Principal Investigators are NOT employed by the organization sponsoring the study.|Any proposed publication was subject to review conditions and timelines agreed between Emergent Product Development UK Ltd and the site Principal Investigator and detailed in the agreements with these parties prior to the start of the study.
22032|NCT00679081|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for at least 30 days in advance of public release. The sponsor can request removal of any confidential or proprietary information provided by sponsor and extend such review period for another 90 days to file patent applications or take other steps to protect the sponsor's intellectual property interests.
22033|NCT00679055|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
22035|NCT00678886|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22036|NCT00678834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22037|NCT00678795|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
22038|NCT00678691|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22039|NCT00678652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22040|NCT00678639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22041|NCT00678587|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22042|NCT00678574|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22043|NCT00678535|Principal Investigators are NOT employed by the organization sponsoring the study.|
22044|NCT00678470|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22045|NCT00678418|Principal Investigators are NOT employed by the organization sponsoring the study.|No individual investigator may publish results until after the publication of the overall study without receiving Alkermes' written approval. After that time, a PI/Institution may publish results for noncommercial purposes. Should an investigator wish to do so, the Sponsor will have 30 days to review the proposed publication. The PI/Institution will delete any Sponsor Confidential Information other than study results and will revise a publication based on regulatory requirements of the Sponsor.
22046|NCT00678392|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22047|NCT00678379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22048|NCT00678301|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22049|NCT00678288|Principal Investigators are NOT employed by the organization sponsoring the study.|Protocol and PI clinical trial agreements.
22050|NCT00678249|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22051|NCT00678210|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22052|NCT00678041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22053|NCT00678015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22054|NCT00677924|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site and the PI may be required to withhold the publication for up to 90 days. Subject to a reasoned request from the sponsor, the publication may be further delayed for a period up to 6 months from the date of first submission to the sponsor.~The sponsor has the right to require deletion of any trade secret, proprietary, or confidential information supplied by the sponsor to the site or the PI. The sponsor shall not otherwise have the right to censor publications."
22055|NCT00677898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22056|NCT00677833|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22057|NCT00677820|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restricion is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22058|NCT00677807|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22059|NCT00677690|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22060|NCT00677534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22061|NCT00677365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22062|NCT00677352|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22063|NCT00677235|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22064|NCT00677092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22065|NCT00677014|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22066|NCT00676897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22067|NCT00676806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22068|NCT00676793|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22069|NCT00676780|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22070|NCT00676715|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
22071|NCT00676689|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator will submit to Edwards all manuscripts or presentations authored by investigator and his/her collaborators which result from the Clinical Study at least thirty days prior to submission of the manuscript for publication or presentation.
22072|NCT00676676|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22073|NCT00676650|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22074|NCT00676585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22075|NCT00676520|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22076|NCT00676494|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators will have the right to publish results of the Study, provided that Investigators submit copies of any proposed publication to Sponsor for review at least 30 days and up to 60 days in advance of publication. Sponsor may extend such review period for another 90 days to file patent applications or protect its Related Rights.
22077|NCT00676455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22078|NCT00676403|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22079|NCT00676364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22080|NCT00676338|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22081|NCT00676208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22082|NCT00676195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22083|NCT00676182|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22084|NCT00676143|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22085|NCT00676130|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22086|NCT00676091|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22087|NCT00676065|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22088|NCT00676052|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22089|NCT00676026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22090|NCT00675987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22091|NCT00675948|Principal Investigators are NOT employed by the organization sponsoring the study.|"Publication Policy:~GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications for example, manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release."
22092|NCT00675922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22093|NCT00675909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22094|NCT00675792|Principal Investigators are NOT employed by the organization sponsoring the study.|In case a proposed publication contains reference to an invention owned by the sponsor or to which the sponsor otherwise has rights, the sponsor may request a reasonable suspension of the publication.
22095|NCT00675766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22096|NCT00675597|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22097|NCT00675584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22098|NCT00675558|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22099|NCT00675506|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22100|NCT00675441|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22101|NCT00675428|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
22102|NCT00675415|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22103|NCT00675259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22104|NCT00675103|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22105|NCT00674986|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22106|NCT00674973|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
22107|NCT00674817|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22108|NCT00674765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22109|NCT00674739|Principal Investigators are NOT employed by the organization sponsoring the study.|For few PIs, there were a restrict that the PI can not publish their trial results with 12 months from the completion of the trial.
22110|NCT00674700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22111|NCT00674661|Principal Investigators are NOT employed by the organization sponsoring the study.|Site has the right to publish or communicate study results upon the earlier of: (a) publication of a multi-center publication of the Study results coordinated by Sponsor; or (b) submission of the Study data by Sponsor to the FDA; provided that the Sponsor reviews the proposed communication of results within ninety (90) days in advance of its release. Sponsor can request delay of publication or data release to allow for filing of patent application prior to the publication or release.
22112|NCT00674622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22113|NCT00674609|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications, for example manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
22114|NCT00674583|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22115|NCT00674492|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22116|NCT00674466|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22117|NCT00674362|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
22118|NCT00674323|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22119|NCT00674297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22120|NCT00674206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22121|NCT00674154|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22122|NCT00674128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22123|NCT00674115|Principal Investigators are NOT employed by the organization sponsoring the study.|
22124|NCT00673959|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI should hold confidential, and not disclose directly or indirectly to any third party onther than Contractors, the data arising out of the study.
22125|NCT00673933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22126|NCT00673881|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22127|NCT00673855|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study.
22128|NCT00673816|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22129|NCT00673764|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study. Alcon reserves the right of prior review of any publication or presentation of information related to the study.
22130|NCT00673738|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22131|NCT00673712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22132|NCT00673673|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22133|NCT00673660|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22134|NCT00673595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22135|NCT00673465|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
22136|NCT00673452|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22137|NCT00673439|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22138|NCT00673400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22139|NCT00673387|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22140|NCT00673361|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22141|NCT00673257|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
22142|NCT00673231|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
22143|NCT00673179|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22144|NCT00673153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor CAN require changes to the communication and CAN extend the embargo.
22145|NCT00673127|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22146|NCT00673114|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22147|NCT00673075|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 60 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential information. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in the publication. On sponsor's request, PI shall delay submission for any pub while sponsor files patent applications. Any publication will give recognition to Sponsor's support.
22148|NCT00673049|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22149|NCT00672984|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually
22150|NCT00672958|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
22151|NCT00672932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22152|NCT00672854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22153|NCT00672841|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22154|NCT00672737|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22155|NCT00672646|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca has the exclusive right to publish the results of the study.
22156|NCT00672633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22157|NCT00672620|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
22158|NCT00672594|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22159|NCT00672555|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22160|NCT00672490|Principal Investigators are NOT employed by the organization sponsoring the study.|
22161|NCT00672477|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22162|NCT00672438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22163|NCT00672256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22164|NCT00672243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22165|NCT00672204|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22166|NCT00672178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22167|NCT00672139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22168|NCT00672100|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22169|NCT00671970|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22170|NCT00671931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22171|NCT00671918|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall not submit a publication to journals or professional societies without the prior written approval of the Sponsor.
22172|NCT00671879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22173|NCT00671853|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22174|NCT00671788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22175|NCT00671749|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22176|NCT00671723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22177|NCT00671671|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22178|NCT00671606|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22179|NCT00671554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22180|NCT00671528|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigators agree not to publish or publicly present any interim results of the study without prior written consent of the SPONSOR. The principal investigator further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the SPONSOR to review copies of abstracts or manuscripts for publication which report any results of the study. The SPONSOR shall have the right to review and comment on any presentation.
22181|NCT00671515|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22182|NCT00671502|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22183|NCT00671437|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22184|NCT00671177|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22185|NCT00671060|All Principal Investigators ARE employed by the organization sponsoring the study.|
22186|NCT00670982|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22187|NCT00670956|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22188|NCT00670930|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
22189|NCT00670800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22190|NCT00670748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22191|NCT00670709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22192|NCT00670631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22193|NCT00670540|Principal Investigators are NOT employed by the organization sponsoring the study.|"The protocol OPTIMEV will follow the international recommendations: Uniforms Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org)"
22194|NCT00670462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22195|NCT00670449|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
22196|NCT00670306|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22197|NCT00670267|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22198|NCT00670241|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22199|NCT00670228|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
22200|NCT00670202|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22201|NCT00670111|Principal Investigators are NOT employed by the organization sponsoring the study.|
22202|NCT00670007|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
22203|NCT00669955|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with the agreement with investigators. Axcan will allow publication after a multi-centre publication or after an agreed period, subject to review by Axcan for confidentiality and intellectual protection.
22204|NCT00669942|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
22205|NCT00669916|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
22206|NCT00669903|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication or presentation of results until the earlier of the publication of the first multi-center publication and the second anniversary of the completion of the multi-center study at all sites. Sponsor must receive a copy of proposed manuscript for review and comment at least 60 days prior to its submission for publication or presentation.
22207|NCT00669877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22208|NCT00669864|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
22209|NCT00669682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22210|NCT00669617|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22211|NCT00669578|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22212|NCT00669552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22213|NCT00669539|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22214|NCT00669461|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22215|NCT00669396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22216|NCT00669331|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22217|NCT00669318|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22218|NCT00669279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22219|NCT00669240|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22220|NCT00669214|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22221|NCT00669110|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22222|NCT00669071|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
22223|NCT00669032|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PIs is that the study results will be presented during scientific meetings or published in scientific journals with prior agreement with the sponsor.
22224|NCT00669019|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22225|NCT00668902|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22226|NCT00668863|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22227|NCT00668811|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22228|NCT00668785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22229|NCT00668746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22230|NCT00668733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22231|NCT00668564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22232|NCT00668525|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor’s confidential info. Upon sponsor’s request, PI shall delete any proprietary info & shall not include raw data in pub. On sponsor’s request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub.
22233|NCT00668434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22234|NCT00668395|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22235|NCT00668382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22236|NCT00668317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22237|NCT00668265|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22238|NCT00668200|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
22239|NCT00667992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22240|NCT00667875|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22241|NCT00667849|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22242|NCT00667810|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22243|NCT00667745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22264|NCT00667095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22244|NCT00667732|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22245|NCT00667693|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22246|NCT00667615|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22247|NCT00667602|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22248|NCT00667589|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22249|NCT00667576|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
22250|NCT00667563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22251|NCT00667511|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22252|NCT00667459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22253|NCT00667446|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
22254|NCT00667420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22255|NCT00667394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22256|NCT00667381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22257|NCT00667368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22258|NCT00667355|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; the Medical Institution shall not disclose any material/information disclosed by Abbott Japan in connection with the Clinical Research or information obtained by conducting the Clinical Research to third parties without Abbott Japan's prior written approval. When Medical Institution intends to publish information obtained by conducting Clinical Research, Institution shall obtain Abbott Japan's prior written approval.
22259|NCT00667342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22260|NCT00667277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22261|NCT00667251|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
22262|NCT00667225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22263|NCT00667186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22265|NCT00666978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22266|NCT00666965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22267|NCT00666926|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22268|NCT00666848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22269|NCT00666835|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22270|NCT00666757|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22271|NCT00666718|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22272|NCT00666705|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22273|NCT00666679|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22274|NCT00666666|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22275|NCT00666588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22276|NCT00666562|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22277|NCT00666536|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22278|NCT00666458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22279|NCT00666406|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter requires a review of results communications (e.g., for confidential information and/or manuscript amendment proposals which do not negatively influence the scientific character of impartiality) ≥30 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., for intellectual property protection)
22280|NCT00666328|Principal Investigators are NOT employed by the organization sponsoring the study.|The site agrees that it will not publish until the earlier of presentation and publication of results or until 12 months after study conclusion. The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of 90 days from the time submitted to the sponsor for review in order to allow sponsor time to file any patent applications. The sponsor cannot require changes to the communication and cannot extend the embargo.
22281|NCT00666276|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22282|NCT00666263|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 18 months after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxter may request an additional delay of ≤120 days(e.g., for intellectual property protection)
22283|NCT00666224|Principal Investigators are NOT employed by the organization sponsoring the study.|"Should the investigator wish to publish the results of this study, he/she agrees to provide Teva with a manuscript for review 60 days prior to submission for publication. Teva retains the right to delete confidential information and to object to suggest publication and/or its timing (at the Company's sole discretion).~If Teva chooses to publish this study a copy will be provided to the investigator at least 30 days prior to the expected date of submission to the intended publisher."
22284|NCT00666211|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22285|NCT00666198|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22286|NCT00666029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22287|NCT00665925|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22288|NCT00665847|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22289|NCT00665704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22290|NCT00665626|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22291|NCT00665470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22292|NCT00665444|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22293|NCT00665431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22294|NCT00665366|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22295|NCT00665353|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22296|NCT00665132|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22297|NCT00665002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22298|NCT00664755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22299|NCT00664742|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22300|NCT00664560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22301|NCT00664534|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22396|NCT00659607|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22302|NCT00664521|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publishing results, Institution and Principal Investigator (PI) must first provide Sponsor with a copy of proposed publication for review at least 30 days prior to submission. If Institution and PI do not agree to modification, they shall so notify Sponsor and postpone submission for additional 60 days to allow Sponsor to seek legal remedies or file patent applications. There is a need for coordinated approach to any publication of results from sites for any multi-site study.
22303|NCT00664430|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
22304|NCT00664326|Principal Investigators are NOT employed by the organization sponsoring the study.|"The agreed point of publication is 12-18 months after database lock at the earliest. Bayer will have 30-45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable).~No publication of single center data should be done prior of publication if multi-center data."
22305|NCT00664209|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22306|NCT00664105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22307|NCT00664066|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
22308|NCT00663962|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22309|NCT00663923|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22310|NCT00663858|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22311|NCT00663819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22312|NCT00663793|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22313|NCT00663702|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22314|NCT00663403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22315|NCT00663260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22316|NCT00663234|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
22317|NCT00663208|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22318|NCT00663169|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22319|NCT00663117|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22320|NCT00663052|Principal Investigators are NOT employed by the organization sponsoring the study.|Wyeth has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22321|NCT00663026|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22322|NCT00662909|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
22323|NCT00662857|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
22324|NCT00662831|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22325|NCT00662818|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
22326|NCT00662675|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22327|NCT00662649|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."
22328|NCT00662558|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22329|NCT00662545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22330|NCT00662532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22331|NCT00662389|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22332|NCT00662363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22333|NCT00662311|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22334|NCT00662207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22335|NCT00662155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22336|NCT00662129|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22337|NCT00662038|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22338|NCT00662025|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22339|NCT00662012|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22340|NCT00661999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22341|NCT00661960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22342|NCT00661895|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22343|NCT00661830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22344|NCT00661778|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22345|NCT00661726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22346|NCT00661713|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis’ agreement with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publications of the pooled data (i.e., data from all sites) in the clinical trial.
22347|NCT00661687|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22348|NCT00661674|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22349|NCT00661661|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22350|NCT00661622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22351|NCT00661609|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites. AZ has the right to request delays: up to 60 days for confidential information, and an additional 90 days to protect intellectual property.
22352|NCT00661583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22353|NCT00661570|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22354|NCT00661544|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22355|NCT00661531|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22356|NCT00661505|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22357|NCT00661492|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22358|NCT00661479|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
22359|NCT00661453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22360|NCT00661427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22361|NCT00661388|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22362|NCT00661362|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator will provide AstraZeneca as soon as possible with preliminary data and drafts of proposed publications and disclosures, whether oral or in writing, with the proposed final manuscript. AZ shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time require that submission for publication or disclosure of the manuscript be delayed.
22363|NCT00661258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22364|NCT00661193|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22365|NCT00661141|Principal Investigators are NOT employed by the organization sponsoring the study.|Horizon requests that any Investigator/institution that plans on presenting or publishing results provide written notification of their request a minimum of 60 days prior to presentation or publication. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsors’ Intellectual Property rights .
22366|NCT00661089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22367|NCT00661037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22368|NCT00660985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22369|NCT00660907|Principal Investigators are NOT employed by the organization sponsoring the study.|If an Investigator requests permission to publish data from this study any such publication is to be agreed with AstraZeneca (AZ) in advance. The investigator agrees to provide AZ as soon as possible with drafts of proposed publications. Unless otherwise agreed, AZ shall have a period of 60 days from receipt of the proposed final manuscript to review it and may within such time require that submission for publication of the manuscript be delayed in order for AZ to file patent applications.
22370|NCT00660829|Principal Investigators are NOT employed by the organization sponsoring the study.|For multicenter studies, joint publication is required to assure that the initial publication is based on all data from all sites and investigators participating in these studies agree not to present data gathered individually or by subgroup centers before the initial publication unless jointly agreed by all other investigators and the sponsor. authorship will be determined by mutual agreement.
22371|NCT00660816|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22372|NCT00660699|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22373|NCT00660660|Principal Investigators are NOT employed by the organization sponsoring the study.|If Sponsor does not publish within 2 years after study completion, PI is permitted to publish, with confidential information removed from manuscript. Sponsor will have opportunity to review and approve publication at least 60 days prior to being submitted/disclosed. Sponsor can request, in writing, an additional 90 day embargo.
22374|NCT00660595|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22375|NCT00660543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22376|NCT00660517|Principal Investigators are NOT employed by the organization sponsoring the study.|"Investigators participating in multicenter studies must agree not to present data gathered individually or by a subgroup of centers before the full, initial publication, unless this has been agreed to by all other investigators and Meda Pharmaceuticals.~Meda Pharmaceuticals requests that it receive copies of any intended communication reasonably in advance (at least 15 working days for an abstract or oral presentation and 45 working days for a manuscript)"
22377|NCT00660504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22378|NCT00660400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22379|NCT00660387|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
22380|NCT00660348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22381|NCT00660309|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22382|NCT00660192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22383|NCT00660179|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22384|NCT00660075|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22385|NCT00660049|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22386|NCT00660023|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22387|NCT00660010|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
22388|NCT00659984|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22389|NCT00659945|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22390|NCT00659880|Principal Investigators are NOT employed by the organization sponsoring the study.|PI may present/publish in meetings, journals, theses, dissertations the results of Investigation provided that RTI will have been furnished copies of any proposed publication/presentation at least 40 days in advance of the submission. RTI will have 30 days after receipt to object & withhold consent to the proposed presentation/publication either because there is patentable subject matter which needs protection and or there is Confidential or inaccurate information contained in the publication
22391|NCT00659815|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be published or presented by the investigator(s) after the review by, and in consultation and agreement with the Sponser, and such that confidential or proprietary information is not disclosed.
22392|NCT00659789|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor (or designee) will prepare a final report on the study. The Investigator may not publish or present any information on this study without the express written approval of the Sponsor. Additionally, the Sponsor, may, for any reason, withhold approval for publication or presentation.
22393|NCT00659737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22394|NCT00659724|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22395|NCT00659633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22397|NCT00659581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22398|NCT00659529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22399|NCT00659490|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca has exclusive rights to publish the results of the tudy
22400|NCT00659438|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
22401|NCT00659425|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22402|NCT00659373|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22403|NCT00659360|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22404|NCT00659334|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22405|NCT00659295|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the physician’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication, or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
22406|NCT00659269|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22407|NCT00659230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22408|NCT00659165|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22409|NCT00659061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22410|NCT00658996|Principal Investigators are NOT employed by the organization sponsoring the study.|
22411|NCT00658814|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22412|NCT00658788|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22413|NCT00658775|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22414|NCT00658736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22415|NCT00658723|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22416|NCT00658697|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22417|NCT00658684|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22418|NCT00658658|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
22419|NCT00658632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22420|NCT00658619|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
22421|NCT00658606|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
22422|NCT00658567|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish the study results, relative to his/her own patients, only after review, comment and approval by the sponsor. No publication of confidential information shall be made without the sponsor’s prior written consent. At least 60 days prior to submitting a manuscript or prior to any public presentation, a copy of the manuscript or presentation will be provided to the sponsor for review and comment. The sponsor has 60 days to review and comment.
22423|NCT00658541|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22424|NCT00658528|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22425|NCT00658411|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22426|NCT00658385|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22427|NCT00658359|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22428|NCT00658333|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22429|NCT00658320|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22430|NCT00658138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22431|NCT00658112|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22432|NCT00657709|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22433|NCT00657657|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22434|NCT00657618|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22435|NCT00657553|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22436|NCT00657540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22437|NCT00657371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22438|NCT00657358|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22439|NCT00657280|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22440|NCT00657267|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22441|NCT00657150|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22442|NCT00657046|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22443|NCT00657020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22444|NCT00656968|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22445|NCT00656916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22446|NCT00656851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22447|NCT00656799|Principal Investigators are NOT employed by the organization sponsoring the study.|In case a proposed publication contains reference to an invention owned by the sponsor or to which the sponsor otherwise has rights, the sponsor may request a reasonable suspension of the publication.
22448|NCT00656669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22449|NCT00656656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22450|NCT00656630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22451|NCT00656617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22452|NCT00656513|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
22453|NCT00656487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22454|NCT00656474|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of up to 90 days. The sponsor can require changes to the communication to remove any confidential information.
22455|NCT00656448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22456|NCT00656370|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to use the information for the purpose of carrying out this study and for no other purpose, unless prior written permission from the Sponsor (Halozyme) is obtained.
22457|NCT00656292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22458|NCT00656201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22459|NCT00656175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22460|NCT00656136|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22461|NCT00656084|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22462|NCT00656058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22463|NCT00656019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22464|NCT00655889|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications or presentations by the Investigator or his associates, were required to be submitted to the sponsor for review and approval prior to publication or presentation in any form.
22465|NCT00655876|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
22466|NCT00655863|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
22467|NCT00655850|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22468|NCT00655824|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22469|NCT00655811|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22470|NCT00655746|All Principal Investigators ARE employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22471|NCT00655733|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22472|NCT00655668|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
22473|NCT00655642|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22474|NCT00655629|Principal Investigators are NOT employed by the organization sponsoring the study.|In the protocol it is specified that all results are the property of the sponsor. The investigator must discuss any publication with the sponsor prior to release and obtain written consent of the sponsor. The investigator must send a draft publication to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication.
22475|NCT00655564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22476|NCT00655551|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22477|NCT00655486|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22478|NCT00655356|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications or presentations by the Investigator or his associates, were required to be submitted to the sponsor for review and approval.
22479|NCT00655083|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22480|NCT00654992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22481|NCT00654953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22482|NCT00654940|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22483|NCT00654927|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
22484|NCT00654901|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
22485|NCT00654875|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22486|NCT00654836|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22487|NCT00654784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22488|NCT00654745|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor reflects the following restrictive language in the Clinical Study Agreements: If identified by Daiichi Sankyo Inc. (DSI), any of DSI's confidential information as defined herein shall be deleted. Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by the Study Site."
22489|NCT00654654|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications or presentations by the Investigator or his associates, were required to be submitted to the sponsor for review and approval prior to publication or presentation in any form.
22490|NCT00654641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22491|NCT00654628|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22492|NCT00654615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22493|NCT00654511|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22494|NCT00654498|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22495|NCT00654420|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
22496|NCT00654381|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22497|NCT00654368|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
22498|NCT00654355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22499|NCT00654329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22500|NCT00654186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22501|NCT00654147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22502|NCT00654095|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigator (PI) agrees, for a period of 5 years following the Effective Date, to retain the Disclosure made to it by or on behalf of Sponsor (SPKK), in confidence and not to disclose it to any third party.~PI further agrees that during such time period it will not, either directly or indirectly, use the Disclosure for any purpose(s) other than that indicated herein without the prior written consent of SPKK."
22503|NCT00654030|Principal Investigators are NOT employed by the organization sponsoring the study.|Study chair (Dr. Edward Hirschowitz) is only party available to disclose, discuss, or publish trial results or information concerning the trial after completion.
22504|NCT00654004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22505|NCT00653939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22506|NCT00653861|Principal Investigators are NOT employed by the organization sponsoring the study.|At least ninety (90) days prior to any proposed submission for publication or presentation of Study data or other findings related to the Study, the Investigator will provide the Sponsor with a manuscript of such submission(s) for review and comment.
22507|NCT00653523|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigator (PI) agrees, for a period of 5 years following the Effective Date, to retain the Disclosure made to it by or on behalf of Sponsor (SPKK), in confidence and not to disclose it to any third party.~PI further agrees that during such time period it will not, either directly or indirectly, use the Disclosure for any purpose(s) other than that indicated herein without the prior written consent of SPKK."
22508|NCT00653328|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22509|NCT00653263|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22510|NCT00653224|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22511|NCT00653159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22512|NCT00653133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22513|NCT00653068|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
22514|NCT00652938|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22515|NCT00652899|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22516|NCT00652834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22517|NCT00652626|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (30) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
22518|NCT00652366|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22519|NCT00652340|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22520|NCT00652327|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22521|NCT00652314|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22522|NCT00652145|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22523|NCT00652093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22524|NCT00652028|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22525|NCT00651924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22526|NCT00651820|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22527|NCT00651794|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22528|NCT00651755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22529|NCT00651625|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22530|NCT00651482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22531|NCT00651313|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22532|NCT00651261|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22533|NCT00651183|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22534|NCT00651157|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22535|NCT00651118|Principal Investigators are NOT employed by the organization sponsoring the study.|"Investigators participating in multicenter studies must agree not to present data gathered individually or by a subgroup of centers before the full, initial publication, unless this has been agreed to by all other investigators and Meda Pharmaceuticals.~Meda Pharmaceuticals requests that it receive copies of any intended communication reasonably in advance (at least 15 working days for an abstract or oral presentation and 45 working days for a manuscript)"
22536|NCT00651040|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22537|NCT00650858|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall provide the sponsor with a copy of any proposed publication for review and comment thirty (30) days prior to submission. JHU may request a delay in publication, not to exceed 90 days if it is necessary to protect any intellectual property.
22538|NCT00650845|Principal Investigators are NOT employed by the organization sponsoring the study.|"No unpublished data given to the investigator may be transmitted to a third party without prior approval of the sponsor in writing. The data are the exclusive property of Guerbet.~The investigator undertakes to submit to Guerbet any draft articles or papers related to this study within 30 days of their submission to the scientific review or the congress scientific committee.~All written or oral papers and publications must have the joint agreement of the investigator and the sponsor."
22539|NCT00650806|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
22540|NCT00650767|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of the sponsor's agreements with its investigators may vary. However, the sponsor does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e. data from all sites) in the clinical trial.
22541|NCT00650585|Principal Investigators are NOT employed by the organization sponsoring the study.|All reports and products must be submitted for review prior to publication.
22542|NCT00650546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22543|NCT00650260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22544|NCT00650104|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22545|NCT00650091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22546|NCT00650078|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication shall be the presentation of a joint, multicenter publication of the Study results. If such a multicenter publication is not submitted within 24 months after conclusion of the Study at all sites, INSTITUTION/INVESTIGATOR may publish the results from the INSTITUTION’S site individually, provided that it is submitted to SPONSOR for review and comment 60 days prior to submission for publication.
22547|NCT00649961|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22548|NCT00649792|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
22549|NCT00649428|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications or presentations by the Investigator or his associates, were required to be submitted to the sponsor for review and approval.
22550|NCT00649389|Principal Investigators are NOT employed by the organization sponsoring the study.|Study site may not publish results of study until after coordinated multicenter publication has been submitted for publication or one year after study has ended, whichever occurs first. Therefore, study site will have the opportunity to publish results of study, provided that Daiichi Sankyo has had the opportunity to review and comment on study site’s proposed publication prior to being submitted for publication with advice of company patent council and in accord with subject protection needs.
22551|NCT00649220|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 weeks before submission. Sponsor to give written opinion within 30 days. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
22552|NCT00648908|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
22553|NCT00648895|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 60 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential information. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in the publication. On sponsor's request, PI shall delay submission for any pub while sponsor files patent applications. Any publication will give recognition to Sponsor's support.
22554|NCT00648167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22555|NCT00648115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22556|NCT00648037|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22557|NCT00647998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22558|NCT00647699|Principal Investigators are NOT employed by the organization sponsoring the study.|Site has the right to publish or communicate study results upon the earlier of: (a) publication of a multi-center publication of the Study results coordinated by Sponsor; or (b) submission of the Study data by Sponsor to the FDA; provided that the Sponsor reviews the proposed communication of results within ninety (90) days in advance of its release. Sponsor can request delay of publication or data release to allow for filing of patent application prior to the publication or release.
22697|NCT00637572|Principal Investigators are NOT employed by the organization sponsoring the study.|All manuscripts, abstracts or other modes of presentation arising from the results of this study must be reviewed and approved in writing by Par, in advance of submission.
22559|NCT00647556|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator has the right to publish or present the data resulting from this study, with agreed upon reviews by all interested parties, and in accordance with any confidentiality agreements that may exist.
22560|NCT00647400|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; the Medical Institution shall not disclose any material/information disclosed by Abbott Japan in connection with the Clinical Research or information obtained by conducting the Clinical Research to third parties without Abbott Japan's prior written approval. When Medical Institution intends to publish information obtained by conducting Clinical Research, Institution shall obtain Abbott Japan's prior written approval.
22561|NCT00647270|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
22562|NCT00646958|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor retains control of all publication rights.
22563|NCT00646776|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22564|NCT00646763|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22565|NCT00646646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22566|NCT00646581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22567|NCT00646399|Principal Investigators are NOT employed by the organization sponsoring the study.|
22568|NCT00646282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22569|NCT00646048|Principal Investigators are NOT employed by the organization sponsoring the study.|
22570|NCT00645970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22571|NCT00645944|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22572|NCT00645853|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22573|NCT00645827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22574|NCT00645788|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreed point of publication is 12-18 months after database lock at the earliest. Bayer will have 30-45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable). No publication of single center data should be done prior of publication if multi-center data.
22575|NCT00645762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22576|NCT00645671|Principal Investigators are NOT employed by the organization sponsoring the study.|"The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with, the Sponsor and such that confidential or proprietary information is not disclosed.~Prior to publication or presentation, a copy of the final text should be forwarded by the Investigator(s) to the Sponsor or its designee for comment."
22577|NCT00645593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22578|NCT00645567|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22579|NCT00645528|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22698|NCT00637494|Principal Investigators are NOT employed by the organization sponsoring the study.|
22580|NCT00645411|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22581|NCT00645359|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22582|NCT00645333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22583|NCT00645164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22584|NCT00645099|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22585|NCT00645047|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22586|NCT00644995|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22587|NCT00644969|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22588|NCT00644917|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22589|NCT00644787|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the Sponsor requires.
22590|NCT00644657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22591|NCT00644592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22592|NCT00644358|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
22593|NCT00644332|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
22594|NCT00644280|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22595|NCT00644228|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22596|NCT00644189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22597|NCT00644059|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22598|NCT00643916|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
22599|NCT00643851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22600|NCT00643760|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22601|NCT00643682|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22602|NCT00643604|Principal Investigators are NOT employed by the organization sponsoring the study.|"There is an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the Principal Investigator's rights to discuss or publish trial results after the trial is completed.~Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the Investigator contract."
22603|NCT00643578|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22604|NCT00643565|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22605|NCT00643487|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22606|NCT00643448|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22607|NCT00643201|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22608|NCT00643123|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22609|NCT00643097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22610|NCT00643006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22611|NCT00642993|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
22612|NCT00642902|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publishing results, Institution and Principal Investigator (PI) must first provide Sponsor with a copy of proposed publication for review at least 30 days prior to submission. If Institution and PI do not agree to modification, they shall so notify Sponsor and postpone submission for additional 60 days to allow Sponsor to seek legal remedies or file patent applications. There is a need for coordinated approach to any publication of results from sites for any multi-site study.
22613|NCT00642850|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22614|NCT00642811|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites.
22615|NCT00642772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22616|NCT00642759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22617|NCT00642746|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22699|NCT00637416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22618|NCT00642707|Principal Investigators are NOT employed by the organization sponsoring the study.|Because the study is a multicenter study, the PI(s) can only publish after the aggregate results of all investigators and institutions participating in the study have been published, and the proposed publication is reviewed by Progenics. In the event that Progenics does not publish the results of the study within eighteen months from availability of final study analysis, the PI can publish provided that the proposed publication is reviewed by Progenics.
22619|NCT00642694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22620|NCT00642668|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22621|NCT00642642|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications or presentations by the Investigator or his associates, were required to be submitted to the sponsor for review and approval prior to publication or presentation in any form.
22622|NCT00642616|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
22623|NCT00642603|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22624|NCT00642473|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22625|NCT00642460|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22626|NCT00642382|Principal Investigators are NOT employed by the organization sponsoring the study.|
22627|NCT00642369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22628|NCT00642356|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22629|NCT00642304|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22630|NCT00642278|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
22631|NCT00642174|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22632|NCT00641862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22633|NCT00641797|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22634|NCT00641745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22635|NCT00641719|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22636|NCT00641706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22637|NCT00641667|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the Sponsor requires.
22638|NCT00641641|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22639|NCT00641563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22640|NCT00641537|Principal Investigators are NOT employed by the organization sponsoring the study.|
22641|NCT00641147|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22642|NCT00641056|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22643|NCT00641043|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22644|NCT00640978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22645|NCT00640926|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor retains publication rights.
22646|NCT00640835|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications shall be submitted to Sponsor 30 days prior to submission for publication, and may be withheld for an additional period, up to 90 days, to allow Sponsor to file patent applications. If a multi-center publication isn't submitted for publication within 12 months of the conclusion of the Study at all sites, or is published in a shorter period, the results from the institution's site may be published individually.
22647|NCT00640822|Principal Investigators are NOT employed by the organization sponsoring the study.|The Company acknowledges the investigators right to publish the entire results of the study, irrespective of outcome. The Company retains the right to have any publication submitted to the Company for review at least 30 days prior to the same paper being submitted for publication or presentation. Investigators must undertake not to submit any part of their individual data for publication without the prior consent of LEO.
22648|NCT00640653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22649|NCT00640614|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22650|NCT00640601|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time require that submission for publication or disclosure of the manuscript be delayed for an additional period of ninety (90) days in order for AstraZeneca to file patent applications.
22651|NCT00640562|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22652|NCT00640510|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22653|NCT00640393|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22654|NCT00640341|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be published or presented by the investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
22655|NCT00640328|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22756|NCT00634582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22656|NCT00640315|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator may prepare the data derived from the Trial for publication. Such data will be submitted to the Sponsor for review at least 60 days prior to submission for publication. The Sponsor should respond within 50 days after receipt of the manuscript. The Investigator agrees that all reasonable comments made by the Sponsor in relation to a proposed publication will be incorporated. Confidential data provided by the Sponsor may not be published without written approval of the Sponsor.
22657|NCT00640250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22658|NCT00640224|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22659|NCT00640042|Principal Investigators are NOT employed by the organization sponsoring the study.|Results may only be published through Sponsor.
22660|NCT00640016|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The Principal Investigator (PIs) also agree for data to be presented first as a joint, multi-center publication.
22661|NCT00639860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22662|NCT00639769|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22663|NCT00639717|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22664|NCT00639678|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22665|NCT00639626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22666|NCT00639509|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22667|NCT00639457|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22668|NCT00639418|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22669|NCT00639379|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
22670|NCT00639223|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22671|NCT00639158|Principal Investigators are NOT employed by the organization sponsoring the study.|Not to publish or present the results before the publication of the multi-center investigator paper, but in no event shall be so restricted after the expiration of twelve (12) months from completion of the studies at all sites. Any presentation or publication to be submitted to Sponsor (in Draft of the same) for Sponsor review and comment.
22672|NCT00639093|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22673|NCT00639002|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
22674|NCT00638989|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22675|NCT00638963|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator (PI) agrees not to publish or publicly present any interim results of the Study without prior written consent of the sponsor. The PI further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of abstracts or manuscripts for publication in accordance with provisions of laws related to protection of sensitive personal data and patentability of inventions.
22676|NCT00638937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22677|NCT00638924|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22678|NCT00638885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22679|NCT00638846|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
22680|NCT00638820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22681|NCT00638716|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22682|NCT00638690|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 60 days from the time submitted to the sponsor for review. After 1) publication of multi-center results, 2) notification by sponsor that a multi-center submission is no longer planned, or 3) the 18 month anniversary of the termination of the study at all sites, the institution and investigator may publish or publicly present study data.
22683|NCT00638651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22684|NCT00638443|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22685|NCT00638378|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study; provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
22686|NCT00638365|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor has right of first publication of trial results, which will be a joint, multi-center publication of the study results from all appropriate sites contributing data, analysis and comments.
22687|NCT00638235|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22688|NCT00638222|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22689|NCT00638183|All Principal Investigators ARE employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
22690|NCT00638157|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If First Publication not published within 1 year of Study conclusion or termination, Investigator has right to publish and disclose the Data. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
22691|NCT00638027|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22692|NCT00638014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22693|NCT00637923|Principal Investigators are NOT employed by the organization sponsoring the study.|Presentation and/or publication is encouraged provided the Sponsor is notified in advance and given the opportunity to review the manuscript or abstract 30 days prior to its submission for presentation at a scientific meeting or for publication in a scientific journal. The investigators will have complete autonomy regarding the content and wording including the decision of whether or not to publish.
22694|NCT00637806|Principal Investigators are NOT employed by the organization sponsoring the study.|
22695|NCT00637780|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22696|NCT00637728|Principal Investigators are NOT employed by the organization sponsoring the study.|
22700|NCT00637377|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidentiality agreement with sponsor, contract with the sponsor via the CRO (Clinical research organization), set up based on local legal requirements, changes addressed+confirmed with local responsible persons; PIs interested in presenting the study on meetings, contacted the sponsor and received slides and approval to do so either by the Clinical Lead or the Medical Affairs department
22701|NCT00637312|Principal Investigators are NOT employed by the organization sponsoring the study.|Within the first 12 months following completion of the study, any publication must be initiated as a multi-center publication in conjunction with other PIs in the study. After 12 months, each PI is able to publish their data, but must first submit the publication to the sponsor within 60 days prior to publication. The sponsor has the right to make reasonable requests to protect the rights and interests of the sponsor.
22702|NCT00637299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22703|NCT00637273|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22704|NCT00637247|Principal Investigators are NOT employed by the organization sponsoring the study.|The manuscript or abstract shall be submitted at least (45) days prior to submission for publication to permit Sponsor to request removal of any Confidential Information and to protect its rights to any patentable inventions set forth therein. Upon Sponsor’s reasonable request, the investigator shall redact Sponsor’s Confidential Information from any such proposed publication or shall delay publication for up to 90 days to permit Sponsor to protect its proprietary Information.
22705|NCT00637195|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22706|NCT00637156|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22707|NCT00637000|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publications shall be submitted to Sponsor 30 days prior to submission for publication, and may be withheld for an additional period, up to 90 days, to allow Sponsor to file patent applications. If a multi-center publication isn't submitted for publication within 12 months of the conclusion of the Study at all sites, or is published in a shorter period, the results from the institution's site may be published individually.
22708|NCT00636987|Principal Investigators are NOT employed by the organization sponsoring the study.|
22709|NCT00636961|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22710|NCT00636818|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22711|NCT00636805|Principal Investigators are NOT employed by the organization sponsoring the study.|Research site shall provide MGI copies of publication at least 30 days prior to submission to allow MGI to protect its copyrights, to determine any Confidential Information (CI) and to check for technical correctness. Site shall consider any MGI comments and delete any CI requested by MGI, unless CI removal changes accuracy or interpretation of results, in which case site and MGI will discuss timing of submission. MGI may request delay of up to 60 days to protect its copyright or patent rights.
22712|NCT00636792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22713|NCT00636701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22714|NCT00636649|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22715|NCT00636636|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agree that the sponsor shall have the right to the first publication of the results of the study which is intended to be joint, multi-center publication. Following the first publication, the PI may publish data or results from the study, provided however PI submits the proposed publication to sponsor for review at least 60 days prior to the data of the proposed publication.Sponsor may remove any information that is considered confidential and or proprietary other than study data.
22716|NCT00636610|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22717|NCT00636441|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22718|NCT00636389|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22719|NCT00636363|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.
22720|NCT00636220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22721|NCT00636207|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
22722|NCT00636194|Principal Investigators are NOT employed by the organization sponsoring the study.|"The results of the study may be published or presented by the Investigator(s) after the review by, and in consultation and agreement with the Sponsor, and such that confidential or proprietary information is not disclosed.~Prior to publication or presentation, a copy of the final text should be forwarded by the Investigator(s) to the Sponsor or its designee, for comment."
22723|NCT00636168|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22724|NCT00636155|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22725|NCT00636077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22726|NCT00635999|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22727|NCT00635882|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator agrees not to publish/present any interim results without prior~sponsor written consent. The investigator agrees to provide to the sponsor, 45 days prior to submission, review copies for publication that report any study results. The sponsor has the right to review and comment. If the parties disagree, investigator agrees to meet with the sponsor, prior to submission for publication, to discuss and resolve any such issues/disagreement."
22728|NCT00635830|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22729|NCT00635817|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
22730|NCT00635804|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22731|NCT00635700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22732|NCT00635661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22733|NCT00635648|Principal Investigators are NOT employed by the organization sponsoring the study.|Twenty-four months after completion of this study or after publication of the multicenter results, an investigator may publish the results for their study site independently. The sponsor must have the opportunity to review all proposed publications or presentations regarding the study 60 days before submission.
22734|NCT00635609|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22735|NCT00635570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22757|NCT00634569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22736|NCT00635492|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22737|NCT00635479|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22738|NCT00635427|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information(excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication
22739|NCT00635362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22740|NCT00635349|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) cannot provide any trial related information to external parties’ without mutual agreement with the Sponsor. This is valid even after the contract is canceled.
22741|NCT00635232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22742|NCT00635219|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub-publications. H. Lundbeck A/S follows the Vancouver declaration with respect to authorship.
22743|NCT00635154|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22744|NCT00635128|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22745|NCT00635102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22746|NCT00635089|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
22747|NCT00635050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22748|NCT00635024|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22749|NCT00634933|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22750|NCT00634920|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
22751|NCT00634907|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22752|NCT00634842|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
22753|NCT00634751|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22754|NCT00634647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22755|NCT00634621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22758|NCT00634543|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) cannot provide any trial related information to external parties’ without mutual agreement with the Sponsor. This is valid even after the contract is cancelled.
22759|NCT00634504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22760|NCT00634322|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22761|NCT00634270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22762|NCT00634244|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22763|NCT00634179|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22764|NCT00634166|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall provide Sponsor with (i) a copy of the papers prepared for publication by him or her as soon as possible, but in any event not less than sixty (60) days prior to their submission to a scientific journal or other publication; or (ii) a reasonably detailed summary or abstract of any oral presentation not less than forty-five (45) days prior to their submission or presentation. Sponsor may comment and remove any confidential information as needed.
22765|NCT00634114|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study withiout AZ approval before this study was completed.
22766|NCT00634088|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period of 60 days or less from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22767|NCT00634049|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication. At least sixty (60) days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy of all such manuscripts and materials , and allow Sponsor sixty (60) days to review and comment on them.
22768|NCT00634036|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22769|NCT00634010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22770|NCT00633984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22771|NCT00633932|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study withiout AZ approval before this study was completed.
22772|NCT00633919|Principal Investigators are NOT employed by the organization sponsoring the study.|ALK must receive copies of any intended communication in advance of publication (at least 15 working days for an abstract or oral presentation and 45 working days for a journal submission). ALK will review the communications for accuracy (thus avoiding potential discrepancies with submissions to health authorities), verify that confidential information is not being inadvertently divulged and provide any relevant supplementary information.
22773|NCT00633893|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22774|NCT00633880|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22775|NCT00633867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22776|NCT00633750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22796|NCT00632632|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22777|NCT00633594|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
22778|NCT00633477|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
22779|NCT00633464|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22780|NCT00633399|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22781|NCT00633360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22782|NCT00633256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22783|NCT00633243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22784|NCT00633217|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22785|NCT00633152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22786|NCT00633139|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22787|NCT00633126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22788|NCT00633087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22789|NCT00633074|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22790|NCT00633009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22791|NCT00632970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22792|NCT00632931|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22793|NCT00632814|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institute shall supply a draft of any intended publication to the Customer not less than 60 (sixty) days before submission it for the publication in question and will supply a draft of any abstract or detailed paper or oral statement intended for public presentation not less than 60 (sixty) days before the earliest of the date of submission of the abstract or delivery of the public presentation. The Institute agrees that in any such publication only such data as is contained in an analysis.
22794|NCT00632749|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights.
22795|NCT00632736|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22797|NCT00632619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22798|NCT00632541|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22799|NCT00632502|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
22800|NCT00632489|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
22801|NCT00632463|Principal Investigators are NOT employed by the organization sponsoring the study.|
22802|NCT00632424|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22803|NCT00632411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22804|NCT00632281|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22805|NCT00632229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22806|NCT00632203|Principal Investigators are NOT employed by the organization sponsoring the study.|"The principal investigator (PI) agrees not to publish/publicly present any interim results of the study without prior written consent from the Sponsor. The PI further agrees to provide 45 days written notice to the Sponsor prior to~submission, to permit the Sponsor to review copies of abstracts/manuscripts for publication, which report any results of the study. The Sponsor shall have the right to review and comment on any presentation."
22807|NCT00632125|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor shall have the right to the first publication or presentation of the results of the study which is intended to be a joint, multi-center publication of the study results. Following the first publication, institutions and/or Principal Investigators may publish or present data or results from the study per the terms of the clinical trial agreement.
22808|NCT00632099|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22809|NCT00632021|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22810|NCT00631969|Principal Investigators are NOT employed by the organization sponsoring the study.|In the protocol it is specified that all results are the property of the sponsor. The investigator must discuss any publication with the sponsor prior to release and obtain written consent of the sponsor. The investigator must send a draft publication to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication.
22811|NCT00631917|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22812|NCT00631748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22813|NCT00631696|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22814|NCT00631670|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22815|NCT00631657|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22918|NCT00624923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22816|NCT00631540|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22817|NCT00631488|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
22818|NCT00631475|Principal Investigators are NOT employed by the organization sponsoring the study.|Actelion, with steering committee, shall complete the review and provide any modifications required to protect Actelion's patent rights and confidential information within sixty (60) days of receipt of the proposed publication. During this period, Investigator shall not permit publication. If Actelion reasonably anticipates filing a patent application claiming an invention arising out of the Study, such publication shall be delayed until after the application is filed.
22819|NCT00631449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22820|NCT00631410|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22821|NCT00631371|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22822|NCT00631358|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor shall be furnished with copies of any proposed disclosure as follows: Published abstracts will be submitted to the sponsor one month prior to submission allowing the sponsor three weeks to respond. Presentations will be submitted to the sponsor one moth prior to submission allowing the sponsor three weeks to respond. Publications will be submitted to the sponsor two months prior to submission allowing the sponsor two months to respond.
22823|NCT00631189|Principal Investigators are NOT employed by the organization sponsoring the study.|If the PI wants to discuss or publish results after the trial is completed he must obtain writing authorization from AstraZeneca
22824|NCT00631020|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22825|NCT00631007|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator and Institution shall only be permitted to publish or present the results of that portion of the Study conducted at Institution with Sponsor’s prior written consent, which consent may be withheld at Sponsor’s sole discretion.
22826|NCT00630994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22827|NCT00630955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22828|NCT00630916|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22829|NCT00630877|Principal Investigators are NOT employed by the organization sponsoring the study.|Provide ABBOTT at least sixty (60) days prior to submission for review, ABBOTT shall return comments within sixty (60) days of receipt of draft. Proposed draft shall be delayed an additional sixty (60) days in addition to the Review Period.
22830|NCT00630864|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22831|NCT00630838|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22832|NCT00630825|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22833|NCT00630786|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
22834|NCT00630747|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤ 180 days from the time submitted to Shire for review. Shire does not prohibit publication but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
22835|NCT00630734|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication or presentation, the PI will provide the sponsor with at least 60 days for review of a manuscript
22836|NCT00630539|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
22837|NCT00630487|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
22838|NCT00630409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22839|NCT00630396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22840|NCT00630344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22841|NCT00630331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22842|NCT00630305|Principal Investigators are NOT employed by the organization sponsoring the study.|
22843|NCT00630292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22844|NCT00630058|Principal Investigators are NOT employed by the organization sponsoring the study.|
22845|NCT00629850|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22846|NCT00629772|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22847|NCT00629707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22848|NCT00629525|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22849|NCT00629499|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
22850|NCT00629265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22851|NCT00629239|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to collaborate with AZ in regard to the contents and formation of any publication or disclosure and to considerate the comments,views and opinions offered by AZ. Prior to any publication or disclosure the PI will provide AZ with preliminary data and drafts of proposed publication or disclosure and the proposed final manuscript. AZ will have a period of 30 days from receipt of the proposed final manuscript to review and may require submission for publication or disclosure be delayed
22852|NCT00629122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22853|NCT00629018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22854|NCT00628927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22855|NCT00628901|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication to remove any confidential information or other proprietary information of Sponsor.
22856|NCT00628862|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22857|NCT00628758|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22858|NCT00628628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22859|NCT00628589|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study.~The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo."
22860|NCT00628498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22861|NCT00628446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22862|NCT00628407|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22863|NCT00628355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22864|NCT00628251|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication of the study results may be made until publication of the results of the multi-centre study or 2 years after study completion, whichever is the sooner
22865|NCT00628212|Principal Investigators are NOT employed by the organization sponsoring the study.|
22866|NCT00628147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22867|NCT00628134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22868|NCT00628108|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22869|NCT00628030|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22870|NCT00627978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22871|NCT00627926|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22872|NCT00627861|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22873|NCT00627705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22874|NCT00627679|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
22875|NCT00627523|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22876|NCT00627497|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI must provide the sponsor a copy of the results communication ninety (90) days prior to submission or disclosure. The sponsor shall not censor the results communication beyond the protection of confidential information. Investigator agrees to delete confidential information prior to any submission, publication, presentation or other disclosure. The sponsor can embargo results communications up to sixty (60) days.
22877|NCT00627458|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22878|NCT00627445|Principal Investigators are NOT employed by the organization sponsoring the study.|Manuscripts for publication will be prepared in collaboration between Investigator(s) and Novo Nordisk. Novo Nordisk will not suppress or veto publications; however Novo Nordisk reserves the right to postpone publication and/or communication for a short time to protect intellectual property.
22879|NCT00627406|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22880|NCT00627393|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications and presentations resulting from studies from the TMH Network must be approved by the Publications and Presentations Committee before submission. The Sponsor (NERI) and funding agency (NHLBI) both are represented on the P&P Committee along with Network Investigators. Members of the P&P Committee can recommend changes to publications.
22881|NCT00627367|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22882|NCT00627094|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22883|NCT00627042|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
22884|NCT00627016|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
22885|NCT00626925|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22886|NCT00626821|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22887|NCT00626808|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it is understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
22888|NCT00626782|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22889|NCT00626743|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release
22890|NCT00626639|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
22891|NCT00626626|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22892|NCT00626574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22893|NCT00626561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22894|NCT00626548|Principal Investigators are NOT employed by the organization sponsoring the study.|"3. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~AstraZeneca can review results communications prior to public release and may within 60 days of receipt require amendments to be made. AstraZeneca can also require that submission or disclosure be delayed to allow for"
22895|NCT00626522|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication and/or presentation whether complete or partial, of any part of the data or results of this trial, will be subject to revision and written agreement between the investigator and sponsor.
22896|NCT00626444|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22897|NCT00626431|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication, whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
22898|NCT00626405|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22899|NCT00626392|Principal Investigators are NOT employed by the organization sponsoring the study.|Provide Abbott at least sixty (60) days prior to submission for review, Abbott shall return comments within sixty (60) days of receipt of draft. Proposed draft shall be delayed an additional sixty (60) days in addition to the Review Period.
22900|NCT00626340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22901|NCT00626327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22902|NCT00626275|Principal Investigators are NOT employed by the organization sponsoring the study.|
22903|NCT00626210|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22904|NCT00626093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22905|NCT00626028|Principal Investigators are NOT employed by the organization sponsoring the study.|
22906|NCT00625989|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22907|NCT00625872|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22908|NCT00625820|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22909|NCT00625742|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22910|NCT00625729|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22911|NCT00625586|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22912|NCT00625443|Principal Investigators are NOT employed by the organization sponsoring the study.|
22913|NCT00625404|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22914|NCT00625391|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22915|NCT00625365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22916|NCT00625183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22917|NCT00625131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22919|NCT00624832|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22920|NCT00624806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22921|NCT00624780|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
22922|NCT00624585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22923|NCT00624559|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22924|NCT00624520|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22925|NCT00624468|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publishing results, Institution and Principal Investigator (PI) must first provide Sponsor with a copy of proposed publication for review at least 30 days prior to submission. If Institution and PI do not agree to modification, they shall so notify Sponsor and postpone submission for additional 60 days to allow Sponsor to seek legal remedies or file patent applications. There is a need for coordinated approach to any publication of results from sites for any multi-site study.
22926|NCT00624442|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor intends to publish the results of the trial in collaboration with the Investigators.
22927|NCT00624416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22928|NCT00624377|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22929|NCT00624338|Principal Investigators are NOT employed by the organization sponsoring the study.|
22930|NCT00624286|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
22931|NCT00624234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22932|NCT00624221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22933|NCT00624195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22934|NCT00624065|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22935|NCT00624052|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22936|NCT00624013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22937|NCT00623974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22938|NCT00623935|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22939|NCT00623831|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22956|NCT00623103|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22940|NCT00623805|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22941|NCT00623779|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22942|NCT00623766|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
22943|NCT00623727|Principal Investigators are NOT employed by the organization sponsoring the study.|"Bayer will have up to 30/45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable).~No publication of single center data should be done prior of publication if multi -center data."
22944|NCT00623714|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22945|NCT00623636|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
22946|NCT00623597|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22947|NCT00623545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22948|NCT00623506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22949|NCT00623480|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator must send a draft manuscript of the publication or abstract to the Sponsor sixty days in advance of submission in order to obtain written approval prior to submission of the final version for publication. In case of a difference of opinion between the Sponsor and the Investigator(s), the contents of the publication will be discussed in order to find a solution which satisfies both parties.
22950|NCT00623467|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is interested in the publication of the results of every study it performs. All relevant aspects regarding publication will be part of the contract between the sponsor and the investigator/institution. The sponsor has committed to the global industry position on disclosure of information about clinical trials. The information regarding the study protocol is made publicly available on the internet at www.clinicaltrials.gov.
22951|NCT00623441|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that results communications are provided to the sponsor at least 90 days prior to submittal for publication or presentation. The sponsor shall not require changes beyond the extent necessary to allow the sponsor to protect its rights in copyrightable material, and to check for technical correctness.
22952|NCT00623428|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
22953|NCT00623233|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22954|NCT00623194|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right not to release data until specified milestones, e.g., a Clinical Trial Report is available. At the end of the trial, one or more manuscripts for publication will be prepared in collaboration between authors and Novo Nordisk. Novo Nordisk will not suppress or veto publications; however Novo Nordisk reserves the right to postpone publication and/or communication for a short time to protect intellectual property.
22955|NCT00623181|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
22957|NCT00623012|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22958|NCT00622908|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has 45 days to review materials and provide comments back to the investigator.
22959|NCT00622869|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
22960|NCT00622739|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22961|NCT00622726|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22962|NCT00622713|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
22963|NCT00622700|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
22964|NCT00622635|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
22965|NCT00622518|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22966|NCT00622440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22967|NCT00622427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22968|NCT00622401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22969|NCT00622388|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22970|NCT00622336|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator has the right to publish and/or present study data after multicentric publication or one year has elapsed until completion this multicentric study provided that he/she (i) furnishes the sponsor a copy of any proposed publication or presentation before its submission, (ii) deletes any sponsor’s confidential data as pointed out by sponsor, and (iii) delays any submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications.
22971|NCT00622284|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22972|NCT00622167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22973|NCT00621985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22974|NCT00621959|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
22975|NCT00621946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22976|NCT00621933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22998|NCT00620945|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22977|NCT00621855|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22978|NCT00621842|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22979|NCT00621777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22980|NCT00621764|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
22981|NCT00621686|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22982|NCT00621621|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22983|NCT00621582|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22984|NCT00621543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22985|NCT00621530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22986|NCT00621517|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22987|NCT00621504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22988|NCT00621348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22989|NCT00621322|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
22990|NCT00621296|Principal Investigators are NOT employed by the organization sponsoring the study.|
22991|NCT00621257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22992|NCT00621244|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigators from publishing. Any publications from a single-site are postponed until the publication of the polled data (ie, data from all sites) in the clinical trial.
22993|NCT00621192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
22994|NCT00621153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
22995|NCT00621140|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
22996|NCT00621049|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
22997|NCT00621023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23286|NCT00606593|Principal Investigators are NOT employed by the organization sponsoring the study.|
22999|NCT00620854|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction is that the Principal Investigator (PI) cannot without the sponsor's prior written consent, transmit, publish, or otherwise disclose to any person or entity either clinical trial results information.
23000|NCT00620828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23001|NCT00620815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23002|NCT00620776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23003|NCT00620763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23004|NCT00620750|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23005|NCT00620711|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23006|NCT00620698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23007|NCT00620659|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23008|NCT00620555|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23009|NCT00620542|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23010|NCT00620464|Principal Investigators are NOT employed by the organization sponsoring the study.|All investigator publications must be based on data validated and released by sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to sponsor, at least six weeks ahead of estimated publication or presentation, for consent. In the event that no response is received within six weeks after submission, the investigator may use the submitted data.
23011|NCT00620425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23012|NCT00620373|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23013|NCT00620282|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones (e.g. when clinical trial report is available), including right to not release interim results because such action can invalidate results of the entire trial. At trial end, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
23014|NCT00620126|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23015|NCT00620113|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
23016|NCT00620074|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23017|NCT00620035|Principal Investigators are NOT employed by the organization sponsoring the study.|SPONSOR recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by SPONSOR. Any such scientific paper, presentation, or other communication concerning the clinical trial described in protocol will first be submitted to SPONSOR, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
23018|NCT00620022|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
23019|NCT00619983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23020|NCT00619970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23021|NCT00619957|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23022|NCT00619918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23023|NCT00619892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23024|NCT00619827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23025|NCT00619801|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23026|NCT00619762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23027|NCT00619723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23028|NCT00619684|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23029|NCT00619645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23030|NCT00619619|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23031|NCT00619502|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
23032|NCT00619489|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
23033|NCT00619476|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23034|NCT00619385|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
23035|NCT00619359|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23036|NCT00619307|Principal Investigators are NOT employed by the organization sponsoring the study.|
23037|NCT00619255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23038|NCT00619242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23039|NCT00619229|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23040|NCT00619190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23041|NCT00619177|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23042|NCT00619151|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23043|NCT00619112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23044|NCT00619099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23045|NCT00619073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23046|NCT00619060|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23047|NCT00618995|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23048|NCT00618982|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) can publish results following completion of study. The PI must discuss a publication with Bayer prior to release&obtain written consent to proceed. The Investigator must send a draft to Bayer at least 30d in advance of submission to obtain approval. Any submission to Bayer will be reviewed w/o unreasonable delay&approval not be withheld unreasonably. In difference of opinion publication will be discussed.
23049|NCT00618956|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential info. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in pub. On sponsor's request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub.
23050|NCT00618839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23051|NCT00618826|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23052|NCT00618813|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
23053|NCT00618787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23054|NCT00618774|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23055|NCT00618748|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23056|NCT00618722|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
23057|NCT00618618|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Study Agreement requires that the investigator or institution obtain written consent from Kythera prior to presenting and/or publishing results of this study.
23058|NCT00618540|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23059|NCT00618514|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23060|NCT00618449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23061|NCT00618436|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23062|NCT00618410|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23063|NCT00618371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23064|NCT00618332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23065|NCT00618072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23066|NCT00617981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23067|NCT00617942|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23068|NCT00617929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23069|NCT00617903|Principal Investigators are NOT employed by the organization sponsoring the study.|A) Investigator shall provide Sponsor with intended publication 60 days upfront publication date, Sponsor has 30 d to comment, recommended changes shall not be unreasonably refused B) Sponsor has the right to ask Investigator to delay publication for a maximum of 90 days C) Investigative data will be pooled and published by Sponsor - no other publication without the consent of all parties prior to publication of the pooled data, or within 12 months after LPLV, whatever comes first
23070|NCT00617890|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the Sponsor. The Investigator further agrees to provide to the Sponsor 45 days prior to submission any publication, presentation, abstracts, manuscripts, or electronic media that report any results of the study. The Sponsor shall have the right to review and comment.
23071|NCT00617851|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23072|NCT00617773|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23073|NCT00617734|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
23074|NCT00617708|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23075|NCT00617669|Principal Investigators are NOT employed by the organization sponsoring the study.|"3. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~AstraZeneca can review results communications prior to public release and may within 60 days of receipt require amendments to be made. AstraZeneca can also require that submission or disclosure be delayed to allow for"
23076|NCT00617604|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or 12 months after data-lock, whichever is first. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication temporarily to seek patent protection.
23077|NCT00617591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23078|NCT00617539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23079|NCT00617461|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23080|NCT00617409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23081|NCT00617396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23082|NCT00617357|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23083|NCT00617305|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
23084|NCT00617279|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23085|NCT00617240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23086|NCT00617201|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23087|NCT00617188|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23088|NCT00617175|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23089|NCT00617123|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
23090|NCT00617097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23091|NCT00617084|Principal Investigators are NOT employed by the organization sponsoring the study.|"Prior to submission the Publication Committee (PC) and all co-authors will review and authorize the publication. >~Abstracts to be submitted to the PC at least 30 days before submission for publication or presentation. >~Manuscripts to be submitted to the PC at least 60 days before submission for publication or presentation. > The Sponsor can review results communications, and can embargo communications regarding trial results prior to public release."
23092|NCT00617058|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23093|NCT00616967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23094|NCT00616928|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23095|NCT00616902|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
23096|NCT00616772|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
23097|NCT00616759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23098|NCT00616655|Principal Investigators are NOT employed by the organization sponsoring the study.|In the event the Study is part of a multi-center study, the first publication of the results of the Study shall be made in conjunction with the results of other participating study sites as a multi-center publication; provided however, if a multi-center publication is not forthcoming within twenty-four (24) months following completion of the Study at all sites, Institution and Investigator shall be free to publish
23099|NCT00616642|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23100|NCT00616629|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23101|NCT00616603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23102|NCT00616577|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23103|NCT00616434|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
23104|NCT00616421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23105|NCT00616343|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23106|NCT00616239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23107|NCT00616200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23108|NCT00616122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23109|NCT00616109|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23110|NCT00616018|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23111|NCT00615992|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23112|NCT00615927|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23113|NCT00615914|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23114|NCT00615901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23115|NCT00615836|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
23116|NCT00615719|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23117|NCT00615589|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23118|NCT00615550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23119|NCT00615472|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23120|NCT00615459|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
23121|NCT00615433|Principal Investigators are NOT employed by the organization sponsoring the study.|For multi-center studies, it is mandatory that the first publication is based on all data obtained from all analyses as stipulated in the protocol. Investigators participating in multicenter studies must agree not to present data gathered individually or by subgroup of centers before the full, initial publication, unless this has been agreed to by all other investigators and also by Sunovion.
23122|NCT00615290|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23123|NCT00615264|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall submit any paper or presentation to the Sponsor for review and comments at least 60 days prior to submitting the same to a third party. Upon receiving any request from the Sponsor to delete any Confidential Information or request to delay in publication up to 90 days to allow the filing of any Sponsor application, the Investigator shall take the request action. Investigator shall not be restricted after 18 months from completion of their site's performance in the study.
23124|NCT00615199|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23125|NCT00615108|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23126|NCT00615069|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator willpostpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating study sites.
23127|NCT00615056|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23128|NCT00615030|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
23129|NCT00615017|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23130|NCT00614991|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23131|NCT00614939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23132|NCT00614926|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23133|NCT00614913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23134|NCT00614874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23135|NCT00614744|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators must adhere to the Neonatal Research Network Publication policies.
23136|NCT00614614|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23137|NCT00614575|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23138|NCT00614523|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial resul
23139|NCT00614484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23140|NCT00614458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23141|NCT00614445|Principal Investigators are NOT employed by the organization sponsoring the study.|No unpublished data given to the investigator may be transmitted to a third party without prior approval of the sponsor in writing. No publications or communications involving the results of the trial are authorized without prior review and written consent from the sponsor. The investigator must agree to send the sponsor for review prior to their submission. The sponsor reserves the right to delete from such materials any part or parts deemed to be confidential or proprietary.
23142|NCT00614406|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23143|NCT00614393|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
23144|NCT00614380|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23145|NCT00614315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23146|NCT00614198|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23147|NCT00614120|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication and other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
23148|NCT00614055|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
23149|NCT00613951|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
23150|NCT00613938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23151|NCT00613925|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23152|NCT00613821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23153|NCT00613730|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial resul
23154|NCT00613626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23155|NCT00613574|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23156|NCT00613509|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
23157|NCT00613405|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23158|NCT00613379|Principal Investigators are NOT employed by the organization sponsoring the study.|Because the study is a multicenter study, the PI(s) can only publish after the aggregate results of all investigators and institutions participating in the study have been published, and the proposed publication is reviewed by Progenics. In the event that Progenics does not publish the results of the study within eighteen months from availability of final study analysis, the PI can publish provided that the proposed publication is reviewed by Progenics.
23159|NCT00613366|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23160|NCT00613327|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23161|NCT00613314|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23162|NCT00613301|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23163|NCT00613106|Principal Investigators are NOT employed by the organization sponsoring the study.|PI reserves the right to publish or otherwise make public the Study results provided that such communication occurs only after (i) the results of the multicenter Study in its entirety have been publicly disclosed by, or with consent of the sponsor or (ii) 18 months after conclusion of the Study at all sites, whichever comes first. Following this, PI can publish, present or use any non-confidential study results following Sponsor review. PI will not make public raw data or Case Reports.
23164|NCT00613080|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23165|NCT00613028|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23166|NCT00613015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23167|NCT00612924|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23168|NCT00612807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23169|NCT00612768|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23170|NCT00612690|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23171|NCT00612677|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23172|NCT00612573|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23173|NCT00612560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23174|NCT00612534|Principal Investigators are NOT employed by the organization sponsoring the study.|prior written consent of sponsor
23175|NCT00612508|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23176|NCT00612456|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23177|NCT00612430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23178|NCT00612352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23179|NCT00612339|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23180|NCT00612313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23181|NCT00612222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23182|NCT00612105|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Valeant supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial
23183|NCT00612066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23184|NCT00612040|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
23185|NCT00611897|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23186|NCT00611884|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any Investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
23187|NCT00611806|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23188|NCT00611767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23189|NCT00611715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23190|NCT00611624|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23191|NCT00611559|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23192|NCT00611533|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23193|NCT00611468|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review.
23194|NCT00611455|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23195|NCT00611442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23196|NCT00611403|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
23197|NCT00611351|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23198|NCT00611325|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23199|NCT00611247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23200|NCT00611130|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23201|NCT00611026|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23202|NCT00610987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23203|NCT00610883|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23204|NCT00610857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23205|NCT00610740|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23206|NCT00610714|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites.
23207|NCT00610701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23208|NCT00610688|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23209|NCT00610675|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23210|NCT00610649|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23211|NCT00610532|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23212|NCT00610441|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23213|NCT00610428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23214|NCT00610363|Principal Investigators are NOT employed by the organization sponsoring the study.|PI/Institution will provide a copy of any publication to Sponsor prior to submission for review. Sponsor may request to remove confidential information from submission, provided that removal does not preclude the complete and accurate presentation and interpretation of the study results.
23215|NCT00610311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23216|NCT00610207|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23217|NCT00610168|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23218|NCT00610155|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23219|NCT00610129|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23220|NCT00609986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23221|NCT00609973|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23222|NCT00609947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23223|NCT00609869|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23224|NCT00609804|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
23225|NCT00609765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23226|NCT00609739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23227|NCT00609674|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23228|NCT00609622|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23229|NCT00609518|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23230|NCT00609492|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23231|NCT00609466|Principal Investigators are NOT employed by the organization sponsoring the study.|Grünenthal GmbH reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither Grünenthal nor the investigator has the right to prohibit publication unless publication can be shown to affect possible patent rights.
23232|NCT00609362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23233|NCT00609336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23234|NCT00609245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23235|NCT00609167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23236|NCT00608985|Principal Investigators are NOT employed by the organization sponsoring the study.|
23237|NCT00608959|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23238|NCT00608907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23239|NCT00608881|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23240|NCT00608868|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23241|NCT00608842|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical study agreement requires that the investigator or institution obtain written consent from Kythera Biopharmaceuticals, Inc. prior to presenting and/or publishing results of this study.
23242|NCT00608829|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of more than 60 days but less than or equal to 180 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
23243|NCT00608777|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23244|NCT00608634|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23245|NCT00608582|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23246|NCT00608569|Principal Investigators are NOT employed by the organization sponsoring the study.|"In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights."
23247|NCT00608543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23248|NCT00608530|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23249|NCT00608517|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23250|NCT00608491|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23251|NCT00608465|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23252|NCT00608426|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23253|NCT00608322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23254|NCT00608244|Principal Investigators are NOT employed by the organization sponsoring the study.|This study is a multicenter collaborative investigation and the clinical trial results are to be published as a collaborative manuscript. Authorship will reflect varying levels of individual contribution to the study by the individual PIs.
23255|NCT00608205|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23256|NCT00608140|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23257|NCT00608023|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23258|NCT00607997|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23259|NCT00607919|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23260|NCT00607893|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23261|NCT00607880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23262|NCT00607867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23263|NCT00607815|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23264|NCT00607789|Principal Investigators are NOT employed by the organization sponsoring the study.|All trial data will be posted & published by the Lindner Center of HOPE (PI: Dr. Susan McElroy)
23265|NCT00607724|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23266|NCT00607672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23267|NCT00607620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23268|NCT00607594|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23269|NCT00607477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23270|NCT00607386|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
23271|NCT00607373|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication for a multi-centre trial must address all centers. Institution will submit for review a proposed publication or presentation at least 60 days prior to submission date. Sponsor has the right to delay publication or presentation for not more than 6 months (contracts have variable timeframes) to address patent applications. Sponsor also has the right to demand in writing the deletion of confidential information, as long as such removal will not preclude publication.
23272|NCT00607321|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23273|NCT00607269|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23274|NCT00607243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23275|NCT00607126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23276|NCT00607113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23277|NCT00607087|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
23278|NCT00607048|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23279|NCT00606944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23280|NCT00606931|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results pending FDA approval or clearance.
23281|NCT00606905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23282|NCT00606892|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23283|NCT00606801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23284|NCT00606684|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23285|NCT00606632|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23287|NCT00606580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23288|NCT00606554|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23289|NCT00606502|Principal Investigators are NOT employed by the organization sponsoring the study.|Allos agreements with investigators (PIs) may vary. The PI may publish/make public data from the study after the earlier of publication by Allos or 24 months after database lock. Allos is allowed 60 days to review and comment on the communication prior to public release. Allos can request removal of confidential information (other than study results).
23290|NCT00606489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23291|NCT00606320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23292|NCT00606281|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23293|NCT00606229|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23294|NCT00606177|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23295|NCT00606138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23296|NCT00606086|Principal Investigators are NOT employed by the organization sponsoring the study.|PI will not publish or present in any forum any writing or discussion that involves Sponsor intellectual property or clinical trial information until the study has been finalized and all completed case report forms have been delivered to Sponsor. The confidentiality obligations will remain in effect for 5 years from the date of termination or expiration of study agreement.
23297|NCT00606034|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23298|NCT00606021|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23299|NCT00606008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23300|NCT00605917|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23301|NCT00605904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23302|NCT00605865|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23303|NCT00605839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23304|NCT00605813|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23305|NCT00605722|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23306|NCT00605696|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23307|NCT00605657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23308|NCT00605540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23309|NCT00605475|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary, however, Novartis does not prohibit any investigator from publishing. Any publications from a single site are postponed until the publication of the pooled data ( i.e., data from all sites ) in the clinical trial.
23310|NCT00605423|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23311|NCT00605384|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
23312|NCT00605358|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23313|NCT00605345|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23314|NCT00605319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23315|NCT00605306|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
23316|NCT00605293|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23317|NCT00605280|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23318|NCT00605267|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23319|NCT00605202|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23320|NCT00605176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23321|NCT00605150|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23322|NCT00605085|Principal Investigators are NOT employed by the organization sponsoring the study.|
23323|NCT00605072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23324|NCT00605033|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator will publish/present results together with other study sites, unless written permission is obtained from Sponsor. Investigator provides 45 days' written notice to Sponsor prior to submission for publication/presentation so that Sponsor can review copies of abstracts/manuscripts reporting results. Sponsor has the right to review/comment on any presentation regarding proprietary information, accuracy and fair balance of the information, and compliance with FDA regulations.
23325|NCT00604968|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish data from the study, a copy must be provided to the sponsor for review at least 60 days before submission for publication. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days. If issues arise regarding scientific integrity or regulatory compliance, the sponsor will review these issues with the investigator. The sponsor will not change scientific content or suppress information.
23364|NCT00603291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23326|NCT00604825|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23327|NCT00604812|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23328|NCT00604786|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23329|NCT00604721|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23330|NCT00604708|Principal Investigators are NOT employed by the organization sponsoring the study.|
23331|NCT00604695|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator shall furnish Sponsor with copy of any proposed publication for review/comment prior to submission for publication, at least thirty (30) days prior to submission for manuscripts and at least fifteen (15) days prior to submission for abstracts. Institution agrees to delete information identified by Sponsor as Confidential Information prior to submission for publication.
23332|NCT00604669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23333|NCT00604565|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23334|NCT00604552|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23335|NCT00604500|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish/present any interim results without prior sponsor written consent. The investigator agrees to provide to the sponsor, 45 days prior to submission, review copies for publication that report any study results. The sponsor has the right to review and comment. If the parties disagree, investigator agrees to meet with the sponsor, prior to submission for publication, to discuss and resolve any such issues/disagreement.
23336|NCT00604461|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23337|NCT00604383|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23338|NCT00604279|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to publication and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The paper that incorporates confidential information requires Sponsor’s written consent. PI will withhold publication for up to an additional 60 days to allow for filing of a patent application.
23339|NCT00604214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the site PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo. An independent Steering Committee responsible for data analyses and publications did not have an embargo.
23340|NCT00604188|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI cannot publish an individual study until a publication disclosing results from multicenter studies is published. The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review.
23341|NCT00604175|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
23342|NCT00604162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23343|NCT00604045|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23344|NCT00604019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23345|NCT00603993|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; most restrictive agreement states Medical Institution shall not disclose materials/information disclosed by Abbott Japan in connection with the Clinical Research, or information obtained by conducting the Clinical Research, to third parties without Abbott Japan's prior written approval. When Medical Institution intends to publish information obtained by conducting the Clinical Research, Medical Institution shall obtain Abbott Japan's prior written approval.
23346|NCT00603915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23347|NCT00603902|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study results are only allowed with prior written consent from Arena Pharmaceuticals, Inc.
23348|NCT00603889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23349|NCT00603837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23350|NCT00603798|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23351|NCT00603746|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23352|NCT00603733|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
23353|NCT00603642|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
23354|NCT00603590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23355|NCT00603564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23356|NCT00603538|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23357|NCT00603525|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23358|NCT00603512|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23359|NCT00603473|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23360|NCT00603447|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
23361|NCT00603408|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23362|NCT00603382|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23363|NCT00603304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23365|NCT00603278|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23366|NCT00603265|Principal Investigators are NOT employed by the organization sponsoring the study.|
23367|NCT00603239|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23368|NCT00603187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23369|NCT00603044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23370|NCT00603018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23371|NCT00602979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23372|NCT00602953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23373|NCT00602927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23374|NCT00602836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23375|NCT00602797|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23376|NCT00602771|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23377|NCT00602641|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23378|NCT00602537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23379|NCT00602472|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23380|NCT00602459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23381|NCT00602446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23382|NCT00602420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23383|NCT00602355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23384|NCT00602290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23385|NCT00602225|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23386|NCT00602043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23387|NCT00601965|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23388|NCT00601952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23389|NCT00601926|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23390|NCT00601900|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23391|NCT00601835|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
23392|NCT00601796|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23393|NCT00601731|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23394|NCT00601718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23395|NCT00601640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23396|NCT00601627|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23397|NCT00601523|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23398|NCT00601458|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23399|NCT00601419|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23400|NCT00601367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23401|NCT00601354|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23402|NCT00601250|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23403|NCT00601172|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23404|NCT00601146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23405|NCT00601107|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
23406|NCT00600938|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
23426|NCT00599326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23407|NCT00600886|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
23408|NCT00600821|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23409|NCT00600756|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23410|NCT00600743|All Principal Investigators ARE employed by the organization sponsoring the study.|The provider of the drug (not sponsor - since this was an investigator initiated protocol) needs to review the results before release. In this case there was a public presentation at a scientific meeting, and the abstract was published. However, before a full report can be released, the provider of the drug needs to review the report.
23411|NCT00600704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23412|NCT00600613|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23413|NCT00600353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23414|NCT00600171|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23415|NCT00600119|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23416|NCT00600106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23417|NCT00600080|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication requires agreement and written authorization from Sponsor.
23418|NCT00600067|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
23419|NCT00600028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23420|NCT00600015|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
23421|NCT00599924|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23422|NCT00599872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23423|NCT00599755|Principal Investigators are NOT employed by the organization sponsoring the study.|Subsequent to multicenter publication, or 24 months after study completion, whichever comes first, an investigator and/or colleague(s) may publish the results for their study site independently. The SPONSOR recommends against this practice due to scientific concerns. The SPONSOR must have the opportunity to review all publications or presentations regarding this study 60 days prior to submission, and any information identified by the SPONSOR as confidential must be deleted prior to submission.
23424|NCT00599521|Principal Investigators are NOT employed by the organization sponsoring the study.|disclosure restriction varies per institutional request/agreement
23425|NCT00599339|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23427|NCT00599313|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23428|NCT00599248|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23429|NCT00599196|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23430|NCT00599131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23431|NCT00599053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23432|NCT00599027|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees not to publish or publicly present any interim results of the study without prior written consent of the sponsor. The PI further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of abstracts or manuscripts for publication.
23433|NCT00599014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23434|NCT00598871|Principal Investigators are NOT employed by the organization sponsoring the study.|RegeneRx (the Sponsor) agreements may vary with individual investigators, but will not prohibit any investigator from publishing. RegeneRx supports the publication of results from all centers of a multi-center trial but requests that reports based on a single-site data not precede the primary publication of the entire clinical trial.
23435|NCT00598832|Principal Investigators are NOT employed by the organization sponsoring the study.|disclosure restriction varies per institutional request/agreement
23436|NCT00598819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23437|NCT00598806|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication is the multi-center publication of Study results from all study sites. Other than the multi-center publication, site may publish an independent publication of data generated by site subject to Sponsor review rights (e.g., review for intellectual property, confidentiality).
23438|NCT00598702|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator may publish 18 months after Cadence's final evaluation of all study data from all sites, whichever occurs first.Manuscripts/abstracts will be provided to Cadence for review and comment at least 30 days prior to submission.Cadence shall have 30 days to respond with comments.
23439|NCT00598689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23440|NCT00598650|Principal Investigators are NOT employed by the organization sponsoring the study.|
23441|NCT00598585|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23442|NCT00598559|Principal Investigators are NOT employed by the organization sponsoring the study.|Before any submission is made, Cadence shall be notified of the intention to publish and shall submit the manuscript to Cadence for review and comment.At least 60 days prior to submission for publication, investigator must submit manuscript to sponsor who has 60 days for review and comment. Publication may delayed at Cadence's written request for a period not to exceed 90 days if it contains a disclosure of an invention.
23443|NCT00598507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23444|NCT00598442|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the primary safety and efficacy results will include data from all appropriate study sites. Either after the first multicenter publication, or following 36 months after the completion of the study, Investigators are free to publish; such publications may not contain Sponsor Confidential Information and may be subject to Sponsor review 60 days prior to submission for publication.
23445|NCT00598273|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the primary safety and efficacy results will include data from all appropriate study sites. Either after the first multicenter publication, or following 36 months after the completion of the study, Investigators are free to publish; such publications may not contain Sponsor Confidential Information and may be subject to Sponsor review 60 days prior to submission for publication.
23446|NCT00598078|Principal Investigators are NOT employed by the organization sponsoring the study.|
23447|NCT00597909|Principal Investigators are NOT employed by the organization sponsoring the study.|
23448|NCT00597896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23449|NCT00597766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23450|NCT00597753|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the primary safety and efficacy results will include data from all appropriate study sites. Either after the first multicenter publication, or following 36 months after the completion of the study, Investigators are free to publish; such publications may not contain Sponsor Confidential Information and may be subject to Sponsor review 60 days prior to submission for publication.
23451|NCT00597727|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23452|NCT00597714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23453|NCT00597701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23454|NCT00597675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23455|NCT00597584|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the primary safety and efficacy results will include data from all appropriate study sites. Either after the first multicenter publication, or following 36 months after the completion of the study, Investigators are free to publish; such publications may not contain Sponsor Confidential Information and may be subject to Sponsor review 60 days prior to submission for publication.
23456|NCT00597558|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23457|NCT00597545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23458|NCT00597519|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23459|NCT00597506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23460|NCT00597493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23461|NCT00597428|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23462|NCT00597402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23463|NCT00597376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23464|NCT00597272|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23465|NCT00597207|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23466|NCT00597116|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
23467|NCT00597038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23468|NCT00597012|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23469|NCT00596960|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23470|NCT00596947|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23471|NCT00596934|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23472|NCT00596830|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23473|NCT00596817|Principal Investigators are NOT employed by the organization sponsoring the study.|The main publication has to be published before any sub-publications. H. Lundbeck A/S follows the Vancouver declaration with respect to authorship.
23474|NCT00596752|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23475|NCT00596687|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23476|NCT00596635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23477|NCT00596622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23478|NCT00596466|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23479|NCT00596453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23480|NCT00596440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23481|NCT00596427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23482|NCT00596362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23483|NCT00596271|Principal Investigators are NOT employed by the organization sponsoring the study.|
23484|NCT00596167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23485|NCT00596102|Principal Investigators are NOT employed by the organization sponsoring the study.|
23486|NCT00596011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23487|NCT00595959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23488|NCT00595946|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23489|NCT00595920|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23490|NCT00595881|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23491|NCT00595868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23492|NCT00595790|Principal Investigators are NOT employed by the organization sponsoring the study.|
23493|NCT00595764|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23494|NCT00595582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23495|NCT00595556|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23496|NCT00595530|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23497|NCT00595517|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AZ approval before this study was completed.
23498|NCT00595504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23499|NCT00595478|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23500|NCT00595465|Principal Investigators are NOT employed by the organization sponsoring the study.|
23501|NCT00595413|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publishing results, Institution and Principal Investigator (PI) must first provide Sponsor with a copy of proposed publication for review at least 30 days prior to submission. If Institution and PI do not agree to modification, they shall so notify Sponsor and postpone submission for additional 60 days to allow Sponsor to seek legal remedies or file patent applications. There is a need for coordinated approach to any publication of results from sites for any multi-site study.
23502|NCT00595361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23503|NCT00595335|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23504|NCT00595309|Principal Investigators are NOT employed by the organization sponsoring the study.|
23505|NCT00595270|Principal Investigators are NOT employed by the organization sponsoring the study.|
23506|NCT00595153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23507|NCT00595127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23508|NCT00595114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23509|NCT00595088|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23510|NCT00595075|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23511|NCT00594958|Principal Investigators are NOT employed by the organization sponsoring the study.|
23512|NCT00594945|Principal Investigators are NOT employed by the organization sponsoring the study.|
23513|NCT00594906|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23514|NCT00594880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23515|NCT00594854|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23516|NCT00594815|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23517|NCT00594685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23518|NCT00594659|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23519|NCT00594646|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23520|NCT00594568|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23521|NCT00594516|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23522|NCT00594464|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23523|NCT00594425|Principal Investigators are NOT employed by the organization sponsoring the study.|All data from the study are free for publication. However if publication of the results may endanger adequate patent protection for new principles,compounds,or formulations,Photocure has the right to decide when the results are free to be published. Before this agreed time, no data from the trial will be published, presented, or communicated, except to regulatory authorities and ethics committees. Both the investigators and Photocure will be given 30 days to review and comment.
23524|NCT00594399|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23525|NCT00594386|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23526|NCT00594308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23527|NCT00594256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23528|NCT00594230|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
23529|NCT00594204|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23530|NCT00594178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23531|NCT00594165|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23532|NCT00594100|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
23533|NCT00594061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23534|NCT00594035|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor can review results at least 30 days prior to public release, and at the request of Sponsor, the PI will withhold submission for an additional period, not to exceed 90 days.~The first publication of the study results shall be made in conjunction with a joint, multi-center publication of the results. If a multi-center publication is not submitted within 12 months after the conclusion of the Study, the PIs may publish the results from their individual site."
23535|NCT00594022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23536|NCT00593957|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23537|NCT00593918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23538|NCT00593866|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23539|NCT00593840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23540|NCT00593827|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
23541|NCT00593814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23542|NCT00593736|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release; such communications can be embargoed for a period up to 150 days to permit actions necessary to preserve sponsor's intellectual property. Sponsor can request changes to the results communication only for the purpose of removing non study related information that is proprietary and confidential to sponsor. Sponsor can require delay of a results communication until the study has been completed at all participating sites.
23543|NCT00593684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23544|NCT00593645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23545|NCT00593606|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23546|NCT00593554|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23547|NCT00593450|Principal Investigators are NOT employed by the organization sponsoring the study.|Dr. Grunwald reports receiving consulting fees from GlaxoSmithKline; and Dr. Jaffe, consulting fees from Neurotech and SurModics. No other potential conflict of interest relevant to this article was reported.
23548|NCT00593385|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication or publicizing of data or results without the Sponsor's prior written permission. Party wishing to publish or publicize will submit proposed manuscript or publication to Sponsor for comment at least 60 days prior to release. Publishing party will make every reasonable attempt to incorporate comments received from Sponsor during 60 day period.The publishing party won't use Sponsor's confidential information in manuscript or publication without the prior written consent of sponsor.
23549|NCT00593372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23550|NCT00593346|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23551|NCT00593333|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23552|NCT00593320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23553|NCT00593112|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23554|NCT00592943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23555|NCT00592904|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23556|NCT00592852|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23557|NCT00592839|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can (i) review results communications prior to public release and can embargo communications regarding trial results for a period of at least 60 days but no more than 180 days from the time submitted to the sponsor for review; and (ii) require in instances of a multi-center study, that a single PI not disclose study data until after the multi-center results are published, provided such results are published within eighteen (18) months of the conclusion of the study.
23558|NCT00592774|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23559|NCT00592761|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23560|NCT00592683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23561|NCT00592631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23562|NCT00592488|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23563|NCT00592475|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated from the Study. Sponsor must receive the manuscript 60 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
23564|NCT00592384|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23565|NCT00592358|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23566|NCT00592319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23567|NCT00592176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23568|NCT00592124|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23569|NCT00592072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23570|NCT00592007|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23571|NCT00591942|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23572|NCT00591864|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23573|NCT00591851|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23574|NCT00591825|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23575|NCT00591773|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
23576|NCT00591760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23577|NCT00591734|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
23578|NCT00591721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23579|NCT00591591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23580|NCT00591578|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
23581|NCT00591565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23582|NCT00591370|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23583|NCT00591344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23584|NCT00591305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23585|NCT00591266|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
23586|NCT00591253|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
23587|NCT00591240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23588|NCT00591227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23589|NCT00591214|Principal Investigators are NOT employed by the organization sponsoring the study.|
23590|NCT00591149|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23591|NCT00591019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23592|NCT00591006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23593|NCT00590980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23594|NCT00590967|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23595|NCT00590902|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23596|NCT00590889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23597|NCT00590863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23598|NCT00590772|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23599|NCT00590759|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites
23600|NCT00590720|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
23601|NCT00590590|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall not publish, or seek to publish, either in whole or in part, any results of the Clinical Investigation without the written consent of the Sponsor.
23602|NCT00590577|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23603|NCT00590564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23604|NCT00590538|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23605|NCT00590460|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23606|NCT00590369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23607|NCT00590317|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23608|NCT00590226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23609|NCT00590161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23610|NCT00590135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23611|NCT00590044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23612|NCT00590031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23613|NCT00590018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23614|NCT00590005|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23615|NCT00589979|Principal Investigators are NOT employed by the organization sponsoring the study.|Delay of 12-18 months from Completion Date to publish results from all sites, embargo of 60 to 180 days from the time communication is submitted to sponsor, and ability to redact confidential information (excluding results).
23616|NCT00589914|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23617|NCT00589888|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23618|NCT00589849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23619|NCT00589836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23620|NCT00589784|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23621|NCT00589693|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23622|NCT00589667|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23623|NCT00589628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23624|NCT00589602|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23625|NCT00589563|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23626|NCT00589550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23627|NCT00589472|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23628|NCT00589303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23629|NCT00589290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23630|NCT00589277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23631|NCT00589121|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
23632|NCT00589108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23633|NCT00588965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23634|NCT00588952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23635|NCT00588900|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23636|NCT00588861|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can conduct a pre-publication review of articles, papers, or presentations which the PI desires to publish. Any such review must be completed by sponsor within thirty (30)days of the submission of the request. The PI must include whatever credits the sponsor deems necessary or appropriate to disclose its proprietary interest to the material disclosed in the article, paper or presentation.
23637|NCT00588848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23638|NCT00588822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23639|NCT00588809|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23640|NCT00588731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23641|NCT00588692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23642|NCT00588666|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23643|NCT00588640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23644|NCT00588536|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23645|NCT00588471|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23646|NCT00588445|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23647|NCT00588406|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23648|NCT00588380|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23649|NCT00588354|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23650|NCT00588341|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23651|NCT00588237|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23652|NCT00588159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23653|NCT00588146|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23654|NCT00588094|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23655|NCT00587990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23656|NCT00587964|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23657|NCT00587860|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23658|NCT00587847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23659|NCT00587834|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review communications prior to public release and can embargo communications regarding trial results for at least 30 days in advance of public release. The sponsor can request removal of any confidential or proprietary information provided by sponsor and extend such review period for another 90 days to file patent applications or take other steps to protect the sponsor's intellectual property interests.
23660|NCT00587795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23661|NCT00587769|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23662|NCT00587678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23663|NCT00587639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23664|NCT00587587|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23665|NCT00587483|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23666|NCT00587457|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
23667|NCT00587431|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23668|NCT00587288|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
23669|NCT00587223|Principal Investigators are NOT employed by the organization sponsoring the study.|Before publishing PI shall submit copies of any proposed publication/presentation to Sponsor for review at least 30 days in advance of submission. Sponsor shall review the data provided in proposed publication against the Study database for consistency. Sponsor reserves right to delete any Confidential Information/proprietary information of Sponsor from the proposed publication/presentation. Sponsor may extend such review period for another 90 days.
23670|NCT00587171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23671|NCT00587158|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23672|NCT00587132|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23673|NCT00587067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23674|NCT00587054|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23675|NCT00587041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23676|NCT00586898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23677|NCT00586846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23678|NCT00586820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23679|NCT00586729|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23680|NCT00586716|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23681|NCT00586703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23682|NCT00586690|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23683|NCT00586664|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement is between contract research organization and third parties on behalf of ISTA Pharmaceuticals, Inc.
23684|NCT00586625|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement is between contract research organization and third parties on behalf of ISTA Pharmaceuticals, Inc.
23685|NCT00586612|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23686|NCT00586573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23687|NCT00586521|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23688|NCT00586495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23689|NCT00586482|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23690|NCT00586469|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23691|NCT00586339|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23692|NCT00586326|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23693|NCT00586313|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23694|NCT00586261|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23695|NCT00586196|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23696|NCT00586170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23697|NCT00586157|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23698|NCT00586105|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23699|NCT00586066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23700|NCT00585975|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI will provide to the sponsor a copy of the proposed publication information for review, comment and approval following completion of the study and at least sixty (60) days prior to submission for publication of any manuscript, or at least thirty (30) days prior to submission for publication of any abstract. If sponsor requests in writing, the PI will withhold publication for an additional sixty (60) days.
23701|NCT00585923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23702|NCT00585910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23703|NCT00585715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23704|NCT00585689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23705|NCT00585650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23706|NCT00585637|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23707|NCT00585585|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23708|NCT00585546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23709|NCT00585533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23710|NCT00585494|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23711|NCT00585468|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23712|NCT00585377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23713|NCT00585351|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23714|NCT00585325|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23715|NCT00585312|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23716|NCT00585286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23717|NCT00585247|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23718|NCT00585221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23719|NCT00585182|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23720|NCT00585169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23721|NCT00585104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23722|NCT00585078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23723|NCT00585052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23724|NCT00585039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23725|NCT00585013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23726|NCT00584987|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23727|NCT00584948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23728|NCT00584935|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator is required to submit the final manuscript to the sponsor prior to publication. The sponsor may suggest changes but investigator retains editorial rights.
23729|NCT00584909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23730|NCT00584857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23731|NCT00584844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23732|NCT00584831|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
23733|NCT00584740|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
23734|NCT00584727|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
23735|NCT00584701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23736|NCT00584558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23737|NCT00584480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23738|NCT00584454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23739|NCT00584415|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23764|NCT00582894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23740|NCT00584402|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23741|NCT00584220|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
23742|NCT00584194|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23743|NCT00584077|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23744|NCT00583947|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
23745|NCT00583908|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.
23746|NCT00583713|Principal Investigators are NOT employed by the organization sponsoring the study.|
23747|NCT00583700|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23748|NCT00583661|Principal Investigators are NOT employed by the organization sponsoring the study.|PI has agreed to discuss or publish trial results only after review by the Publication Committee and the sponsor.
23749|NCT00583622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23750|NCT00583596|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23751|NCT00583557|Principal Investigators are NOT employed by the organization sponsoring the study.|For multi-center trials, no investigator will be authorized to publish study results from an individual center until the earlier of the multi-center trial results are published or 12 months after the end or termination of the multi-center trial at all sites. All manuscripts and abstracts must be submitted to the sponsor for review least 30 days prior to submission for publication or for presentation at a scientific meeting. The sponsor may delay publication for up to 3 months.
23752|NCT00583492|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23753|NCT00583466|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23754|NCT00583453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23755|NCT00583375|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23756|NCT00583362|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23757|NCT00583219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23758|NCT00583115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23759|NCT00583102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23760|NCT00582972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23761|NCT00582946|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23762|NCT00582933|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23763|NCT00582907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23765|NCT00582816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23766|NCT00582790|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23767|NCT00582738|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
23768|NCT00582712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23769|NCT00582660|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23770|NCT00582608|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23771|NCT00582556|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23772|NCT00582517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23773|NCT00582491|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23774|NCT00582426|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e. data from all sites) in the clinical trial.
23775|NCT00582400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23776|NCT00582361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23777|NCT00582309|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor may evaluate results and choose not to be a coauthor on the publication.
23778|NCT00582205|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23779|NCT00582114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23780|NCT00582075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23781|NCT00582036|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23782|NCT00582010|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23783|NCT00581971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23784|NCT00581945|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
23785|NCT00581919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23786|NCT00581867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23787|NCT00581854|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23788|NCT00581828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23789|NCT00581776|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23790|NCT00581581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23791|NCT00581555|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23792|NCT00581542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23793|NCT00581529|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23794|NCT00581399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23795|NCT00581386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23796|NCT00581360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23797|NCT00581347|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23798|NCT00581308|Principal Investigators are NOT employed by the organization sponsoring the study.|Gore has the right to review disclosures, requesting a delay of less than 90 days. Each investigator will postpone single center publications until after disclosure of multi-center data, less than 12 months from study completion/termination at all participating sites.
23799|NCT00581256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23800|NCT00581230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23801|NCT00581113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23802|NCT00581100|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
23803|NCT00581061|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23804|NCT00581048|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23805|NCT00580983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23806|NCT00580970|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23807|NCT00580957|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23808|NCT00580866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23809|NCT00580853|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23810|NCT00580840|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
23811|NCT00580801|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees that before he/she publishes any results of this trial he/she shall allow at least 45 days for the Sponsor to review the pre-publication manuscript prior to submission of the manuscript to the Publisher. In accordance with generally recognized principles of scientific collaboration, co-authorship with any company personnel will be discussed and mutually agreed upon before submission of the manuscript to the Publisher.
23812|NCT00580788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23813|NCT00580723|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23814|NCT00580671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23815|NCT00580645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23816|NCT00580606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23817|NCT00580502|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23818|NCT00580398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23819|NCT00580372|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23820|NCT00580333|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23821|NCT00580294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23822|NCT00580229|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23823|NCT00580151|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23824|NCT00580138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23825|NCT00580073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23826|NCT00580047|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23827|NCT00580034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23828|NCT00579982|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23829|NCT00579826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23830|NCT00579813|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23831|NCT00579670|Principal Investigators are NOT employed by the organization sponsoring the study.|
23832|NCT00579501|Principal Investigators are NOT employed by the organization sponsoring the study.|Before submitting the paper or abstract or disclose information to public concerning trabectedin (YONDELIS®), PharmaMar must be provided of 15 days in case of abstract and 30 days in case of full paper, to review and approve the publication to assure that confidential and proprietary data are protected. Primary authorship for publication is hold by the coordinating investigator of this project. Following authors will be named according to the number of patients treated under this protocol.
23833|NCT00579436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23834|NCT00579345|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23835|NCT00579254|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
23836|NCT00579137|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23837|NCT00579111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23838|NCT00579098|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23839|NCT00579059|Principal Investigators are NOT employed by the organization sponsoring the study.|Biomet owns copyright to database.
23840|NCT00578968|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23841|NCT00578942|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23842|NCT00578929|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor reserves the right of review 60 days prior to any publication or presentation of information related to the study. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than study data and results. The Institution and the Primary Investigator agree not to publish any study related material other than above.
23843|NCT00578903|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23844|NCT00578877|Principal Investigators are NOT employed by the organization sponsoring the study.|"Data obtained from a clinical trial in which 2 or more research centers participate cannot be published or presented by any of the individual investigators before the end of the clinical trial. Only after publication of the pooled results can data from individual centers be published.~When the Principal Investigator wishes to write a paper using data collected from his or her own center, the Recipient Institution agrees to allow CONRAD and USAID the opportunity to review & provide comments."
23845|NCT00578864|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23846|NCT00578812|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators and Institutions will allow NuVasive to review and comment on any presentation or publication of any study information prior to its release to ensure such documents are accurate and do not disclose any trade secret or other confidential information. No information may be disclosed regarding the study without NuVasive’s written permission.
23847|NCT00578786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23848|NCT00578734|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication must be joint, multicenter publication in conjunction with a presentation. Following multicenter publication, proposed publications or presentations must be submitted to sponsor 30 days in advance. In the event of an objection by sponsor, PI agrees to delay the publication or presentation until modifications or revisions have been made to protect Sponsor's patent rights, copyrights, or proprietary rights.
23849|NCT00578617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23850|NCT00578565|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23851|NCT00578552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23852|NCT00578539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23853|NCT00578461|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23854|NCT00578448|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
23855|NCT00578383|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23856|NCT00578331|Principal Investigators are NOT employed by the organization sponsoring the study.|
23857|NCT00578318|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23858|NCT00578305|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23859|NCT00578279|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23860|NCT00578227|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23861|NCT00578214|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23862|NCT00578175|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23863|NCT00578136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23864|NCT00578071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23865|NCT00577889|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23866|NCT00577863|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23867|NCT00577824|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23868|NCT00577772|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23869|NCT00577720|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23870|NCT00577707|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23871|NCT00577655|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If review shows that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for up to 90 additional days to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure of multicenter data, but not longer than 12 months from study completion/termination at all participating sites.
23872|NCT00577642|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23873|NCT00577629|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23874|NCT00577512|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23875|NCT00577473|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23876|NCT00577460|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
23877|NCT00577408|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23878|NCT00577395|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Study Site and Principal Investigator agree that all data, calculations, interpretations, opinions, and recommendations regarding the study will be the property of the Sponsor. The Study Site and Principal Investigator agree to consider the results as confidential information subject to use restrictions.~The names of the Investigator(s) will not be used by P&GP for commercial purposes without appropriate written permission, unless required by law or government regulation."
23879|NCT00577382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23880|NCT00577356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23881|NCT00577135|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23882|NCT00577122|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23883|NCT00577096|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23884|NCT00577083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23885|NCT00577031|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23886|NCT00577005|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23887|NCT00576927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23888|NCT00576901|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23889|NCT00576823|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the investigators can publish the results. Prior to the publication, the sponsor can review and request changes to the manuscript, provided they do not jeopardize the accuracy and/or the scientific value of the publication. The approval is given in writing by the sponsor, not to exceed 90 days.~To protect by a property right any information the sponsor can postpone the publication, for a period not to exceed 18 months."
23890|NCT00576758|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23891|NCT00576732|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
23892|NCT00576693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23893|NCT00576628|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23894|NCT00576576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23895|NCT00576524|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23896|NCT00576472|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23897|NCT00576420|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥45 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., for intellectual property protection)
23898|NCT00576381|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23899|NCT00576316|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23900|NCT00576303|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23901|NCT00576251|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor is allowed 30 days to review publication. With reasonable justification, sponsor may require the publication to be withheld an additional 60 days to obtain patent protection. Sponsor may request deletion of any trade secret, proprietary, or confidential information.
23902|NCT00576199|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
23903|NCT00576147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23904|NCT00576056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23905|NCT00575965|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23906|NCT00575887|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23907|NCT00575666|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23908|NCT00575588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23909|NCT00575510|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23910|NCT00575380|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot publish or discuss trial results until written communication is received from Inspire
23911|NCT00575367|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot publish or discuss trial results until written communication is received from Inspire Pharmaceuticals, Inc.
23912|NCT00575185|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23913|NCT00575159|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23914|NCT00575146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23934|NCT00574171|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23915|NCT00575094|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
23916|NCT00575042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23917|NCT00575029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23918|NCT00575016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23919|NCT00574990|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23920|NCT00574951|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23921|NCT00574912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23922|NCT00574873|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23923|NCT00574847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23924|NCT00574834|Principal Investigators are NOT employed by the organization sponsoring the study.|Results of this trial were too preliminary to report. Trial was ended due to lack of funding to complete. No conclusions could be drawn from existing data.
23925|NCT00574795|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
23926|NCT00574704|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23927|NCT00574548|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
23928|NCT00574405|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23929|NCT00574340|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23930|NCT00574288|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
23931|NCT00574275|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
23932|NCT00574249|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator shall provide Abbott at least (60) days prior to publication or presentation, for Abbott's review and comment, to ascertain whether any patent subject matter or Abbott confidential information are disclosed. During the review, Abbott may request a delay for up to six (6) months from the date of first submission to Abbott in order to protect proprietary information.
23933|NCT00574236|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23935|NCT00574145|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23936|NCT00574080|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23937|NCT00574067|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23938|NCT00573937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23939|NCT00573872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23940|NCT00573859|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23941|NCT00573833|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23942|NCT00573794|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
23943|NCT00573768|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23944|NCT00573755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23945|NCT00573534|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23946|NCT00573508|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
23947|NCT00573469|Principal Investigators are NOT employed by the organization sponsoring the study.|All PIs were prohibited to disclose all information related to this study without AZ approval before this study was completed.
23948|NCT00573443|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23949|NCT00573430|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23950|NCT00573391|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23951|NCT00573313|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23952|NCT00573287|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23953|NCT00573261|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23954|NCT00573248|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23955|NCT00573183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23956|NCT00573170|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
23957|NCT00573157|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publishing results, Institution and Principal Investigator (PI) must first provide Sponsor with a copy of proposed publication for review at least 30 days prior to submission. If Institution and PI do not agree to modification, they shall so notify Sponsor and postpone submission for additional 60 days to allow Sponsor to seek legal remedies or file patent applications. There is a need for coordinated approach to any publication of results from sites for any multi-site study.
23958|NCT00573144|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23959|NCT00573131|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23960|NCT00573066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23961|NCT00572936|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23962|NCT00572910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23963|NCT00572897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23964|NCT00572832|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23965|NCT00572728|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23966|NCT00572624|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23967|NCT00572572|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23968|NCT00572533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23969|NCT00572468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23970|NCT00572260|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23971|NCT00572156|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23972|NCT00572117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23973|NCT00572039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23974|NCT00571987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23975|NCT00571974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23976|NCT00571961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23977|NCT00571948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23978|NCT00571922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23979|NCT00571701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23980|NCT00571688|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23981|NCT00571662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23982|NCT00571649|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23983|NCT00571428|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the 60 to 180 day restriction above, since this is a multicenter study, first publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish
23984|NCT00571324|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23985|NCT00571194|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23986|NCT00571103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23987|NCT00571064|Principal Investigators are NOT employed by the organization sponsoring the study.|
23988|NCT00571038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23989|NCT00570960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23990|NCT00570921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23991|NCT00570908|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23992|NCT00570778|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
23993|NCT00570765|Principal Investigators are NOT employed by the organization sponsoring the study.|Per protocol, Intercept retains ownership of the study data. Proposed publications based on the study shall be approved prior to submission for publications and will not be unreasonably withheld.
23994|NCT00570739|Principal Investigators are NOT employed by the organization sponsoring the study.|"The following language is employed: If identified by DSI, any of DSI's confidential information as defined herein shall be deleted...Nothing in this publication section shall be taken as giving DSI and right of editorial control over any publication prepared by the Study Site."
23995|NCT00570713|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
23996|NCT00570700|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23997|NCT00570687|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
23998|NCT00570674|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
23999|NCT00570531|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24000|NCT00570505|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 120 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24001|NCT00570492|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24002|NCT00570401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24003|NCT00570362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24004|NCT00570349|Principal Investigators are NOT employed by the organization sponsoring the study.|
24005|NCT00570310|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24006|NCT00570232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24007|NCT00570141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24008|NCT00570089|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24009|NCT00570063|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24010|NCT00570037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24011|NCT00569946|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24012|NCT00569868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24013|NCT00569855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24014|NCT00569803|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24015|NCT00569777|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may not publish or publicly present the data and or results of the study without prior approval from Vistakon.
24016|NCT00569673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24017|NCT00569660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24018|NCT00569582|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24019|NCT00569530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24020|NCT00569374|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24021|NCT00569309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24022|NCT00569270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24023|NCT00569231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24024|NCT00569192|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24025|NCT00569166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24026|NCT00569127|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24027|NCT00569010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24028|NCT00568958|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24029|NCT00568854|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24030|NCT00568776|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish after release of multi-center study publication, or 18 months after database lock of overall study. Sponsor has 60 days to review any proposed publication and request removal of Sponsor’s confidential information. Sponsor may request an additional 90 days if filing a patent.
24031|NCT00568685|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24032|NCT00568555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24033|NCT00568451|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24034|NCT00568399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24035|NCT00568386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24036|NCT00568334|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24037|NCT00568178|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24038|NCT00568087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24039|NCT00568061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24040|NCT00568022|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24041|NCT00567996|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. any publications from a single-site are postponed until the publication of the pooled date (i.e., data from all sites) in the clinical trial.
24042|NCT00567892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24043|NCT00567879|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
24044|NCT00567840|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator or any Sub-Investigator shall submit any oral or written publication or abstract concerning this study to the Sponsor not less than thirty (30) days prior to submission to any journal, other publication or meeting, for review and removal of confidential information.
24045|NCT00567593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24046|NCT00567567|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
24047|NCT00567541|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24048|NCT00567502|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
24049|NCT00567476|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
24050|NCT00567320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24051|NCT00567307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24052|NCT00567268|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24053|NCT00567255|Principal Investigators are NOT employed by the organization sponsoring the study.|If not already published by Sponsor as part of a multi-center publication, 18 months after conclusion of the study at all study centers, PI may publish the results for PI’s study center individually. Prior to such publication, PI must provide Sponsor with at least 60 days to review and comment on the proposed publication. The review period may be extended by an additional 30 days upon request. Sponsor may delay publication for up to an additional 6 month period to file for patent protection.
24054|NCT00567242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24055|NCT00567229|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24056|NCT00567190|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24057|NCT00567164|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of subgroup data and single center data shall not be performed until the complete study has been published. All relevant aspects regarding publication will be part of the contract between the sponsor and the investigator/institution.
24058|NCT00567112|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
24059|NCT00567008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24060|NCT00566995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24061|NCT00566982|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
24062|NCT00566969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24063|NCT00566943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24064|NCT00566930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24065|NCT00566852|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
24066|NCT00566735|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24067|NCT00566722|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
24068|NCT00566709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24069|NCT00566696|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24070|NCT00566631|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24071|NCT00566579|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24072|NCT00566527|Principal Investigators are NOT employed by the organization sponsoring the study.|Sanofi Pasteur MSD shall have sixty days to review these documents and may refuse to give its consent in part or whole for confidential reasons (including but not limited to intellectual property rights, whether patentable or not).
24073|NCT00566501|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24074|NCT00566462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24075|NCT00566254|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24076|NCT00566150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24077|NCT00566111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24078|NCT00566020|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24079|NCT00565812|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24080|NCT00565747|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidentiality until publication of the main results of the study
24081|NCT00565721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24082|NCT00565643|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24083|NCT00565617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24084|NCT00565604|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24085|NCT00565461|Principal Investigators are NOT employed by the organization sponsoring the study.|
24107|NCT00564070|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24086|NCT00565448|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
24087|NCT00565409|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24088|NCT00565370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24089|NCT00565266|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24090|NCT00565136|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24091|NCT00565110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24092|NCT00565084|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24093|NCT00565058|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24094|NCT00565045|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24095|NCT00564954|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary; however, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24096|NCT00564902|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24097|NCT00564889|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24098|NCT00564876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24099|NCT00564850|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24100|NCT00564733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24101|NCT00564681|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
24102|NCT00564629|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither the Institution nor the Investigator shall have the right to publish the Institution findings without prior written consent of Cadence.
24103|NCT00564486|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution or Investigator may publish the results of the study (without raw data, detailed patient Case Report Forms, or patient identification) only after such cooperative publication, or 18 months after Cadence's final evaluation of all study data from all sites, whichever occurs first. At least 60 days prior to submission, or prior to any public presentation, a copy of the abstract, manuscript or presentation will be provided to Cadence who will have 60 days to respond with comments.
24104|NCT00564447|Principal Investigators are NOT employed by the organization sponsoring the study.|
24105|NCT00564278|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24106|NCT00564265|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24108|NCT00563797|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24109|NCT00563706|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24110|NCT00563576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24111|NCT00563381|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24112|NCT00563368|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
24113|NCT00563316|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
24114|NCT00563290|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24115|NCT00562965|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24116|NCT00562861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24117|NCT00562627|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24118|NCT00562588|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24119|NCT00562484|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24120|NCT00562354|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24121|NCT00562328|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24122|NCT00562315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24123|NCT00562302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24124|NCT00562159|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts and the right to review and comment on the data analysis and presentation.
24125|NCT00562120|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24126|NCT00562094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24127|NCT00561977|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24128|NCT00561951|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24129|NCT00561925|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24130|NCT00561912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24131|NCT00561834|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24132|NCT00561821|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24133|NCT00561795|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24134|NCT00561730|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24135|NCT00561678|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24136|NCT00561652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24137|NCT00561600|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24138|NCT00561574|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24139|NCT00561470|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
24140|NCT00561457|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24141|NCT00561431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24142|NCT00561418|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24143|NCT00561392|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24144|NCT00561353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24145|NCT00561340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24146|NCT00561145|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24147|NCT00561080|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators must first obtain written consent from Sanofi Pasteur MSD. If consent is given, all abstracts manuscripts, texts, or presentation, etc... shall be sent to Sanofi Pasteur MSD for review and approval prior to their publication or presentation. Sanofi Pasteur MSD shall have sixty days to review these documents and may refuse to give its consent in part or whole for confidential reasons (including but not limited to intellectual property rights, whether patentable or not).
24148|NCT00561015|Principal Investigators are NOT employed by the organization sponsoring the study.|As per revised Protocol dated 14 Feb 2008, Investigator may not submit for publication or presentation, the results of trial without prior written consent of Sponsor. The Investigator agrees to allow at least 45 days for Sponsor to review pre-publication manuscript prior to submission to Publisher. In accordance with generally recognized principles of scientific collaboration, co-authorship with any company personnel will be discussed and mutually agreed upon before submission to Publisher.
24149|NCT00561002|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
24150|NCT00560950|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24151|NCT00560937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24152|NCT00560885|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor can review communications prior to public release and can embargo communication regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the tim submitted to the sponsor for review. The sponsor can redact or modify the proposed publication to remove any language the sponsor believes would be detrimental to intellectual property or inaccurately reflect the results of the study.
24153|NCT00560859|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24154|NCT00560833|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24155|NCT00560794|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
24156|NCT00560755|Principal Investigators are NOT employed by the organization sponsoring the study.|Sanofi Pasteur MSD shall have sixty days to review these documents and may refuse to give its consent in part or whole for confidential reasons (including but not limited to intellectual property rights, whether patentable or not).
24157|NCT00560703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24158|NCT00560612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24159|NCT00560573|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24160|NCT00560560|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24161|NCT00560508|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24162|NCT00560417|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24163|NCT00560404|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24164|NCT00560391|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24165|NCT00560352|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24166|NCT00560313|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24167|NCT00560235|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24168|NCT00560105|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24169|NCT00560066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24170|NCT00559988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24171|NCT00559962|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can publish after sponsor reviews the proposed publication. PI must give sponsor at least 60 days to review before publication. PI needs to obtain sponsor’s prior written consent to publish confidential information, which shall not be unreasonably withheld or delayed. The PI shall, upon request of sponsor, delete any confidential information which would prejudice the securing of adequate intellectual property protection from the publication.
24172|NCT00559949|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24173|NCT00559936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24174|NCT00559897|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24175|NCT00559845|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
24176|NCT00559754|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24177|NCT00559637|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24178|NCT00559585|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24179|NCT00559507|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24180|NCT00559377|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24181|NCT00559364|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions vary in accordance with each agreement with the individual investigators. Sponsor will allow publication but will prohibit disclosure of Sponsor's confidential information within any publication and can defer publication for a period of time to allow for Sponsor to obtain patent or other intellectual property right protection.
24182|NCT00559273|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
24183|NCT00559104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24184|NCT00559013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24185|NCT00558896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24186|NCT00558870|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24187|NCT00558831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24188|NCT00558792|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be presented during scientific symposia or published in a scientific journal only after review by Bracco in accordance with the guidelines set forth in the applicable publication or financial agreement.
24189|NCT00558753|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24190|NCT00558701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24191|NCT00558636|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24192|NCT00558571|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24193|NCT00558558|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24194|NCT00558467|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24195|NCT00558428|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24196|NCT00558363|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24197|NCT00558285|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24198|NCT00558272|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
24199|NCT00558259|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24200|NCT00558246|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24201|NCT00558103|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24202|NCT00558064|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
24203|NCT00558025|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24204|NCT00558012|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24205|NCT00557947|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24206|NCT00557856|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24207|NCT00557830|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication or presentation of Sponsored Research results, Researcher agrees to provide Bayer with such presentation, abstract, or manuscript at least 30 days prior to its presentation or submission for the sole purpose of allowing Bayer to redact confidential information and protect any existing or future patients. The Principal Investigator shall acknowledge Bayer contributions where appropriate.
24208|NCT00557622|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24209|NCT00557505|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24210|NCT00557492|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24211|NCT00557466|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24212|NCT00557440|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24213|NCT00557362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24214|NCT00557349|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24215|NCT00557323|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
24216|NCT00557310|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24217|NCT00557284|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24218|NCT00557245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24219|NCT00557076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24220|NCT00556998|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24241|NCT00555997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24221|NCT00556972|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24222|NCT00556946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24223|NCT00556933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24224|NCT00556894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24225|NCT00556712|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24226|NCT00556673|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24227|NCT00556543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24228|NCT00556504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24229|NCT00556491|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24230|NCT00556478|Principal Investigators are NOT employed by the organization sponsoring the study.|Details of the Study and his/her results shall not be publicized or published in any form to cooperative publication without prior, written consent of Pharm-Olam or the Sponsor. Such approval is necessary to prevent premature disclosure of trade secrets and other confidential information.
24231|NCT00556452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24232|NCT00556439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24233|NCT00556426|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24234|NCT00556400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24235|NCT00556374|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
24236|NCT00556322|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24237|NCT00556166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24238|NCT00556140|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24239|NCT00556075|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication, Investigator shall submit to the Sponsor a copy of any proposed publication. Sponsor shall have sixty (60) days to review the proposed publication for possible disclosure of Sponsor’s Confidential Information and, upon request of Sponsor, Investigator shall delete any of Sponsor’s Confidential Information or withhold submission of such publication to allow Sponsor to protect its intellectual property rights
24240|NCT00556049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24242|NCT00555906|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24243|NCT00555893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24244|NCT00555880|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
24245|NCT00555750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24246|NCT00555672|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24247|NCT00555620|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24248|NCT00555581|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24249|NCT00555568|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24250|NCT00555477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24251|NCT00555464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24252|NCT00555438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24253|NCT00555425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24254|NCT00555360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24255|NCT00555321|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24256|NCT00555217|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24257|NCT00555152|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24258|NCT00555061|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24259|NCT00555048|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24260|NCT00555009|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24261|NCT00554996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24262|NCT00554970|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24263|NCT00554853|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24264|NCT00554840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24265|NCT00554801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24266|NCT00554749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24267|NCT00554671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24268|NCT00554619|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24269|NCT00554515|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24270|NCT00554463|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
24271|NCT00554372|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24272|NCT00554294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24273|NCT00554229|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca can review results communications prior to public release and may within 60 days of receipt require amendments to be made. AstraZeneca can also require that submission or disclosure be delayed to allow for the filing of a patent application.
24274|NCT00554216|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
24275|NCT00554190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24276|NCT00554099|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24277|NCT00553969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24278|NCT00553839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24279|NCT00553787|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
24280|NCT00553735|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24281|NCT00553696|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24282|NCT00553644|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24283|NCT00553631|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
24284|NCT00553605|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24285|NCT00553514|Principal Investigators are NOT employed by the organization sponsoring the study.|
24286|NCT00553501|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24287|NCT00553475|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
24288|NCT00553462|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24289|NCT00553436|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24290|NCT00553358|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
24291|NCT00553332|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24292|NCT00553319|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24293|NCT00553280|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24294|NCT00553267|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24295|NCT00553202|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
24296|NCT00553150|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24297|NCT00553098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24298|NCT00552812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24299|NCT00552786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24300|NCT00552760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24301|NCT00552695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24302|NCT00552669|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24303|NCT00552578|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24304|NCT00552513|Principal Investigators are NOT employed by the organization sponsoring the study.|PHRI agreements may vary with individual investigators, but will not prohibit any investigator from publishing. PHRI supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24305|NCT00552448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24306|NCT00552422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24307|NCT00552409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24308|NCT00552396|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24309|NCT00552344|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24310|NCT00552305|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
24311|NCT00552279|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24312|NCT00552240|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24313|NCT00552188|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented as a joint, multi-center publication prior to publishing individual site results.
24314|NCT00552175|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24315|NCT00552110|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24316|NCT00552084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24317|NCT00552058|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
24318|NCT00552032|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator agrees not to publish or publicly present any interim results of the Study without prior written consent of the SPONSOR. The Principal Investigator further agrees to provide thirty (30) days written notice to the SPONSOR prior to submission for publication or presentation to permit the SPONSOR to review copies of abstracts or manuscripts for publication which report any results of the Study.
24319|NCT00551759|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24320|NCT00551746|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24321|NCT00551707|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24322|NCT00551642|Principal Investigators are NOT employed by the organization sponsoring the study.|
24324|NCT00551460|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24325|NCT00551421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24326|NCT00551369|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
24327|NCT00551291|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24328|NCT00551213|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
24329|NCT00551200|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24330|NCT00551174|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24331|NCT00551161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24332|NCT00551135|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24333|NCT00551070|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24334|NCT00551031|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
24335|NCT00550953|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
24336|NCT00550862|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications or lectures involving study material or data will be submitted for approval to Intercept Pharmaceuticals prior to submission to any journal/publication/lecture according to the clinical trial agreement.
24337|NCT00550836|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24338|NCT00550771|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigators (PIs) agree not to publish/publicly present any interim study results without prior sponsor written consent. The PIs further agree to provide 45 days written notice to the sponsor, prior to submission for publication or presentation, to permit the sponsor to review abstracts/manuscripts, which report any study results. The sponsor has the right to review/comment. If the parties disagree, the PIs agree to meet with the sponsor, prior to submission, to discuss/resolve.
24339|NCT00550745|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24340|NCT00550732|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigators agree to provide review copies of abstracts or manuscripts for publication (including texts of oral presentations) which report any results of the protocol study to the sponsor, 30 days prior to submission for publication or presentation. The sponsor shall have the right to review and comment on the data analysis and presentation with regard to proprietary information and the accuracy of the information contained in the publication.
24456|NCT00544869|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24341|NCT00550680|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24342|NCT00550654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24343|NCT00550589|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24344|NCT00550550|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator agrees not to publish or publicly present any interim results~of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of publications that report any results of the study. The sponsor shall have the right to review and comment with respect to proprietary information, data accuracy, and fair balance in compliance with FDA regulations."
24345|NCT00550537|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24346|NCT00550459|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24347|NCT00550446|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24348|NCT00550420|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24349|NCT00550407|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24350|NCT00550394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24351|NCT00550368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24352|NCT00550277|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
24353|NCT00550173|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24354|NCT00550147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24355|NCT00550043|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study, provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
24356|NCT00549939|Principal Investigators are NOT employed by the organization sponsoring the study.|"If no publication has occurred within 12 months after trial completion, the investigators can publish the results. Prior to publication, the sponsor shall review the manuscript and can request changes, provided they do not jeopardize the accuracy and/or the scientific value of the publication. The approval is given in writing by the sponsor, not to exceed 90 days.~To protect by a property right any information the sponsor can postpone the publication, for a period not to exceed 18 months."
24357|NCT00549900|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24358|NCT00549822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24359|NCT00549783|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24360|NCT00549770|Principal Investigators are NOT employed by the organization sponsoring the study.|
24361|NCT00549757|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
24362|NCT00549718|Principal Investigators are NOT employed by the organization sponsoring the study.|For multi-center studies, it is mandatory that the first publication is based on all data obtained from all analyses as stipulated in the protocol. Investigators participating in multicenter studies must agree not to present data gathered individually or by subgroup of centers before the full, initial publication, unless this has been agreed to by all other investigators and also by DSP-Sepracor.
24363|NCT00549640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24364|NCT00549601|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24365|NCT00549562|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24366|NCT00549549|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24367|NCT00549445|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24368|NCT00549393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24369|NCT00549328|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24370|NCT00549302|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24371|NCT00549198|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24372|NCT00549172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24373|NCT00549055|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24374|NCT00548886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24375|NCT00548860|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24376|NCT00548847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24377|NCT00548808|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24378|NCT00548717|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24379|NCT00548691|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24380|NCT00548548|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24381|NCT00548470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24382|NCT00548431|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24383|NCT00548418|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24384|NCT00548405|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can publish after sponsor published, after a defined period of time after study completion, and/or with written Sponsor approval. Generally PI gives sponsor a draft 60 days before publication. Sponsor can ask that confidential information can be removed, and can further defer publication upon notifying PI that it will file a patent application on inventions contained in the draft.
24385|NCT00548340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24386|NCT00548327|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24387|NCT00548262|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24388|NCT00548249|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24389|NCT00548184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24390|NCT00548145|Principal Investigators are NOT employed by the organization sponsoring the study.|
24391|NCT00548132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24392|NCT00548041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24393|NCT00547911|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24394|NCT00547703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24395|NCT00547638|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24396|NCT00547534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24397|NCT00547521|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period <= 60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24398|NCT00547456|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24399|NCT00547378|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24400|NCT00547365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24401|NCT00547157|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
24402|NCT00547118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24403|NCT00547105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24404|NCT00546910|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24405|NCT00546897|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24406|NCT00546884|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24407|NCT00546871|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥90 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., for intellectual property protection)
24408|NCT00546819|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication guidelines.
24409|NCT00546754|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24410|NCT00546728|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24411|NCT00546715|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
24412|NCT00546637|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24413|NCT00546572|Principal Investigators are NOT employed by the organization sponsoring the study.|Wyeth has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24414|NCT00546481|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
24415|NCT00546429|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24416|NCT00546377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24417|NCT00546364|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24537|NCT00539110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24418|NCT00546351|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
24419|NCT00546273|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure of the results has to be previously arranged if mutually agreeable to both investigators and the company manufacturer of the vaccine RUTI: Archivel Farma S.L.
24420|NCT00546260|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo. Additionally, individual publication may occur after coordinated multi-center publication.
24421|NCT00546156|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24422|NCT00546117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24423|NCT00546104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24424|NCT00546078|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24425|NCT00546052|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24426|NCT00546000|Principal Investigators are NOT employed by the organization sponsoring the study.|
24427|NCT00545974|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24428|NCT00545948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24429|NCT00545844|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24430|NCT00545792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24431|NCT00545779|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
24432|NCT00545766|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
24433|NCT00545753|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24434|NCT00545740|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
24435|NCT00545688|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24436|NCT00545662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24437|NCT00545623|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24650|NCT00532493|Principal Investigators are NOT employed by the organization sponsoring the study.|
24438|NCT00545584|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24439|NCT00545571|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24440|NCT00545506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24441|NCT00545441|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24442|NCT00545402|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24443|NCT00545363|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24444|NCT00545298|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is only allowed to publish the results of the trial with the permission of the Sponsor
24445|NCT00545272|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24446|NCT00545233|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24447|NCT00545181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24448|NCT00545168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24449|NCT00545155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24450|NCT00545103|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
24451|NCT00545064|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24452|NCT00545051|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24453|NCT00545025|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24454|NCT00544908|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24455|NCT00544882|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
24457|NCT00544817|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
24458|NCT00544778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24459|NCT00544713|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24460|NCT00544674|Principal Investigators are NOT employed by the organization sponsoring the study.|Single site data may be published/presented prior to the publication of multi-center data from overall study if agreed to by the sponsor in writing, or 12 months have elapsed following termination or completion of the study, whichever comes first.
24461|NCT00544648|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24462|NCT00544557|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24463|NCT00544544|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24464|NCT00544440|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24465|NCT00544167|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
24466|NCT00543985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24467|NCT00543855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24468|NCT00543803|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24469|NCT00543764|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24470|NCT00543725|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24471|NCT00543569|Principal Investigators are NOT employed by the organization sponsoring the study.|Standard Restriction Description: Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or 12 months after data-lock, whichever is first. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication for up to 60 days to seek patent protection.
24472|NCT00543543|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
24473|NCT00543400|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24474|NCT00543296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24495|NCT00541866|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24475|NCT00543140|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed that the first publication of results should be made in conjunction with the presentation of a joint, multicenter publication of the results with the PIs from all sites contributing data, analyses, and comments. If this publication was not submitted within 12 months after conclusion of the Study at all sites, or after Sponsor confirmed there would be no multicenter Study publication, whichever is first, the PIs could have published the results from their individual sites.
24476|NCT00543101|Principal Investigators are NOT employed by the organization sponsoring the study.|Site Investigators (PIs) agree not to individually publish the results of the study. They may participate in a joint publication of the study results with the sponsor.
24477|NCT00542997|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.
24478|NCT00542971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24479|NCT00542880|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to any publication or disclosure, the PI provides AstraZeneca with preliminary data and drafts and with the proposed final manuscript. AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript to review it and may within such time frame require that submission for publication or disclosure be delayed.
24480|NCT00542828|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24481|NCT00542815|Principal Investigators are NOT employed by the organization sponsoring the study.|
24482|NCT00542789|Principal Investigators are NOT employed by the organization sponsoring the study.|
24483|NCT00542750|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24484|NCT00542620|Principal Investigators are NOT employed by the organization sponsoring the study.|The Steering Committee has the right to publish the entire results of the trial. Any such scientific paper, presentation, communication, or other information concerning the investigation must be approved by the Steering Committee, and copies submitted in writing to Novo Nordisk prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
24485|NCT00542542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24486|NCT00542490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24487|NCT00542425|Principal Investigators are NOT employed by the organization sponsoring the study.|"The PI/Institution may publish/present results of the Study provided that the Publication is reviewed by the Sponsor for Confidential Information at least 60 days prior to submission. If the Publication contains patent-related information, the submission shall be delayed for 90 days.~The Institution/PI will not publish until after the data from the multi-center study is published in a combined paper as long as it is completed within 18 months from the date of study completion."
24488|NCT00542386|Principal Investigators are NOT employed by the organization sponsoring the study.|
24489|NCT00542321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24490|NCT00542308|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site and the PI may be required to withhold the publication for up to 90 days. Subject to a reasoned request from the sponsor, the publication may be further delayed for a period up to 6 months from the date of first submission to the sponsor.~The sponsor has the right to require deletion of any trade secret, proprietary, or confidential information supplied by the sponsor to the site or the PI. The sponsor shall not otherwise have the right to censor publications."
24491|NCT00542269|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24492|NCT00542178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24493|NCT00541970|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24494|NCT00541931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24536|NCT00539188|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24496|NCT00541775|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24497|NCT00541671|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24498|NCT00541658|Principal Investigators are NOT employed by the organization sponsoring the study.|The findings of the study may be published in a scientific journal or presented at a scientific meeting. Before submitting the results of the study for publication or presentation, the Investigator will allow the sponsor 30 days in which to review and comment on the manuscript.
24499|NCT00541593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24500|NCT00541450|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that an investigator and/or his/her colleagues may publish the results for their study site independently subsequent to the multicenter publication, or 24 months after completion of the study, whichever comes first. The sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review.
24501|NCT00541346|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24502|NCT00541307|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator will provide the materials to the sponsor at least 30 days in advance of submission for publication or public disclosure. The sponsor has the right to make modifications as necessary to protect proprietary information or correct inaccuracies in technical specifications or device descriptions.
24503|NCT00541242|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
24504|NCT00541229|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24505|NCT00541190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24506|NCT00541099|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24507|NCT00541034|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24508|NCT00540969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24509|NCT00540722|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24510|NCT00540644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24511|NCT00540592|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24512|NCT00540579|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
24513|NCT00540514|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Celgene with a copy of the papers prior to their submission; Celgene shall complete its review within 60 days after receipt. Upon Celgene’s request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of patentable material.
24514|NCT00540449|Principal Investigators are NOT employed by the organization sponsoring the study.|
24515|NCT00540436|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24516|NCT00540423|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24517|NCT00540293|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
24518|NCT00540228|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24519|NCT00540124|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24520|NCT00540046|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24521|NCT00540007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24522|NCT00539994|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24523|NCT00539942|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24524|NCT00539864|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24525|NCT00539734|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24526|NCT00539695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24527|NCT00539617|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24528|NCT00539591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24529|NCT00539539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24530|NCT00539526|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
24531|NCT00539513|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24532|NCT00539305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24533|NCT00539279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24534|NCT00539253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24535|NCT00539240|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24538|NCT00539032|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
24539|NCT00539006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24540|NCT00538980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24541|NCT00538915|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24542|NCT00538902|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
24543|NCT00538863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24544|NCT00538850|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24545|NCT00538824|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24546|NCT00538785|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
24547|NCT00538733|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24548|NCT00538642|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24549|NCT00538629|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
24550|NCT00538616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24551|NCT00538590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24552|NCT00538512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24553|NCT00538473|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24554|NCT00538434|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
24555|NCT00538304|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
24556|NCT00538291|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24557|NCT00538213|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24558|NCT00537979|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
24559|NCT00537940|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24560|NCT00537823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24561|NCT00537810|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24562|NCT00537771|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24563|NCT00537745|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24564|NCT00537680|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24565|NCT00537511|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene’s request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation.
24566|NCT00537485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24567|NCT00537407|Principal Investigators are NOT employed by the organization sponsoring the study.|
24568|NCT00537394|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
24569|NCT00537381|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24570|NCT00537329|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24571|NCT00537316|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's representative will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
24572|NCT00537303|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
24573|NCT00537290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24574|NCT00537277|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
24575|NCT00537238|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24576|NCT00537199|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24577|NCT00537095|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
24578|NCT00537082|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24579|NCT00537056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24580|NCT00537030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24581|NCT00537017|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
24582|NCT00536991|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24583|NCT00536978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24584|NCT00536913|Principal Investigators are NOT employed by the organization sponsoring the study.|
24585|NCT00536874|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24586|NCT00536809|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24587|NCT00536744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24588|NCT00536731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24589|NCT00536575|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
24590|NCT00536510|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24591|NCT00536484|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24592|NCT00536471|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24593|NCT00536380|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees not to publish or publicly present any interim results of Study without prior written consent of sponsor. PI further agrees to provide 45 days written notice to sponsor prior to submission for publication or presentation to permit sponsor to review copies of abstracts or manuscripts for publication (including, without limitation, slides and text of oral or other public presentations and text of any transmission through any electronic media) which report any results of Study.
24594|NCT00536341|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
24595|NCT00536263|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator (PI) agrees not to publish/present any interim results of the study without prior written consent of the sponsor. The PI further agrees to provide 45 days written notice to the sponsor prior to submission for publication/presentation to permit the sponsor to review copies of abstracts/manuscripts which report any study results. The sponsor shall have the right to review and comment. If the parties disagree the PI agrees to meet with the sponsor to discuss and resolve.
24596|NCT00536198|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24597|NCT00536172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24598|NCT00536120|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
24599|NCT00536107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24600|NCT00535938|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 4 weeks from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24601|NCT00535873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24602|NCT00535847|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24603|NCT00535821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24604|NCT00535782|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24605|NCT00535769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24606|NCT00535730|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24607|NCT00535652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24608|NCT00535626|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center's results at the completion of the study.These manuscripts & abstracts will be delayed until after the multi-center publication is submitted.All publications shall be submitted to the sponsor for review at least 60 days prior to the submission for publication.The sponsor shall not edit or otherwise influence the publications other than to ensure that confidential information is not disclosed and that the data is accurately represented.
24609|NCT00535587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24610|NCT00535496|Principal Investigators are NOT employed by the organization sponsoring the study.|Any scientific paper, presentation, or other communication concerning the clinical trial will first be submitted at least six weeks ahead of publication or presentation, for written consent. The Sponsor shall have the right to make its consent conditional upon proper representation of the interpretation and discussion of the data.
24611|NCT00535405|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24612|NCT00535392|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
24613|NCT00535301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24614|NCT00535288|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24615|NCT00535262|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24616|NCT00535223|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24617|NCT00535145|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24618|NCT00535132|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24619|NCT00535002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24620|NCT00534976|Principal Investigators are NOT employed by the organization sponsoring the study.|Subsequent to a multicenter publication, or 24 months after completion of the study, whichever comes first, an investigator may publish the results for their study site independently. However, the SPONSOR does not recommend separate publication of individual study site results. The SPONSOR must have the opportunity to review all proposed communications regarding this study 60 days prior to submission. Any information identified by the SPONSOR as confidential must be deleted.
24621|NCT00534937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24622|NCT00534833|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
24623|NCT00534794|Principal Investigators are NOT employed by the organization sponsoring the study.|PI cannot publish or discuss trial results until written communication is received from Inspire.
24624|NCT00534638|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24625|NCT00534599|Principal Investigators are NOT employed by the organization sponsoring the study.|If Sponsor does not publish within 2 years after study completion, PI is permitted to publish, with confidential information removed from manuscript. Sponsor will have opportunity to review and approve publication at least 60 days prior to being submitted/disclosed. Sponsor can request, in writing, an additional 90 day embargo.
24626|NCT00534495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24627|NCT00534417|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator shall submit a copy of any manuscript or material proposed for publication or the text of any presentation relating to the results of the Study to AstraZeneca and Roche for review and comment at least 30 days prior to its submission for publication or presentation.
24628|NCT00534404|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24629|NCT00534365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24630|NCT00534352|Principal Investigators are NOT employed by the organization sponsoring the study.|If TTCA does not publish within 12 months after study conclusion or after TTCA confirms there will be no multicenter publication, Institution may publish their results from their site individually, provided TTCA has 60 day review for confidentiality and additional 60 day delay for patent application.
24651|NCT00532480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24631|NCT00534313|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24632|NCT00534248|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24633|NCT00534209|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24634|NCT00534105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24635|NCT00534092|Principal Investigators are NOT employed by the organization sponsoring the study.|
24636|NCT00534001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24637|NCT00533949|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
24638|NCT00533897|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24639|NCT00533702|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
24640|NCT00533546|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24641|NCT00533507|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24642|NCT00533442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24643|NCT00533351|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 40 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
24644|NCT00533273|Principal Investigators are NOT employed by the organization sponsoring the study.|Auxilium Pharmaceuticals, Inc. agreements may vary with individual investigators but will not prohibit any investigator from publishing. Auxilium supports the publication of results from all centers of a multicenter trial but requests that reports based on single site data not precede the primary publication of the entire clinical trial.
24645|NCT00533117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24646|NCT00532948|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24647|NCT00532935|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24648|NCT00532883|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24649|NCT00532779|Principal Investigators are NOT employed by the organization sponsoring the study.|If not already published by Sponsor as part of a multi-center publication, 18 months after conclusion of the study at all study centers, PI may publish the results for PI’s study center individually. Prior to such publication, PI must provide Sponsor with at least 60 days to review and comment on the proposed publication. The review period may be extended by an additional 30 days upon request. Sponsor may delay publication for up to an additional 6 month period to file for patent protection.
24652|NCT00532441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24653|NCT00532298|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24654|NCT00532259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24655|NCT00532155|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 30 days in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed 90 days).
24656|NCT00532129|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24657|NCT00531960|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24658|NCT00531947|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator is free to publish for their own research or publication objectives, provided that such does not disclose Confidential Information. At least 45 days prior the Investigator shall submit for Sponsor review. Sponsor will advise of revisions necessary to preserve confidential and proprietary information. The first publication of the results shall be a joint Multi-Center publication of results with the investigators from all study sites contributing data.
24659|NCT00531934|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24660|NCT00531882|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24661|NCT00531843|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24662|NCT00531817|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24663|NCT00531752|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24664|NCT00531661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24665|NCT00531518|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24666|NCT00531479|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24667|NCT00531453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24668|NCT00531427|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24746|NCT00527748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24669|NCT00531284|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
24670|NCT00531206|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24671|NCT00531050|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24672|NCT00531011|Principal Investigators are NOT employed by the organization sponsoring the study.|The publication of the aggregate data is subject to the prior agreement of all the various sites participating in the study. Publication of the clinical data collected during the Study, can be only after notifying the SPONSOR in advance in order to allow the SPONSOR to verify compliance with confidentiality obligations and intellectual property rights of the SPONSOR.
24673|NCT00530946|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
24674|NCT00530920|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24675|NCT00530894|Principal Investigators are NOT employed by the organization sponsoring the study.|"Site cannot publish or present on overall study results not yet published. PI may publish his own clinical study data subject to EW review prior submission or presentation, but data analyses of site-specific results can occur only in intervals as specified in the CSA.~Publication of site-specific results cannot include claims of device safety and effectiveness and requires EW review."
24676|NCT00530855|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24677|NCT00530842|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24678|NCT00530816|Principal Investigators are NOT employed by the organization sponsoring the study.|After the study is completed and all case report forms have been sent to Sponsor, Institution shall have the right to publish or otherwise make public any data resulting from the study under this agreement after publication of a multi-center publication coordinated by Sponsor with respect to the data resulting from the study, or 12 months after the Study is completed at all participating sites if a multi-center publication is not submitted by Sponsor for publication within such 12 month period.
24679|NCT00530790|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of the multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24680|NCT00530777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24681|NCT00530764|Principal Investigators are NOT employed by the organization sponsoring the study.|"Publication Policy:~GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications for example, manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release."
24682|NCT00530712|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24683|NCT00530634|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24684|NCT00530504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results without permission of the sponsor.
24685|NCT00530439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24686|NCT00530348|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can publish after sponsor published, after a defined period of time after study completion, and/or with written sponsor approval. Generally PI gives sponsor a draft 60 days before publication. Sponsor can ask that confidential information be removed, and can further defer publication upon notifying PI that it will file a patent application on inventions contained in the draft.
24687|NCT00530335|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24688|NCT00530270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24689|NCT00530257|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24690|NCT00530218|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24691|NCT00530088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24692|NCT00530075|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24693|NCT00530023|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24694|NCT00529802|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24695|NCT00529789|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24696|NCT00529763|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24697|NCT00529659|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24698|NCT00529633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24699|NCT00529568|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24700|NCT00529555|Principal Investigators are NOT employed by the organization sponsoring the study.|
24701|NCT00529542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24702|NCT00529529|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
24703|NCT00529516|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24704|NCT00529464|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24705|NCT00529451|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24706|NCT00529399|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24707|NCT00529308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24708|NCT00529282|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24709|NCT00529243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24710|NCT00529217|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24711|NCT00529204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24712|NCT00529191|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24713|NCT00529152|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to review manuscript at least 60 days prior to submission and posters/abstracts at least 30 days. If review indicates potentially patentable or confidential information would be disclosed, submission may be delayed an extra 30 days to allow filing the necessary patent applications and to co-operate with the sponsor to protect confidential information. Investigator will delay single center publications until after disclosure of pooled data (all sites) by Sponsor.
24714|NCT00529126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24715|NCT00529100|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24716|NCT00529087|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
24717|NCT00529035|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24718|NCT00528957|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
24719|NCT00528931|Principal Investigators are NOT employed by the organization sponsoring the study.|Auxilium Pharmaceuticals, Inc. agreements may vary with individual investigators but will not prohibit any investigator from publishing. Auxilium supports the publication of results from all centers of a multicenter trial but requests that reports based on single site data not preceed the primary publication of the entire clinical trial.
24720|NCT00528879|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24721|NCT00528866|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
24722|NCT00528840|Principal Investigators are NOT employed by the organization sponsoring the study.|Auxilium Pharmaceuticals, Inc. agreements may vary with individual investigators but will not prohibit any investigator from publishing. Auxilium supports the publication of results from all centers of a multicenter trial but requests that reports based on single site data not preceed the primary publication of the entire clinical trial.
24723|NCT00528801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24724|NCT00528788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24725|NCT00528775|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24726|NCT00528645|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24767|NCT00526799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24727|NCT00528606|Principal Investigators are NOT employed by the organization sponsoring the study.|Auxilium Pharmaceuticals, Inc. agreements may vary with individual investigators but will not prohibit any investigator from publishing. Auxilium supports the publication of results from all centers of a multicenter trial but requests that reports based on single site data not preceed the primary publication of the entire clinical trial.
24728|NCT00528567|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24729|NCT00528541|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release for a period that is not less than 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication.
24730|NCT00528528|Principal Investigators are NOT employed by the organization sponsoring the study.|As per revised Protocol dated 21 Dec 2007, Investigator may not submit for publication or presentation, the results of trial without prior written consent of Sponsor. The Investigator agrees to allow at least 45 days for Sponsor to review prepublication manuscript prior to submission to Publisher. In accordance with generally recognized principles of scientific collaboration, co-authorship with any company personnel will be discussed and mutually agreed upon before submission to Publisher.
24731|NCT00528450|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24732|NCT00528424|Principal Investigators are NOT employed by the organization sponsoring the study.|Auxilium Pharmaceuticals, Inc. agreements may vary with individual investigators but will not prohibit any investigator from publishing. Auxilium supports the publication of results from all centers of a multicenter trial but requests that reports based on single site data not precede the primary publication of the entire clinical trial.
24733|NCT00528411|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites.
24734|NCT00528398|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24735|NCT00528372|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24736|NCT00528268|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24737|NCT00528190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24738|NCT00528112|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigators (PIs) have to send the publication to sponsor 90 days prior to planned publishing. The sponsor has maximum 60 days for review and for recommending changes or mark parts that have to be deleted from the publication due to harming sponsor’s confidentiality rights. Sponsor can request a delay in publication release up to 6 months.
24739|NCT00528021|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24740|NCT00527982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24741|NCT00527943|Principal Investigators are NOT employed by the organization sponsoring the study.|All draft publications will be submitted to the Publication Committee for review. Full-length papers will be submitted at least 45 days prior to submission to a journal. Abstracts or public presentations (eg, poster) will be submitted at least 14 days in advance.
24742|NCT00527904|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees that the first publication will be a multi-center publication of the study results. Following this multi-center publication, PI can publish, present or use any non-confidential study results following Sponsor review and comment.
24743|NCT00527878|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24744|NCT00527826|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24745|NCT00527787|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees that the first publication will be a multi-center publication of the study results. Following this multi-center publication, PI can publish, present or use any non-confidential results following Sponsor review and comment.
24747|NCT00527735|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
24748|NCT00527722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24749|NCT00527644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24750|NCT00527618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24751|NCT00527605|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24752|NCT00527592|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor does not guarantee the Investigator’s right to publish study results since this is a pilot trial with results intended primarily for internal use. Alcon reserves the right of prior review of any publication or presentation of information related to the study.
24753|NCT00527566|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24754|NCT00527514|Principal Investigators are NOT employed by the organization sponsoring the study.|“If identified by Daiichi Sankyo, Inc. (DSI), any of DSI’s confidential information as defined herein shall be deleted…Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by Study Site.”
24755|NCT00527488|Principal Investigators are NOT employed by the organization sponsoring the study.|After the end of the study, one or more manuscripts for joint publication may be prepared in collaboration between the investigator(s) offered authorship and Ferring Pharmaceuticals A/S (Ferring). Ferring reserves the right to be last author(s) in all publications related to this study. In the event of any disagreement in the content of any publication, both the Investigator’s and Ferring’s opinion will be fairly and sufficiently represented in the publication.
24756|NCT00527475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24757|NCT00527423|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. There IS agreement between the Principal Investigator and the Sponsor that restricts the PI’s rights to discuss or publish study results until Sponsor can review and comment. Sponsor can also remove confidential or proprietary information.
24758|NCT00527397|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
24759|NCT00527332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24760|NCT00527319|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24761|NCT00527124|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24762|NCT00527111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24763|NCT00527098|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24764|NCT00527072|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24765|NCT00526994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24766|NCT00526890|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24768|NCT00526669|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24769|NCT00526630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24770|NCT00526474|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators agreed not to publish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agreed to provide to the sponsor review copies of abstracts or manuscripts for publication 45 days prior to submission.
24771|NCT00526331|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24772|NCT00526292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24773|NCT00526227|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators to publish study results per the publication plan/protocol following Medtronic's review to determine whether confidential information (CI) is disclosed. Any such CI is deleted prior to publication/presentation. Medtronic may not censor/interfere with the publication except as described. Investigators may not publish any single-site publications until the main multi-site study publication has occurred."
24774|NCT00526188|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24775|NCT00526162|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators to publish study results per the publication plan/protocol following Medtronic's review to determine whether confidential information (CI) is disclosed. Any such CI is deleted prior to publication/presentation. Medtronic may not censor/interfere with the publication except as described. Investigators may not publish any single-site publications until the main multi-site study publication has occurred."
24776|NCT00526123|Principal Investigators are NOT employed by the organization sponsoring the study.|SPONSOR shall have the right to review and comment on such publication with respect to disclosure of SPONSOR Confidential Information prior to submission and review, and no such SPONSOR Confidential Information shall be disclosed therein without SPONSOR’s express written consent. Such review and comment will be provided within 30 calendar days from the date of receipt by the SPONSOR. Investigator shall delete any SPONSOR confidential information contained in such publication.
24777|NCT00526110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24778|NCT00526097|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24779|NCT00526058|Principal Investigators are NOT employed by the organization sponsoring the study.|The Site may publish its own results of the FUTURA Trial after a cooperative publication or 12 months after Sponsor's final evaluation of all the FUTURA Trial data from all sites, whichever occurs first. At least 90 days prior to submitting a manuscript to a publisher or other outside persons or prior to any public presentation, a copy of the abstract, manuscript, or presentation will be provided to Sponsor for review and comment. Sponsor shall have said 90 day period to respond w/ comment.
24780|NCT00525915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24781|NCT00525902|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24782|NCT00525876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24783|NCT00525837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24784|NCT00525824|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24785|NCT00525798|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24786|NCT00525733|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24787|NCT00525629|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24788|NCT00525603|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24789|NCT00525525|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24790|NCT00525512|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24791|NCT00525499|Principal Investigators are NOT employed by the organization sponsoring the study.|The Institution and Investigator agree not to publish the results of this study without the prior written consent of Sponsor.
24792|NCT00525421|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24793|NCT00525265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24794|NCT00525174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24795|NCT00525161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24796|NCT00525148|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
24797|NCT00525135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24798|NCT00525031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24799|NCT00524940|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
24800|NCT00524771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24801|NCT00524745|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24802|NCT00524680|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24803|NCT00524589|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24804|NCT00524576|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24805|NCT00524537|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
24806|NCT00524511|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24807|NCT00524485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24808|NCT00524459|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24809|NCT00524420|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24810|NCT00524394|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24811|NCT00524368|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor will not unreasonably withhold consent to publish the data generated in this trial. However, it is the policy of the Sponsor not to allow the investigators to publish their results or findings prior to the Sponsor’s publication of the overall trial results. The investigator agrees that before he/she publishes any results of this trial, he/she shall allow at least 45 days for the Sponsor to review the prepublication manuscript prior to submission of the manuscript to the publisher.
24812|NCT00524342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24813|NCT00524316|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24814|NCT00524303|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24815|NCT00524264|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24816|NCT00524225|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24817|NCT00524173|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24818|NCT00524134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24819|NCT00524121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24820|NCT00524043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24821|NCT00524030|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24822|NCT00523991|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24823|NCT00523978|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24824|NCT00523939|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24825|NCT00523848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24826|NCT00523809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24827|NCT00523744|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24828|NCT00523718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24829|NCT00523705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24830|NCT00523640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24831|NCT00523614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24832|NCT00523549|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
24833|NCT00523419|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24834|NCT00523367|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24835|NCT00523341|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
24836|NCT00523237|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24837|NCT00522951|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24838|NCT00522925|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24839|NCT00522873|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24840|NCT00522795|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24841|NCT00522626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24842|NCT00522548|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24843|NCT00522457|Principal Investigators are NOT employed by the organization sponsoring the study.|The Site may publish the results of the Study after such cooperative publication, or 1 year after Sponsor's final evaluation of all the Study data from all sites, whichever occurs first. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Fresenius Biotech at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
24844|NCT00522431|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication statement in clinical trial agreement
24845|NCT00522418|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator and Site agree not to publish or otherwise publicaly disclose clinical data generated in connection with the Study, unless approved in advance in writing by Cyberonics. Investigators and Site agree to provide Cyberonics with a copy of any proposed publication, abstract, or presentation relating to the research conducted under this Agreement at least 30 days prior to submission for publication or presentation.
24846|NCT00522392|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24847|NCT00522379|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
24848|NCT00522301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24849|NCT00522275|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
24850|NCT00522171|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has at least 60 days for review to ensure non disclosure of Confidential information. If Study is a multicenter study, PI agrees that the first publication shall include results from all PIs contributing data. If multicenter publication is not submitted within 12 months,or after Sponsor confirms there will be no multicenter Study publication, the Institution and/or such PI may publish the results from their respective site individually in accordance with this paragraph.
24851|NCT00522041|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication statement in clinical trial agreement.
24852|NCT00521989|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24853|NCT00521976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24854|NCT00521924|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI) has the right to publish/publicly present the results of the Study, but may not to publish/publicly present any interim results. PI must provide 45 days written notice to Sponsor prior to submission for publication/presentation to permit Sponsor to review drafts for publication which report any results arising out of the Study. Sponsor shall have the right to review and comment on any Public Presentation.
24855|NCT00521885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24856|NCT00521599|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of sponsor. The investigator further agrees to provide the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication. The sponsor has the right to review and comment. If the parties disagree, the investigator agrees to meet with the sponsor's representative in order to resolve such issues.
24857|NCT00521586|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
24858|NCT00521456|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24859|NCT00521365|Principal Investigators are NOT employed by the organization sponsoring the study.|
24860|NCT00521352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24861|NCT00521339|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
24862|NCT00521144|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24863|NCT00521079|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24864|NCT00521053|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24865|NCT00521014|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24866|NCT00521001|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24867|NCT00520975|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24888|NCT00519779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24868|NCT00520936|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24869|NCT00520845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24870|NCT00520767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24871|NCT00520741|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24872|NCT00520676|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24873|NCT00520572|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24874|NCT00520546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24875|NCT00520494|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
24876|NCT00520468|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24877|NCT00520403|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24878|NCT00520351|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24879|NCT00520299|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24880|NCT00520286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24881|NCT00520234|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24882|NCT00520130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24883|NCT00520039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24884|NCT00520013|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24885|NCT00519896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24886|NCT00519831|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24887|NCT00519818|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24889|NCT00519649|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24890|NCT00519636|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24891|NCT00519623|Principal Investigators are NOT employed by the organization sponsoring the study.|"PI is restricted from using, disclosing, presenting or publishing trial information without the prior written consent from the Sponsor.~PI is not an employee of the Sponsor but was paid to conduct the study at the Sponsor's Phase 1 Clinical Resarch Unit."
24892|NCT00519584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24893|NCT00519532|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
24894|NCT00519428|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24895|NCT00519376|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24896|NCT00519285|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission to a journal, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
24897|NCT00519194|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24898|NCT00519090|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data in the clinical trial.
24899|NCT00519077|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24900|NCT00518986|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24901|NCT00518882|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
24902|NCT00518713|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review and approve all proposed abstracts, manuscripts, or presentations regarding this study prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
24903|NCT00518687|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
24904|NCT00518622|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24905|NCT00518531|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
24906|NCT00518349|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24945|NCT00515827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24907|NCT00518336|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24908|NCT00518323|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24909|NCT00518284|Principal Investigators are NOT employed by the organization sponsoring the study.|"Study data will not be published in part before complete multicenter data have been reported in full, unless more than 18 months have elapsed since completion of the Study.~Investigator/institution must supply copy of presentation or publication to Celgene 30 days of prior to submission for publication. Celgene may request in writing within that 30 days that Celgene Confidential Information be deleted or be granted a 60 day delay prior to publication for intellectual property filings."
24910|NCT00518206|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24911|NCT00518180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24912|NCT00518115|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24913|NCT00518089|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24914|NCT00518011|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24915|NCT00517933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24916|NCT00517881|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24917|NCT00517829|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24918|NCT00517751|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24919|NCT00517699|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24920|NCT00517634|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24921|NCT00517595|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the proposed publication or presentation must be submitted to the funders for review and comment two months prior to the presentation or submission for publication. An additional 60 day delay of presentation or publication may be requested by the funder.
24922|NCT00517556|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24923|NCT00517530|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
24924|NCT00517413|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
24925|NCT00517361|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24926|NCT00517296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24927|NCT00517192|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
24928|NCT00517075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24929|NCT00517010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24930|NCT00516919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24931|NCT00516906|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24932|NCT00516893|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
24933|NCT00516737|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24934|NCT00516503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24935|NCT00516386|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24936|NCT00516321|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24937|NCT00516295|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24938|NCT00516269|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24939|NCT00516217|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
24940|NCT00516165|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24941|NCT00516139|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24942|NCT00516074|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24943|NCT00516048|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24944|NCT00515879|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24946|NCT00515697|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if the draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. The sponsor may request publication delay up to 90 days to seek patent protection.
24947|NCT00515671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24948|NCT00515619|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
24949|NCT00515541|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24950|NCT00515502|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24951|NCT00515463|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
24952|NCT00515437|Principal Investigators are NOT employed by the organization sponsoring the study.|Individual investigators may publish results 1 year after the completion of the trial if a multi-center publication has not occurred.
24953|NCT00515294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24954|NCT00515216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24955|NCT00515203|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
24956|NCT00515177|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24957|NCT00515112|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24958|NCT00515099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24959|NCT00515086|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or the publication of the trial results in their entirety.
24960|NCT00515073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24961|NCT00515034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24962|NCT00515008|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24963|NCT00514943|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
24964|NCT00514917|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall provide the Steering Committee a copy of any manuscript, abstract or oral communication derived from the study for review and comment at least 30 days in advance of any submission. The Sponsor's representatives shall have the right to review and/or delay any publication or presentation to prevent disclosure of Sponsor's confidential information and preserve intellectual property rights.
24965|NCT00514904|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24966|NCT00514852|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
24967|NCT00514813|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
24968|NCT00514735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24969|NCT00514709|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
24970|NCT00514683|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI’s intellectual property rights
24971|NCT00514592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24972|NCT00514514|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
24973|NCT00514501|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24974|NCT00514449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24975|NCT00514215|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24976|NCT00514137|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24977|NCT00514020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24978|NCT00513799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24979|NCT00513708|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24980|NCT00513695|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24981|NCT00513682|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions may vary in accordance with each agreement that is negotiated with individual investigators. Sponsor will allow publication after multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and defer publication for period of time to allow Sponsor to obtain patent or other intellectual property right protection.
24982|NCT00513617|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24983|NCT00513604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24984|NCT00513526|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24985|NCT00513500|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24986|NCT00513474|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24987|NCT00513435|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24988|NCT00513409|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
24989|NCT00513370|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication and presentation of this Study shall reside with Abbott. No independent manuscript may be submitted for publication until the first manuscript has been accepted for publication or twelve (12) months after completion of Study at all sites, which ever occurs first.
24990|NCT00513357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24991|NCT00513344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24992|NCT00513305|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24993|NCT00513292|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24994|NCT00513240|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24995|NCT00513071|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
24996|NCT00513019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24997|NCT00512902|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
24998|NCT00512876|Principal Investigators are NOT employed by the organization sponsoring the study.|"All materials that reflects the WRAMC affiliation must be approved and properly cleared before the material is submitted for public dissemination and publication. All publications whereby WRAMC is cited in the bylines will state on the cover page the following sample disclaimer: The views expressed in this [article, book chapter, speech, presentation, etc.] are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or U.S. Government."
24999|NCT00512798|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25000|NCT00512707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25001|NCT00512278|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25002|NCT00512252|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25003|NCT00512148|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator is free to individually communicate, orally present, or publish in scientific journals or other scholarly media the study information at the conclusion of the study without the prior approval of the sponsor provided that 1) the results of the study in its entirety have been publically disclosed by or with the consent of the sponsor 2)18 months after the conclusion of the study at all sites, whichever is first to occur.
25004|NCT00512096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25005|NCT00511992|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25006|NCT00511914|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25007|NCT00511901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25008|NCT00511862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25009|NCT00511836|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI/Institution may publish study results for noncommercial purposes. Sponsor will have 30 days to review a proposed publication. PI/Institution will delete any Sponsor Confidential Information other than study results, will revise a publication based on regulatory requirements of Sponsor as manufacture of the study drug, and will delay publication for no more than 60 days to allow for filing of patent applications to protect Sponsor’s intellectual property contained in such publication.
25010|NCT00511810|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25011|NCT00511797|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor will confirm the contents before disclosure.
25012|NCT00511706|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
25013|NCT00511667|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
25014|NCT00511472|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
25015|NCT00511433|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the Sponsor, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
25016|NCT00511355|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the SPONSOR. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the SPONSOR, at least six weeks ahead of estimated publication or presentation, for consent, which shall not be withheld unreasonably.
25017|NCT00511342|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the SPONSOR. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the SPONSOR, at least six weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
25018|NCT00511329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25019|NCT00511238|Principal Investigators are NOT employed by the organization sponsoring the study.|After the study is completed and all case report forms have been sent to Sponsor, Institution shall have the right to publish or otherwise make public any data resulting from the study under this agreement after publication of a multi-center publication coordinated by Sponsor with respect to the data resulting from the study, or 12 months after the Study is completed at all participating sites if a multi-center publication is not submitted by Sponsor for publication within such 12 month period.
25020|NCT00511199|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the SPONSOR. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the SPONSOR, at least six weeks ahead of estimated publication or presentation, for consent, which shall not be withheld unreasonably.
25021|NCT00511173|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25022|NCT00511147|Principal Investigators are NOT employed by the organization sponsoring the study.|Site may publish results from the study, after providing sponsor 30 days’ notice prior to submitting a manuscript or other materials related to the study to any outside party. At sponsor's request, site will remove any confidential information (other than study results), and site will upon sponsor's request delay publication or presentation for a period of up to 120 days to allow sponsor to protect its interests in any sponsor inventions
25023|NCT00511134|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25024|NCT00511108|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25025|NCT00511095|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25026|NCT00511004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25027|NCT00510952|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25028|NCT00510887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25029|NCT00510874|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25030|NCT00510835|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25031|NCT00510809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25032|NCT00510783|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25033|NCT00510744|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25034|NCT00510692|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25035|NCT00510653|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25036|NCT00510510|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25037|NCT00510497|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25038|NCT00510484|Principal Investigators are NOT employed by the organization sponsoring the study.|At 60 days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy and allow Sponsor 60 days to review and comment.
25039|NCT00510458|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator shall have privileges for their own center's results at the completion of the study.These manuscripts and abstracts will be delayed until after the multi-center publication is submitted. All publications shall be submitted to the sponsor for review at least 60 days prior to submission for publication. Stryker’s review ensures no disclosure of confidential info, no promotion of off-label use, and data is accurate.
25040|NCT00510289|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25041|NCT00510276|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25042|NCT00510224|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25043|NCT00510146|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25044|NCT00510068|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25045|NCT00509925|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
25046|NCT00509899|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the first publication, the Institution and/or Principal Investigator may publish data or results from the Study; provided, however, that the Institution and/or Principal Investigator submits the proposed publication to the Sponsor for review at least sixty (60) days prior to the date of the proposed publication. Sponsor may remove from the proposed publication any information that is considered confidential and/or proprietary other than Study data and results.
25047|NCT00509873|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
25048|NCT00509795|Principal Investigators are NOT employed by the organization sponsoring the study.|After completion of the trial, the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review; provided that the sponsor can remove confidential or proprietary information from such communications. The sponsor cannot require other changes to the communication and cannot extend the embargo.
25049|NCT00509769|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25050|NCT00509600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25051|NCT00509587|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25052|NCT00509496|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25053|NCT00509392|Principal Investigators are NOT employed by the organization sponsoring the study.|The data/info related to Study are legal property of VNUS & can be used by PI for publication, communication or scientific presentation only after duly informing VNUS of proposed dissemination, providing to VNUS for review/comment a copy of said proposed publication, communication or scientific presentation & allowing at least 30 days from the time of receipt by VNUS for VNUS to provide comment on said proposed publication, communication or scientific presentation prior to said dissemination.
25054|NCT00509366|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25055|NCT00509288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25056|NCT00509262|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
25057|NCT00509249|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25058|NCT00509236|Principal Investigators are NOT employed by the organization sponsoring the study.|Subsequent to the multicenter publication, or 24 months after completion of the study, whichever comes first, an investigator and/or colleagues may publish the results for their study site independently. The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
25059|NCT00509223|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25060|NCT00509197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25061|NCT00509106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25062|NCT00509067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25063|NCT00509041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25064|NCT00509028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25065|NCT00509002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25066|NCT00508924|Principal Investigators are NOT employed by the organization sponsoring the study.|
25067|NCT00508872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25068|NCT00508820|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
25069|NCT00508755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25070|NCT00508742|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25071|NCT00508716|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25072|NCT00508651|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it is understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
25073|NCT00508521|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25074|NCT00508482|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25075|NCT00508469|Principal Investigators are NOT employed by the organization sponsoring the study.|
25076|NCT00508404|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
25077|NCT00508391|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25078|NCT00508274|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
25079|NCT00508183|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25080|NCT00508157|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25081|NCT00508144|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25082|NCT00508118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25083|NCT00508027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25084|NCT00508001|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
25085|NCT00507819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25086|NCT00507767|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25087|NCT00507689|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
25088|NCT00507559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25089|NCT00507546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25090|NCT00507507|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
25091|NCT00507455|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site only after Sponsor‘s prior written consent.
25092|NCT00507442|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25093|NCT00507429|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25094|NCT00507416|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi-site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
25095|NCT00507208|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25096|NCT00507130|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
25097|NCT00506948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25098|NCT00506922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25099|NCT00506883|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25100|NCT00506857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25101|NCT00506831|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25102|NCT00506714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25103|NCT00506675|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25104|NCT00506662|Principal Investigators are NOT employed by the organization sponsoring the study.|The Steering Committee has the right to publish the entire results of the trial. Any such scientific paper, presentation, communication, or other information concerning the investigation described in this protocol, must be approved by the Steering Committee, and copies submitted in writing to Novo Nordisk prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
25105|NCT00506597|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25106|NCT00506493|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25107|NCT00506454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25108|NCT00506441|Principal Investigators are NOT employed by the organization sponsoring the study.|
25109|NCT00506415|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
25110|NCT00506389|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the Sponsor, at least 6 weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
25111|NCT00506350|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25112|NCT00506285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25113|NCT00506155|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25114|NCT00506077|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25115|NCT00506064|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25116|NCT00506025|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25117|NCT00505934|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
25118|NCT00505921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25119|NCT00505895|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25120|NCT00505778|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25121|NCT00505765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25122|NCT00505752|Principal Investigators are NOT employed by the organization sponsoring the study.|
25123|NCT00505687|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
25124|NCT00505661|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25125|NCT00505635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25126|NCT00505622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25127|NCT00505518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25128|NCT00505414|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor and the Sponsor's designee reserves the right to review any publication pertaining to the trial at least 30 days before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
25129|NCT00505375|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25130|NCT00505362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25131|NCT00505284|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25132|NCT00505076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25133|NCT00504985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25134|NCT00504894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25135|NCT00504881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25136|NCT00504777|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25137|NCT00504751|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25138|NCT00504725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25139|NCT00504660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25140|NCT00504595|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25141|NCT00504556|Principal Investigators are NOT employed by the organization sponsoring the study.|A study site may not publish results of a study until after a coordinated multicenter publication has been submitted for publication or until one year after the study has ended, whichever occurs first. The study site will have the opportunity to publish results of the study, provided Daiichi Sankyo has had the opportunity to review and comment on the study site’s proposed publication prior to being submitted for publication with the advice of patent council and need for subject protection.
25142|NCT00504504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25143|NCT00504426|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25144|NCT00504309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25145|NCT00504257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25146|NCT00504231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25147|NCT00504166|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25148|NCT00504153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25149|NCT00504075|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the Study results will be allowed only with prior written approval from Sponsor, said consent not to be unreasonably withheld. At the request of Sponsor, the Institution and/or Investigator shall delete any Confidential Information pertaining to Sponsor's Inventions from any proposed publications prior to submitting or presenting the materials. Any and all publications will give appropriate recognition of any support received from Sponsor.
25150|NCT00504023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25151|NCT00503997|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25152|NCT00503984|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25153|NCT00503906|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25154|NCT00503880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25155|NCT00503841|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25156|NCT00503776|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25157|NCT00503750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25158|NCT00503698|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any investigator plans for publication and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
25159|NCT00503425|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25160|NCT00503399|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25161|NCT00503308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25162|NCT00503139|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25163|NCT00503113|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25164|NCT00503009|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25165|NCT00502996|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
25166|NCT00502944|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25167|NCT00502905|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25168|NCT00502853|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25169|NCT00502840|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25170|NCT00502801|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25171|NCT00502775|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25172|NCT00502697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25173|NCT00502671|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25174|NCT00502593|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25175|NCT00502320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25176|NCT00502242|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25177|NCT00502216|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25178|NCT00502203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25179|NCT00501995|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25180|NCT00501969|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
25181|NCT00501943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25182|NCT00501891|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25183|NCT00501852|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25184|NCT00501644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25227|NCT00499343|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25185|NCT00501631|Principal Investigators are NOT employed by the organization sponsoring the study.|No individual Investigator may publish results without written agreement from Alkermes. Should an Investigator wish to publish or present the data at a meeting, a copy of the manuscript or abstract must be provided to the Sponsor at least 30 days prior to the submission for review and approval. Any revisions will be negotiated in good faith by the Investigator and Sponsor.
25186|NCT00501592|Principal Investigators are NOT employed by the organization sponsoring the study.|All proposed publications based on this study shall be approved by the Sponsor prior to submission for publication. Such approval will not be unreasonably witheld. Publications will reflect the contributions made by the Investigators, Sponsor personnel and other groups involved in the study.
25187|NCT00501540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25188|NCT00501345|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25189|NCT00501293|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
25190|NCT00501228|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25191|NCT00501085|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25192|NCT00501059|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25193|NCT00501046|Principal Investigators are NOT employed by the organization sponsoring the study.|
25194|NCT00501007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25195|NCT00500760|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
25196|NCT00500682|Principal Investigators are NOT employed by the organization sponsoring the study.|
25197|NCT00500656|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25198|NCT00500578|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25199|NCT00500539|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or the publication of the trial results in their entirety.
25200|NCT00500448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25201|NCT00500370|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25202|NCT00500357|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25203|NCT00500331|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25204|NCT00500318|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of the Sponsor. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and the Sponsor."
25228|NCT00499252|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25205|NCT00500292|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
25206|NCT00500240|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25207|NCT00500149|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after SPONSOR confirms there shall be no multicenter Study publication, the INSTITUTION and/or such PRINCIPAL INVESTIGATOR may publish the results from the INSTITUTION site individually.
25208|NCT00500110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25209|NCT00500071|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
25210|NCT00499915|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25211|NCT00499889|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25212|NCT00499863|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
25213|NCT00500266|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25214|NCT00499746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25215|NCT00499694|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25216|NCT00499681|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25217|NCT00499655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25218|NCT00499616|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
25219|NCT00499603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25220|NCT00499590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25221|NCT00499486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25222|NCT00499473|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25223|NCT00499460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25224|NCT00499447|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25225|NCT00499408|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25226|NCT00499369|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25229|NCT00499122|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25230|NCT00499109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25231|NCT00499096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25232|NCT00499031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25233|NCT00498940|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25234|NCT00498927|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25235|NCT00498797|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
25236|NCT00498706|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25237|NCT00498628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25238|NCT00498615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25239|NCT00498602|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25240|NCT00498550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25241|NCT00498485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25242|NCT00498433|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
25243|NCT00498368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25244|NCT00498355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25245|NCT00498186|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
25246|NCT00498173|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25247|NCT00497874|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25248|NCT00497796|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
25249|NCT00497770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25250|NCT00497198|Principal Investigators are NOT employed by the organization sponsoring the study.|
25251|NCT00497146|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
25252|NCT00497081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25253|NCT00497055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25254|NCT00496964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25255|NCT00496873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25256|NCT00496860|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25257|NCT00496834|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25258|NCT00496808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25259|NCT00496782|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25260|NCT00496769|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25261|NCT00496730|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25262|NCT00496626|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25263|NCT00496587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25264|NCT00496483|Principal Investigators are NOT employed by the organization sponsoring the study.|The study is a multicenter collaborative investigation and the clinical trial results are to be published as a collaborative manuscript. Authorship will reflect varying levels of individual contribution to the study by the individual PI’s.
25265|NCT00496470|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to any publication or disclosure, the PI provides AstraZeneca with preliminary data and drafts and with the proposed final manuscript. AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript to review it and may within such time frame require that submission for publication or disclosure be delayed.
25266|NCT00496379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25267|NCT00496366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25268|NCT00496340|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25269|NCT00496262|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.
25290|NCT00494806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25270|NCT00496197|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25271|NCT00496080|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25272|NCT00496054|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25273|NCT00495820|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25274|NCT00495794|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25275|NCT00495755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25276|NCT00495677|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25277|NCT00495625|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25278|NCT00495612|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25279|NCT00495586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25280|NCT00495521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25281|NCT00495495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25282|NCT00495469|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25283|NCT00495391|Principal Investigators are NOT employed by the organization sponsoring the study.|Presentation and/or publication is encouraged provided the Sponsor is notified in advance and given the opportunity to review the manuscript or abstract 30 days prior to its submission for presentation at a scientific meeting or for publication in a scientific journal. The investigators will have complete autonomy regarding the content and wording including the decision of whether or not to publish.
25284|NCT00495222|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25285|NCT00495157|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25286|NCT00495131|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25287|NCT00495079|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25288|NCT00494975|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25289|NCT00494871|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25291|NCT00494780|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25292|NCT00494676|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25293|NCT00494585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25294|NCT00494507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25295|NCT00494494|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25296|NCT00494481|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
25297|NCT00494442|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review and comment prior to publication. In order to ensure that the Sponsor will be able to make comments and suggestions where pertinent, material for public dissemination will be submittted to the Sponsor for review at least sixty (60) days prior to submission for publication, public dissemination, or review by a publication committee
25298|NCT00494299|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25299|NCT00494234|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25300|NCT00494221|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
25301|NCT00494143|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25302|NCT00494091|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25303|NCT00494026|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25304|NCT00494013|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25305|NCT00493974|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25306|NCT00493805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25307|NCT00493779|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25308|NCT00493649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25309|NCT00493636|Principal Investigators are NOT employed by the organization sponsoring the study.|"Onyx has the right to require the deletion of any Confidential Information in a publication. If Onyx believes that information contained in the publication is patentable and communicates that in writing, the submission/delivery of the publication may be delayed for up to 60 additional days to allow for the filing of a United States (and any other appropriate) patent application(s)."
25310|NCT00493454|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25311|NCT00493311|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish only after cooperative publication or 18 months after sponsor's final evaluation of study data, whichever occurs first. At least 60 days prior to submission for publication, investigator must submit manuscript to sponsor for review and comment. Sponsor has 60 day period thereafter to respond with comment. Investigator will remove confidential information at the request of sponsor.
25312|NCT00493285|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it is understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
25313|NCT00493246|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator may publish 18 months after Cadence's final evaluation of all study data from all sites, whichever occurs first.Manuscripts/abstracts will be provided to Cadence for review and comment at least 30 days prior to submission.Cadence shall have 30 days to respond with comments.
25314|NCT00493220|Principal Investigators are NOT employed by the organization sponsoring the study.|For this study, Baxter requires a review of any planned PI results communications (eg, for confidential information) up to 90 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (eg, to allow for intellectual property protection).
25315|NCT00493181|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25316|NCT00493038|Principal Investigators are NOT employed by the organization sponsoring the study.|"The results of the trial as well as any discoveries and inventions, are exclusive property of the Promoter.~Publications on scientific review, comments or presentations about the study in scientific environment must be agreed between the Sponsor and the investigator who engages to submit to Bayer, any publication by sending one text or presentations at least 60 days before the expected publication for comments and corrections."
25317|NCT00493012|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25318|NCT00492973|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25319|NCT00492856|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25320|NCT00492752|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator must send a draft manuscript to be submitted for publication or to be presented or abstract to Bayer at least 60 days in advance of submission in order to obtain approval prior to submission of the final version for publication or presentation. In case of a difference of opinion between Bayer and the Investigator(s), the contents of the publication will be discussed in order to find a solution, which satisfies both parties.
25321|NCT00492726|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreed point of publication is 12/18 months after database lock at the earliest. Bayer will have up to 30/45 days to review publications and may request an additional publication delay of up to 60 days to allow for filing a patent application (if applicable). No publication of single center data should be done prior of publication if multi-center data.
25322|NCT00492622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25323|NCT00492583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25324|NCT00492557|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25325|NCT00492544|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25326|NCT00492531|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25327|NCT00492401|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25328|NCT00492349|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25329|NCT00492336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25330|NCT00492297|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication will be discussed with the sponsor prior to release and written consent of the sponsor will be obtained. A draft manuscript of the publication or abstract must be sent to sponsor thirty days in advance of submission.
25331|NCT00492284|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication materials will be reviewed and commented on by the Sponsor prior to submission for publication; Names of all Investigators and Sponsor representatives responsible for study design and analysis of results will be disclosed in the publication.
25332|NCT00492232|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period up to 150 days to permit actions necessary to preserve sponsor's intellectual property; can request changes to the results communication only for the purpose of removing non study related information that is proprietary and confidential to sponsor; can require delay of a results communication until the study has been completed at all participating sites.
25333|NCT00492206|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25334|NCT00492089|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25335|NCT00492063|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25336|NCT00492024|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25337|NCT00491894|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
25338|NCT00491829|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25339|NCT00491764|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must provide to sponsor 45 days prior to submission for publication/presentation, review copies of content to be presented that contains any results of the study. The sponsor has the right to review/comment with regard to proprietary information, accuracy, and fair balance. If disagreements arise concerning appropriateness of content to be presented, investigator must meet with sponsor prior to submission for publication to make good faith efforts to discuss/resolve any issues/disagreement.
25340|NCT00491738|Principal Investigators are NOT employed by the organization sponsoring the study.|
25341|NCT00491608|Principal Investigators are NOT employed by the organization sponsoring the study.|ZymoGenetics (ZG) agreements vary by trial, but each states that presentation/publication (p/p) cannot disclose Confidential Information (CI), excluding trial results; p/p may not begin until the earlier of 18 months after study end, ZG/lead investigator publishes, or ZG notification that multicenter publication is not planned; ZG has specified time for draft review before submission/presentation and may delay or modify content, require CI removal, and delay p/p for patent application filing.
25342|NCT00491556|Principal Investigators are NOT employed by the organization sponsoring the study.|The Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by the protocol team and AMLG.
25343|NCT00491530|Principal Investigators are NOT employed by the organization sponsoring the study.|Provide ABBOTT at least sixty (60) days prior to submission for review, ABBOTT shall return comments within sixty (60) days of receipt of draft. Proposed draft shall be delayed an additional sixty (60) days in addition to the Review Period.
25344|NCT00491504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's represnetatives will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
25345|NCT00491400|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25346|NCT00491387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25347|NCT00491374|Principal Investigators are NOT employed by the organization sponsoring the study.|
25348|NCT00491322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25349|NCT00491244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25350|NCT00491179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25351|NCT00491075|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25352|NCT00490971|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25353|NCT00490945|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25354|NCT00490919|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25355|NCT00490841|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25356|NCT00490815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25357|NCT00490802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25358|NCT00490724|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on PI is that the Sponsor can review results communications prior to public release and can embargo communications regarding results for a period as the Sponsor requires.
25359|NCT00490698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25360|NCT00490646|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25361|NCT00490568|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25362|NCT00490555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25363|NCT00490542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25364|NCT00490490|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25365|NCT00490477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25366|NCT00490451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25367|NCT00490269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25368|NCT00490256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25369|NCT00490139|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
25370|NCT00490100|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25371|NCT00490061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25372|NCT00490035|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25373|NCT00490022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25374|NCT00490009|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25375|NCT00489970|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25376|NCT00489866|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25377|NCT00489853|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to any publication or disclosure, the PI provides AstraZeneca with preliminary data and drafts and with the proposed final manuscript. AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript to review it and may within such time frame require that submission for publication or disclosure be delayed.
25378|NCT00489736|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such publication for comment at least 45 days before any submission for publication. If requested by the Sponsor, any submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
25379|NCT00489554|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25380|NCT00489541|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
25381|NCT00489489|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator can publish only the results of the work performed pursuant to this protocol. Prior to publication, the investigator provides the sponsor with the manuscript for review and comment at least 45 days in advance of its submission for publication.~The sponsor can require the investigator to withhold publication an additional 90 days to allow for filing a patent application or taking such other measures as sponsor deems appropriate to establish and preserve its proprietary rights."
25382|NCT00489476|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25383|NCT00489424|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25384|NCT00489411|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25385|NCT00489359|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25386|NCT00489268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25387|NCT00489255|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25388|NCT00489216|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25389|NCT00489086|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25390|NCT00488865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25391|NCT00488826|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
25392|NCT00488774|Principal Investigators are NOT employed by the organization sponsoring the study.|Twelve months after study ends, Sponsor will be provided with a copy of materials at least 45 days prior to submission, with details of proposed date, journal or conference name of publication & it will have 30 days post receipt to send written request that publication be delayed on the basis it exposes intellectual property that requires propriety protection but it will be only for 60 days after which Investigator will be free to publish. The participation of Sponsor will be acknowledged.
25393|NCT00488683|Principal Investigators are NOT employed by the organization sponsoring the study.|the terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25394|NCT00488644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25395|NCT00488631|Principal Investigators are NOT employed by the organization sponsoring the study.|12 months after study ends, sponsor will be provided with a copy of the materials at least 45 days prior to submission, with details of proposed date, journal or conference name of publication & it will have 30 days post receipt to send a written request that the publication be delayed on the basis it exposes intellectual property that requires propriety protection but it will be only for 60 days after which investigator will be free to publish. The participation of sponsor will be acknowledged.
25396|NCT00488618|Principal Investigators are NOT employed by the organization sponsoring the study.|"All data generated in this study will be the property of Forest Research Institute, Inc. An integrated clinical and statistical report will be prepared at the completion of the study.~Publication of the results by the Investigator will be subject to mutual agreement between the Investigator and Forest Research Institute, Inc."
25397|NCT00488592|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25398|NCT00488514|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25399|NCT00488488|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25400|NCT00488475|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25401|NCT00488345|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25402|NCT00488319|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. Expedited reviews will be arranged for abstracts, poster presentations, or other materials. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application.
25403|NCT00488293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25404|NCT00488059|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25405|NCT00488033|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25406|NCT00487981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25407|NCT00487942|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25408|NCT00487825|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25409|NCT00487747|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25410|NCT00487721|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25411|NCT00487695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25412|NCT00487669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25413|NCT00487578|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study data collected by Investigator is authorized subject to the following:Investigator is free to publish results of its part of study in collaboration with other investigators subsequent to the multicenter publication issued by Clinvest. If no multicenter publication is submitted within 12 months of end of study, investigator may publish results of its data. Investigator shall submit a copy of manuscript or abstract to Clinvest for review 30 days prior to journal submission.
25414|NCT00487565|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25415|NCT00487552|Principal Investigators are NOT employed by the organization sponsoring the study.|Each PI/site is restricted from making any publication until the multi-center publication has been presented (published) or 12 months after conclusion/abandonment/or termination of the Study (in the case where the multi-center publication has not been submitted within the 12 months) or Cook confirms there will be no multi-center publication.
25416|NCT00487539|Principal Investigators are NOT employed by the organization sponsoring the study.|12 months after study ends, Sponsor will be provided with a copy of the materials at least 45 days prior to submission, with details of proposed date, journal or conference name of publication & it will have 30 days post receipt to send a written request that the publication be delayed on the basis it exposes intellectual property that requires propriety protection but it will be only for 60 days after which Investigator will be free to publish. The participation of Sponsor will be acknowledged.
25417|NCT00487461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25418|NCT00487435|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25419|NCT00487396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25420|NCT00487279|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be reviewed by the Sponsor, Executive Sterring Committe and the Publications Committee at least 30 days prior to submittal. In the event that no multi-center study publication occurs within 12 months of study completion, investigators may publish the restuls of the study data from those subjects enrolled in a study at the Institution provided the Sponsor, Executive Steering Committee and Publicaiton Committee review at least 30 days prior to submittal.
25421|NCT00487240|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25422|NCT00487188|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25423|NCT00487162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25424|NCT00487084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25425|NCT00486954|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25426|NCT00486902|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25427|NCT00486863|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25428|NCT00486837|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the Investigator(s), the contents of the publication will be discussed in order to find a solution which satisfies both parties.
25429|NCT00486811|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor and the Sponsor's designee reserves the right to review any publication pertaining to the trial at least 30 days before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
25430|NCT00486759|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25431|NCT00486720|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25432|NCT00486642|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25433|NCT00486525|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25434|NCT00486447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25435|NCT00486434|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25436|NCT00486330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25437|NCT00486291|Principal Investigators are NOT employed by the organization sponsoring the study.|After Sponsor's written notification that publication of results is no longer planned or 12 months after termination of the study at all sites, Institution & PI may publish, upon written approval from Sponsor, results of the Study. Sponsor will be given the opportunity to review any proposed publication at least 60 days prior to submission for publication or disclosure. Upon Sponsor's written request, Institution and PI shall not publish or disclose information related to the Study.
25438|NCT00486278|Principal Investigators are NOT employed by the organization sponsoring the study.|The information obtained during the conduct of this trial is considered confidential and can be used by Novo Nordisk for regulatory purposes and for the general development of the trial product. The information obtained during this trial may be made available to other physicians who are conducting other clinical trials with the trial product, if deemed necessary by Novo Nordisk.
25439|NCT00486265|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to provide a copy of the publication to AZ for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ authorized MC publication or a period up to 18 months from study completion at all sites. AZ has the right to request delays: up to 60 days for confidential information, and an additional 90 days to protect intellectual property.
25440|NCT00486252|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
25441|NCT00486226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25442|NCT00486044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25443|NCT00486031|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25444|NCT00486018|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25445|NCT00485953|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25446|NCT00485836|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25447|NCT00485758|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25448|NCT00485732|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25449|NCT00485693|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25450|NCT00485485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25451|NCT00485472|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
25452|NCT00485433|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25453|NCT00485303|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25454|NCT00485264|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
25455|NCT00485173|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25456|NCT00485134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25457|NCT00485069|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25458|NCT00484939|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25459|NCT00484679|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25460|NCT00484419|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor reflects the following restrictive language in the Clinical Study Agreements: If identified by DSI, any of DSI's confidential information as defined herein shall be deleted…Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by the Study Site."
25461|NCT00484393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25462|NCT00484315|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator shall have the right to publish the results, provided that before publishing, the PI shall submit copies of any proposed publication or presentation to Sponsor for review at least sixty (60) days in advance of submission for publication or presentation to a publisher or other third party. Sponsor reserves the right to delete any confidential information or other proprietary information of Sponsor from the proposed publication or presentation.
25463|NCT00484289|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25464|NCT00484185|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25465|NCT00484159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25466|NCT00484094|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25467|NCT00483938|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
25468|NCT00483756|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25469|NCT00483717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25470|NCT00483704|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
25471|NCT00483652|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
25472|NCT00483574|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
25473|NCT00483548|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25474|NCT00483496|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications relating to the TRIAL and results therefrom are subject to prior mutual agreement of the SPONSOR and the INVESTIGATOR.
25475|NCT00483405|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25476|NCT00483379|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI will delay submission of a publication until the earlier of; (i) publication of the multi-center data by Genzyme (ii)12-24 months after study completion or termination of the Study at all sites, or (iii) Genzyme notification that a publication will not occur. PI will send Genzyme a draft 60 days before publication. Genzyme can defer publication 90-120 days upon notifying PI that it will file a patent application on inventions contained in the draft.
25477|NCT00483327|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25478|NCT00483262|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25479|NCT00483223|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25480|NCT00483184|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25481|NCT00483119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25482|NCT00483041|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
25483|NCT00483002|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25484|NCT00482911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25485|NCT00482729|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25486|NCT00482703|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25487|NCT00482677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25488|NCT00482625|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25489|NCT00482612|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications must be based on data validated and released by the Sponsor. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the Sponsor, at least 6 weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
25490|NCT00482547|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25491|NCT00482391|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25492|NCT00482274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25493|NCT00482170|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25494|NCT00482053|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25495|NCT00482014|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25496|NCT00481988|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25497|NCT00481871|Principal Investigators are NOT employed by the organization sponsoring the study.|Allos agreements with investigators (PIs) may vary. The PI may publish/make public data from the trial after the earlier of publication by Allos or 18 months after study completion. Allos can review results communications prior to public release and can embargo communications regarding trial results for a period less than or equal to 90 days from submission for review. Allos can request changes to the communication related to confidential or patent information, or to ensure accuracy.
25498|NCT00481845|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25499|NCT00481832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25500|NCT00481767|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25501|NCT00481676|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. any publications from a single-site are postponed until the publication of the pooled date (ie, data from all sites) in the clinical trial.
25502|NCT00481507|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25503|NCT00481351|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25504|NCT00481247|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25505|NCT00481195|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25506|NCT00481078|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25507|NCT00481065|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25508|NCT00480987|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25509|NCT00480857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25510|NCT00480779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25511|NCT00480740|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25512|NCT00480636|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25513|NCT00480532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25514|NCT00480493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25515|NCT00480324|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25554|NCT00477633|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25516|NCT00479882|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
25517|NCT00479856|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25518|NCT00479765|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25519|NCT00479713|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25520|NCT00479674|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25521|NCT00479557|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25522|NCT00479466|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25523|NCT00479401|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
25524|NCT00479388|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25525|NCT00479336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25526|NCT00479258|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
25527|NCT00479232|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
25528|NCT00479154|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25529|NCT00479089|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25530|NCT00479037|Principal Investigators are NOT employed by the organization sponsoring the study.|After publication of the results or 24 months after Clinical Trial Report has been finalised, whichever comes first, Nycomed acknowledge the Investigator's rights to publish results from this trial. Any such scientific paper, presentation, communication, or other information concerning the investigation described in this protocol, must be submitted to Nycomed prior to submission for publication/presentation for review. Review comments will be given within a month from receipt of the manuscript.
25531|NCT00478933|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25532|NCT00478881|Principal Investigators are NOT employed by the organization sponsoring the study.|Publishing incl confidential information only after Bayer written approval. Manuscript to Bayer 60 days before submission. Confidential Information to be deleted. Other Bayer comments to be considered, if they do not alter the scientific character. If no Bayer comment within 45 days, consider approval given. If multisite study Principal Investigator (PI) not to independently publish results before publication of multisite paper, but PI not restricted from 24 months from study completion onwards.
25533|NCT00478777|Principal Investigators are NOT employed by the organization sponsoring the study.|"Multicenter publication must include input from investigators and Celgene, agreement to be established before publication. It has priority over subset (single center) publication, for duration of 1 year after study completion.~Individual investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. In this case, Celgene has the right to comment and right to ask delay of publication for 90 days."
25534|NCT00478673|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The sponsor can require changes to the communication to remove any confidential information or other proprietary information of Sponsor.
25535|NCT00478647|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire's agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial's multi-center publication.
25536|NCT00478608|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
25537|NCT00478569|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study related publication will be multi-center or single-center publications. All proposed site publications and presentations will be submitted to (sponsor) NPS Pharmaceuticals for review in advance of publication.
25538|NCT00478556|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25539|NCT00478335|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25540|NCT00478257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25541|NCT00478244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25542|NCT00478231|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25543|NCT00478218|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25544|NCT00478205|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25545|NCT00478192|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
25546|NCT00478140|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25547|NCT00478062|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25548|NCT00478036|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25549|NCT00478023|Principal Investigators are NOT employed by the organization sponsoring the study.|Grünenthal GmbH reserves the right to review any publication pertaining to the trial before it is submitted for publication. Neither Grünenthal nor the coordinating Investigator/Investigator has the right to prohibit publication unless publication can be shown to affect possible patent rights.
25550|NCT00477971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25551|NCT00477750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25552|NCT00477685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25553|NCT00477672|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish the study results, relative to his/her own patients, only after review, comment and approval by the sponsor. No publication of confidential information shall be made without the sponsor’s prior written consent. At least 60 days prior to submitting a manuscript or prior to any public presentation, a copy of the manuscript or presentation will be provided to the sponsor for review and comment. The sponsor has 60 days to review and comment.
25555|NCT00477607|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25556|NCT00477594|Principal Investigators are NOT employed by the organization sponsoring the study.|After the multicenter publication or 12 months after completion of the study the PI may publish the results of his/her data from the study. The PI shall provide the sponsor with an advance copy at least 60 days prior to planned submission and the Sponsor shall have 60 days to review (contracts have variable timeframes; maximum times are stated here). The sponsor may request the deletion of any confidential information, or a delay in submission for an additional period not to exceed 90 days.
25557|NCT00477490|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention
25558|NCT00477464|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25559|NCT00477451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25560|NCT00477386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25561|NCT00477334|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25562|NCT00477295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25563|NCT00477269|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
25564|NCT00477230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25565|NCT00477204|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review.
25566|NCT00477191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25567|NCT00477165|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25568|NCT00477152|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs vary per individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (eg, for confidential information) up to 90 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (eg, to allow for intellectual property protection).
25569|NCT00477087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25570|NCT00476957|Principal Investigators are NOT employed by the organization sponsoring the study.|For any publication or presentation of the Protected Materials or any portion thereof, a manuscript of the paper, abstract or other materials will be provided by Consultant to Sponsor for its approval at least sixty (60) days for manuscripts and thirty (30) days for presentations prior to outside submission. Medtronic shall have the right to request reasonable modifications of any manuscript or other materials to be published or presented.
25571|NCT00476827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25572|NCT00476788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25573|NCT00476645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25574|NCT00476593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25575|NCT00476476|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25576|NCT00476242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25577|NCT00476229|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25578|NCT00476151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25579|NCT00476086|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25580|NCT00476047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25581|NCT00476021|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25582|NCT00476008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25583|NCT00475904|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25584|NCT00475878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25585|NCT00475865|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator can publish only the results of the work performed pursuant to this protocol. Prior to publication, the investigator provides the sponsor with the manuscript for review and comment at least 45 days in advance of its submission for publication.~The sponsor can require the investigator to withhold publication an additional 90 days to allow for filing a patent application or taking such other measures as sponsor deems appropriate to establish and preserve its proprietary rights."
25586|NCT00475852|Principal Investigators are NOT employed by the organization sponsoring the study.|The Executive and Steering Committees is responsible for the creation, review, and submission of publications and presentations after study completion. The Investigator agrees that all data are the property of the Sponsors and subject to confidentiality and use restrictions until results are presented in the public domain. Publications or presentations must be submitted to the Sponsors and necessary committees for review before publication, public dissemination, or review by a third-parties.
25587|NCT00475787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25588|NCT00475735|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25589|NCT00475722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25590|NCT00475709|Principal Investigators are NOT employed by the organization sponsoring the study.|
25591|NCT00475670|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25592|NCT00475657|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25593|NCT00475501|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25594|NCT00475423|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25595|NCT00475332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25596|NCT00475319|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25597|NCT00475306|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25598|NCT00475241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25599|NCT00475228|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25600|NCT00475176|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25601|NCT00475150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25602|NCT00475085|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25603|NCT00475033|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25604|NCT00474994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25605|NCT00474968|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25606|NCT00474955|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25607|NCT00474929|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25608|NCT00474903|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25609|NCT00474851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25610|NCT00474812|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25611|NCT00474786|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25612|NCT00474760|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25613|NCT00474708|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
25614|NCT00474630|Principal Investigators are NOT employed by the organization sponsoring the study.|If not already published by Sponsor as part of a multi-center publication, 18 months after conclusion of the study at all study centers, PI may publish the results for PI’s study center individually. Prior to such publication, PI must provide Sponsor with at least 60 days to review and comment on the proposed publication. The review period may be extended by an additional 30 days upon request. Sponsor may delay publication for up to an additional 6 month period to file for patent protection.
25653|NCT00472082|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25615|NCT00474539|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
25616|NCT00474526|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25617|NCT00474487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25618|NCT00474383|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25619|NCT00474266|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25620|NCT00474240|Principal Investigators are NOT employed by the organization sponsoring the study.|Information is unavailable.
25621|NCT00474201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25622|NCT00474188|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present the data generated from the study provided that the investigator shall (i) furnish the sponsor with a copy of any proposed publication or presentation at least thirty (30) days in advance of the submission of such material, (ii) delete from such material any confidential information of the sponsor, and (iii) delay submission of same for up to sixty (60) days to permit the preparation and filing of intellectual property applications.
25623|NCT00474175|Principal Investigators are NOT employed by the organization sponsoring the study.|Wyeth has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25624|NCT00474123|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25625|NCT00474058|Principal Investigators are NOT employed by the organization sponsoring the study.|“UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.”
25626|NCT00474045|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk (NN) reserves the right not to release data until specified milestones, e.g. Clinical Trial Report is available. This includes the right not to release interim results, because the release of such information can invalidate the results of the trial. At the end of the trial, one or more manuscripts for publication will be prepared in collaboration between authors and NN. NN reserves the right to postpone publication and communication for a short time to protect intellectual property.
25627|NCT00473889|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25628|NCT00473876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25629|NCT00473837|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25630|NCT00473824|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25631|NCT00473746|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25632|NCT00473668|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25652|NCT00472199|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
25633|NCT00473655|Principal Investigators are NOT employed by the organization sponsoring the study.|PI has the right to publish Study results in scientific journals. PI may use the Study results but not publish any results until: the date of the first Study results publication or the end of the 18-month period following the completion of the Study. PI shall provide AZ with the material for review. AZ has the right to publish the Study results
25634|NCT00473642|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25635|NCT00473590|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25636|NCT00473564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25637|NCT00473512|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25638|NCT00473434|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25639|NCT00473382|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25640|NCT00473330|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25641|NCT00473265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25642|NCT00473083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25643|NCT00472849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25644|NCT00472797|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither Institution nor any Principal Investigators shall publish or present any results from such Study to any third parties until: (i) EMD Serono publishes the results from all sites participating in such Study; (ii) Institution receives notification from EMD Serono that publication of the multi-site results is no longer planned; or (iii) twenty-four (24) months following the completion of the multi-site study at all sites, whichever occurs first.
25645|NCT00472732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25646|NCT00472641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25647|NCT00472576|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25648|NCT00472446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25649|NCT00472420|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25650|NCT00472303|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor reserves the right to review any publication pertaining to the trial at least 30 days before it is submitted for publication. Neither party has the right to prohibit publication unless publication can be shown to affect possible patent rights.
25651|NCT00472290|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial resul
25654|NCT00472056|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25655|NCT00472030|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25656|NCT00471822|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25657|NCT00471718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25658|NCT00471705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25659|NCT00471536|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25660|NCT00471497|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
25661|NCT00471445|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25662|NCT00471380|Principal Investigators are NOT employed by the organization sponsoring the study.|Any formal presentation of data publication from this study has to be a joint presentation from both the Investigators and the Sponsor. Being the study multicentric, it is mandatory that the first publication is based on data from all the centres, analysed according to the protocol. Data from a single Centre can not be presented, unless there Is a formal agreement from the other Investigators and Alcon.
25663|NCT00471354|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25664|NCT00471328|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25665|NCT00471315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25666|NCT00471276|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25667|NCT00471237|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25668|NCT00471146|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25669|NCT00471107|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25670|NCT00471068|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25671|NCT00470847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25672|NCT00470834|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25673|NCT00470626|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25674|NCT00470600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25675|NCT00470548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25676|NCT00470535|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25677|NCT00470470|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25678|NCT00470418|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25679|NCT00470392|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25680|NCT00470366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25681|NCT00470301|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25682|NCT00470275|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
25683|NCT00470262|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25684|NCT00470184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25685|NCT00470158|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25686|NCT00470106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25687|NCT00470067|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25688|NCT00470054|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25689|NCT00469898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25690|NCT00469859|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
25691|NCT00469833|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25692|NCT00469508|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25693|NCT00469456|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential info. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in pub. On sponsor's request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub.
25694|NCT00469391|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25695|NCT00469274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25696|NCT00469209|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25697|NCT00469092|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk maintains the right to be informed of any plans for publications and to review any scientific paper, presentation, communication or other information concerning the investigation described in this protocol. Any such communication must be submitted in writing to the Novo Nordisk trial manager prior to submission for comments. Comments will be given within four weeks from receipt of the planned communication.
25698|NCT00469079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25699|NCT00468910|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25700|NCT00468858|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25701|NCT00468845|Principal Investigators are NOT employed by the organization sponsoring the study.|
25702|NCT00468819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25703|NCT00468728|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25704|NCT00468676|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25705|NCT00468650|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
25706|NCT00468585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25707|NCT00468559|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25708|NCT00468546|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
25709|NCT00468481|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25710|NCT00468312|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's represnetatives will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
25711|NCT00468299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25712|NCT00468286|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
25713|NCT00468208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25714|NCT00468143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25715|NCT00468104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25716|NCT00468052|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25717|NCT00467961|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25718|NCT00467896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25719|NCT00467870|Principal Investigators are NOT employed by the organization sponsoring the study.|
25720|NCT00467857|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications and presentations resulting from this multi-center trial sponsored by Kimberly-Clark must be approved by all investigators and the sponsor.
25721|NCT00467844|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25722|NCT00467831|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25723|NCT00467779|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25724|NCT00467753|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25725|NCT00467740|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
25726|NCT00467649|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25727|NCT00467610|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25728|NCT00467597|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25729|NCT00467584|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25730|NCT00467558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25731|NCT00467519|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
25732|NCT00467389|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25733|NCT00467363|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25734|NCT00467298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25735|NCT00467285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25736|NCT00467259|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25737|NCT00467077|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25738|NCT00467051|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
25739|NCT00467038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25740|NCT00466960|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25741|NCT00466947|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25742|NCT00466882|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25743|NCT00466817|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25744|NCT00466752|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25745|NCT00466687|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25746|NCT00466505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25747|NCT00466323|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25748|NCT00466310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25749|NCT00466206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25750|NCT00466193|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor agrees to review manuscripts within sixty (60) days prior to submission for publication. If sponsor determines the publication includes patentable subject matter, sponsor may take an additional sixty (60) days to permit the filing of any patent applications.
25751|NCT00466167|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
25752|NCT00465998|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25753|NCT00465985|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25754|NCT00465972|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25755|NCT00465894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25756|NCT00465816|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25757|NCT00465738|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 weeks before submission. Sponsor to give written opinion within 30 days. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
25758|NCT00465647|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25759|NCT00465569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25760|NCT00465530|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25761|NCT00465361|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25762|NCT00465179|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25763|NCT00465101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25764|NCT00465088|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to release; Sponsor shall receive up to 180 days for review. Differences shall be resolved in good faith through appropriate scientific debate.
25765|NCT00464945|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
25766|NCT00464815|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25767|NCT00464737|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
25768|NCT00464711|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25769|NCT00464698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25770|NCT00464685|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
25771|NCT00464672|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25772|NCT00464646|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25773|NCT00464568|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25774|NCT00464542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25775|NCT00464490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25776|NCT00464464|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25777|NCT00464438|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
25778|NCT00464334|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
25779|NCT00464308|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25819|NCT00462020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25780|NCT00464269|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25781|NCT00464204|Principal Investigators are NOT employed by the organization sponsoring the study.|All investigators agreed that there will be one or more publications describing the study and the results. No center or combination of centers will submit their results for publication separately. Highest recruiting centers and Fresenius Kabi will contribute authors. The writing of the manuscript will be a collaborative effort.
25782|NCT00464087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25783|NCT00463866|Principal Investigators are NOT employed by the organization sponsoring the study.|
25784|NCT00463840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25785|NCT00463801|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25786|NCT00463788|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25787|NCT00463606|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
25788|NCT00463580|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25789|NCT00463567|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25790|NCT00463437|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25791|NCT00463385|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
25792|NCT00463346|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25793|NCT00463229|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25794|NCT00463047|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25795|NCT00462982|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25796|NCT00462943|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
25797|NCT00462917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25798|NCT00462865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25799|NCT00462839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25800|NCT00462826|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25801|NCT00462748|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25802|NCT00462735|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25803|NCT00462722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25804|NCT00462709|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to sponsor for pre-review. If sponsor requests, PI must delete sponsor confidential information before publication and/or delay publication for 90 days so sponsor can file for patents or take other action to protect its patent rights.
25805|NCT00462670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25806|NCT00462644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25807|NCT00462605|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25808|NCT00462501|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25809|NCT00462462|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25810|NCT00462449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25811|NCT00462423|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25812|NCT00462384|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25813|NCT00462345|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25814|NCT00462332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25815|NCT00462306|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25816|NCT00462280|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25817|NCT00462228|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications and Copyrights: INSTITUTE will be free to publish papers dealing with final results of research under this Agreement, 90 days after submitting such papers to FOREST for review providing that INSTITUTE gives due regard to FOREST’s comments on the proposed publication.
25818|NCT00462072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25820|NCT00461981|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
25821|NCT00461851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25822|NCT00461812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25823|NCT00461786|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25824|NCT00461734|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25825|NCT00461708|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25826|NCT00461682|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25827|NCT00461630|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25828|NCT00461591|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication is the multi-center publication of Study results from all study sites. Other than the multi-center publication, site may publish an independent publication of data generated by site subject to Sponsor review rights (e.g., review for intellectual property, confidentiality).
25829|NCT00461513|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25830|NCT00461500|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25831|NCT00461331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25832|NCT00461305|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor will confirm the contents before disclosure.
25833|NCT00461292|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
25834|NCT00461253|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25835|NCT00461175|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25836|NCT00461123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25837|NCT00461097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25838|NCT00461045|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25839|NCT00461032|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25840|NCT00460993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25841|NCT00460811|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that publication cannot be made for 24 months from the date of final data lock of the study, the sponsor can review the publication prior to public release, sponsor requires a minimum 60 day review period for each publication, sponsor can request removal of confidential information of sponsor (not including results of trial), and sponsor can request an additional delay period of 60 days in order to protect potentially patentable information.
25842|NCT00460798|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25843|NCT00460746|Principal Investigators are NOT employed by the organization sponsoring the study.|If TTCA does not publish within 12 months after study conclusion or after TTCA confirms there will be no multicenter publication, Institution may publish their results from their site individually, provided TTCA has 60 day review for confidentiality and additional 60 day delay for patent application.
25844|NCT00460655|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25845|NCT00460603|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25846|NCT00460577|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25847|NCT00460564|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25848|NCT00460551|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site and the PI may be required to withhold the publication for up to 90 days. Subject to a reasoned request from the sponsor, the publication may be further delayed for a period up to 6 months from the date of first submission to the sponsor.~The sponsor has the right to require deletion of any trade secret, proprietary, or confidential information supplied by the sponsor to the site or the PI. The sponsor shall not otherwise have the right to censor publications."
25849|NCT00460525|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25850|NCT00460434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25851|NCT00460421|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (approximately up to 90 days). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
25852|NCT00460408|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25853|NCT00460265|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
25854|NCT00460239|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25855|NCT00460109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25856|NCT00460031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25857|NCT00459979|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25858|NCT00459953|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25859|NCT00459875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25860|NCT00459862|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25861|NCT00459810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25862|NCT00459732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25863|NCT00459706|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25864|NCT00459667|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is interested in the publication of the results of every study it performs. As some of the information concerning the study drug and the sponsor's development activities may be strictly confidential, any publication manuscript (including conference contributions, etc.) must first be reviewed by the sponsor before its submission or presentation. Publication of subgroup data and single center data shall not be performed until the complete study has been published.
25865|NCT00459537|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25866|NCT00459381|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25867|NCT00459368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25868|NCT00459355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25869|NCT00459342|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25870|NCT00459316|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
25871|NCT00459303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25872|NCT00459290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25873|NCT00459186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25874|NCT00459134|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25875|NCT00459121|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25876|NCT00459108|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25877|NCT00459056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25878|NCT00459043|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25879|NCT00458952|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25880|NCT00458822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25881|NCT00458705|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25882|NCT00458536|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25883|NCT00458406|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25884|NCT00458393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25885|NCT00458302|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (SP) shall have the 1st right to present the Data without approval from the Principal Investigator (PI). If no publication is submitted by SP within 12 months after closure, or after SP confirms there will be no publication, the PI shall have the right to publish. Prior to submission, the PI will provide the SP with at least 45 days for review of a manuscript. If requested, the PI will withhold such publication for up to an additional 60 days to allow for filing of a patent application
25886|NCT00458237|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25887|NCT00458211|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25888|NCT00457977|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25889|NCT00457951|Principal Investigators are NOT employed by the organization sponsoring the study.|Confidentiality and Non-Disclosure Agreement
25890|NCT00457821|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25891|NCT00457795|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
25892|NCT00457743|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
25893|NCT00457730|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25894|NCT00457691|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25895|NCT00457418|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator (PI) agrees not to publish/present any interim results of the study without Sponsor's prior written consent. The PI further agrees to provide to the sponsor 30 days prior to submission, review copies. The sponsor shall have editorial rights and the right to review and comment. If the parties disagree, PI agrees to meet with the sponsor's representatives for the purpose of making good faith efforts to discuss and resolve any such issues or disagreement.
25896|NCT00457392|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25897|NCT00457301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25898|NCT00457249|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
25899|NCT00457197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25900|NCT00457015|Principal Investigators are NOT employed by the organization sponsoring the study.|Dyax agreements vary, but Dyax will not prohibit any investigator from publishing. Dyax reviews publications prior to public release and can request deferral by up to 60 days beyond the proposed publication date if necessary to preserve its intellectual property. Dyax can request changes to publications to remove non-study-related confidential information. Dyax can also request deferral of single-center publications until after disclosure of the clinical trial's primary publication.
25901|NCT00457002|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25902|NCT00456989|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25903|NCT00456885|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25904|NCT00456846|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Celgene with a copy of the papers prior to their submission; Celgene shall complete its review within 60 days after receipt. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of patentable material.
25905|NCT00456807|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25906|NCT00456755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25907|NCT00456625|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25908|NCT00456612|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25909|NCT00456599|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25910|NCT00456547|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25911|NCT00456521|Principal Investigators are NOT employed by the organization sponsoring the study.|If not already published by Sponsor as part of a multi-center publication, 18 months after conclusion of the study at all study centers, PI may publish the results for PI’s study center individually. Prior to such publication, PI must provide Sponsor with at least 60 days to review and comment on the proposed publication. The review period may be extended by an additional 30 days upon request. Sponsor may delay publication for up to an additional 6 month period to file for patent protection.
25912|NCT00456508|Principal Investigators are NOT employed by the organization sponsoring the study.|Dyax agreements vary, but Dyax will not prohibit any investigator from publishing. Dyax reviews publications prior to public release and can request deferral by up to 60 days beyond the proposed publication date if necessary to preserve its intellectual property. Dyax can request changes to publications to remove non-study-related confidential information. Dyax can also request deferral of single-center publications until after disclosure of the clinical trial's primary publication.
25913|NCT00456495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25914|NCT00456365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25915|NCT00456261|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
25916|NCT00456014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25917|NCT00455975|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
25918|NCT00455962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25919|NCT00455923|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25920|NCT00455858|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, should be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
25921|NCT00455741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25922|NCT00455702|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25923|NCT00455663|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25924|NCT00455650|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25925|NCT00455533|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25926|NCT00455520|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication. The sponsor can embargo for an additional 60 days to allow for the filing of a patent application.
25927|NCT00455455|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25928|NCT00455429|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25929|NCT00455312|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25930|NCT00455195|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
25931|NCT00455013|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25932|NCT00454987|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25933|NCT00454909|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25988|NCT00451204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25934|NCT00454857|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
25935|NCT00454818|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25936|NCT00454805|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
25937|NCT00454779|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
25938|NCT00454649|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25939|NCT00454636|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25940|NCT00454584|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
25941|NCT00454571|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25942|NCT00454532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25943|NCT00454363|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25944|NCT00454324|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25945|NCT00454246|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."
25946|NCT00454207|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
25947|NCT00454194|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25948|NCT00454181|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25949|NCT00454142|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25989|NCT00451191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25950|NCT00454116|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
25951|NCT00454051|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
25952|NCT00453999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25953|NCT00453986|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25954|NCT00453973|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications may not contain Sponsor confidential information, and will be subject to Sponsor review prior to submission for publication.
25955|NCT00453479|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25956|NCT00453388|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25957|NCT00453362|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
25958|NCT00453349|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25959|NCT00453336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25960|NCT00453310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25961|NCT00453206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25962|NCT00453193|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25963|NCT00453180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25964|NCT00453154|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25965|NCT00453102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25966|NCT00453063|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
25967|NCT00452868|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25968|NCT00452790|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
25969|NCT00452699|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26242|NCT00436826|Principal Investigators are NOT employed by the organization sponsoring the study.|
25970|NCT00452673|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
25971|NCT00452543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25972|NCT00452530|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
25973|NCT00452452|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
25974|NCT00452426|Principal Investigators are NOT employed by the organization sponsoring the study.|
25975|NCT00452400|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
25976|NCT00452387|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publication or presentation of Sponsored Research results, Researcher agrees to provide Bayer with such presentation or manuscript at least 30 days prior to its submission for the sole purpose of allowing Bayer to redact confidential information and protect any existing or future patents. The Principal Investigator shall acknowledge Bayer contributions where appropriate.
25977|NCT00452374|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25978|NCT00452361|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
25979|NCT00452348|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25980|NCT00452335|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25981|NCT00452114|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25982|NCT00451958|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript. Additional time may be required to allow Ferring to seek patent protection of the invention.
25983|NCT00451906|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
25984|NCT00451698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25985|NCT00451451|Principal Investigators are NOT employed by the organization sponsoring the study.|The provisions of our agreement are subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication
25986|NCT00451321|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25987|NCT00451282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25990|NCT00451048|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25991|NCT00450983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25992|NCT00450866|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25993|NCT00450801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25994|NCT00450749|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
25995|NCT00450723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25996|NCT00450658|Principal Investigators are NOT employed by the organization sponsoring the study.|PI reserves the right to publish or otherwise make public the Study results provided that such communication occurs only after (i) the results of the multicenter Study in its entirety have been publicly disclosed by, or with consent of the sponsor or (ii) 18 months after conclusion of the Study at all sites, whichever comes first. Following this, PI can publish, present or use any non-confidential study results following Sponsor review. PI will not make public raw data or Case Reports.
25997|NCT00450619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
25998|NCT00450580|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
25999|NCT00450450|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
26000|NCT00450437|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26001|NCT00450424|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26002|NCT00450411|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
26003|NCT00450385|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26004|NCT00450372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26005|NCT00450333|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
26006|NCT00450294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26007|NCT00450255|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26008|NCT00450242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26009|NCT00450216|Principal Investigators are NOT employed by the organization sponsoring the study.|PI reserves the right to publish or otherwise make public the Study results provided that such communication occurs only after (i) the results of the multicenter Study in its entirety have been publicly disclosed by, or with consent of the sponsor or (ii) 18 months after conclusion of the Study at all sites, whichever comes first. Following this, PI can publish, present or use any non-confidential study results following Sponsor review. PI will not make public raw data or Case Reports.
26010|NCT00450112|Principal Investigators are NOT employed by the organization sponsoring the study.|SKK has the right to review the disclosures. Investigator shall not make any publication of study data, results or similar information without the express of permission of SKK.
26011|NCT00450073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26012|NCT00449956|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26013|NCT00449930|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26014|NCT00449865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26015|NCT00449787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26016|NCT00449748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26017|NCT00449696|Principal Investigators are NOT employed by the organization sponsoring the study.|SKK has the right to review the disclosures. Investigator shall not make any publication of study data, information, results or similar information without the express of permission of SKK.
26018|NCT00449644|Principal Investigators are NOT employed by the organization sponsoring the study.|It is the policy of the sponsor not to allow the investigators to publish their results or findings prior to the sponsor’s publication of the overall trial results.The investigator agrees that before he/she publishes any results of this trial, he/she shall provide the sponsor with at least 45 days for full review of the prepublication manuscript prior to submission of the manuscript to the publisher.
26019|NCT00449540|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26020|NCT00449176|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26021|NCT00449163|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26022|NCT00449150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26023|NCT00449072|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator can independently publish study results from his site after the primary publication by the steering committee, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
26024|NCT00449046|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26025|NCT00449033|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator, whilst free to use data from the study for scientific purposes, must not publish any document relating to the Trial without first notifying Bayer in writing and obtaining written consent. Bayer recognizes the right of the investigator to publish the results upon completion of the study. The investigator must send a draft manuscript of the publication or abstract to Bayer 60 days ahead of submission to obtain approval prior to submission of the final version for publication.
26026|NCT00448916|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26027|NCT00448864|Principal Investigators are NOT employed by the organization sponsoring the study.|
26028|NCT00448760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26029|NCT00448708|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26030|NCT00448682|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26280|NCT00434421|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26031|NCT00448630|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26032|NCT00448591|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26033|NCT00448539|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26034|NCT00448448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26035|NCT00448435|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit an investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not preceed the primary publication of the entire clinical trial.
26036|NCT00448357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26037|NCT00448344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26038|NCT00448279|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26039|NCT00448227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is typically a disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.
26040|NCT00448201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26041|NCT00448175|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26042|NCT00448136|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26043|NCT00448123|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26044|NCT00448019|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26045|NCT00447902|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
26046|NCT00447876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26047|NCT00447603|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
26048|NCT00447590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26049|NCT00447499|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26050|NCT00447421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26051|NCT00447382|Principal Investigators are NOT employed by the organization sponsoring the study.|One or more manuscripts for publication will be prepared in collaboration between Investigator(s) and Novo Nordisk. Novo Nordisk will not suppress or veto publications; however Novo Nordisk reserves the right to postpone publication and/or communication for a short time to protect intellectual property.
26052|NCT00447330|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26053|NCT00447278|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26054|NCT00447265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26055|NCT00447226|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26056|NCT00447122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26057|NCT00447057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26058|NCT00447005|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26059|NCT00446992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26060|NCT00446849|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
26061|NCT00446797|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26062|NCT00446654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26063|NCT00446641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26064|NCT00446563|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26065|NCT00446511|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26066|NCT00446459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26067|NCT00446446|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26068|NCT00446290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26069|NCT00446264|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26300|NCT00433654|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26070|NCT00446251|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26071|NCT00446199|Principal Investigators are NOT employed by the organization sponsoring the study.|(A) PI will provide copy to Sponsor at least (30) days prior to date of planned submission or presentation. Sponsor will have thirty (30) days to review and provide feedback. If proposed publication presents material adverse effect on the confidentiality of Sponsor's information, then PI shall delay or prevent such publication. (B) In a multi-center trial, the investigative data will be pooled and published as a collaborative effort with consent from all parties including the Sponsor.
26072|NCT00446147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26073|NCT00446134|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Valeant supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26074|NCT00446095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26075|NCT00446030|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 60 days in advance of any submission for publication. The Sponsor may request for the publication to be delayed for a limited time, not to exceed 90 days to preserve its proprietary rights.
26076|NCT00445939|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; most restrictive agreement states Medical Institution shall not disclose materials/information disclosed by Abbott Japan in connection with the Clinical Research, or information obtained by conducting the Clinical Research, to third parties without Abbott Japan’s prior written approval. When Medical Institution intends to publish information obtained by conducting the Clinical Research, Medical Institution shall obtain Abbott Japan’s prior written approval.
26077|NCT00445887|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26078|NCT00445848|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26079|NCT00445770|Principal Investigators are NOT employed by the organization sponsoring the study.|Wyeth has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26080|NCT00445744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26081|NCT00445705|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
26082|NCT00445692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26083|NCT00445679|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26084|NCT00445601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26085|NCT00445588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26086|NCT00445549|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26087|NCT00445484|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26355|NCT00429949|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26088|NCT00445458|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26089|NCT00445432|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
26090|NCT00445341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26091|NCT00445328|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26092|NCT00445315|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26093|NCT00445302|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 12 months after study completion. PI gives Genzyme a draft 30 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 90 days upon notifying PI that it will file a patent application on inventions contained in the draft.
26094|NCT00445263|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26095|NCT00445224|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26096|NCT00445211|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26097|NCT00445146|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
26098|NCT00445003|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26099|NCT00444951|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
26100|NCT00444925|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26101|NCT00444912|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
26102|NCT00444821|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26103|NCT00444795|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26104|NCT00444626|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigators (PI) will give Genzyme a draft manuscript or draft publication 60 days before publication. Genzyme will make every reasonable attempt to review publication or manuscript and give feedback in such 60 day period. PI will not use Genzyme confidential information without prior written consent.
26105|NCT00444600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26610|NCT00415519|Principal Investigators are NOT employed by the organization sponsoring the study.|
26106|NCT00444587|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
26107|NCT00444535|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
26108|NCT00444457|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26109|NCT00444275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26110|NCT00444145|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26111|NCT00444106|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26112|NCT00444067|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor can review results at least 30 days prior to public release, and at the request of Sponsor, the PI will withhold submission for an additional period, not to exceed 30 days.~The first publication of the study results shall be made in conjunction with a joint, multi-center publication of the results. If a multi-center publication is not submitted within 12 months after the conclusion of the study, the PI may publish the results from their individual site."
26113|NCT00443898|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26114|NCT00443872|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26115|NCT00443820|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26116|NCT00443781|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication, abstract, or presentation shall be submitted unless the multi-center report has been published. If report is not submitted within 24 months after completion, PI can present outcomes from their site. Proposed publications or presentations to be submitted to sponsor for review at least 60 days in advance. If proposed publication or presentation contains subject matter which is deemed to warrant intellectual property protection, sponsor may delay up to an additional 90 days.
26117|NCT00443755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26118|NCT00443729|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26119|NCT00443703|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26120|NCT00443651|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26121|NCT00443599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26122|NCT00443560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26123|NCT00443534|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26124|NCT00443456|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26125|NCT00443430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26126|NCT00443352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26127|NCT00443261|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26128|NCT00443209|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
26129|NCT00443118|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26130|NCT00443053|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26131|NCT00443040|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator understands and agrees that the first publication of the results of the Research Study, if any, shall be a multicenter publication of the results from all sites. Institution shall not publish, present, or use any results of the Research Study for any purpose until such Research Study has been completed in its entirety at all sites and until such multi-center study publication has been published or for a period of one year following such completion, whichever occurs first.
26132|NCT00442962|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
26133|NCT00442936|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
26134|NCT00442897|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26135|NCT00442702|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26136|NCT00442689|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26137|NCT00442611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26138|NCT00442598|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26139|NCT00442572|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26140|NCT00442559|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26141|NCT00442546|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26142|NCT00442507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26143|NCT00442468|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26144|NCT00442416|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26145|NCT00442364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26146|NCT00442351|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is not allowed to release any interim results of the Study without prior consent of the sponsor, and must provide 45 days written notice to the sponsor prior to public release to permit the sponsor's review. The PI can use the study results for his/her own teaching, research, and publication purposes only, not for commercial purposes, except as authorized by the sponsor. No publication shall contain any trade secret or proprietary/confidential information of the sponsor.
26147|NCT00442338|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26148|NCT00442286|Principal Investigators are NOT employed by the organization sponsoring the study.|The site must notify CVRx and a designated Publication Committee 30 days before submission. The complete text of the publication is required for review. If CVRx does not respond within 30 days of the date received by CVRx, the site may proceed with publication. If CVRx determines that there are changes to be made, the publication maybe delayed for up to 90 days. The site must not submit a publication without the satisfaction of the Publication Committee.
26149|NCT00442169|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
26150|NCT00442117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26151|NCT00442013|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26152|NCT00441974|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26153|NCT00441792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26154|NCT00441766|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
26155|NCT00441727|Principal Investigators are NOT employed by the organization sponsoring the study.|
26156|NCT00441701|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media, eg, any computer access system such as the Internet, World Wide Web, etc.) that report any results of the study.
26157|NCT00441584|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26158|NCT00441558|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26159|NCT00441545|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
26160|NCT00441480|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26161|NCT00441467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26162|NCT00441441|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26163|NCT00441363|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26164|NCT00441337|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26165|NCT00441285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26166|NCT00441272|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26167|NCT00441259|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
26168|NCT00441168|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26169|NCT00441142|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26170|NCT00441116|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will no prohibit any investigator form publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26171|NCT00441103|Principal Investigators are NOT employed by the organization sponsoring the study.|
26172|NCT00441090|Principal Investigators are NOT employed by the organization sponsoring the study.|
26173|NCT00441064|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or the publication of the trial results in their entirety.
26174|NCT00441012|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26175|NCT00440947|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26176|NCT00440830|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26177|NCT00440700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26178|NCT00440557|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restrictions on the PI are pre- review of publications prior to public release. Sponsor can embargo trial result publication for up to 120 days. The PI may not publish the sponsor's confidential information without consent. In multi-center trials, individual PI's may publish results only if the study group has not published results 12 months after study completion, abandonment, or termination. The sponsor cannot require changes to the scientific content and cannot extend the embargo.
26179|NCT00440531|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26180|NCT00440518|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
26181|NCT00440505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26182|NCT00440466|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
26183|NCT00440401|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26184|NCT00440310|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26185|NCT00440297|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26186|NCT00440271|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
26187|NCT00440232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26188|NCT00440193|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26189|NCT00440180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26190|NCT00440115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26191|NCT00440050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26192|NCT00440011|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26193|NCT00439946|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
26194|NCT00439777|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26195|NCT00439738|Principal Investigators are NOT employed by the organization sponsoring the study.|
26196|NCT00439725|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26197|NCT00439647|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or the publication of the trial results in their entirety.
26198|NCT00439608|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26199|NCT00439569|Principal Investigators are NOT employed by the organization sponsoring the study.|The Publication Policy for the National Institute of Neurological Disorders and Stroke (NINDS) Pilot Therapeutic Trials Network (NPTUNE) outlines procedures for the development and review of concept sheets, abstracts, publications,presentations. Investigators must submit an application to the NPTUNE Publications Committee for the use of data. A Writing Committee, appointed by the Publications Committee,is responsible for initiating, coordinating, and approving publications and presentations.
26200|NCT00439517|Principal Investigators are NOT employed by the organization sponsoring the study.|
26201|NCT00439413|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26202|NCT00439335|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26203|NCT00439309|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26204|NCT00439270|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26205|NCT00439244|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26206|NCT00439231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26207|NCT00439218|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators must submit an application to the NPTUNE Publications Committee for the use of data. A Writing Committee, appointed by the Publications Committee, is responsible for initiating, coordinating, and approving publications and presentations.
26208|NCT00439179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26209|NCT00439140|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
26210|NCT00438971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26211|NCT00438932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26212|NCT00438880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26213|NCT00438854|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26214|NCT00438815|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to sponsor for pre-review. If sponsor requests, PI must delete sponsor confidential information before publication and/or delay publication for 90 days so sponsor can file for patents or take other action to protect its patent rights.
26215|NCT00438802|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26216|NCT00438750|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26217|NCT00438672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26218|NCT00438659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26219|NCT00438490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26220|NCT00438464|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26221|NCT00438451|Principal Investigators are NOT employed by the organization sponsoring the study.|This study was supported (as investigator-initated trial) by an educational grant from UCB GmbH, Germany. A disclosure restriction applies on the PI in that UCB can review results communications prior to public release and can embargo communications regarding trial results for a period of 90 days from the time submitted. As of Jan-01-2012 the study chair is an employee to UCB Biosciences GmbH working as Medical Director in the Therapeutic Area CNS within Global Projects and Development.
26222|NCT00438399|Principal Investigators are NOT employed by the organization sponsoring the study.|Any intent of the investigator to publish or disclose in any way the information requires the sponsor's prior written approval. The investigator shall provide their draft of such publication to sponsor to review and approval at least 2 months prior to the date of intended publication. Sponsor shall have the absolute right to determine whether information may be published by the investigator.
26223|NCT00438360|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26224|NCT00438204|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26225|NCT00438191|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26226|NCT00438100|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26227|NCT00437983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26228|NCT00437645|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure Restriction Description: The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
26229|NCT00437489|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26230|NCT00437398|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26231|NCT00437281|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26232|NCT00437203|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26233|NCT00437125|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26234|NCT00437073|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26235|NCT00437034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26236|NCT00436982|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26237|NCT00436969|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26238|NCT00436956|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26239|NCT00436917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26240|NCT00436904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26241|NCT00436852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26243|NCT00436748|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26244|NCT00436644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26245|NCT00436618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26246|NCT00436605|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26247|NCT00436566|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26248|NCT00436553|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or until the publication of the trial results in their entirety.
26249|NCT00436501|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26250|NCT00436436|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26251|NCT00436345|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26252|NCT00436332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26253|NCT00436215|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26254|NCT00436163|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26255|NCT00436046|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26256|NCT00436007|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26257|NCT00435994|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26258|NCT00435942|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator must provide Bolton Medical with the proposed publication for review. Bolton Medical had 30 days to review and had discretion to make changes.
26259|NCT00435929|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
26260|NCT00435825|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26261|NCT00435812|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26262|NCT00435591|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
26263|NCT00435539|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26264|NCT00435487|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26265|NCT00435461|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26266|NCT00435409|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26267|NCT00435370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26268|NCT00435188|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26269|NCT00435162|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26270|NCT00435045|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26271|NCT00435019|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
26272|NCT00434993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26273|NCT00434967|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time require that submission for publication or disclosure of the manuscript be delayed in order for AstraZeneca to file patent applications.
26274|NCT00434954|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26275|NCT00434876|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26276|NCT00434759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26277|NCT00434642|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26278|NCT00434590|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26279|NCT00434434|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26281|NCT00434356|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study.
26282|NCT00434330|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications may not contain Sponsor confidential information, and will be subject to Sponsor review prior to submission for publication.
26283|NCT00434304|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26284|NCT00434278|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26285|NCT00434252|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26286|NCT00434226|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study.
26287|NCT00434213|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after SPONSOR confirms there shall be no multicenter Study publication, the INSTITUTION and/or such PRINCIPAL INVESTIGATOR may publish the results from the INSTITUTION site individually.
26288|NCT00434161|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
26289|NCT00434148|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
26290|NCT00434122|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restiction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
26291|NCT00434109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26292|NCT00434057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26293|NCT00434018|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26294|NCT00433992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26295|NCT00433966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26296|NCT00433914|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26297|NCT00433836|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26298|NCT00433771|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26299|NCT00433745|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26301|NCT00433550|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26302|NCT00433537|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26303|NCT00433446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26304|NCT00433381|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26305|NCT00433329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26306|NCT00433290|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26307|NCT00433199|Principal Investigators are NOT employed by the organization sponsoring the study.|At 60 days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy and allow Sponsor 60 days to review and comment.
26308|NCT00433160|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26309|NCT00433017|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26310|NCT00433004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26311|NCT00432991|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26312|NCT00432965|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26313|NCT00432835|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26314|NCT00432809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26315|NCT00432744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26316|NCT00432666|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 wks before submission. Sponsor to give written opinion within 30 d. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
26317|NCT00432601|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26318|NCT00432562|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of data related to the Study, including publication in special medical magazines, or the disclosure at medical congresses shall be previously authorized in writing by the Sponsor, whereby the Principal Investigator should present the material with an anticipation of not less than 60 days as from the publication or medical congress. The Sponsor decides upon the authorship of any publication related to the Study.
26319|NCT00432458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26320|NCT00432445|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26321|NCT00432380|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26322|NCT00432341|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release for a period that is not less than 60 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication.
26323|NCT00432276|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
26324|NCT00432237|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26325|NCT00432159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26326|NCT00432042|Principal Investigators are NOT employed by the organization sponsoring the study.|Sanofi Pasteur MSD shall have sixty days to review these documents and may refuse to give its consent in part or whole for confidential reasons (including but not limited to intellectual property rights, whether patentable or not).
26327|NCT00431964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26328|NCT00431951|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI must obtain the sponsor's written consent to publish any study results and must notify the sponsor within 30 working days prior to publishing.
26329|NCT00431847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26330|NCT00431834|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26331|NCT00431626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26332|NCT00431496|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26333|NCT00431444|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26334|NCT00431184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26335|NCT00431132|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication, or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
26336|NCT00431067|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
26337|NCT00431041|Principal Investigators are NOT employed by the organization sponsoring the study.|"PIs may not present or publish data prior to publication of the multicenter data or 12 months have elapsed following database lock.~Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of up to 90 days from the time submitted to the sponsor for review.~PIs may not engage in contacts with the media related to the study, study interventions or data without prior written consent."
26338|NCT00430950|Principal Investigators are NOT employed by the organization sponsoring the study.|Results of Study shall not be published without prior express written consent and approval of Sponsor. If Contractor wishes to use data generated at Sites by Investigator, such data includes but not limited to data used in collection of metrics, copy of any intended publication, details of use must be sent in writing to Quintiles and Sponsor for review. Sponsor has right to change proposed publication and/or prohibit publication and Contractor must comply with requirements of Sponsor
26339|NCT00430937|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26340|NCT00430781|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26341|NCT00430768|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26342|NCT00430755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26343|NCT00430716|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26344|NCT00430677|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
26345|NCT00430638|Principal Investigators are NOT employed by the organization sponsoring the study.|If identified by Daiichi Sankyo Inc.(DSI), any of DSI's confidential information, as defined to the author, shall be deleted. Nothing in our site agreement shall be taken as giving DSI any right of editorial control over any publication prepared by the study site.
26346|NCT00430625|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
26347|NCT00430573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26348|NCT00430508|Principal Investigators are NOT employed by the organization sponsoring the study.|Results of Study shall not be published without prior express written consent and approval of Sponsor. If Contractor wishes to use data generated at Sites by Investigator, such data includes but not limited to data used in collection of metrics, copy of any intended publication, details of use must be sent in writing to Quintiles and Sponsor for review. Sponsor has right to change proposed publication and/or prohibit publication and Contractor must comply with requirements of Sponsor
26349|NCT00430495|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publishing results, Institution and Principal Investigator (PI) must first provide Sponsor with a copy of proposed publication for review at least 30 days prior to submission. If Institution and PI do not agree to modification, they shall so notify Sponsor and postpone submission for additional 60 days to allow Sponsor to seek legal remedies or file patent applications. There is a need for coordinated approach to any publication of results from sites for any multi-site study.
26350|NCT00430352|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26351|NCT00430300|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26352|NCT00430248|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
26353|NCT00430092|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26354|NCT00430027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26356|NCT00429923|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26357|NCT00429793|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26358|NCT00429702|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26359|NCT00429663|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26360|NCT00429572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26361|NCT00429507|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26362|NCT00429494|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26363|NCT00429416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26364|NCT00429403|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26365|NCT00429364|Principal Investigators are NOT employed by the organization sponsoring the study.|All publications and presentations resulting from studies from the PHN Network must be approved by the Publications and Presentations Committee before submission. The Sponsor (NERI) and funding agency (NHLBI) both are represented on the P&P Committee along with Network Investigators. Members of the P&P Committee can recommend changes to publications.
26366|NCT00429299|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26367|NCT00429273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26368|NCT00429182|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26369|NCT00429169|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26370|NCT00429143|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26371|NCT00429104|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26372|NCT00429026|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26373|NCT00428974|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26374|NCT00428948|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26375|NCT00428922|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26376|NCT00428844|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication is initiated by Cubist. If first publication not published within 1 year of study conclusion or termination, Investigator has right to publish and disclose the Data. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Cubist at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
26377|NCT00428792|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26378|NCT00428610|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26379|NCT00428597|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26380|NCT00428584|Principal Investigators are NOT employed by the organization sponsoring the study.|Neither Institution nor any Principal Investigators shall publish or present any results from such Study to any third parties until: (i) EMD Serono publishes the results from all sites participating in such Study; (ii) Institution receives notification from EMD Serono that publication of the multi-site results is no longer planned; or (iii) twenty-four (24) months following the completion of the multi-site study at all sites, whichever occurs first.
26381|NCT00428441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26382|NCT00428389|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26383|NCT00428298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26384|NCT00428246|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26385|NCT00428220|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26386|NCT00428207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26387|NCT00428116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26388|NCT00428090|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26389|NCT00428077|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26390|NCT00427999|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
26391|NCT00427973|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26392|NCT00427960|Principal Investigators are NOT employed by the organization sponsoring the study.|
26393|NCT00427934|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26394|NCT00427921|Principal Investigators are NOT employed by the organization sponsoring the study.|Responsibility of preparation and maintenance of the single database, first publication, and, presentation of Study shall reside with Abbott. No independent manuscript may be submitted for publication until first manuscript has been accepted for publication or twelve (12) months after completion of the Study at all sites, which ever occurs first.
26395|NCT00427895|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26396|NCT00427804|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26397|NCT00427791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26398|NCT00427778|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26399|NCT00427765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26400|NCT00427700|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26401|NCT00427661|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26402|NCT00427635|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26403|NCT00427557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26404|NCT00427349|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26405|NCT00427336|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26406|NCT00427037|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26407|NCT00427011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26408|NCT00426855|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26409|NCT00426842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26410|NCT00426764|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene's request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation.
26411|NCT00426751|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26412|NCT00426660|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26413|NCT00426556|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial.
26414|NCT00426361|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26415|NCT00426283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26416|NCT00426270|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26417|NCT00426231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26418|NCT00426153|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26419|NCT00426127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26420|NCT00425945|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26421|NCT00425854|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication
26422|NCT00425802|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26423|NCT00425750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26424|NCT00425698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26425|NCT00425672|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26426|NCT00425607|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26427|NCT00425503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26428|NCT00425438|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26429|NCT00425386|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26430|NCT00425373|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26431|NCT00425308|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure Restriction Description: The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26432|NCT00425269|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26433|NCT00425113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26434|NCT00425100|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26435|NCT00425061|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26436|NCT00424827|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26437|NCT00424775|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26438|NCT00424762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26439|NCT00424749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26440|NCT00424645|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26441|NCT00424632|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26442|NCT00424619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26443|NCT00424593|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26444|NCT00424554|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator (PI) agrees not to publish or publicly present any interim results of the Study without prior written consent of the sponsor. The PI further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review, without limitation, including editorial rights. If the parties disagree, the PI agrees to meet with the sponsor to discuss and resolve any such issues or disagreement.
26445|NCT00424528|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
26446|NCT00424515|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26447|NCT00424502|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26448|NCT00424476|Principal Investigators are NOT employed by the organization sponsoring the study.|For multi-center trials, no investigator will be authorized to publish study results from an individual center until the earlier of the multi-center trial results are published or 12 months after the end or termination of the multi-center trial at all sites. All manuscripts and abstracts must be submitted to the sponsor for review at least 30 days prior to submission for publication or for presentation at a scientific meeting. The sponsor may delay publication for up to 3 months.
26449|NCT00424398|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement is between contract research organization and third parties on behalf of ISTA Pharmaceuticals, Inc.
26450|NCT00424385|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26451|NCT00424372|Principal Investigators are NOT employed by the organization sponsoring the study.|
26452|NCT00424346|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26453|NCT00424294|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26454|NCT00424268|Principal Investigators are NOT employed by the organization sponsoring the study.|The study results may be published and/or presented at scientific meetings. Prior to any submission, all manuscripts/abstracts must be presented to the sponsor for possible comments.
26455|NCT00424255|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26456|NCT00424190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26457|NCT00424177|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26458|NCT00424047|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator has the right to publish and/or present study data after multicentric publication or one year has elapsed until completion of this multicentric study provided that he/she (i) furnishes the sponsor a copy of any proposed publication or presentation before its submission, (ii) deletes any sponsor’s confidential data as pointed out by sponsor, and (iii) delays any submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications.
26459|NCT00424021|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26460|NCT00424008|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish/present any interim results without prior sponsor written consent. The investigator agrees to provide to the sponsor, 45 days prior to submission, review copies for publication that report any study results. The sponsor has the right to review and comment. If the parties disagree, investigator agrees to meet with the sponsor, prior to submission for publication, to discuss and resolve any such issues/disagreement.
26461|NCT00423943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26462|NCT00423930|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26463|NCT00423917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26464|NCT00423891|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26465|NCT00423878|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26466|NCT00423852|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26467|NCT00423813|Principal Investigators are NOT employed by the organization sponsoring the study.|
26468|NCT00423800|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of 45 days from the time submitted to the sponsor for review.
26469|NCT00423735|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26470|NCT00423722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26471|NCT00423683|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26472|NCT00423670|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator agrees to provide to the sponsor thirty (30) days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including slides and texts of oral or other public presentations and texts of any transmission through any electronic media) that report any results of the study.
26473|NCT00423657|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26474|NCT00423605|Principal Investigators are NOT employed by the organization sponsoring the study.|
26475|NCT00423592|Principal Investigators are NOT employed by the organization sponsoring the study.|
26476|NCT00423579|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall not publish or publicly present the study results without prior written authorization from the sponsor, except for dispositions in the Ministerial Circular n. 6 dated 02 SEP 2002. The investigator shall notify the sponsor in writing of any publication submission or presentation reporting results of the study 30 days prior to submission or presentation to permit sponsor review.
26477|NCT00423488|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees not to publish or publicaly present results without prior written authorization from the sponsor, except than for the dispositions provided for in Ministerial Circular n.6 of 02 SEP 2002 and, particularly, disposition n.1a) The investigator further agrees to provide 30 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of material(including text for oral presentation) that report study results.
26478|NCT00423449|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
26479|NCT00423436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26480|NCT00423358|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26481|NCT00423332|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
26482|NCT00423319|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26483|NCT00423293|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26484|NCT00423267|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator agrees not to publish or present any interim results~of the study without the Sponsor's prior written consent. The investigator further agrees to provide review copies to the Sponsor 45 days prior to submission for publication or presentation. The sponsor has the right to review and comment. If the parties disagree concerning the appropriateness of the data analysis and presentation, and/or confidentiality, investigator agrees to meet with the sponsor to discuss and resolve."
26485|NCT00423189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26486|NCT00423176|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26487|NCT00423150|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator agrees not to publish or publicly present any interim results~of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor, 45 days prior to submission, review copies of abstracts or manuscripts for publication that report any results of the study. If the parties disagree, investigator agrees to meet with the sponsor, prior to submission, for the purpose of making good faith efforts to discuss/resolve any such issues."
26488|NCT00423098|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26489|NCT00423085|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26490|NCT00423046|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26491|NCT00422942|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26492|NCT00422903|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26493|NCT00422812|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26494|NCT00422799|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26495|NCT00422734|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26496|NCT00422695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26497|NCT00422669|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigational Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication."
26498|NCT00422656|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26499|NCT00422513|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights"
26500|NCT00422448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26501|NCT00422422|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
26502|NCT00422383|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26503|NCT00422292|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
26504|NCT00422279|Principal Investigators are NOT employed by the organization sponsoring the study.|I understand that I retain the right to publish the data from the clinical work that I perform. I agree that Nobel Biocare USA, LLC will be allowed to review and comment on such a document prior to its publication to ensure that the document does not disclose any trade secrets or other confidential information which may be known to me by virtue of my participation in the clinical study. I will not disclose any information regarding the study without permission from Nobel Biocare USA, LLC.
26505|NCT00422227|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26506|NCT00422201|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26507|NCT00422162|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26508|NCT00422097|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period <or=60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
26509|NCT00422058|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk’s Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
26510|NCT00422032|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26511|NCT00421993|Principal Investigators are NOT employed by the organization sponsoring the study.|Following the expiration of twenty-four (24) months after the completion of the Study, Investigator shall have the right to publish the results of the Study; provided, however that Sponsor shall have the right to review any proposed publication generated from the Study prior to publication or presentation. The Sponsor shall have the absolute right to refuse the publication altogether, to delay it or to amend its contents as it deems fit.
26512|NCT00421954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26513|NCT00421928|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26514|NCT00421889|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26515|NCT00421733|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
26516|NCT00421707|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26517|NCT00421603|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26518|NCT00421408|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26519|NCT00421343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26520|NCT00421174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26521|NCT00420992|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the Sponsor for review. Sponsor may request a delay in publication to allow the filing of patent applications before publication or release. The sponsor can require deletion of Confidential Information or request correction of inaccuracies.
26522|NCT00420927|Principal Investigators are NOT employed by the organization sponsoring the study.|Any investigator or institution that plans on presenting/publishing results disclosure, should provide written notification to Abbott within 60 days of their presentation/publication. Abbott requests that no presentation/publication will be allowed until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay of any proposed presentation/publication maybe requested if Abbott needs to secure patent or other proprietary protection.
26523|NCT00420849|Principal Investigators are NOT employed by the organization sponsoring the study.|"Multicenter publication must include input from investigators and Celgene, agreement to be established before publication. It has priority over subset (single center) publication, for duration of 1 year after study completion.~Individual investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. In this case, Celgene has the right to comment and right to ask delay of publication for 180 days."
26524|NCT00420784|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26525|NCT00420745|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26526|NCT00420641|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26527|NCT00420628|Principal Investigators are NOT employed by the organization sponsoring the study.|"The results of the study may be published or presented by the investigator(s) after the review by, and in consultation and agreement with Bausch & Lomb, and such that confidential or proprietary information is not disclosed.~Prior to publication or presentation, a copy of the final text should be forwarded by the investigator(s) to Bausch & Lomb or its designee, for comment."
26528|NCT00420511|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26529|NCT00420459|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26530|NCT00420420|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26531|NCT00420407|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26532|NCT00420342|Principal Investigators are NOT employed by the organization sponsoring the study.|(A). PI will provide copy to Sponsor sixty (60) days. Sponsor will have thirty (30) days to review and provide feedback. (B). If proposed publication presents material adverse effect on Sponsor's confidentiality information, then PI shall delay or prevent such publication. (C) In multi-center trial, the investigative data will be pooled and published as a collaborative effort with consent from all parties including the Sponsor.
26533|NCT00420316|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26534|NCT00420303|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26535|NCT00420290|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26536|NCT00420238|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26537|NCT00420212|Principal Investigators are NOT employed by the organization sponsoring the study.|The provisions of the agreements are subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
26538|NCT00420199|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26539|NCT00420147|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26540|NCT00420095|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26541|NCT00420056|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26542|NCT00420017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26543|NCT00420004|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26544|NCT00419952|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may use the Multi-Center Study Results and the Site Data for the limited purpose of his or her own research and academic analysis until the earlier of the publication of the first Multi-Center Study at all participating sites
26545|NCT00419926|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26546|NCT00419770|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26547|NCT00419757|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26548|NCT00419744|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may use the Multi-Center Study Results and the Site Data for the limited purpose of his or her own research and academic analysis until the earlier of the publication of the first Multi-center Publication and the second anniversary of the completion of the Multi-center Study at all participating sites.
26549|NCT00419445|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26550|NCT00419393|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
26551|NCT00419380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26552|NCT00419341|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26553|NCT00419315|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26554|NCT00419263|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26555|NCT00419159|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26556|NCT00419120|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator is free to individually communicate, orally present or publish in scientific journals or other scholarly media the study information at the conclusion of the study without the prior approval of the sponsor provided that 1)the results of the study in its entirely have been publically disclosed by or with the consent of the sponsor 2)18 months after the conclusion of the study at all sites whichever is first to occur.
26557|NCT00419094|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
26558|NCT00419003|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26559|NCT00418977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26560|NCT00418964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26561|NCT00418951|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26562|NCT00418938|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26563|NCT00418886|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
26564|NCT00418834|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26565|NCT00418717|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26566|NCT00418691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26567|NCT00418665|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
26568|NCT00418574|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that result communications shall be exchanged and discussed with the sponsor 60 days prior to submission for publication or presentation.
26611|NCT00415506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26569|NCT00418561|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicentre publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicentre Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
26570|NCT00418522|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26571|NCT00418379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26572|NCT00418314|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications and presentations proposed by participating centers should be furnished to sponsor for review and comment 30 days (manuscripts) or 7 days (abstracts) prior to submission for publication. Sponsor reserves the right to deny submission of study results if based on data owned by sponsor.
26573|NCT00418262|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26574|NCT00418184|Principal Investigators are NOT employed by the organization sponsoring the study.|
26575|NCT00418145|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26576|NCT00418093|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26577|NCT00418028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26578|NCT00418015|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26579|NCT00417989|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26580|NCT00417976|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26581|NCT00417963|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26582|NCT00417885|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26583|NCT00417612|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26584|NCT00417482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26585|NCT00417417|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26586|NCT00417274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26587|NCT00417248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26588|NCT00417170|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26612|NCT00415493|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26589|NCT00417079|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the study will be made jointly in the name of all wholehearted collaborators. Other papers will be authored based on the contributions of the individuals to the overall study. Substudies with scientific merit which have received prior approval from the Steering Committee (SC) may be published in the names of the contributing investigators. A copy of all manuscripts will be provided to the sponsors for their review. The final decision to publish articles will be made by the SC.
26590|NCT00417027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26591|NCT00416884|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26592|NCT00416793|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26593|NCT00416715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26594|NCT00416624|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26595|NCT00416598|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26596|NCT00416572|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26597|NCT00416520|Principal Investigators are NOT employed by the organization sponsoring the study.|
26598|NCT00416494|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26599|NCT00416455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26600|NCT00416195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26601|NCT00416182|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26602|NCT00416078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26603|NCT00415909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26604|NCT00415870|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26605|NCT00415857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26606|NCT00415623|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26607|NCT00415610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26608|NCT00415597|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the Sponsor for review. Sponsor may request a delay in publication to allow the filing of patent applications before publication or release. The sponsor can require deletion of Confidential Information or request correction of inaccuracies.
26609|NCT00415532|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
26613|NCT00415194|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26614|NCT00415168|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26615|NCT00415051|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26616|NCT00414973|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26617|NCT00414908|Principal Investigators are NOT employed by the organization sponsoring the study.|At 60 days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy and allow Sponsor 60 days to review and comment.
26618|NCT00414817|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26619|NCT00414726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26620|NCT00414700|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26621|NCT00414661|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26622|NCT00414635|Principal Investigators are NOT employed by the organization sponsoring the study.|Site investigators agree not to individually publish the results of the study. They may participate in a joint publication of the study results with the sponsor.
26623|NCT00414609|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26624|NCT00414596|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26625|NCT00414544|Principal Investigators are NOT employed by the organization sponsoring the study.|Study results were presented and published at national meetings. Standard confidentiality agreements were signed by PIs for company confidential information.
26626|NCT00414518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26627|NCT00414466|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26628|NCT00414453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26629|NCT00414440|Principal Investigators are NOT employed by the organization sponsoring the study.|"Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety."
26630|NCT00414388|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26631|NCT00414310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26632|NCT00414206|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26633|NCT00414167|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26634|NCT00414050|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26635|NCT00414011|Principal Investigators are NOT employed by the organization sponsoring the study.|"All materials that reflects the WRAMC affiliation must be approved and properly cleared before the material is submitted for public dissemination and publication. All publications whereby WRAMC is cited in the bylines will state on the cover page the following sample disclaimer: The views expressed in this [article, book chapter, speech, presentation, etc.] are those of the author(s) and do not reflect the official policy of the Department of Army, Department of Defense, or U.S. Government."
26636|NCT00413972|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26637|NCT00413959|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26638|NCT00413920|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26639|NCT00413894|Principal Investigators are NOT employed by the organization sponsoring the study.|The study being conducted under this agreement is part of the overall study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the study, but after the first publication or presentation that involves the overall study. Sponsor may request that confidential information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26640|NCT00413777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26641|NCT00413699|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the investigator is that the sponsor can review results communications at least 30 days prior to public release and can embargo communications regarding trial results for a period that is no more than an additional 60 days. Investigators will, on request, remove any previously undisclosed confidential information (other than the study results themselves) before disclosure.
26642|NCT00413660|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26643|NCT00413634|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
26644|NCT00413582|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26645|NCT00413478|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26646|NCT00413413|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26647|NCT00413400|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26648|NCT00413374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26649|NCT00413335|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26650|NCT00413283|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
26651|NCT00413244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26652|NCT00413231|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) and institution agree not to publish the results of the study until after the earliest of the following: a)conclusion of the study, b)the early termination of the study, c)at discretion and approval of the sponsor, or d)after sponsor confirms there will be no multicenter study publication, whichever occurs first. PI and institution further agree to submit to sponsor copies of any proposed publication or public presentation at least sixty days before dissemination.
26653|NCT00413218|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of this study may be published or presented at scientific meetings. If this is foreseen, the investigator agrees to submit all manuscripts or abstracts to the Sponsor at least 1 month prior to the submission of any such information to an editorial board or scientific review committee. This allows the Sponsor to protect proprietary information and to provide comments based on information from other studies that may not yet be available to the investigator.
26654|NCT00413192|Principal Investigators are NOT employed by the organization sponsoring the study.|
26655|NCT00413153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26656|NCT00413062|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR recognizes the right of the investigator(s) to publish, but all publications must be based on data validated and released by the SPONSOR. Any such scientific paper, presentation, or other communication concerning the clinical trial will first be submitted to the SPONSOR, at least six weeks ahead of estimated publication or presentation, for consent, which shall not be withheld unreasonably.
26657|NCT00413049|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26658|NCT00413036|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator can publish/present study data after multicenter publication is submitted or 1 yr after study completion. Investigator shall (i) furnish the sponsor a copy of any proposed publication/presentation at least 60 days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for up to 90 days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
26659|NCT00413010|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26660|NCT00412984|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26661|NCT00412971|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26662|NCT00412958|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26663|NCT00412932|Principal Investigators are NOT employed by the organization sponsoring the study.|"If identified by Daiichi Sankyo, Inc. (DSI), any of DSI's confidential information as defined herein shall be deleted. Nothing in this Publication section shall be taken as giving DSI the right of editorial control over any publication prepared by the study site."
26664|NCT00412893|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication for review and comment. Sponsor may delay the publication for up to 60 days to seek patent protection.
26665|NCT00412867|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor's consent must be obtained in advance if the investigator or other study-related personnel in the study center intend to publish information obtained via this study at a scientific conference or similar venue.
26666|NCT00412854|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26667|NCT00412841|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26668|NCT00412750|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26669|NCT00412737|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26670|NCT00412607|Principal Investigators are NOT employed by the organization sponsoring the study.|Please contact Biosense Webster for additional information.
26671|NCT00412542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26672|NCT00412529|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26673|NCT00412516|Principal Investigators are NOT employed by the organization sponsoring the study.|All results communication must be reviewed and approved by the sponsor. The sponsor has 60 days to review results communications and provide comments.
26674|NCT00412464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26675|NCT00412451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26676|NCT00412425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26677|NCT00412373|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26678|NCT00412360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26679|NCT00412243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26680|NCT00412217|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26681|NCT00412113|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26682|NCT00412087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26683|NCT00412074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26684|NCT00412061|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26685|NCT00411788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26686|NCT00411762|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26687|NCT00411749|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26688|NCT00411671|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26689|NCT00411645|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
26690|NCT00411619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26691|NCT00411554|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26692|NCT00411463|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26693|NCT00411450|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26694|NCT00411411|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26695|NCT00411398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26696|NCT00411216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26697|NCT00411151|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26698|NCT00411086|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26699|NCT00410904|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26700|NCT00410891|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26701|NCT00410826|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26702|NCT00410813|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26703|NCT00410761|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
26704|NCT00410605|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26705|NCT00410514|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site's manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
26706|NCT00410488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26707|NCT00410423|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26708|NCT00410410|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26709|NCT00410384|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26710|NCT00410280|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26711|NCT00410202|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26712|NCT00410189|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26713|NCT00410163|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26714|NCT00410150|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26715|NCT00410124|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
26716|NCT00410072|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
26717|NCT00410059|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26718|NCT00410046|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26719|NCT00409838|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26720|NCT00409825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26721|NCT00409786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26722|NCT00409773|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26723|NCT00409747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26724|NCT00409708|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26725|NCT00409682|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
26819|NCT00403130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26726|NCT00409617|Principal Investigators are NOT employed by the organization sponsoring the study.|Provide ABBOTT at least thirty (30) days prior to submission for review, ABBOTT shall return comments promptly. Proposed draft shall be delayed an additional sixty (60) days in addition to the Review Period.
26727|NCT00409578|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26728|NCT00409565|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26729|NCT00409539|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
26730|NCT00409409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26731|NCT00409344|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26732|NCT00409331|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26733|NCT00409292|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26734|NCT00409240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26735|NCT00409188|Principal Investigators are NOT employed by the organization sponsoring the study.|After conclusion of the study, an integrated clinical and statistical study report shall be written by the Sponsor in consultation with the Coordinating Investigator based on the protocol. The first publication will be a full publication of all data from all sites. The Sponsor is entitled to delay publication in order to obtain patent protection. The ICMJE criteria for authorship will be followed. A separate publication plan will be set up to describe further publications.
26736|NCT00409175|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26737|NCT00409006|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26738|NCT00408993|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26739|NCT00408928|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26740|NCT00408902|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26741|NCT00408876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26742|NCT00408694|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26743|NCT00408681|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26744|NCT00408629|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
26745|NCT00408603|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26746|NCT00408590|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26747|NCT00408499|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26748|NCT00408460|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26749|NCT00408421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26750|NCT00408408|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26751|NCT00408317|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions may vary in accordance with each agreement that is negotiated with individual investigators. Sponsor will allow publication after multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and defer publication for period of time to allow Sponsor to obtain patent or other intellectual property right protection.
26752|NCT00408200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26753|NCT00408070|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26754|NCT00407966|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26755|NCT00407888|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26756|NCT00407797|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26757|NCT00407758|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26758|NCT00407745|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26759|NCT00407654|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26760|NCT00407563|Principal Investigators are NOT employed by the organization sponsoring the study.|Proposed publication must be submitted to Funder at least 60 days prior to the submission for publication. If Funder requests in writing, the proposed publication may be held for an additional 90 days.
26761|NCT00407550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26762|NCT00407537|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26763|NCT00407511|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26764|NCT00407485|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26765|NCT00407381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26766|NCT00407355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26767|NCT00407030|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 weeks before submission. Sponsor to give written opinion within 30 days. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
26768|NCT00406848|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26769|NCT00406783|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must provide sponsor w/ review copies of abstracts or manuscripts for publication that report any results of the study, 45 days before submission for publication or presentation. The sponsor shall have the right to review/comment on the material. If the parties disagree about the appropriateness of the material, PI must meet with sponsor's representatives before submission for publication, for the purpose of making good faith efforts to discuss and resolve any issues of disagreement.
26770|NCT00406718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26771|NCT00406692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26772|NCT00406653|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26773|NCT00406640|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26774|NCT00406393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26775|NCT00406367|Principal Investigators are NOT employed by the organization sponsoring the study.|No results to be published without written agreement by sponsor; manuscripts to be sent to sponsor at least 6 weeks before submission. Sponsor to give written opinion within 30 days. Sponsor is entitled to exert influence on the contents of publications, to postpone publications up to 36 months after end of the study, and to name co-authors. In case of justified doubts of sponsor, the INVESTIGATOR will consider these doubts in the publication as long as the scientific neutrality is not affected.
26776|NCT00406354|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26777|NCT00406315|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26778|NCT00406276|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26779|NCT00406133|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26780|NCT00406107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26781|NCT00406029|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study.
26782|NCT00405964|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26783|NCT00405938|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
26784|NCT00405912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26785|NCT00405821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26786|NCT00405756|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene’s request, proposed publication or presentation will be delayed up to 90 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation.
26787|NCT00405704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26788|NCT00405652|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26789|NCT00405639|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26790|NCT00405587|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26791|NCT00405548|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26792|NCT00405509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26793|NCT00405288|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26794|NCT00405275|Principal Investigators are NOT employed by the organization sponsoring the study.|"Dr. O'Dell is an employee of the Sponsor. Dr. Edward Keystone is not.~Per the signed Investigator Agreement, PIs agreed to maintaining the confidentiality of study data and not publishing study data without prior approval of the study's Executive Committee."
26795|NCT00405067|Principal Investigators are NOT employed by the organization sponsoring the study.|PI can publish after sponsor has 60 days to review the proposed publication. PI is committed to publish the results of the study in a cooperative publication with other investigators prior to individual publication. PI needs sponsor’s prior consent to publish confidential information, not to be unreasonably withheld. The PI shall, upon sponsor’s request, delete from the publication any confidential information which would prejudice the securing of adequate intellectual property protection.
26796|NCT00404924|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
26797|NCT00404820|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
26798|NCT00404768|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26799|NCT00404755|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26820|NCT00403117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26800|NCT00404651|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
26801|NCT00404547|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26802|NCT00404495|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26803|NCT00404352|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to publish any results communication in connection with the study. The PI shall submit any communications including study results to the sponsor for review 30 working days prior to communication submission. The sponsor can request the PI to modify or delete any sponsor's proprietary information. If the PI refuses the modification, the submission shall be postponed for 60 days from PI refusal, to provide the sponsor the opportunity to file a patent or seek legal remedies.
26804|NCT00404248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26805|NCT00404092|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26806|NCT00404079|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26807|NCT00404066|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26808|NCT00403845|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
26809|NCT00403767|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26810|NCT00403754|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
26811|NCT00403585|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26812|NCT00403546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26813|NCT00403481|Principal Investigators are NOT employed by the organization sponsoring the study.|If identified by Daiichi Sankyo Inc., any of DSI's confidential information, as defined to the author, shall be deleted. Nothing in our site agreement shall be taken as giving Daiichi Sankyo, Inc. any right of editorial control over any publication prepared by the study site.
26814|NCT00403455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26815|NCT00403403|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26816|NCT00403390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26817|NCT00403273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26818|NCT00403234|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26821|NCT00402987|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26822|NCT00402896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26823|NCT00402883|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
26824|NCT00402740|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator (PI), Institute, and Research Site (RS) acknowledge this is a multi-center study. An independent, joint publication is anticipated from investigators in the study, including the PI. Therefore, the PI, Institute, and RS agree not to publish or present the results before the publication of the multi-center investigator paper, but in no event shall PI, Institute, and/or RS be so restricted after the expiration of twelve months from completion of the Study at all sites.
26825|NCT00402727|Principal Investigators are NOT employed by the organization sponsoring the study.|If Bayer informs coordinating investigator's hospital that such publication could be expected to have an adverse effect on the confidentiality of any confidential information, then the coordinatin investigator's hospital shall prevent the publication, unless the confidential information can be deleted from the publication without having adetrimental effect on the scientific correctness of the publication.
26826|NCT00402714|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26827|NCT00402688|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26828|NCT00402649|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26829|NCT00402597|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26830|NCT00402363|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26831|NCT00402337|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that publication cannot be made for 24 months from the date of final data lock of the study, the sponsor can review the publication prior to public release, sponsor requires a minimum 60 day review period for each publication, sponsor can request removal of confidential information of sponsor (not including results of trial), and sponsor can request an additional delay period of 60 days in order to protect potentially patentable information.
26832|NCT00402324|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26833|NCT00402285|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26834|NCT00402246|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigational Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication."
26835|NCT00402233|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
26836|NCT00402194|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26837|NCT00402168|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26838|NCT00402103|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26839|NCT00402051|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26840|NCT00402025|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26841|NCT00401973|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26842|NCT00401960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26843|NCT00401882|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26844|NCT00401843|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
26845|NCT00401830|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
26846|NCT00401817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26847|NCT00401778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26848|NCT00401752|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26849|NCT00401726|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
26850|NCT00401622|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26851|NCT00401544|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26852|NCT00401531|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
26853|NCT00401414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26854|NCT00401401|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site and the PI may be required to withhold the publication for up to 90 days. Subject to a reasoned request from the sponsor, the publication may be further delayed for a period up to 6 months from the date of first submission to the sponsor.~The sponsor has the right to require deletion of any trade secret, proprietary, or confidential information supplied by the sponsor to the site or the PI. The sponsor shall not otherwise have the right to censor publications."
26855|NCT00401258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26856|NCT00401245|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26857|NCT00401193|Principal Investigators are NOT employed by the organization sponsoring the study.|
26858|NCT00401102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26859|NCT00400946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26860|NCT00400881|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26861|NCT00400829|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26862|NCT00400803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26863|NCT00400764|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26864|NCT00400712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26865|NCT00400686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26866|NCT00400634|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26867|NCT00400569|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26868|NCT00400400|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26869|NCT00400205|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26870|NCT00400179|Principal Investigators are NOT employed by the organization sponsoring the study.|Taiho agreements vary with individual investigators, but do not prohibit any from publishing. Taiho is provided time to review material discussing trial results (generally 30 to 120 days with possible extension), and can remove undisclosed confidential, proprietary and intellectual property rights-related information. Authors have final control and approval of publication content of final study results. The investigator agrees not to publish any results before the first multicenter publication.
26871|NCT00400153|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
26872|NCT00399893|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26873|NCT00399880|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26874|NCT00399802|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission.
26875|NCT00399763|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26897|NCT00397982|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26876|NCT00399568|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator may publish only after cooperative publication or 18 months after sponsor's final evaluation of study data, whichever occurs first. At least 60 days prior to submission for publication, investigator must submit manuscript to sponsor for review and comment. Sponsor has 60 day period thereafter to respond with comment. Investigator will remove confidential information at the request of sponsor.
26877|NCT00399542|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26878|NCT00399516|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26879|NCT00399360|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26880|NCT00399308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26881|NCT00399035|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
26882|NCT00398983|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26883|NCT00398918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26884|NCT00398866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26885|NCT00398632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26886|NCT00398567|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26887|NCT00398476|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26888|NCT00398411|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26889|NCT00398398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26890|NCT00398320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26891|NCT00398216|Principal Investigators are NOT employed by the organization sponsoring the study.|A study site may not publish results of a study until after a coordinated multicenter publication has been submitted for publication or until one year after the study has ended, whichever occurs first. The study site will have the opportunity to publish results of the study, provided Daiichi Sankyo has had the opportunity to review and comment on the study site’s proposed publication prior to being submitted for publication with the advice of patent council and need for subject protection.
26892|NCT00398138|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26893|NCT00398112|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26894|NCT00398086|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Celgene with a copy of the papers prior to their submission; Celgene shall complete its review within 30 days after receipt. Upon Celgene’s request, proposed publication or presentation can be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of patentable material.
26895|NCT00398073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26896|NCT00398047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26898|NCT00397930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26899|NCT00397904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26900|NCT00397891|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26901|NCT00397878|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26902|NCT00397839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26903|NCT00397631|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26904|NCT00397540|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26905|NCT00397514|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26906|NCT00397488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26907|NCT00397462|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26908|NCT00397254|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator is free to publish results of it's part of the study in collaboration with the other investigators subsequent to the multicenter publication issued by Clinvest. Principal Investigator (PI) may publish results of it's data with copy of any manuscript for review to Clinvest 60 days prior to submission for publication.
26909|NCT00397215|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26910|NCT00397189|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26911|NCT00397150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26912|NCT00397046|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26913|NCT00397033|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26914|NCT00396981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26915|NCT00396877|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months after trial completion, the Investigator can publish the results. Prior to publication, the sponsor shall review the manuscript and can request changes, provided they do not jeopardize the accuracy and/or the scientific value of the publication. The approval is given in writing by the sponsor, not exceeding 90 days.
26916|NCT00396812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26917|NCT00396656|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
26918|NCT00396630|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26919|NCT00396591|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator has the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 for abstracts) in advance of any submission for publication. The Sponsor may request for the publication to be delayed for a limited time, not to exceed 90 days to preserve its proprietary rights.
26920|NCT00396565|Principal Investigators are NOT employed by the organization sponsoring the study.|Without prior notification to the sponsor, the PI cannnot dislose trial results and related documents of trials to a third party.
26921|NCT00396409|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26922|NCT00396383|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
26923|NCT00396331|Principal Investigators are NOT employed by the organization sponsoring the study.|PI agrees to submit the draft of any proposed public release or proposed publication to Genzyme and Genzyme may review the proposed public release or draft of the publication for up to 30 days prior to submission for public release, presentation or use. PI agrees (1) to withhold submission for an additional period not to exceed 60 days to allow Genzyme to take action to protect patent rights or trade secret rights (2) to give due consideration to any editorial comments of Genzyme.
26924|NCT00396318|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26925|NCT00396292|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26926|NCT00396279|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
26927|NCT00396266|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
26928|NCT00396253|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26929|NCT00396201|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
26930|NCT00396162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26931|NCT00396136|Principal Investigators are NOT employed by the organization sponsoring the study.|
26932|NCT00396097|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26933|NCT00396084|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26934|NCT00396032|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26935|NCT00396019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26936|NCT00396006|Principal Investigators are NOT employed by the organization sponsoring the study.|The data from the study shall be published (if applicable) by the sponsor. The investigators and the steering committee may be involved if agreed to by the sponsor. Neither the investigator nor any other person within his/her institution has the right to publish separately or individually without permission by the sponsor.
26937|NCT00395993|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26938|NCT00395967|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
26939|NCT00395876|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26940|NCT00395863|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be presented during scientific symposia or published in a scientific journal only after review by Bracco in accordance with the guidelines set forth in the applicable publication or financial agreement.
26941|NCT00395850|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26942|NCT00395746|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
26943|NCT00395733|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs shall provide sponsor with an advance copy of any proposed publication or oral presentation at least ninety (90) days prior to the date of the planned submission or presentation. Sponsor shall have sixty (60) days to recommend any changes it reasonably believes are necessary for scientific purposes or to preserve the confidentiality of sponsor’s confidential information. PIs agree that the adoption of such recommended changes shall not be unreasonably refused.
26944|NCT00395694|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26945|NCT00395642|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to submit copies of any proposed publication to Sponsor for review at least 30 days in advance of submission for publication or presentation. Sponsor may delete any Confidential Information or other proprietary information. In addition, Sponsor may extend such review period for another 90 days to file patent applications or take other steps to protect its intellectual property interests.
26946|NCT00395629|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
26947|NCT00395512|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
26948|NCT00395486|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26949|NCT00395460|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs shall provide sponsor with an advance copy of any proposed publication or oral presentation at least ninety (90) days prior to the date of the planned submission or presentation. Sponsor shall have sixty (60) days to recommend any changes it reasonably believes are necessary for scientific purposes or to preserve the confidentiality of sponsor’s confidential information. PIs agree that the adoption of such recommended changes shall not be unreasonably refused.
26950|NCT00395447|Principal Investigators are NOT employed by the organization sponsoring the study.|All information obtained from BIOTRONIK or PharmaLink concerning the research ideas used in this study and all information obtained under or concerning this study is considered BIOTRONIK property. Investigator will maintain such information in confidence and not release it to anyone without written consent from BIOTRONIK or prior public disclosure, with the exception of information required by law or regulations to be disclosed to the reviewing IRB, the patient, or the FDA.
26951|NCT00395343|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26952|NCT00395304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26953|NCT00395291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26954|NCT00395226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26955|NCT00395161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26956|NCT00395135|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of study results are only allowed with prior written consent from Arena Pharmaceuticals, Inc.
26957|NCT00395083|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26958|NCT00395057|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo
26959|NCT00395044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26960|NCT00395018|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26961|NCT00394953|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26962|NCT00394914|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator agrees not to publish or publicly present any interim results~of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication that report any results of the study. The sponsor shall have the right to review and comment with respect to publications, abstracts, slides, and manuscripts."
26963|NCT00394901|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
26964|NCT00394888|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26965|NCT00394836|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26966|NCT00394771|Principal Investigators are NOT employed by the organization sponsoring the study.|Details of the study and its results shall not be publicized or published in any form to cooperative publication without prior, written consent of sponsor. Such approval is necessary to prevent premature disclosure of trade secrets and other confidential information.
26967|NCT00394706|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26968|NCT00394654|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
26969|NCT00394589|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26970|NCT00394524|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26971|NCT00394472|Principal Investigators are NOT employed by the organization sponsoring the study.|AZ shall have 30 days from the proposed final manuscript for any disclosure to review it and may within such time require that submission for publication/disclosure be delayed in order for AZ to file patent applications. If study site/investigator requests permission to publish data(incl oral presentations) it is to be agreed with AZ before publ.
26972|NCT00394433|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26973|NCT00394355|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal investigator (PI) agrees not to publish or publicly present any interim results of the study without prior written consent of the sponsor. The PI further agrees to provide to the sponsor, 30 days prior to submission, review copies for publication that report any study results. The sponsor has the right to review and comment. If the parties disagree, PI agrees to meet with the sponsor, prior to submission for publication, to discuss and resolve any such issues or disagreement.
26974|NCT00394329|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26975|NCT00394277|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
26976|NCT00394251|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it has been more than 2 years since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decided publication would hinder patent applications, Investigator must delay submission for up to 1 year. Investigator must delete confidential information before submission.
26977|NCT00394212|Principal Investigators are NOT employed by the organization sponsoring the study.|First publication of study results will be the multicenter results. In the event no multicenter publication has been made within one to two years of the completion of the study at all centers, Investigators will be free to publish their own single-center results. Investigators seeking publication must submit a draft for sponsor review at least 60 days prior to submission of the draft for publication. Sponsor cannot require changes to the communication and cannot extend the embargo.
26978|NCT00394095|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26979|NCT00394082|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it has been more than 2 years since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decided publication would hinder patent applications, Investigator must delay submission for up to 1 year. Investigator must delete confidential information before submission.
26980|NCT00393978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26981|NCT00393939|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
26982|NCT00393913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26983|NCT00393887|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26984|NCT00393874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26985|NCT00393861|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26986|NCT00393848|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26987|NCT00393796|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26988|NCT00393718|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
26989|NCT00393705|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
26990|NCT00393523|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
26991|NCT00393510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26992|NCT00393484|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
26993|NCT00393458|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
26994|NCT00393380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26995|NCT00393367|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26996|NCT00393094|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26997|NCT00393068|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
26998|NCT00393042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
26999|NCT00393029|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27000|NCT00392951|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27001|NCT00392925|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27002|NCT00392860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27003|NCT00392834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27004|NCT00392821|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
27005|NCT00392808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27006|NCT00392782|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27007|NCT00392769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27027|NCT00391768|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27008|NCT00392704|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
27009|NCT00392678|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27010|NCT00392665|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27011|NCT00392496|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27012|NCT00392444|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27013|NCT00392392|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
27014|NCT00392379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27015|NCT00392288|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27016|NCT00392236|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27017|NCT00392223|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27018|NCT00392210|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27019|NCT00392197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27020|NCT00392171|Principal Investigators are NOT employed by the organization sponsoring the study.|Study Chair agrees not to publish/present any interim results without prior Sponsor written consent. Investigators agree to provide 30 days to review prior to submission. Sponsor shall have proper representation/editorial rights/right to review/comment with regard to proprietary information. If the parties disagree concerning the appropriateness and/or confidentiality of information, Investigators agree to discuss and resolve any such issues prior to submission.
27021|NCT00391989|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27022|NCT00391976|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
27023|NCT00391898|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27024|NCT00391872|Principal Investigators are NOT employed by the organization sponsoring the study.|An Investigator agrees to provide a copy of the publication to AstraZeneca (AZ) for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites.
27025|NCT00391846|Principal Investigators are NOT employed by the organization sponsoring the study.|
27026|NCT00391807|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27028|NCT00391716|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27029|NCT00391625|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire’s agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤180 days from the time submitted to Shire for review. Shire does not prohibit publication, but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial’s multi-center publication.
27030|NCT00391599|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27031|NCT00391586|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27032|NCT00391469|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27033|NCT00391443|Principal Investigators are NOT employed by the organization sponsoring the study.|Actelion, with steering committee, shall complete the review and provide any modifications required to protect Actelion's patent rights and confidential information within sixty (60) days of receipt of the proposed publication. During this period, Investigator shall not permit publication. If Actelion reasonably anticipates filing a patent application claiming an invention arising out of the Study, such publication shall be delayed until after the application is filed.
27034|NCT00391391|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
27035|NCT00391365|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27036|NCT00391274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27037|NCT00391222|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27038|NCT00391092|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request the Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
27039|NCT00391079|Principal Investigators are NOT employed by the organization sponsoring the study.|GW will coordinate the dissemination of data from this study and may solicit input and assistance from the principal investigator. All publications for example, manuscripts, abstracts, oral/slide presentations or book chapters based on this study, must be submitted to GW for corporate review before release.
27040|NCT00391053|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
27041|NCT00391027|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27042|NCT00390884|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27043|NCT00390858|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27044|NCT00390806|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27045|NCT00390780|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27046|NCT00390689|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
27047|NCT00390611|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 but =180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
27048|NCT00390572|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27049|NCT00390559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27050|NCT00390546|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27051|NCT00390468|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27052|NCT00390455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27053|NCT00390429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27054|NCT00390416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27055|NCT00390364|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27056|NCT00390234|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27057|NCT00390221|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
27058|NCT00390182|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27059|NCT00390013|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27060|NCT00389974|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27061|NCT00389857|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27062|NCT00389831|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27063|NCT00389818|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27064|NCT00389805|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27084|NCT00388349|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27065|NCT00389597|Principal Investigators are NOT employed by the organization sponsoring the study.|The clinical site must submit to the Company, for review, any manuscripts, papers, summaries, abstracts, outlines or other media for publication at least 60 days before disclosure for the Company to review. The company has 30 days to review the proposed publication for any patentable subject matter or designated confidential information or confidential health information and by written notice to the site/PI identify such text so that the Company has time to file a patent application.
27066|NCT00389532|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
27067|NCT00389519|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agreed not to individually publish results of the study. Investigators may participate in a joint multicenter publication of the study results. Written notice must be provided to King. King has the right to review the publication and can require deletion of Confidential Information and delay of publication to allow for filing of patent applications.
27068|NCT00389493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27069|NCT00389467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27070|NCT00389441|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27071|NCT00389324|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution or Principal investigator (PI) furnishes Talecris a copy of any proposed publication (either in writing or oral) of results of the study performed under the protocol, at least 30 days before the date of submission for publication or presentation. Talecris can ask the Principal Investigator to remove Confidential Information before publication or Talecris shall have an additional time, not to exceed 60 days, to file a patent application for such Confidential Information.
27072|NCT00389207|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
27073|NCT00389168|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27074|NCT00389064|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to collaborate in good faith with AstraZeneca with regards to the contents and formation of any publication or disclosure to be made by the PI and to pay due consideration to the comments, views and opinions offered by AstraZeneca
27075|NCT00388973|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to collaborate in good faith with AstraZeneca with regard to the contents and formation of any publication or disclosure to be made by the PI and to pay due consideration to the comments, views and opinions offered by AstraZeneca.
27076|NCT00388947|Principal Investigators are NOT employed by the organization sponsoring the study.|AMS (sponsor) is the sole owner of the conglomerate data inputted into the POWER database and has the right to publish such data at its sole discretion. Registry Physician will provide AMS with a copy of any data, finding, result, article, abstract, manuscripts, presentation, or other information intended for publication, at least thirty (30) days prior to submission of same for publication.
27077|NCT00388804|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27078|NCT00388726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27079|NCT00388583|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
27080|NCT00388505|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27081|NCT00388453|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27082|NCT00388414|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27083|NCT00388362|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27085|NCT00388154|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27086|NCT00388037|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27087|NCT00387959|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27088|NCT00387894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27089|NCT00387881|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the Publication of results from all centers of a multi-center trial but requests that reports based on Single-site data not precede the primary publication of the entire clinical trial.
27090|NCT00387829|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27091|NCT00387790|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27092|NCT00387764|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27093|NCT00387751|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27094|NCT00387725|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27095|NCT00387712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27096|NCT00387673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27097|NCT00387660|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27098|NCT00387647|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27099|NCT00387621|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27100|NCT00387426|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27101|NCT00387348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27102|NCT00387335|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27103|NCT00387153|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right to the 1st publication within 12 months of study conclusion. After, the institution/PI may publish data after submission to the sponsor for review.
27104|NCT00387127|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27125|NCT00385918|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27105|NCT00387088|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
27106|NCT00387036|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27107|NCT00387023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27108|NCT00387010|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
27109|NCT00386880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27110|NCT00386776|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27111|NCT00386607|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27112|NCT00386477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27113|NCT00386425|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27114|NCT00386360|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27115|NCT00386334|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
27116|NCT00386308|Principal Investigators are NOT employed by the organization sponsoring the study.|
27117|NCT00386256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27118|NCT00386243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27119|NCT00386152|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27120|NCT00386100|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27121|NCT00386022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27122|NCT00386009|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27123|NCT00385996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27124|NCT00385944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27126|NCT00385840|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27127|NCT00385827|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27128|NCT00385801|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27129|NCT00385788|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27130|NCT00385762|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27131|NCT00385736|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
27132|NCT00385723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27133|NCT00385684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27134|NCT00385671|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27135|NCT00385593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27136|NCT00385580|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27137|NCT00385541|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27138|NCT00385515|Principal Investigators are NOT employed by the organization sponsoring the study.|Individual investigators are restricted from disclosure of results until 24 months after the completion of the Study at all participating research centers. Sponsor can review results communication prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days.
27139|NCT00385268|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27140|NCT00385216|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27141|NCT00385203|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
27142|NCT00385138|Principal Investigators are NOT employed by the organization sponsoring the study.|"PI communications regarding trial results are prohibited until after the communication and publication of the multi-center results by Sponsor, but no more than 12 months after conclusion of the trial at all sites.~PI must submit results communications to sponsor for review at least 40 days prior to submission for publication and Sponsor may embargo such communications for a period that is less than or equal to 135 days solely to seek appropriate patent protection."
27143|NCT00385008|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27144|NCT00384956|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27164|NCT00383643|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27145|NCT00384930|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27146|NCT00384865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27147|NCT00384813|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27148|NCT00384748|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27149|NCT00384670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27150|NCT00384397|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27151|NCT00384332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27152|NCT00384293|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27153|NCT00384241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27154|NCT00384189|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
27155|NCT00384176|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
27156|NCT00384085|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
27157|NCT00384059|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27158|NCT00384033|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27159|NCT00383942|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27160|NCT00383786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27161|NCT00383760|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27162|NCT00383747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27163|NCT00383721|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator has the right to publish or publicly present results. The investigator agrees not to publish or publicly present any interim results without prior written consent of the sponsor. The investigator agrees to provide to the sponsor 45 days before submission for publication that~report results of the study. The sponsor shall have the right to review & comment with respect to publications, abstracts, slides, & manuscripts & the right to review & comment on the data & presentation."
27165|NCT00383565|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27166|NCT00383552|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator agrees not to publish/present any interim results without prior~sponsor written consent. The investigator agrees to provide to the sponsor, 45 days prior to submission, review copies for publication that report any study results. The sponsor has the right to review and comment. If the parties disagree, investigator agrees to meet with the sponsor, prior to submission for publication, to discuss and resolve any such issues/disagreement."
27167|NCT00383500|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27168|NCT00383435|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator has the right to publish or publicly present results. The investigator agrees not to publish or publicly present any interim results without prior written consent of the sponsor. The investigator agrees to provide to the sponsor 45 days before submission for publication that report results of the study. The sponsor shall have the right to review & comment with respect to publications, abstracts, slides, & manuscripts & the right to review & comment on the data & presentation.
27169|NCT00383331|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27170|NCT00383266|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27171|NCT00383240|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27172|NCT00383162|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27173|NCT00383149|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27174|NCT00383123|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27175|NCT00383110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27176|NCT00383084|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27177|NCT00383071|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27178|NCT00383019|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
27179|NCT00382993|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27180|NCT00382967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27181|NCT00382928|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27182|NCT00382863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27183|NCT00382785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27184|NCT00382733|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27185|NCT00382720|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months after trial completion, the Investigator can publish the results. Prior to publication, the sponsor shall review the manuscript and can request changes, provided they do not jeopardize the accuracy and/or the scientific value of the publication. The approval is given in writing by the sponsor, not exceeding 90 days.
27186|NCT00382590|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27187|NCT00382408|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can (i) review results communications prior to public release and can embargo communications regarding trial results for a period of at least 60 days but no more than 180 days from the time submitted to the sponsor for review; and (ii) require in instances of a multi-center study, that a single PI not disclose study data until after the multi-center results are published, provided such results are published within eighteen (18) months of the conclusion of the study.
27188|NCT00382291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27189|NCT00382174|Principal Investigators are NOT employed by the organization sponsoring the study.|RegeneRx (RGN) agreements may vary with individual PIs, but will not prohibit any PI from publishing. RGN supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27190|NCT00382148|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study.
27191|NCT00382109|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior sponsor approval.
27192|NCT00382031|Principal Investigators are NOT employed by the organization sponsoring the study.|"The site and the PI may be required to withhold the publication for up to 90 days. Subject to a reasoned request from the sponsor, the publication may be further delayed for a period up to 6 months from the date of first submission to the sponsor.~The sponsor has the right to require deletion of any trade secret, proprietary, or confidential information supplied by the sponsor to the site or the PI. The sponsor shall not otherwise have the right to censor publications."
27193|NCT00382018|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27194|NCT00381940|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27195|NCT00381888|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27196|NCT00381862|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27197|NCT00381849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27198|NCT00381810|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27199|NCT00381797|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27200|NCT00381706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27201|NCT00381693|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27202|NCT00381680|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27203|NCT00381641|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27204|NCT00381628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27205|NCT00381615|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27206|NCT00381563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27207|NCT00381550|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27208|NCT00381485|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27209|NCT00381381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27210|NCT00381303|Principal Investigators are NOT employed by the organization sponsoring the study.|If TTCA does not publish within 12 months after study conclusion or after TTCA confirms there will be no multicenter publication, Institution may publish their results from their site individually, provided TTCA has 60 day review for confidentiality and additional 60 day delay for patent application.
27211|NCT00381238|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27212|NCT00381095|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27213|NCT00381043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27214|NCT00381004|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27215|NCT00380978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27216|NCT00380874|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
27217|NCT00380861|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27218|NCT00380718|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27219|NCT00380692|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27220|NCT00380588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27221|NCT00380367|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27222|NCT00380250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27223|NCT00380081|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor agrees to review manuscripts within a reasonable period of time. If sponsor determines the publication included patentable subject matter, sponsor will be granted no less than 120 days to prepare patent applications.
27224|NCT00380068|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs have right disclose data upon publication of a multi-center publication coordinated by Sponsor or 18 months after Study is completed at all sites if multi-center publication is not submitted by Sponsor within 12 mos. PI to furnish Sponsor with copy of proposed disclosure at least 90 days prior to proposed disclosure. Sponsor has right to ensure accuracy of disclosure and request deletion of confidential information. Sponsor may not make editorial changes to the results or conclusions.
27225|NCT00380029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27226|NCT00379912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27227|NCT00379899|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
27228|NCT00379834|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27229|NCT00379821|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27230|NCT00379808|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27231|NCT00379795|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27232|NCT00379769|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27233|NCT00379639|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene’s request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation
27234|NCT00379587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27235|NCT00379574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27236|NCT00379353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27237|NCT00379340|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27238|NCT00379288|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to publish/present any interim results without prior sponsor written consent. The investigator agrees to provide to the sponsor, 45 days prior to submission, review copies for publication that report any study results. The sponsor has the right to review and comment. If the parties disagree, investigator agrees to meet with the sponsor, prior to submission for publication, to discuss and resolve any such issues/disagreement.
27239|NCT00379236|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
27240|NCT00379210|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27241|NCT00379197|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27242|NCT00379145|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27243|NCT00379080|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27244|NCT00378898|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27245|NCT00378703|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27246|NCT00378599|Principal Investigators are NOT employed by the organization sponsoring the study.|Lead investigator agrees not to publish or publicly present any interim results of the Study without prior written consent of the sponsor. Lead investigator further agrees to provide 45 days written notice to the sponsor prior to submission for publication or presentation to permit the sponsor to review copies of abstracts or manuscripts for publication, which report any results of the Study. Sponsor shall have the right to review and comment on any presentation, including editorial rights.
27247|NCT00378573|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
27248|NCT00378560|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27249|NCT00378534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27250|NCT00378508|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27251|NCT00378378|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27252|NCT00378352|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27253|NCT00378326|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27254|NCT00378209|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27255|NCT00378105|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27256|NCT00378079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27257|NCT00378014|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
27258|NCT00377962|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
27259|NCT00377858|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27260|NCT00377832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27279|NCT00376805|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27261|NCT00377819|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
27262|NCT00377741|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27263|NCT00377676|Principal Investigators are NOT employed by the organization sponsoring the study.|After FDA filing, Principal Liaison shall be free to publish the results of the Study subject only to the provisions of Section 7 regarding Veroscience Proprietary Information. The Principal Liaison shall furnish Veroscience with a copy of any proposed publication for review and comment prior to submission for publication, at least thirty (30) days prior to submission for manuscripts and at least fifteen (15) days prior to submission for abstracts.
27264|NCT00377637|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27265|NCT00377572|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27266|NCT00377520|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27267|NCT00377455|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27268|NCT00377429|Principal Investigators are NOT employed by the organization sponsoring the study.|"The 1st publication of study results shall be a multicenter publication or disclosure coordinated by sponsor.~Prior to submitting for publication, the Investigator shall allow sponsor at least 60 days to review the proposed Publication. Proposed Publications shall not include either Fresenius Biotech confidential information other than the study results or personal data on any patient. If parties disagree, parties will meet to discuss and resolve any disagreements."
27269|NCT00377403|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27270|NCT00377364|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27271|NCT00377312|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27272|NCT00377299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27273|NCT00377260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27274|NCT00377234|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27275|NCT00377156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27276|NCT00376961|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27277|NCT00376948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27278|NCT00376935|Principal Investigators are NOT employed by the organization sponsoring the study.|Restriction Description:In accordance with the Clinical Trial Agreement between NIAID (DAIDS)and company collaborators,NIAID provides companies with a copy of any abstract,press release,or manuscript prior to submission for publication with sufficient time for company review and comment.The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and 5 business days for abstracts,to preserve U.S. or foreign patent or other intellectual property rights.
27280|NCT00376688|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27281|NCT00376675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27282|NCT00376597|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27283|NCT00376558|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27284|NCT00376532|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27285|NCT00376506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27286|NCT00376363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27287|NCT00376259|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27288|NCT00376220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27289|NCT00376168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27290|NCT00375999|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27291|NCT00375973|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27292|NCT00375934|Principal Investigators are NOT employed by the organization sponsoring the study.|
27293|NCT00375752|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until publication of the pooled data (i.e.,data from all sites)in the clinical trial.
27294|NCT00375713|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27295|NCT00375674|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27296|NCT00375609|Principal Investigators are NOT employed by the organization sponsoring the study.|Due to multiple studies, centers and countries this will vary.
27297|NCT00375518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27298|NCT00375505|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety
27299|NCT00375492|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27300|NCT00375427|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27301|NCT00375219|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor's review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor's designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
27302|NCT00374907|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27303|NCT00374868|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27304|NCT00374842|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27305|NCT00374803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27306|NCT00374556|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27307|NCT00374543|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27308|NCT00374452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27309|NCT00374335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27310|NCT00374322|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27311|NCT00374244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27312|NCT00374231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27313|NCT00374140|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27314|NCT00374127|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27315|NCT00374088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27316|NCT00373958|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27317|NCT00373880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27318|NCT00373698|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27319|NCT00373685|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27320|NCT00373529|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
27321|NCT00373490|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27322|NCT00373425|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 60 days prior to publication for review and comment. Sponsor may delay the publication for up to 6 months to seek patent protection.
27323|NCT00373386|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27324|NCT00373360|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27325|NCT00373334|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the principal investigator is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 360 days from the time submitted to the sponsor for review. The sponsor cannot extend the embargo.
27326|NCT00373295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27327|NCT00373269|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27328|NCT00373256|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27329|NCT00373113|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27330|NCT00372996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27331|NCT00372970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27332|NCT00372957|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27333|NCT00372775|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27334|NCT00372697|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
27335|NCT00372619|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27336|NCT00372593|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27337|NCT00372567|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27338|NCT00372528|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27339|NCT00372489|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications may not contain Sponsor confidential information, and may be subject to Sponsor review 30 days prior to submission for publication.
27340|NCT00372424|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27341|NCT00372411|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27342|NCT00372385|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27343|NCT00372190|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27344|NCT00372112|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27345|NCT00372060|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27346|NCT00371865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27347|NCT00371839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27348|NCT00371826|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
27349|NCT00371787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27350|NCT00371761|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator and Institution agree not to publish or publicly present any interim results of the study. Principal Investigator and Institution further agree to provide 45 days written notice to Sponsor prior to submission for publication or presentation to permit Sponsor to review drafts of abstracts and manuscripts for publication.
27351|NCT00371683|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27352|NCT00371644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27353|NCT00371631|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27354|NCT00371566|Principal Investigators are NOT employed by the organization sponsoring the study.|: GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27355|NCT00371540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27356|NCT00371462|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27357|NCT00371449|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27358|NCT00371436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27359|NCT00371397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27360|NCT00371345|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27361|NCT00371293|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27362|NCT00371267|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27363|NCT00371254|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27364|NCT00371176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27365|NCT00371150|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication
27366|NCT00371137|Principal Investigators are NOT employed by the organization sponsoring the study.|
27367|NCT00370994|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27368|NCT00370838|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27369|NCT00370682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27370|NCT00370552|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period of 60 days or less from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
27371|NCT00370331|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27372|NCT00370292|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27373|NCT00370149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27374|NCT00370071|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27375|NCT00370032|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27376|NCT00369967|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27377|NCT00369941|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
27378|NCT00369928|Principal Investigators are NOT employed by the organization sponsoring the study.|It will be the Sponsor’s responsibility to convene and charter a Publications Committee consisting of representation from the Sponsor and key academic and investigational centers. The Publications Committee will be primarily responsible for the creation, review, and submission of publications and presentations relating to the major aspects of the study (design, baseline data, mortality and safety data) and ancillary analyses after the completion of the study.
27379|NCT00369915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27461|NCT00365261|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27380|NCT00369824|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27381|NCT00369785|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27382|NCT00369746|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27383|NCT00369681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27384|NCT00369668|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27385|NCT00369655|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27386|NCT00369590|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27387|NCT00369577|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27388|NCT00369564|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27389|NCT00369512|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27390|NCT00369486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27391|NCT00369382|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27392|NCT00369343|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27393|NCT00369317|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27394|NCT00369278|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27395|NCT00369265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27396|NCT00369226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27397|NCT00369161|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or publication of the trial results in their entirety.
27398|NCT00369122|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27399|NCT00368992|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27400|NCT00368979|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27401|NCT00368966|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27402|NCT00368940|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27403|NCT00368927|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27404|NCT00368875|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27405|NCT00368849|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27406|NCT00368745|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27407|NCT00368641|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27408|NCT00368550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27409|NCT00368537|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27410|NCT00368472|Principal Investigators are NOT employed by the organization sponsoring the study.|
27411|NCT00368459|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27412|NCT00368316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27413|NCT00368290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27414|NCT00368277|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27415|NCT00368251|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27416|NCT00368108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27417|NCT00368069|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27418|NCT00367991|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27419|NCT00367835|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually
27420|NCT00367770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27421|NCT00367744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27422|NCT00367679|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27423|NCT00367640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27424|NCT00367601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27425|NCT00367484|Principal Investigators are NOT employed by the organization sponsoring the study.|
27426|NCT00367432|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27427|NCT00367380|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27428|NCT00367341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27429|NCT00367237|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator must provide 30 days written notice to sponsor prior to submission for publication/presentation, so that sponsor can review the material(s). If the parties disagree concerning the appropriateness of the material for publication, the investigator must meet with sponsor prior to publication/presentation, in order to make good faith efforts to discuss and resolve any disagreements.
27430|NCT00367133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27431|NCT00367055|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27432|NCT00366899|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27433|NCT00366678|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27434|NCT00366626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27435|NCT00366548|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27436|NCT00366457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27437|NCT00366444|Principal Investigators are NOT employed by the organization sponsoring the study.|
27438|NCT00366340|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27439|NCT00366301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27440|NCT00366275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27441|NCT00366249|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27460|NCT00365274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27442|NCT00366106|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the disclosure must be given to Millennium for review at least 30 days before it is submitted for publication or disclosure. If a Development is contained in the disclosure, Research Organization and/or Principal Investigator defer publication or disclosure for 90 days from the time Millennium notifies that it wants to file a patent application on the Development provided such notice was provided by Millennium within 30 days of the copy first provided to Millennium.
27443|NCT00366028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27444|NCT00365976|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27445|NCT00365872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27446|NCT00365859|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27447|NCT00365846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27448|NCT00365768|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27449|NCT00365716|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27450|NCT00365599|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27451|NCT00365547|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27452|NCT00365508|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27453|NCT00365456|Principal Investigators are NOT employed by the organization sponsoring the study.|After publication of the results or 24 months after Clinical Trial Report has been finalised, whichever comes first, Nycomed acknowledge the Investigator's rights to publish results from this trial. Any such scientific paper, presentation, communication, or other information concerning the investigation described in this protocol, must be submitted to Nycomed prior to submission for publication/presentation for review. Review comments will be given within a month from receipt of the manuscript.
27454|NCT00365417|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27455|NCT00365391|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27456|NCT00365378|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27457|NCT00365365|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission for publication. The Sponsor may request for the publication to be delayed for upto 90 days to preserve its proprietary rights.
27458|NCT00365352|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27459|NCT00365300|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27462|NCT00365209|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27463|NCT00365144|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27464|NCT00365105|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
27465|NCT00365053|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27466|NCT00364949|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27467|NCT00364923|Principal Investigators are NOT employed by the organization sponsoring the study.|Allos agreements with investigators (PIs) may vary. The PI may publish/make public data from the trial after the earlier of publication by Allos or 18 months after study completion. Allos can review results communications prior to public release and can embargo communications regarding trial results for a period less than or equal to 90 days from submission for review. Allos can request changes to the communication related to confidential or patent information, or to ensure accuracy.
27468|NCT00364858|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
27469|NCT00364845|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27470|NCT00364832|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27471|NCT00364819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27472|NCT00364793|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27473|NCT00364611|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 60 days in advance of any submission for publication. The Sponsor may request for the publication to be delayed for a limited time, not to exceed 90 days to preserve its proprietary rights.
27474|NCT00364533|Principal Investigators are NOT employed by the organization sponsoring the study.|A provision provides for 60 day prior review by sponsor extendable by 60 days to file a patent application and prior written consent of sponsor for disclosure of confidential information, if any.
27475|NCT00364377|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27476|NCT00364351|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
27477|NCT00364286|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27478|NCT00364182|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27479|NCT00364156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27480|NCT00364130|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27481|NCT00364013|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27482|NCT00363896|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
27483|NCT00363883|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27484|NCT00363805|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27485|NCT00363779|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27486|NCT00363675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27487|NCT00363545|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27488|NCT00363480|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27489|NCT00363467|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27490|NCT00363415|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27491|NCT00363311|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27492|NCT00363298|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27493|NCT00363246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27494|NCT00363168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27495|NCT00363142|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27496|NCT00363129|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27497|NCT00363077|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27498|NCT00363051|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis's agreements with it's investigators vary. However, Novartis does not prohibit any investigator from publishing. Any publication from a single-center site is postponed until the publication of the pooled data ( i.e. data from all sites) in the clinical trial.
27499|NCT00363038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27500|NCT00362882|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27501|NCT00362817|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27502|NCT00362648|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27503|NCT00362609|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
27504|NCT00362466|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27505|NCT00362453|Principal Investigators are NOT employed by the organization sponsoring the study.|The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Complementary and Alternative Medicine or the National Institutes of Health. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript.
27506|NCT00362440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27507|NCT00362414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27508|NCT00362401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27509|NCT00362375|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27510|NCT00362336|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27511|NCT00362297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27512|NCT00362232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27513|NCT00362180|Principal Investigators are NOT employed by the organization sponsoring the study.|PI gives Sponsor a draft 90 days before publication. Sponsor has the right to demand that confidential information be removed, and can defer publication another 180 days upon notifying PI that it will file a patent application on inventions contained in the draft.
27514|NCT00362128|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27515|NCT00362115|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
27516|NCT00361972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27517|NCT00361712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27518|NCT00361634|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial resul
27519|NCT00361595|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27594|NCT00357370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27520|NCT00361569|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can (i) review results communications prior to public release and can embargo communications regarding trial results for a period of at least 60 days but no more than 180 days from the time submitted to the sponsor for review; and (ii) require in instances of a multi-center study, that a single PI not disclose study data until after the multi-center results are published, provided such results are published within eighteen (18) months of the conclusion of the study.
27521|NCT00361504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27522|NCT00361439|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27523|NCT00361374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27524|NCT00361335|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
27525|NCT00361283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27526|NCT00361270|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27527|NCT00361257|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
27528|NCT00361231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27529|NCT00361218|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27530|NCT00361140|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27531|NCT00360971|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
27532|NCT00360828|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27533|NCT00360724|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27534|NCT00360698|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
27535|NCT00360685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27536|NCT00360672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27537|NCT00360568|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
27538|NCT00360555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27595|NCT00357331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27539|NCT00360529|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Sprout Pharmaceuticals publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
27540|NCT00360490|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator shall provide Sponsor an advanced copy of any proposed publication at least 60 days prior to the planned date of publication. Sponsor shall have 30 days to recommend changes. Institution and Principal Investigator agree that adoption of recommended changes shall not be unreasonably refused.
27541|NCT00360412|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27542|NCT00360399|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27543|NCT00360360|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
27544|NCT00360334|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27545|NCT00360308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27546|NCT00360282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27547|NCT00360269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27548|NCT00360243|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27549|NCT00360230|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27550|NCT00360126|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27551|NCT00360009|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27552|NCT00359983|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27553|NCT00359944|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27554|NCT00359801|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27555|NCT00359788|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
27556|NCT00359762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27557|NCT00359736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27558|NCT00359632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27559|NCT00359619|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27560|NCT00359424|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication will be authored prior to 12 mos after publication of the primary results without consent of the Publications Subcommittee. 12 mos after this time an Investigator may publish the results at the Collaborating Institution. No institution involved may be restricted from publishing independently 12 mos from publication of the primary paper. After 12 mo all manuscripts from the study must be submitted to the PI/Publications Subcommittee 45 days prior to any submission.
27561|NCT00359281|Principal Investigators are NOT employed by the organization sponsoring the study.|
27562|NCT00359216|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27563|NCT00359203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27564|NCT00359138|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27565|NCT00359073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27566|NCT00359021|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees that before he/she publishes any results of this trial, he/she shall provide the sponsor with at least 45 days for full review of the pre-publication manuscript prior to submission of the manuscript to the publisher.
27567|NCT00358956|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
27568|NCT00358917|Principal Investigators are NOT employed by the organization sponsoring the study.|This study has varying agreements that have been negotiated individually; however, it appears that the most restrictive of the agreements states that following the first publication/presentation of the study by Abbott (or twelve [12] months after the completion of the study at all sites, whichever occurs first), the Principal Investigator (PI) shall, during a period of twelve (12) months, have the right to publish/present the results of the site.
27569|NCT00358826|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented as a joint, multi-center publication.
27570|NCT00358735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27571|NCT00358670|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to release and can embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to the sponsor for review. If the parties disagree on the communication, the investigator and sponsor's representative will meet for the purpose of making a good faith effort to discuss and resolve any such issues or disagreement.
27572|NCT00358644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27573|NCT00358579|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27574|NCT00358527|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is not allowed to release any interim results of the Study without prior consent of the sponsor, and must provide 45 days written notice to the sponsor prior to public release to permit the sponsor's review. The PI can use the study results for his/her own teaching, research, and publication purposes only, not for commercial purposes, except as authorized by the sponsor. No publication shall contain any trade secret or proprietary/confidential information of the sponsor.
27575|NCT00358501|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27576|NCT00358462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27577|NCT00358449|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27578|NCT00358436|Principal Investigators are NOT employed by the organization sponsoring the study.|All the information related to this clinical trial is considered strictly confidential and is the property of Almirall. This information will not be given to a third party without the written consent of Almirall. Publication and/or presentation, whether complete or partial, of any part of the data or results of this trial will be subject to revision and written agreement between the investigator and Almirall.
27579|NCT00358332|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27580|NCT00358215|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27581|NCT00358150|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
27582|NCT00358007|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27583|NCT00357994|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
27584|NCT00357968|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27585|NCT00357955|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27586|NCT00357903|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
27587|NCT00357877|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27588|NCT00357760|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27589|NCT00357734|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27590|NCT00357656|Principal Investigators are NOT employed by the organization sponsoring the study.|"Agreements with PIs may vary per requirements of individual PI, but contain common elements.~For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication. Baxalta requires a review of results communication (e.g. for confidential information) >= 30 days prior to submission. Baxalta may request an additional delay of <=120 days (e.g. for intellectual property protection)."
27591|NCT00357552|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
27592|NCT00357500|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27593|NCT00357396|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27596|NCT00357162|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27597|NCT00357110|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI will provide ASTRAZENECA as soon as possible with preliminary data and drafts of proposed results communications and with the proposed final draft at least 14 days prior to submission of an abstract and 30 days prior to submission of a manuscript. ASTRAZENECA can, upon written request, embargo communications regarding trial results for no more than 45 days from the date of the written request. ASTRAZENECA cannot require changes to the communication and cannot extend the embargo.
27598|NCT00357097|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27599|NCT00357032|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27600|NCT00357006|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27601|NCT00356915|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27602|NCT00356889|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27603|NCT00356863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27604|NCT00356811|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27605|NCT00356603|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27606|NCT00356590|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
27607|NCT00356525|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27608|NCT00356434|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27609|NCT00356421|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
27610|NCT00356408|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
27611|NCT00356304|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27612|NCT00356278|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27613|NCT00356265|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27614|NCT00356200|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27615|NCT00356187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27616|NCT00356148|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27617|NCT00356135|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27618|NCT00356122|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 60 days in advance of any submission for publication. The Sponsor may request for the publication to be delayed for a limited time, not to exceed 90 days to preserve its proprietary rights.
27619|NCT00356057|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results.
27620|NCT00356031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27621|NCT00355914|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27622|NCT00355797|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27623|NCT00355784|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27624|NCT00355706|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27625|NCT00355615|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27626|NCT00355472|Principal Investigators are NOT employed by the organization sponsoring the study.|
27627|NCT00355394|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27628|NCT00355368|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27629|NCT00355342|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27630|NCT00355199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27631|NCT00355147|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27632|NCT00355134|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27633|NCT00355121|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27634|NCT00355082|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27635|NCT00355030|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27636|NCT00354978|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27637|NCT00354913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27638|NCT00354887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27639|NCT00354835|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27640|NCT00354770|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27641|NCT00354744|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27642|NCT00354679|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27643|NCT00354640|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27644|NCT00354614|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27645|NCT00354601|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27646|NCT00354484|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27647|NCT00354432|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27648|NCT00354341|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27649|NCT00354172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27650|NCT00354159|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Medtronic reviews publications to determine if confidential information (CI) is included. Any such CI is deleted before publication. Medtronic may not censor/interfere with the publication. Investigators may publish single-site publications after a decision by Medtronic that no multi-site study publication will be done or 12 months after the study is closed, whichever is earlier."
27651|NCT00354107|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27652|NCT00354029|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27653|NCT00353977|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27654|NCT00353873|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27655|NCT00353834|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27656|NCT00353795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27657|NCT00353704|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27658|NCT00353652|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27659|NCT00353496|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27660|NCT00353431|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27661|NCT00353418|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27662|NCT00353366|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27663|NCT00353301|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27664|NCT00353275|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27665|NCT00353262|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27666|NCT00353119|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27667|NCT00352911|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27668|NCT00352885|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27669|NCT00352846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27670|NCT00352781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27671|NCT00352755|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27672|NCT00352690|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27673|NCT00352664|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27674|NCT00352612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27675|NCT00352534|Principal Investigators are NOT employed by the organization sponsoring the study.|
27676|NCT00352417|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 30 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable.
27677|NCT00352365|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27678|NCT00352118|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27679|NCT00352105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27680|NCT00352053|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
27681|NCT00352027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27682|NCT00351936|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27683|NCT00351819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27684|NCT00351741|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27685|NCT00351533|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27686|NCT00351468|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
27687|NCT00351416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27688|NCT00351377|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27689|NCT00351351|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27690|NCT00351299|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27691|NCT00351273|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27692|NCT00351039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27693|NCT00351000|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27694|NCT00350870|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27695|NCT00350844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27696|NCT00350792|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27697|NCT00350779|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27698|NCT00350727|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27699|NCT00350636|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27700|NCT00350623|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27701|NCT00350545|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27702|NCT00350532|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27703|NCT00350519|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27704|NCT00350402|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27705|NCT00350363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27706|NCT00350272|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to submitting/presenting a manuscript or materials relating to a Study to a publisher, reviewer, or outside person, the Institution shall provide to Achillion a copy of all such manuscripts or materials, and Achillion shall have thirty (30) days to review and comment. The Institution shall, upon Achillion's request, further delay publication or presentation for a period of up to sixty (60) days to allow Achillion to protect its interests in any Achillion Inventions.
27707|NCT00350220|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27708|NCT00350207|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
27709|NCT00350142|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27710|NCT00350025|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27711|NCT00349921|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27712|NCT00349908|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27713|NCT00349778|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27714|NCT00349752|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27715|NCT00349713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27716|NCT00349622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27717|NCT00349466|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27718|NCT00349388|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27719|NCT00349349|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27720|NCT00349336|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27721|NCT00348933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27722|NCT00348881|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27723|NCT00348816|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27724|NCT00348790|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27725|NCT00348686|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27726|NCT00348673|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27727|NCT00348556|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27728|NCT00348374|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27729|NCT00348348|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has 45 days to review materials and provide comments back to the investigator.
27730|NCT00348309|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27731|NCT00348283|Principal Investigators are NOT employed by the organization sponsoring the study.|Provide ABBOTT at least sixty (60) days prior to submission for review, ABBOTT shall return within sixty (60) days. Proposed draft shall be delayed an additional sixty (60) days in addition to the Review Period
27732|NCT00348140|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27733|NCT00347958|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27734|NCT00347932|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has 45 days to review materials and provide comments back to the investigator.
27735|NCT00347919|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27736|NCT00347776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27737|NCT00347438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27738|NCT00347360|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the Publication of results from all centers of a multi-center trial but requests that reports based on Single-site data not precede the primary publication of the entire clinical trial.
27739|NCT00347308|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27740|NCT00347269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27741|NCT00347022|Principal Investigators are NOT employed by the organization sponsoring the study.|"Draft of publication to be submitted by the coordinating investigator (no more than 6 months after getting study results) to sponsor and other investigators for review at least 1 month before the submission to the scientific review. Comments to be reviewed and approved by the coordinating investigator and sponsor.~Each investigator agrees not to publish the comparison of the renal tolerance involving only the patients he/she has included."
27763|NCT00345540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27742|NCT00347009|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27743|NCT00346905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27744|NCT00346775|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27745|NCT00346697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27746|NCT00346632|Principal Investigators are NOT employed by the organization sponsoring the study.|
27747|NCT00346476|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27748|NCT00346398|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27749|NCT00346333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27750|NCT00346268|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27751|NCT00346216|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27752|NCT00346164|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27753|NCT00346151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27754|NCT00346034|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results
27755|NCT00345969|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27756|NCT00345878|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27757|NCT00345839|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27758|NCT00345683|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27759|NCT00345631|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27760|NCT00345605|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27761|NCT00345592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27762|NCT00345579|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27764|NCT00345397|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27765|NCT00345384|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27766|NCT00345371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27767|NCT00345332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27768|NCT00345293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27769|NCT00345254|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27770|NCT00345176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27771|NCT00345046|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27772|NCT00345033|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27773|NCT00344968|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27774|NCT00344773|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27775|NCT00344682|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27776|NCT00344500|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27777|NCT00344487|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27778|NCT00344461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27779|NCT00344448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27780|NCT00344370|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27781|NCT00344305|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restricion is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27782|NCT00344175|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27783|NCT00344032|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27784|NCT00344019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27785|NCT00343915|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27786|NCT00343889|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
27787|NCT00343863|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27788|NCT00343785|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27789|NCT00343564|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor intends to publish the results of the trial in collaboration with the Investigators.
27790|NCT00343512|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27791|NCT00343460|Principal Investigators are NOT employed by the organization sponsoring the study.|A period of 60 working days for presentational material and abstracts and 90 days for manuscripts is permitted for the sponsor's review. The sponsor can request modifications of any manuscript or other materials to be published or presented. The sponsor can also request additional time to obtain additional patent protection or take such other measures to establish and preserve its intellectual property and proprietary rights before publishing information from this trial.
27792|NCT00343382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27793|NCT00343291|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27794|NCT00343252|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27795|NCT00343083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27796|NCT00343044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27797|NCT00342628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27798|NCT00342563|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27799|NCT00342355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27800|NCT00340834|Principal Investigators are NOT employed by the organization sponsoring the study.|"There IS an agreement between the Principal Investigator and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."
27801|NCT00340704|Principal Investigators are NOT employed by the organization sponsoring the study.|Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights.
27802|NCT00340678|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27803|NCT00340379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27804|NCT00339833|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27805|NCT00339183|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27846|NCT00336505|Principal Investigators are NOT employed by the organization sponsoring the study.|
27806|NCT00339144|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27807|NCT00339079|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27808|NCT00339040|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and Merck & Co., Inc., NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
27809|NCT00338988|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27810|NCT00338962|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27811|NCT00338884|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27812|NCT00338806|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27813|NCT00338741|Principal Investigators are NOT employed by the organization sponsoring the study.|
27814|NCT00338598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27815|NCT00338455|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27816|NCT00338286|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days.
27817|NCT00338104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27818|NCT00338039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27819|NCT00337987|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27820|NCT00337935|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27821|NCT00337818|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27822|NCT00337779|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
27823|NCT00337727|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27824|NCT00337675|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27869|NCT00334893|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27825|NCT00337662|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27826|NCT00337610|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27827|NCT00337571|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27828|NCT00337467|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27829|NCT00337428|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27830|NCT00337350|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27831|NCT00337285|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
27832|NCT00337272|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must provide Sponsor an advance copy of any proposed publication whether in journals or in conferences or other public forum at least 60 days prior to any submission for publication or public presentation so that Sponsor may determine whether it contains any Confidential Information of Sponsor, and/or any discovery or invention is made.
27833|NCT00337207|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27834|NCT00337194|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27835|NCT00337168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27836|NCT00337129|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27837|NCT00337103|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27838|NCT00337077|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27839|NCT00336973|Principal Investigators are NOT employed by the organization sponsoring the study.|
27840|NCT00336895|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27841|NCT00336856|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27842|NCT00336817|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27843|NCT00336700|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27844|NCT00336583|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27845|NCT00336544|Principal Investigators are NOT employed by the organization sponsoring the study.|
27847|NCT00336492|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27848|NCT00336479|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27849|NCT00336323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27850|NCT00336284|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide copies of any abstracts, papers or manuscripts to the Sponsor for review within a reasonable period prior to submittal for publication. BIOTRONIK limits its review to a determination of whether Confidential Information (CI) is disclosed and may not attempt to censor or in any way interfere with the investigator's presentation or conclusions beyond the extent necessary to protect CI or to allow to protect its rights in patentable or copyrightable material.
27851|NCT00336232|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27852|NCT00335972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27853|NCT00335959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27854|NCT00335829|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27855|NCT00335777|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27856|NCT00335738|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27857|NCT00335725|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27858|NCT00335556|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
27859|NCT00335517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27860|NCT00335504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27861|NCT00335478|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27862|NCT00335452|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the study is made jointly in the name of all wholehearted collaborators. Other papers are authored based on the contributions of the individuals to the overall study. Sub-studies with scientific merit which have received prior approvals of the Steering Committee may be published separately in the names of contributing Investigators. A copy of all manuscripts are provided to the Sponsors for their review and the final decision to publish is made by the Steering Committee.
27863|NCT00335322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27864|NCT00335283|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27865|NCT00335257|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27866|NCT00335153|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
27867|NCT00335140|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27868|NCT00334958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27870|NCT00334815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27871|NCT00334802|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27872|NCT00334633|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27873|NCT00334542|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27874|NCT00334295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27875|NCT00334282|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27876|NCT00334204|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27877|NCT00334113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27878|NCT00334074|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27879|NCT00334061|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27880|NCT00333983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27881|NCT00333970|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27882|NCT00333879|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27883|NCT00333866|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
27884|NCT00333840|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27885|NCT00333814|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
27886|NCT00333801|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27887|NCT00333788|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27888|NCT00333775|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27889|NCT00333762|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27890|NCT00333710|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27891|NCT00333619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27892|NCT00333437|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27893|NCT00333359|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27894|NCT00333229|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial or disclosure of trial results in their entirety.
27895|NCT00333138|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27896|NCT00332839|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
27897|NCT00332722|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27898|NCT00332709|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety.
27899|NCT00332696|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure Restriction Description: The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or of the trial results in their entirety.
27900|NCT00332644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27901|NCT00332605|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27902|NCT00332579|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27903|NCT00332488|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
27904|NCT00332462|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27905|NCT00332332|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27906|NCT00332241|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27907|NCT00332189|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the results shall be made in a joint publication. If such a multi-center publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however, to compliance with the other terms of the agreement.
27908|NCT00332163|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27909|NCT00331864|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
27910|NCT00331799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27911|NCT00331773|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
27912|NCT00331760|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27913|NCT00331682|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27914|NCT00331552|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27915|NCT00331422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27916|NCT00331409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27917|NCT00331344|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27918|NCT00331006|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter donated Factor VIII and Genentech donated rituximab for the study. Both Baxter and Genentech can review results communications prior to public release for a period of time less than or equal to 60 days from the time submitted to them for review. These companies cannot require changes to the communication.
27919|NCT00330967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27920|NCT00330928|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27921|NCT00330915|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27922|NCT00330876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27923|NCT00330759|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
27924|NCT00330733|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27925|NCT00330681|Principal Investigators are NOT employed by the organization sponsoring the study.|
27926|NCT00330668|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator may publish or report data from their own subjects. The trial data in aggregate are the property of Tercica, Inc. and may not be published without permission of Tercica, Inc. Tercica, Inc. will be the final arbitrator of issues relating to the publication or presentation of the aggregate data.
27927|NCT00330616|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27928|NCT00330564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27929|NCT00330460|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
27930|NCT00330421|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27931|NCT00330382|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27932|NCT00330343|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27933|NCT00330174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27934|NCT00330161|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27935|NCT00329901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27936|NCT00329849|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27937|NCT00329836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27938|NCT00329797|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
27939|NCT00329784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27940|NCT00329771|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27941|NCT00329745|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27942|NCT00329732|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27943|NCT00329719|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27944|NCT00329641|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27945|NCT00329602|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27946|NCT00329550|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27947|NCT00329524|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27948|NCT00329433|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27949|NCT00329420|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
27950|NCT00329407|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27951|NCT00329238|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
27952|NCT00329160|Principal Investigators are NOT employed by the organization sponsoring the study.|
27953|NCT00329108|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27954|NCT00329030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27955|NCT00328926|Principal Investigators are NOT employed by the organization sponsoring the study.|
27956|NCT00328861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27957|NCT00328783|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27958|NCT00328770|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27959|NCT00328627|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
27960|NCT00328614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27961|NCT00328562|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27962|NCT00328510|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27963|NCT00328263|Principal Investigators are NOT employed by the organization sponsoring the study.|Any proposed publication or formal presentation of the data directly derived from the study shall be submitted to Bio-K+. Bio-K+ will have 15 business days to give comments to the Investigator.This review is no way intended to restrict publication of facts or opinions formulated by the Investigator through this research.
27964|NCT00328198|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after an independent multi-investigator publication (in which the PI can participate) or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
27965|NCT00328172|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
27966|NCT00328094|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27967|NCT00328042|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27968|NCT00328016|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27969|NCT00327717|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27970|NCT00327470|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
27971|NCT00327444|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days) in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
27972|NCT00327392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27973|NCT00327340|Principal Investigators are NOT employed by the organization sponsoring the study.|All investigators had an agreement with the Canadian Urological Oncology Group (CUOG). The investigators were to provide CUOG with text to be presented or published 45 days prior to the release for review. Results from one institution were not to be presented before the multi-center publication. If there is no multi-center publication within 12 months after the Study completion the Investigator had the right to publish the results.
27974|NCT00327171|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study, for review and comment at least 45 days in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
27975|NCT00327015|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27976|NCT00326963|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
27977|NCT00326950|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27978|NCT00326924|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27979|NCT00326911|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators agreed to delay independently publishing or disclosing data, findings or conclusions from the study except as part of a multi-center publication. Upon study publication or if draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to confidential information review/redaction by sponsor. Sponsor may request publication delay up to 90 days to seek patent protection.
27980|NCT00326898|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27981|NCT00326885|Principal Investigators are NOT employed by the organization sponsoring the study.|The Site may publish the results of the Study after such cooperative publication, or 1 year after Sponsor's final evaluation of all the Study data from all sites, whichever occurs first. Prior to any submission for publication, presentation, or communication of results or information arising from the Study, Investigator shall provide Fresenius Biotech at least 90 days for review and comment upon the manuscript or other material for such publication or presentation.
27982|NCT00326872|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27983|NCT00326781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27984|NCT00326716|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
27985|NCT00326612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27986|NCT00326599|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27987|NCT00326495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27988|NCT00326417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27989|NCT00326196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27990|NCT00326183|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27991|NCT00326170|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27992|NCT00326118|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
27993|NCT00326001|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27994|NCT00325897|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27995|NCT00325819|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27996|NCT00325780|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
27997|NCT00325754|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27998|NCT00325598|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
27999|NCT00325468|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28000|NCT00325442|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28001|NCT00325416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28002|NCT00325403|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the results of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28003|NCT00325234|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28004|NCT00325195|Principal Investigators are NOT employed by the organization sponsoring the study.|Multicenter publication is to be generated before any individual PI publishes on the results. If multicenter publication is not completed within 18 months from the date of completion, then PI can publish individual results from the Study. Sponsor can review results prior to public release and embargo for no more than 90 days. Sponsor can request removal of Confidential Information only.
28005|NCT00325156|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28006|NCT00325143|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28007|NCT00325130|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28008|NCT00325078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28009|NCT00325039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28010|NCT00324987|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28011|NCT00324961|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28012|NCT00324896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28013|NCT00324870|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28014|NCT00324857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28015|NCT00324805|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28016|NCT00324740|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28017|NCT00324701|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28018|NCT00324675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28019|NCT00324649|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other scholarly media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years."
28020|NCT00324415|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28021|NCT00324350|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28022|NCT00324272|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28023|NCT00324259|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28024|NCT00324233|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28025|NCT00324168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28044|NCT00323271|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28026|NCT00324155|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28027|NCT00324116|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28028|NCT00324038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28029|NCT00323882|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28030|NCT00323869|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28031|NCT00323739|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
28032|NCT00323635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28033|NCT00323622|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28034|NCT00323609|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28035|NCT00323557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28036|NCT00323492|Principal Investigators are NOT employed by the organization sponsoring the study.|After conclusion of the study and without prior written approval from Gilead Sciences, investigators in this study may communicate, orally present, or publish in scientific journals or other scholarly media only after the following conditions have been met: results of the study in their entirety have been publicly disclosed by or with the consent of Gilead Sciences in an abstract, manuscript, or presentation form; or study has been completed at all study sites for at least 2 years.
28037|NCT00323479|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28038|NCT00323427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28039|NCT00323414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28040|NCT00323362|Principal Investigators are NOT employed by the organization sponsoring the study.|The CINJ PI, and all co-authors, prior to submission or use, must review any abstract or manuscript.
28041|NCT00323310|Principal Investigators are NOT employed by the organization sponsoring the study.|The results of the study may be presented during scientific symposia or published in a scientific journal only after review by Bracco in accordance with the guidelines set forth in the applicable publication or financial agreement.
28042|NCT00323297|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28043|NCT00323284|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28045|NCT00323258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28046|NCT00323193|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28047|NCT00323115|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28048|NCT00323063|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28049|NCT00323037|Principal Investigators are NOT employed by the organization sponsoring the study.|The publishing party will submit any proposed manuscript or publication to the sponsor for comment at least 60 days prior to its release. The publishing party will make every reasonable attempt to incorporate comments received from the sponsor, and will upon request remove any previously undisclosed confidential information, prior to publication or disclosure. There will be no publication or publicizing of individual site data or results prior to the multicenter publication.
28050|NCT00322881|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28051|NCT00322868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28052|NCT00322855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28053|NCT00322842|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
28054|NCT00322777|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28055|NCT00322712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28056|NCT00322621|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28057|NCT00322556|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
28058|NCT00322491|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
28059|NCT00322465|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28060|NCT00322452|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent applications.
28061|NCT00322439|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28062|NCT00322387|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
28063|NCT00322374|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28064|NCT00322348|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the Principal Investigator and the Sponsor (or its agents). The only disclosure restriction on the PI is that they cannot disclose or publish any information to do with the trial without consent from AstraZeneca.
28065|NCT00322335|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28066|NCT00322309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28067|NCT00322231|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28068|NCT00322153|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential info. Upon sponsor's request, PI shall delete any proprietary info & shall not include raw data in pub. On sponsor's request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub.
28069|NCT00322101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28070|NCT00322049|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28071|NCT00321984|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28072|NCT00321971|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28073|NCT00321932|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28074|NCT00321919|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28075|NCT00321906|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28076|NCT00321893|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28077|NCT00321854|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28078|NCT00321828|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28079|NCT00321789|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28080|NCT00321763|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28081|NCT00321737|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28120|NCT00319644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28082|NCT00321711|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
28083|NCT00321698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28084|NCT00321685|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28085|NCT00321672|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review. The PI shall comply with the sponsor's requests to delete references to trade secrets, intellectual properties or other proprietary information.
28086|NCT00321646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28087|NCT00321620|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28088|NCT00321594|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28089|NCT00321464|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28090|NCT00321373|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28091|NCT00321321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28092|NCT00321269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28093|NCT00320801|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28094|NCT00320788|Principal Investigators are NOT employed by the organization sponsoring the study.|After completion of the trial, the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review; provided that the sponsor can remove confidential or proprietary information from such communications. The sponsor cannot require other changes to the communication and cannot extend the embargo.
28095|NCT00320749|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28096|NCT00320710|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
28097|NCT00320671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28098|NCT00320606|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28099|NCT00320593|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28100|NCT00320541|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28101|NCT00320528|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28102|NCT00320515|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28103|NCT00320489|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28104|NCT00320424|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28105|NCT00320411|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28106|NCT00320398|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28107|NCT00320385|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28108|NCT00320372|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28109|NCT00320281|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28110|NCT00320255|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28111|NCT00320242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28112|NCT00320216|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28113|NCT00320190|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication
28114|NCT00320112|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28115|NCT00319982|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28116|NCT00319839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28117|NCT00319748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28118|NCT00319735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28119|NCT00319696|Principal Investigators are NOT employed by the organization sponsoring the study.|
28121|NCT00319592|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28122|NCT00319553|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28123|NCT00319501|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28124|NCT00319449|Principal Investigators are NOT employed by the organization sponsoring the study.|"The principal investigator (PI) agrees not to publish or publicly present~any interim results of the Study without prior written consent of the SPONSOR.~The PI further agrees to provide thirty (30) days written notice to the SPONSOR prior to submission for publication or presentation to allow SPONSOR to review abstracts or manuscripts for publication."
28125|NCT00319436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28126|NCT00319254|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28127|NCT00319111|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from multi-center studies must be published or presented at congresses only in their entirety and not as individual center data, except for ancillary studies. Any study-related article or abstract written independently by investigators should be submitted to Actelion for review at least 60 days prior to submission for publication or presentation.
28128|NCT00319098|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28129|NCT00319046|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28130|NCT00319020|Principal Investigators are NOT employed by the organization sponsoring the study.|Any study-related article or abstract written independently by investigators should be submitted to Actelion for review at least 60 days prior to submission for publication or presentation.
28131|NCT00318929|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28132|NCT00318812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28133|NCT00318708|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28134|NCT00318656|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28135|NCT00318591|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28136|NCT00318565|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28137|NCT00318474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28138|NCT00318461|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
28139|NCT00318409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28140|NCT00318370|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28141|NCT00318292|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28142|NCT00318136|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28143|NCT00317941|Principal Investigators are NOT employed by the organization sponsoring the study.|According the contract he signed, If results should have been edited, the Principal Investigators (PI) should have been obtained the agreement from the sponsor 90 days before the publication. The PI was not allowed to communicate within a public way the information on the study without having obtained the sponsor’s agreement.
28144|NCT00317720|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28145|NCT00317642|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
28146|NCT00317473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28147|NCT00317239|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28148|NCT00317226|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28149|NCT00317109|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28150|NCT00317044|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28151|NCT00316914|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28152|NCT00316888|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28153|NCT00316862|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28154|NCT00316719|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28155|NCT00316706|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28156|NCT00316693|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28157|NCT00316355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28158|NCT00316303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28159|NCT00316277|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28160|NCT00316264|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
28161|NCT00316225|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28162|NCT00316199|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28163|NCT00316186|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28164|NCT00316173|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28165|NCT00316121|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI cannot publish the results without consent of Sponsor. The results must be given to Sponsor 60 days prior to use. This review is not meant to curtail distribution of data, but to identify confidential material and/or to review the content for conformance to regulations. The Sponsor has the right to edit materials to preserve confidentiality of proprietary information. If requested, the Institution and PI will withhold publication for 60 days to allow for filing of a patent application.
28166|NCT00316082|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28167|NCT00316017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28168|NCT00316004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28169|NCT00315939|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28170|NCT00315822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28171|NCT00315731|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28172|NCT00315705|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
28173|NCT00315627|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28174|NCT00315614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28175|NCT00315588|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28176|NCT00315458|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28177|NCT00315445|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28178|NCT00315341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28179|NCT00315328|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28180|NCT00315302|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28181|NCT00315146|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28182|NCT00315120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28183|NCT00315055|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
28184|NCT00314951|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28185|NCT00314808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28186|NCT00314574|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."
28187|NCT00314366|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28188|NCT00314353|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28189|NCT00314340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28190|NCT00314327|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28191|NCT00314262|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28192|NCT00314249|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor’s confidential info. Upon sponsor’s request, PI shall delete any proprietary info & shall not include raw data in pub. On sponsor’s request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub.
28193|NCT00314236|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure restriction on the Institution/PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is > 60 days but ≤ 90 days from time submitted to sponsor for review. Sponsor can require changes to communication. Control over publication/presentation shall be extended for maximum of 2 years after termination of Trial, after which Institution/PI shall be free to publish/present without restraint.
28194|NCT00314145|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28195|NCT00314132|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28196|NCT00314106|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28253|NCT00309452|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28197|NCT00313911|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28198|NCT00313846|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28199|NCT00313820|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28200|NCT00313781|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28201|NCT00313716|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28202|NCT00313703|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28203|NCT00313612|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28204|NCT00313586|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28205|NCT00313443|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28206|NCT00313313|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28207|NCT00313300|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28208|NCT00313209|Principal Investigators are NOT employed by the organization sponsoring the study.|The study results may be published and/or presented at scientific meetings. Prior to any submission, all manuscripts/abstracts must be presented to the sponsor for possible comments.
28209|NCT00313170|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28210|NCT00313144|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs vary per individual PI, but contain common elements. Baxter may require a review of results communications (e.g., for confidential information & intellectual property) ≥45 days prior to submission or communication for review and comment. Baxter reserves the right to remove all confidential information from all publications.
28211|NCT00313014|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28212|NCT00312923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28213|NCT00312897|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28214|NCT00312884|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28254|NCT00309387|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28215|NCT00312858|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28216|NCT00312845|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28217|NCT00312728|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28218|NCT00312572|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28219|NCT00312494|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28220|NCT00312377|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
28221|NCT00312338|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28222|NCT00312221|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28223|NCT00312208|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
28224|NCT00312195|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28225|NCT00311766|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28226|NCT00311584|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
28227|NCT00311402|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
28228|NCT00311376|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28229|NCT00311363|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28230|NCT00311311|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28231|NCT00311181|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28232|NCT00311155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28233|NCT00310856|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigators from publishing. Any publications from a single site are postponed until the publication of the pool data (i.e., data from all sites) in the clinical trial.
28234|NCT00310817|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28235|NCT00310804|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28236|NCT00310791|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28237|NCT00310466|Principal Investigators are NOT employed by the organization sponsoring the study.|ALK must receive copies of any intended communication in advance of publication (at least 15 working days for an abstract or oral presentation and 45 working days for a journal submission). ALK will review the communications for accuracy (thus avoiding potential discrepancies with submissions to health authorities), verify that confidential information is not being inadvertently divulged and provide any relevant supplementary information.
28238|NCT00310440|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28239|NCT00310427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28240|NCT00310401|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28241|NCT00310375|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28242|NCT00310362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28243|NCT00310310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28244|NCT00310076|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28245|NCT00309985|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28246|NCT00309946|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28247|NCT00309907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28248|NCT00309777|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28249|NCT00309751|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28250|NCT00309738|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28251|NCT00309608|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28252|NCT00309465|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28255|NCT00309244|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multi-center Study publication, PI may publish the Study results subject to MNKD rights herein.
28256|NCT00308997|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28257|NCT00308737|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
28258|NCT00308711|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28259|NCT00308620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28260|NCT00308581|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28261|NCT00308555|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28262|NCT00308516|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
28263|NCT00308308|Principal Investigators are NOT employed by the organization sponsoring the study.|MannKind has right to 1st joint multicenter publication. After 1st publication PI may publish data only if PI submits proposed publication to MNKD for review 60 days prior to publication date. MNKD may remove any confidential information. If a multicenter publication is not submitted 12 months after conclusion, abandonment, or termination of the Study at all sites, or if MNKD confirms there will be no multicenter Study publication, PI may publish the Study results subject to MNKD rights herein.
28264|NCT00308230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28265|NCT00308139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28266|NCT00308113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28267|NCT00308087|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigator agrees to provide sponsor with an advance copy of any proposed publication or presentation at least 60 days prior to the planned submission or presentation. Genzyme shall have 30 days in which to recommend changes and to inform investigator if confidential information is contained. In the event of the latter, investigator will delay or prevent publication for no more that 90 days to permit sponsor to file a patent application.
28268|NCT00308074|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28269|NCT00308061|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28270|NCT00307931|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28271|NCT00307801|Principal Investigators are NOT employed by the organization sponsoring the study.|Schering AG is interested in the publication of the results of every study. As some of the information concerning the study drug and development activities at Schering AG may be of strictly confidential nature, any publication manuscript must first be reviewed by the sponsor before its submission or presentation.
28272|NCT00307736|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28273|NCT00307684|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28274|NCT00307489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28275|NCT00307437|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28276|NCT00307333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28277|NCT00307294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28278|NCT00307164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28279|NCT00307151|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscript and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
28280|NCT00307125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28281|NCT00307086|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28282|NCT00307047|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators will not use Trial related data without written consent of sponsor for any purpose other than Trial completion or generation of publication material. Publication or presentation of results from a trial site are not allowed until publication and/or presentation of multi-center results. Sponsor must receive materials at least 60 days prior to the proposed date of the presentation or the initial submission of proposed publication in order to be reviewed by the sponsor.
28283|NCT00307034|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28284|NCT00306917|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28285|NCT00306891|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site or an Investigator requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
28286|NCT00306852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28287|NCT00306787|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28288|NCT00306670|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28289|NCT00306592|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
28290|NCT00306527|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28291|NCT00306488|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28292|NCT00306384|Principal Investigators are NOT employed by the organization sponsoring the study.|The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property.
28293|NCT00306293|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28294|NCT00306202|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28295|NCT00306189|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
28296|NCT00306163|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28297|NCT00305942|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
28298|NCT00305877|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28299|NCT00305864|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28300|NCT00305773|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28301|NCT00305760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28302|NCT00305643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28303|NCT00305604|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28304|NCT00305578|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28305|NCT00305565|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28306|NCT00305448|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28307|NCT00305344|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28308|NCT00305253|Principal Investigators are NOT employed by the organization sponsoring the study.|Local PIs are required to review results with Dr. Miller before releasing.
28309|NCT00305227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28310|NCT00305162|Principal Investigators are NOT employed by the organization sponsoring the study.|"PI communications regarding trial results are prohibited until after the communication and publication of the multi-center results by Sponsor, but no more than 12 months after conclusion of the trial at all sites.~PI must submit results communications to sponsor for review at least 40 days prior to submission for publication and Sponsor may embargo such communications for a period that is less than or equal to 135 days solely to seek appropriate patent protection."
28311|NCT00304954|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28312|NCT00304915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28313|NCT00304746|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28314|NCT00304707|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28315|NCT00304356|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28316|NCT00304278|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28317|NCT00304265|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28318|NCT00304187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28319|NCT00304161|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28320|NCT00304096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28321|NCT00304083|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28322|NCT00304070|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
28323|NCT00304031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28324|NCT00303979|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PI's may not publish single-site data until the main multi-site publication has occurred."
28325|NCT00303966|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28326|NCT00303953|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28327|NCT00303901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28328|NCT00303862|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28329|NCT00303823|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28330|NCT00303667|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28331|NCT00303628|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28332|NCT00303602|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28333|NCT00303511|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28334|NCT00303485|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
28335|NCT00303472|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28336|NCT00303459|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28337|NCT00303446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28338|NCT00303329|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28339|NCT00303316|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28340|NCT00303186|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28341|NCT00303108|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28342|NCT00303069|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28343|NCT00302952|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28344|NCT00302848|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28345|NCT00302731|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28346|NCT00302718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28347|NCT00302458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28348|NCT00302328|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28349|NCT00302211|Principal Investigators are NOT employed by the organization sponsoring the study.|Written permission to publish results must be obtained in advance from Actelion (formerly CoTherix). Manuscript of any proposed publication must be sent to Actelion at least 30 days in advance of the submission date. Actelion will inform in writing of any objection of specific content in the proposed publication.In addition, the institution shall either delete disclosure of all potentially patentable inventions or delay submission of the proposed publication for up to 90 days.
28350|NCT00302159|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28351|NCT00302133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28352|NCT00302107|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28353|NCT00302081|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28354|NCT00302068|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28355|NCT00302055|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28356|NCT00302042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28357|NCT00302003|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
28358|NCT00301964|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28359|NCT00301873|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28360|NCT00301834|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28361|NCT00301821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28362|NCT00301808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28363|NCT00301756|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28364|NCT00301418|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28365|NCT00301366|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor, thirty days in advance of submission, in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution that satisfies both parties.
28366|NCT00301262|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28367|NCT00301080|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28368|NCT00301028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28369|NCT00300885|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28370|NCT00300781|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28465|NCT00292370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28371|NCT00300755|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
28372|NCT00300742|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28373|NCT00300677|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28374|NCT00300495|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28375|NCT00300482|Principal Investigators are NOT employed by the organization sponsoring the study.|Not to publish or present the results before the publication of the multi-center investigator paper, but in no event shall be so restricted after the expiration of twelve (12) months from completion of the studies at all sites. Any presentation or publication to be submitted to Sponsor (in draft of the same) for Sponsor review and comment.
28376|NCT00300469|Principal Investigators are NOT employed by the organization sponsoring the study.|Not to publish or present the results before the publication of the multi-center investigator paper, but in no event shall be so restricted after the expiration of twelve (12) months from completion of the studies at all sites. Any presentation or publication to be submitted to Sponsor (in draft of the same) for Sponsor review and comment.
28377|NCT00300456|Principal Investigators are NOT employed by the organization sponsoring the study.|Not to publish or present the results before the publication of the multi-center investigator paper, but in no event shall be so restricted after the expiration of twelve (12) months from completion of the studies at all sites. Any presentation or publication to be submitted to Sponsor (in draft of the same) for Sponsor review and comment.
28378|NCT00300430|Principal Investigators are NOT employed by the organization sponsoring the study.|Not to publish or present the results before the publication of the multi-center investigator paper, but in no event shall be so restricted after the expiration of twelve (12) months from completion of the studies at all sites. Any presentation or publication to be submitted to Sponsor (in draft of the same) for Sponsor review and comment.
28379|NCT00300391|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28380|NCT00300365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28381|NCT00300274|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28382|NCT00300235|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28383|NCT00299975|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28384|NCT00299741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28385|NCT00299702|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28386|NCT00299689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28387|NCT00299546|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28388|NCT00299494|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28389|NCT00299416|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28390|NCT00299221|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28391|NCT00299156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28392|NCT00299130|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28393|NCT00299104|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28394|NCT00299000|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the results shall be made by the Sponsor in a joint publication. If such a multicenter publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from site individually, subject however to comply with the other terms of the agreement.
28395|NCT00298766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28396|NCT00298740|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28397|NCT00298610|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28398|NCT00298558|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period of 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28399|NCT00298363|Principal Investigators are NOT employed by the organization sponsoring the study.|"After conclusion of the study and without prior written approval from Gilead, investigators in this study may communicate, orally present, or publish in scientific journals or other media only after the following conditions have been met:~The results of the study in their entirety have been publicly disclosed by or with the consent of Gilead in an abstract, manuscript, or presentation form; or~The study has been completed at all study sites for at least 2 years"
28400|NCT00298272|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
28401|NCT00298233|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28402|NCT00298155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28403|NCT00298090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28404|NCT00297830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28405|NCT00297778|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28406|NCT00297648|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28407|NCT00297596|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
28408|NCT00297492|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28409|NCT00297427|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28466|NCT00292318|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28410|NCT00297258|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28411|NCT00297232|Principal Investigators are NOT employed by the organization sponsoring the study.|Our agreement is subject to confidentiality but generally the PI can publish, for noncommercial purposes only, results and methods of the trial, but no other Sponsor Confidential Information. PI must give Sponsor no less than 60 days to review any manuscript for a proposed publication and must delay publication for up to an additional 90 days thereafter if Sponsor needs to file any patent application to protect any of Sponsor's intellectual property contained in the proposed publication.
28412|NCT00297167|Principal Investigators are NOT employed by the organization sponsoring the study.|Restrictions may vary in accordance with each agreement that is negotiated with individual investigators. Sponsor will allow publication after multi-center publication has been published or after an agreed period of time if no such multi-center publication is submitted for publication. Sponsor can ask that Sponsor’s confidential information be removed from any publication and defer publication for period of time to allow Sponsor to obtain patent or other intellectual property right protection.
28413|NCT00297115|Principal Investigators are NOT employed by the organization sponsoring the study.|The study results may be published and/or presented at scientific meetings. Prior to any submission, all manuscripts/abstracts must be presented to the sponsor for possible comments.
28414|NCT00297102|Principal Investigators are NOT employed by the organization sponsoring the study.|The study results may be published and/or presented at scientific meetings. Prior to any submission, all manuscripts/abstracts must be presented to the sponsor for possible comments.
28415|NCT00297037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28416|NCT00296816|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor encourages the publication of the results of their studies, using only clean, checked and validated data in order to ensure the accuracy of the results.~At least 45 days in advance of proposed submission, the Investigator should forward a copy of the manuscript or abstract for review by the sponsor, and, if necessary, delay publication or communication for a limited time in order to protect the confidentiality or proprietary nature of any information contained therein."
28417|NCT00296647|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28418|NCT00296517|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the Publication of results from all centers of a multi-center trial but requests that reports based on Single-site data not precede the primary publication of the entire clinical trial.
28419|NCT00296504|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28420|NCT00296491|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28421|NCT00296400|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28422|NCT00296374|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28423|NCT00296335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28424|NCT00296322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28425|NCT00296296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28426|NCT00296244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28427|NCT00296231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28428|NCT00296192|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28429|NCT00296036|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28430|NCT00295880|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28431|NCT00295854|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28432|NCT00295750|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
28433|NCT00295633|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28434|NCT00295503|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28435|NCT00295490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28436|NCT00295061|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution which satisfies both parties.
28437|NCT00295009|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28438|NCT00294762|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28439|NCT00294723|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones. This includes the right to not release interim results, because the release of such information can invalidate the results of the entire trial. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
28440|NCT00294684|Principal Investigators are NOT employed by the organization sponsoring the study.|
28441|NCT00294671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28442|NCT00294658|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28443|NCT00294645|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PIs may not publish single-site data until the main multi-site publication has occurred."
28444|NCT00294554|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28445|NCT00294515|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28446|NCT00294398|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28447|NCT00294060|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators to publish study results per the publication plan/protocol following Medtronic's review to determine whether confidential information (CI) is disclosed. Any such CI is deleted prior to publication/presentation. Medtronic may not censor/interfere with the publication except as described. Investigators may not publish any single-site publications until the main multi-site study publication has occurred."
28448|NCT00294047|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28449|NCT00293813|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
28450|NCT00293722|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28451|NCT00293709|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28452|NCT00293579|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28453|NCT00293540|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28454|NCT00293462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28455|NCT00293384|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28456|NCT00293293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28457|NCT00293267|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28458|NCT00293254|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial, but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28459|NCT00293241|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28460|NCT00293059|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28461|NCT00293020|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28462|NCT00292981|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.
28463|NCT00292591|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28464|NCT00292461|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28467|NCT00292227|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28468|NCT00292188|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28469|NCT00292162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28470|NCT00291876|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28471|NCT00291694|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28472|NCT00291655|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28473|NCT00291577|Principal Investigators are NOT employed by the organization sponsoring the study.|
28474|NCT00291551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28475|NCT00291343|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28476|NCT00291330|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the results of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28477|NCT00291317|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28478|NCT00291226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28479|NCT00291187|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28480|NCT00291161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28481|NCT00291135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28482|NCT00291018|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28483|NCT00290888|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28484|NCT00290810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28485|NCT00290771|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
28486|NCT00290758|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28487|NCT00290732|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28488|NCT00290693|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28489|NCT00290654|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28490|NCT00290615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28491|NCT00290537|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28492|NCT00290472|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28493|NCT00290407|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28494|NCT00290329|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28495|NCT00290290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28496|NCT00290251|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28497|NCT00290238|Principal Investigators are NOT employed by the organization sponsoring the study.|If the PI expects to participate in the publication or presentation of data generated in the performance of the study, any reports, abstracts, manuscripts, or other presentation materials shall be submitted to the sponsor for review prior to submission for publication or presentation. The sponsor shall have 30 calendar days to respond with any requested revisions in order to protect the sponsor's confidential information.
28498|NCT00290199|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28499|NCT00290186|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28500|NCT00290147|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28501|NCT00289991|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28502|NCT00289978|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28503|NCT00289913|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication guidelines.
28504|NCT00289900|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
28505|NCT00289887|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28506|NCT00289874|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28507|NCT00289848|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28508|NCT00289783|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28509|NCT00289770|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28510|NCT00289757|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28511|NCT00289744|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28512|NCT00289718|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28513|NCT00289536|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter’s agreements with PIs vary per individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥45 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (e.g., to allow for intellectual property protection).
28514|NCT00289471|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28515|NCT00289458|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28516|NCT00289341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28517|NCT00289289|Principal Investigators are NOT employed by the organization sponsoring the study.|
28518|NCT00289276|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PI's may not publish single-site data until the main multi-site publication has occurred."
28519|NCT00289211|Principal Investigators are NOT employed by the organization sponsoring the study.|Clinical Study Agreement. Most restrictive provision - PI will not publish results until after first of: multicenter publication is published or 24 months from study end. Thereafter, PI may publish his results. PI must provide copy of proposed publication to sponsor for pre-review. If sponsor requests, PI must delete sponsor confidential information before publication and/or delay publication for 90 days so sponsor can file for patents or take other action to protect its patent rights.
28520|NCT00289198|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28521|NCT00289185|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28522|NCT00289133|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28523|NCT00289120|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28524|NCT00289107|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28525|NCT00289094|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28549|NCT00287053|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28526|NCT00289016|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28527|NCT00288912|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28528|NCT00288886|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28529|NCT00288860|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28530|NCT00288704|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI,after completion of a trial,is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the sponsor for review;provided that the sponsor can remove confidential or proprietary information from such communications. The sponsor cannot require other changes to the communication and cannot extend the embargo.
28531|NCT00288639|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28532|NCT00288626|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28533|NCT00288600|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28534|NCT00288587|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28535|NCT00288574|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28536|NCT00288509|Principal Investigators are NOT employed by the organization sponsoring the study.|A publication of results from all sites in this multicenter study is expected. If the sponsor no longer plans this or 6 months after study completion at all sites, the PI may publish the results. He will supply any proposed publication to the sponsor for review and comment at least 30 days before submission for publication. If the sponsor believes a patent application should be filed, the publication will be delayed for another 60 days or until patent filing; with a maximum delay of 90 days.
28537|NCT00288080|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
28538|NCT00288067|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28539|NCT00288054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28540|NCT00287872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28541|NCT00287729|Principal Investigators are NOT employed by the organization sponsoring the study.|
28542|NCT00287716|Principal Investigators are NOT employed by the organization sponsoring the study.|
28543|NCT00287586|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28544|NCT00287365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28545|NCT00287339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28546|NCT00287222|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28547|NCT00287118|Principal Investigators are NOT employed by the organization sponsoring the study.|
28548|NCT00287079|Principal Investigators are NOT employed by the organization sponsoring the study.|
28550|NCT00286949|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28551|NCT00286754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28552|NCT00286741|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28553|NCT00286728|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28554|NCT00286494|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28555|NCT00286468|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28556|NCT00286455|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28557|NCT00286442|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28558|NCT00286429|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study at all study sites. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28559|NCT00286325|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28560|NCT00286221|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28561|NCT00286182|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28562|NCT00286156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28563|NCT00286091|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28564|NCT00286078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28565|NCT00285857|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28566|NCT00285818|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28567|NCT00285779|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28568|NCT00285649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28569|NCT00285584|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28570|NCT00285467|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28571|NCT00285246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28572|NCT00285207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28573|NCT00285012|Principal Investigators are NOT employed by the organization sponsoring the study.|
28574|NCT00284934|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28575|NCT00284856|Principal Investigators are NOT employed by the organization sponsoring the study.|"The SPONSOR must have the opportunity to review all proposed abstracts,~manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as~confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines."
28576|NCT00284739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28577|NCT00284557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28578|NCT00284518|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28579|NCT00284180|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
28580|NCT00284154|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
28581|NCT00284141|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to independently publish study results from his site after a multicenter publication, or 12 months after the completion of the study by all sites. He must provide the sponsor a copy of any such publication derived from the study for review and comment at least 45 days (20 days for abstracts) in advance of any submission, and delay publication till the approval of the publication is given in writing by the Sponsor (not to exceed ninety days).
28582|NCT00284089|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28583|NCT00284050|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28584|NCT00283868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28585|NCT00283842|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication
28586|NCT00283816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28587|NCT00283803|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28588|NCT00283712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28589|NCT00283686|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28590|NCT00283595|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28591|NCT00283504|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28592|NCT00283439|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
28593|NCT00283400|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28594|NCT00283387|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28595|NCT00283296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28596|NCT00283244|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28597|NCT00283075|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28598|NCT00283062|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall provide the Steering Committee a copy of any manuscript, abstract or oral communication derived from the study for review and comment at least 30 days in advance of any submission. The Sponsor's representatives shall have the right to review and/or delay any publication or presentation to prevent disclosure of Sponsor's confidential information and preserve intellectual property rights.
28599|NCT00283049|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
28600|NCT00282984|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months (mo) from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28601|NCT00282971|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28602|NCT00282919|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28603|NCT00282867|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28604|NCT00282828|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28605|NCT00282815|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28606|NCT00282672|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28607|NCT00282568|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or until 18 months have elapsed following study completion. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document.
28645|NCT00280241|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28608|NCT00282464|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28609|NCT00282438|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28610|NCT00282347|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28611|NCT00282334|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28612|NCT00282308|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28613|NCT00282295|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28614|NCT00282282|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28615|NCT00282256|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or until 18 months have elapsed following study completion. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document.
28616|NCT00282243|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or until 18 months have elapsed following study completion. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document.
28617|NCT00282152|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28618|NCT00282113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28619|NCT00282087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28620|NCT00282048|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28621|NCT00281957|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28622|NCT00281918|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28623|NCT00281879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28624|NCT00281840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28625|NCT00281827|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28646|NCT00280150|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28626|NCT00281697|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28627|NCT00281658|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28628|NCT00281632|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28629|NCT00281580|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28630|NCT00281528|Principal Investigators are NOT employed by the organization sponsoring the study.|Upon investigator submission of a publication or presentation to Celgene, Celgene shall complete its review within 60 days after receipt of the proposed publication or presentation. Upon Celgene’s request, proposed publication or presentation will be delayed up to 60 additional days to enable Celgene to secure adequate intellectual property protection of property of Celgene that would be affected by such proposed publication or presentation
28631|NCT00281463|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28632|NCT00281320|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution will provide manuscripts, abstracts, or the full text of any other intended disclosure to the sponsor at least 30 days prior to submission for publication or other disclosure. If any patent action is required to protect intellectual property rights, Institution agrees to delay the disclosure for a period not to exceed and additional 60 days. Institution will, on request, remove any previously undisclosed Confidential Information (other than study results) before disclosure.
28633|NCT00281099|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigational Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication."
28634|NCT00281021|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28635|NCT00280917|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28636|NCT00280904|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28637|NCT00280826|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28638|NCT00280748|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28639|NCT00280735|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28640|NCT00280683|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28641|NCT00280566|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28642|NCT00280397|Principal Investigators are NOT employed by the organization sponsoring the study.|Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.
28643|NCT00280384|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28644|NCT00280293|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28647|NCT00280059|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28648|NCT00279955|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PI's may not publish single-site data until the main multi-site publication has occurred."
28649|NCT00279916|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28650|NCT00279708|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28651|NCT00279591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28652|NCT00279500|Principal Investigators are NOT employed by the organization sponsoring the study.|Separate IP agreement.
28653|NCT00279305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28654|NCT00279214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28655|NCT00279201|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28656|NCT00278993|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28657|NCT00278954|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the Study results will be allowed only with prior written approval from Sponsor, said consent not to be unreasonably withheld. At the request of Sponsor, the Institution and/or Investigator shall delete any Confidential Information pertaining to Sponsor's Inventions from any proposed publications prior to submitting or presenting the materials. Any and all publications will give appropriate recognition of any support received from Sponsor.
28658|NCT00278915|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI cannot disclose or publish any Confidential Information to do with the trial without consent from AstraZeneca, and, for other information, the PI must withhold from publishing or presenting for 90 days if requested to do so by AstraZeneca.
28659|NCT00278889|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
28660|NCT00278876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28661|NCT00278863|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28662|NCT00278655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28663|NCT00278525|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28664|NCT00278473|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28665|NCT00278395|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28666|NCT00278343|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28667|NCT00277524|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28668|NCT00277446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28669|NCT00277394|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28670|NCT00277355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28671|NCT00277212|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28672|NCT00277095|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28673|NCT00276861|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28674|NCT00276614|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28675|NCT00276549|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28676|NCT00276484|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28677|NCT00276458|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28678|NCT00276419|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28679|NCT00276406|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28680|NCT00276380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28681|NCT00276250|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28682|NCT00276159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28683|NCT00276094|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can embargo results from a PI's center until the combined results from the completed study have been published in full or the sponsor confirms there will be no multicenter study publication. Results communications must be provided to the sponsor for review at least 60 days before submission for publication. By written request, the sponsor can extend the embargo up to an additional 60 days. The sponsor cannot require changes to scientific content and cannot further extend the embargo.
28684|NCT00276016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28685|NCT00275834|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28686|NCT00275821|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28687|NCT00275561|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28688|NCT00275509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28689|NCT00275392|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28690|NCT00275340|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28691|NCT00275301|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28692|NCT00275275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28693|NCT00275262|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
28694|NCT00275028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28695|NCT00275002|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28696|NCT00274937|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
28697|NCT00274924|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28698|NCT00274846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28699|NCT00274781|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28700|NCT00274768|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28701|NCT00274742|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28702|NCT00274716|Principal Investigators are NOT employed by the organization sponsoring the study.|The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines.
28703|NCT00274651|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28704|NCT00274625|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28705|NCT00274469|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28706|NCT00274456|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications of this multicenter trial should include input from INVESTIGATORS, his/her colleagues, and SPONSOR personnel. Such input should be reflected in publication authorship, and agreement regarding order of authors should be established before writing a manuscript. Subsequent to the multicenter publication or one year after completion of the study, whichever occurs first, an investigator and/or his/her colleagues may publish the results of INVESTIGATOR's part of the study independently.
28707|NCT00274287|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28708|NCT00274261|Principal Investigators are NOT employed by the organization sponsoring the study.|
28709|NCT00273910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28710|NCT00273858|Principal Investigators are NOT employed by the organization sponsoring the study.|Wyeth has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28711|NCT00273793|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28712|NCT00273754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28713|NCT00273182|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators (PI) to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (CI), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PI's may not publish single-site data until the main multi-site publication has occurred."
28714|NCT00273052|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centres of a multi-centre trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28715|NCT00272987|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
28716|NCT00272961|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28717|NCT00272844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28718|NCT00272792|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the results shall be made by Sponsor in a joint publication. If such a multi-center publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however to comply with the other terms of the agreement.
28719|NCT00272779|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28720|NCT00272337|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28721|NCT00272311|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28722|NCT00272168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28723|NCT00272038|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28724|NCT00271947|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28725|NCT00271856|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28726|NCT00271817|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28727|NCT00271739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28728|NCT00271609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28729|NCT00271596|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28730|NCT00271570|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28731|NCT00271544|Principal Investigators are NOT employed by the organization sponsoring the study.|"Generally, contracts allow investigators to publish study results per the protocol and publication plan. Medtronic reviews publications to determine if confidential information (CI) is included. Any such CI is deleted before publication. Medtronic may not censor/interfere with the publication. Investigators may publish single-site publications after a decision by Medtronic that no multi-site study publication will be done or 12 months after the study is closed, whichever is earlier."
28732|NCT00271375|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28733|NCT00271219|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28734|NCT00271154|Principal Investigators are NOT employed by the organization sponsoring the study.|"In most cases, contracts allow investigators to publish study results per the publication plan/protocol following Medtronic's review to determine whether confidential information (CI) is disclosed. Any such CI is deleted prior to publication/presentation. Medtronic may not censor/interfere with the publication except as described. Investigators may not publish any single-site publications until the main multi-site study publication has occurred."
28735|NCT00271024|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28736|NCT00271011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28737|NCT00270998|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28738|NCT00270894|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor shall submit to Aventis for review of confidential information and patent protection purposes, any manuscript or abstract prepared for publication at least 30 days prior to submission to publisher. Upon written request by Aventis to Sponsor within such 30 days, Sponsor agrees to delay such publication until Aventis determines that the publication will not compromise any patent rights. However, such delay shall not exceed 90 additional days.
28739|NCT00270855|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28740|NCT00270842|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28741|NCT00270790|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28742|NCT00270634|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28743|NCT00270296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28744|NCT00270257|Principal Investigators are NOT employed by the organization sponsoring the study.|All study abstracts and publications are subject to HPTN Publication and Public Information Policies and Clinical Trial Agreements between NIAID (DAIDS) and company collaborators. The publication or other disclosure can be delayed for up to thirty additional business days for manuscripts & five business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
28745|NCT00270231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28746|NCT00270205|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
28747|NCT00269919|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28748|NCT00269633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28749|NCT00269477|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28750|NCT00269152|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28751|NCT00269113|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28752|NCT00268996|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28753|NCT00268983|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28754|NCT00268905|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28755|NCT00268892|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
28756|NCT00268762|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28757|NCT00268463|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28758|NCT00268437|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28759|NCT00268346|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28760|NCT00268242|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28761|NCT00268203|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28762|NCT00267969|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28763|NCT00267956|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28764|NCT00267774|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28765|NCT00267748|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28766|NCT00267696|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28767|NCT00267670|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28768|NCT00267644|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28769|NCT00267631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28770|NCT00267488|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28771|NCT00267293|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28772|NCT00267202|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28773|NCT00267189|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28774|NCT00267150|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28775|NCT00267111|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28776|NCT00267098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28777|NCT00267085|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28778|NCT00267059|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28779|NCT00267046|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28780|NCT00267007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28781|NCT00266877|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28782|NCT00266864|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28783|NCT00266825|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28784|NCT00266812|Principal Investigators are NOT employed by the organization sponsoring the study.|
28785|NCT00266799|Principal Investigators are NOT employed by the organization sponsoring the study.|If investigator wishes to publish study information, a copy of the manuscript must be provided to sponsor for review at least 60 days before submission of publication/presentation. In the event issues arise regarding scientific integrity/regulatory compliance, sponsor will review these issues with investigator. Investigator will not publish data derived from the individual site until 12 months after conclusion/abandonment/termination of study at all sites.
28786|NCT00266695|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28787|NCT00266656|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28788|NCT00266630|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28789|NCT00266409|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28790|NCT00266279|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28791|NCT00266227|Principal Investigators are NOT employed by the organization sponsoring the study.|
28792|NCT00266110|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28793|NCT00266032|Principal Investigators are NOT employed by the organization sponsoring the study.|Bayer Schering Pharma (BSP AG) coordinates publishing of study results. Principal investigators (PIs) provide BSP AG with a draft at least 90 days prior to date of planned submission or presentation. BSP AG shall have 60 days to recommend any changes. BSP AG can prevent or delay publication by informing PIs within 60 days of BSP AG´s receipt of the document about to be published. PIs shall not publish press releases/other public statements about study/study drug without BSP AG´s written consent.
28794|NCT00265941|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
28795|NCT00265889|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28796|NCT00265850|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28797|NCT00265798|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28798|NCT00265785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28799|NCT00265759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28800|NCT00265616|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28801|NCT00265512|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28802|NCT00265473|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28803|NCT00265395|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28804|NCT00265382|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28805|NCT00265343|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication/presentation of data may not be made without prior review and comment by the Sponsor; all reasonable comments of Sponsor will be incorporated as far as the scientific data content is not impaired. A complete copy shall be provided to the Sponsor at least 60 days prior to date of submission. Participation in the Study involves a commitment to publish data from the study in a cooperative publication prior to publication/presentation or on an individual basis.
28806|NCT00265330|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28807|NCT00265317|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28808|NCT00265239|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28809|NCT00265200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28810|NCT00265122|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28811|NCT00265109|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28812|NCT00265096|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28813|NCT00265083|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28814|NCT00264875|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28815|NCT00264849|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28816|NCT00264810|Principal Investigators are NOT employed by the organization sponsoring the study.|"Each Investigator and Institution agree that the 1st publication of study results shall be a joint, multi-center publication.~Each Investigator, Coordinator, and Institution agree to submit publications to the RNS® System Study Publication Committee for review prior to submission for publication (at least 30 days for manuscripts and at least 7 days for abstracts) to assure that publication does not compromise the scientific integrity of the study or contain confidential NeuroPace information."
28817|NCT00264797|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28818|NCT00264641|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28819|NCT00264576|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28820|NCT00264550|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28821|NCT00264537|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
28822|NCT00264498|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28823|NCT00264381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28824|NCT00264303|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
28825|NCT00264290|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28826|NCT00264238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28847|NCT00262509|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28827|NCT00264147|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28828|NCT00264004|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
28829|NCT00263887|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed within thirty days and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution, which satisfies both parties.
28830|NCT00263757|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28831|NCT00263666|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28832|NCT00263328|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28833|NCT00263211|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28834|NCT00262964|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28835|NCT00262951|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28836|NCT00262925|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28837|NCT00262873|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28838|NCT00262860|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28839|NCT00262847|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28840|NCT00262834|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28841|NCT00262821|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28842|NCT00262743|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28843|NCT00262730|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28844|NCT00262639|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28845|NCT00262600|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
28846|NCT00262522|Principal Investigators are NOT employed by the organization sponsoring the study.|Provide ABBOTT at least thirty (30) days prior to submission for review, ABBOTT shall return comments within thirty (30) days of receipt of draft. Proposed draft shall be delayed an additional sixty (60) days in addition to the Review Period
28848|NCT00262314|Principal Investigators are NOT employed by the organization sponsoring the study.|
28849|NCT00262301|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to its submission or disclosure. The sponsor may request to delete information identified by sponsor as confidential information prior to submitting such manuscript and/or abstract for publication. For a multi-center study, the investigator must wait (i) at least 24 months after the study is completed at all sites or (ii) until after the multi-center publication.
28850|NCT00262223|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28851|NCT00262119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28852|NCT00262080|Principal Investigators are NOT employed by the organization sponsoring the study.|Dyax agreements vary, but Dyax will not prohibit any investigator from publishing. Dyax reviews publications prior to public release and can request deferral by up to 60 days beyond the proposed publication date if necessary to preserve its intellectual property. Dyax can request changes to publications to remove non-study-related confidential information. Dyax can also request deferral of single-center publications until after disclosure of the clinical trial’s primary publication.
28853|NCT00262067|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28854|NCT00262041|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28855|NCT00262028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28856|NCT00262002|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigators from publishing. Any publications from a single site are postponed until the publication of the pool data (i.e., data from all sites) in the clinical trial.
28857|NCT00261950|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
28858|NCT00261846|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28859|NCT00261833|Principal Investigators are NOT employed by the organization sponsoring the study.|CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial.
28860|NCT00261716|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28861|NCT00261495|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28862|NCT00261443|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28863|NCT00260962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28864|NCT00260832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28865|NCT00260689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28866|NCT00260533|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28867|NCT00260429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28868|NCT00260208|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28869|NCT00260195|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28870|NCT00260065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28871|NCT00259857|All Principal Investigators ARE employed by the organization sponsoring the study.|Agreement with Merck: to submit a copy of any proposed abstract, manuscript and/or press release to Merck for review and comment at least 30 days prior to submission for publication or presentation.
28872|NCT00259740|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
28873|NCT00259649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28874|NCT00259610|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28875|NCT00259298|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28876|NCT00259285|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28877|NCT00259272|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28878|NCT00259090|Principal Investigators are NOT employed by the organization sponsoring the study.|AZ shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time request that submission for publication or disclosure of the manuscript be delayed for no more than an additional 45 days in order for AZ to file patent applications.
28879|NCT00259012|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
28880|NCT00258908|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28881|NCT00258895|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28882|NCT00258882|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28883|NCT00258856|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28923|NCT00255177|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28884|NCT00258830|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28885|NCT00258817|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28886|NCT00258674|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28887|NCT00258440|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28888|NCT00258362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28889|NCT00258349|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28890|NCT00258310|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28891|NCT00258206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28892|NCT00258154|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28893|NCT00258011|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
28894|NCT00257933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28895|NCT00257920|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28896|NCT00257894|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28897|NCT00257686|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28898|NCT00257660|Principal Investigators are NOT employed by the organization sponsoring the study.|A publication of results from all sites in this multicenter study is expected. If the sponsor no longer plans this or 6 months after study completion at all sites, the PI may publish the results. He will supply any proposed publication to the sponsor for review and comment at least 30 days before submission for publication. If the sponsor believes a patent application should be filed, the publication will be delayed for another 60 days or until patent filing; with a maximum delay of 90 days.
28899|NCT00257608|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
28900|NCT00257556|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restiction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
28901|NCT00257322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28902|NCT00257309|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28903|NCT00257192|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28904|NCT00257166|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
28905|NCT00257010|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28906|NCT00256997|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28907|NCT00256984|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28908|NCT00256867|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28909|NCT00256750|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28910|NCT00256724|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28911|NCT00256698|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that they cannot disclose or publish any information to do with the trial without consent from AstraZeneca
28912|NCT00256308|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28913|NCT00256295|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28914|NCT00256282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28915|NCT00256243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28916|NCT00256204|Principal Investigators are NOT employed by the organization sponsoring the study.|Should the Oversight Committee wish to publish the results of this study, the Oversight Committee agrees to provide Teva with a manuscript for review 60 days prior to submission for publication. Teva retains the right to delete from the manuscript confidential information and to object to suggested publication and/or its timing (at the sole discretion of Teva).
28917|NCT00256126|Principal Investigators are NOT employed by the organization sponsoring the study.|
28918|NCT00255970|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28919|NCT00255840|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28920|NCT00255723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28921|NCT00255684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28922|NCT00255190|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28924|NCT00255164|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28925|NCT00255151|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28926|NCT00255125|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28927|NCT00255086|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28928|NCT00255047|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28929|NCT00255034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28930|NCT00255008|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28931|NCT00254995|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
28932|NCT00254982|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees not to pubish or publicly present any interim results of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any elecontronic media) that report any results of study.
28933|NCT00254592|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28934|NCT00254566|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28935|NCT00254540|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
28936|NCT00254501|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28937|NCT00254462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28938|NCT00254293|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
28939|NCT00254163|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28940|NCT00254072|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28941|NCT00253981|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28942|NCT00253890|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28943|NCT00253747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28944|NCT00253708|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28945|NCT00253643|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28946|NCT00253630|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28947|NCT00253513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28948|NCT00253448|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28949|NCT00253435|Principal Investigators are NOT employed by the organization sponsoring the study.|
28950|NCT00253370|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28951|NCT00253019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28952|NCT00252967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28953|NCT00252733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28954|NCT00252720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28955|NCT00252694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28956|NCT00252629|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28957|NCT00252590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28958|NCT00252564|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28959|NCT00252538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28960|NCT00252512|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28961|NCT00252499|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28962|NCT00252382|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
28963|NCT00252239|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28964|NCT00252187|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28965|NCT00252174|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28966|NCT00252057|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28967|NCT00251979|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca shall have a period of 30 days from receipt of the proposed final manuscript for any publication or other disclosure to review it and may within such time require that submission for publication or disclosure of the manuscript be delayed.
28968|NCT00251927|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28969|NCT00251862|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28970|NCT00251758|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28971|NCT00251745|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28972|NCT00251719|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28973|NCT00251693|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
28974|NCT00251641|Principal Investigators are NOT employed by the organization sponsoring the study.|PI must provide sponsor w/ review copies of abstracts or manuscripts for publication that report any results of the study, 45 days before submission for publication or presentation. The sponsor shall have the right to review/comment on the material. If the parties disagree about the appropriateness of the material, PI must meet with sponsor's representatives before submission for publication, for the purpose of making good faith efforts to discuss and resolve any issues of disagreement.
28975|NCT00251589|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28976|NCT00251316|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28977|NCT00251303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28978|NCT00251238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28979|NCT00251225|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28980|NCT00251004|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
28981|NCT00250926|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28982|NCT00250835|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28983|NCT00250718|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28984|NCT00250705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28985|NCT00250679|Principal Investigators are NOT employed by the organization sponsoring the study.|In addition to the <60-180 day restriction above, since this is a multicenter study, 1st publication of study results shall be made with other participating study sites as a multicenter publication; if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish.
28986|NCT00250588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28987|NCT00250497|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28988|NCT00250484|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28989|NCT00250458|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28990|NCT00250432|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28991|NCT00250276|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
28992|NCT00249873|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the study will be made jointly in the name of all wholehearted collaborators. Other papers will be authored based on the contributions of the individuals to the overall study. Substudies with scientific merit which have received prior approval from the Steering Committee (SC) may be published in the names of the contributing investigators. A copy of all manuscripts will be provided to the sponsors for their review. The final decision to publish articles will be made by the SC.
28993|NCT00249834|Principal Investigators are NOT employed by the organization sponsoring the study.|
28994|NCT00249821|Principal Investigators are NOT employed by the organization sponsoring the study.|
28995|NCT00249808|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28996|NCT00249795|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication of the study will be made jointly in the name of all wholehearted collaborators. Other papers will be authored based on the contributions of the individuals to the overall study. Substudies with scientific merit which have received prior approval from the Steering Committee (SC) may be published in the names of the contributing investigators. A copy of all manuscripts will be provided to the sponsors for their review. The final decision to publish articles will be made by the SC.
28997|NCT00249613|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28998|NCT00249496|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
28999|NCT00249470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29000|NCT00249444|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29001|NCT00249379|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29002|NCT00249288|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29003|NCT00249249|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29004|NCT00249002|Principal Investigators are NOT employed by the organization sponsoring the study.|"Study data will not be published in part before the complete multicenter data has been reported in full, unless more than 1 year has elapsed since completion of the Study.~Investigator/institution must supply copy of presentation or publication to Celgene within 30 days of submission for publication. Celgene may request in writing within that 30 days that Celgene Confidential Information be deleted or be granted a 60 day delay prior to publication to permit intellectual property filings."
29005|NCT00248807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29006|NCT00248794|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29007|NCT00248781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29008|NCT00248651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29009|NCT00248638|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29010|NCT00248625|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29011|NCT00248612|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29012|NCT00248560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29013|NCT00248547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29014|NCT00248495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29015|NCT00248287|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29016|NCT00248170|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
29017|NCT00247962|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29018|NCT00247676|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29019|NCT00247624|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29020|NCT00247611|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29021|NCT00247416|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29022|NCT00247377|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29023|NCT00247273|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29024|NCT00246805|Principal Investigators are NOT employed by the organization sponsoring the study.|should INVESTIGATOR contemplate publishing/presenting, he shall provide copies of any abstracts, papers, or manuscripts to sponsor for review at least 30 days prior to submittal for publication or presentation. Sponsor shall limit its review to a determination of whether Confidential Information is disclosed and to check for technical correctness and shall not attempt to censor or in any way interfere with PARTICIPATING INSTITUTION’s or INVESTIGATOR’s presentation or conclusions
29025|NCT00246753|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29026|NCT00246740|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29048|NCT00245037|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29027|NCT00246571|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29028|NCT00246519|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29029|NCT00246376|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29030|NCT00246337|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29031|NCT00246324|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29032|NCT00246259|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29033|NCT00246090|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29034|NCT00246025|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29035|NCT00246012|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29036|NCT00245960|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29037|NCT00245856|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29038|NCT00245635|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29039|NCT00245570|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29040|NCT00245557|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29041|NCT00245518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29042|NCT00245466|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
29043|NCT00245219|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29044|NCT00245128|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29045|NCT00245102|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29046|NCT00245063|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29047|NCT00245050|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29049|NCT00245011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29050|NCT00244985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29051|NCT00244933|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29052|NCT00244881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29053|NCT00244855|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29054|NCT00244764|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29055|NCT00244751|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29056|NCT00244725|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29057|NCT00244712|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29058|NCT00244621|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29059|NCT00244374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29060|NCT00244140|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29061|NCT00244101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29062|NCT00244010|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29063|NCT00243932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29064|NCT00243919|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29065|NCT00243659|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29066|NCT00243503|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29067|NCT00243412|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
29088|NCT00241839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29068|NCT00243386|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter’s agreements with PIs may vary per requirements of the individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or ≤2 years after study completion. Baxter requires a review of results communications (e.g., for confidential information) ≥60 days prior to submission or communication. Baxter may request an additional delay of ≤60 days (e.g., intellectual property protection)
29069|NCT00243347|Principal Investigators are NOT employed by the organization sponsoring the study.|If a Study Site, or an investigator, requests permission to publish data from this study, any such publication (including oral presentations) is to be agreed with AstraZeneca prior to publication.
29070|NCT00243269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29071|NCT00243243|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29072|NCT00243191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29073|NCT00243074|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29074|NCT00243061|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29075|NCT00243022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29076|NCT00242710|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29077|NCT00242684|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29078|NCT00242658|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29079|NCT00242632|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29080|NCT00242619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29081|NCT00242580|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29082|NCT00242567|Principal Investigators are NOT employed by the organization sponsoring the study.|"Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed.~The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of pooled data (i.e.,data from all sites) in clinical trial."
29083|NCT00242502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29084|NCT00242385|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs vary per individual PI, but contain common elements. Baxter requires a review of results communications (e.g., for confidential information) ≥60 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (e.g., to allow for intellectual property protection).
29085|NCT00242216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29086|NCT00241969|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29087|NCT00241904|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29089|NCT00241644|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29090|NCT00241358|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29091|NCT00241280|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29092|NCT00241176|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29093|NCT00240994|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29094|NCT00240981|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29095|NCT00240539|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29096|NCT00240526|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29097|NCT00240500|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29098|NCT00240487|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29099|NCT00240331|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29100|NCT00240227|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29101|NCT00240162|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29102|NCT00240110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29103|NCT00240097|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29104|NCT00240071|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29105|NCT00239928|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days.Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites.Investigator may not disclose previously undisclosed confidential info other than study results.
29106|NCT00239837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29107|NCT00239733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29108|NCT00239720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29109|NCT00239681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29110|NCT00239642|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29111|NCT00239356|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29112|NCT00239226|Principal Investigators are NOT employed by the organization sponsoring the study.|INVESTIGATOR may publish/present the results of the work. However, INVESTIGATOR shall provide copies of any abstracts, or manuscripts to the sponsor for review at least 30 (thirty) days prior to submittal for publication or presentation. The sponsor shall limit its review to a determination of whether Confidential Information is disclosed and to check for technical correctness. Sponsor shall not attempt to censor or in any way interfere with INVESTIGATOR’s presentation or conclusions.
29113|NCT00239005|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29114|NCT00238615|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29115|NCT00238433|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29116|NCT00238420|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29117|NCT00238355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29118|NCT00238303|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29119|NCT00238264|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
29120|NCT00238238|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29121|NCT00238121|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29122|NCT00238108|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29123|NCT00237809|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29124|NCT00237796|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29125|NCT00237770|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29126|NCT00237744|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29127|NCT00237718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29128|NCT00237692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29129|NCT00237666|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29130|NCT00237458|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 but <= 180 days to review results communications prior to public release and may delete information that is confidential and compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that the results shall be published regardless of outcome.
29171|NCT00232544|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29131|NCT00237185|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
29132|NCT00237042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29133|NCT00236977|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29134|NCT00236951|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29135|NCT00236938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29136|NCT00236899|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29137|NCT00236197|Principal Investigators are NOT employed by the organization sponsoring the study.|
29138|NCT00236184|Principal Investigators are NOT employed by the organization sponsoring the study.|
29139|NCT00236080|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29140|NCT00235989|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29141|NCT00235872|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
29142|NCT00235833|Principal Investigators are NOT employed by the organization sponsoring the study.|Disclosure agreements vary; most restrictive agreement states Medical Institution shall not disclose materials/information disclosed by Abbott Japan in connection with the Clinical Research, or information obtained by conducting the Clinical Research, to third parties without Abbott Japan's prior written approval. When Medical Institution intends to publish information obtained by conducting the Clinical Research, Medical Institution shall obtain Abbott Japan's prior written approval.
29143|NCT00235755|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29144|NCT00235716|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29145|NCT00235573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29146|NCT00235456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29147|NCT00235443|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
29148|NCT00235391|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29149|NCT00235326|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29172|NCT00232505|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29150|NCT00234884|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
29151|NCT00234832|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
29152|NCT00234494|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29153|NCT00234286|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29154|NCT00234104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29155|NCT00234078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29156|NCT00234065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29157|NCT00234039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29158|NCT00233987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29159|NCT00233948|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29160|NCT00233519|Principal Investigators are NOT employed by the organization sponsoring the study.|National Institutes of Health (NIH) can review the content of planned submissions prior to public release (3 weeks notice requested) to insure integrity of the NIH and the Data Safety Monitoring Board (DMSB)staff.
29161|NCT00233454|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29162|NCT00233402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29163|NCT00233324|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29164|NCT00233103|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29165|NCT00233090|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29166|NCT00233064|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
29167|NCT00232739|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29168|NCT00232596|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29169|NCT00232583|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29170|NCT00232557|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29173|NCT00232479|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29174|NCT00232180|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29175|NCT00232141|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29176|NCT00231894|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29177|NCT00231816|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29178|NCT00231777|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29179|NCT00231478|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights."
29180|NCT00231465|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29181|NCT00231309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29182|NCT00231283|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29183|NCT00231179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29184|NCT00231153|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29185|NCT00231114|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29186|NCT00231062|Principal Investigators are NOT employed by the organization sponsoring the study.|If requested by Sponsor, Investigator(s) shall delay the submission of any publication or presentation for up to sixty (60) days from the date of Sponsor’s request to permit the preparation and filing of related patent applications by Sponsor or for Sponsor to take other steps to protect its intellectual property interests.
29187|NCT00230971|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29188|NCT00230802|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29189|NCT00230737|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29190|NCT00230282|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29191|NCT00230178|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
29192|NCT00230126|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29193|NCT00230100|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29194|NCT00230048|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29195|NCT00230022|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29196|NCT00230009|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29197|NCT00229970|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29198|NCT00229957|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29199|NCT00229931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29200|NCT00229723|Principal Investigators are NOT employed by the organization sponsoring the study.|The Principal Investigator (PI) agrees to collaborate on the contents and formation of any publication and to pay due consideration to comments and opinions offered. AstraZeneca have 30 days for final manuscript review and may require that submission for publication be delayed in order to file patent applications.
29201|NCT00229658|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29202|NCT00229619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29203|NCT00229203|Principal Investigators are NOT employed by the organization sponsoring the study.|
29204|NCT00228943|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29205|NCT00228917|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29206|NCT00228813|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29207|NCT00228566|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29208|NCT00228553|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29209|NCT00228384|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator will provide the materials to the sponsor at least 30 days in advance of submission for publication or public disclosure. The sponsor has the right to make modifications as necessary to protect proprietary information or correct inaccuracies in technical specifications or device descriptions.
29210|NCT00227994|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29211|NCT00227903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29212|NCT00227760|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29213|NCT00227721|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29214|NCT00227591|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29215|NCT00227539|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29216|NCT00227370|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29217|NCT00227344|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between the Principal Investigator (PI)/Institution and the Sponsor (or its agents) that restricts the PI’s rights to discuss, present or publish trial results after the trial is completed. Please contact Biosense Webster, Inc. for additional information.
29218|NCT00227305|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca as sponsor will first publish results for the multicenter study
29219|NCT00227266|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29220|NCT00227019|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29221|NCT00226941|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29222|NCT00226811|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29223|NCT00226655|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29224|NCT00226590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29225|NCT00226577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29226|NCT00226239|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29227|NCT00225784|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29228|NCT00225732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29229|NCT00225498|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29230|NCT00225420|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29231|NCT00225277|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo trial results communications up to 150 days to permit actions necessary to preserve sponsor's intellectual property. Sponsor can request changes to the results communication only for the purpose of removing non study related information that is proprietary and confidential to sponsor. Sponsor can require delay of a results communication until the study has been completed at all participating sites.
29232|NCT00225251|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29233|NCT00225212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29253|NCT00223704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29234|NCT00225147|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to its submission or disclosure. The sponsor may request to delete information identified by sponsor as confidential information prior to submitting such manuscript and/or abstract for publication. For a multi-center study, the investigator must wait (i) at least 24 months after the study is completed at all sites or (ii) until after the multi-center publication.
29235|NCT00225017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29236|NCT00224952|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29237|NCT00224874|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29238|NCT00224770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the funding agency (NIH/NINDS) can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days from the time submitted to the funding agency for review. The funding agency cannot require changes to the communication and cannot extend the embargo.
29239|NCT00224484|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29240|NCT00224289|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29241|NCT00224133|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29242|NCT00224120|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29243|NCT00224107|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29244|NCT00224055|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29245|NCT00224042|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29246|NCT00224029|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29247|NCT00224016|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29248|NCT00224003|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29249|NCT00223977|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29250|NCT00223821|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29251|NCT00223808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29252|NCT00223795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29254|NCT00223678|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29255|NCT00223665|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29256|NCT00223652|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29257|NCT00223496|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29258|NCT00223236|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29259|NCT00222729|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29260|NCT00222105|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29261|NCT00221299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29262|NCT00221195|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29263|NCT00221117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29264|NCT00221104|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29265|NCT00220961|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29266|NCT00220805|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution which satisfies both parties.
29267|NCT00220779|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution which satisfies both parties.
29268|NCT00220740|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must send a draft manuscript of the publication or abstract to the sponsor thirty days in advance of submission in order to obtain approval prior to submission of the final version for publication. This will be reviewed promptly and approval will not be withheld unreasonably. In case of a difference of opinion between the sponsor and the investigator(s), the contents of the publication will be discussed in order to find a solution that satisfies both parties.
29269|NCT00220727|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator will be free to disclose at scientific meetings and to publish in the scientific literature data resulting from these trials. A copy of any manuscript must be sent to sponsor for review at least 1 month prior to submission for publication.
29270|NCT00220701|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29271|NCT00220636|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29272|NCT00219557|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29273|NCT00219544|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29274|NCT00219349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29275|NCT00219284|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
29276|NCT00219141|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29277|NCT00218634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29278|NCT00218543|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29279|NCT00218465|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29280|NCT00218439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29281|NCT00218335|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29282|NCT00218296|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29283|NCT00218062|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29284|NCT00218023|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29285|NCT00217971|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29286|NCT00217724|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29287|NCT00217672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29288|NCT00217620|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29289|NCT00217581|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29290|NCT00217490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29291|NCT00217464|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29292|NCT00217438|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication. In the event the sponsor decides a patent application should be filed, the embargo may extend up to an additional 60 days or until a patent application is filed.
29293|NCT00217425|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29294|NCT00217399|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29295|NCT00217087|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29296|NCT00217022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29297|NCT00216736|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29298|NCT00216671|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29299|NCT00216476|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29300|NCT00216320|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29301|NCT00216203|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29302|NCT00216125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29303|NCT00216099|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29304|NCT00216086|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29305|NCT00216060|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29306|NCT00215943|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29307|NCT00215930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29308|NCT00215787|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29309|NCT00215683|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
29310|NCT00215657|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
29311|NCT00215553|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29312|NCT00215540|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29313|NCT00215150|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29314|NCT00215137|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29315|NCT00214903|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29316|NCT00214786|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29317|NCT00214539|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29318|NCT00214526|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29319|NCT00214487|Principal Investigators are NOT employed by the organization sponsoring the study.|The Investigator acknowledges that the data to be collected is proprietary. The Investigator agrees not to publish, divulge, reveal, disclose or otherwise make available, the data to others without the permission of sponsor unless the data have already been, or are subsequently published or disclosed by order of a court of law. The Investigator will not be free to publish papers dealing with the results of any Research performed under this Agreement without the consent of sponsor.
29320|NCT00214461|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
29321|NCT00214383|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29322|NCT00214201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29323|NCT00214136|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29324|NCT00214019|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29325|NCT00213980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29326|NCT00213135|Principal Investigators are NOT employed by the organization sponsoring the study.|
29327|NCT00212758|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29328|NCT00212355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is an agreement between the sponsor and PI that no restricts the PI's right but need to discuss the timing of publish date of trial results after the trial is completed.
29329|NCT00212264|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29330|NCT00212134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29331|NCT00211887|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29332|NCT00211809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29333|NCT00211692|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29334|NCT00211536|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29335|NCT00211510|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29336|NCT00211237|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29337|NCT00211172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29338|NCT00211081|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29339|NCT00210639|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29340|NCT00210626|Principal Investigators are NOT employed by the organization sponsoring the study.|All information which is supplied by COBS to the investigator & not previously published & any data generated as a result of the study are confidential & remain the sole property of COBS. Investigator will not use the information for other purposes without COBS prior written consent.
29341|NCT00210470|Principal Investigators are NOT employed by the organization sponsoring the study.|At least 60 days prior to submitting or presenting a manuscript or other materials relating to the Study to a publisher, reviewer, or other outside persons, the Site shall provide to Sponsor a copy of all such manuscripts and materials, and allow Sponsor 60 days to review and comment on them. If Sponsor requests, the Site shall remove any Confidential Information (other than Study results) prior to submitting or presenting the materials.
29342|NCT00209560|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29343|NCT00209417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29344|NCT00209339|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29345|NCT00209274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29346|NCT00209170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29347|NCT00209131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29348|NCT00209092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29349|NCT00209027|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29350|NCT00208975|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29351|NCT00208949|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29352|NCT00208767|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29353|NCT00208507|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29354|NCT00208494|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29355|NCT00208325|Principal Investigators are NOT employed by the organization sponsoring the study.|DePuy reserves the right to review the contents of publications in advance.The PI may freely disclose the trial results only after DePuy has been given the opportunity of reviewing the proposed results communications at least 30 days prior to the intended release.DePuy will advise the PI of any perceived errors,omissions or corrections but the PI will retain final editorial control.In case of disagreement,DePuy and the PI will make every effort to meet in order to discuss and resolve any issues.
29356|NCT00208091|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29357|NCT00208026|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29358|NCT00207883|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29359|NCT00207740|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29360|NCT00207727|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the PI is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29361|NCT00207714|Principal Investigators are NOT employed by the organization sponsoring the study.|Generally, the only disclosure restriction on the Principal Investigator is that the sponsor has 60 days to review results communications prior to public release and can embargo communications regarding trial results for a period that does not exceed 180 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29362|NCT00207142|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29363|NCT00207090|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29364|NCT00206726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29365|NCT00206518|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29366|NCT00206440|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29367|NCT00206427|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29368|NCT00206336|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29369|NCT00206323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29370|NCT00206102|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to collaborate in good faith with AstraZeneca with regards to the contents and formation of any publication or disclosure to be made by the PI and to pay due consideration to the comments, views and opinions offered by AstraZeneca
29371|NCT00206076|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29372|NCT00205881|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators were not permitted to disclose study results until the Sponsor had completed data analyses and report generation for regulatory purposes, and/or received regulatory approval. The Sponsor agreed to notify the Investigators when they were free to publish, present or use any results arising out of this study for their own instructional, research, or publication objectives, provided that such publication did not disclose any of the Sponsor's proprietary information.
29373|NCT00205855|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29374|NCT00205803|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29375|NCT00205777|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29376|NCT00205712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29377|NCT00205504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29378|NCT00205374|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29379|NCT00205348|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29380|NCT00205049|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29381|NCT00204932|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29382|NCT00204373|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29383|NCT00203996|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29384|NCT00203931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29385|NCT00203892|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29386|NCT00203502|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29387|NCT00203476|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29388|NCT00203424|Principal Investigators are NOT employed by the organization sponsoring the study.|The obligations of confidentiality shall apply for a period of 5 years beyond termination of Agreement between Sponsor and PI,but do not apply to the extent information:is or later becomes generally known to the public;is obtained from third party without restriction who had legal right to disclose;is already possessed by PI,as demonstrated by recipient’s written records predating receipt from Sponsor;or is required to be disclosed pursuant to a subpoena,law,regulation,or other legal proceeding.
29389|NCT00203411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29390|NCT00203307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29391|NCT00203294|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29392|NCT00203268|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29393|NCT00203242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29394|NCT00203229|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29395|NCT00203216|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29396|NCT00203203|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29397|NCT00203047|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
29398|NCT00202878|Principal Investigators are NOT employed by the organization sponsoring the study.|All draft publications (eg, original manuscripts and abstracts of data and information relating to the IMPROVE-IT clinical study) shall be submitted to the Publication Committee at least 45 days prior to submission to a journal or public presentation.
29399|NCT00202839|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator and Institution further agree to provide forty-five (45) days written notice to Sponsor prior to submission for publication or presentation to permit Sponsor to review drafts of abstracts and manuscripts for publication.
29400|NCT00202722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29401|NCT00202644|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
29402|NCT00202449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29403|NCT00201877|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29404|NCT00201864|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29405|NCT00201851|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29406|NCT00201838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29407|NCT00201825|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29408|NCT00201773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29409|NCT00201760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29410|NCT00201734|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29411|NCT00201643|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29412|NCT00201448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29413|NCT00201409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29414|NCT00201240|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29415|NCT00201201|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29416|NCT00201123|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29417|NCT00201006|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29418|NCT00200967|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29419|NCT00200785|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29420|NCT00200356|Principal Investigators are NOT employed by the organization sponsoring the study.|
29421|NCT00200343|Principal Investigators are NOT employed by the organization sponsoring the study.|
29422|NCT00200161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29423|NCT00200057|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29424|NCT00199914|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29425|NCT00199381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29426|NCT00198822|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29427|NCT00198133|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29428|NCT00198081|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29429|NCT00198042|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29430|NCT00198029|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29431|NCT00197496|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29432|NCT00197392|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29433|NCT00197236|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29434|NCT00197184|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29435|NCT00197119|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29436|NCT00197106|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29437|NCT00197028|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29438|NCT00197015|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29439|NCT00197002|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29440|NCT00196976|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29441|NCT00196937|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29442|NCT00196716|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
29443|NCT00196326|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can (i) review results communications prior to public release and can embargo communications regarding trial results for a period of at least 60 days but no more than 180 days from the time submitted to the sponsor for review; and (ii) require in instances of a multi-center study, that a single PI not disclose study data until after the multi-center results are published, provided such results are published within eighteen (18) months of the conclusion of the study.
29444|NCT00196313|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can (i) review results communications prior to public release and can embargo communications regarding trial results for a period of at least 60 days but no more than 180 days from the time submitted to the sponsor for review; and (ii) require in instances of a multi-center study, that a single PI not disclose study data until after the multi-center results are published, provided such results are published within eighteen (18) months of the conclusion of the study.
29445|NCT00196196|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29446|NCT00196105|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29447|NCT00195819|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
29448|NCT00195715|Principal Investigators are NOT employed by the organization sponsoring the study.|Any investigator or institution that plans on presenting/publishing results disclosure, should provide written notification to Abbott within 60 days of their presentation/publication. Abbott requests that no presentation/publication will be allowed until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay of any proposed presentation/publication maybe requested if Abbott needs to secure patent or other proprietary protection.
29449|NCT00195702|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection
29450|NCT00195676|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
29451|NCT00195663|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
29452|NCT00195650|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
29453|NCT00195507|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29454|NCT00195494|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29455|NCT00195442|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29456|NCT00195429|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29457|NCT00195403|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29458|NCT00195351|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29459|NCT00195338|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29460|NCT00195273|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29461|NCT00195260|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29462|NCT00195039|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29463|NCT00195013|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29464|NCT00194896|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29465|NCT00194792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29466|NCT00194779|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29467|NCT00194675|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29468|NCT00194610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29469|NCT00194532|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29470|NCT00194129|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29471|NCT00194077|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29472|NCT00194025|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29473|NCT00194012|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29474|NCT00193609|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29475|NCT00193596|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29476|NCT00193492|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the propsed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites
29477|NCT00193479|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29478|NCT00193453|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29479|NCT00193427|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29480|NCT00193414|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at the site.
29481|NCT00193375|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29482|NCT00193258|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29483|NCT00193219|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29484|NCT00193206|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29485|NCT00193180|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29486|NCT00193128|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29487|NCT00193063|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29488|NCT00193050|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29489|NCT00193037|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review/embargo results communications prior to public release for a period that is >60 days but ≤180 days from date submitted to sponsor, who may require changes to the communication in order to remove specifically identified confidential information (other than study data) and/or delay the proposed publication to enable the sponsor to seek patent protection for inventions. The PI may not publish its results until 18 mos. after the trial has been completed at all sites.
29490|NCT00192647|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
29491|NCT00192296|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
29492|NCT00192075|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29493|NCT00192036|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29494|NCT00192023|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29495|NCT00191984|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29496|NCT00191945|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29497|NCT00191906|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29498|NCT00191854|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29499|NCT00191815|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29500|NCT00191789|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29501|NCT00191724|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29502|NCT00191646|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29503|NCT00191477|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29504|NCT00191451|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29505|NCT00191386|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29506|NCT00191334|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29507|NCT00191308|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29508|NCT00191282|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29509|NCT00191269|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29510|NCT00191191|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29511|NCT00191165|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29512|NCT00191152|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29513|NCT00191139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29514|NCT00191113|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29515|NCT00191100|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29516|NCT00190983|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29517|NCT00190775|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29518|NCT00190749|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29519|NCT00190684|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29520|NCT00190671|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29521|NCT00189540|Principal Investigators are NOT employed by the organization sponsoring the study.|Multi-center all inclusive initial publication planned. Any proposed publications must be submitted to the steering committee and sponsor thirty (30) days prior to publication submission.
29522|NCT00189488|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
29523|NCT00189475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29524|NCT00189462|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29525|NCT00189436|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29526|NCT00189423|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29527|NCT00189306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29528|NCT00189202|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29529|NCT00189137|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29530|NCT00189098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29531|NCT00187889|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29532|NCT00187876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29533|NCT00187720|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29534|NCT00187681|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29535|NCT00187655|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29536|NCT00187486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29537|NCT00187226|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29538|NCT00187200|Principal Investigators are NOT employed by the organization sponsoring the study.|Publications and presentation should be presented to sponsor 30 days (manuscripts) or 7 days (abstracts) prior to submission for publication. The sponsor reserves the right to deny submission of study results if based on data owned by sponsor.
29539|NCT00187135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29540|NCT00187096|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29541|NCT00186901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29542|NCT00186888|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29543|NCT00186875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29544|NCT00186628|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29545|NCT00186537|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29546|NCT00186485|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29547|NCT00186446|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29548|NCT00186186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29549|NCT00186121|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29550|NCT00186069|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29551|NCT00186056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29552|NCT00186043|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29553|NCT00186017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29554|NCT00185965|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29555|NCT00185731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29556|NCT00185692|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29557|NCT00185679|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29558|NCT00185640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29559|NCT00185614|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29560|NCT00185588|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29561|NCT00185458|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigators agree to allow the sponsor to review any manuscripts and to negotiate the times and forums of their publication.
29562|NCT00185380|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor is interested in the publication of the results of every study. As some of the information concerning the study drug and the sponsor's development activities may be strictly confidential, any publication manuscript (including conference contributions, etc.) must first be reviewed by the sponsor before its submission or presentation.
29563|NCT00185211|Principal Investigators are NOT employed by the organization sponsoring the study.|Submit for review any manuscript / abstract related to the Study at least 90 days prior to publication.The proposed publication / presentation shall only be made after BSP has obtained adequate patent protection for the Results, or after the patentable information has been taken out of the publication/presentation.
29564|NCT00184717|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial. Any such scientific paper, presentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication/presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
29565|NCT00184600|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk reserves the right to not release data until specified milestones are reached. This includes the right to not release interim results of clinical trials, because that can invalidate results of the entire trial. At the end of the trial, one or more manuscripts for publication will be prepared collaboratively between Investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for less than 60 days to protect intellectual property.
29566|NCT00184548|Principal Investigators are NOT employed by the organization sponsoring the study.|Novo Nordisk acknowledges the Investigator’s right to publish the entire results of the trial in accordance with the latest Vancouver guidelines. Any such scientific paper, resentation, communication or other information concerning the investigation described in this protocol, must be submitted in writing to Novo Nordisk Trial Manager prior to submission for publication / presentation for comments. Comments will be given within four weeks from receipt of the manuscript.
29567|NCT00184093|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29568|NCT00184054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29569|NCT00184028|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29570|NCT00184002|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29571|NCT00183963|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29572|NCT00183872|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29573|NCT00183794|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29574|NCT00183729|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29575|NCT00183677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29576|NCT00183625|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29577|NCT00183469|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29578|NCT00183456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29579|NCT00183430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29580|NCT00183339|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29581|NCT00183274|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29582|NCT00183248|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29583|NCT00183196|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29584|NCT00183092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29585|NCT00182793|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29586|NCT00182767|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29587|NCT00182754|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29588|NCT00182728|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29589|NCT00182689|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29590|NCT00182637|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29591|NCT00182091|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29592|NCT00182078|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29593|NCT00182000|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29594|NCT00181883|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29595|NCT00181844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29596|NCT00181766|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29597|NCT00181714|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29598|NCT00181623|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29599|NCT00181610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29600|NCT00181155|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29601|NCT00180687|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29602|NCT00180479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29603|NCT00180323|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29604|NCT00180271|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29605|NCT00179959|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29606|NCT00179673|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
29607|NCT00179660|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (60) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
29608|NCT00179647|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present the clinical data generated from the study provided that such Investigator shall furnish sponsor with a copy of the proposed publication or presentation at least 60 days in advance of submission, delete any confidential information, and delay submission for up to 90 days to permit the preparation and filing of appropriate intellectual property applications.
29609|NCT00179621|Principal Investigators are NOT employed by the organization sponsoring the study.|"Multicenter publication must include input from investigators and Celgene, agreement to be established before publication. It has priority over subset (single center) publication, for duration of 1 year after study completion.~Individual investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. In this case, Celgene has the right to comment and right to ask delay of publication for 90 days."
29610|NCT00179517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29611|NCT00179478|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29612|NCT00179413|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29613|NCT00179309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29614|NCT00178919|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29615|NCT00178841|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29616|NCT00178711|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29617|NCT00178685|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29618|NCT00178633|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29619|NCT00178503|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29620|NCT00178477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29621|NCT00178464|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29622|NCT00178256|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29623|NCT00178191|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29624|NCT00178178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29625|NCT00178126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29626|NCT00177970|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29627|NCT00177866|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29628|NCT00177671|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29629|NCT00177307|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29630|NCT00177294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29631|NCT00177255|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29632|NCT00177216|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29633|NCT00177164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29634|NCT00176917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29635|NCT00176904|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29636|NCT00176878|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29637|NCT00176865|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29638|NCT00176852|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29639|NCT00176839|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29640|NCT00176826|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29641|NCT00176800|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29642|NCT00176644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29643|NCT00176631|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29644|NCT00176605|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29645|NCT00176501|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29646|NCT00176488|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29647|NCT00176462|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29648|NCT00176436|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29649|NCT00176306|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29650|NCT00176254|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29651|NCT00176228|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29652|NCT00176202|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29653|NCT00175877|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29654|NCT00175019|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
29655|NCT00175006|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
29656|NCT00174967|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
29657|NCT00174954|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
29658|NCT00174941|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
29659|NCT00174915|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
29660|NCT00174785|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such publication for comment at least 45 days before any submission for publication. If requested by the Sponsor, any submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
29661|NCT00174460|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29662|NCT00174447|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29663|NCT00174382|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29664|NCT00174291|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29665|NCT00174265|Principal Investigators are NOT employed by the organization sponsoring the study.|Except for compelling legal reasons, neither the sponsor nor the investigator will communicate to third parties any result of the clinical trial before the clinical trial report has been released by the sponsor.
29666|NCT00174252|All Principal Investigators ARE employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29667|NCT00174187|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29668|NCT00172185|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29669|NCT00172042|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29670|NCT00171925|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29671|NCT00171873|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29672|NCT00171834|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29673|NCT00171704|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigators are NOT employed by the organization sponsoring the study. Other disclosure agreement that restricts the right of the PI to discuss or publish trial results after the trial is completed. The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in clinical trial.
29674|NCT00171340|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29675|NCT00171314|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29676|NCT00171301|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29677|NCT00171210|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29678|NCT00171054|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29679|NCT00170950|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29680|NCT00170846|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29681|NCT00170625|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29682|NCT00170157|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29683|NCT00169442|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29684|NCT00168844|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29685|NCT00168831|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29686|NCT00168818|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
29687|NCT00168805|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
29688|NCT00168454|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29689|NCT00168428|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29690|NCT00168389|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29691|NCT00168337|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29692|NCT00168324|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29693|NCT00168311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29694|NCT00168298|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29695|NCT00168103|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.
29696|NCT00168064|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29697|NCT00168038|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator must provide a copy of any results communication to the sponsor for review at least 30 days prior to public release. The sponsor may request any changes necessary to prevent forfeiture of patent rights to data not in the public domain. For a multi-center study, the investigator must wait (i) at least 1 year after the study is completed at all sites or (ii) until notified by the sponsor that no multi-center publication is planned before seeking publication review.
29698|NCT00167778|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29699|NCT00167544|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29700|NCT00167414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29701|NCT00167388|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29702|NCT00167310|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29703|NCT00167245|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29704|NCT00167206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29705|NCT00167180|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29706|NCT00167102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29707|NCT00166712|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29708|NCT00166517|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29709|NCT00166504|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29710|NCT00166361|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29711|NCT00166296|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29712|NCT00166205|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI shall have the right to publish the results of research to include in any publication. The PI will provide the Sponsor with at least sixty (60) days for review of a manuscript. No paper that incorporates Sponsor Confidential Information will be submitted for publication without Sponsor's prior written agreement.
29713|NCT00166166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29714|NCT00166114|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29715|NCT00166036|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29716|NCT00165984|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29717|NCT00165958|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29718|NCT00165841|Principal Investigators are NOT employed by the organization sponsoring the study.|
29719|NCT00165789|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29720|NCT00165776|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29721|NCT00165698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29722|NCT00165672|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29723|NCT00165646|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29724|NCT00165503|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29725|NCT00163657|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29726|NCT00163293|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29727|NCT00163215|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29728|NCT00163189|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29729|NCT00163020|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29730|NCT00162981|Principal Investigators are NOT employed by the organization sponsoring the study.|Principal Investigator agrees to delete, at Sponsor’s request, from any proposed Public Presentation any information or material that Sponsor deems confidential or proprietary.
29731|NCT00162942|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29732|NCT00162773|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29733|NCT00162370|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29734|NCT00162266|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29735|NCT00162136|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29736|NCT00162123|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29796|NCT00153920|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29737|NCT00162097|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29738|NCT00162032|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29739|NCT00161616|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
29740|NCT00161473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29741|NCT00161382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29742|NCT00161213|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29743|NCT00160706|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29744|NCT00160693|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29745|NCT00160641|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29746|NCT00160563|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
29747|NCT00160524|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29748|NCT00160251|Principal Investigators are NOT employed by the organization sponsoring the study.|The principal investigator (PI) agrees to provide review copies to the sponsor 30 days prior to submission. The sponsor shall have editorial rights and the right to review and comment on the data analysis and presentation with regard to proprietary information, accuracy of information, and to ensure that the presentation is fairly balanced and in compliance with regulations. If the parties disagree, the PI agrees to meet with the sponsor to discuss and resolve any such issues or disagreement.
29749|NCT00160199|Principal Investigators are NOT employed by the organization sponsoring the study.|Independent analysis and/or publication of these data by the investigator or any member of his/her staff are not permitted without prior written consent of Solvay Pharmaceuticals,Inc. Written permission will be contingent on the review by Solvay Pharmaceuticals, Inc. of the statistical analysis and manuscript and providing for non-disclosure of Solvay Pharmaceuticals, Inc. confidential or proprietary information.
29750|NCT00159965|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29751|NCT00159913|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29752|NCT00159874|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29753|NCT00159861|Principal Investigators are NOT employed by the organization sponsoring the study.|
29754|NCT00159822|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29755|NCT00159783|Principal Investigators are NOT employed by the organization sponsoring the study.|"If study is part of a multicenter trial, Investigator agrees that the first publication is to be a joint publication covering all centers. However, if a joint manuscript has not been submitted for publication within 12 mos of completion or termination of study at all participating sites, Investigator is free to publish separately.~The sponsor should review any publication prior to submission for publication to ensure no confidential information is released inadvertently."
29756|NCT00159432|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29757|NCT00159419|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29758|NCT00158925|Principal Investigators are NOT employed by the organization sponsoring the study.|
29759|NCT00158756|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29760|NCT00158743|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29761|NCT00158600|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
29762|NCT00158379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29763|NCT00158262|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29764|NCT00158249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29765|NCT00158223|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29766|NCT00158197|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29767|NCT00158184|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29768|NCT00158054|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29769|NCT00157950|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29770|NCT00157820|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29771|NCT00157755|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29772|NCT00157573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29773|NCT00157248|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
29774|NCT00157209|Principal Investigators are NOT employed by the organization sponsoring the study.|By signing this protocol, the investigator affirms to the Sponsor that information furnished by the Sponsor will be maintained in confidence, and such information will be divulged to the IRB/IEC under an appropriate understanding of confidentiality with such a committee. It is required that copies of all papers, abstracts, articles, etc. that contain study data are to be forward to the Sponsor for review 30 days prior to submission for publication.
29775|NCT00157196|Principal Investigators are NOT employed by the organization sponsoring the study.|The study as a whole will be published prior to any individual investigator publications. It is required that copies of all papers, abstracts, articles, etc. that contain study data are to be forward to the Sponsor for review 30 days prior to submission for publication.
29776|NCT00157157|Principal Investigators are NOT employed by the organization sponsoring the study.|Baxter's agreements with PIs vary per individual PI, but contain common elements. For this study, PIs are restricted from independently publishing results until the earlier of the primary multicenter publication or 1 year after study completion. Baxter requires a review of results communications (e.g., for confidential information) 30 days prior to submission or communication. Baxter may request an additional delay of up to 90 days (e.g., to allow for intellectual property protection).
29777|NCT00157014|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
29778|NCT00156936|Principal Investigators are NOT employed by the organization sponsoring the study.|Should a PI wish to disclose results, the sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days but less than or equal to 90 days from the time submitted to the sponsor for review. Revisions will be negotiated in good faith. For a multicenter study, the institution/PI agree to publish/publicly present the results together with the other sites unless the sponsor grants written permission in advance.
29779|NCT00156923|Principal Investigators are NOT employed by the organization sponsoring the study.|Should a PI wish to disclose results, the sponsor will review the results communications prior to public release and can embargo results communications for a period of at least 30 days but less than or equal to 90 days from the time submitted to the sponsor for review. Revisions will be negotiated in good faith. For a multicenter study the institution/PI agree to publish/publicly present the results together with the other sites unless the sponsor grants written permission in advance.
29780|NCT00156910|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
29781|NCT00156819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29782|NCT00156715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29783|NCT00156533|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29784|NCT00156390|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29785|NCT00156247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29786|NCT00156065|Principal Investigators are NOT employed by the organization sponsoring the study.|Except for compelling legal reasons, neither the sponsor nor the investigator will communicate to third parties any result of the clinical trial before the CTR has been released by the sponsor.
29787|NCT00156013|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29788|NCT00154466|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29789|NCT00154375|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29790|NCT00154310|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29791|NCT00154297|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29792|NCT00154284|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29793|NCT00154102|Principal Investigators are NOT employed by the organization sponsoring the study.|
29794|NCT00154063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29795|NCT00153985|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29797|NCT00153816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29798|NCT00153179|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29799|NCT00153166|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29800|NCT00153101|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29801|NCT00153062|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29802|NCT00152971|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract
29803|NCT00152763|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29804|NCT00152516|Principal Investigators are NOT employed by the organization sponsoring the study.|UCB has > 60 days but <= 180 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
29805|NCT00152009|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
29806|NCT00151996|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
29807|NCT00151892|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
29808|NCT00151814|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29809|NCT00151775|Principal Investigators are NOT employed by the organization sponsoring the study.|If identified by Daiichi Sankyo Inc.(DSI), any of DSI's confidential information, as defined to the author, shall be deleted. Nothing in our site agreement shall be taken as giving DSI any right of editorial control over any publication prepared by the study site.
29810|NCT00151476|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29811|NCT00151411|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29812|NCT00151372|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29813|NCT00151320|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29814|NCT00151281|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29815|NCT00150969|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29816|NCT00150618|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
29817|NCT00150592|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
29818|NCT00150462|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
29819|NCT00150345|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29820|NCT00150176|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor will be provided an opportunity to review any proposed publication or other type of disclosure before it is submitted or otherwise disclosed.~Materials for intended disclosure must be provided to sponsor at least 30 days before they are submitted for publication or otherwise disclosed. If any patent action is required to protect intellectual property rights, then the disclosure must be delayed for a period not to exceed an additional 60 days."
29821|NCT00149994|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29822|NCT00149890|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29823|NCT00149825|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29824|NCT00149799|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29825|NCT00149747|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29826|NCT00149669|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29827|NCT00149643|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29828|NCT00149630|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29829|NCT00149396|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29830|NCT00149227|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29831|NCT00149214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29832|NCT00148954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29833|NCT00148798|Principal Investigators are NOT employed by the organization sponsoring the study.|
29834|NCT00148759|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29835|NCT00148733|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29836|NCT00148668|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29837|NCT00148317|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29838|NCT00148122|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29839|NCT00148109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29840|NCT00147966|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29841|NCT00147823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29842|NCT00147745|Principal Investigators are NOT employed by the organization sponsoring the study.|If identified by Daiichi Sankyo, Inc. (DSI), any of DSI's confidential information as defined herein shall be deleted…Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by Study Site.
29843|NCT00147537|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29844|NCT00147498|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29845|NCT00147446|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29846|NCT00147316|Principal Investigators are NOT employed by the organization sponsoring the study.|
29847|NCT00147290|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29848|NCT00147277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29849|NCT00147238|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29850|NCT00147225|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29851|NCT00147212|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29852|NCT00147199|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the United Therapeutics publication policy. The rights of the investigator and of the sponsor with regard to publication of the results are described in the investigator contract.
29853|NCT00147030|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29854|NCT00146848|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 30 days from the time submitted to the sponsor for review.
29855|NCT00146770|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
29856|NCT00146757|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
29857|NCT00146640|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29858|NCT00146328|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29859|NCT00146172|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29860|NCT00145795|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29861|NCT00145704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29862|NCT00145626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29863|NCT00145600|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29864|NCT00145587|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29865|NCT00145574|Principal Investigators are NOT employed by the organization sponsoring the study.|"Sponsor reflects the following restrictive language in the Clinical Study Agreements: If identified by Daiichi Sankyo,Inc. (DSI), any of DSI's confidential information as defined herein shall be deleted…Nothing in this publication section shall be taken as giving DSI any right of editorial control over any publication prepared by the Study Site."
29866|NCT00145509|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution will provide manuscripts, abstracts, or the full text of any other intended disclosure to the sponsor at least 30 days prior to submission for publication or other disclosure. If any patent action is required to protect intellectual property rights, Institution agrees to delay the disclosure for a period not to exceed and additional 60 days. Institution will, on request, remove any previously undisclosed Confidential Information (other than study results) before disclosure.
29867|NCT00145496|Principal Investigators are NOT employed by the organization sponsoring the study.|Except for compelling legal reasons, neither the sponsor nor the investigator will communicate to third parties any result of the clinical trial before the clinical trial report has been released by the sponsor.
29868|NCT00145418|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29869|NCT00145327|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29870|NCT00145249|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29871|NCT00145119|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29872|NCT00145041|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29873|NCT00144963|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29874|NCT00144781|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
29875|NCT00144391|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29876|NCT00144339|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29877|NCT00144300|Principal Investigators are NOT employed by the organization sponsoring the study.|Other - Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29878|NCT00144170|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
29879|NCT00144027|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29880|NCT00143845|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29881|NCT00143819|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29882|NCT00143598|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29883|NCT00143507|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review publication and/or communication related to the study results and can require changes. In case of a patent application, the sponsor can delay its authorization for publication or communication of the study results until the date of international registration of the patent.
29884|NCT00143455|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29885|NCT00143403|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29886|NCT00143390|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29887|NCT00143312|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29888|NCT00143247|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29889|NCT00142935|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29890|NCT00142909|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29891|NCT00142818|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29892|NCT00142792|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29893|NCT00142597|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29894|NCT00142506|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29895|NCT00142415|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29896|NCT00142298|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or the publication of the trial results in their entirety.
29897|NCT00142168|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29898|NCT00142116|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29899|NCT00141921|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
29900|NCT00141817|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29901|NCT00141778|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29902|NCT00141765|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29903|NCT00141739|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29904|NCT00141726|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29905|NCT00141518|Principal Investigators are NOT employed by the organization sponsoring the study.|AbbVie requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. AbbVie requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if AbbVie needs to secure patent or proprietary protection.
29906|NCT00141453|Principal Investigators are NOT employed by the organization sponsoring the study.|Results of Study shall not be published without prior express written consent and approval of Sponsor. Sponsor has right to change proposed publication and/or prohibit publication and Contractor must comply with requirements of Sponsor.
29907|NCT00141297|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29908|NCT00141271|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 mo from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29909|NCT00141219|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29910|NCT00141115|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29911|NCT00141102|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29912|NCT00141037|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29913|NCT00140842|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29914|NCT00140621|Principal Investigators are NOT employed by the organization sponsoring the study.|Prior to publishing results from this study in academic meetings, medical journals, etc., the investigator and subinvestigator of the post-manufacturing/marketing clinical study must obtain the approval from the sponsor of the post-manufacturing/marketing clinical study in writing.
29915|NCT00140556|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29916|NCT00140426|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29917|NCT00140413|Principal Investigators are NOT employed by the organization sponsoring the study.|With respect to any proposed publication, the PI must submit to the sponsor a copy of the proposed publication at least 2 months prior to submission for the purposes of: providing the sponsor the oppotunity to review and comment on the contents of proposed publication; and to identify any trade secret, proprietary or confidential information to be removed from the proposed publication. The sponsor will provide comments within 30 days of receipt of proposed publication.
29918|NCT00140244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29919|NCT00140231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29958|NCT00135200|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29920|NCT00140140|Principal Investigators are NOT employed by the organization sponsoring the study.|Celgene shall complete its review within 30 days after receipt of a proposed publication or presentation submitted by the investigator. Upon request, the publication/presentation might be delayed up to 60 additional days for Celgene to secure intellectual property protection. Subsequent to the multicenter publication or one year after study completion, whichever occurs first, an investigator and/or his/her colleagues may publish the results of INVESTIGATOR's part of the study independently.
29921|NCT00139997|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29922|NCT00139776|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29923|NCT00139737|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29924|NCT00139659|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29925|NCT00139477|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29926|NCT00138671|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29927|NCT00138658|Principal Investigators are NOT employed by the organization sponsoring the study.|"The sponsor can review proposed written or oral material which describes the results of the Study prior to public release and can embargo communications for a period that is less than or equal to 60 days from the time submitted to the sponsor for review.~The results from one institution shall not be presented before the multi-center publication. If there is no multi-center publication within 12 months after the Study completion the Investigator shall have the right to publish the results."
29928|NCT00138645|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29929|NCT00138424|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29930|NCT00138294|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29931|NCT00138203|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29932|NCT00138151|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29933|NCT00138125|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29934|NCT00138073|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29935|NCT00138034|Principal Investigators are NOT employed by the organization sponsoring the study.|"Freek W.A. Verheugt~has to following potential conflict of interest:~received educational and research grants from Bayer Healthcare, Roche, Eli Lilly and Boehringer Ingelheim~received honoraria for consultancies from Daiichi-Sankyo, Eli Lilly, Merck, The Medicines Company and Bayer Healthcare"
29936|NCT00137969|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
29937|NCT00137631|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29938|NCT00137449|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosure, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29939|NCT00137436|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29940|NCT00137423|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of <60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), <12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29941|NCT00137280|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29942|NCT00137267|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29943|NCT00137111|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29944|NCT00137046|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29945|NCT00136955|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
29946|NCT00136916|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
29947|NCT00136838|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29948|NCT00136812|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29949|NCT00136760|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29950|NCT00136695|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29951|NCT00136357|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29952|NCT00136318|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29953|NCT00136084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29954|NCT00135798|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29955|NCT00135694|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29956|NCT00135356|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
29957|NCT00135330|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29959|NCT00134901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29960|NCT00134784|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29961|NCT00134719|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29962|NCT00134563|Principal Investigators are NOT employed by the organization sponsoring the study.|"The investigator can publish only the results of the work performed pursuant to this protocol. Prior to publication, the investigator provides the sponsor with the manuscript for review and comment at least 45 days in advance of its submission for publication.~The sponsor can require the investigator to withhold publication an additional 90 days to allow for filing a patent application or taking such other measures as sponsor deems appropriate to establish and preserve its proprietary rights."
29963|NCT00134381|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29964|NCT00134056|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29965|NCT00134043|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29966|NCT00134004|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29967|NCT00133978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29968|NCT00133952|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29969|NCT00133809|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29970|NCT00133705|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29971|NCT00133575|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29972|NCT00132873|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29973|NCT00132808|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
29974|NCT00132769|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
29975|NCT00132730|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation.
29976|NCT00132691|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29977|NCT00132678|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29978|NCT00132496|Principal Investigators are NOT employed by the organization sponsoring the study.|
29979|NCT00132314|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29980|NCT00132132|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29981|NCT00132028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29982|NCT00132002|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29983|NCT00131937|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29984|NCT00131911|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
29985|NCT00131885|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29986|NCT00131677|Principal Investigators are NOT employed by the organization sponsoring the study.|All presentations and publications of data from CDC funded studies are subject to CDC clearance prior to publication or presentation.
29987|NCT00131664|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29988|NCT00131573|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29989|NCT00131508|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29990|NCT00131456|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29991|NCT00131378|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29992|NCT00131352|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, principal investigator (PI) can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
29993|NCT00131248|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29994|NCT00130923|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29995|NCT00130832|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29996|NCT00130793|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
29997|NCT00130780|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
29998|NCT00130728|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study.
29999|NCT00130689|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30000|NCT00130637|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30001|NCT00130520|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30002|NCT00130286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30003|NCT00130247|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30004|NCT00130208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30005|NCT00130117|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30006|NCT00130039|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30007|NCT00129974|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30008|NCT00129961|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
30009|NCT00129766|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
30010|NCT00129727|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30011|NCT00129623|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30012|NCT00129545|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30013|NCT00129480|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30014|NCT00129467|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30015|NCT00129441|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30016|NCT00129402|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30017|NCT00129311|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30018|NCT00129285|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30019|NCT00129272|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30020|NCT00129259|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30021|NCT00129246|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30022|NCT00129220|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30023|NCT00129129|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30024|NCT00129116|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30025|NCT00128921|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30026|NCT00128830|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30027|NCT00128713|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30028|NCT00128661|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30029|NCT00128492|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts/presentations) prior. Any Gilead confidential information in the document(s) must be deleted or, if requested publication, delayed for up to 45 days to permit Gilead to obtain intellectual property protection.
30030|NCT00128401|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30031|NCT00128219|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30032|NCT00128206|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30033|NCT00128193|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30034|NCT00128180|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30035|NCT00127933|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30036|NCT00127855|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30037|NCT00127842|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30038|NCT00127803|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
30039|NCT00127790|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30040|NCT00127712|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30041|NCT00127660|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30042|NCT00127530|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
30043|NCT00127439|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30044|NCT00127413|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30045|NCT00127231|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30046|NCT00127218|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30047|NCT00127192|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30048|NCT00127166|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial. The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission.
30049|NCT00127101|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30050|NCT00127036|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30051|NCT00126776|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30052|NCT00126750|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30053|NCT00126737|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30054|NCT00126659|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30055|NCT00126594|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30056|NCT00126581|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30057|NCT00126568|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30058|NCT00126555|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30059|NCT00126503|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30060|NCT00126490|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30061|NCT00126438|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI and/or institution is that the Sponsor can review results communications prior to public release and can restrict communications regarding trial results for a period that is more than 30 days (publications/abstracts) but not to exceed 90 days (patent related issues) from the time submitted to the Sponsor to review. The PI may be asked to remove any Sponsor confidential information and/or delay publication to protect any proprietary information.
30082|NCT00124748|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30062|NCT00126425|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI and/or institution is that the Sponsor can review results communications prior to public release and can restrict communications regarding trial results for a period that is more than 30 days (publications/abstracts) but not to exceed 90 days (patent related issues) from the time submitted to the Sponsor to review. The PI may be asked to remove any Sponsor confidential information and/or delay publication to protect any proprietary information.
30063|NCT00126191|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30064|NCT00126126|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30065|NCT00126113|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30066|NCT00125957|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30067|NCT00125931|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30068|NCT00125762|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30069|NCT00125658|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30070|NCT00125619|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30071|NCT00125593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30072|NCT00125528|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30073|NCT00125515|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30074|NCT00125268|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30075|NCT00125242|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30076|NCT00125190|Principal Investigators are NOT employed by the organization sponsoring the study.|
30077|NCT00125164|Principal Investigators are NOT employed by the organization sponsoring the study.|Each investigator may publish or report data from their own subjects. The trial data in aggregate are the property of Tercica, Inc. and may not be published without permission of Tercica, Inc. Tercica, Inc. will be the final arbitrator of issues relating to the publication or presentation of the aggregate data.
30078|NCT00125138|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI could publish the results of the Study after the earlier of (a) the cooperative publication of the data, or (b) 18 months after Sponsor’s final evaluation of all data; the PI will submit for review and approval any proposed abstracts and manuscripts at least 45 days prior to submission. The Institution and PI agree to delete any information the Sponsor deems confidential or proprietary; if the parties disagree, then they agree to meet prior to submission to discuss and resolve the issues.
30079|NCT00125034|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30080|NCT00124982|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30081|NCT00124943|Principal Investigators are NOT employed by the organization sponsoring the study.|"Study data will not be published in part before the complete multicenter data has been reported in full, unless more than 1 year has elapsed since completion of the Study.~Investigator/institution must supply copy of presentation or publication to Celgene within 30 days of publication. Celgene may request in writing within that 30 days that Celgene Confidential Information be deleted or be granted a 60 day delay prior to publication to permit intellectual property filings."
30103|NCT00123162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30083|NCT00124735|Principal Investigators are NOT employed by the organization sponsoring the study.|Any scientific paper, presentation, or other communication concerning the clinical trial described in the protocol will first be submitted to Organon, at least 6 weeks ahead of estimated publication or presentation, for written consent, which shall not be withheld unreasonably.
30084|NCT00124709|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30085|NCT00124657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30086|NCT00124618|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30087|NCT00124579|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30088|NCT00124462|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30089|NCT00124449|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
30090|NCT00124176|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30091|NCT00124072|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30092|NCT00124020|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30093|NCT00123955|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30094|NCT00123734|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30095|NCT00123682|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30096|NCT00123643|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30097|NCT00123630|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30098|NCT00123604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30099|NCT00123487|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30100|NCT00123474|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30101|NCT00123422|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30102|NCT00123409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30104|NCT00123123|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30105|NCT00122980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30106|NCT00122954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30107|NCT00122681|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30108|NCT00122460|Principal Investigators are NOT employed by the organization sponsoring the study.|
30109|NCT00122447|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30110|NCT00122382|Principal Investigators are NOT employed by the organization sponsoring the study.|
30111|NCT00122369|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30112|NCT00122317|Principal Investigators are NOT employed by the organization sponsoring the study.|Participation in this multicenter study involved a commitment to publish the data from the study in a cooperative publication prior to release of study results on an individual basis.
30113|NCT00122187|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30114|NCT00122135|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30115|NCT00122109|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30116|NCT00121836|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30117|NCT00121810|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30118|NCT00121719|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30119|NCT00121667|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30120|NCT00121641|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30121|NCT00121485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30122|NCT00121472|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30123|NCT00121238|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30124|NCT00121225|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30125|NCT00121199|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30126|NCT00121186|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30127|NCT00121134|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30128|NCT00120874|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30129|NCT00120627|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30130|NCT00120523|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30131|NCT00120406|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30132|NCT00120289|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30133|NCT00120250|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30134|NCT00120042|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30135|NCT00119678|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30136|NCT00119405|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30137|NCT00119392|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30138|NCT00119379|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30139|NCT00119262|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30140|NCT00119158|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30141|NCT00119041|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30142|NCT00119015|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30143|NCT00118911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30144|NCT00118898|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30145|NCT00118755|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30146|NCT00118742|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30147|NCT00118703|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30148|NCT00118534|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30149|NCT00118482|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30150|NCT00118430|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30151|NCT00118417|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30152|NCT00118404|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30153|NCT00118378|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30154|NCT00118365|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30155|NCT00118352|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30156|NCT00118287|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30157|NCT00118248|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30158|NCT00118157|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30159|NCT00118144|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30160|NCT00118131|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30161|NCT00118092|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30162|NCT00118053|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30163|NCT00118040|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30164|NCT00117988|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30165|NCT00117962|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30225|NCT00113399|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30166|NCT00117949|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
30167|NCT00117845|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30168|NCT00117806|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30169|NCT00117793|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30170|NCT00117715|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30171|NCT00117676|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.
30172|NCT00117637|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication will be discussed with the sponsor prior to release and written consent of the sponsor will be obtained. A draft manuscript of the publication or abstract must be sent to sponsor thirty days in advance of submission.
30173|NCT00117598|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30174|NCT00117585|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30175|NCT00117572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30176|NCT00117559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30177|NCT00117338|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30178|NCT00117325|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30179|NCT00117312|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
30180|NCT00117286|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
30181|NCT00117156|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30182|NCT00116857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30183|NCT00116844|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30184|NCT00116831|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30223|NCT00113490|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.The PIs also agree for data to be presented first as a joint, multi-center publication.
30185|NCT00116805|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.
30186|NCT00116779|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of ublication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
30187|NCT00116753|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review the draft manuscript prior to publication and can request delay of publication where any contents are deemed patentable by the sponsor or confidential to the sponsor. Comments will be given within four weeks from receipt of the draft manuscript.
30188|NCT00116688|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30189|NCT00116649|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30190|NCT00116428|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI is allowed to publish but must submit draft publication(s) to Biosense Webster, Inc. at least 30 days prior to submission for publication or presentation.
30191|NCT00116272|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30192|NCT00116207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30193|NCT00116168|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.
30194|NCT00115934|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30195|NCT00115869|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30196|NCT00115804|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30197|NCT00115765|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30198|NCT00115739|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30199|NCT00115349|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30200|NCT00115297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30201|NCT00115063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30202|NCT00114972|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30224|NCT00113425|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30203|NCT00114959|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor has the right 60 days before submission for publication to review/provide comments. If the Sponsor’s review shows that potentially patentable subject matter would be disclosed, publication or public disclosure shall be delayed for up to 90 additional days in order for the Sponsor, or Sponsor’s designees, to file the necessary patent applications. In multicenter trials, each PI will postpone single center publications until after disclosure or publication of multicenter data.
30204|NCT00114777|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30205|NCT00114634|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30206|NCT00114530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30207|NCT00114517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30208|NCT00114504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30209|NCT00114244|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30210|NCT00114231|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30211|NCT00114166|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30212|NCT00114140|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30213|NCT00114127|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30214|NCT00114101|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30215|NCT00113919|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30216|NCT00113880|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome. The PIs also agree for data to be presented first as a joint, multi-center publication.
30217|NCT00113841|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30218|NCT00113763|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30219|NCT00113607|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30220|NCT00113568|Principal Investigators are NOT employed by the organization sponsoring the study.|
30221|NCT00113529|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30222|NCT00113516|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30226|NCT00113386|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30227|NCT00113373|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30228|NCT00113360|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30229|NCT00113334|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30230|NCT00113321|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30231|NCT00113295|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30232|NCT00113269|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document. Sponsor may delay the publication for an additional 60 days to seek patent protection.
30233|NCT00113230|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30234|NCT00113217|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30235|NCT00113087|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30236|NCT00113022|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30237|NCT00112957|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30238|NCT00112918|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30239|NCT00112905|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30240|NCT00112866|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30241|NCT00112840|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30242|NCT00112736|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30243|NCT00112723|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30244|NCT00112671|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30245|NCT00112593|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30246|NCT00112489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30247|NCT00112463|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30248|NCT00112437|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30249|NCT00112385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30250|NCT00112359|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.
30251|NCT00112294|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30252|NCT00112151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30253|NCT00112112|Principal Investigators are NOT employed by the organization sponsoring the study.|MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome.The principal investigators (PIs) also agree for data to be presented first as a joint, multi-center publication.
30254|NCT00112047|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI may publish study results 2 years after the completion of the study or earlier with the advance written permission of Gilead. The PI will submit any proposed publication or presentation of study results together with the name of the proposed scientific journal, forum or confeence to Gilead prior to submission or presentation (30 days prior for manuscripts and 15 days for abstracts and oral presentations).
30255|NCT00111917|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30256|NCT00111839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30257|NCT00111813|Principal Investigators are NOT employed by the organization sponsoring the study.|"The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the SPONSOR as~confidential must be deleted prior to submission. SPONSOR review can be expedited to meet publication guidelines."
30258|NCT00111800|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30259|NCT00111761|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30260|NCT00111657|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30261|NCT00111007|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30262|NCT00110994|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30301|NCT00108160|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30263|NCT00110890|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30264|NCT00110812|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30265|NCT00110617|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30266|NCT00110513|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30267|NCT00110461|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs may not publish trial results for 18 months - 2 years after trial is completed.
30268|NCT00110396|Principal Investigators are NOT employed by the organization sponsoring the study.|SPONSOR shall have the right to publish or present any results or information, including the Study Results, arising in connection with the STUDY for any purposes. The INSTITUTION, its officers, agents, employees and affiliated entities shall not publish or use any results or information arising in connection with the STUDY, including the Study Results, for professional, research, training or other purposes without SPONSOR’s prior written consent.
30269|NCT00110357|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
30270|NCT00110305|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30271|NCT00110214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30272|NCT00110149|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30273|NCT00110136|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30274|NCT00110084|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30275|NCT00110019|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30276|NCT00109967|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30277|NCT00109928|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30278|NCT00109876|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30279|NCT00109850|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30280|NCT00109837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30281|NCT00109772|Principal Investigators are NOT employed by the organization sponsoring the study.|Results from a center cannot be submitted for publication before results of multicenter study are published unless it is more than 1 year since study completion. Then, Investigator can publish if manuscript is submitted to Celgene 60 days prior to submission. If Celgene decides publication would hinder drug development, Investigator must delay submission for up to 90 days. Investigator must delete confidential information before submission or defer publication to permit patent applications.
30282|NCT00109733|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30283|NCT00109590|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights”.
30284|NCT00109577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30285|NCT00109473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30286|NCT00109343|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30287|NCT00109031|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
30288|NCT00109005|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30289|NCT00108953|Principal Investigators are NOT employed by the organization sponsoring the study.|The institution of the Coordinating Investigator (CI) has the right, consistent with academic standards, to publish any proposed publication written by the consultant as part of their services under this agreement. If the sponsor believes that any proposed publication contained any confidential information, the sponsor shall notify the CI, and the CI shall remove such confidential information.
30290|NCT00108862|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
30291|NCT00108732|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30292|NCT00108628|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30293|NCT00108550|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30294|NCT00108524|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30295|NCT00108485|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30296|NCT00108433|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30297|NCT00108355|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30298|NCT00108342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30299|NCT00108303|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30300|NCT00108277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30302|NCT00108082|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30303|NCT00108069|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30304|NCT00107991|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30305|NCT00107978|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30306|NCT00107952|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30307|NCT00107900|Principal Investigators are NOT employed by the organization sponsoring the study.|A study site may not publish results of a study until after a coordinated multicenter publication has been submitted for publication or until one year after the study has ended, whichever occurs first. The study site will have the opportunity to publish results of the study, provided Daiichi Sankyo has had the opportunity to review and comment on the study site’s proposed publication prior to being submitted for publication with the advice of patent council and need for subject protection.
30308|NCT00107783|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30309|NCT00107653|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
30310|NCT00107614|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30311|NCT00107575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30312|NCT00107536|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30313|NCT00107380|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30314|NCT00107315|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30315|NCT00107276|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30316|NCT00107198|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30317|NCT00107172|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30318|NCT00107120|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results communications prior to public release & can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor’s confidential info. Upon sponsor’s request, PI shall delete any proprietary info & shall not include raw data in pub. On sponsor’s request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub.
30319|NCT00107042|Principal Investigators are NOT employed by the organization sponsoring the study.|The Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by the protocol team and AMLG.
30320|NCT00106964|Principal Investigators are NOT employed by the organization sponsoring the study.|The Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions Publication Policy outlines procedures for the development and review of abstracts, publications and presentations. The Adolescent Medicine Leadership Group (AMLG) retains custody of and primary rights to the data. Use of data must be approved by protocol team and AMLG.
30321|NCT00106938|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30322|NCT00106704|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30323|NCT00106639|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30324|NCT00106626|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30325|NCT00106535|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30326|NCT00106431|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor can review results at least 60 days prior to the date of submission for publication or public disclosure; sponsor will complete review within review period and will have authority to require institution/PI to delete confidential information other than the results.
30327|NCT00106392|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document.
30328|NCT00106353|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30329|NCT00106249|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30330|NCT00106184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30331|NCT00106119|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30332|NCT00106106|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30333|NCT00106080|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30334|NCT00106028|Principal Investigators are NOT employed by the organization sponsoring the study.|The findings of the study may be published in a scientific journal or presented at a scientific meeting. Before submitting the results of the study for publication or presentation, the Investigator will allow the Sponsor 30 days in which to review and comment on the manuscript.
30335|NCT00106002|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30336|NCT00105989|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30337|NCT00105586|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30338|NCT00105560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30339|NCT00105534|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator shall not publish, present or use any data or results arising out of the performance of this study for their own instruction, research or publication without the prior express written consent of Sponsor.
30340|NCT00105521|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30341|NCT00105482|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30342|NCT00105469|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and Principal Investigator shall not publish, present or use any data or results arising out of the performance of this study for their own instruction, research or publication without the prior express written consent of Sponsor.
30343|NCT00105443|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30344|NCT00105235|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30345|NCT00105196|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
30346|NCT00105183|Principal Investigators are NOT employed by the organization sponsoring the study.|"Protocol: The 1st publication of study results shall be a complete, joint multicenter publication or disclosure coordinated by sponsor. Later publications will reference 1st publication.~Prior to submitting for publication, the Investigator shall allow sponsor at least 30 days to review the proposed Publication. Proposed Publications shall not include either Fresenius Biotech confidential information other than the study results or personal data on any patient, such as name or initials."
30347|NCT00105157|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30348|NCT00105079|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30349|NCT00105066|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30350|NCT00105027|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30351|NCT00105001|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30352|NCT00104884|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30353|NCT00104871|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30354|NCT00104728|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30355|NCT00104650|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30356|NCT00104637|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30357|NCT00104572|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30358|NCT00104520|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution and investigator may publish or present the results of the trial generated there with prior written consent of Gilead; or 2 years after the trial has ended at all institutions. Proposed publications/target venue must go to Gilead 30 days (manuscripts) or 15 days (abstracts/presentations) prior. Any Gilead confidential information in the document(s) must be deleted, or if requested publication delayed for up to 45 days to permit Gilead to obtain intellectual property protection.
30359|NCT00104416|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30360|NCT00104299|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30361|NCT00104247|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the results shall be made by Sponsor in a joint publication. If such a multi-center publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however to comply with the other terms of the agreement.
30362|NCT00104234|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the results shall be made by Sponsor in a joint publication. If such a multicenter publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however to comply with the other terms of the agreement.
30363|NCT00104104|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial; or disclosure of the trial results in their entirety.
30364|NCT00104052|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30365|NCT00103857|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30366|NCT00103844|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30367|NCT00103740|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30368|NCT00103662|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
30369|NCT00103610|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
30370|NCT00103506|Principal Investigators are NOT employed by the organization sponsoring the study.|A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.
30371|NCT00103311|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30372|NCT00103259|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30373|NCT00103207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30374|NCT00103194|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30375|NCT00103142|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30376|NCT00103116|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30377|NCT00103012|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30378|NCT00102804|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30379|NCT00102687|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i)furnish the sponsor a copy of any proposed publication or presentation generally thirty (30) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
30380|NCT00102596|All Principal Investigators ARE employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30381|NCT00102531|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30382|NCT00102518|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30383|NCT00102440|Principal Investigators are NOT employed by the organization sponsoring the study.|No publication related to study results will be published prior to publication of a multi-center report submitted for publication within 18 months after conclusion or termination of a study. Results publications will be submitted to sponsor for review 60 days in advance of publication. Sponsor can require removal of confidential information unrelated to study results. Sponsor can embargo a proposed publication for another 60 days to preserve intellectual property.
30384|NCT00102063|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30385|NCT00101933|Principal Investigators are NOT employed by the organization sponsoring the study.|The disclosure restrictions on the PI allow for the sponsor to review results communications prior to public release and to embargo communications regarding trial results for a period that is less than or equal to 45 days from the time submitted to sponsor for review. The sponsor is also allowed to require changes for technical correctness and to protect confidential information, copyrightable or patentable material; and when reasonably requested, extend the embargo up to an additional 60 days.
30386|NCT00101907|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30387|NCT00101868|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30388|NCT00101816|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30389|NCT00101686|Principal Investigators are NOT employed by the organization sponsoring the study.|
30390|NCT00101660|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30391|NCT00101647|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30392|NCT00101582|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
30393|NCT00101452|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30394|NCT00101439|Principal Investigators are NOT employed by the organization sponsoring the study.|The Sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission. Sponsor review can be expedited to meet publication guidelines.
30395|NCT00101413|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30396|NCT00101400|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30397|NCT00101361|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30398|NCT00101283|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30399|NCT00101192|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30400|NCT00101166|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30401|NCT00101101|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30402|NCT00101036|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30403|NCT00100932|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30404|NCT00100841|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30405|NCT00100815|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30406|NCT00100802|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30407|NCT00100789|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30408|NCT00100698|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30409|NCT00100659|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30410|NCT00100230|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30411|NCT00100178|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30412|NCT00100048|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30413|NCT00099983|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30414|NCT00099632|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
30415|NCT00099437|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that they cannot publish any information to do with the trial without written consent from Quintiles.
30416|NCT00099359|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30417|NCT00099268|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30418|NCT00099047|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30419|NCT00099021|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30420|NCT00098956|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30421|NCT00098865|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30422|NCT00098839|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30423|NCT00098813|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30424|NCT00098787|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30425|NCT00098774|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30426|NCT00098748|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30427|NCT00098722|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30428|NCT00098670|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30429|NCT00098475|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30430|NCT00098371|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30431|NCT00098345|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
30432|NCT00098306|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30433|NCT00098293|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30434|NCT00098254|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30435|NCT00098059|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30436|NCT00098020|Principal Investigators are NOT employed by the organization sponsoring the study.|There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30437|NCT00097981|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30438|NCT00097786|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30439|NCT00097773|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30440|NCT00097721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30441|NCT00097708|Principal Investigators are NOT employed by the organization sponsoring the study.|
30442|NCT00097695|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30443|NCT00097591|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30444|NCT00097539|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30445|NCT00097500|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30446|NCT00097448|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30447|NCT00097370|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30448|NCT00097253|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30449|NCT00096993|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30450|NCT00096954|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30451|NCT00096941|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30452|NCT00096785|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30453|NCT00096681|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30454|NCT00096538|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30455|NCT00096486|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30456|NCT00096460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30457|NCT00096447|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30458|NCT00096382|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30459|NCT00096356|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30460|NCT00096278|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30461|NCT00096265|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30462|NCT00096226|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30463|NCT00096200|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30464|NCT00096174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30465|NCT00096161|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30466|NCT00096135|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior sponsor approval.
30467|NCT00096122|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30468|NCT00096109|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30469|NCT00096044|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30470|NCT00096031|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30471|NCT00096018|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30472|NCT00095979|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30473|NCT00095940|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30474|NCT00095875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30475|NCT00095836|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30476|NCT00095784|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30477|NCT00095628|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30478|NCT00095576|Principal Investigators are NOT employed by the organization sponsoring the study.|"As this study is part of a multicenter trial, publications derived from this study should include input from the principal investigator, his/her colleagues, the other investigators in this trial, and SPONSOR personnel.~The SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication guidelines."
30479|NCT00095563|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30480|NCT00095498|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30481|NCT00095303|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30482|NCT00095238|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30483|NCT00095212|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30484|NCT00095199|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30485|NCT00095173|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30486|NCT00095147|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30487|NCT00095121|Principal Investigators are NOT employed by the organization sponsoring the study.|Publication must include results in their entirety and not as individual center data. Results may be published/presented at scientific meetings. All manuscripts/abstracts must be submitted to Gilead prior to submission. Any formal publication of the study in which input of Gilead personnel exceeded that of conventional monitoring will be considered as a joint publication by the investigator and the appropriate Gilead personnel.
30488|NCT00095056|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30489|NCT00094900|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30490|NCT00094887|Principal Investigators are NOT employed by the organization sponsoring the study.|
30491|NCT00094861|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits sponsor a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Sponsor may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, investigator agrees not to publish any results before the first multi-center publication.
30492|NCT00094835|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30511|NCT00093756|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30493|NCT00094809|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30494|NCT00094770|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30495|NCT00094757|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30496|NCT00094653|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30497|NCT00094575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30498|NCT00094536|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30499|NCT00094497|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30500|NCT00094458|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30501|NCT00094328|Principal Investigators are NOT employed by the organization sponsoring the study.|The PI agrees to collaborate with AstraZeneca on the contents and formation of any publication or disclosure and to pay due consideration to comments and opinions offered. AstraZeneca have 60 days for final manuscript review and may require that submission for publication be delayed for a further 90 days in order to file patent applications.
30502|NCT00094302|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30503|NCT00094172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30504|NCT00094107|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30505|NCT00094094|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30506|NCT00094055|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30507|NCT00093847|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30508|NCT00093808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30509|NCT00093795|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30510|NCT00093782|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30568|NCT00089752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30512|NCT00093496|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30513|NCT00093470|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30514|NCT00093379|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30515|NCT00093145|Principal Investigators are NOT employed by the organization sponsoring the study.|Institution may publish the results of its findings if a multicenter publication is not forthcoming within 18 months after study completion. Institution shall provide Sponsor a copy of the manuscript at least 30 days prior to submission; if no response is received within 30 days the publication or presentation may proceed without delay. Sponsor may request that Confidential Information be deleted. Publication may be delayed for an additional 60 days if patentable matter is included.
30516|NCT00093041|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30517|NCT00093015|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30518|NCT00092677|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30519|NCT00092547|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30520|NCT00092534|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30521|NCT00092521|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30522|NCT00092495|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30523|NCT00092456|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30524|NCT00092443|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30525|NCT00092417|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30526|NCT00092131|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30527|NCT00092118|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30528|NCT00091962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30529|NCT00091949|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30530|NCT00091832|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30531|NCT00091819|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30532|NCT00091793|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30533|NCT00091572|Principal Investigators are NOT employed by the organization sponsoring the study.|
30534|NCT00091507|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30535|NCT00091442|Principal Investigators are NOT employed by the organization sponsoring the study.|If an investigator wishes to publish information from the study, a copy of the manuscript must be provided to the sponsor for review at least 60 days before submission. Expedited reviews will be arranged if needed. If requested by the sponsor in writing, the investigator will withhold such publication for up to an additional 60 days to allow for filing of a patent application. The sponsor will not mandate modifications to scientific content and does not have the right to suppress information.
30536|NCT00091390|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30537|NCT00091273|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30538|NCT00091260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30539|NCT00091169|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30540|NCT00091026|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30541|NCT00090987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30542|NCT00090857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30543|NCT00090844|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30544|NCT00090779|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights”.
30545|NCT00090766|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
30546|NCT00090753|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
30547|NCT00090610|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30548|NCT00090584|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30549|NCT00090519|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30550|NCT00090493|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30551|NCT00090363|Principal Investigators are NOT employed by the organization sponsoring the study.|AstraZeneca can review results communications prior to public release and may within 30 days of receipt require that submission or disclosure be delayed for up to 2 months in order to file patent applications. AstraZeneca can also, within 30 days of receipt, require amendments to be made in order to protect its patent and / or corporate interests.
30552|NCT00090545|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30553|NCT00090285|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. Any information identified by the sponsor as confidential must be deleted prior to submission.
30554|NCT00090259|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30555|NCT00090233|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30556|NCT00090220|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication or presentation
30557|NCT00090402|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30558|NCT00090142|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30559|NCT00090103|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30560|NCT00090051|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30561|NCT00003224|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30562|NCT00089999|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30563|NCT00089986|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30564|NCT00089973|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30565|NCT00089895|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30566|NCT00089843|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30567|NCT00089791|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30569|NCT00089778|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30570|NCT00089674|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30571|NCT00089661|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30572|NCT00089648|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30573|NCT00089635|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
30574|NCT00089583|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30575|NCT00089609|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30576|NCT00089544|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30577|NCT00089505|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
30578|NCT00089479|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30579|NCT00089414|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30580|NCT00089297|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30581|NCT00089141|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30582|NCT00089076|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30583|NCT00089011|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30584|NCT00088985|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30585|NCT00088972|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30586|NCT00088907|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30587|NCT00088881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30588|NCT00088634|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30589|NCT00088621|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30590|NCT00088595|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30591|NCT00088530|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30592|NCT00088465|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30593|NCT00088374|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30594|NCT00088218|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30595|NCT00088166|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30596|NCT00088153|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30597|NCT00087698|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30598|NCT00087685|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30599|NCT00087672|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30600|NCT00087646|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30601|NCT00087633|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30602|NCT00087607|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights
30603|NCT00087594|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30604|NCT00087568|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
30605|NCT00087555|Principal Investigators are NOT employed by the organization sponsoring the study.|
30606|NCT00087529|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30607|NCT00087516|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30608|NCT00087490|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30609|NCT00087438|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30610|NCT00087152|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30611|NCT00087139|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30612|NCT00086996|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30613|NCT00086957|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30614|NCT00086684|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30615|NCT00086619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30616|NCT00086580|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after an independent multi-investigator publication (in which the PI can participate) or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
30617|NCT00086411|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30618|NCT00086385|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30619|NCT00086515|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30620|NCT00086502|Principal Investigators are NOT employed by the organization sponsoring the study.|Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30621|NCT00086450|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30622|NCT00086346|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
30623|NCT00086281|Principal Investigators are NOT employed by the organization sponsoring the study.|
30624|NCT00086307|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30625|NCT00086190|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30626|NCT00086138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30627|NCT00086047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30628|NCT00085917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30629|NCT00085839|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30630|NCT00085735|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30631|NCT00085709|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30632|NCT00085644|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
30633|NCT00085631|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30634|NCT00085566|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30635|NCT00085540|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30636|NCT00085436|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30637|NCT00085423|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30638|NCT00085410|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30639|NCT00085293|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30640|NCT00085254|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30641|NCT00085202|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30642|NCT00085098|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30643|NCT00084864|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30644|NCT00084838|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30645|NCT00084747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30646|NCT00084682|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30647|NCT00084617|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30648|NCT00084487|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30649|NCT00084409|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30650|NCT00084383|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30651|NCT00084318|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30652|NCT00084266|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30653|NCT00084136|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights
30654|NCT00084084|Principal Investigators are NOT employed by the organization sponsoring the study.|Shire's agreements with investigators vary. All agreements provide Shire the right to embargo communications regarding trial results prior to public release for a period ≤ 180 days from the time submitted to Shire for review. Shire does not prohibit publication but can require the removal of confidential information (excluding trial results) and can request postponement of a single-center publication until after disclosure of the trial's multi-center publication.
30655|NCT00083915|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30656|NCT00083889|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30657|NCT00004146|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30658|NCT00083759|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor will have at least 30 days to request revisions to a proposed Publication. Institution will delete any Confidential Information provided by Sponsor, will delay Publication submission for a further 90 days for the filing of patent applications, and will not issue a press release about the Study without the Sponsor’s prior written consent.
30659|NCT00083720|Principal Investigators are NOT employed by the organization sponsoring the study.|Investigators may not independently publish/disclose any study data, findings or conclusions except as part of an overall multi-center publication. After final publication, or if a draft publication is not produced within approximately 6 months of the final report of the study results, investigators may independently publish, subject to review for sponsor confidential information which may be redacted at sponsor request. Publication may be delayed up to 90 days to seek patent protection.
30660|NCT00083616|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.
30661|NCT00083551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30662|NCT00083382|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30663|NCT00082888|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30664|NCT00082810|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30665|NCT00082758|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30666|NCT00083226|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30667|NCT00083174|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30668|NCT00083122|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30669|NCT00082433|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
30670|NCT00082381|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30671|NCT00082407|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30672|NCT00082368|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30673|NCT00082355|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30674|NCT00082342|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30675|NCT00082329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30676|NCT00082173|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30677|NCT00003726|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30678|NCT00081939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30679|NCT00082017|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30680|NCT00081861|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30681|NCT00081770|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30682|NCT00081731|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30683|NCT00081653|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30684|NCT00081497|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, Principal Investigator (PI) can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
30685|NCT00081458|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30742|NCT00003222|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30686|NCT00081328|Principal Investigators are NOT employed by the organization sponsoring the study.|This work was conducted by a collaborative group. All investigators in the study group adhere to the Publications & Presentations Policy. The policy spells out procedures for proposing, developing, and submitting publications and presentations using study data. Once results have been published or presented, all members of the study group are free to discuss them.
30687|NCT00081289|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30688|NCT00081263|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30689|NCT00081159|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30690|NCT00080938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30691|NCT00080912|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30692|NCT00080899|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30693|NCT00080535|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30694|NCT00080483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30695|NCT00002525|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30696|NCT00080470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30697|NCT00080301|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial’s primary publication.
30698|NCT00080288|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30699|NCT00080223|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30700|NCT00002540|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30701|NCT00080119|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
30702|NCT00079937|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial.
30703|NCT00009737|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
30743|NCT00076804|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30704|NCT00079781|Principal Investigators are NOT employed by the organization sponsoring the study.|Each Investigator, Coordinator, and Institution agree to submit publications to the RNS® System Study Publication Committee for review prior to submission for publication (at least 30 days for manuscripts and at least 7 days for abstracts) to assure that publication does not compromise the scientific integrity of the study or contain confidential NeuroPace information. NeuroPace may require that presentation/publication be withheld for up to 60 days to allow for filing of a patent application.
30705|NCT00079677|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30706|NCT00002601|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30707|NCT00079417|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30708|NCT00079391|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30709|NCT00079339|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30710|NCT00079326|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30711|NCT00079274|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30712|NCT00079183|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30713|NCT00079040|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30714|NCT00079001|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30715|NCT00078949|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30716|NCT00078767|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30717|NCT00078754|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30718|NCT00078728|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30719|NCT00078715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30720|NCT00005947|Principal Investigators are NOT employed by the organization sponsoring the study.|A provision provides for sponsor review up to 45 days with the right to request modification based on disclosure of confidential information; extendable by 60 days to file a patent application.
30721|NCT00078559|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30722|NCT00002597|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30723|NCT00078377|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30724|NCT00076687|Principal Investigators are NOT employed by the organization sponsoring the study.|A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
30744|NCT00076752|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30725|NCT00078403|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve US or foreign patent or other intellectual property rights.
30726|NCT00078325|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30727|NCT00078312|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30728|NCT00078286|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30729|NCT00077974|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30730|NCT00077857|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30731|NCT00077766|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
30732|NCT00077922|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30733|NCT00077675|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30734|NCT00077649|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30735|NCT00077636|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30736|NCT00077623|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
30737|NCT00077610|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30738|NCT00077376|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30739|NCT00077207|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30740|NCT00077064|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30741|NCT00076999|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
30745|NCT00076622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30746|NCT00076570|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30747|NCT00003298|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30748|NCT00076336|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
30749|NCT00076258|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30750|NCT00076245|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30751|NCT00076219|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30752|NCT00076102|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30753|NCT00076050|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30754|NCT00076024|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30755|NCT00076011|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30756|NCT00075946|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30757|NCT00075881|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30758|NCT00075829|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30759|NCT00075816|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30760|NCT00075803|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30761|NCT00075764|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30762|NCT00075725|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval
30763|NCT00075608|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30764|NCT00075582|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30765|NCT00075504|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30766|NCT00075478|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30767|NCT00075400|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30768|NCT00075335|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30769|NCT00075270|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30770|NCT00075218|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30771|NCT00075088|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30772|NCT00075023|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30773|NCT00074984|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
30774|NCT00074958|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after Genzyme publishes or 18 months after study completion. PI gives Genzyme a draft 60 days before publication. Genzyme can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
30775|NCT00074815|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30776|NCT00074802|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30777|NCT00074711|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30778|NCT00074581|Principal Investigators are NOT employed by the organization sponsoring the study.|All study abstracts and publications are subject to HPTN Publication and Public Information Policies and Clinical Trial Agreements between NIAID (DAIDS) and company collaborators. The publication or other disclosure can be delayed for up to thirty additional business days for manuscripts and five business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
30779|NCT00074412|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trial Agreement between NIAID (DAIDS) & company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review & comment. The publication or other disclosure can be delayed for up to thirty additional business days for manuscripts & five business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
30780|NCT00074308|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30781|NCT00074269|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30782|NCT00074165|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30783|NCT00074152|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30784|NCT00074035|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30785|NCT00073983|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30786|NCT00073957|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30787|NCT00073918|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30788|NCT00073528|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
30789|NCT00073333|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30790|NCT00073307|Principal Investigators are NOT employed by the organization sponsoring the study.|"The agreed point of publication is 12-18 months after database lock at the earliest.~Bayer will have up to 30/45 days to review publications, and may request an additional publication delay of up to 60 days to allow for filing a Patent Application (if applicable).~No publication of single center data should be done prior of publication if multi -center data."
30791|NCT00073073|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30792|NCT00073021|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30793|NCT00073008|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30794|NCT00072761|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30795|NCT00072475|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30796|NCT00072449|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30797|NCT00072293|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30798|NCT00072280|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30799|NCT00072189|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30800|NCT00072176|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30801|NCT00071981|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30802|NCT00072566|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30803|NCT00072514|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30804|NCT00071812|Principal Investigators are NOT employed by the organization sponsoring the study.|For multi-center trials, no investigator will be authorized to publish study results from an individual center until the multi-center trial results are published. All manuscripts and abstracts must be submitted to the sponsor for review at least 30 days prior to submission for publication or for presentation at a scientific meeting. Proposed abstracts and publications will be reviewed promptly.
30805|NCT00071799|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present study data provided that the investigator shall (i) furnish the sponsor a copy of any proposed publication or presentation generally thirty (30) days in advance of the submission, (ii) delete any confidential information of the sponsor, and (iii) delay submission for generally up to ninety (90) days to permit the preparation and filing of intellectual property applications or until sponsor gives its consent in a timely manner.
30806|NCT00071890|Principal Investigators are NOT employed by the organization sponsoring the study.|The sponsor can review results communications prior to public release and can embargo communications regarding trial results with no delay specified
30807|NCT00071760|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30808|NCT00071721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30809|NCT00071513|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30810|NCT00071487|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30811|NCT00071396|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30812|NCT00071110|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30813|NCT00071032|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30814|NCT00071006|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30815|NCT00070941|Principal Investigators are NOT employed by the organization sponsoring the study.|"According to the NIH -grant that supported this clinical trial all publications must be reported to the grant office prior to the release of publications.~Statement from NIH award letter:~This includes manuscripts submitted or accepted for publication to the awarding component. Report only those publications resulting directly from this grant and those publications. If there have been no publications, so state."
30816|NCT00071058|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30817|NCT00003907|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30818|NCT00070564|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30819|NCT00070499|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30820|NCT00070317|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30821|NCT00070291|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30822|NCT00070135|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30823|NCT00070109|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30824|NCT00070018|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30825|NCT00069953|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30826|NCT00069784|Principal Investigators are NOT employed by the organization sponsoring the study.|"The Steering Committee will be responsible for preparing summaries of the study results for publication in the medical literature, and will have the right to submit such summaries for publication after a review by the sponsor. In such cases comments from the sponsor to the Steering Committee are to be provided within 15 working days. All comments will be carefully considered by the Steering Committee who nevertheless have the final decision on the content of the manuscript."
30827|NCT00069823|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30828|NCT00069641|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30829|NCT00069277|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30830|NCT00069264|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30831|NCT00069329|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30832|NCT00069238|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30833|NCT00069121|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30834|NCT00069108|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30835|NCT00069095|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30836|NCT00069160|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30837|NCT00068822|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30838|NCT00068770|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30839|NCT00068718|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30840|NCT00068601|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30841|NCT00068588|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30842|NCT00068575|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30843|NCT00068445|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30844|NCT00068419|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30845|NCT00068406|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30846|NCT00068393|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30847|NCT00068380|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30848|NCT00068367|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30849|NCT00068341|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30851|NCT00068237|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30852|NCT00068107|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30853|NCT00067990|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30854|NCT00067808|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30855|NCT00067470|Principal Investigators are NOT employed by the organization sponsoring the study.|The first publication of the results shall be made by Sponsor in a joint publication. If such a multi-center publication is not submitted within 12 months after conclusion of the study, the PI may publish the results from their site individually, subject however to comply with the other terms of the agreement.
30856|NCT00067236|Principal Investigators are NOT employed by the organization sponsoring the study.|Data, calculations, interpretations, opinions, and recommendations will be the property of P&GP. Manuscripts for publication will be drafted by the Expert Panel which will select appropriate journals in which to publish. P&GP, through its Expert Panel representation, will provide technical/editorial/review assistance. Other manuscript(s) will supported as appropriate. These materials must be submitted to P&GP and the Expert Panel for review prior to publication
30857|NCT00066963|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30858|NCT00066937|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30859|NCT00066807|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30860|NCT00066781|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30861|NCT00066742|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30862|NCT00066703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30863|NCT00066690|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30864|NCT00066573|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30865|NCT00066469|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30866|NCT00066365|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30867|NCT00066222|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30868|NCT00066170|Principal Investigators are NOT employed by the organization sponsoring the study.|
30869|NCT00066066|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30870|NCT00065806|Principal Investigators are NOT employed by the organization sponsoring the study.|PIs agree to follow the CARRA Publication Guidelines. https://www.carragroup.org/about-carra/carra-policies/carra-endorsed-studies-policies
30871|NCT00014560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30872|NCT00065611|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30873|NCT00065507|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
30960|NCT00054847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30874|NCT00065468|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30875|NCT00065442|Principal Investigators are NOT employed by the organization sponsoring the study.|A provision provides for sponsor review up to 45 days with the right to request modification based on disclosure of confidential information; extendable by 60 days to file a patent application.
30876|NCT00065429|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30877|NCT00065260|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30878|NCT00065156|Principal Investigators are NOT employed by the organization sponsoring the study.|Unless approved by Celgene, single center data will not be published before multicenter data, unless more than 1 year has elapsed since completion of the Study. Thereafter, Investigator may publish single center data provided that Investigator shall: i) provide a copy of the publication to Celgene at least 60 days in advance of submission for publication; ii) delete Celgene Confidential Information and; iii) delay submission up to 90 additional days to permit intellectual property filings.
30879|NCT00065065|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30880|NCT00003895|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30881|NCT00064987|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30882|NCT00064844|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30883|NCT00064753|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30884|NCT00064792|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30885|NCT00064701|Principal Investigators are NOT employed by the organization sponsoring the study.|Institute and/or Principal Investigator may publish trial data generated at their specific study site after Sponsor publication of the multi-center data or until 18 months have elapsed following study completion. Sponsor must receive a site’s manuscript at least 30 days prior to publication to ensure that no confidential information of Sponsor is included in the document.
30886|NCT00064662|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30887|NCT00064350|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30888|NCT00064337|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30889|NCT00064298|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30890|NCT00064259|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30891|NCT00064038|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30892|NCT00064025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30893|NCT00063999|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30894|NCT00063986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30895|NCT00063934|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30896|NCT00063635|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30897|NCT00063622|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30898|NCT00063570|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30899|NCT00063362|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30900|NCT00063258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30901|NCT00063154|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30902|NCT00063232|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30903|NCT00062764|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30904|NCT00062751|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
30905|NCT00062738|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30906|NCT00062647|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30907|NCT00062439|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30908|NCT00062374|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30909|NCT00062010|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30910|NCT00061945|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30911|NCT00061932|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30912|NCT00061893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30913|NCT00061633|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30914|NCT00061373|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30915|NCT00061048|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30916|NCT00060944|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30917|NCT00060840|Principal Investigators are NOT employed by the organization sponsoring the study.|
30918|NCT00060528|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30919|NCT00060424|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30920|NCT00060346|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30921|NCT00060333|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30922|NCT00060008|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30923|NCT00059839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30924|NCT00059787|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30925|NCT00059475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30926|NCT00059332|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30927|NCT00059215|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30928|NCT00058825|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30929|NCT00058552|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30930|NCT00058539|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
30931|NCT00058240|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30932|NCT00058214|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30933|NCT00058019|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30934|NCT00057954|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30935|NCT00057941|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30936|NCT00057876|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30937|NCT00057863|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30938|NCT00057837|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30939|NCT00057811|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30940|NCT00057785|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30941|NCT00057746|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30942|NCT00023673|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30943|NCT00057681|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30944|NCT00057577|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30945|NCT00057551|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30946|NCT00057330|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30947|NCT00056862|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30948|NCT00056563|Principal Investigators are NOT employed by the organization sponsoring the study.|
30949|NCT00056550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30950|NCT00056498|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30951|NCT00056472|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30952|NCT00056407|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
30953|NCT00056316|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30954|NCT00056160|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator shall have the right to publish and/or present the clinical data generated from the study provided that such Investigator shall furnish sponsor with a copy of the proposed publication or presentation at least 60 days in advance of submission, delete any confidential information, and delay submission for up to 90 days to permit the preparation and filing of appropriate intellectual property applications.
30955|NCT00055692|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30956|NCT00055601|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30957|NCT00055497|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
30958|NCT00055471|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30959|NCT00055237|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30961|NCT00054717|Principal Investigators are NOT employed by the organization sponsoring the study.|Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract.
30962|NCT00054704|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30963|NCT00054691|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30964|NCT00054665|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30965|NCT00054639|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30966|NCT00054353|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30967|NCT00054327|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30968|NCT00054275|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30969|NCT00054132|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30970|NCT00054028|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30971|NCT00053898|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30972|NCT00053846|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30973|NCT00053703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30974|NCT00053677|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30975|NCT00053495|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.
30976|NCT00053482|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications
30977|NCT00053417|Principal Investigators are NOT employed by the organization sponsoring the study.|The INSTITUTION shall submit any such manuscript or release to the SPONSOR for comment prior to publication or release at least forty-five (45) days in advance of submission for publication. If the parties disagree concerning appropriateness of the data analysis and presentation, INSTITUTION agrees to meet with SPONSOR’s representatives for the purpose of making good faith efforts to discuss and resolve any issues or disagreement.
30978|NCT00053365|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30979|NCT00053352|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30980|NCT00053014|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30981|NCT00003830|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30982|NCT00052962|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30983|NCT00052715|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30984|NCT00052429|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30985|NCT00049543|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30986|NCT00049530|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30987|NCT00049517|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30988|NCT00049504|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30989|NCT00049322|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30990|NCT00049257|Principal Investigators are NOT employed by the organization sponsoring the study.|The obligations of confidentiality shall apply for a period of 5 yrs beyond termination of Agreement between Sponsor and Investigator,but do not apply to the extent information:is or later becomes known to public;is obtained from a third party without restriction who had a legal right to disclose;is possessed by Investigators,as demonstrated by recipient’s written records predating receipt from Sponsor;is required to be disclosed pursuant to a subpoena, law, regulation or other legal proceeding.
30991|NCT00049127|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30992|NCT00049036|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30993|NCT00048997|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30994|NCT00047385|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
30995|NCT00047320|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval.
30996|NCT00047008|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
30997|NCT00046930|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30998|NCT00046891|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
30999|NCT00046839|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31000|NCT00045734|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31001|NCT00045708|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31002|NCT00045630|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31003|NCT00045487|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31004|NCT00045435|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31005|NCT00045305|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31006|NCT00045162|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31007|NCT00045110|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31008|NCT00045032|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
31009|NCT00042991|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31010|NCT00042939|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31011|NCT00041132|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31012|NCT00041119|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31013|NCT00041080|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31014|NCT00041067|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31015|NCT00040937|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31016|NCT00040846|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31017|NCT00040742|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31018|NCT00039377|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31019|NCT00039195|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31020|NCT00039130|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval
31021|NCT00036738|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31022|NCT00033657|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31023|NCT00033631|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
31024|NCT00033540|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31025|NCT00033514|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31026|NCT00033371|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31027|NCT00033293|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior Sponsor approval
31028|NCT00031694|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31029|NCT00030901|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31030|NCT00030823|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31031|NCT00028769|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31032|NCT00028002|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31033|NCT00027846|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain sponsor approval.
31034|NCT00027560|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31035|NCT00026494|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31036|NCT00026312|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31037|NCT00026221|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31038|NCT00026208|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31039|NCT00025662|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31040|NCT00025506|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31041|NCT00025259|Principal Investigators are NOT employed by the organization sponsoring the study.|Must obtain prior approval.
31042|NCT00025233|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31043|NCT00025155|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31044|NCT00024258|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31045|NCT00024167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31046|NCT00024102|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31047|NCT00023764|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31068|NCT00011986|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31048|NCT00023712|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31049|NCT00022698|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
31050|NCT00022672|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
31051|NCT00022659|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31052|NCT00022633|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31053|NCT00022516|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31054|NCT00022490|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31055|NCT00021255|Principal Investigators are NOT employed by the organization sponsoring the study.|If no publication has occurred within 12 months of the completion of the study, the Investigator shall have the right to publish/present independently the results of the study. The Investigator shall provide the Sponsor with a copy of any such presentation/publication for comment at least 30 days before any presentation/submission for publication. If requested by the Sponsor, any presentation/submission shall be delayed up to 90 days, to allow the Sponsor to preserve its proprietary rights.
31056|NCT00021229|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31057|NCT00020722|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31058|NCT00019747|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31059|NCT00019682|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31060|NCT00019604|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31061|NCT00017563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31062|NCT00016913|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31063|NCT00016354|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31064|NCT00015847|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31065|NCT00014495|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31066|NCT00012298|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31067|NCT00012012|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
31069|NCT00010257|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31070|NCT00009945|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31071|NCT00008385|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31072|NCT00008138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31073|NCT00006916|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31074|NCT00006903|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31075|NCT00006721|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31076|NCT00006478|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31077|NCT00006392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31078|NCT00006389|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31079|NCT00006244|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31080|NCT00006237|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31081|NCT00006110|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31082|NCT00006101|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31083|NCT00006011|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31084|NCT00005957|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31085|NCT00005879|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31086|NCT00005803|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31087|NCT00005047|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31088|NCT00005044|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
31089|NCT00004888|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31090|NCT00004859|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31093|NCT00004143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31094|NCT00004092|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31095|NCT00004054|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
31096|NCT00003910|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31097|NCT00003901|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31098|NCT00003896|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31099|NCT00003875|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31100|NCT00003869|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31101|NCT00003820|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31102|NCT00003782|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31103|NCT00003702|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31104|NCT00003659|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31105|NCT00003641|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31106|NCT00003631|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31107|NCT00003590|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31108|NCT00003537|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31109|NCT00003535|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31110|NCT00003483|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31111|NCT00003479|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31112|NCT00003477|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31113|NCT00003476|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31114|NCT00003475|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31115|NCT00003474|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31116|NCT00003473|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31117|NCT00003472|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31118|NCT00003471|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31119|NCT00003470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31120|NCT00003469|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31121|NCT00003468|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31122|NCT00003460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31123|NCT00003459|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31124|NCT00003458|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31125|NCT00003457|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31126|NCT00003456|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31127|NCT00003453|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31128|NCT00003389|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31129|NCT00003377|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31130|NCT00003199|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31131|NCT00003138|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31132|NCT00002975|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31133|NCT00002931|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31134|NCT00002874|Principal Investigators are NOT employed by the organization sponsoring the study.|PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.
31135|NCT00002850|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31136|NCT00002842|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31137|NCT00002766|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31138|NCT00002651|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31139|NCT00002558|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31140|NCT00052078|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31141|NCT00051636|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial.
31142|NCT00051558|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31143|NCT00051363|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31144|NCT00051168|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31145|NCT00051025|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31146|NCT00050986|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31147|NCT00050960|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31148|NCT00050778|Principal Investigators are NOT employed by the organization sponsoring the study.|In multi-site studies, PI can publish after sponsor publishes or 18 months after study completion. PI gives sponsor a draft 60 days before publication. Sponsor can ask that confidential information be removed, and can defer publication another 60 days upon notifying PI that it will file a patent application on inventions contained in the draft.
31149|NCT00050622|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31150|NCT00050167|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31151|NCT00050089|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31152|NCT00050011|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
31153|NCT00049842|Principal Investigators are NOT employed by the organization sponsoring the study.|No public presentation/publication of any interim results will be made by any principal investigator (PI) or any other member of the study staff without the Sponsor's prior written consent. The PI further agrees to provide to the sponsor 30 days prior to submission, review copies that report any results of the study. The sponsor shall have the right to review, comment, and edit. If the parties disagree, the PI agrees to meet with the sponsor to discuss and resolve any such issues/disagreement.
31154|NCT00048932|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
31155|NCT00048815|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31156|NCT00048581|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
31157|NCT00048568|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
31158|NCT00048893|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31159|NCT00048737|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31160|NCT00048724|Principal Investigators are NOT employed by the organization sponsoring the study.|The investigator agrees to provide review copies to the sponsor 30 days prior to submission for publication or presentation. The sponsor shall have editorial rights and the right to review and comment on the data analysis and presentation. If the parties disagree, investigator agrees to meet with the sponsor's representatives for the purpose of making good faith efforts to discuss and resolve any such issues.
31161|NCT00048542|Principal Investigators are NOT employed by the organization sponsoring the study.|Abbott requests that any investigator or institution that plans on presenting/publishing results disclosure, provide written notification of their request 60 days prior to their presentation/publication. Abbott requests that no presentation/publication will be instituted until 12 months after a study is completed, or after the first presentation/publication whichever occurs first. A delay may be proposed of a presentation/publication if Abbott needs to secure patent or proprietary protection.
31162|NCT00048347|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31163|NCT00048165|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
31164|NCT00048074|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights
31165|NCT00048061|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights
31166|NCT00048048|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
31167|NCT00048035|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor’s intellectual property rights.
31168|NCT00047879|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31169|NCT00047697|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31170|NCT00047619|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31171|NCT00047463|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31172|NCT00046475|Principal Investigators are NOT employed by the organization sponsoring the study.|If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually.
31173|NCT00046566|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31174|NCT00046228|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31175|NCT00045942|Principal Investigators are NOT employed by the organization sponsoring the study.|The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety.
31176|NCT00044655|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31177|NCT00044512|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement between Sponsor and PI should be reached before publication
31178|NCT00044213|Principal Investigators are NOT employed by the organization sponsoring the study.|Enrolling Centers must abide by all TACT and NIH conflict of interest policies. Decisions about authorship on all multi-center publications resulting from research under this agreement will be made by the TACT Publica¬tions Committee prior to publication. No publications or other public disclosure shall be made until the TACT results are unblinded and results from all sites have been received and analyzed or TACT has been abandoned at all sites.
31179|NCT00044044|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31180|NCT00044005|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31181|NCT00043979|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31182|NCT00043550|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31183|NCT00043186|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
31184|NCT00042432|Principal Investigators are NOT employed by the organization sponsoring the study.|The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.
31185|NCT00042224|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31186|NCT00041938|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31187|NCT00041756|Principal Investigators are NOT employed by the organization sponsoring the study.|
31188|NCT00041717|Principal Investigators are NOT employed by the organization sponsoring the study.|Sponsor (Acorda) has right to review and comment on proposed publications within a specified time frame, up to 60 days; multi-center trials require joint publication unless specifically permitted otherwise.
31189|NCT00041470|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31190|NCT00040664|Principal Investigators are NOT employed by the organization sponsoring the study.|GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
31191|NCT00041392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31192|NCT00040365|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31193|NCT00039871|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31194|NCT00039741|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31195|NCT00038948|Principal Investigators are NOT employed by the organization sponsoring the study.|The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.
31196|NCT00038857|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31197|NCT00038727|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31198|NCT00038610|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31199|NCT00038467|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
31200|NCT00038103|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of < 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), < 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential info other than study results.
31201|NCT00037830|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31202|NCT00036569|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31203|NCT00036270|Principal Investigators are NOT employed by the organization sponsoring the study.|Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.
31204|NCT00035932|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
31205|NCT00035815|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31206|NCT00035555|Principal Investigators are NOT employed by the organization sponsoring the study.|Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period ≤60 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication.
31207|NCT00033917|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31208|NCT00032630|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31209|NCT00032591|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31210|NCT00032487|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31211|NCT00031551|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31212|NCT00031486|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31213|NCT00031460|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31214|NCT00031447|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31215|NCT00030992|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31216|NCT00030147|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31217|NCT00029536|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31218|NCT00029172|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31219|NCT00029146|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31220|NCT00029107|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31221|NCT00028262|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31222|NCT00028093|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31223|NCT00027378|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31224|NCT00027027|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
31225|NCT00025883|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31226|NCT00023595|Principal Investigators are NOT employed by the organization sponsoring the study.|The agreement is that all publications need to be reviewed and approved by the Policy and Publication Committee and the Sponsor prior to publication.
31227|NCT00023452|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31228|NCT00023322|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31229|NCT00023309|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31230|NCT00022763|Principal Investigators are NOT employed by the organization sponsoring the study.|The Study being conducted under this Agreement is part of the Overall Study. Investigator is free to publish in reputable journals or to present at professional conferences the results of the Study, but only after the first publication or presentation that involves the Overall Study. The Sponsor may request that Confidential Information be deleted and/or the publication be postponed in order to protect the Sponsor's intellectual property rights.
31231|NCT00016718|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
31232|NCT00014911|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31233|NCT00006604|Principal Investigators are NOT employed by the organization sponsoring the study.|In accordance with the Clinical Trials Agreement between NIAID (DAIDS) and company collaborators, NIAID (DAIDS) provides companies with a copy of any abstract, press release, or manuscript prior to submission for publication with sufficient time for company review and comment. The publication/other disclosure can be delayed for up to 30 additional business days for manuscripts and five (5) business days for abstracts, to preserve U.S. or foreign patent or other intellectual property rights.
31234|NCT00004978|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31235|NCT00021541|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31236|NCT00018031|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31237|NCT00015457|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31238|NCT00013611|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31239|NCT00010803|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31240|NCT00010439|Principal Investigators are NOT employed by the organization sponsoring the study.|Agreement with Merck: to submit a copy of any proposed abstract, manuscript and/or press release to Merck for review and comment at least 30 days prior to submission for publication or presentation.
31241|NCT00007644|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31242|NCT00007475|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31243|NCT00007345|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31244|NCT00006489|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31245|NCT00006409|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31246|NCT00006305|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31247|NCT00006289|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31248|NCT00006184|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31249|NCT00006178|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31250|NCT00006170|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31251|NCT00006156|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31252|NCT00006164|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31253|NCT00006151|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31254|NCT00005937|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31255|NCT00005908|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31256|NCT00005906|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31257|NCT00005901|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31258|NCT00005669|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31259|NCT00004980|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31260|NCT00004732|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31261|NCT00004635|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31262|NCT00004563|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31263|NCT00004562|Principal Investigators are NOT employed by the organization sponsoring the study.|The NIH Public Access Policy ensures that the public has access to the published results of NIH funded research. It requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital archive PubMed Central upon acceptance for publication. To help advance science and improve human health, the Policy requires that these papers are accessible to the public on PubMed Central no later than 12 months after publication.
31264|NCT00004547|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31265|NCT00001984|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31266|NCT00001962|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31267|NCT00001959|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31268|NCT00001941|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31269|NCT00000392|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31270|NCT00001832|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31271|NCT00001723|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31272|NCT00001703|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31273|NCT00001656|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31274|NCT00001596|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31275|NCT00001586|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31276|NCT00001575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31277|NCT00001566|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31278|NCT00001304|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31279|NCT00001262|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31280|NCT00001213|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31281|NCT00001151|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31282|NCT00000378|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31283|NCT00000371|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31284|NCT00000620|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31285|NCT00000575|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31286|NCT00000479|All Principal Investigators ARE employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31287|NCT00004500|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31288|NCT00004412|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31289|NCT00000143|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31290|NCT00000142|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31291|NCT00000136|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
31292|NCT00000135|Principal Investigators are NOT employed by the organization sponsoring the study.|
31293|NCT00000134|Principal Investigators are NOT employed by the organization sponsoring the study.|The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.
31294|NCT00000125|Principal Investigators are NOT employed by the organization sponsoring the study.|There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
